{
    "total_score": 6011,
    "score_ratio": 0.8194955691888207,
    "results": [
        {
            "query_idx": 1,
            "query": "What year was the first collection of cancer PDOs established, what are the primary sources of these samples, and which structural form do they closely mimic?",
            "retrieved_metrics": {
                "reference_idx": [
                    1728,
                    1739,
                    1974
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The first collection of cancer PDOs was reported in #2015#, derived mainly from #single biopsies# or tissue fragments, and they form a #three-dimensional# system replicating tumor characteristics accurately.",
            "predicted_answer": "The first collection of well-established cancer PDOs was reported in 2015. Primary sources are single biopsies or small fragments of surgically resected tissue. They closely mimic the three-dimensional, multicellular structure of human tumors.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts from the reference: it mentions the year 2015, primary sources as single biopsies or tissue fragments, and the resemblance to a three-dimensional multicellular structure. The meaning is consistent, with no omissions or contradictions."
        },
        {
            "query_idx": 2,
            "query": "What is the procedure for determining the interaction of compounds with a genetic mutation, and which specific animal models and environmental settings are used in the corresponding in vivo experiments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1113,
                    1140,
                    1141
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Compounds' interactions with #KRAS G12D mutation# are assessed using #IC50 ratio#. In vivo experiments use #female BALB/c and SCID male mice# under #sterile conditions with autoclaved food and acidified water#.",
            "predicted_answer": "To determine the interaction of compounds with a genetic mutation, in vitro experiments calculate IC50 values for both wild-type and mutant cell lines. In vivo experiments use immunodeficient SCID male mice for subcutaneous tumor models, housed in sterile conditions.",
            "score": 1,
            "explanation": "The predicted answer includes IC50 values and SCID male mice. However, it misses \"KRAS G12D mutation,\" the \"IC50 ratio,\" the use of \"female BALB/c mice,\" and the specific \"environmental settings\" like \"autoclaved food and acidified water.\" Thus, several key facts are missing."
        },
        {
            "query_idx": 3,
            "query": "Which enzyme's reduction enhances a chemotherapy drug's effectiveness in lung cancer and influences proliferation and resistance in other cancers, affecting therapeutic approaches?",
            "retrieved_metrics": {
                "reference_idx": [
                    1334,
                    1337,
                    1348
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #knockdown of CPT1A# enhances cisplatin sensitivity in lung cancer, may regulate #prostate cancer cell proliferation#, and supports #anoikis resistance and metastasis#, crucial for therapy advancement strategies.",
            "predicted_answer": "CPT1A's reduction enhances cisplatin's effectiveness in lung cancer and influences proliferation and resistance in other cancers, such as glioblastoma and prostate cancer, affecting therapeutic approaches.",
            "score": 1,
            "explanation": "The predicted answer correctly mentions CPT1A as an enzyme but does not explicitly mention \"knockdown,\" which is essential for the key fact. It accurately includes the aspect of proliferation, yet omits \"anoikis resistance and metastasis,\" impacting completeness."
        },
        {
            "query_idx": 4,
            "query": "What combination of technologies can be employed to effectively target and treat intracellular bacterial infections by overcoming resistance and ensuring precise delivery within host cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    37,
                    48,
                    41
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #phage therapy# involves creating #phage cocktails# for enhanced #therapeutic success# and leveraging #targeted intracellular delivery# to combat intracellular bacterial infections.",
            "predicted_answer": "Phage therapy, combined with phage cocktails and phage-based vaccines, can effectively target and treat intracellular bacterial infections by overcoming resistance and ensuring precise delivery within host cells.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference, such as phage therapy and phage cocktails, as well as the concept of targeted delivery within host cells. Although the predicted answer additionally mentions phage-based vaccines, it does not contradict the reference. Therefore, the completeness and alignment are maintained."
        },
        {
            "query_idx": 5,
            "query": "How does a specific protein associated with the APC/C complex contribute to cell-cycle regulation changes and their impact on cell proliferation and apoptosis in cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1557,
                    1559
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The protein #Ube2c# links with #APC/C#, leading to #enhanced cell-cycle regulation#; overexpression results in increased #proliferation# and reduced #apoptosis# in cancer cells.",
            "predicted_answer": "Ube2c, associated with the APC/C complex, polyubiquitinates proteins for degradation, influencing cell-cycle regulation. In cancer cells, Ube2c inhibits apoptosis and enhances proliferation, contributing to tumor growth.",
            "score": 5,
            "explanation": "The Predicted Answer covers all the key facts: the role of Ube2c with APC/C, its effects on cell-cycle regulation, proliferation, and apoptosis. It doesn't contradict the Reference Answer and aligns with the trend of Ube2c's role in cancer cells. No significant omissions or errors were found."
        },
        {
            "query_idx": 6,
            "query": "What innovation in cancer research is known for closely resembling human tumors, aiding drug development through enhanced understanding of tumor biology, and facing challenges due to financial and scalability issues?",
            "retrieved_metrics": {
                "reference_idx": [
                    1979,
                    1993,
                    1985
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#PDOs# replicate patient tumors, aiding in #drug development# by improving understanding of tumor biology. They face challenges like #financial and scalability issues#, limiting broader clinical application.",
            "predicted_answer": "Patient-derived organoids (PDOs) closely resemble human tumors, enhancing drug development and tumor biology understanding. However, they face challenges such as high costs and scalability issues.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts: #PDOs#, #drug development#, and #financial and scalability issues#. The overall meaning is consistent with the reference answer, capturing the innovation's role and challenges without any contradictions or significant omissions."
        },
        {
            "query_idx": 7,
            "query": "Why has modern cancer drug development moved away from traditional dose-escalation designs to incorporate pharmacogenomics, and pharmacodynamics in dose optimization?",
            "retrieved_metrics": {
                "reference_idx": [
                    695,
                    696
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Traditional designs lack #comprehensive clinical, PK, and PD data#, necessitating #pharmacogenomics, TDM, and pharmacodynamics# for effective dose optimization in cancer drug therapy development.",
            "predicted_answer": "Modern cancer drug development has shifted towards pharmacogenomics and pharmacodynamics because traditional dose-escalation designs, like the 3+3 method, lack robust evidence and do not collect adequate data for optimal dose selection. These new approaches allow for more personalized and effective treatments.",
            "score": 1,
            "explanation": "The predicted answer captures the modern shift in cancer drug development from traditional methods due to lack of comprehensive data, aligning with the reference. However, it misses key elements like therapeutic drug monitoring (TDM) and the specific roles of comprehensive clinical, PK, and PD data."
        },
        {
            "query_idx": 8,
            "query": "What roles do phages play in the delivery of genetic material for gene editing, precision targeting for cancer therapy, and the advancement of innovative oncological treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    5,
                    105,
                    74
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phages serve as #vectors for CRISPR-Cas systems#, enable #precision drug targeting# in cancer therapy, and represent significant #advances in phage-based therapies# through targeted delivery and immune system stimulation in oncological treatment.",
            "predicted_answer": "Phages play roles in gene editing by delivering genetic material, such as CRISPR-Cas systems, to specific cells. In cancer therapy, they are engineered to target tumor-specific markers, delivering therapeutic agents and stimulating anti-tumor immune responses, thus advancing innovative oncological treatments.",
            "score": 3,
            "explanation": "The Predicted Answer includes the key roles of phages in delivering CRISPR-Cas systems and targeting cancer-specific markers for innovative treatments. However, it misses the emphasis on phages as vectors for \"precision drug targeting\" specifically, which affects completeness."
        },
        {
            "query_idx": 9,
            "query": "How do phage-based vaccines interact with immune cells to activate responses, and what design strategies are employed to ensure they deliver antigens effectively for broad protection?",
            "retrieved_metrics": {
                "reference_idx": [
                    60,
                    61,
                    49
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phage-based vaccines activate immune responses by #interacting with pattern-recognition receptors#, #stimulating B cell clonal expansion#, and #using phages as antigen carriers# for effective delivery and broad protection.",
            "predicted_answer": "Phage-based vaccines activate immune responses by interacting with PRRs on APCs, facilitating antigen presentation, and stimulating T and B cell activation. Design strategies include integrating antigenic peptides into phages and using phage display systems for effective antigen delivery and broad protection.",
            "score": 3,
            "explanation": "The predicted answer covers the interaction with PRRs and the use of phages as antigen carriers, aligning with the reference. However, it omits the key fact of stimulating B cell clonal expansion. Therefore, it is generally aligned but missing one crucial detail affecting completeness."
        },
        {
            "query_idx": 10,
            "query": "What technology is utilized in drug discovery for accelerating therapeutic ligand identification, encounters challenges related to library diversity, and sees advancements in data analysis through computational methods?",
            "retrieved_metrics": {
                "reference_idx": [
                    88,
                    90,
                    91
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #phage-display technology# accelerates the #identification of therapeutic ligands#, faces challenges in #enhancing library diversity#, and benefits from #advanced algorithms# in data analysis.",
            "predicted_answer": "Phage-display technology is used in drug discovery for rapid ligand identification. It faces challenges with library diversity and benefits from advancements in data analysis through computational methods, enhancing the design of therapeutic antibodies.",
            "score": 5,
            "explanation": "The Predicted Answer accurately includes all the key facts from the Reference Answer: it mentions \"phage-display technology,\" \"identification of therapeutic ligands,\" \"library diversity,\" and \"computational methods.\" The coverage is comprehensive without contradictions, aligning with the overall trend."
        },
        {
            "query_idx": 11,
            "query": "How does the novel method utilize specific strategies and its inherent advantages to address the challenges associated with bacterial biofilms' protective environment?",
            "retrieved_metrics": {
                "reference_idx": [
                    28,
                    29,
                    40
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The approach involves using #phage therapy# to tackle #biofilm eradication challenges#, with #specificity, self-replication#, and #synergy# as key advantages.",
            "predicted_answer": "Phage-based treatments utilize bacteriophages to disrupt and penetrate biofilms, targeting specific bacterial strains. This approach enhances the accessibility of immune cells and can be combined with antibiotics for improved efficacy, offering a promising alternative to traditional antimicrobial therapies.",
            "score": 3,
            "explanation": "The predicted answer includes the use of phage-based treatments and addresses biofilms, aligning with the reference's emphasis on \"phage therapy\" and \"biofilm challenges\". It lacks explicit mention of \"self-replication\" and \"synergy,\" which impacts completeness."
        },
        {
            "query_idx": 12,
            "query": "What technological method started in the early 1980s that integrates a specific strategy to address the challenges of anti-cancer drug development?",
            "retrieved_metrics": {
                "reference_idx": [
                    137,
                    138,
                    214
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #computer-aided drug design# approach initiated in the 1980s effectively addresses #challenges# in anti-cancer drug development by incorporating #nanotechnology# as a precise strategy.",
            "predicted_answer": "Computer-aided drug design (CADD) is the technological method that started in the early 1980s to address the challenges of anti-cancer drug development.",
            "score": 3,
            "explanation": "The predicted answer mentions \"computer-aided drug design\" and its start in the early 1980s, aligning with the reference. However, it lacks the mention of \"nanotechnology\" being used as a precise strategy, a key fact in the reference answer."
        },
        {
            "query_idx": 13,
            "query": "Which compound demonstrates adequate solubility for therapeutic application, exhibits selective inhibition of a tumor model with the KRAS G12D mutation, and shows selectivity towards the PANC-1 cancer cell line?",
            "retrieved_metrics": {
                "reference_idx": [
                    1117,
                    1122,
                    1118
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Compound #14# has adequate solubility for use, demonstrates #selective# inhibition against the KRAS G12D mutation, and is selective toward the #PANC-1# cancer cell line.",
            "predicted_answer": "Compound 14 demonstrates adequate solubility, selective inhibition of the KRAS G12D tumor model, and selectivity towards the PANC-1 cancer cell line.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts from the Reference Answer: \"Compound 14,\" \"adequate solubility,\" \"selective inhibition of the KRAS G12D tumor model,\" and \"selectivity towards the PANC-1 cancer cell line.\" It fully reflects the meaning and details of the Reference Answer."
        },
        {
            "query_idx": 14,
            "query": "What advanced technologies are pivotal in enhancing patient-derived organoid (PDO) models, and what are the specific challenges these technologies face concerning PDOs' scalability and tumor-stroma interaction replication?",
            "retrieved_metrics": {
                "reference_idx": [
                    1992,
                    1997,
                    1991
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Technologies like #single-cell analysis#, #organ-on-a-chip models#, #AI tools#, and #microfluidics# propel PDOs by reflecting tumor heterogeneity. Yet, hurdles include #cost#, #scalability#, and replicating #tumor-stroma interactions#.",
            "predicted_answer": "Single-cell analysis, organ-on-a-chip models, and AI-driven tools are pivotal in enhancing PDOs. Challenges include scalability, cost, and accurately replicating tumor-stroma interactions. Microfluidics can help address some of these by enabling real-time drug interaction assessments.",
            "score": 5,
            "explanation": "The predicted answer captures all key technologies (single-cell analysis, organ-on-a-chip models, AI tools) and challenges (cost, scalability, and replicating tumor-stroma interactions) mentioned in the reference answer, including microfluidics. The meaning and trend align with no significant omissions or contradictions."
        },
        {
            "query_idx": 15,
            "query": "What diagnostic tool is included in the classification of a major health organization, capable of reclassifying cases, and is implemented in various countries for enhanced diagnostics?",
            "retrieved_metrics": {
                "reference_idx": [
                    515,
                    519,
                    518
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#DNA methylation profiling# is a diagnostic tool in the #World Health Organization# classification, allowing for #reclassification of cases#, and is #globally implemented# to enhance diagnostic accuracy.",
            "predicted_answer": "DNA methylation-based classification, included in the WHO classification of CNS tumors, is a diagnostic tool that can reclassify cases and is being implemented in various countries to enhance diagnostic precision.",
            "score": 5,
            "explanation": "The 'Predicted Answer' covers all key facts such as \"DNA methylation-based classification,\" \"WHO classification,\" \"reclassification of cases,\" and \"implemented in various countries.\" The wording differs slightly, but the meaning and important details align with the 'Reference Answer.'"
        },
        {
            "query_idx": 16,
            "query": "What specific features make epidrugs advantageous in cancer treatment, considering their target enzymes, mechanisms of action like cell cycle impacts, and the significance of epigenetic change reversibility?",
            "retrieved_metrics": {
                "reference_idx": [
                    537,
                    540,
                    465
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Epidrugs utilize #target enzymes# for #epigenetic regulation#, produce #antitumor effects# via #cell cycle arrest#, and owe their efficiency to the #reversibility# of epigenetic changes as #drug targets#.",
            "predicted_answer": "Epidrugs target enzymes that modify epigenetic marks, impacting cell cycle, differentiation, and apoptosis. Their ability to reverse epigenetic changes, unlike irreversible genetic mutations, makes them advantageous in cancer treatment. They also enhance antitumor immune responses.",
            "score": 3,
            "explanation": "The predicted answer mentions the #target enzymes#, the role of #epigenetic changes#, and the #reversibility# in epigenetic changes for cancer treatment. However, it does not explicitly mention #cell cycle arrest# as a mechanism for antitumor effects, focusing instead on apoptosis and immune response."
        },
        {
            "query_idx": 17,
            "query": "What is the difference in electron affinity between N-ethyl toluene-4-sulphonamide and 2,5-Dichlorothiophene-3-sulfonamide, which component mainly influences a critical orbital in the former, and how do their potential maps differ?",
            "retrieved_metrics": {
                "reference_idx": [
                    227,
                    228,
                    226
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #electrophilicity index# for 8a is 0.110 eV and 0.161 eV for 8b, showing 8b has higher electron affinity. The #sulphonamide group# mainly influences 8a’s HOMO. Their #electrostatic potential# maps show varied electron attraction areas.",
            "predicted_answer": "2,5-Dichlorothiophene-3-sulfonamide has a higher electron affinity. In N-ethyl toluene-4-sulphonamide, the sulphonamide group mainly influences the HOMO. The potential maps show red areas with high electron-attracting potential due to oxygen atoms, and blue areas with lower electron-donating potential due to hydrogen atoms.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies that 2,5-Dichlorothiophene-3-sulfonamide has a higher electron affinity and that the sulphonamide group influences N-ethyl toluene-4-sulphonamide's HOMO. However, it lacks specific values for the electrophilicity index and does not describe the varied electron attraction areas clearly as electrostatic potential maps."
        },
        {
            "query_idx": 18,
            "query": "What are the key issues related to racial and ethnic minority participation in phase 1 cancer trials, considering challenges in trial access, reporting practices, and demographic enrollment disparities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1429,
                    1438,
                    1426
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The study identifies worsening #disparities# in trial access for minority groups, significant #limitations# in race/ethnicity reporting, and persistent #demographic disparities# in phase 1 cancer trial enrollment.",
            "predicted_answer": "Key issues include worsening disparities in minority participation, lack of reporting on race and ethnicity, and systemic biases affecting access to trial sites. These challenges limit the generalizability of safety and efficacy findings across diverse populations.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts of worsening disparities, lack of reporting on race/ethnicity, and demographic enrollment disparities. All emphasized points in the reference answer are reflected in the predicted answer with no significant omissions or contradictory information present."
        },
        {
            "query_idx": 19,
            "query": "What measurement in 3D organoid analysis is linked to a certain cellular aspect, and which software platform uses an advanced neural network for tracking these structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1759,
                    1760
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The 3D organoid's #volume# correlates with #live cell count#, and #OrganoID# uses a #convolutional neural network# for enhanced tracking.",
            "predicted_answer": "Volume is linked to the live cell count in 3D organoid analysis. OrganoID, a software platform using a convolutional neural network, tracks these structures.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the linked measurement (volume), the related cellular aspect (live cell count), and the software platform (OrganoID) using the technology (convolutional neural network). All key facts are present, aligned, and contain no significant omissions or contradictions."
        },
        {
            "query_idx": 20,
            "query": "What technology facilitates expression of biological molecules, necessitates precise engineering for targeting, and requires overcoming significant regulatory challenges in its medical applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    1,
                    103,
                    106
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Phage display technology# expresses biological molecules, involving #precise phage engineering# for targeting, and faces #significant regulatory challenges# to ensure its medical application safety and efficacy.",
            "predicted_answer": "Phage display technology facilitates the expression of biological molecules, requires precise engineering for targeting, and faces significant regulatory challenges in medical applications.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer, covering all key aspects such as phage display technology, precise engineering, and regulatory challenges. The meaning is consistent with no significant omissions or errors. Key facts are present and trends are aligned."
        },
        {
            "query_idx": 21,
            "query": "How are combinations of specific drugs altering lung cancer treatments, considering their mechanisms and recent progress, including clinical evaluations and paradigm shifts in approvals for use in non-small cell lung cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    165,
                    212,
                    164
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Lung cancer treatments are being transformed by #ADCs#, with recent #Patritumab deruxtecan# and #telisotuzumab vedotin# evaluations, and a pivotal #Trastuzumab deruxtecan# approval for #NSCLC# indicating a paradigm shift.",
            "predicted_answer": "Recent progress in lung cancer treatment includes the use of antibody-drug conjugates (ADCs) like trastuzumab deruxtecan, which has been FDA-approved for NSCLC. ADCs, either alone or in combination, are showing transformative potential, with ongoing clinical trials evaluating their efficacy and safety.",
            "score": 3,
            "explanation": "The predicted answer covers key concepts like ADCs and the approval of Trastuzumab deruxtecan for NSCLC, aligning with the reference's trends. However, it omits Patritumab deruxtecan and telisotuzumab vedotin evaluations, which are crucial details, impacting completeness."
        },
        {
            "query_idx": 22,
            "query": "How do spheroids with significant size model complex tumor environments, and what roles do diverse cell types play in their structural and functional variations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1713,
                    1715,
                    1720
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Spheroids larger than #500 µm# effectively model complex tumor environments with a #layered structure#. Their structure and functions are shaped by #cell type variations# in #heterotypic spheroids#.",
            "predicted_answer": "Spheroids with significant size model complex tumor environments by forming layers that mimic in vivo avascular tumors, including proliferating, quiescent, and necrotic regions. Diverse cell types in heterotypic spheroids, such as cancer-associated fibroblasts and immune cells, contribute to structural and functional variations, enhancing the simulation of tumor-stromal interactions and drug resistance.",
            "score": 3,
            "explanation": "The predicted answer accurately reflects the reference by including the concept of spheroids modeling complex environments through layered structures and diverse cell types like fibroblasts and immune cells contributing to structural variations. However, it omits the specific size key fact of \"#500 µm#.\""
        },
        {
            "query_idx": 23,
            "query": "What interactions are involved in stabilizing a DNA-ligand compound, and which protein-ligand complex shows the highest hydrogen bond energy?",
            "retrieved_metrics": {
                "reference_idx": [
                    248,
                    249,
                    255
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #DNA-Doxorubicin# complex is stabilized by #hydrogen bonds# and #hydrophobic interactions#, and the #p53-Doxorubicin# complex exhibits the highest hydrogen bond energy.",
            "predicted_answer": "Hydrogen bonds and hydrophobic interactions stabilize the DNA-Doxorubicin complex. The p53-Doxorubicin complex shows the highest hydrogen bond energy at -420.2 kcal/mol.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by identifying both the DNA-Doxorubicin complex's stabilization through hydrogen bonds and hydrophobic interactions, and the p53-Doxorubicin complex as having the highest hydrogen bond energy. All key points marked with # in the reference are present in the predicted answer."
        },
        {
            "query_idx": 24,
            "query": "Which signaling axis involving a specific protein is associated with radiation resistance, is overexpressed in acute myeloid leukemia indicating poor prognosis, and is a proposed treatment target in breast, prostate, and colon cancers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1340,
                    1342,
                    1326
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #CPT1A# protein is linked to the #PGC1α/CEBPB/CPT1A/FAO signaling axis# for radiation resistance, overexpressed in #AML# indicating poor prognosis, and targeted in #breast#, #prostate#, and #colon cancer#.",
            "predicted_answer": "The CPT1A signaling axis is associated with radiation resistance, overexpressed in acute myeloid leukemia indicating poor prognosis, and proposed as a treatment target in breast, prostate, and colon cancers.",
            "score": 3,
            "explanation": "The Predicted Answer captures the key elements: \"CPT1A,\" its relation to radiation resistance, its overexpression in AML, and its targeting in breast, prostate, and colon cancers. However, the specific signaling axis \"PGC1α/CEBPB/CPT1A/FAO\" is not mentioned, slightly affecting completeness."
        },
        {
            "query_idx": 25,
            "query": "How do recent advancements in cancer research models overcome the limitations of traditional laboratory and live animal methods, and what technological innovations support these improvements?",
            "retrieved_metrics": {
                "reference_idx": [
                    1964,
                    1968,
                    1973
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Recent cancer research improvements have overcome limitations of #traditional in vitro# and #in vivo models# through #patient-derived organoids# and technological advancements like #3D bioprinting#.",
            "predicted_answer": "Recent advancements in cancer research, such as patient-derived organoids (PDOs), overcome the limitations of traditional methods by better replicating human tumor biology. Technological innovations like 3D bioprinting, synthetic hydrogels, and microfluidic systems support these improvements, providing more accurate and personalized models.",
            "score": 3,
            "explanation": "The predicted answer includes key facts about overcoming limitations with patient-derived organoids and technological innovations like 3D bioprinting, consistent with the reference answer. However, it misses the explicit mention of \"traditional in vitro and in vivo models,\" which affects completeness slightly."
        },
        {
            "query_idx": 26,
            "query": "Which types of cancer are being targeted by phage therapy, and why are research efforts essential for advancing these treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    71,
                    72,
                    67
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phage therapy targets #solid tumors# and #hematological malignancies#. Conducting #clinical trials# is essential to advance these treatments by addressing limitations and realizing their full potential.",
            "predicted_answer": "Phage therapy is being explored for solid tumors like breast, lung, and colon cancers, as well as hematological malignancies. Research efforts are essential to enhance immune responses, improve tumor targeting, and integrate phage-based therapies with conventional treatments, advancing their efficacy and safety.",
            "score": 3,
            "explanation": "The predicted answer covers the target of phage therapy in both solid tumors and hematological malignancies. It emphasizes the need for enhancing immune responses and improving therapy, aligning with the need for advanced research. However, it misses the explicit mention of \"conducting clinical trials\" from the reference."
        },
        {
            "query_idx": 27,
            "query": "How do FDA regulatory processes for expedited drug development utilize special designations in diseases with unmet needs, and what impact do these designations have on the approval timing of cancer treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    641,
                    1892,
                    631
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The FDA's #five review programs# expedite drug development for #diseases with unmet needs#, significantly enhancing the #approval speed of cancer treatments# targeting these conditions.",
            "predicted_answer": "The FDA uses special designations like orphan, fast track, accelerated approval, priority review, and breakthrough therapy to expedite the development and approval of drugs for diseases with unmet needs. These designations can significantly reduce the approval time for cancer treatments.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of the FDA's use of special designations to expedite drug approval and mentions several designations. It aligns with the reference, emphasizing expedited processes for unmet needs and cancer treatment approval speed. No significant omissions are present."
        },
        {
            "query_idx": 28,
            "query": "What clinical trial model aims to enhance logistics and efficiency by promoting broader patient participation and improving remote data handling techniques?",
            "retrieved_metrics": {
                "reference_idx": [
                    1843,
                    1847,
                    1845
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #decentralized trials# model focuses on #patient-centricity# to boost participation, tackle access barriers, and enhance #remote data collection#, improving logistics and efficiency in cancer trials.",
            "predicted_answer": "Decentralized clinical trials (DCTs) aim to enhance logistics and efficiency by promoting broader patient participation and improving remote data handling techniques, reducing patient burden and increasing flexibility.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies \"decentralized clinical trials\" and mentions \"broader patient participation\" and \"improving remote data handling,\" which aligns well with the reference's focus on enhancing logistics and efficiency. However, it misses the specific term \"patient-centricity.\""
        },
        {
            "query_idx": 29,
            "query": "What effects does B7-H3 expression have on cancer metastasis, treatment resistance, and immune evasion, and how do these effects relate to potential anti-cancer therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1358,
                    1364,
                    1350
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The expression of #B7-H3# enhances cancer metastasis; it induces #treatment resistance# and helps cancers evade immunity, making it a #target for anti-cancer therapies#.",
            "predicted_answer": "B7-H3 expression promotes cancer metastasis, treatment resistance, and immune evasion by enhancing tumor proliferation and reducing glycolytic capacity. It is associated with poor patient prognosis and has emerged as a promising target for anti-cancer therapies.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference: B7-H3 expression promotes cancer metastasis, induces treatment resistance, helps in immune evasion, and is a potential target for anti-cancer therapies. While phrasing differs, all important details are adequately covered."
        },
        {
            "query_idx": 30,
            "query": "What is the shared duration between a type of market protection granted in the EU and a statistic about anticancer drugs, and how are these connected to orphan designation issues with biomarker-based subgroups?",
            "retrieved_metrics": {
                "reference_idx": [
                    1920,
                    1921,
                    1064
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The EU grants a #10-year marketing exclusivity# period, matching the #10-year challenge# of records for #294 orphan-designated anticancer drugs#, highlighting issues with #biomarker-based subgroup# EMA orphan designations.",
            "predicted_answer": "The shared duration is 10 years for EMA's market exclusivity and 7 years for FDA's. These are connected to orphan designation issues as the EMA rarely agrees with the FDA on biomarker-based subgroups, affecting eligibility and exclusivity periods.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the shared 10-year market exclusivity in the EU and mentions issues with biomarker-based subgroup designations. However, it misses the specific detail of \"294 orphan-designated anticancer drugs.\" Overall, it aligns with the reference but lacks one key fact."
        },
        {
            "query_idx": 31,
            "query": "What are the necessary regulatory requirements and standardization protocols needed for the international approval and clinical implementation of phage therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    26,
                    94,
                    98
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The international approval of phage therapy requires adherence to #regulatory and safety standards from FDA and EMA#, establishing #standardized protocols# for production, and developing #harmonized global approval standards#.",
            "predicted_answer": "For international approval and clinical implementation of phage therapy, stringent regulatory and safety standards must be met. This includes rigorous testing for safety, purity, and efficacy, adherence to guidelines from the FDA and EMA, and conducting well-designed clinical trials. Standardization of protocols and harmonizing global standards are also essential.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts including adherence to FDA and EMA standards, the need for standardized protocols, and harmonizing global standards, aligning with the reference answer. It effectively conveys the regulatory and safety requirements for phage therapy approval."
        },
        {
            "query_idx": 32,
            "query": "What is the name of the environment involved in cancer growth and drug response variation, and what are its primary cellular components?",
            "retrieved_metrics": {
                "reference_idx": [
                    1487,
                    1711,
                    385
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #tumor microenvironment (TME)#, with its #heterogeneous cell populations#, plays a crucial role in impacting both #tumor growth# and #drug response#.",
            "predicted_answer": "The environment involved is the Tumor Microenvironment (TME). Its primary cellular components include malignant cells, cancer-associated fibroblasts, stem cells, endothelial cells, and various immune cells.",
            "score": 3,
            "explanation": "The Predicted Answer identifies the \"tumor microenvironment\" (TME) and lists its cellular components, reflecting the Reference Answer's emphasis on \"heterogeneous cell populations.\" While it doesn't explicitly mention \"tumor growth\" and \"drug response,\" these are implied by \"cancer growth and drug response variation.\""
        },
        {
            "query_idx": 33,
            "query": "What is a specialized method employed to combat multidrug-resistant bacteria, improved through genetic modifications and combined treatments, and associated with addressing a significant number of annual global deaths?",
            "retrieved_metrics": {
                "reference_idx": [
                    4,
                    27,
                    16
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Phage therapy# targets #MDR bacteria#, enhanced by #genetic engineering# and #combination with antibiotics#, potentially mitigating #700,000 annual deaths# linked to antibiotic resistance.",
            "predicted_answer": "Phage therapy is a specialized method to combat multidrug-resistant bacteria. It involves genetically modified phages and can be combined with antibiotics for enhanced efficacy, addressing a significant number of annual global deaths caused by antibiotic resistance.",
            "score": 3,
            "explanation": "The predicted answer covers phage therapy, its role against MDR bacteria, enhancement via genetic modifications, and combination with antibiotics. However, it lacks the specific detail of #700,000 annual deaths#, which affects completeness. The key trends are aligned with no contradictions."
        },
        {
            "query_idx": 34,
            "query": "What metric is utilized to assess the impact of consuming a specific plant leaf on lipid levels, and what additional evaluation is necessary regarding safety despite observed non-toxicity in animals?",
            "retrieved_metrics": {
                "reference_idx": [
                    330,
                    331,
                    336
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The consumption of #R. chingii Hu leaf# shows an #effective rate# reduction in lipid levels. However, further #safety evaluation# is needed despite no animal toxicity observed.",
            "predicted_answer": "The metric used to assess the impact on lipid levels is the total effective rate of reducing blood lipids, which was 80.4%. Despite observed non-toxicity in animals, additional long-term safety and toxicology studies are necessary.",
            "score": 3,
            "explanation": "The predicted answer aligns generally with the reference but lacks specific mention of #R. chingii Hu leaf#. It captures the effective rate reduction and the need for further safety evaluation. The absence of the specific plant name impacts completeness, leading to a missing key fact affecting the score."
        },
        {
            "query_idx": 35,
            "query": "What types of patient-derived models are utilized for testing the efficacy of anticancer agents, predicting individual patient treatment responses, and guiding personalized treatment selection?",
            "retrieved_metrics": {
                "reference_idx": [
                    1717,
                    1794,
                    1462
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Spheroids# are used for #testing anticancer agents# and for #predicting individual treatment responses#, while #organoids# assist in #guiding personalized treatment selection#.",
            "predicted_answer": "Patient-derived models, such as spheroids and organoids, are used to test anticancer agents, predict individual treatment responses, and guide personalized treatment. These models maintain the original tumor's characteristics, allowing for more accurate efficacy testing and response prediction.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes spheroids and organoids, aligning with the 'Reference Answer', mentioning their uses in testing anticancer agents, predicting treatment responses, and guiding personalized treatment. Key facts marked by # are present; no significant omissions or inconsistencies are present."
        },
        {
            "query_idx": 36,
            "query": "What are the primary challenges siRNA therapies face in moving from development to clinical implementation, considering their commercial progress and inherent pharmaceutical limitations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2118,
                    2122,
                    2128
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "siRNA therapies encounter the #three 'E' challenges#, involving #commercialization efforts# and #low bioavailability and rapid clearance#.",
            "predicted_answer": "The primary challenges for siRNA therapies include targeted accumulation and cellular uptake (entry), endolysosomal escape (escape), and in vivo pharmaceutical performance (efficacy). These issues limit their clinical translation despite commercial progress.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference by mentioning challenges like targeted accumulation (entry) and endolysosomal escape (escape), consistent with the reference's 'three E challenges'. However, it misses 'commercialization efforts' and 'low bioavailability and rapid clearance', affecting completeness."
        },
        {
            "query_idx": 37,
            "query": "What are the advantages of focusing on a particular enzyme type for drug repurposing in cancer treatment, considering the diversity in original drug uses and the enzyme's specific role in oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1821,
                    1838,
                    1844
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Focusing on #kinase binding sites# for drug repurposing offers #advantages# due to #variations in initial uses and targets# and their crucial #role and abundance in cancer therapy#.",
            "predicted_answer": "Focusing on a particular enzyme type, like kinases, for drug repurposing in cancer treatment leverages their fundamental role in cell regulation and the promiscuous nature of their binding sites, increasing the likelihood of identifying effective inhibitors from existing therapeutics.",
            "score": 3,
            "explanation": "The predicted answer mentions focusing on kinase binding sites for drug repurposing and highlights their role in cell regulation, aligning with the reference's emphasis on kinase sites. However, it does not fully address the 'variations in initial uses and targets' and 'abundance in cancer therapy,' key facts in the reference."
        },
        {
            "query_idx": 38,
            "query": "How is the combination of phage therapy and antibiotics used to treat bacterial infections, and through what mechanisms does it enhance efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    23,
                    25,
                    43
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #phage-antibiotic therapy# enhances treatment efficacy against #resistant bacterial infections# through #synergistic bacterial lysis# and #immune response modulation#.",
            "predicted_answer": "The combination of phage therapy and antibiotics enhances efficacy by reducing bacterial load, restoring antibiotic sensitivity, and modulating host immune responses. This synergistic effect is particularly useful in treating multidrug-resistant infections, as seen in studies with Pseudomonas aeruginosa and Mycobacterium abscessus.",
            "score": 3,
            "explanation": "The predicted answer covers key aspects like phage-antibiotic therapy enhancing efficacy, immune response modulation, and resistance to bacterial infections. However, it lacks explicit mention of \"synergistic bacterial lysis.\" The presence of multidrug-resistant examples illustrates the trend well, but the missing detail about lysis affects completeness."
        },
        {
            "query_idx": 39,
            "query": "How do physiologically based quantitative systems pharmacology (QSP) models facilitate decision-making in oncology drug development, particularly from early trials to later optimization using real-world data integration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1607,
                    1615,
                    1623
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Physiologically based #QSP models# inform drug development decisions, enhance #early dose/regimen evaluation#, and #refine dose optimization# post-first-in-human studies with real-world data integration for effective trials.",
            "predicted_answer": "QSP models facilitate decision-making in oncology drug development by informing dose selection, especially in early trials, and supporting dose optimization using real-world data. They help integrate mechanistic understanding with clinical outcomes, aiding in the evaluation of therapeutic index and efficacy in different patient populations.",
            "score": 3,
            "explanation": "The predicted answer includes key elements such as QSP models informing dose selection and optimization, and the integration of real-world data. However, it misses the emphasis on \"early dose/regimen evaluation\" as found in the reference. Overall, the trend aligns but lacks one key detail."
        },
        {
            "query_idx": 40,
            "query": "How do computational technologies assist in the development of anticancer drugs and the customization of cancer treatments according to both genetic profiles and environmental factors?",
            "retrieved_metrics": {
                "reference_idx": [
                    124,
                    1215,
                    113
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #AI# accelerates drug discovery, predicts #treatment response#, and employs #machine learning# to identify treatment patterns specific to genetic and environmental factors.",
            "predicted_answer": "Computational technologies, especially AI and machine learning, analyze genomic and molecular data to identify cancer cell vulnerabilities, predict treatment responses, and tailor therapies to individual genetic profiles and environmental factors, enhancing drug development and personalized cancer treatments.",
            "score": 5,
            "explanation": "The predicted answer covers key elements such as the use of AI and machine learning, prediction of treatment responses, and customization based on genetic and environmental factors. It aligns with the reference, capturing the essence and purpose of computational technologies in cancer treatment development."
        },
        {
            "query_idx": 41,
            "query": "What combination of technologies enhances the structural analysis of complex biological macromolecules and boosts the data processing in drug development?",
            "retrieved_metrics": {
                "reference_idx": [
                    877,
                    878
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The combination of #cryo-EM# and #AI# enhances the structural analysis of biological macromolecules and accelerates data processing in drug development.",
            "predicted_answer": "Cryo-EM and AI enhance the structural analysis of complex biological macromolecules. AI accelerates data processing, predicts protein conformations, and evaluates drug efficacy, significantly speeding up drug development.",
            "score": 5,
            "explanation": "The predicted answer clearly includes both key technologies, \"cryo-EM\" and \"AI,\" identified in the reference answer. It also aligns with the overall purpose regarding enhancing structural analysis and accelerating data processing in drug development. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 42,
            "query": "What innovative approach in drug development uses a model to evaluate drug efficacy and toxicity, simulates organ architecture for therapeutic research, and identifies genomic alterations for individualized treatment plans?",
            "retrieved_metrics": {
                "reference_idx": [
                    1965,
                    1967,
                    1982
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #PDOs# provides a predictive model for #evaluating drug efficacy and toxicity#, mimics organ functions in #cancer research#, and identifies genomic alterations for #personalized cancer treatment# plans.",
            "predicted_answer": "Patient-derived organoids (PDOs) are an innovative approach in drug development. They simulate organ architecture, evaluate drug efficacy and toxicity, and identify genomic alterations for personalized treatment plans.",
            "score": 3,
            "explanation": "The predicted answer effectively conveys the role of PDOs in simulating organ architecture, evaluating drug efficacy and toxicity, and identifying genomic alterations for personalized treatment plans. However, it omits the specific context of cancer research and personalized cancer treatment, which are emphasized in the reference answer."
        },
        {
            "query_idx": 43,
            "query": "What method is essential across all drug development paths, how many repurposed drugs entered clinical phases from 2012 to 2017, and in what disease area is drug repurposing critically impactful?",
            "retrieved_metrics": {
                "reference_idx": [
                    1822,
                    1825,
                    2231
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The required method is #structure-activity relationships#. Almost #72% of 170 repurposed drugs# entered clinical phases from 2012 to 2017. Drug repurposing plays a critical role in #cancer therapy#.",
            "predicted_answer": "Establishing efficacy for the therapeutic target is essential across all drug development paths. From 2012 to 2017, 170 repurposed drugs entered the pipeline, with 72% in clinical phases. Drug repurposing is critically impactful in cancer therapy.",
            "score": 3,
            "explanation": "The Predicted Answer correctly identifies cancer therapy as a critical area for drug repurposing and gives the percentage of repurposed drugs entering clinical phases. However, it incorrectly states the essential method as \"establishing efficacy\" instead of \"structure-activity relationships.\" Thus, it misses one key fact."
        },
        {
            "query_idx": 44,
            "query": "What is the method used in cancer treatment that involves disrupting critical genetic dependencies and employs compounds that act across several similar genetic targets?",
            "retrieved_metrics": {
                "reference_idx": [
                    1927,
                    1928,
                    1960
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The approach involves #synthetic lethality# by disrupting crucial #dependencies between gene paralogs#, employing inhibitors that target #multiple associated paralogs# in cancer therapy.",
            "predicted_answer": "The method used in cancer treatment that involves disrupting critical genetic dependencies and employs compounds that act across several similar genetic targets is known as targeting synthetic lethal paralogs. This approach exploits the sensitivity of cells with a mutation in one gene to the inhibition of another, often using drugs that inhibit multiple paralogs simultaneously.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key concepts emphasized in the reference: \"synthetic lethality,\" \"dependencies between gene paralogs,\" and \"targeting multiple associated paralogs.\" It is aligned in meaning without contradictions, effectively capturing the core ideas."
        },
        {
            "query_idx": 45,
            "query": "What strategies must be implemented for the clinical use of phages to protect them from environmental stresses, ensure safety and efficacy, and explore their potential in cancer therapy and vaccine delivery?",
            "retrieved_metrics": {
                "reference_idx": [
                    79,
                    86,
                    87
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Implement #protective measures and concentration strategies# for phages, conduct #rigorous safety, pharmacokinetics, and efficacy testing#, and explore phages in #targeted cancer therapy and vaccine delivery#.",
            "predicted_answer": "To protect phages from environmental stresses, encapsulation in nano/micro formulations and concentration strategies are essential. For safety and efficacy, rigorous clinical testing is required. In cancer therapy and vaccine delivery, phage vectors can be engineered to deliver targeted therapies and enhance immune responses.",
            "score": 5,
            "explanation": "The predicted answer includes protective measures, encapsulation, concentration strategies, and rigorous clinical testing, aligning with the reference. It also mentions phages in cancer therapy and vaccine delivery, matching all the emphasized points. The trends align well without missing key facts."
        },
        {
            "query_idx": 46,
            "query": "What system utilizes filamentous structures to present foreign antigens and is highly regarded for its roles against a variety of pathogens and in novel vaccine development?",
            "retrieved_metrics": {
                "reference_idx": [
                    52,
                    56,
                    62
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #phage-display systems# use #filamentous phages# like M13 to present #foreign antigens#, enhancing immune response and effectively targeting #bacterial, viral pathogens#, and promising in #cancer immunotherapy#.",
            "predicted_answer": "Phage-display systems, particularly filamentous phages like M13 and T7, are used to present foreign antigens on their surface, enhancing immune responses and making them valuable for vaccine development against diverse pathogens.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions \"phage-display systems,\" \"filamentous phages like M13,\" and \"foreign antigens,\" aligning with the reference key facts. However, it omits critical details like targeting \"bacterial, viral pathogens\" and being \"promising in cancer immunotherapy,\" affecting completeness."
        },
        {
            "query_idx": 47,
            "query": "What specific transformation in the pancreatic tumor microenvironment obstructs drug delivery, and what approach targets this blockage by altering the extracellular matrix?",
            "retrieved_metrics": {
                "reference_idx": [
                    387,
                    406,
                    386
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The obstruction is due to a #dense fibrotic stroma#, which limits drug delivery. The strategy involves #ECM remodeling# to penetrate the #fibrotic capsule# that blocks access.",
            "predicted_answer": "The dense fibrotic stroma, primarily formed by cancer-associated fibroblasts and pancreatic stellate cells, obstructs drug delivery. Approaches targeting this blockage include using metalloproteinases to degrade the extracellular matrix, thus improving drug access.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the obstruction caused by the dense fibrotic stroma and mentions an approach to alter the extracellular matrix, aligning with the reference. However, it does not explicitly describe ECM remodeling as the strategy to penetrate the fibrotic capsule."
        },
        {
            "query_idx": 48,
            "query": "How does DSF influence cancer cell glycolysis through metal interaction, and what key molecular expression changes occur as a result of this influence?",
            "retrieved_metrics": {
                "reference_idx": [
                    781,
                    782
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "DSF affects cancer cell glycolysis through a #copper-dependent# process and reduces expression of S6K1, MYC, impacting #cellular mechanisms# like apoptosis and cell metabolism.",
            "predicted_answer": "DSF inhibits cancer cell glycolysis in a copper-dependent manner, reducing the expression of key molecules like S6K1, MYC, GLUT1, PKM2, and LDHA, which are crucial for cellular metabolism and survival.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the #copper-dependent# process and lists several key molecules (S6K1, MYC) but adds additional molecules (GLUT1, PKM2, LDHA) not specified in the reference, affecting #cellular mechanisms# like metabolism. However, it omits \"apoptosis,\" slightly affecting completeness."
        },
        {
            "query_idx": 49,
            "query": "How does a technology-focused approach in drug design address the challenges of compound diversity and efficiency introduced by high-throughput screening and emerging computational methods?",
            "retrieved_metrics": {
                "reference_idx": [
                    148,
                    147
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Fragment-based drug design (FBDD)# tackles compound diversity issues while benefiting from #speed acceleration in drug discovery through emerging technologies# like high-throughput screening and combinatorial chemistry.",
            "predicted_answer": "A technology-focused approach, such as fragment-based drug design (FBDD), addresses compound diversity and efficiency by starting with small molecular fragments. This reduces the screening library size, enhances structural diversity, and mitigates undesirable ADMET properties, making it more efficient and cost-effective.",
            "score": 3,
            "explanation": "The predicted answer identifies fragment-based drug design (FBDD) as addressing compound diversity but omits the reference's focus on speed acceleration in drug discovery via technologies like high-throughput screening. It aligns with the trend but lacks this critical detail, impacting completeness."
        },
        {
            "query_idx": 50,
            "query": "How can mathematical models be used to enhance the translation of experimental cancer research models to clinical applications while adhering to ethical standards and reducing research expenses?",
            "retrieved_metrics": {
                "reference_idx": [
                    1812,
                    1815,
                    1709
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #mathematical models# enhances #translation from 3D cancer research models# to clinical applications, aligning with #ethical standards# like the 3Rs, and reduces experimental costs.",
            "predicted_answer": "Mathematical models can enhance the translation of experimental cancer research to clinical applications by improving 3D in vitro models, predicting outcomes, reducing wet-lab experiments, and adhering to ethical standards, thus lowering costs.",
            "score": 3,
            "explanation": "The predicted answer covers key points such as the use of mathematical models for translation, enhancing 3D models, adherence to ethical standards, and cost reduction. However, it lacks explicit mention of the 3Rs, impacting completeness slightly but still reflecting the overall trend."
        },
        {
            "query_idx": 51,
            "query": "How does a specific technological advancement enhance early detection of cancer, improve the precision of diagnostic imaging, and facilitate personalized treatment strategies through molecular analysis?",
            "retrieved_metrics": {
                "reference_idx": [
                    125,
                    131,
                    112
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI enhances #early cancer detection# by improving #diagnostic precision# of medical imaging and facilitates #personalized treatment strategies# using molecular profile analysis.",
            "predicted_answer": "AI enhances early cancer detection by identifying subtle irregularities in medical images, improving diagnostic precision. It also personalizes treatment through molecular analysis, enabling targeted therapies that match each patient's unique genetic profile, thus increasing efficacy and reducing side effects.",
            "score": 5,
            "explanation": "The predicted answer covers all key points: AI's role in early cancer detection, improved diagnostic precision, and personalized treatment through molecular analysis. All emphasized information in the reference is reflected in the predicted response, with no significant omissions or errors."
        },
        {
            "query_idx": 52,
            "query": "What was the chosen dose for further cancer treatment trials after evaluating multiple doses, and what is the finalized recommended dose for NSCLC after comprehensive dose optimization?",
            "retrieved_metrics": {
                "reference_idx": [
                    199,
                    198,
                    1596
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "For further trials, a dose of #10 mg/kg# was selected after assessing #8 to 18 mg/kg#. The optimized recommended NSCLC dose is #5.4 mg/kg#.",
            "predicted_answer": "The chosen dose for further cancer treatment trials was 10 mg/kg. The finalized recommended dose for NSCLC after comprehensive dose optimization is 5.4 mg/kg every 3 weeks.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key facts: the chosen dose of 10 mg/kg for further trials and the recommended dose of 5.4 mg/kg for NSCLC. The reference’s range (8 to 18 mg/kg) isn't directly mentioned but does not affect completeness. The core information is consistent."
        },
        {
            "query_idx": 53,
            "query": "How did the effectiveness of PEGPH20 in treating HA-high tumors during Phase 2 and Phase 3 trials of metastatic pancreatic ductal adenocarcinoma differ?",
            "retrieved_metrics": {
                "reference_idx": [
                    408,
                    409
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The addition of #PEGPH20# showed #promising results# in a #Phase 2 trial# for HA-high tumors, but demonstrated #no significant improvement# during a #Phase 3 trial#.",
            "predicted_answer": "In Phase 2 trials, PEGPH20 showed significant improvement in progression-free survival for HA-high tumors. However, Phase 3 trials did not confirm any significant clinical benefits when PEGPH20 was added to nab-paclitaxel/gemcitabine treatment.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts from the reference answer: PEGPH20 was effective in Phase 2 trials with HA-high tumors but showed no significant improvement in Phase 3 trials. The overall trend and details such as trial phases are consistent. No important details are missing."
        },
        {
            "query_idx": 54,
            "query": "What limitations do traditional 3D cancer models have regarding vascular networks, what techniques address these limitations by constructing vascularized tumor models, and how are these models applied to pancreatic cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    2178,
                    2188,
                    2216
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Traditional 3D models #lack vascular networks#. Techniques like #soft lithography#, #3D printing#, and #microfluidics# address this, applied to #pancreatic cancer#, characterized by #angiogenic factors# and reduced #vascularity#.",
            "predicted_answer": "Traditional 3D cancer models lack a perfusable vascular network, limiting their ability to mimic tumor angiogenesis. Techniques like tumor-on-a-chip, which integrates microfluidics and 3D cell culture, address this by constructing vascularized tumor models. These models are applied in pancreatic cancer to study its aggressive nature and angiogenic factors.",
            "score": 3,
            "explanation": "The predicted answer captures the lack of vascular networks, microfluidics as a technique, and application to pancreatic cancer with its angiogenic factors. However, it misses soft lithography, 3D printing, and reduced vascularity details, affecting completeness but not alignment."
        },
        {
            "query_idx": 55,
            "query": "What are the specific properties of Topsentin B\\$_{1}\\$, Topsentin B\\$_{2}\\$, and Nortopsentins A-C, in terms of their structural feature and effectiveness against cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1248,
                    1250,
                    1257
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Topsentin B\\$_{1}\\$ has #cytotoxic effects# on select cancer cells. Topsentin B\\$_{2}\\$ and similar #bisindole alkaloids# show moderate effects, while Nortopsentins A-C, with #2,4-bis(3'-indolyl)imidazole#, exhibit significant anticancer activity.",
            "predicted_answer": "Topsentin B₁ and B₂, along with Nortopsentins A-C, are bisindole alkaloids. Topsentin B₁ shows significant cytotoxicity against P388 and moderate inhibitory effects on HL-60, HCT-8, A-549, and T47D cancer cells. Nortopsentins A-C have a 2,4-bis(3'-indolyl)imidazole structure and exhibit strong inhibitory effects on P338 cells.",
            "score": 3,
            "explanation": "The Predicted Answer includes most key facts: Topsentin B₁'s cytotoxicity, bisindole alkaloid nature of Topsentin B₁ and B₂, and the 2,4-bis(3'-indolyl)imidazole structure for Nortopsentins A-C. However, it inaccurately emphasizes Topsentin B₁'s stronger effects compared to B₂ and omits moderate effects for B₂."
        },
        {
            "query_idx": 56,
            "query": "Which enzyme, through its isoforms, is responsible for starting the mitochondrial transport of long-chain fatty acids by facilitating their conversion and transfer across membranes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1306,
                    1305,
                    1304
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The enzyme #CPT1A#, with specific isoforms, initiates mitochondrial transport of long-chain fatty acids by transferring acyl groups to #carnitine#, converting acyl-CoA to #acyl-carnitine#.",
            "predicted_answer": "CPT1, through its isoforms CPT1A, CPT1B, and CPT1C, initiates mitochondrial transport of long-chain fatty acids by converting them to acyl-carnitine, which then crosses the mitochondrial membranes.",
            "score": 5,
            "explanation": "The Predicted Answer includes CPT1 and its isoforms, matching the enzyme from the Reference Answer. It also covers the conversion to acyl-carnitine and mitochondrial transport, which are the key actions. \"CPT1A\" is specified in the reference, but this omission doesn't significantly impact the overall understanding."
        },
        {
            "query_idx": 57,
            "query": "What are the recent FDA-approved treatments for hemophilia that address prior challenges in gene therapy and what significant impact have they made?",
            "retrieved_metrics": {
                "reference_idx": [
                    358,
                    441,
                    444
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Recent #FDA-approved treatments# for hemophilia include #etranacogene dezaparvovec# and #valoctocogene roxaparvovec#, which involved #overcoming previous technical challenges# in gene therapy.",
            "predicted_answer": "In 2022, the FDA approved Hemgenix for hemophilia B, and in 2023, Roctavian for hemophilia A. These gene therapies offer a one-time treatment, reducing the need for regular infusions and providing a curative approach.",
            "score": 1,
            "explanation": "The predicted answer mentions the FDA-approved gene therapies but uses commercial names (Hemgenix and Roctavian) instead of the scientific names (etranacogene dezaparvovec and valoctocogene roxaparvovec). It misses the specific technical advancements mentioned in the reference. The overall trend aligns, but key details are absent."
        },
        {
            "query_idx": 58,
            "query": "What drug includes trastuzumab linked to another component, is designed for NSCLC with a specific mutation type, and has demonstrated an exact median progression-free survival in trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    181,
                    186,
                    180
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The drug #T-DXd# contains trastuzumab linked to #deruxtecan#, targets #HER2-mutant NSCLC#, and shows a #median progression-free survival of 11.3 months# in trials.",
            "predicted_answer": "Fam-trastuzumab deruxtecan (T-DXd) includes trastuzumab linked to deruxtecan, designed for NSCLC with HER2 mutations, and demonstrated a median progression-free survival of 11.3 months in trials.",
            "score": 5,
            "explanation": "The predicted answer aligns perfectly with the reference answer. It mentions T-DXd with trastuzumab linked to deruxtecan, targeting HER2-mutant NSCLC, and reports a median progression-free survival of 11.3 months. All key facts and trends emphasized by # symbols in the reference are present."
        },
        {
            "query_idx": 59,
            "query": "How does the AAV vector interact with cell receptors for entry, and at which specific step does the conversion of its genetic material occur during gene delivery?",
            "retrieved_metrics": {
                "reference_idx": [
                    428,
                    435,
                    430
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The AAV vector starts by #initiating viral entry# through #binding specific receptors#, and its #single-stranded DNA genome# of #4.7 kb# is converted to #double-stranded DNA# at #step 6# in the pathway.",
            "predicted_answer": "AAV vectors bind to cell surface receptors and co-receptors, triggering endocytosis. After intracellular trafficking to the nucleus, the AAV single-stranded DNA is converted into double-stranded DNA, which occurs before transcription.",
            "score": 3,
            "explanation": "The predicted answer accurately covers the interaction of AAV vectors with cell receptors and the conversion of single-stranded to double-stranded DNA. However, it lacks detail on the single-stranded DNA being 4.7 kb and that conversion occurs at step 6. Hence, one key detail is missing."
        },
        {
            "query_idx": 60,
            "query": "What imaging technique is used in drug development to evaluate biological target engagement, provide reliable receptor binding information, and quantify changes in receptor levels across various diseases?",
            "retrieved_metrics": {
                "reference_idx": [
                    1501,
                    1502,
                    1513
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The imaging method is #positron emission tomography (PET)#, aiding drug development by #revealing target engagement#, #providing receptor binding data#, and #quantifying changes in receptor density# across diseases.",
            "predicted_answer": "Positron emission tomography (PET) with selective radioligands is used to evaluate biological target engagement, provide reliable receptor binding information, and quantify changes in receptor levels across various diseases.",
            "score": 5,
            "explanation": "The predicted answer effectively captures all key elements highlighted in the reference answer, specifically mentioning PET as the imaging method, evaluating target engagement, providing receptor binding information, and quantifying changes in receptor levels. The essence and details align well without significant omission or contradiction."
        },
        {
            "query_idx": 61,
            "query": "How does the selectivity and potency of MRTX-1133 vary between PANC-1 and BxPC3 cell lines with the KRAS G12D mutation, based on IC50 and other measures across initial screenings?",
            "retrieved_metrics": {
                "reference_idx": [
                    1114,
                    1116,
                    1112
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The compound #MRTX-1133# shows #lower selectivity# for #KRAS G12D# in #PANC-1#, consistent #IC50# in #BxPC3#, but #low potency# in screening compared to other compounds.",
            "predicted_answer": "MRTX-1133 shows lower selectivity and higher IC50 values for the KRAS G12D mutation in PANC-1 cells compared to BxPC3 cells, indicating reduced potency and selectivity in PANC-1.",
            "score": 3,
            "explanation": "The predicted answer captures key elements: MRTX-1133, lower selectivity and higher IC50 in PANC-1, consistent with lower potency. However, it does not mention IC50 consistency in BxPC3 or a comparison to other compounds, affecting completeness."
        },
        {
            "query_idx": 62,
            "query": "What methods were applied to analyze the properties of specific compounds regarding their effects on cancer cell lines and interactions with DNA?",
            "retrieved_metrics": {
                "reference_idx": [
                    222,
                    256,
                    245
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Molecular docking and density functional theory# assessed properties and interactions of #N-ethyl toluene-4-sulphonamide (8a)# on cancer cell lines. It #interacts with DNA#, affecting its structure.",
            "predicted_answer": "Experimental and computational methods were used, including in-vitro cell line experiments, molecular docking, and density functional theory (DFT) to analyze the compounds' effects on cancer cell lines and their interactions with DNA.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference answer in terms of methods used, specifically mentioning molecular docking and DFT. It however lacks specific mention of N-ethyl toluene-4-sulphonamide (8a) and its specific interaction with DNA affecting its structure, omitting these key details."
        },
        {
            "query_idx": 63,
            "query": "What approach facilitates targeting cancer using synthetic lethality, particularly involving tumor suppressors and paralog relationships, and how does this broaden the scope beyond druggable oncogenes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1930,
                    1936,
                    1932
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The method of #BRCA/PARP synthetic lethality# effectively targets genetic losses using #tumor suppressors and paralogs#, such as #paralog pairs A1 and A2#, expanding beyond druggable oncogenes.",
            "predicted_answer": "Synthetic lethality, especially through paralog relationships, allows targeting of tumor suppressors and other non-druggable genes. This approach broadens the scope beyond oncogenes by enabling the development of therapies for a wider range of genetic alterations, including those in tumor suppressors and passenger genes.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of synthetic lethality involving tumor suppressors and paralogs, as well as broadening to non-druggable genes. However, it lacks specific mention of the #BRCA/PARP# example and #paralog pairs A1 and A2#. These omissions reduce completeness."
        },
        {
            "query_idx": 64,
            "query": "How does a novel research model contribute to the study of colorectal cancer mechanisms, its treatment advancements, and understanding of associated molecular pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1394,
                    1413,
                    1388
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The novel #organoid technology# aids colorectal cancer research by providing #CRC organoids# for diverse applications, offering insights into #molecular pathways# critical for understanding cancer development and treatments.",
            "predicted_answer": "Novel research models like colorectal cancer organoids contribute by accurately representing tumor environments, facilitating the study of molecular pathways, drug screening, and personalized treatment approaches, thus advancing both the understanding and treatment of colorectal cancer.",
            "score": 3,
            "explanation": "The predicted answer covers the key concepts of #organoid technology# and #molecular pathways# mentioned in the reference. It accurately discusses the role of organoids in CRC research. However, it lacks mention of #CRC organoids# specifically, affecting completeness."
        },
        {
            "query_idx": 65,
            "query": "What dosage and tumor variant were involved in evaluating compound 14's inhibition efficiency, and what was the measured antiproliferative metric for this compound against this tumor variant?",
            "retrieved_metrics": {
                "reference_idx": [
                    1123,
                    1128,
                    1111
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "At a dosage of #6 mg/kg#, #Compound 14# specifically inhibits KRAS G12D mutant tumors, indicated by an antiproliferative #IC50 value of 5.5 µM# against the PANC-1 cell line.",
            "predicted_answer": "Compound 14 was evaluated at a dosage of 6 mg/kg, 2-3x/week, against the PANC-1 KRAS G12D tumor variant. The antiproliferative metric measured was an IC50 value of 5.5 µM for this compound against the PANC-1 cell line.",
            "score": 5,
            "explanation": "The predicted answer matches all the key facts from the reference answer: it states the dosage of 6 mg/kg, the KRAS G12D tumor variant, and the IC50 value of 5.5 µM against the PANC-1 cell line. The overall information and trend are consistent without omissions."
        },
        {
            "query_idx": 66,
            "query": "Modify the multi-hop query\nWhat strategy aims to overcome drug resistance and side effects in cancer treatment by using existing drugs to target cancer hallmarks and the tumor microenvironment, while integrating multiple drugs for enhanced efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    758,
                    760,
                    2260
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer",
            "predicted_answer": "Drug repurposing, combined with multi-drug therapy, targets cancer hallmarks and the tumor microenvironment to enhance efficacy, overcome resistance, and reduce side effects.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the reference by describing the use of drug repurposing with multi-drug therapy to target cancer hallmarks and the tumor microenvironment. It includes the aims of enhancing efficacy, overcoming resistance, and reducing side effects, covering all key facts."
        },
        {
            "query_idx": 67,
            "query": "What model system assists in understanding drug responses in tissues, explores tumor characteristics, and supports investigation into infection mechanisms effectively?",
            "retrieved_metrics": {
                "reference_idx": [
                    1396,
                    1782,
                    1406
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Organoids# facilitate understanding of #drug responses#, explore #tumor heterogeneity#, and support #bacterial studies# effectively.",
            "predicted_answer": "Organoids effectively assist in understanding drug responses in tissues, exploring tumor characteristics, and investigating infection mechanisms due to their ability to mimic original tissue traits and support bacterial growth.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions \"organoids\" and their role in understanding \"drug responses,\" \"exploring tumor characteristics,\" and \"investigating infection mechanisms.\" However, it doesn't specify \"tumor heterogeneity\" or \"bacterial studies,\" missing some emphasis on heterogeneity and bacteria."
        },
        {
            "query_idx": 68,
            "query": "How does the molecule B7-H3 contribute to the activation of signaling pathways, affect cancer behaviors, and interact with immune functions in cancer treatment strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1363,
                    1365,
                    1369
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The molecule #B7-H3 activates pathways# like ERK and PI3K, #contributes to malignant cancer behaviors#, and plays a role in #immune inhibition and cancer cell senescence#, impacting treatments.",
            "predicted_answer": "B7-H3 activates signaling pathways like ERK, PI3K, and Stat3, promoting cancer cell proliferation and tumor growth. It also inhibits cytotoxic immune cells, contributing to tumor progression and resistance to immune responses.",
            "score": 1,
            "explanation": "The predicted answer mentions B7-H3 activating ERK and PI3K pathways and inhibiting immune cells, aligning with the reference. However, it omits cancer cell senescence and specific details about malignant behaviors. Overall, it matches the trend but misses two key facts."
        },
        {
            "query_idx": 69,
            "query": "How do compounds 10 and 14 interact with the KRAS G12D mutation using a particular method, and which structural features of these compounds enhance their effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    1115,
                    1129,
                    1125
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Compounds 10 and 14 exhibit #selectivity# towards the #mutated KRAS# using a method that binds GAP and KRAS G12D, with #interaction# features enhancing their performance.",
            "predicted_answer": "Compounds 10 and 14 interact with the KRAS G12D mutation by binding to both GAP and the mutant, effectively gluing them together. Structural features like the imidazo-pyrazinyl, thienopyrimidine, and phenyl groups in compound 10 enhance their effectiveness by fitting into the hydrophilic pocket of KRAS.",
            "score": 3,
            "explanation": "The predicted answer details how compounds interact with multiple features like GAP and KRAS and gives structural specifics like imidazo-pyrazinyl, showing interaction features. However, it omits the emphasized concept of selectivity towards mutated KRAS, affecting completeness and precision."
        },
        {
            "query_idx": 70,
            "query": "How is AI utilized to enhance cancer treatment customization, adaptation, and personalized outcome prediction?",
            "retrieved_metrics": {
                "reference_idx": [
                    119,
                    1211,
                    1220
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#AI-driven predictive modeling# enhances cancer treatment by facilitating #targeted therapies# customization, enabling adaptive #treatment plans#, and forecasting #personalized outcomes#.",
            "predicted_answer": "AI enhances cancer treatment by enabling targeted therapies, predicting patient responses to treatments, and adapting to tumor evolution. Machine learning algorithms analyze historical and real-time data to customize treatment plans, improving efficacy and reducing side effects.",
            "score": 3,
            "explanation": "The predicted answer covers key aspects such as targeting therapies, adapting treatment, and prediction, aligning with the reference's focus on AI-driven modeling for targeted therapies, adaptive plans, and personalized outcomes. However, it lacks explicit mention of \"AI-driven predictive modeling.\""
        },
        {
            "query_idx": 71,
            "query": "How was the distribution of research and development efforts analyzed for various cancer types, and what were the observed differences in the focus of trials between common and rare cancers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1197,
                    1206,
                    1204
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The distribution of efforts was #measured# via a global database, revealing #greater# inequality in trials for rare cancers, alongside an #inequity pro-low need bias# affecting trial focus across cancer types.",
            "predicted_answer": "The distribution of R&D efforts for various cancer types was analyzed using a global database of clinical trials from 1996 to 2016. The study found that while there is a concentration of trials in high-need cancers, there is a pro-low need inequity when considering relative need, especially for rare cancers.",
            "score": 5,
            "explanation": "Both the predicted and reference answers mention the analysis of R&D efforts using a global database. The predicted answer covers the inequality and bias in trials, though not explicitly mentioning \"greater\" inequality. The overall trend and focus on rare cancer disparities are consistent."
        },
        {
            "query_idx": 72,
            "query": "What limitations in nutrient distribution, extracellular interactions, and environmental conditions prevent traditional 2D culture systems from accurately mimicking in vivo tumor characteristics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1705,
                    2181,
                    2180
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Traditional 2D cultures #fail to mimic diffusion-limited nutrient distribution#, #lack extracellular matrix interactions#, and provide a #simplified environment# unlike the complex in vivo tumor characteristics.",
            "predicted_answer": "Traditional 2D culture systems fail to mimic in vivo tumor characteristics due to uniform nutrient and oxygen access, lack of 3D architecture, absence of extracellular matrix interactions, and inability to replicate the complex tumor microenvironment and its cellular components.",
            "score": 5,
            "explanation": "The predicted answer covers \"uniform nutrient and oxygen access,\" aligning with \"diffusion-limited nutrient distribution,\" mentions the \"lack of extracellular matrix interactions,\" and describes a \"simplified environment\" through the inability to replicate the \"complex tumor microenvironment.\" No key facts are missing, trends align well."
        },
        {
            "query_idx": 73,
            "query": "What are the variations in KRAS mutations in lung, pancreatic, and colorectal cancers, and how do these variations influence their oncogenic behavior across these cancer types?",
            "retrieved_metrics": {
                "reference_idx": [
                    1094,
                    1145,
                    1127
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The KRAS mutations involve the #G12C variant# primarily in #lung cancer#, differing from #G12D-type mutations#, which are predominant in #pancreatic and colorectal cancers#.",
            "predicted_answer": "KRAS mutations vary by cancer type: G12C is common in lung cancer, while G12D and G12V are frequent in pancreatic and colorectal cancers. These variations influence oncogenic behavior, with G12C being a major driver in lung cancer and G12D/V acting as minor drivers in other types.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts: #G12C variant# in #lung cancer# and #G12D# in #pancreatic and colorectal cancers#. It mentions G12V, which isn't emphasized in the reference, but no contradictions appear. The primary variations and their roles across cancer types are consistent."
        },
        {
            "query_idx": 74,
            "query": "Which inhibitor was approved by the FDA for IDH2 mutations, experienced an indication extension in a subsequent year, and later showed effectiveness when used in combination therapy for IDH1 mutations?",
            "retrieved_metrics": {
                "reference_idx": [
                    600,
                    603,
                    604
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #IDH2# inhibitor's FDA approval led to a #2019# extension, while #ivosidenib# with azacitidine was effective for #IDH1# mutations in combination therapy.",
            "predicted_answer": "Enasidenib was approved by the FDA for IDH2 mutations in 2017. The indication was later extended for ivosidenib, which also showed effectiveness in combination with azacitidine for IDH1 mutations.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies enasidenib's approval for IDH2 and the combination therapy effectiveness of ivosidenib with azacitidine for IDH1. However, it inaccurately states enasidenib got the indication extension instead of being specific about the IDH2 inhibitor's 2019 extension, which is crucial."
        },
        {
            "query_idx": 75,
            "query": "How do increased levels of a certain chemical influence biochemical parameters and tumor characteristics in human tumors and rat models both in vitro and in vivo?",
            "retrieved_metrics": {
                "reference_idx": [
                    839,
                    840
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Elevated #ascorbic acid# in human tumors reduces #HIF-1 α#, #VEGF#, and #GLUT1# expression, decreasing malignancy. In rats, it decreases #HIF-1 α# expression, reduces #tumor growth#, and lowers #vascular density#.",
            "predicted_answer": "Elevated ascorbic acid levels in human and rat tumors, both in vitro and in vivo, correlate with decreased expression of HIF-1α, VEGF, and GLUT1, leading to reduced malignancy and tumor growth.",
            "score": 1,
            "explanation": "The predicted answer correctly identifies elevated ascorbic acid and its impact on HIF-1α, VEGF, and GLUT1 expression, and malignancy reduction. However, it omits rat-specific details: decreased tumor growth and reduced vascular density. Trends align, but more than one key fact is missed."
        },
        {
            "query_idx": 76,
            "query": "What specific type of vaccine is engineered to target diverse pathogen strains, what pathogens does it target, and what construction techniques enhance its immune response effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    55,
                    66,
                    53
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The vaccine involves #Multivalent phage-based vaccines#, targets bacterial strains like #Streptococcus pneumoniae and Escherichia coli#, and utilizes a #Construction method for inserting epitopes in phages# for enhanced immune responses.",
            "predicted_answer": "Multivalent phage-based vaccines target diverse pathogen strains, including SARS-CoV-2, Streptococcus pneumoniae, and Staphylococcus aureus. They use techniques like displaying multiple antigenic epitopes and inserting antigen-encoding genes to enhance immune response effectiveness.",
            "score": 1,
            "explanation": "The predicted answer mentions \"Multivalent phage-based vaccines,\" which aligns with the reference. It correctly lists \"Streptococcus pneumoniae\" but misses \"Escherichia coli.\" The predicted answer includes SARS-CoV-2 and Staphylococcus aureus, which aren't in the reference. It discusses \"inserting antigen-encoding genes,\" which partly aligns with the construction method mentioned."
        },
        {
            "query_idx": 77,
            "query": "What methods are utilized for the in silico analysis of ADMET properties of plant-based molecules, and what impact do these analyses have on the selection process of promising phytomolecules in drug development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1677,
                    1681
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In silico methods evaluate #ADMET analyses# of plant-based molecules, impacting the selection of #phytomolecules# by reducing late-stage drug development failures.",
            "predicted_answer": "In silico analysis of ADMET properties uses tools like QikProp, pkCSM, and DataWarrior. These analyses help select promising phytomolecules by predicting their pharmacokinetics and toxicity, reducing late-stage drug development failures.",
            "score": 5,
            "explanation": "The predicted answer covers the key aspects mentioned in the reference: it refers to \"ADMET\" analysis and \"phytomolecules\" by discussing the impact on drug development and reducing failures. However, it includes specific tools (QikProp, pkCSM, DataWarrior) not mentioned in the reference, which doesn't affect alignment."
        },
        {
            "query_idx": 78,
            "query": "What experimental strategy is being developed to achieve gene modulation in cervicovaginal tissues, including the specific targeting molecule and cell type involved?",
            "retrieved_metrics": {
                "reference_idx": [
                    379,
                    378,
                    381
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The strategy involves #RNA interference# that utilizes #Chol-siRNAs# to achieve #gene silencing# specifically in mucosal dendritic cells within cervicovaginal tissues.",
            "predicted_answer": "RNA interference (RNAi) using chol-siRNAs is being developed to modulate genes in cervicovaginal tissues, specifically targeting the CD45 gene in mucosal dendritic cells, including intraepithelial and lamina propria DCs.",
            "score": 5,
            "explanation": "The Predicted Answer accurately includes all key facts from the Reference Answer: the strategy of RNA interference, use of Chol-siRNAs, and targeting of mucosal dendritic cells for gene modulation in cervicovaginal tissues. There are no significant omissions or errors, and the answers are consistent in meaning."
        },
        {
            "query_idx": 79,
            "query": "What is the overall response rate observed in NSCLC patients characterized by a certain overexpression level when treated with a particular monoclonal antibody-drug conjugate that includes a valine-citrulline linker?",
            "retrieved_metrics": {
                "reference_idx": [
                    201,
                    200
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The ORR in #NSCLC c-Met high patients# was #53.8%# when treated with #Telisotuzumab vedotin#, which includes #MMAE# and demonstrated #antitumor activity#.",
            "predicted_answer": "In NSCLC patients with high c-Met overexpression, the overall response rate (ORR) when treated with Teliso-V, a monoclonal antibody-drug conjugate with a valine-citrulline linker, was 53.8%.",
            "score": 1,
            "explanation": "The predicted answer includes the key facts: high c-Met overexpression NSCLC patients, an ORR of 53.8%, Teliso-V (an acceptable abbreviation of Telisotuzumab vedotin), and the valine-citrulline linker. However, it misses \"MMAE\" and \"antitumor activity,\" two key emphasized details."
        },
        {
            "query_idx": 80,
            "query": "What process involves toxin release via lysosomal degradation, requires high-affinity antibody guidance with low immunogenicity, and targets specific cell antigens?",
            "retrieved_metrics": {
                "reference_idx": [
                    914,
                    919,
                    913
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The process involves #toxin# release via lysosomal degradation leading to #apoptosis#, requiring #high-affinity#, #low-immunogenicity# #antibody-guidance# to target #specific antigens#.",
            "predicted_answer": "The process described is the mechanism of action of antibody-drug conjugates (ADCs), which use high-affinity antibodies to target specific cell antigens, ensuring low immunogenicity and precise toxin delivery via lysosomal degradation.",
            "score": 3,
            "explanation": "The predicted answer captures most of the key aspects: \"toxin release via lysosomal degradation,\" \"high-affinity antibodies,\" \"low immunogenicity,\" and \"target specific cell antigens.\" However, it omits mentioning \"apoptosis\" as a result of the process, impacting completeness."
        },
        {
            "query_idx": 81,
            "query": "What is the percentage specificity of the Galleri test reported in clinical studies, and how accurate is the MCED-Scr version in identifying the origin of cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    512,
                    513
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The Galleri test has a specificity of #99.5%#, and the refined MCED-Scr version accurately predicts cancer origin with #97%# accuracy.",
            "predicted_answer": "The Galleri test has a specificity of 99.5% for cancer signal detection. The MCED-Scr version accurately identifies the origin of cancer with 97% accuracy.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts with the correct percentages: the Galleri test specificity of 99.5% and the MCED-Scr version's 97% accuracy in identifying cancer origin. It aligns with the reference answer, with no significant omissions or contradictions."
        },
        {
            "query_idx": 82,
            "query": "Modify the multi-hop query:\nWhat is the treatment effective for patients with BCG-unresponsive high-risk non-muscle-invasive bladder cancer, and what therapy is considered for later stages in cancer with specific genetic features?",
            "retrieved_metrics": {
                "reference_idx": [
                    1859,
                    1862
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "Pembrolizumab monotherapy is effective for BCG-unresponsive high-risk non-muscle-invasive bladder cancer. For later stages with specific genetic features, Derazantinib and other targeted therapies like Tazemetostat or T-cell therapy can be considered.",
            "score": 5,
            "explanation": "The key facts from the reference answer should mention both treatments: Pembrolizumab for BCG-unresponsive high-risk non-muscle-invasive bladder cancer and therapies for later stages. The predicted answer includes Pembrolizumab, covering the first part, and mentions Derazantinib and similar therapies for later stages, aligning with the overall trend."
        },
        {
            "query_idx": 83,
            "query": "Which dual inhibitors have received regulatory approval for their effectiveness in oncology due to targeting H3K27me3 reduction, and what types of cancer are they approved to treat?",
            "retrieved_metrics": {
                "reference_idx": [
                    576,
                    577,
                    575
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Dual inhibitors targeting #H3K27me3 reduction# include those leading to #Valemetostat's approval# in Japan for adult T-cell leukemia/lymphoma and #Tazemetostat's FDA approval# for follicular lymphoma and epithelioid sarcoma.",
            "predicted_answer": "Valemetostat, a dual EZH1/2 inhibitor, has received regulatory approval in Japan for treating relapsed or refractory adult T-cell leukemia/lymphoma. Tazemetostat, an EZH2 inhibitor, is approved for follicular lymphoma and epithelioid sarcoma.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies Valemetostat's approval in Japan for adult T-cell leukemia/lymphoma and Tazemetostat's approval for follicular lymphoma and epithelioid sarcoma. However, it does not specify that Tazemetostat received FDA approval. All other key facts are present and aligned."
        },
        {
            "query_idx": 84,
            "query": "What components and methods are involved in phage-based systems for drug-delivery, including drug expression on vectors, targeting via phage modification, and the use of particle formations for therapeutic applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    81,
                    84,
                    85
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phage-based systems involve #drugs expressed on the capsid#, incorporate #surface-display systems for targeting#, and utilize #virus-like particles as antigen scaffolds# for enhanced therapeutic delivery.",
            "predicted_answer": "Phage-based drug-delivery systems involve expressing drugs on phage capsids or tail fibers, modifying phages to display targeting ligands, and using encapsulation techniques. These methods enable targeted delivery of therapeutic proteins, peptides, or genetic material.",
            "score": 3,
            "explanation": "The predicted answer captures drug expression on phage structures and mentions targeting ligands, aligning with drugs on the capsid and surface-display systems in the reference. However, it does not reference the use of virus-like particles as antigen scaffolds, missing a crucial component."
        },
        {
            "query_idx": 85,
            "query": "How does AI influence specific phases in the development of anti-cancer drugs, and what are its data requirements for these impacts?",
            "retrieved_metrics": {
                "reference_idx": [
                    140,
                    159,
                    276
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI's impact includes #anti-cancer drug design# advancements, leveraging #large reliable datasets#, and significantly enhancing #preclinical drug development# processes.",
            "predicted_answer": "AI influences anti-cancer drug development by aiding in image classification, predicting protein structures, and drug-protein interactions. It requires large, reliable datasets for training, essential for molecular screening, target identification, and generating in silico molecules.",
            "score": 3,
            "explanation": "The predicted answer mentions AI's role in anti-cancer drug development processes using large datasets, aligning with the reference's impact on drug design and reliable data use. However, it misses explicit mention of \"preclinical drug development,\" leaving out a crucial phase."
        },
        {
            "query_idx": 86,
            "query": "Which drugs have been tested for treating tumors related to a genetic disorder caused by a specific gene mutation, and what were the trial outcomes and genetic cause of this disorder?",
            "retrieved_metrics": {
                "reference_idx": [
                    675,
                    677,
                    1092
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The drugs #Belzutifan# and #Sunitinib# were tested for tumors linked to a #von Hippel-Lindau gene# mutation. Belzutifan showed significant efficacy, whereas sunitinib had limited success.",
            "predicted_answer": "Belzutifan, a HIF2α inhibitor, showed significant efficacy in treating renal cell carcinomas, hemangioblastomas, and pancreatic neuroendocrine tumors in VHL syndrome, with an acceptable safety profile. Sunitinib and dovitinib also showed some efficacy but had limited responses and toxicity issues. VHL is caused by mutations in the VHL tumor suppressor gene on chromosome 3p25.",
            "score": 5,
            "explanation": "The predicted answer successfully covers all key facts from the reference: it mentions Belzutifan and Sunitinib, their efficacy, and the von Hippel-Lindau (VHL) gene mutation. It also adds additional relevant details. This alignment and completeness result in a full score."
        },
        {
            "query_idx": 87,
            "query": "How is technology leveraged to both streamline the selection of participants and forecast patient responses in clinical trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    126,
                    274,
                    280
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Clinical trials utilize #AI# for optimization, accelerate participant recruitment with #big data#, and predict patient responses using #in silico trials#.",
            "predicted_answer": "AI streamlines participant selection and forecasts patient responses in clinical trials by analyzing past data, identifying suitable candidates, and predicting reactions. This accelerates recruitment and enhances trial effectiveness, though it requires addressing data privacy and ethical concerns.",
            "score": 1,
            "explanation": "The predicted answer mentions AI for streamlining selection and forecasting responses, aligning with the reference. However, it does not mention #big data# and #in silico trials# emphasized in the reference, missing two key technological aspects. The overall trend aligns, but important details are omitted."
        },
        {
            "query_idx": 88,
            "query": "What enzyme-mediated process modifies protein function relevant to oncological conditions and encounters specific approval difficulties when utilizing its redirection for innovative therapy development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1833,
                    1842,
                    1840
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #enzyme# process involving #kinases# modifies protein conformation, linked to #oncological# growth, and faces #regulatory difficulties# with approval in new therapeutic applications.",
            "predicted_answer": "The enzyme-mediated process that modifies protein function in oncological conditions is phosphorylation, catalyzed by kinases. This process alters protein function and can be targeted for therapy. However, it faces regulatory challenges and difficulties in clinical approval when repurposed.",
            "score": 5,
            "explanation": "The key facts from the reference answer include enzymes, kinases, the link to oncological conditions, and regulatory difficulties. These are all present in the predicted answer. The prediction does not contradict and aligns with the overall trend of the reference. Minor differences in wording do not impact meaning."
        },
        {
            "query_idx": 89,
            "query": "What statistical significance levels and tumor volume thresholds were used to evaluate the effects of treatments on pancreatic tumor growth, particularly concerning compound 14?",
            "retrieved_metrics": {
                "reference_idx": [
                    1121,
                    1144,
                    1124
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The evaluation involved #compound 14# effects on pancreatic models by measuring #tumor volume exceeding 1600 mm³# and confirming significance at #p ≤ 0.05 and p ≤ 0.0001#.",
            "predicted_answer": "The statistical significance levels used were p ≤ 0.05 and p ≤ 0.0001, indicated by * and **** respectively. The tumor volume threshold for terminating the experiment was over 1600 mm³.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts from the Reference Answer: compound 14, tumor volume threshold of 1600 mm³, and significance levels of p ≤ 0.05 and p ≤ 0.0001. The overall alignment is accurate without any significant omissions or contradictions."
        },
        {
            "query_idx": 90,
            "query": "How do expedited drug approval processes impact trial design, affect drug safety, and allow for external factors like economic incentives to influence outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1891,
                    1913,
                    1889
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #expedited approval# process influences #trial design# by favoring #small trials#, affecting safety through #unrecognized adverse events#, and allowing #economic incentives# to compromise #post-marketing safety revisions#.",
            "predicted_answer": "Expedited drug approval processes can lead to shorter, smaller trials, potentially missing some adverse events. This may result in more post-marketing safety issues and required phase 4 trials, which are often delayed or not initiated. Economic incentives can also influence the outcomes.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts emphasized: expedited approval, trial design, smaller trials, potential adverse events, economic incentives' influence, and issues with post-marketing safety. However, it mentions \"phase 4 trials\" not specifically highlighted in the Reference Answer, but aligns with the trend of safety monitoring."
        },
        {
            "query_idx": 91,
            "query": "How do metastasis-on-a-chip and tumor-on-a-chip models individually contribute to cancer research, and which specific processes or systems are studied within each model?",
            "retrieved_metrics": {
                "reference_idx": [
                    1459,
                    2056,
                    2189
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Metastasis-on-a-chip# models explore #cancer therapies# affecting #metastatic processes#. #Tumor-on-a-chip# platforms analyze #vascular systems#, focusing on blood flow dynamics and developing #vascularized models#.",
            "predicted_answer": "Metastasis-on-a-chip models study the invasion rate, stages of the metastatic cascade, and evaluate various cancer therapies. Tumor-on-a-chip models focus on tumor growth, vascularization, nutrient exchange, and drug delivery, providing insights into the tumor microenvironment and drug development.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of both models but is missing key elements. It mentions metastatic stages and cancer therapies for metastasis-on-a-chip and tumor microenvironment for tumor-on-a-chip but omits specifics like blood flow dynamics crucial for vascular systems in the reference."
        },
        {
            "query_idx": 92,
            "query": "What specific drug combination improves progression-free survival in chemotherapy, how is its efficacy in TNBC influenced by genetic mutations, and what time interval impacts its activity level?",
            "retrieved_metrics": {
                "reference_idx": [
                    652,
                    662,
                    656
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Addition of veliparib to carboplatin-paclitaxel# improves survival. #Carboplatin shows efficacy# in TNBC with genetic stratification, and #activity increases after a platinum-free interval over 180 days#.",
            "predicted_answer": "The combination of veliparib with carboplatin-paclitaxel improves progression-free survival in TNBC. Efficacy is influenced by genetic mutations, with non-gBRCA carriers benefiting more from carboplatin. A platinum-free interval over 180 days enhances veliparib activity.",
            "score": 5,
            "explanation": "The predicted answer accurately presents the importance of adding veliparib to carboplatin-paclitaxel for improving progression-free survival. It captures the influence of genetic stratification and the significance of a platinum-free interval over 180 days on activity levels. All key facts emphasized are present and consistent."
        },
        {
            "query_idx": 93,
            "query": "What impact does variability in the methodologies for culturing organoids and spheroids have on cancer treatment evaluations, and what strategies are proposed to enhance their consistency and reliability?",
            "retrieved_metrics": {
                "reference_idx": [
                    1803,
                    1990,
                    1722
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #variability in spheroid and organoid methodologies# hinders anticancer evaluations, necessitating #uniform methods for reliable data# and #standardized protocols to boost study reproducibility#.",
            "predicted_answer": "Variability in culturing methodologies for organoids and spheroids leads to inconsistent and unreliable results, hampering their use in cancer treatment evaluations. Strategies to enhance consistency include standardizing culture protocols, improving culture media, and utilizing bioprinting techniques.",
            "score": 3,
            "explanation": "The Predicted Answer aligns generally with the Reference Answer, mentioning variability and the need for standardized protocols. However, it omits the necessity for \"uniform methods for reliable data,\" a crucial point emphasized by the # symbols in the Reference Answer, affecting completeness."
        },
        {
            "query_idx": 94,
            "query": "How does the reduction of a specific RNA component influence apoptosis through changes in splicing, and where in the body are these components highly concentrated in certain pathological conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    2010,
                    2008
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Reduction of #PNCTR# alters splicing to induce #apoptosis#, and PNCTR is highly enriched in #metastatic lesions# within lymph nodes.",
            "predicted_answer": "Reduction of PNCTR, an RNA component, influences apoptosis by altering splicing patterns, which is partly regulated by PTBP1. These components are highly concentrated in cancer cells and metastatic lesions within lymph nodes.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts that the reduction of PNCTR influences apoptosis through changes in splicing and mentions its concentration in metastatic lesions within lymph nodes, consistent with the Reference Answer. The addition of PTBP1 and cancer cells doesn't contradict the reference."
        },
        {
            "query_idx": 95,
            "query": "How does the number of special FDA designations influence the approval speed of cancer treatments, and what are its implications on both treatment costs and clinical benefits?",
            "retrieved_metrics": {
                "reference_idx": [
                    617,
                    618,
                    615
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Multiple special designations# lead to faster approval times, higher #treatment costs#, and increased #clinical benefit# for treatments addressing high unmet needs.",
            "predicted_answer": "Multiple special FDA designations for cancer treatments lead to faster approval and potentially greater clinical benefits, especially for high unmet needs. However, they are also linked to less robust trial evidence and higher drug prices.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts that multiple special FDA designations result in faster approval and increased clinical benefits, consistent with the reference. However, it mentions higher drug prices rather than higher treatment costs, which might imply the same but lacks precise alignment."
        },
        {
            "query_idx": 96,
            "query": "How do certain viral agents disrupt protective bacterial matrices and enhance antimicrobial treatments, especially against persistent infections, when used in combination with traditional antibiotics?",
            "retrieved_metrics": {
                "reference_idx": [
                    2,
                    32,
                    11
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The production of phage-derived #enzymes# disrupts bacterial biofilms, aiding in treating #biofilm-associated infections#. When combined with antibiotics, this method enhances efficacy against #resistant bacterial strains#.",
            "predicted_answer": "Phages disrupt bacterial biofilms by penetrating and degrading the matrix, enhancing the efficacy of traditional antibiotics. This synergistic approach improves treatment outcomes, especially against persistent infections, by overcoming bacterial resistance.",
            "score": 1,
            "explanation": "The predicted answer aligns with the overall trend but lacks mention of \"phage-derived enzymes\" and \"biofilm-associated infections,\" both key facts in the reference answer. While it covers the enhancement of antibiotic efficacy and target of persistent infections, these omissions affect completeness."
        },
        {
            "query_idx": 97,
            "query": "What advancements in modeling brain cancer use patient-derived organoids that include vascular components to assess precise drug efficacy and resistance?",
            "retrieved_metrics": {
                "reference_idx": [
                    1976,
                    2093,
                    1972
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Methods involving #glioblastoma organoids# predict #treatment effects# and discover drugs, using a #preclinical model# including #endothelial cells# for precise personalized therapy evaluation in brain cancer.",
            "predicted_answer": "Recent advancements in modeling brain cancer include the use of patient-derived organoids that incorporate vascular components, such as endothelial cells. These models enhance the accuracy of drug efficacy and resistance predictions, facilitating personalized treatment plans and improving therapeutic outcomes.",
            "score": 3,
            "explanation": "The predicted answer mentions patient-derived organoids and vascular components like endothelial cells, aligning with the reference. However, it misses the terms \"glioblastoma organoids,\" \"treatment effects,\" and \"preclinical model,\" hence lacking some key details emphasized in the reference."
        },
        {
            "query_idx": 98,
            "query": "What are the specific clinical outcomes and statistical comparisons between TIL therapy and immunotherapy for advanced melanoma, particularly regarding disease control rates, overall response rates, and meta-analysis findings?",
            "retrieved_metrics": {
                "reference_idx": [
                    944,
                    946,
                    945
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Clinical trials show #TIL therapy# for advanced melanoma outperforms #immunotherapy# with higher #disease control and response rates#; meta-analysis reports consistent #ORR and CRR# improvements.",
            "predicted_answer": "TIL therapy for advanced melanoma showed better outcomes compared to immunotherapy, with an 80% disease control rate and a 36% overall response rate in one trial. A Phase 3 trial found TIL therapy had a 49% ORR versus 21% for anti-PD-1. Meta-analysis indicated a 41% ORR and 12% complete response rate for TIL + IL-2.",
            "score": 3,
            "explanation": "The Predicted Answer includes key facts such as TIL therapy's higher disease control rate and overall response rate compared to immunotherapy, aligning with the Reference Answer's emphasis on TIL's superior performance. However, it lacks specific mention of the reference’s complete response rate improvements (CRR), affecting completeness."
        },
        {
            "query_idx": 99,
            "query": "Which specific pharmacokinetic measurement is correlated with patient outcomes, and what treatment modification can enhance patient responses by affecting this measurement over time?",
            "retrieved_metrics": {
                "reference_idx": [
                    715,
                    717,
                    681
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #Median AUC# measurement correlates with patient outcomes. #Dose escalation# enhances drug exposure, improving #time to response# and the likelihood of achieving partial responses.",
            "predicted_answer": "The Area Under the Curve (AUC) is correlated with patient outcomes. Dose escalation can enhance patient responses by increasing AUC, leading to better clinical outcomes and higher response rates.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies AUC as the key pharmacokinetic measurement and mentions dose escalation, aligning with the reference answer. However, it omits the specific mention of \"Median AUC\" and \"time to response,\" affecting completeness."
        },
        {
            "query_idx": 100,
            "query": "What are the challenges faced by racial and ethnic minorities in accessing phase 1 cancer trials, and what gaps exist in research on their participation in these trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    1434,
                    1439,
                    1428
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Access to #phase 1 trials# is crucial, yet there is #underenrollment# of certain racial and ethnic groups. Moreover, there are no studies on #disparities# in these early-phase trials.",
            "predicted_answer": "Racial and ethnic minorities face challenges such as underenrollment and limited access to trial sites in phase 1 cancer trials. Research gaps include a lack of studies specifically examining demographic disparities in these early-stage trials, leading to potential inequities in treatment access and generalizability of results.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts: access to phase 1 trials, underenrollment of racial and ethnic minorities, and lack of studies on disparities. It maintains alignment with the reference answer, mentioning relevant challenges and research gaps without omitting key information."
        },
        {
            "query_idx": 101,
            "query": "What specific 3D cell culture method aids in the development of breast cancer treatments and provides additional benefits for anticancer drug research?",
            "retrieved_metrics": {
                "reference_idx": [
                    339,
                    350,
                    1710
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #3D spheroid culture# technique specifically supports #breast cancer drug# development due to its #drug resistance# profiles, serving as effective #3D in vitro models# for #anticancer drug# research.",
            "predicted_answer": "3D spheroid culture methods, such as those using MCF-7 cell spheroids, aid in the development of breast cancer treatments and provide more physiologically relevant microenvironments for anticancer drug research.",
            "score": 3,
            "explanation": "The predicted answer mentions \"3D spheroid culture methods\" and links them to \"breast cancer treatments\" and \"anticancer drug research,\" aligning with the reference's highlighted facts. However, it misses the emphasis on \"drug resistance\" and \"3D in vitro models,\" crucial for completeness."
        },
        {
            "query_idx": 102,
            "query": "What treatment strategy targets BRCA mutations through a vulnerability mechanism, and what particular genetic characteristic in colorectal cancer is addressed by immune modulation therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    649,
                    687,
                    1926
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #synthetic lethality# strategy targets #BRCA# mutations with #PARP inhibitors#, while #colorectal cancer# with high #microsatellite instability# benefits from #immune checkpoint inhibitors#.",
            "predicted_answer": "PARP inhibitors target BRCA mutations by exploiting synthetic lethality. Immune checkpoint inhibitors address high microsatellite instability or mismatch repair deficiency in colorectal cancer.",
            "score": 5,
            "explanation": "The predicted answer accurately captures all key details: it identifies that PARP inhibitors exploit synthetic lethality to target BRCA mutations and that immune checkpoint inhibitors are used for colorectal cancer with high microsatellite instability. No important details are missing, and there is no contradictory information."
        },
        {
            "query_idx": 103,
            "query": "What drug approval method expedites clinical trials by using particular surrogate endpoints, and how does this relate to the innovation level of drugs with multiple FDA designations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1910,
                    1911,
                    633
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #accelerated approval# method shortens trial duration through surrogate endpoints like #tumor response rate#, expediting innovative drugs with #multiple special designations# and enhancing their FDA approval processes.",
            "predicted_answer": "The accelerated approval method expedites clinical trials by using surrogate endpoints, such as tumor shrinkage. Drugs with multiple FDA designations, including accelerated approval, are often more innovative, as measured by biotechnological and clinical novelty.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions the use of surrogate endpoints in the accelerated approval method and relates it to the innovation of drugs with multiple FDA designations. However, it generalizes with \"biotechnological and clinical novelty\" instead of specifying \"multiple special designations\" as in the reference, affecting completeness."
        },
        {
            "query_idx": 104,
            "query": "How can artificial intelligence enhance the detection accuracy of cancerous tissues in radiological images, and which specific imaging modalities and anomalies are involved?",
            "retrieved_metrics": {
                "reference_idx": [
                    1212,
                    1628,
                    1209
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI enhances cancer detection by using #image analysis algorithms# for #CT# and #MRI# scans, precisely detecting cancerous #anomalies# that radiologists might miss.",
            "predicted_answer": "AI enhances cancer detection accuracy in radiological images by using machine learning to analyze CT, MRI, PET, and X-ray scans. It identifies subtle patterns, defines tumor boundaries, and distinguishes between cancerous and non-cancerous tissues, improving diagnosis and treatment planning.",
            "score": 3,
            "explanation": "The predicted answer aligns well with the reference answer, mentioning AI use in CT and MRI imaging, and detecting anomalies. However, while it includes additional modalities like PET and X-ray, it lacks specific emphasis on \"image analysis algorithms,\" causing a minor omission."
        },
        {
            "query_idx": 105,
            "query": "What cell therapy targets specific antigens in hematological cancers and has shown promising clinical trial results but also faces challenges regarding safety and effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    953,
                    2111
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#CART cell therapy# effectively targets #CD19 antigens# in #hematological cancers#, such as leukemia and lymphoma, but faces #cytokine release syndrome (CRS)# as a significant concern.",
            "predicted_answer": "CART cell therapy targets specific antigens in hematological cancers, showing promising clinical trial results. However, it faces challenges such as severe cytokine release syndrome and limited effectiveness against solid tumors.",
            "score": 3,
            "explanation": "The predicted answer covers CART cell therapy and its targets in hematological cancers, aligning with the reference. However, it lacks mention of CD19 antigens, critical to the therapy's specificity. Other points like cytokine release syndrome are mentioned, so the missing key fact affects completeness."
        },
        {
            "query_idx": 106,
            "query": "How do AI-driven methods affect the sensitivity of cancer screening systems, improve early detection, and what specific issues must be addressed to achieve effective screening?",
            "retrieved_metrics": {
                "reference_idx": [
                    1214,
                    1247,
                    1208
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI-driven cancer screening enhances #sensitivity# and #early detection#, reducing false positives. Challenges like #algorithm bias# need addressing for effective implementation.",
            "predicted_answer": "AI-driven methods enhance the sensitivity of cancer screening, enabling early detection by identifying subtle patterns indicative of early-stage cancer. To achieve effective screening, issues such as algorithm bias, data quality, and regulatory compliance must be addressed.",
            "score": 3,
            "explanation": "The Predicted Answer covers key facts such as enhanced sensitivity, early detection, and mentions algorithm bias. However, it misses reducing false positives, present in the Reference. Thus, while aligned overall, it misses one key detail affecting completeness."
        },
        {
            "query_idx": 107,
            "query": "What components are involved in the advanced delivery system of an mRNA vaccine that has shown specific benefits in T-cell response and survival outcomes in pancreatic cancer clinical trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    416,
                    420,
                    983
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The mRNA vaccine #Autogene cevumeran#, using #mRNA-lipoplex nanoparticles# and including #modified nucleosides#, showed #T-cell expansion# and improvements in #recurrence-free survival# in pancreatic cancer trials.",
            "predicted_answer": "The advanced delivery system of the mRNA vaccine involves mRNA-lipoplex nanoparticles, which incorporate modified nucleosides like pseudouridine to prevent immunostimulation and enhance cellular uptake, protecting the mRNA from degradation.",
            "score": 1,
            "explanation": "The predicted answer includes \"mRNA-lipoplex nanoparticles\" and \"modified nucleosides,\" aligning with the reference. It lacks mention of \"Autogene cevumeran,\" \"T-cell expansion,\" and \"improvements in recurrence-free survival\" in pancreatic cancer trials, resulting in the omission of multiple key facts."
        },
        {
            "query_idx": 108,
            "query": "How do non-representative datasets in AI healthcare impact model performance related to bias concerns, ethical considerations in patient care, and the necessity for diverse datasets?",
            "retrieved_metrics": {
                "reference_idx": [
                    1235,
                    1239,
                    130
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of non-representative datasets in AI healthcare leads to #algorithmic bias due to data issues#, creates #ethical challenges in AI cancer care#, and highlights the necessity for #diverse and inclusive datasets# for unbiased models.",
            "predicted_answer": "Non-representative datasets in AI healthcare can lead to biased models, which may perform poorly for underrepresented groups, raising ethical concerns and emphasizing the need for diverse datasets to ensure equitable patient care.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of algorithmic bias and ethical concerns in healthcare due to non-representative datasets, as well as the need for diverse datasets to avoid these issues. However, the specific mention of \"AI cancer care\" is missing, impacting completeness slightly."
        },
        {
            "query_idx": 109,
            "query": "What are the types of bioactive compounds found in R. chingii Hu, and how do they contribute to anticancer effects, particularly through specific cellular mechanisms in human cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    319,
                    316,
                    320
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The bioactive compounds in R. chingii Hu include #Tiliroside# and #Quercetin# which are #flavonoids#, demonstrating strong anti-lung cancer activity, and #alkaloids# that trigger apoptosis and autophagy in tumors.",
            "predicted_answer": "R. chingii Hu contains bioactive compounds like tiliroside, quercetin, and alkaloids, which contribute to anticancer effects by inducing apoptosis, inhibiting cell proliferation, and modulating pathways such as E2Fs/Caspase-3, PI3K/Akt/mTOR, and Wnt/β-catenin in human cancer cells.",
            "score": 3,
            "explanation": "The predicted answer includes tiliroside, quercetin, and alkaloids, aligning with the reference. It mentions apoptosis but not autophagy. It discusses E2Fs/Caspase-3, PI3K/Akt/mTOR, and Wnt/β-catenin pathways, which are not in the reference. It lacks the emphasis on flavonoids and anti-lung cancer activity."
        },
        {
            "query_idx": 110,
            "query": "How do therapies that involve targeting numerous cancer pathways and utilizing novel applications of existing drugs improve the effectiveness of cancer treatment strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    2234,
                    2249,
                    861
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Combinatory therapies# enhance cancer treatment by #targeting multiple pathways# and include #drug repurposing# to improve treatment effectiveness and overcome resistance.",
            "predicted_answer": "Combination therapies that target multiple cancer pathways and repurpose existing drugs can improve treatment effectiveness by addressing tumor heterogeneity, overcoming resistance, and targeting various cellular mechanisms, leading to better outcomes and reduced relapse.",
            "score": 5,
            "explanation": "The Predicted Answer aligns closely with the Reference Answer. It covers key concepts such as \"combination therapies,\" \"targeting multiple pathways,\" and \"drug repurposing\" that lead to improved treatment effectiveness. Although phrasing differs, the meaningful content is consistent, with no notable omissions."
        },
        {
            "query_idx": 111,
            "query": "What processes are integral to the approval and monitoring of novel therapeutics involving bacteriophages in international markets, and what obstacles are critical to address for clinical integration?",
            "retrieved_metrics": {
                "reference_idx": [
                    95,
                    99,
                    35
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Approval processes involve #regulatory frameworks# in the #United States and Europe#; essential monitoring includes #post-market surveillance strategies#. Addressing #regulatory hurdles# is vital for clinical integration.",
            "predicted_answer": "Regulatory approval and monitoring of bacteriophage therapeutics involve navigating guidelines from agencies like the FDA and EMA, conducting rigorous clinical trials, and implementing post-market surveillance. Key obstacles include standardizing protocols, addressing immune responses, and overcoming regulatory hurdles.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer by addressing regulatory frameworks (FDA and EMA) in the US and Europe, emphasizing post-market surveillance, and noting the importance of overcoming regulatory hurdles. It covers all key facts without significant omissions or contradictions."
        },
        {
            "query_idx": 112,
            "query": "What is the energy associated with the compound's interaction with Asn208, and in what ways do these interactions vary from those with Gly165, relevant to inhibitor development?",
            "retrieved_metrics": {
                "reference_idx": [
                    235,
                    236,
                    234
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The binding energy with #Asn208# is #-4.9 kcal/mol#, involving #hydrogen and hydrophobic# interactions. Differences with #Gly165# inform inhibitor #design#.",
            "predicted_answer": "The energy associated with (8a) interacting with Asn208 is -4.9 kcal/mol, involving a hydrogen bond. Interactions with Gly165, seen with (8b), differ as they involve distinct residues, suggesting varied binding modes relevant for inhibitor design.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions the interaction energy of -4.9 kcal/mol with Asn208 and hydrogen bonding, aligning closely with the reference. However, it misses \"hydrophobic interactions\" with Asn208. Although the trend regarding Gly165 and inhibitor design is present, the omission impacts completeness."
        },
        {
            "query_idx": 113,
            "query": "What methodologies are employed in preclinical studies of cancer drug development, and what statistical outcomes characterize the efficiency of the development process?",
            "retrieved_metrics": {
                "reference_idx": [
                    136,
                    1704,
                    1818
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #use of 2D cell cultures and animal models# in preclinical studies leads to a #lengthy and costly process#, compounded by a #high attrition rate#.",
            "predicted_answer": "Preclinical studies in cancer drug development use 2D cell cultures and animal models. Statistical outcomes show that only 10% of tested compounds reach the market, with a 5% approval rate for Phase I anti-cancer drugs, highlighting low efficiency.",
            "score": 1,
            "explanation": "The predicted answer includes the use of 2D cell cultures and animal models, aligning with the key fact in the reference. However, it misses the emphasis on the lengthy and costly process and high attrition rate mentioned in the reference, which affects overall completeness."
        },
        {
            "query_idx": 114,
            "query": "What are the comparative structural and functional advantages of scaffold-based 3D models and microfluidic systems in modeling physiological processes for studying resistance mechanisms and drug interactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    2185,
                    2187,
                    1498
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Scaffold-based #3D tumor models# offer greater #drug resistance#, whereas #tumor-on-a-chip# platforms support #perfusion culture# and exhibit #structural differences#. #Microfluidic systems# facilitate #T790M mutation# analysis and observe #phenotypic changes#.",
            "predicted_answer": "Scaffold-based 3D models support vascularization and greater drug resistance, but are limited to static culture. Microfluidic systems, like tumor-on-a-chip, simulate dynamic physiological processes, enabling better analysis of resistance mechanisms and drug interactions.",
            "score": 1,
            "explanation": "The Predicted Answer covers the key idea of greater drug resistance in scaffold-based 3D models and the simulation of physiological processes by microfluidic systems. However, it lacks details about perfusion culture, structural differences, T790M mutation analysis, and phenotypic changes. These omissions impact completeness significantly."
        },
        {
            "query_idx": 115,
            "query": "What challenges are associated with developing affordable cancer treatments in low- and middle-income countries, in terms of representation in trials, relevant cost considerations, and the involvement of local investigators?",
            "retrieved_metrics": {
                "reference_idx": [
                    736,
                    738,
                    741
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The challenges include #minimal representation in trials#, leading to inequities, #high costs with irrelevant endpoints#, and the need for resources for #local investigators focused on biosimilars and repurposing#.",
            "predicted_answer": "Challenges include minimal representation of LMICs in trials, high costs of drugs with marginal benefits, and lack of local investigator involvement. Trials need to be designed with relevant endpoints and increased collaboration between HICs and LMICs to ensure affordable and equitable cancer care.",
            "score": 3,
            "explanation": "The predicted answer mentions the challenges of minimal representation in LMICs, high costs of drugs, and lack of local investigator involvement, which aligns with the reference. However, it misses the focus on biosimilars and repurposing, which are emphasized in the reference."
        },
        {
            "query_idx": 116,
            "query": "What techniques analyze the cellular surroundings, study genetic changes via DNA methylation and chromatin accessibility, and optimize therapeutic strategies combining epigenetic drugs with other treatments for cancer therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    607,
                    610,
                    612
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Characterizing the #tumor microenvironment# using #single-cell# methods, exploring #DNA methylation# and #chromatin accessibility#, and combining with #epigenetic drug# strategies enhance cancer treatment #efficacy#.",
            "predicted_answer": "Single-cell approaches like scATAC-seq and single-cell DNA methylation sequencing analyze cellular surroundings and genetic changes. These techniques, combined with multiomic analysis, help optimize therapeutic strategies by identifying synergies between epigenetic drugs and other cancer therapies.",
            "score": 3,
            "explanation": "The predicted answer includes key techniques like single-cell methods, DNA methylation, and chromatin accessibility, aligned with the reference. It also mentions optimizing therapeutic strategies with epigenetic drugs. However, it omits the specific mention of the \"tumor microenvironment,\" affecting completeness slightly."
        },
        {
            "query_idx": 117,
            "query": "What treatment strategy targets intracellular bacteria, shows efficacy against antibiotic-resistant pathogens, and enhances infection clearance when combined with host immune responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    45,
                    44,
                    42
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #phages# targets #intracellular bacteria#, is effective against #antibiotic-resistant pathogens# like Salmonella, and enhances clearance when combined with the host #immune response#.",
            "predicted_answer": "Phage therapy targets intracellular bacteria, shows efficacy against antibiotic-resistant pathogens, and enhances infection clearance when combined with host immune responses. It can penetrate and disrupt intracellular bacteria, offering a promising adjunctive treatment.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer by mentioning phage therapy targeting intracellular bacteria, its efficacy against antibiotic-resistant pathogens, and its enhancement of infection clearance when combined with host immune responses. No key facts are missing, and there are no contradictions."
        },
        {
            "query_idx": 118,
            "query": "What combination treatment methodology in 3D tumor models effectively reduces tumor cell viability and simultaneously impacts animal study approaches in oncological drug development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1795,
                    1806
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The combination of #AV3# and gemcitabine in innovative #spheroids# markedly decreased tumor cell viability, offering insights into reducing animal studies in drug development.",
            "predicted_answer": "The combination of gemcitabine and AV3 in 3D heterospheroids significantly reduces tumor cell viability. This approach, validated in both in vitro and in vivo models, enhances drug development by reducing and informing animal studies.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions the combination of gemcitabine and AV3, capturing the key fact. It mentions \"3D heterospheroids\" which aligns with \"spheroids\" in the reference answer, and also addresses the impact on drug development. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 119,
            "query": "Which molecular target's involvement in cancer metabolism is crucial for its survival and proliferation, influences breast cancer's resistance to radiotherapy, and is being considered for targeted therapy development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1301,
                    1330,
                    1331
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The involvement of #CPT1A# in cancer metabolism is crucial for growth. Its #inhibition# impacts breast cancer's resistance to radiotherapy, and it is a promising #therapeutic target#.",
            "predicted_answer": "CPT1A is crucial for cancer metabolism, survival, and proliferation. It influences breast cancer's resistance to radiotherapy and is being considered for targeted therapy development.",
            "score": 3,
            "explanation": "The key facts regarding CPT1A's involvement in cancer metabolism and its importance as a therapeutic target are present in the predicted answer. However, the predicted answer misses the specific emphasis on \"inhibition\" affecting radiotherapy resistance, which affects completeness."
        },
        {
            "query_idx": 121,
            "query": "What range of antigens does TCR-T therapy target, what complex facilitates its signal transmission, and what engineering technique is applied to modify T-cell therapies for enhanced specificity?",
            "retrieved_metrics": {
                "reference_idx": [
                    948,
                    947,
                    2110
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "TCR-T therapy targets #a wide range of intratumoral antigens#, forms a #TCR-CD3 complex# to transmit signals, and is modified through #CRISPR-Cas9# for enhanced efficacy in solid tumors.",
            "predicted_answer": "TCR-T therapy targets a wide range of intratumoral antigens, including TAAs and TSAs. The TCR-CD3 complex facilitates signal transmission. CRISPR-Cas9 is used to engineer T-cells for enhanced specificity.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects all key facts from the reference answer, including the targeting of a wide range of intratumoral antigens, the role of the TCR-CD3 complex, and the use of CRISPR-Cas9 for enhanced specificity. There are no omissions or contradictions."
        },
        {
            "query_idx": 122,
            "query": "What is the protein degradation mechanism that uses E3 ligase for treating certain cancers, and what are the specific drug candidates in clinical trials applying this technology?",
            "retrieved_metrics": {
                "reference_idx": [
                    572,
                    1577,
                    569
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The mechanism is #ubiquitination and degradation# via #PROTACs#, with drugs like #Arv-110# and #Arv-471# in trials for specific cancers.",
            "predicted_answer": "The mechanism is called PROTAC, which uses E3 ligase to ubiquitinate and degrade target proteins. Specific drug candidates in clinical trials include Arv-110 for prostate cancer and Arv-471 for breast cancer.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the mechanism as PROTAC, detailing ubiquitination and protein degradation. It also lists the specific drug candidates, Arv-110 and Arv-471, as in clinical trials, aligning well with the reference. All key facts and trends are captured without omission."
        },
        {
            "query_idx": 123,
            "query": "Which endocrine-related cancer has shown an increased frequency and is linked to immune complications caused by a viral pandemic?",
            "retrieved_metrics": {
                "reference_idx": [
                    2147,
                    2151
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #rise in thyroid cancer# is linked to #autoimmune complications# due to the #COVID-19 pandemic#.",
            "predicted_answer": "Thyroid cancer, an endocrine malignancy, has shown an increased frequency and is linked to immune complications following the COVID-19 pandemic.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer by mentioning the increase in thyroid cancer linked to the COVID-19 pandemic. However, it omits the specific mention of \"autoimmune complications.\" This missing detail affects completeness but doesn't contradict the reference."
        },
        {
            "query_idx": 124,
            "query": "Which compounds have demonstrated anticancer activity against both MCF-7 and HeLa cell lines, and identify the derivative that shows broad efficacy across various cancer types?",
            "retrieved_metrics": {
                "reference_idx": [
                    1261,
                    1274,
                    223
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Compounds #27# and #29# target #MCF-7#, while compound #8b# targets #HeLa# and #MCF-7#. N-methylated derivative #73# shows efficacy against multiple cancer types.",
            "predicted_answer": "Compounds 27 and 29 show anticancer activity against both MCF-7 and HeLa cell lines. The N-methylated derivative 73 of synthetic pyrazine bisindole exhibits broad efficacy across various cancer types, including leukemia, lung, colon, CNS, ovarian, kidney, and breast cancers.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies compounds 27 and 29 for both cell lines, matching the reference answer for MCF-7 but misses compound 8b for HeLa. It also accurately identifies the broad efficacy of N-methylated derivative 73. Thus, it aligns with the key facts but omits one for HeLa."
        },
        {
            "query_idx": 125,
            "query": "What is established from patient biopsy-derived cells for drug testing, verified in multiple cancers, and leads to establishing a repository to support personalized treatment research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1448,
                    1465,
                    1405
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#PDOs# are cultivated from biopsy-derived cells, with verified #predictability# in various cancers, leading to a #biobank# creation aimed at advancing #personalized treatment# research.",
            "predicted_answer": "Patient-derived organoids (PDOs) are established from patient biopsy-derived cells for drug testing, verified in multiple cancers including colorectal, prostate, and pancreatic. This leads to establishing a repository to support personalized treatment research.",
            "score": 3,
            "explanation": "The Predicted Answer mentions PDOs, biopsy-derived cells, verification in multiple cancers, and personalized treatment, aligning with the Reference Answer. However, it omits the specific term \"predictability\" and does not mention \"biobank.\" These omissions affect completeness."
        },
        {
            "query_idx": 126,
            "query": "What CRISPR-based method utilizes a streamlined transcription process to address recombination and transcriptional bias issues while enabling the targeting of several genes with a single setup?",
            "retrieved_metrics": {
                "reference_idx": [
                    1954,
                    1953,
                    1955
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #Cas12a# system processes #multiple guides from a single transcript#, avoiding #promoter bias and recombination# seen in SpCas9, while the #(en)AsCas12a# variant efficiently targets #multiple genes in one construct#.",
            "predicted_answer": "The CRISPR-based method that addresses recombination and transcriptional bias while enabling the targeting of several genes with a single setup is the use of Cas12a, which can process multiple guides from a single, compact transcript.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the use of Cas12a for processing multiple guides from a single transcript, aligning with key facts in the reference. However, it omits the mention of the (en)AsCas12a variant and its efficacy in targeting multiple genes. Thus, it misses one key fact."
        },
        {
            "query_idx": 127,
            "query": "Which specific selenourea compounds demonstrate radical scavenging activity and antitumor effects, particularly in HeLa cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1868,
                    1885,
                    1867
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #Selenourea-based compound 6# exhibits radical scavenging, #N-phenylselenourea# demonstrates antitumor effects on #HeLa cells#, and #selenoureas# efficiently scavenge radicals.",
            "predicted_answer": "Compounds 41 and 42, both containing selenourea groups, demonstrate radical scavenging activity and antitumor effects, particularly in HeLa cells, with IC50 values of 1.9-11.8 µM and 0.7-6.6 µM, respectively.",
            "score": 1,
            "explanation": "The predicted answer identifies compounds 41 and 42 with radical scavenging and antitumor effects, unlike the reference, which specifically notes compound 6 and N-phenylselenourea. The predicted answer misses key details from the reference and instead presents potentially differing information without contradiction."
        },
        {
            "query_idx": 128,
            "query": "What methods are used to extract marine-derived bisindoles, how are these compounds identified for cancer therapy development, and which examples highlight their progression to clinical drug approval?",
            "retrieved_metrics": {
                "reference_idx": [
                    1245,
                    1298,
                    1246
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Marine-derived bisindoles are extracted using #organic solvents# and #chromatography#. Identified for #anticancer drug development#, they have led to #approved drugs with anticancer effects#.",
            "predicted_answer": "Marine-derived bisindoles are extracted using organic solvents and chromatography. They are identified for cancer therapy through their unique biological activities. Examples like midostaurin, lestaurtinib, and enzastaurin highlight their progression to clinical approval.",
            "score": 3,
            "explanation": "The predicted answer aligns largely with the reference answer, mentioning \"organic solvents\" and \"chromatography\" for extraction, and focuses on identifying via unique biological activities for cancer therapy. However, it misses the emphasis on \"anticancer drug development\" and \"approved drugs with anticancer effects\"."
        },
        {
            "query_idx": 129,
            "query": "How are advancements in creating complex human disease models changing the drug development process and improving its outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1151,
                    1154,
                    1150
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Advancements in #bioengineering# lead to #bioengineered human-based models# that foster a #paradigm shift#, enhancing #clinical translation# processes with high #clinical mimicry# in drug development.",
            "predicted_answer": "Advancements in creating complex human disease models, such as organoids and organs-on-chips, are improving the drug development process by providing better clinical biomimicry. This leads to more accurate predictions, higher translation rates, and reduced costs, ultimately benefiting patients.",
            "score": 3,
            "explanation": "The predicted answer covers trends such as clinical biomimicry and improved drug development but lacks explicit mention of bioengineering or bioengineered models, which are highlighted as key facts in the reference. This omission affects the completeness of the answer."
        },
        {
            "query_idx": 130,
            "query": "What challenges affect siRNA bioavailability inside hepatocytes, taking into account surface receptor abundance, cellular internalization difficulties, and intracellular molecule breakdown processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2134,
                    2131,
                    2130
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The siRNA bioavailability in hepatocytes is limited by challenges like #endosomal escape#, low #expression levels# of #receptors#, high #siRNA degradation#, restricted #expression range#, low #siRNA escape rate#, and advantageous #receptor characteristics#.",
            "predicted_answer": "Challenges include low surface receptor abundance, inefficient cellular internalization, and significant intracellular breakdown. Only a small fraction of siRNA escapes endosomes, with most degrading before reaching the cytoplasm. ASGPR-mediated uptake is more effective but still faces endosomal escape issues.",
            "score": 1,
            "explanation": "The 'Predicted Answer' aligns with the 'Reference Answer' by mentioning endosomal escape, low receptor presence, and high siRNA degradation. However, it omits details about restricted expression range and advantageous receptor characteristics. The trends align but two key facts are missing."
        },
        {
            "query_idx": 131,
            "query": "What method is used for testing drugs on a particular breast cancer cell type that is cost-effective, contributes to individualized treatment development, and is utilized in studying drug resistance?",
            "retrieved_metrics": {
                "reference_idx": [
                    341,
                    354,
                    1789
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #spheroid culture method# tests drugs on #MCF-7 cells#, is #inexpensive#, facilitates #personalized medicine#, and helps investigate #drug resistance mechanisms#.",
            "predicted_answer": "The spheroid culture method is used for testing drugs on breast cancer cells. It is cost-effective, suitable for individualized treatment development, and useful in studying drug resistance. This method requires fewer cells and mimics in vivo conditions.",
            "score": 3,
            "explanation": "The predicted answer aligns well with the reference. It covers the #spheroid culture method# being #cost-effective#, aiding in #individualized treatment development/personalized medicine#, and #studying drug resistance#. However, it misses the specific #MCF-7 cells# detail, which reduces completeness slightly."
        },
        {
            "query_idx": 132,
            "query": "How are diverse computational methodologies applied for identifying potential anti-cancer compounds, and what roles do ligand-based and structure-based pharmacophore models play in this process?",
            "retrieved_metrics": {
                "reference_idx": [
                    1651,
                    1652,
                    1666
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Computational strategies# include #virtual screening, molecular dynamics, and machine learning#. Ligand-based models use #known actives#; structure-based models analyze #receptor-ligand interactions# for anti-cancer phytomolecules.",
            "predicted_answer": "Diverse computational methodologies, including virtual screening, molecular dynamics, and machine learning, are used to identify potential anti-cancer compounds. Ligand-based pharmacophore models use known active compounds, while structure-based models require a receptor-ligand complex to understand binding interactions. Both approaches help in discovering new anti-cancer leads from phytomolecules.",
            "score": 5,
            "explanation": "The predicted answer includes all key computational strategies mentioned in the reference—virtual screening, molecular dynamics, and machine learning. It correctly describes ligand-based and structure-based pharmacophore models and their roles, aligned with the reference. All key facts and trends are reflected without omissions or contradictions."
        },
        {
            "query_idx": 133,
            "query": "What animal age, immune status classifications, and model characteristics are necessary for developing human breast cancer bone metastasis models, and how do these factors affect tumor development?",
            "retrieved_metrics": {
                "reference_idx": [
                    2069,
                    2074,
                    2062
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Animal models require #5 to 8 weeks age#, classification by #immune status# like immunodeficient, such as #BALB/c nude#, affecting metastatic #tumorigenesis stages# and growth processes.",
            "predicted_answer": "For developing human breast cancer bone metastasis models, animals aged 5 to 8 weeks are essential. Models can be immunocompetent (complete immune system) or immunodeficient (e.g., BALB/c nude, NOD SCID), affecting tumor growth and immune interaction.",
            "score": 3,
            "explanation": "The predicted answer matches the key facts from the reference, including the necessity of animals aged 5 to 8 weeks and the use of immunodeficient classifications like BALB/c nude. It mentions effects on tumor growth, aligning with the trend. However, it lacks specific mention of metastatic tumorigenesis stages."
        },
        {
            "query_idx": 134,
            "query": "What process allows for the high-density creation of cancer models, enhancing their three-dimensional complexity and precision, to enable detailed studies of tumor interactions with different cell types?",
            "retrieved_metrics": {
                "reference_idx": [
                    2045,
                    2048,
                    1970
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #bioprinting# enables the creation of high-density cancer models, #supports three-dimensional# structuring, and #enhances the complexity and precision# of tumor models for studying cellular interactions.",
            "predicted_answer": "High-density bioprinting allows for the creation of complex, three-dimensional cancer models with precise cell distribution and interactions, using bioinks that are printable, cross-linkable, and biocompatible. This method enhances tumor model accuracy and supports detailed studies of tumor interactions.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts from the reference answer. It mentions \"bioprinting,\" the enhancement of \"three-dimensional\" complexity, and the \"precision\" of tumor models for studying interactions, which aligns with the emphasized points. No significant details are missing."
        },
        {
            "query_idx": 135,
            "query": "What molecular docking analysis aspects are crucial for understanding the interaction of compounds with DNA and the specific interaction types seen in DNA-cisplatin complexes?",
            "retrieved_metrics": {
                "reference_idx": [
                    230,
                    232,
                    246
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The analysis revealed #intercalation with DNA# for Compounds (8a) and (8b), identified #docking scores for DNA-cisplatin#, and noted #hydrophobic interactions with residues Phe256, Thr255, Tyr204, and Leu168#.",
            "predicted_answer": "Crucial aspects include binding affinity, intercalation ability, and specific interaction types such as hydrogen bonding and hydrophobic interactions. In DNA-cisplatin complexes, key interactions involve covalent bonding with purine bases.",
            "score": 1,
            "explanation": "The predicted answer mentions intercalation and hydrophobic interactions, aligning with the key facts about intercalation and hydrophobic interactions in the reference. However, it lacks the specificity of docking scores and interactions with specific residues, impacting completeness."
        },
        {
            "query_idx": 136,
            "query": "What research model is used in studying the effects of gene interactions on adenoma progression while facing limitations in representing later cancer stages?",
            "retrieved_metrics": {
                "reference_idx": [
                    1392,
                    1390
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#APC(Min/+) mice# are used to study gene interaction effects on adenoma progression and face limitations in accurately representing #advanced cancer stages#.",
            "predicted_answer": "APC(Min/+) mice are used to study gene interactions on adenoma progression but are limited in representing later cancer stages. Supplementary models like PDX and organoids are needed for advanced CRC research.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies APC(Min/+) mice as the research model used to study adenoma progression and notes the limitation in representing advanced cancer stages. It adds information about supplementary models for further research, which does not contradict the reference. All key facts are covered."
        },
        {
            "query_idx": 137,
            "query": "Modify the multi-hop query:\nWhat therapeutic strategy is utilized to overcome the inadequacy of single-agent cancer treatments by incorporating established and innovative medications, including examining their simultaneous deployment for potential improvement in disease management?",
            "retrieved_metrics": {
                "reference_idx": [
                    2230,
                    2250,
                    860
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "Combinatory therapy, which integrates established and innovative medications, including repurposed drugs, is used to target the multifaceted oncogenic signaling network, improving treatment efficacy and overcoming resistance in cancer management.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the therapeutic strategy involving combinatory therapy that incorporates both established and innovative medications to improve cancer treatment efficacy. It aligns with the overall trend and does not contradict the reference answer, despite the reference not providing specific key points."
        },
        {
            "query_idx": 138,
            "query": "Which immune molecule modulates the tumor microenvironment by affecting cytokine production, macrophage phenotype, and influences tumor cell behaviors through specific signaling pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1361,
                    1359,
                    1349
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#B7-H3# modifies the #immunosuppressive microenvironment#, influences macrophage #polarization#, involves the #JAK-STAT3# pathway, and is crucial in #cancer progression#.",
            "predicted_answer": "B7-H3 modulates the tumor microenvironment by promoting IL-10 and TGF-β1 production, inhibiting T cell and NK cell activity, and influencing macrophage polarization towards the M2 phenotype, which contributes to an immunosuppressive environment.",
            "score": 1,
            "explanation": "The predicted answer includes the key molecule \"B7-H3\" and its role in modulating the tumor microenvironment. It mentions macrophage polarization, which aligns with the reference. However, it misses the \"JAK-STAT3\" pathway and \"cancer progression,\" impacting completeness."
        },
        {
            "query_idx": 139,
            "query": "What emerging alternative treatment in oncology demonstrates superior tumor recognition compared to blood-derived immune cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    942,
                    943
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#CARNK# is an alternative cancer treatment showing #greater than 60%# tumor recognition, outperforming blood-derived immune cells.",
            "predicted_answer": "TIL therapy, using Tumor-Infiltrating Lymphocytes, demonstrates superior tumor recognition, with over 60% of TILs identifying tumors compared to less than 0.5% of blood-derived immune cells.",
            "score": 1,
            "explanation": "The predicted answer incorrectly identifies the emerging treatment as TIL therapy, while the reference specifies CARNK. Both mention over 60% tumor recognition but differ in treatment and cell types. This constitutes a significant omission, affecting accuracy and completeness."
        },
        {
            "query_idx": 140,
            "query": "What variations in molecular docking characteristics, such as bonding types and affinity scores, are identified in comparing two distinct ligand-protein complexes and one with the same ligand but a different protein?",
            "retrieved_metrics": {
                "reference_idx": [
                    241,
                    247,
                    242
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "In molecular docking, #NFκB-doxorubicin# forms #hydrogen bonds# with a score of #-4.52 kcal/mol#. #NFκB-cisplatin# lacks hydrogen bonds, scoring #-2.38 kcal/mol#. #p53-cisplatin# has #hydrogen bonds# and scores #-3.27 kcal/mol#.",
            "predicted_answer": "Comparing the complexes, variations include different docking scores and types of bonds. For example, NFκB-doxorubicin has a moderate score (-4.52 kcal/mol) with hydrogen bonds, while NFκB-cisplatin and Caspase 3-cisplatin have weak scores (-2.38 and -2.57 kcal/mol) with only hydrophobic interactions.",
            "score": 1,
            "explanation": "The predicted answer includes correct information about NFκB-doxorubicin and NFκB-cisplatin but misses details about p53-cisplatin, notably the presence of hydrogen bonds and its score (-3.27 kcal/mol). There’s an error with substituting Caspase 3-cisplatin instead of p53-cisplatin, impacting completeness."
        },
        {
            "query_idx": 141,
            "query": "Modify the multi-hop query:  \nWhich transmembrane protein, involved in cancer pathology, is found at immune cell interaction sites, suppresses immune activation, and is a focus in advancing therapeutic interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1355,
                    1387,
                    1385
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "B7-H3 is a transmembrane protein involved in cancer pathology, found at immune cell interaction sites. It suppresses T cell activation and is a focus in advancing therapeutic interventions, including monoclonal antibodies and CAR-T therapy.",
            "score": 5,
            "explanation": "The predicted answer includes key facts from the reference: #B7-H3 as a transmembrane protein#, #involved in cancer pathology#, #found at immune cell interaction sites#, #suppresses T cell activation#, and #is a focus in advancing therapeutic interventions#. No significant omissions or errors."
        },
        {
            "query_idx": 142,
            "query": "What are the primary motivations for adopting innovative techniques in drug development, and what challenges impede their use specifically in natural product-derived anti-cancer drug research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1654,
                    1697,
                    1703
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #high costs and time consumption# of traditional methods drive the use of #ML tools#, yet they face #limited evidence# in #NP-derived anticancer# drug research, lacking resources and tools.",
            "predicted_answer": "Primary motivations for adopting innovative techniques in drug development include reducing costs and time. Challenges in natural product-derived anti-cancer drug research include limited publicly available ML models and the dominance of traditional methods.",
            "score": 1,
            "explanation": "The predicted answer correctly identifies the motivation of reducing costs and time. However, it lacks mention of #ML tools#, #limited evidence#, and the focus on #NP-derived anticancer# research, which are key facts highlighted in the reference answer."
        },
        {
            "query_idx": 143,
            "query": "How is artificial intelligence fundamentally transforming cancer care in terms of enhancing treatment personalization, improving disease progression understanding, and integrating emerging healthcare trends?",
            "retrieved_metrics": {
                "reference_idx": [
                    115,
                    127,
                    1232
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI is reshaping cancer care with #precision oncology# enhancing personalization, #predictive modeling# offering disease insights, and future #trends# such as multi-omics shaping the next advancements.",
            "predicted_answer": "AI is transforming cancer care by enabling precision oncology, which personalizes treatments based on individual patient and disease profiles. It enhances understanding of disease progression through predictive modeling and integrates emerging trends like multi-omics and explainable AI, improving treatment efficacy and patient outcomes.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts: precision oncology, predictive modeling, and emerging trends like multi-omics and explainable AI. It aligns with the reference answer's meaning and details, with no significant omissions or errors."
        },
        {
            "query_idx": 144,
            "query": "How do three-dimensional (3D) models address the limitations of two-dimensional (2D) models and animal models in bone metastasis research, and what challenges do 3D models themselves face?",
            "retrieved_metrics": {
                "reference_idx": [
                    2084,
                    2081,
                    2064
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Advanced #3D models# overcome #static conditions# of 2D models and #ethical, cost# concerns of animal models but face challenges like #irregular cellular proliferation#.",
            "predicted_answer": "3D models address 2D and animal model limitations by replicating the tumor microenvironment, enabling better drug efficacy testing, and overcoming ethical and cost issues. However, 3D models face challenges such as irregular cell proliferation, autofluorescence, and genetic/epigenetic alterations.",
            "score": 3,
            "explanation": "The predicted answer captures the key points of 3D models addressing limitations of 2D models and animal models, including cost and ethical issues. It also identifies challenges like irregular cell proliferation. However, \"static conditions\" of 2D models emphasized in the reference answer are not explicitly mentioned."
        },
        {
            "query_idx": 145,
            "query": "What methodology uses predictive models to assess patient data continuously, ensuring personalized care, and employs decision support systems for optimizing therapy plans based on specific disease traits?",
            "retrieved_metrics": {
                "reference_idx": [
                    123,
                    128,
                    1219
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#AI-driven prediction modeling# ensures #real-time analysis# of patient data for personalized care and integrates #treatment planning# with decision support systems to optimize therapy selection based on disease traits.",
            "predicted_answer": "The methodology that uses predictive models to continuously assess patient data, ensuring personalized care, and employs decision support systems for optimizing therapy plans based on specific disease traits is AI-driven prediction modeling.",
            "score": 1,
            "explanation": "The predicted answer mentions \"AI-driven prediction modeling,\" aligning with the reference. However, it lacks the concepts of \"real-time analysis\" and \"treatment planning,\" which are crucial for assessing data continuously and integrating decision support systems. These omissions affect the answer's completeness."
        },
        {
            "query_idx": 146,
            "query": "How do phage vaccines enhance immune responses and act as adjuvants through receptor activation?",
            "retrieved_metrics": {
                "reference_idx": [
                    51,
                    58,
                    75
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Phage vaccines# stimulate immune responses by activating #naïve T-cells# and B-cell responses. Their #adjuvant activity# involves #TLRs# and #PRRs#, with phages enhancing efficacy by #presenting viral antigens#.",
            "predicted_answer": "Phage vaccines enhance immune responses by activating Toll-like receptors and other pattern-recognition receptors, which boosts antigen presentation and cytokine production. This self-adjuvanting activity, along with the presentation of antigens to T-cells, enhances both cellular and humoral immunity.",
            "score": 3,
            "explanation": "The predicted answer covers key facts such as phage vaccines activating TLRs and PRRs, and enhancing immune responses, aligning with the overall trend of the reference. However, it misses specific mentions of directly activating naïve T-cells and B-cell responses. Despite this, there is no contradiction."
        },
        {
            "query_idx": 147,
            "query": "What structural features and mechanisms in a lung cancer treatment enhance targeting and what resistance mechanisms affect the efficacy of targeted cytotoxic delivery?",
            "retrieved_metrics": {
                "reference_idx": [
                    168,
                    206,
                    166
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Antibody-drug conjugates (#structure and mechanism#) enhance targeting as #agents of precision oncology#. Resistance involves #adaptations affecting drug binding#, impacting effectiveness.",
            "predicted_answer": "ADCs enhance targeting in lung cancer by delivering cytotoxic agents to cells with specific surface targets. Resistance mechanisms include reduced target expression, upregulation of drug efflux pumps, and altered endocytosis and lysosomal trafficking.",
            "score": 1,
            "explanation": "The predicted answer partially matches the reference answer. It covers how ADCs enhance targeting but omits their description as \"agents of precision oncology.\" While it mentions resistance mechanisms, it misses \"#adaptations affecting drug binding#,\" impacting completeness."
        },
        {
            "query_idx": 148,
            "query": "How do lymphatic systems and vascular perfusion affect drug behavior in tumor models, and what technologies have advanced the design of these models for enhanced treatment assessment?",
            "retrieved_metrics": {
                "reference_idx": [
                    2214,
                    2232,
                    2043
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Drug accumulation# is influenced by the presence of a #lymphatic drainage system#. #Perfusion# impacts #tumor spheroid volume#, while #bioprinting# and #microfluidics# advance #tumor models# for improved treatment evaluation.",
            "predicted_answer": "Lymphatic systems and vascular perfusion influence drug behavior in tumor models by affecting drug clearance and accumulation. Advanced technologies like bioprinting and microfluidics have improved the design of these models, enabling more realistic simulations of tumor vasculature and enhanced treatment assessment.",
            "score": 3,
            "explanation": "The predicted answer mentions \"drug accumulation\" and \"lymphatic systems\" but omits the specific impact on \"tumor spheroid volume\" noted in the reference. It correctly includes \"bioprinting\" and \"microfluidics\" for model enhancement. The trend aligns, but one key detail is missing."
        },
        {
            "query_idx": 149,
            "query": "How are three-dimensional systems derived from lung epithelial cells implemented to support critical tumor-related processes, including expression of specific proteins, and what are their implications in cellular development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1473,
                    2183,
                    2033
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#3D models derived from lung epithelial cells# facilitate #tumor development and metastasis# by replicating #tumor tissue features like morphology and pro-angiogenic protein expression#.",
            "predicted_answer": "Three-dimensional systems from lung epithelial cells, such as spheroids and scaffold-based models, support tumor-related processes by mimicking in vivo conditions, enhancing specific protein expression, and facilitating cell-cell and cell-ECM interactions, which are crucial for cellular development and drug testing.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by discussing 3D models and their role in replicating in vivo conditions and enhancing protein expression. However, it misses specific emphasis on \"tumor tissue features like morphology and pro-angiogenic protein expression” and the specifics of \"metastasis,” which are critical details."
        },
        {
            "query_idx": 150,
            "query": "How do organoids contribute to advancements in precision oncology, particularly in analyzing genetic expressions, optimizing personalized medicine through pharmacogenomics, and evaluating new therapeutic approaches?",
            "retrieved_metrics": {
                "reference_idx": [
                    1419,
                    1980,
                    1797
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Organoids contribute by enabling the analysis of #gene expression# in colorectal cancer, advancing personalized oncology through #pharmacogenomics#, and facilitating testing of therapies such as #ERK inhibitors# for liver cancer.",
            "predicted_answer": "Organoids contribute to precision oncology by enabling drug sensitivity testing, analyzing genetic expressions, and evaluating new treatments. Their high similarity to original tumors supports personalized medicine, optimizing pharmacogenomics and enhancing therapeutic effectiveness.",
            "score": 1,
            "explanation": "The predicted answer covers analyzing genetic expressions and contributions to personalized medicine through pharmacogenomics, aligning with the reference. However, it lacks the specific mention of ERK inhibitors for liver cancer and colorectal cancer as an example. Therefore, it misses more than one key fact."
        },
        {
            "query_idx": 151,
            "query": "What specific cell model configurations are utilized to assess anticancer drug efficacy before animal testing and predict in vivo responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    1764,
                    1770,
                    1793
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Spheroids# enhance drug efficacy prediction compared to 2D models. #3D in vitro models# align with spheroid-derived xenograft responses. #Heterospheroids# integrate cancer and stromal cells to pre-test anticancer efficacy.",
            "predicted_answer": "2D cell cultures and 3D spheroids are used to assess anticancer drug efficacy. Spheroids, particularly heterospheroids with cancer cells and stellate cells, better predict in vivo responses compared to 2D models.",
            "score": 3,
            "explanation": "The predicted answer covers key facts about spheroids and the comparison to 2D models. It acknowledges heterospheroids with cancer and stellate cells. However, it does not explicitly mention \"3D in vitro models\" and their alignment with xenograft responses, missing one key emphasis from the reference."
        },
        {
            "query_idx": 152,
            "query": "What specific engineered antibody fragments are designed to improve tumor uptake and clearance rates and mitigate issues associated with prolonged serum circulation and immune-related side effects?",
            "retrieved_metrics": {
                "reference_idx": [
                    911,
                    912
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#scFv fragments# improve imaging with short half-life, while #medium-sized fragments# like Diabodies enhance tumor uptake and clearance, reducing #prolonged serum presence# and #immune-related risks#.",
            "predicted_answer": "Specific engineered antibody fragments such as scFv, diabodies, and PEGylated Fab fragments are designed to improve tumor uptake and clearance rates. These smaller fragments have a shorter half-life, reducing immune-related side effects and enhancing tumor penetration.",
            "score": 5,
            "explanation": "The predicted answer includes important facts such as \"scFv fragments\" and \"diabodies,\" which align with the reference. It also mentions smaller fragments' shorter half-life and reduced immune effects, covering \"prolonged serum presence\" and \"immune-related risks\". No major omissions or errors were observed."
        },
        {
            "query_idx": 153,
            "query": "What are the observed differences in drug effectiveness when using organoid models in non-small cell lung cancer and adenocarcinoma compared to gastrointestinal cancers using patient-derived models?",
            "retrieved_metrics": {
                "reference_idx": [
                    762,
                    1484,
                    761
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "PDOs show #Cisplatin#'s limited efficacy in #NSCLC#, while EGFR tumoroids facilitate #targeted therapies#. Patient-derived models evaluate #drug reactions# in #HCC# and #CRC#, enhancing understanding of resistance.",
            "predicted_answer": "In non-small cell lung cancer and adenocarcinoma, organoid models have shown that drugs like cisplatin are less effective compared to cell lines, indicating potential resistance. In gastrointestinal cancers, organoids accurately recapitulate drug responses and treatment resistance, aiding in evaluating therapies.",
            "score": 1,
            "explanation": "The predicted answer includes the key fact about cisplatin's limited efficacy in NSCLC but misses the mention of targeted therapies facilitated by EGFR tumoroids and specific evaluations in HCC and CRC. It covers general trends but lacks some details emphasized in the reference."
        },
        {
            "query_idx": 154,
            "query": "How do compounds 45, 31, and 37-39 affect both the progression of the cell cycle and the activity of a key kinase in cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1266,
                    1263,
                    1265
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Compound 45#, #Compound 31#, and #Compounds 37, 38, and 39# lead to G2/M phase arrest and inhibit #CDK1 activity# in cancer cells.",
            "predicted_answer": "Compounds 45, 31, and 37-39 inhibit CDK1 activity, leading to G2/M phase cell cycle arrest and increased apoptosis in cancer cells. Compound 31 specifically constrains cells to the G2/M phase, while 37-39 block the cell cycle by reducing phosphorylated survivin.",
            "score": 5,
            "explanation": "The predicted answer covers all the key facts: the involvement of compounds 45, 31, 37-39, inhibition of CDK1 activity, and G2/M phase arrest in cancer cells. The additional detail about apoptosis and phosphorylated survivin does not contradict the reference."
        },
        {
            "query_idx": 155,
            "query": "How do chemical gradients, variations in metabolism within spheroid inner layers, and spheroid density collectively impact therapeutic strategies and their effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    2036,
                    2037,
                    1714
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Chemical gradients increase #drug resistance#. Variations in inner layers' metabolism impact #radiation therapy#. Higher #spheroid density# restricts drug #transport#.",
            "predicted_answer": "Chemical gradients, variations in metabolism within spheroid inner layers, and increased spheroid density collectively enhance drug resistance by limiting drug penetration and altering cellular responses, thus impacting therapeutic effectiveness.",
            "score": 3,
            "explanation": "The Predicted Answer mentions chemical gradients and increased spheroid density contributing to drug resistance and limited drug penetration, aligning with the Reference's mention of drug resistance and restricted drug transport. However, it misses the specific impact on \"radiation therapy\" linked to metabolism variations, affecting completeness."
        },
        {
            "query_idx": 156,
            "query": "Which clinical trial established a new standard of care for colorectal cancer by supporting an immune checkpoint inhibitor's approval for cases with genetic characteristics involving microsatellite instability?",
            "retrieved_metrics": {
                "reference_idx": [
                    671,
                    1036,
                    672
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The clinical trial #KEYNOTE177# established a new treatment standard by leading to #pembrolizumab# approval in June 2020 for colorectal cancer with #high microsatellite instability# and #mismatch repair deficiency# based on #PFS benefit#.",
            "predicted_answer": "The KEYNOTE-177 trial established a new standard of care for colorectal cancer with high microsatellite instability, supporting pembrolizumab's approval due to its durable response and better safety profile.",
            "score": 3,
            "explanation": "The predicted answer matches the key facts in the reference: the trial KEYNOTE-177, pembrolizumab approval, and high microsatellite instability. However, it omits 'mismatch repair deficiency' and the 'PFS benefit', which affects answer completeness."
        },
        {
            "query_idx": 157,
            "query": "What was the approval rate for new medications targeting a specific type of illness from 2020 to 2021, and what roles do artificial intelligence technologies play in enhancing treatment methods for these illnesses?",
            "retrieved_metrics": {
                "reference_idx": [
                    269,
                    1210,
                    1222
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "In 2020-2021, #40% of drugs approved# were for #cancer#. AI enhances #precision and workflow# in treatment and aids in identifying #biomarkers# for personalized therapy.",
            "predicted_answer": "The context does not provide the specific approval rate for new medications. However, 40% of FDA-approved drugs in 2020 and 2021 were for various types of cancers. AI technologies enhance treatment methods by improving precision, discovering new biomarkers, and personalizing therapies.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes the key facts from the 'Reference Answer': \"40% of drugs approved were for cancer\" and the role of AI in enhancing precision, discovering biomarkers, and personalizing therapies. It captures all essential points and aligns with the reference's overall meaning."
        },
        {
            "query_idx": 158,
            "query": "What biases challenge the assessment of a diabetes drug's efficacy when it is repurposed for cancer treatment in retrospective studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    2265,
                    2264
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The efficacy assessment of the diabetes drug #metformin# for cancer treatment in retrospective studies is challenged by #selection bias# and #immortal time bias#.",
            "predicted_answer": "Selection bias and immortal time bias challenge the assessment of a diabetes drug's efficacy when repurposed for cancer treatment in retrospective studies. These biases can lead to overestimation of the treatment's benefits.",
            "score": 3,
            "explanation": "The predicted answer includes the key biases: selection bias and immortal time bias, which are highlighted in the reference answer. However, it omits the specific mention of the drug #metformin#, which is a key fact, affecting completeness."
        },
        {
            "query_idx": 159,
            "query": "What strategy in drug development incorporates patient genetic profiles for optimizing dosage and considers emerging drug-gene interactions while aligning with new therapeutic policy recommendations?",
            "retrieved_metrics": {
                "reference_idx": [
                    703,
                    731,
                    692
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The strategy involves #exposure differentiation# using genetic profiles, accounts for #emerging interactions# in treatment development, and aligns with #genome-guided treatment# policies.",
            "predicted_answer": "The strategy in drug development that incorporates patient genetic profiles for optimizing dosage and considers emerging drug-gene interactions, while aligning with new therapeutic policy recommendations, is pharmacogenomics-guided dose stratification.",
            "score": 1,
            "explanation": "The predicted answer closely aligns with the reference answer's emphasis on using genetic profiles for dosage optimization and considering emerging drug-gene interactions. However, it lacks specific mention of \"exposure differentiation\" and \"genome-guided treatment\" policies, missing more than one key fact."
        },
        {
            "query_idx": 160,
            "query": "What selective nucleophilic agent is employed in the production of clinical PET radiotracers, and in what types of reactions is this agent specifically involved?",
            "retrieved_metrics": {
                "reference_idx": [
                    1523,
                    1524,
                    1522
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#$^{18}$F fluoride# serves as a selective nucleophilic agent for the #synthesis of clinically used PET radiotracers#, involved in #nucleophilic substitution reactions#, contrasting with electrophilic substitutions used by [$^{18}$F]fluorine.",
            "predicted_answer": "$^{18}$F fluoride is the selective nucleophilic agent used in producing clinical PET radiotracers. It is involved in nucleophilic substitution reactions, both aliphatic and aromatic, for synthesizing radiotracers like [$^{18}$F]FDG, $^{18}$F-FLT, $^{18}$F-FES, and $^{18}$F-choline.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts: $^{18}$F fluoride as a selective nucleophilic agent for PET radiotracers and its involvement in nucleophilic substitution reactions. It does not mention the contrast with electrophilic substitutions highlighted in the reference, which affects completeness."
        },
        {
            "query_idx": 161,
            "query": "What are the advantages in terms of cost savings and time efficiency of using existing drug compounds compared to developing new drug compounds in the pharmaceutical field?",
            "retrieved_metrics": {
                "reference_idx": [
                    1829,
                    2235
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Using existing drug compounds offers #85% cost reduction# and shortens the market timeline to #6.5 years# compared to developing new drug compounds.",
            "predicted_answer": "Using existing drug compounds for new indications can save up to 85% in costs, reducing expenses from $1.778-3.0 billion to about $300 million. It also significantly cuts development time from 13-15 years to approximately 6.5 years, enhancing time efficiency.",
            "score": 5,
            "explanation": "The predicted answer accurately covers both key facts: an #85% cost reduction# and a time reduction to #6.5 years#, as highlighted in the reference answer. The information is consistent with the reference, with no significant omissions or alterations, covering all essential details."
        },
        {
            "query_idx": 162,
            "query": "Which technique was utilized for editing oncogenes, leading to colorectal tumor development, and which genetic pathway and specific gene mutations are implicated in this process?",
            "retrieved_metrics": {
                "reference_idx": [
                    1407,
                    1409,
                    1408
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #CRISPRCas9# method edited genes, causing colorectal tumors involving the #CIN# pathway, with #APC# mutations playing a pivotal role in cancer development.",
            "predicted_answer": "CRISPR-Cas9 was used to edit oncogenes, leading to colorectal tumor development. The CIN pathway is implicated, with specific mutations in APC and TP53 playing a key role.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference: it mentions CRISPR-Cas9, CIN pathway, and APC mutations. Additionally, it adds detail with TP53, which aligns with the reference. All necessary information and trends are present and aligned with no contradictions."
        },
        {
            "query_idx": 163,
            "query": "What structural element in second and third-generation CAR-T cells enhances their functional mechanisms by involving specific molecules that lead to the apoptosis of tumor cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    928,
                    926
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #co-stimulatory domains# in second and third-generation CAR-T cells enhance functionality and promote tumor cell apoptosis via increased release of #cytotoxic molecules# like perforin and granzyme B.",
            "predicted_answer": "The incorporation of co-stimulatory domains, such as CD28 and 4-1BB, in second and third-generation CAR-T cells enhances their functional mechanisms. These domains improve the cells' potency, persistence, and ability to induce apoptosis in tumor cells through cytotoxic molecules like perforin and granzyme B.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts: the presence of #co-stimulatory domains# and the use of #cytotoxic molecules#, specifically perforin and granzyme B, which aligns with the reference answer. The overall trend and details are accurately reflected."
        },
        {
            "query_idx": 164,
            "query": "What recent advancements in the use of non-blood bodily fluids are contributing to the support and refinement of oncology therapies, and what challenges are associated with these advancements?",
            "retrieved_metrics": {
                "reference_idx": [
                    1641,
                    1653,
                    302
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The detection of #ctDNA# in #CSF# aids #drug development# for oncology, despite #challenges# in its identification.",
            "predicted_answer": "Recent advancements in using ctDNA from blood and CSF are refining oncology therapies by enabling noninvasive monitoring of tumor response and genetic changes. Challenges include variable ctDNA levels, detection difficulties, and representation of full tumor genetics.",
            "score": 3,
            "explanation": "The predicted answer covers the detection of ctDNA in CSF and mentions challenges associated with it. However, it omits the specific mention of aiding \"drug development\" for oncology. Overall, it aligns with the trend but misses this key fact."
        },
        {
            "query_idx": 165,
            "query": "What system enhances the translational application of 3D models in medical research, specifically integrating advanced gene-editing techniques for cancer study improvements?",
            "retrieved_metrics": {
                "reference_idx": [
                    2091,
                    2092,
                    1816
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#3D organoid models# offer #personalized drug screening# integrated with #CRISPR-Cas9#. These models improve #predictive accuracy# over traditional methods, particularly with #genetically engineered glioma organoids#.",
            "predicted_answer": "CRISPR-Cas9-based gene editing integrated with 3D organoid models, particularly glioma cerebral organoids, enhances translational applications in cancer research by enabling precise genetic modifications and high-throughput screening.",
            "score": 1,
            "explanation": "The predicted answer covers key elements such as the use of \"CRISPR-Cas9\" and \"3D organoid models,\" specifically mentioning \"glioma cerebral organoids.\" However, it misses \"personalized drug screening\" and \"predictive accuracy,\" impacting completeness."
        },
        {
            "query_idx": 166,
            "query": "What method involves manipulating the GAP protein's positioning to create spaces facilitating the formation of new binding sites for small, drug-like molecules?",
            "retrieved_metrics": {
                "reference_idx": [
                    1132,
                    1133,
                    1131
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The method involves the #translation of GAP# protein to establish #artificially created spacing#, enabling #novel binding sites for small molecules#.",
            "predicted_answer": "The method involves translating the GAP protein away from RAS using a 5 Å vector, creating spaces for small, drug-like molecules to bind and form new binding sites.",
            "score": 5,
            "explanation": "The predicted answer effectively captures the key concepts of translating the GAP protein and creating spaces for new binding sites, aligning well with the overall intention of the reference. However, it explicitly mentions a \"5 Å vector,\" which is absent in the reference answer, but does not contradict it."
        },
        {
            "query_idx": 167,
            "query": "What specific role should combination therapies and regulatory frameworks play, given the technical challenges in phage engineering and delivery, to enhance phage therapy effectiveness against resistant bacterial infections?",
            "retrieved_metrics": {
                "reference_idx": [
                    102,
                    104,
                    14
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Addressing #technical challenges# in phage engineering and delivery, refining #regulatory frameworks#, and utilizing #combination therapies# are crucial for effective phage therapy against resistant bacterial infections.",
            "predicted_answer": "Combination therapies, such as phage-antibiotic mixes, can synergistically target resistant bacteria, improving treatment outcomes. Regulatory frameworks must address safety, standardization, and public acceptance to support the responsible development and clinical use of phage-based treatments.",
            "score": 3,
            "explanation": "The predicted answer includes \"combination therapies\" and mentions \"regulatory frameworks,\" partially aligning with the reference answer. However, it misses the crucial emphasis on \"technical challenges\" in phage engineering and delivery, affecting completeness. Trends are consistent, but one key fact is missing."
        },
        {
            "query_idx": 168,
            "query": "Modified multi-hop query:\nWhat biotechnological techniques are employed to develop bacteriophages targeting antibiotic-resistant bacteria, and what are the resulting enhancements in their targeting accuracy and adaptability for wider applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    22,
                    101,
                    21
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modified answer:",
            "predicted_answer": "Biotechnological techniques like CRISPR-Cas systems, synthetic biology, and genome editing are used to develop bacteriophages targeting antibiotic-resistant bacteria. These engineered phages show enhanced targeting accuracy and adaptability, making them more effective and specific for various applications.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as the use of biotechnological techniques like CRISPR-Cas systems, synthetic biology, and genome editing to develop bacteriophages. It also mentions enhanced targeting accuracy and adaptability for wider applications. It reflects the meaning and key aspects of the reference."
        },
        {
            "query_idx": 169,
            "query": "What potential new drug targets could be identified that involve endosomal processes in epithelial cells, particularly those affecting the transmission of HIV to immune cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    372,
                    371,
                    374
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Potential drug targets involve genes related to #endosomal uptake# and #sequestration in epithelial cells#, impacting #HIV transmission# to #immune cells#, expanding interventions beyond #established mechanisms#.",
            "predicted_answer": "Potential new drug targets in epithelial cells involving endosomal processes include clathrin, caveolin, GalCer, and TIM-1 for endosomal uptake, and ICAM-1 for cell-to-cell transmission to immune cells.",
            "score": 3,
            "explanation": "The predicted answer covers endosomal processes through specific proteins (clathrin, caveolin, etc.), aligning with reference's focus on endosomal uptake in epithelial cells. While it addresses HIV transmission and potential drug targets, it lacks emphasis on sequestration and expanding interventions. Despite alignment, it misses a key aspect."
        },
        {
            "query_idx": 170,
            "query": "Modify the multi-hop query:\nHow does an agent affect cellular pathways in glioblastoma and oral squamous cell carcinoma, and what molecular mechanisms contribute to changes in cancer cell dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    797,
                    799
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "MBZ affects cellular pathways in glioblastoma and oral squamous cell carcinoma by inhibiting cell migration, invasion, and modulating EMT markers. It downregulates proteins like FAK, Rho-A, and Rac1 GTPase, disrupts cadherin equilibrium, and suppresses tumor growth through microtubule inhibition and JAK2/STAT3/Bcl-2 signaling.",
            "score": 5,
            "explanation": "The 'Predicted Answer' effectively describes MBZ's impact on glioblastoma and oral squamous cell carcinoma's cellular pathways, emphasizing inhibition of cell migration, modulation of markers, and suppression of tumor growth mechanisms. It covers key facts and is consistent with reference trends, despite minor wording deviations."
        },
        {
            "query_idx": 171,
            "query": "How does a certain genome-editing tool improve cellular model accuracy in drug screening and decrease errors, while also identifying potential targets in oncological treatment development?",
            "retrieved_metrics": {
                "reference_idx": [
                    2088,
                    2117,
                    2101
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #CRISPR# tool enhances cellular model accuracy in screening, reduces #off-target effects#, and identifies #cancer targets#, optimizing oncology drug development and precision applications.",
            "predicted_answer": "CRISPR improves cellular model accuracy by generating multiple mutations to simulate disease genotypes, enabling precise drug screening and reducing errors. It also identifies potential oncological targets through high-throughput genetic screening with greater specificity than previous methods.",
            "score": 3,
            "explanation": "The Predicted Answer includes key facts about CRISPR enhancing model accuracy and identifying cancer targets, aligning with the Reference Answer. However, it omits the reduction of \"off-target effects,\" which is a crucial detail emphasized in the Reference Answer, affecting completeness."
        },
        {
            "query_idx": 172,
            "query": "What nuclear structure shows distinct characteristics across cancer cell lines, is associated with malignancy features, and has potential utility in developing cancer treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    2003,
                    2002,
                    1998
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #PNC# shows #distinct characteristics in cancer lines#, links with #malignancy features like metastasis#, and is a proposed #marker for developing anti-cancer therapies#.",
            "predicted_answer": "The perinucleolar compartment (PNC) shows distinct characteristics across cancer cell lines, is associated with malignancy features, and has potential utility in developing cancer treatments. Its prevalence increases with metastatic potential and is linked to worse patient outcomes.",
            "score": 5,
            "explanation": "The predicted answer includes all key points from the reference: the PNC's distinct characteristics in cancer cell lines, its association with malignancy features like metastasis, and its utility in developing cancer treatments. Additional details enhance rather than contradict these points."
        },
        {
            "query_idx": 173,
            "query": "Which identifiers correspond to the compounds that independently exhibit tumor selectivity, significant cytotoxicity with no effect on normal cells, and demonstrated anti-proliferative activity in 60 human tumor cell lines?",
            "retrieved_metrics": {
                "reference_idx": [
                    1260,
                    1264,
                    1268
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Compound 24# exhibited tumor selectivity, #compound 29# showed significant cytotoxicity and sparing normal cells, and #compounds 35 and 36# had anti-proliferative activity with apoptosis induction.",
            "predicted_answer": "Compounds 24, 29, 35, and 36 exhibit tumor selectivity, significant cytotoxicity, and anti-proliferative activity in 60 human tumor cell lines without affecting normal cells.",
            "score": 5,
            "explanation": "The predicted answer matches all key facts from the reference: compounds 24, 29, 35, and 36 are linked to tumor selectivity, cytotoxicity, and anti-proliferative activity in 60 tumor cell lines, and they don't affect normal cells. There are no significant omissions or errors."
        },
        {
            "query_idx": 174,
            "query": "Which tumor-specific ligands are used in the development of anticancer PROTACs, their molecular targets, and which compound is currently being tested in clinical trials for therapeutic effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    887,
                    888,
                    889
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The ligands for #E3 ligases# target #AR, ER, and BTK#. Currently, #Bavdegalutamide# is undergoing #clinical trials# to evaluate its effectiveness in treatment.",
            "predicted_answer": "Tumor-specific ligands for E3 ligases like CRBN and VHL are used in anticancer PROTACs. Compounds in clinical trials include Bavdegalutamide (AR), ARV-471 (ER), and NX-2127 (BTK).",
            "score": 5,
            "explanation": "The predicted answer correctly identifies E3 ligases and AR, ER, and BTK as targets. It lists Bavdegalutamide as being in clinical trials, aligning with the reference. While additional details are provided, no key facts are missing or contradictory."
        },
        {
            "query_idx": 175,
            "query": "How does fascaplysin impact drug sensitivity, the viability of glioma cells specifically, and the cell cycle through a specific kinase inhibition in cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1276,
                    1280,
                    1277
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Fascaplysin enhances #anticancer drug efficacy#, reduces #glioma cell# viability by inducing apoptosis, and inhibits #CDK4#-mediated cell cycle progression in various cancer cells.",
            "predicted_answer": "Fascaplysin enhances drug sensitivity and reduces glioma cell viability by inhibiting CDK4, impacting the cell cycle. It also sensitizes cells to methotrexate-induced apoptosis and synergistically induces cell death through apoptosis and autophagy.",
            "score": 5,
            "explanation": "The predicted answer captures the key points: enhanced drug sensitivity (#anticancer drug efficacy#), reduced #glioma cell# viability, and inhibition of #CDK4#. While it mentions additional mechanisms like autophagy, no critical information from the reference is omitted or contradicted."
        },
        {
            "query_idx": 176,
            "query": "What was the outcome of the FDA's evaluation of a specific genetic mutation-related therapy for pancreatic cancer, and how does it compare to findings in a similar genetic context in breast cancer research?",
            "retrieved_metrics": {
                "reference_idx": [
                    668,
                    667,
                    655
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #FDA approved olaparib in 2019# for #g BRCA pancreatic cancer maintenance# based on the #POLO trial#, while the #OlympiA trial# investigated #HER2-negative breast cancer# with #g BRCA mutation# for survival outcomes.",
            "predicted_answer": "The FDA approved olaparib for gBRCA-mutated pancreatic cancer based on the POLO trial, which showed a PFS benefit but no overall survival advantage. In contrast, the OlympiA trial in breast cancer with similar mutations demonstrated significant invasive disease-free survival benefits with olaparib.",
            "score": 1,
            "explanation": "The Predicted Answer correctly mentions the FDA approval of olaparib for gBRCA-mutated pancreatic cancer (though the year 2019 is missing) and the POLO trial. It aligns with the reference's mention of the OlympiA trial but omits the details about HER2-negative breast cancer. Thus, two key facts are not fully covered."
        },
        {
            "query_idx": 177,
            "query": "Which specific compounds identified through the UPLC-MS/MS analysis demonstrate interactions with significant cancer-related pathways and targets?",
            "retrieved_metrics": {
                "reference_idx": [
                    1687,
                    1689
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The compounds #isoquercitrin, quercetin, berberine, chlorogenic acid, and caffeic acid# demonstrate #synergistic interactions with cancer-related targets and pathways#.",
            "predicted_answer": "The UPLC-MS/MS analysis identified 5 anti-cancer compounds: isoquercitrin, quercetin, berberine, chlorogenic acid, and caffeic acid. These compounds interact with 4 molecular targets (AKT1, CASP3, MAPK1, TP53) and 15 cancer-related pathways for colorectal, endometrial, and non-small cell lung cancers.",
            "score": 5,
            "explanation": "The predicted answer includes all five key compounds identified in the reference. It also provides additional details on molecular targets and cancer types, which align with the reference's theme of interactions with cancer-related pathways. There are no omissions, and the overall meaning is consistent."
        },
        {
            "query_idx": 178,
            "query": "How do genetic mutations influence prognosis and pathway activation in colorectal cancer, and what role do they play in cancer progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    1411,
                    1418,
                    1412
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #BRAF V600E# mutation correlates with poor prognosis through #MSI-H#, while the #serrated pathway# associates with #BRAF V600E# and #CIMP#. #TGFb RII# and #ACVR# interact, influencing #MSI CRC# dynamics.",
            "predicted_answer": "Genetic mutations, such as BRAF V600E and TGFb RII, influence colorectal cancer prognosis by activating pathways like MAPK/ERK and TGFb, leading to poor outcomes. MSI-H, often linked with MMR gene silencing, is a key factor in cancer progression and prognosis.",
            "score": 1,
            "explanation": "The 'Predicted Answer' includes key facts like BRAF V600E and TGFb RII influencing pathways, but misses the serrated pathway and ACVR interaction. It aligns generally but lacks completeness on MSI-H through BRAF V600E and serrated pathway involvement with CIMP, affecting the score."
        },
        {
            "query_idx": 179,
            "query": "What mechanisms are necessary to address cellular membrane challenges, degradation barriers such as the blood-brain barrier, and how can receptor identification and ligand engineering enhance siRNA delivery?",
            "retrieved_metrics": {
                "reference_idx": [
                    376,
                    2129,
                    2143
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Overcoming #cellular membrane challenges# requires addressing #degradation barriers, including the blood-brain barrier#. Enhancing siRNA delivery involves #receptor identification# and #ligand engineering#.",
            "predicted_answer": "To address cellular membrane challenges and the blood-brain barrier, mechanisms such as receptor-mediated endocytosis, ligand engineering, and endosomal escape strategies are necessary. Identifying specific receptors and designing targeted ligands can enhance siRNA delivery and improve its efficacy.",
            "score": 5,
            "explanation": "The predicted answer includes key elements such as cellular membrane challenges, the blood-brain barrier, receptor identification, and ligand engineering, which are emphasized in the reference answer. The predicted answer also expands on these topics with details like receptor-mediated endocytosis and endosomal escape, aligning well with the reference's trend."
        },
        {
            "query_idx": 180,
            "query": "How does genistein influence cellular mechanisms related to cancer prevention, particularly concerning protein activation, DNA impact, and regional differences in daily intake?",
            "retrieved_metrics": {
                "reference_idx": [
                    800,
                    802,
                    807
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Genistein #activates JNK and Ask1# proteins, leading to the #induction of double-strand breaks in DNA#. In Asian populations, the #median daily intake# of isoflavones is significantly higher, potentially lowering cancer incidences.",
            "predicted_answer": "Genistein activates proteins like JNK and Ask1, which are involved in DNA damage response, and reduces oxidative stress by activating Nrf2. It also inhibits DNA topoisomerase II, leading to DNA double-strand breaks. Higher daily intake in Asian countries correlates with lower cancer incidence, suggesting its role in cancer prevention.",
            "score": 3,
            "explanation": "The predicted answer correctly mentions the activation of JNK and Ask1 and the DNA-related effects but introduces Nrf2 activation and oxidative stress, which are not in the reference. It misses the specific mention of \"double-strand breaks,\" but aligns with the trend of regional intake differences affecting cancer incidence."
        },
        {
            "query_idx": 181,
            "query": "Which immune checkpoint molecule's interaction with antigen-presenting cells involves a specific binding component, and how is inhibiting this interaction being utilized in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    903,
                    905
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The molecule #LAG-3# binds to #MHC class II# on APCs, sending inhibitory signals. Targeting #LAG-3# helps counteract its role in tumor #immune evasion# in exhausted T cells.",
            "predicted_answer": "LAG-3 binds to MHC class II molecules on antigen-presenting cells, transmitting inhibitory signals that reduce T cell responses. Inhibiting this interaction is being explored in cancer treatment to enhance T cell activity and combat tumor immune evasion.",
            "score": 5,
            "explanation": "The predicted answer includes key facts from the reference: LAG-3 binding to MHC class II and its role in immune evasion. It aligns well with the reference trend, though it doesn't specifically mention \"exhausted T cells.\" Otherwise, it effectively covers the required details."
        },
        {
            "query_idx": 182,
            "query": "What systems evaluate tissue-specific drug responses, enhance preclinical oncology model efficiency, and ensure diverse subtype representation to advance personalized cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1458,
                    1460,
                    1966
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #same-organ paired organoid system# evaluates specific drug responses, #biobanks of PDOs# boost preclinical efficiency, and #diverse representation in organoid biobanks# aids personalized cancer treatment.",
            "predicted_answer": "Organoid biobanks and high-throughput screening technologies evaluate tissue-specific drug responses, enhance preclinical oncology model efficiency, and ensure diverse subtype representation, advancing personalized cancer treatment.",
            "score": 1,
            "explanation": "The predicted answer mentions \"organoid biobanks\" and \"high-throughput screening technologies\" but misses the specific \"same-organ paired organoid system\" and \"biobanks of PDOs.\" Although it touches on the theme of personalized cancer treatment, it misses more than one key fact, affecting completeness."
        },
        {
            "query_idx": 183,
            "query": "Modify the multi-hop query: \nHow do cancer-on-a-chip systems replicate tumor structural features and environmental conditions, and what specific components and methods are used in these systems to achieve this replication?",
            "retrieved_metrics": {
                "reference_idx": [
                    2058,
                    2186,
                    2053
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "Cancer-on-a-chip systems replicate tumor structural features and environmental conditions by using micro- and nano-fabrication methods to mimic mechanical properties like shear stress and ECM stiffness. They also use hydrogels and microfluidic channels to simulate in vivo structures and forces, allowing for the culture of tumor-derived cells in a controlled environment.",
            "score": 3,
            "explanation": "The 'Predicted Answer' captures the key facts about using micro- and nano-fabrication methods to replicate tumor features, along with the use of hydrogels and microfluidic channels. However, it lacks specific details about environmental conditions and specific methods used, which are emphasized in the 'Reference Answer'."
        },
        {
            "query_idx": 184,
            "query": "What examples highlight the process of obtaining reliable drug activity signals in glioma and the need for improved trial efficiency, specifically in the context of costly clinical trials for rare cancers such as GBM?",
            "retrieved_metrics": {
                "reference_idx": [
                    284,
                    309,
                    307
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "A #process# for reliable drug signals in #glioma# exists. Rare cancers, including GBM, #need improved trial efficiency#. A #costly RCT example# in GBM exceeded #$250 million#.",
            "predicted_answer": "The clinical development of nivolumab in GBM, involving over 1,700 patients and costing over $250 million, highlights the need for more efficient trial designs. Improved early-stage signals and adaptive trials can enhance efficiency and reduce costs in rare cancers like GBM.",
            "score": 5,
            "explanation": "The predicted answer aligns with the key facts in the reference. It mentions the need for improved trial efficiency in GBM, a costly RCT exceeding $250 million, and the focus on glioma. While details on \"process\" for drug signals are less explicit, the overall trend is consistent."
        },
        {
            "query_idx": 185,
            "query": "How do orphan and non-orphan indications compare in terms of progression-free survival duration, quality-adjusted life years gained, and the frequency of breakthrough designations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1069,
                    1902,
                    1068
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Orphan indications exhibit higher #progression-free survival#, greater #incremental quality-adjusted life years (QALYs)# gained, and are more frequently awarded the #breakthrough designation# compared to non-orphan indications.",
            "predicted_answer": "Orphan indications show a 13% greater progression-free survival and 1.5 months greater survival gain compared to non-orphan indications. They also offer 0.25 QALYs gained versus 0.05 for non-orphan. Orphan indications are more frequently granted breakthrough designations.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts emphasized in the reference: it discusses greater progression-free survival, incremental QALYs for orphan indications, and their higher frequency of breakthrough designations compared to non-orphan indications. The details align well with the reference, demonstrating accuracy and completeness."
        },
        {
            "query_idx": 186,
            "query": "What ethical and legal considerations are crucial for addressing data security and privacy challenges in the implementation of AI technologies in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1224,
                    1233,
                    133
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The implementation of AI in cancer treatment involves #ethical and regulatory considerations#, necessitates compliance with #strict data privacy laws like HIPAA#, and faces challenges in overcoming #data security and privacy issues#.",
            "predicted_answer": "Crucial ethical and legal considerations include protecting patient privacy, preventing data breaches, and ensuring compliance with data privacy laws such as HIPAA. Strong data protection measures, like access controls, encryption, and anonymization, are essential to secure sensitive medical information.",
            "score": 5,
            "explanation": "The 'Predicted Answer' covers the key issues of ethical and legal considerations, compliance with HIPAA, and data security and privacy challenges mentioned in the 'Reference Answer'. The predicted text aligns with the trends in the reference and includes technical approaches like encryption and anonymization. No significant omissions or errors were found."
        },
        {
            "query_idx": 187,
            "query": "What genetic markers are associated with altered treatment outcomes or adjustments, such as physiological changes or dose modifications, in patients receiving medications?",
            "retrieved_metrics": {
                "reference_idx": [
                    724,
                    727,
                    725
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The genetic marker #VEGFR2# is related to #sunitinib toxicities#, #CYP3A5 *1 allele# leads to #dose reductions# due to toxicity, and #UGT1A1 *28# causes a #bilirubin increase# with specific treatments.",
            "predicted_answer": "SNPs in VEGFR2, FLT3, VEGF-A, eNOS, CYP1A1, NR1I3, ABCB1, ABCG2, UGT1A1, CYP1A2, and HFE are associated with altered treatment outcomes, including toxicity, dose modifications, and physiological changes in patients receiving medications like sunitinib and pazopanib.",
            "score": 3,
            "explanation": "The predicted answer includes #VEGFR2# and #UGT1A1#, aligning with the reference answer. However, the #CYP3A5 *1 allele# is missing, impacting the completeness regarding dose modifications and bilirubin increase. Overall, the trend aligns, but the omission affects the score."
        },
        {
            "query_idx": 188,
            "query": "How does the FDA's Project Optimus recommend structuring dose-response trials in cancer treatment, and what methods are used to pinpoint effective dosages and assess genetic impact on drug responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    700,
                    699,
                    734
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The FDA's #Project Optimus# proposes #randomized dose-response trials#; the #MTD# is identified using #DLTs# for efficacy, and #PGx factors# modify drug response in oncology.",
            "predicted_answer": "Project Optimus recommends randomized, parallel dose-response trials to evaluate multiple dosages, comparing activity and safety. Dose selection is based on preclinical and clinical data. Genetic impact is assessed through pharmacogenomic (PGx) factors that influence drug response and toxicity.",
            "score": 3,
            "explanation": "The predicted answer covers the key points of randomized dose-response trials and PGx factors. While it discusses dose selection based on data, it omits the mention of MTD identification using DLTs. Overall, it is mostly aligned but misses a crucial detail affecting completeness."
        },
        {
            "query_idx": 189,
            "query": "What global health challenge does drug repurposing predominantly focus on, which involves specific regulatory considerations, and what strategies are suggested to improve therapeutic outcomes through this approach?",
            "retrieved_metrics": {
                "reference_idx": [
                    756,
                    1828,
                    2229
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The challenge drug repurposing focuses on is the #high incidence of cancer#, requiring a #regulatory framework for repurposed drugs#, and suggesting #combinatory treatments# to improve cancer therapy outcomes.",
            "predicted_answer": "Drug repurposing predominantly focuses on cancer, a major global health challenge. Strategies to improve therapeutic outcomes include addressing regulatory considerations for out-of-patent drugs and emphasizing combinatory treatments.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies cancer as the global health challenge focused on by drug repurposing, which matches the reference. It also addresses regulatory considerations and combinatory treatments, aligning well with all key points in the reference answer, with no significant omissions."
        },
        {
            "query_idx": 190,
            "query": "How do molecularly targeted and immune-oncology agents differ from traditional cytotoxic agents in their dosing strategies and side effect profiles, and why is there a need for enhanced approaches?",
            "retrieved_metrics": {
                "reference_idx": [
                    698,
                    701,
                    757
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Novel treatments, like #molecularly targeted# and #immune-oncology agents#, have #unique dosing strategies#, typically #below MTD#, with #fewer side effects#, necessitating #strategies for higher efficacy and reduced side effects#.",
            "predicted_answer": "Molecularly targeted and immune-oncology agents have dosing strategies based on target saturation, wider therapeutic index, and fewer off-target side effects compared to cytotoxic agents. This necessitates enhanced approaches for optimal efficacy and safety.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts of molecularly targeted and immune-oncology agents having unique dosing strategies with fewer side effects, aligning with the overall trend for optimal efficacy and safety. It misses \"below MTD,\" affecting completeness but not overall consistency."
        },
        {
            "query_idx": 191,
            "query": "How do the mechanisms of gene duplication contribute to the development of specific lethal genetic interactions within paralogs in model organisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1935,
                    1950,
                    1943
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Paralog pairs form through #gene duplication# such as small-scale and whole-genome duplications. In model organisms, these lead to #synthetic lethal interactions# especially when #protein sequence identity is high#.",
            "predicted_answer": "Gene duplication creates paralogs, which can develop specific lethal genetic interactions. In model organisms, about 25-35% of paralog pairs show synthetic sick or lethal interactions, often due to their retained common functionality allowing compensation for each other's loss.",
            "score": 1,
            "explanation": "The predicted answer covers the basic concepts of gene duplication leading to paralogs and mentions synthetic lethal interactions. However, it misses two key points: #types of duplications# and #protein sequence identity#. Therefore, while generally aligned, important specifics are absent."
        },
        {
            "query_idx": 192,
            "query": "How do modifications in chemical structure influence the effectiveness of a renal cell carcinoma treatment after multiple previous therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    685,
                    683,
                    679
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modifications improved #pharmacokinetic properties# and potency; in renal cancer patients, belzutifan showed #antitumor activity# with a median PFS of #14.5 months# after extensive prior therapies.",
            "predicted_answer": "Modifications in chemical structure, such as changing the germinal difluoro group to the vicinal difluoro group in belzutifan, improve pharmacokinetics and potency, enhancing treatment effectiveness in heavily pretreated renal cell carcinoma patients.",
            "score": 1,
            "explanation": "The predicted answer mentions improvements in pharmacokinetics and potency, reflecting chemical modifications in line with the reference. However, it lacks mention of the specific antitumor activity and the median PFS of 14.5 months, missing important specifics from the reference answer."
        },
        {
            "query_idx": 193,
            "query": "What specific cellular components are absent in organoids used for colorectal cancer research affecting treatment evaluations, and what recent developments in organoid cultivation improve these evaluations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1397,
                    1400,
                    1402
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Organoids from #Matrigel# miss #mesenchymal cells#, limiting #chemotherapy evaluation#. Recently, #metastatic organoids# were cultivated to enhance drug evaluation in colorectal cancer.",
            "predicted_answer": "Organoids used for colorectal cancer research lack mesenchymal cells, immune cells, and other non-cancerous cells. Recent developments include the successful cultivation of metastatic organoids, which improve drug screening and treatment evaluation.",
            "score": 1,
            "explanation": "The predicted answer mentions the absence of mesenchymal cells, which is aligned with the reference. It also acknowledges the cultivation of metastatic organoids, aligning with the noted advancements. However, it omits the connection to Matrigel and chemotherapy evaluation, missing two key facts."
        },
        {
            "query_idx": 194,
            "query": "How does a particular mutation in a gene disrupt its enzymatic activity, and what molecular feature has historically complicated drug development for therapies targeting this gene?",
            "retrieved_metrics": {
                "reference_idx": [
                    882,
                    1108
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #G12C# mutation decreases #KRAS# enzymatic activity, complicating #RAS# targeting due to #undruggability# linked to its lack of binding cavities.",
            "predicted_answer": "The G12C mutation in KRAS reduces its GTPase activity, causing it to remain in an active GTP-bound state, leading to continuous activation of downstream pathways. The lack of binding cavities on the RAS protein surface has historically made it challenging to develop drugs targeting this gene.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts: the G12C mutation, the KRAS gene, reduced enzymatic activity, and the lack of binding cavities leading to undruggability. The phrasing aligns without contradictions, covering all critical elements emphasized in the Reference Answer."
        },
        {
            "query_idx": 195,
            "query": "What comprehensive medical imaging technique involves a series of sequential steps including radionuclide production and aims to achieve high sensitivity measurements, especially when compared to MRI, to capture physiological changes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1510,
                    1546,
                    1511
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #PET imaging process# involves #high sensitivity detection of annihilated photons#, enabling #low concentration measurements#, with steps including #radionuclide production leading to detailed physiological imaging#.",
            "predicted_answer": "The comprehensive medical imaging technique that involves sequential steps including radionuclide production and aims for high sensitivity, especially compared to MRI, is Positron Emission Tomography (PET). It captures physiological changes with high sensitivity by detecting photons from radiotracers.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies PET imaging, highlights its high sensitivity, and mentions detecting photons from radiotracers, aligning with the reference. However, it misses \"low concentration measurements,\" which slightly impacts completeness."
        },
        {
            "query_idx": 196,
            "query": "What are the observed treatment response rates and mutation types associated with HER3-DXd’s efficacy in heavily pre-treated NSCLC patients, and how do these results vary across different trial cohorts?",
            "retrieved_metrics": {
                "reference_idx": [
                    191,
                    192,
                    188
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The study shows #preliminary antitumor activity# in EGFR-driven NSCLC, efficacy across #EGFR TKI resistance# mechanisms, and #high ORR# in HER2-mutant NSCLC in the #DESTINY-Lung01 trial#.",
            "predicted_answer": "In heavily pre-treated NSCLC patients, HER3-DXd at 5.6 mg/kg showed an ORR of 25%, with efficacy across various EGFR TKI resistance mechanisms, including C797S, MET amplification, and HER2 mutation. DCR was 70%, and DoR was 7 months.",
            "score": 1,
            "explanation": "The predicted answer mentions HER3-DXd's efficacy in EGFR TKI resistance, aligning with the reference. However, it lacks mention of the DESTINY-Lung01 trial, preliminary antitumor activity, and high ORR specifically in HER2-mutant NSCLC. Multiple key facts emphasized are missing, affecting completeness."
        },
        {
            "query_idx": 197,
            "query": "What are the specific compounds that exhibit antitumor properties on human tumor cell lines, including one with prominent effects in a low micromolar range, and another showing inhibition across diverse cell lines?",
            "retrieved_metrics": {
                "reference_idx": [
                    1259,
                    1275,
                    1271
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The compounds are #Bisindole pyrazole 21#, showing activity against human cell lines; #Compound 74#, with cytotoxicity in low micromolar range; and #Pyrazinone bisindole compound 67#, inhibiting various tumor cell lines.",
            "predicted_answer": "Compound 74, a pyrimidine bisindole, shows prominent antitumor effects in the low micromolar range (GI50: 0.16-1.42 µM) across diverse cell lines. Pyrazinone bisindole compound 67 also exhibits strong inhibition across multiple tumor cell lines (GI50: 6.6-74.8 µM).",
            "score": 3,
            "explanation": "The predicted answer accurately includes the key facts about \"Compound 74\" and \"Pyrazinone bisindole compound 67,\" including the low micromolar range and inhibition across diverse cell lines. However, it omits \"Bisindole pyrazole 21.\" This omission affects the completeness of the information."
        },
        {
            "query_idx": 198,
            "query": "How does the number of kinases encoded by the human genome relate to their significance in cancer drug development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1820,
                    1834
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The human genome encodes over #518 kinases#, crucial for #cancer drug development#, with challenges in #specificity of kinase inhibition# impacting drug discovery.",
            "predicted_answer": "The human genome encodes over 518 kinases, which play critical roles in cancer when dysregulated. Their abundance and involvement in cellular processes make them significant targets for cancer drug development, with over 62 inhibitors already approved.",
            "score": 3,
            "explanation": "The predicted answer covers two of the three key facts: \"over 518 kinases\" and \"crucial for cancer drug development.\" However, it omits the challenge related to the \"specificity of kinase inhibition,\" affecting drug discovery, impacting the answer's completeness."
        },
        {
            "query_idx": 199,
            "query": "How do engineered phages utilize specific targeting mechanisms and genetic modifications to enhance their role in both gene therapy and immunotherapy applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    82,
                    80,
                    70
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phage-mediated systems employ #targeting specificity# through engineered ligands, leverage #genetic engineering techniques# for functionality, and significantly impact #gene therapy# and #immunotherapy# by delivering therapeutic genes and stimulating immune responses.",
            "predicted_answer": "Engineered phages use specific targeting ligands for precise delivery to targeted cells. They can carry therapeutic payloads like genes, peptides, and proteins. In gene therapy, they deliver genes to target cells, and in immunotherapy, they stimulate anti-tumor immune responses by displaying tumor-specific antigens.",
            "score": 3,
            "explanation": "The predicted answer covers targeting specificity with engineered ligands and highlights phage roles in gene therapy and immunotherapy by delivering genes and stimulating immune responses. However, it lacks explicit mention of genetic engineering techniques crucial for functionality, leading to missing a key fact."
        },
        {
            "query_idx": 200,
            "query": "How does the mechanism of SARS-CoV-2 infection relate to its impact on the thyroid gland, particularly concerning pathological conditions associated with infection?",
            "retrieved_metrics": {
                "reference_idx": [
                    2153,
                    2154
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "SARS-CoV-2's infection involves #receptor recognition# and #membrane fusion#, impacting the thyroid by #causing thyroid diseases# and triggering a #cytokine storm#.",
            "predicted_answer": "SARS-CoV-2 infects the thyroid by binding to ACE2 receptors and using TMPRSS2 for cell entry, leading to potential alterations in the pituitary-thyroid axis. This can result in conditions like subacute thyroiditis, Hashimoto's thyroiditis, and thyrotoxicosis, often due to an induced inflammatory response and cytokine storm.",
            "score": 3,
            "explanation": "The predicted answer mentions ACE2 receptors and TMPRSS2, aligning with receptor recognition and partly with membrane fusion. It covers cytokine storm and thyroid diseases, such as subacute thyroiditis. However, it lacks a specific mention of membrane fusion. Overall, the meaning is consistent, with one minor omission."
        },
        {
            "query_idx": 201,
            "query": "What legislative act incentivizes drug development for ultra-rare diseases and permits approvals based on specific types of clinical trials that could potentially lead to inaccurate efficacy assessments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1058,
                    1071,
                    1079
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #Orphan Drug Act of 1983# encourages drug development for #ultra-rare diseases# by permitting approvals through #small, non-randomized trials#, potentially affecting the #accuracy of efficacy outcomes#.",
            "predicted_answer": "The Orphan Drug Act of 1983 incentivizes drug development for ultra-rare diseases and allows approvals based on small, non-robust clinical trials, which may lead to overestimated efficacy.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts: \"Orphan Drug Act of 1983,\" \"ultra-rare diseases,\" and trial types leading to potential efficacy issues (described as \"small, non-robust clinical trials\"). While terms differ slightly, they effectively align with non-randomized, suggesting potential efficacy inaccuracies. No significant omissions or errors exist."
        },
        {
            "query_idx": 202,
            "query": "Which compounds exhibit varying levels of antitumor activity across different cancer cell lines, requiring comparisons from multiple studies to determine effective inhibitory concentrations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1887,
                    1893,
                    1880
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Selenazole 46# is active against melanoma, breast, and liver cancer cells. #Diselenide 32# targets breast cancer cells. #Derivative 22# affects breast, colon, leukemia, hepatocarcinoma, and prostate cancer cells.",
            "predicted_answer": "Selenazole 45, 46, and 22, along with diselenide 32, exhibit varying antitumor activities across different cancer cell lines, requiring comparisons from multiple studies to determine effective inhibitory concentrations.",
            "score": 1,
            "explanation": "The predicted answer includes all four compounds mentioned in the reference. However, it only specifies the varying antitumor activity and need for comparative studies, without stating the specific cancer cells each compound targets (#Selenazole 46#, #Diselenide 32#, #Derivative 22#). These omissions impact completeness."
        },
        {
            "query_idx": 203,
            "query": "How were early-stage transcriptome datasets and subsequent analytical tools utilized to uncover multi-target properties of plant-derived compounds against cervical cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1694,
                    1695
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #ArrayExpress database# provided cervical cancer datasets, leading to the creation of #compound target networks (CTNs)# that demonstrate the multi-target properties of plant-derived compounds.",
            "predicted_answer": "Early-stage transcriptome datasets from cervical cancer patients were analyzed using tools like Network Analyst for differential gene expression. This, combined with compound target networks and enrichment analysis, helped uncover the multi-target properties of plant-derived compounds against cervical cancer.",
            "score": 3,
            "explanation": "The predicted answer mentions the use of compound target networks and enrichment analysis, aligning with the reference's mention of CTNs. However, it omits the key fact about using the #ArrayExpress database#, affecting completeness."
        },
        {
            "query_idx": 204,
            "query": "What are the key technological methods that combine to enhance cancer study models by incorporating substrate material analysis?",
            "retrieved_metrics": {
                "reference_idx": [
                    2019,
                    2082
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The use of #artificial intelligence# with #3D models# enhances the study of cancer by precisely analyzing substrate materials to predict cellular behavior and tumor progression.",
            "predicted_answer": "Artificial intelligence, 3D modeling, and substrate material analysis combine to enhance cancer study models. These technologies predict cellular behavior, tumor progression, and metastasis by examining the chemical, geometric, and mechanical properties of substrates.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts found in the reference answer: \"artificial intelligence,\" \"3D modeling,\" and the analysis of \"substrate materials.\" It also expands upon this by mentioning additional aspects such as predicting cellular behavior and tumor progression, aligning well with the reference's intent."
        },
        {
            "query_idx": 205,
            "query": "How does AI contribute to advancements in cancer drug development through innovative algorithmic approaches, including predictive modeling, therapeutic identification, and rational drug design?",
            "retrieved_metrics": {
                "reference_idx": [
                    162,
                    1218,
                    1243
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI contributes to cancer drug development by creating #interpretable models#, supporting #predictive modeling and therapeutic identification#, and enabling #drug repurposing and combination strategies# for enhanced efficacy.",
            "predicted_answer": "AI contributes to cancer drug development by predicting drug-target interactions, identifying druggable vulnerabilities, and designing new molecules. It accelerates therapeutic identification, optimizes drug design, and enhances rational drug development through advanced algorithms and predictive modeling.",
            "score": 3,
            "explanation": "The Predicted Answer covers predictive modeling, therapeutic identification, and rational drug design, aligning with the Reference Answer's focus. However, it lacks details on \"interpretable models\" and \"drug repurposing and combination strategies.\" While trends align, these omissions affect completeness."
        },
        {
            "query_idx": 206,
            "query": "How do signaling pathways and receptor interactions contribute to the effectiveness of a targeted drug in altering progression-free survival in medullary and differentiated thyroid cancers?",
            "retrieved_metrics": {
                "reference_idx": [
                    2161,
                    2162
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #VEGF# and #VEGFR# pathways in thyroid cancer are targeted by #vandetanib#, which inhibits #tyrosine kinase# receptors, thus enhancing #PFS# in both MTC and DTC.",
            "predicted_answer": "Signaling pathways like PI3K/Akt/mTOR and MAPK, along with receptor interactions such as VEGFR, are targeted by MKIs. These drugs block tyrosine kinase receptors, inhibiting angiogenesis and tumor growth, thereby prolonging progression-free survival in medullary and differentiated thyroid cancers.",
            "score": 3,
            "explanation": "The predicted answer includes key concepts such as VEGFR, tyrosine kinase receptors, and progression-free survival (PFS), which are mentioned in the reference answer. However, it misses the specific mention of vandetanib and the naming of VEGF. Thus, it aligns overall but lacks one key fact."
        },
        {
            "query_idx": 207,
            "query": "How does artificial intelligence assist in the transformation of cancer treatment through the interpretation of genetic data and the linkage of molecular alterations to therapy responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    116,
                    1216,
                    120
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The integration of #AI# in genomic profiling enables the #linkage of molecular alterations to treatment responses#, signifying a #transformation in cancer treatment#.",
            "predicted_answer": "Artificial intelligence assists in cancer treatment by analyzing genetic data to identify specific mutations and linking these molecular alterations to therapy responses, enabling tailored treatments that target individual patient profiles and improve outcomes.",
            "score": 5,
            "explanation": "The predicted answer covers the key points from the reference: use of AI in genomic profiling (artificial intelligence assists in cancer treatment), linking molecular alterations to therapy responses, and transforming cancer treatment by enabling tailored treatments for better outcomes. The overall trend aligns without omissions."
        },
        {
            "query_idx": 208,
            "query": "What genetic interaction is confirmed through a method focused on specific validation techniques and involves genes that are not often altered?",
            "retrieved_metrics": {
                "reference_idx": [
                    1940,
                    1947,
                    1948
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The interaction between #MAP2K1 (MEK1) and MAP2K2 (MEK2)# is confirmed using #low-throughput validation# and is associated with #rarely mutated genes#.",
            "predicted_answer": "The context describes methods to identify synthetic lethal interactions, including those involving rarely altered genes. These interactions are validated using low-throughput techniques, focusing on specific gene pairs in various cellular contexts.",
            "score": 1,
            "explanation": "The predicted answer mentions synthetic lethal interactions validated using low-throughput techniques and with rarely altered genes. However, it does not specify the interaction between MAP2K1 (MEK1) and MAP2K2 (MEK2), which is a key fact emphasized in the reference answer."
        },
        {
            "query_idx": 209,
            "query": "What are the specific metrics used to evaluate the effectiveness of Selenocystine, MeSeCys, and Selenomethionine against multiple types of cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1870,
                    1871,
                    1872
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The cytotoxic #IC$\\_{50}$ values# are 3.6-34.5 µM for #SeCys#, 54-632.8 µM for #MeSeCys#, and 40-130 µM for #SeMet#, measured across different cancer cell lines.",
            "predicted_answer": "The effectiveness of Selenocystine, MeSeCys, and Selenomethionine against cancer cells is evaluated using IC50 values. Selenocystine showed IC50 values of 3.6-34.5 µM, MeSeCys 54-632.8 µM, and Selenomethionine 40-130 µM across various cancer cell lines.",
            "score": 5,
            "explanation": "The predicted answer encompasses all the key metrics outlined in the reference answer: IC50 values for Selenocystine (SeCys), MeSeCys, and Selenomethionine (SeMet) across different cancer cell lines. It accurately reflects the specified numbers and detail without contradictions."
        },
        {
            "query_idx": 210,
            "query": "What effects arise in glioblastoma cells when passenger genes, which have a genetic duplication partner, experience recurrent deletions, and how can these deletions assist in identifying broader cancer cell vulnerabilities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1938,
                    1937
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The deletion of #ENO1# in glioblastoma makes cells vulnerable to #ENO2# inhibition, highlighting how passenger gene deletions with paralogs can reveal #potential cancer vulnerabilities#.",
            "predicted_answer": "Recurrent deletions of passenger genes with paralogs in glioblastoma can lead to synthetic lethality, making cells sensitive to inhibition of the remaining paralog. This exposes vulnerabilities that can be targeted for cancer therapy.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by mentioning that recurrent deletions of passenger genes with paralogs in glioblastoma lead to vulnerabilities that can be exploited for cancer therapy. It captures the concept of synthetic lethality, synonymous with the vulnerability highlighted in the reference."
        },
        {
            "query_idx": 211,
            "query": "How do models derived from specific cell types replicate cellular architectures and how do these properties contribute to accurately representing therapy responses compared to traditional two-dimensional methods?",
            "retrieved_metrics": {
                "reference_idx": [
                    1442,
                    1443,
                    1445
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Models derived from #stem cells# possess a #three-dimensional# structure, enhancing therapy modeling accuracy, while #in vitro# methods lack real-world response observation.",
            "predicted_answer": "Organoid models, derived from specific cell types, replicate cellular architectures by self-organizing into 3D structures that mimic native tissue. This 3D structure and cellular interplay better represent therapy responses, including angiogenesis and hypoxia, compared to 2D methods.",
            "score": 1,
            "explanation": "The predicted answer mentions \"3D structures,\" effectively capturing the reference's emphasis on \"three-dimensional.\" However, it omits the key fact about \"stem cells\" and \"in vitro methods.\" While the overall trend aligns, missing multiple key facts affects completeness."
        },
        {
            "query_idx": 212,
            "query": "What are the specific average Root Mean Square Fluctuation (RMSF) values for Caspase-3 complexes with Compound (8b) and doxorubicin, highlighting the difference in residues' stability?",
            "retrieved_metrics": {
                "reference_idx": [
                    253,
                    254
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #RMSF for Caspase-3-doxorubicin# is #2.4 Å#, while #Caspase-3-Compound (8b)# is #2.3 Å#. Both values suggest #comparable residue stability#.",
            "predicted_answer": "The average RMSF values for Caspase-3 complexes with Compound (8b) and doxorubicin are 2.3 Å and 2.4 Å, respectively. Residues 100-200 showed fewer fluctuations and remained stable in both complexes.",
            "score": 5,
            "explanation": "The Predicted Answer includes the average RMSF values for Caspase-3 with Compound (8b) and doxorubicin (2.3 Å and 2.4 Å), aligning with the Reference Answer. It also confirms the stability across the residues, fully capturing the key facts without contradictions."
        },
        {
            "query_idx": 213,
            "query": "What is the mechanism involving small-molecule inhibitors and degrader technologies that exploit the genetic relationship between SMARCA2 and SMARCA4 for therapeutic development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1956,
                    1958,
                    1931
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The mechanism involves targeting the #ATPase domain of SMARCA2# using #PROTACs# to utilize #synthetic lethal interactions# with SMARCA4 in therapeutic strategies.",
            "predicted_answer": "Small-molecule inhibitors and degrader technologies, such as PROTACs, target the ATPase domain of SMARCA2 in SMARCA4 mutant cells, exploiting their synthetic lethal relationship for therapeutic development. This approach degrades the entire protein, reducing concerns about domain-specific druggability.",
            "score": 5,
            "explanation": "The predicted answer includes the key details emphasized in the reference: targeting the ATPase domain of SMARCA2, using PROTACs, and leveraging synthetic lethality with SMARCA4. The meaning is consistent, and no significant details are omitted, aligning well with the reference's trend."
        },
        {
            "query_idx": 214,
            "query": "What factors hinder the broader adoption of 3D in vitro cancer models in predicting drug efficacy compared to traditional 2D models, and how do new models improve preclinical testing in oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1807,
                    2032,
                    2269
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The challenges for #3D in vitro cancer models# include accurately reflecting tumor growth. #2D models# fail to replicate tumor structure. #Emerging 3D models# better mimic in vivo drug resistance.",
            "predicted_answer": "Factors hindering 3D in vitro cancer models include biased efficacy metrics, limited qualitative comparisons, and high costs. New 3D models, like tumor organoids, better mimic in vivo conditions and drug resistance, improving preclinical testing accuracy.",
            "score": 3,
            "explanation": "The predicted answer mentions \"3D in vitro cancer models\" and explains the limitations regarding efficacy, which aligns with the reference. It also notes how new models mimic in vivo drug resistance. However, it incorrectly mentions \"2D models,\" missing the emphasis on \"effectively replicating tumor structure.\""
        },
        {
            "query_idx": 215,
            "query": "Modify the multi-hop query:  \nWhat methods or strategies should be applied to improve the effectiveness of drug repurposing for multifactorial disorders targeting various biological mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    825,
                    2244,
                    1832
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer:",
            "predicted_answer": "To improve drug repurposing for multifactorial disorders, apply systematic approaches like virtual screening, and focus on simultaneous multiple targeting. Validate findings through comprehensive in vitro and in vivo experiments. Consider integrating repurposed drugs with existing therapies for better efficacy.",
            "score": 1,
            "explanation": "The predicted answer aligns with the trend of the reference answer, covering virtual screening, multi-targeting, and validation through experiments. However, it misses emphasizing #improving computational methods# and #enhancing the understanding of disease mechanisms#. Thus, it misses more than one key fact."
        },
        {
            "query_idx": 216,
            "query": "How do phages interact with the host immune system to combat intracellular bacteria, and what processes do they use to affect immune responses and target bacteria within cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    13,
                    38,
                    57
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phages employ #phage proteins# to interact with #immune cells#, enabling them to #penetrate host cells# and modulate the #innate immune-signaling pathway# to address intracellular bacterial infections.",
            "predicted_answer": "Phages can penetrate host cells, deliver genetic material, and replicate to lyse intracellular bacteria. They also modulate the immune response by interacting with immune cells, enhancing pro-inflammatory cytokines, and modulating TLR pathways, which aids in bacterial clearance.",
            "score": 1,
            "explanation": "The predicted answer captures the interaction with immune cells and penetration of host cells, aligning with the reference. However, it lacks specific mention of \"phage proteins\" and does not fully address the modulation of \"innate immune-signaling pathway,\" missing two key details and affecting completeness."
        },
        {
            "query_idx": 217,
            "query": "What screening technique is suitable for general HPV detection using similar sample collection methods, and offers different sensitivity rates compared to HPV genotyping, specifically in noninvasive cervical cancer screening?",
            "retrieved_metrics": {
                "reference_idx": [
                    493,
                    494,
                    490
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#DNA methylation# tests use similar sampling methods, offer #1.22 relative sensitivity# for ≥ CIN2 detection, and serve as a #noninvasive# option in cervical cancer screening.",
            "predicted_answer": "DNA methylation assays are suitable for general HPV detection and offer different sensitivity rates compared to HPV genotyping. They can use the same sample collection methods and provide higher sensitivity for detecting ≥ CIN2 lesions.",
            "score": 3,
            "explanation": "The predicted answer mentions DNA methylation assays and their suitability for HPV detection and different sensitivity rates, aligning with the reference. However, it omits details like \"1.22 relative sensitivity\" and the mention of the process being \"noninvasive,\" affecting completeness."
        },
        {
            "query_idx": 218,
            "query": "What is the average number of somatic mutations in pancreatic tumors, and what therapeutic challenges arise from their genetic diversity, including the roles of KRAS, TP53, CDKN2A, and SMAD4 mutations?",
            "retrieved_metrics": {
                "reference_idx": [
                    393,
                    412,
                    394
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Pancreatic tumors average #50-65 somatic mutations#, creating a #continuously moving target# due to genetic diversity. Treatment is challenging because of #four characteristic oncogenic driver mutations# like KRAS and TP53.",
            "predicted_answer": "Pancreatic tumors typically have 50-65 somatic mutations. Genetic diversity, including KRAS, TP53, CDKN2A, and SMAD4 mutations, creates a complex barrier for effective therapy, requiring combination and personalized treatment approaches.",
            "score": 3,
            "explanation": "The predicted answer matches the key facts from the reference regarding the number of somatic mutations (50-65) and includes the genetic barrier posed by KRAS, TP53, CDKN2A, and SMAD4 mutations. However, it omits the idea of a \"continuously moving target\" from the genetic diversity as described in the reference."
        },
        {
            "query_idx": 219,
            "query": "What is the target molecule involved in cancer therapy that is selectively expressed in tumor cells, with a method for targeted delivery using therapeutic agents, and plays a significant role in cell metabolic processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1354,
                    1384,
                    1373
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The molecule #B7-H3# is crucial for cancer therapy, utilizing #radionuclides# for precise targeting in tumors, significantly influencing #energy metabolism# within cancer cells.",
            "predicted_answer": "B7-H3 is the target molecule, selectively expressed in tumor cells. It plays a significant role in cell metabolic processes and can be targeted using therapeutic agents like radioimmunotherapy for cancer treatment.",
            "score": 3,
            "explanation": "The key facts \"B7-H3\" and \"significant role in cell metabolic processes\" are present in both answers. The predicted answer mentions \"radioimmunotherapy\" for targeting but omits \"radionuclides\" specifically. The overall trend is aligned, but one key fact is missing, affecting completeness."
        },
        {
            "query_idx": 220,
            "query": "What substances impact MCF-7 spheroid growth, what receptor is involved, and how do variations in time and concentration affect their efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    347,
                    346,
                    356
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The substances #G15# and #G-1# target #GPER#, inhibiting MCF-7 spheroid growth, with #G-1#'s effects varying based on the exposure duration and concentration.",
            "predicted_answer": "G-1 and G15, antagonists of GPER, significantly inhibit MCF-7 spheroid growth. Their efficacy is time- and concentration-dependent, with higher concentrations and longer treatment times leading to greater inhibition.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: substances G15 and G-1, their targeting of GPER, and that their efficacy depends on time and concentration, affecting MCF-7 spheroid growth. The information aligns well with the reference answer, with no significant omissions or contradictions."
        },
        {
            "query_idx": 221,
            "query": "What are the inherent limitations of using AAV vectors in gene therapy and the associated biological challenges that need addressing?",
            "retrieved_metrics": {
                "reference_idx": [
                    438,
                    973,
                    440
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Gene therapy with AAV vectors faces #transgene size# limitations, #packaging capacity# challenges, and #immunogenicity# concerns, particularly in #rAAV-mediated therapies#.",
            "predicted_answer": "AAV vectors have a limited packaging capacity of about 4.7 kb, restricting the size of transgenes. Additionally, vector uptake, intracellular transport, and uncoating can be inefficient. Immunological barriers, including pre-existing immunity to AAV, also pose significant challenges.",
            "score": 3,
            "explanation": "The predicted answer effectively captures the key facts from the reference: it mentions \"limited packaging capacity\" and \"immunological barriers.\" However, it does not explicitly mention \"transgene size\" or \"rAAV-mediated therapies,\" although these are implied. Overall, it aligns but misses some detail."
        },
        {
            "query_idx": 222,
            "query": "How does a specific prebiotic influence gut microbiota to prevent specific cancer metastasis, enhance immune response, and interact with epigenetic proteins to potentially inhibit breast cancer progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    817,
                    819,
                    818
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Inulin# affects #gut microbiota# to prevent #CRC liver metastasis#, boosts #immune response#, and modulates #epigenetic proteins#, potentially inhibiting #breast cancer progression# through these #mechanisms#.",
            "predicted_answer": "Inulin, as a prebiotic, modulates gut microbiota to prevent cancer metastasis, enhances immune responses by augmenting intestinal immune cells, and interacts with epigenetic proteins, reducing expression of HDAC2, HDAC8, and DNA methyltransferase 3b, which may inhibit breast cancer progression.",
            "score": 3,
            "explanation": "The predicted answer mentions that inulin influences gut microbiota, enhances immune response, and interacts with epigenetic proteins, aligning with the reference emphasis. However, the predicted answer specifies cancer metastasis generally rather than CRC liver metastasis, missing a critical detail."
        },
        {
            "query_idx": 223,
            "query": "Which genome-editing technique is used to increase cancer treatment effectiveness by editing genes linked to immune checkpoints and efficiently discovering cancer-related genetic targets?",
            "retrieved_metrics": {
                "reference_idx": [
                    2104,
                    2120,
                    2089
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #CRISPR-Cas# method boosts treatment by enhancing #immunotherapy#, editing #immune checkpoint# genes, and efficiently finding #cancer-related genes#.",
            "predicted_answer": "CRISPR-Cas9 is used to increase cancer treatment effectiveness by editing genes linked to immune checkpoints and efficiently discovering cancer-related genetic targets.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key points mentioned in the reference answer: the use of CRISPR-Cas9, editing of immune checkpoint genes, and the discovery of cancer-related genetic targets. It aligns with the reference, covering all emphasized facts without contradictions or omissions."
        },
        {
            "query_idx": 224,
            "query": "Modify the multi-hop query\nHow does the interaction of repetitive RNA with CDK13 in the PNC affect its role in the cell cycle and RNA surveillance, leading to aggressive melanoma?",
            "retrieved_metrics": {
                "reference_idx": [
                    2013,
                    2012,
                    2014
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer",
            "predicted_answer": "The interaction of repetitive RNA with CDK13 in the PNC sequesters CDK13, disrupting its normal functions in cell cycle regulation and RNA surveillance. This sequestration may lead to aggressive melanoma by impairing these critical processes.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer's trend, noting that repetitive RNA-CDK13 interaction affects cell cycle regulation and RNA surveillance. It misses a specific impact, like how this interaction precisely alters CDK13 function. Overall, key facts are present but one crucial detail is missing."
        },
        {
            "query_idx": 225,
            "query": "What approach is suggested to improve resource distribution and tackle challenges inhibiting participation in early-phase cancer drug development trials in specific low and middle-income countries?",
            "retrieved_metrics": {
                "reference_idx": [
                    740,
                    750,
                    753
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Implementing a #tier-based system# efficiently allocates resources to overcome #barriers#, significantly enhancing #participation# from LMICs in early-phase cancer drug trials.",
            "predicted_answer": "A tier-based system is suggested to improve resource distribution and tackle challenges in early-phase cancer drug development trials in low and middle-income countries. This includes enhancing research infrastructure, mentoring local investigators, and fostering global partnerships.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer, mentioning a \"tier-based system\" for resource distribution, and addresses overcoming challenges (\"barriers\") in early-phase trials in LMICs. However, it does not explicitly mention \"participation.\" Despite this, the overall trend aligns well with the reference."
        },
        {
            "query_idx": 226,
            "query": "How do shifts in the design and preparation of tumor drugs, alongside the introduction of diverse treatment modalities, illustrate changes in contemporary cancer treatment strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    867,
                    873,
                    875
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Shifts are marked by the #transformation in treatment strategies#, moving from #small molecules to large molecules#, and introducing a #diverse array of innovative therapies# in cancer treatment.",
            "predicted_answer": "Shifts in tumor drug design and preparation, along with the introduction of diverse treatments like targeted therapies, ADCs, cell-based, and gene therapies, reflect a move towards more personalized, effective, and less toxic cancer treatment strategies.",
            "score": 3,
            "explanation": "The predicted answer aligns with the overall trend of the reference by indicating shifts towards innovative cancer treatments. It captures the emphasis on diverse therapies and transformation in strategies. However, it misses the specific transition from small to large molecules, impacting completeness."
        },
        {
            "query_idx": 227,
            "query": "How do the first and second generations of CAR-M differ in their components and resulting impact on macrophage polarization and pro-inflammatory responses in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    940,
                    949
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The first-generation CAR-M uses #TIR# for M1 polarization. Second-generation CAR-M adds #CD3 ζ#, enhancing #pro-inflammatory responses# and sustaining M1 activation.",
            "predicted_answer": "The first generation of CAR-M uses TIR to replace CD3 ζ, enhancing M1 polarization. The second generation connects both TIR and CD3 ζ, leading to stronger and more sustained M1 activation and enhanced pro-inflammatory responses.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts: first-generation using #TIR# for M1 polarization and the second-generation adding #CD3 ζ# to enhance #pro-inflammatory responses# and sustain M1 activation. There are no significant omissions or contradictions present."
        },
        {
            "query_idx": 228,
            "query": "Compare the unique strategies and performance outcomes in tests designed to detect early stage HCC, including those using genetic targets, methylation biomarkers, and a combination of methylation and protein markers.",
            "retrieved_metrics": {
                "reference_idx": [
                    501,
                    503,
                    499
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #epiLiver# test detects early stage A HCC with sensitivity at #84.5%# and specificity at #95%#. The #HCCBloodTest# uses #SEPT9 methylation#, with a sensitivity of #76.70%# and specificity of #64.10%#. The #HelioLiver# combines #methylation and protein markers#, achieving a sensitivity of #76%# and specificity of #91%#.",
            "predicted_answer": "The epiLiver test uses methylation of specific genes, achieving 84.5% sensitivity and 95% specificity for early HCC. The HCCBloodTest, using SEPT9 methylation, has 76.70% sensitivity and 64.10% specificity. The HelioLiver test combines 77 CpG sites and protein markers, reaching 76% sensitivity and 91% specificity for early-stage HCC.",
            "score": 5,
            "explanation": "The Predicted Answer includes all emphasized key facts from the Reference Answer: the precise names of the tests (epiLiver, HCCBloodTest, HelioLiver), the use of methylation and protein markers, and exact sensitivity and specificity percentages for early-stage HCC. No important details are missing, and the information is consistent."
        },
        {
            "query_idx": 229,
            "query": "How do survival rates differ between two advanced treatment modalities for a specific cancer, as shown in large-scale cohort studies conducted in two different countries?",
            "retrieved_metrics": {
                "reference_idx": [
                    1005,
                    1007
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Cohort studies show #proton therapy# achieves better five-year survival in Germany (91% vs. 98%) than #carbon-ion therapy#, while Japan reports higher efficacy for carbon-ion therapy #across risk groups#.",
            "predicted_answer": "Large-scale cohort studies show that in Germany, proton therapy had higher 5-year overall (98% vs. 91%) and progression-free survival (85% vs. 50%) rates compared to carbon ion therapy for prostate cancer. In Japan, carbon ion therapy showed better 5-year overall survival rates, especially for low-risk patients (100%).",
            "score": 1,
            "explanation": "The predicted answer mentions that in Germany, proton therapy had higher survival rates, consistent with the reference. However, it differs in the comparison accuracy of survival rates between the two therapies. Additionally, the reference mentions Japan's efficacy across risk groups, which is only partly reflected in the predicted answer."
        },
        {
            "query_idx": 230,
            "query": "What are the prerequisites and potential difficulties in advancing combination therapy of repurposed drugs to specific phases of clinical trials, considering the role of preliminary investigations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2258,
                    2259,
                    2267
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The lack of #thorough preclinical investigations# in repurposing drugs increases the #cost and complexity# of trials, hindering progression to #phase II or III for approval#.",
            "predicted_answer": "Preliminary investigations must assess drug interactions, optimal dosages, and synergistic effects. Challenges include coordinating dosing and timing, understanding different mechanisms of action, and ensuring a strong evidence base before advancing to clinical trials.",
            "score": 1,
            "explanation": "The predicted answer acknowledges the need for preliminary investigations but lacks coverage of the reference's emphasized points about the \"lack of thorough preclinical investigations,\" \"cost and complexity,\" and \"hindering progression to phase II or III.\" Thus, more than one key fact is missing."
        },
        {
            "query_idx": 231,
            "query": "Which initiative focuses on transforming dose optimization in oncology drug development, was highlighted at the 2022 symposium, and utilizes specific methods to address complex challenges associated with this process?",
            "retrieved_metrics": {
                "reference_idx": [
                    694,
                    1584,
                    1583
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Project Optimus# enhances dose optimization in oncology, highlighted at the #2022 ACoP symposium#, addressing complex challenges using #quantitative modeling# techniques for improved patient outcomes.",
            "predicted_answer": "Project Optimus, highlighted at the 2022 ACoP Annual Meeting, focuses on transforming dose optimization in oncology drug development. It uses model-informed methods and integrates diverse data sources to address complex challenges.",
            "score": 3,
            "explanation": "The Predicted Answer mentions \"Project Optimus\" and \"2022 ACoP Annual Meeting,\" matching two key facts. It addresses complex challenges using \"model-informed methods,\" consistent with \"quantitative modeling.\" However, it omits \"patient outcomes.\" Despite this, key insights are retained without contradictions."
        },
        {
            "query_idx": 232,
            "query": "What medications received FDA approval in 2020 and 2022 for post-remission therapy, a rare pediatric leukemia, and a specific chromosomal syndrome?",
            "retrieved_metrics": {
                "reference_idx": [
                    544,
                    547,
                    542
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The FDA approved #azacitidine tablets# for #AML# in 2020, #azacitidine# for pediatric #juvenile myelomonocytic leukemia# in 2022, and a #decitabine and cedazuridine combination# for #MDS#.",
            "predicted_answer": "In 2020, ONUREG (azacitidine) was approved for AML in CR. In 2022, azacitidine (Vidaza) was approved for pediatric JMML. No specific chromosomal syndrome medications were mentioned.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions #azacitidine# for #AML# in 2020 and #azacitidine# for #juvenile myelomonocytic leukemia# in 2022, aligning with the reference. However, it omits the #decitabine and cedazuridine combination# for #MDS#, missing a key fact and not achieving full completeness."
        },
        {
            "query_idx": 233,
            "query": "How do genetic variations in metabolism and transporters potentially alter the effectiveness of TKIs used in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    722,
                    723
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Genetic variations, such as #pharmacogenetic variation#, affect TKI response. Specific #pharmacogenes# involved include CYP3A4/5, OCT1, ABCB1, and ABCG2.",
            "predicted_answer": "Genetic variations in metabolism and transporters, such as CYP3A4/5, OCT1, ABCB1, and ABCG2, can alter the effectiveness of TKIs by changing drug exposure and response, potentially leading to differences in efficacy and toxicity.",
            "score": 3,
            "explanation": "The Predicted Answer aligns with the Reference Answer by mentioning genetic variations in relevant genes like CYP3A4/5, OCT1, ABCB1, and ABCG2. However, it lacks the explicit mention of \"pharmacogenetic variation\" and \"pharmacogenes,\" which are key emphasized terms in the Reference Answer."
        },
        {
            "query_idx": 234,
            "query": "What must be used to stabilize urine samples for ctDNA analysis, which registered assay employs a particular genetic alteration in stool DNA for CRC detection, and how many trials assess these DNA methylation biomarkers?",
            "retrieved_metrics": {
                "reference_idx": [
                    480,
                    484,
                    534
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Preservatives# are crucial for stabilizing urine cfDNA in ctDNA analysis. #Cologuard# uses stool DNA for CRC detection. #67 trials# examine DNA methylation biomarkers for advancing clinical epigenetics.",
            "predicted_answer": "Preservatives must be used to stabilize urine samples for ctDNA analysis. Cologuard (Exact Sciences) employs a genetic alteration in stool DNA for CRC detection. 33 trials assess DNA methylation biomarkers for CRC.",
            "score": 3,
            "explanation": "The predicted answer captures the use of preservatives and Cologuard correctly but misstates the number of trials as 33 instead of 67. The overall trend aligns, but the significant error in trial numbers affects completeness."
        },
        {
            "query_idx": 235,
            "query": "How does a compound's binding preference and evaluation method relate to its selective antitumor effects in a KRAS G12D mutated model?",
            "retrieved_metrics": {
                "reference_idx": [
                    1120,
                    1136,
                    1130
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The selective antitumor effect targets #KRAS G12D# mutation, utilizing #MRTX1133# binding to the GDP-bound form, with antiproliferative efficacy assessed by the #MTT assay#.",
            "predicted_answer": "A compound's binding preference, such as MRTX1133 for GDP-bound KRAS$^{G12D}$, and evaluation methods like MTT assays, help confirm its selective antitumor effects in KRAS G12D mutated models, as seen in PANC-1 cells.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts highlighted in the reference: it mentions KRAS G12D mutation, MRTX1133’s binding to GDP-bound KRAS, and evaluation through MTT assays, consistent with the reference’s meaning and main points without omission or contradiction."
        },
        {
            "query_idx": 236,
            "query": "Which biological process allows cancer cells to detach and circulate, and what specific environmental and genetic factors associated with a tumor environment enhance this process and increase metastatic potential?",
            "retrieved_metrics": {
                "reference_idx": [
                    396,
                    397
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#EMT# enables cancer cell detachment and circulation. Increased #metastatic potential# is driven by genetic alterations and selection pressures within a #pro-tumorigenic TME#.",
            "predicted_answer": "The process allowing cancer cells to detach and circulate is epithelial-mesenchymal transition (EMT), triggered by transcription factors like SNAIL, TWIST, and ZEB. Genetic factors such as TP53 and SMAD4 mutations, along with a pro-tumorigenic tumor microenvironment, enhance this process and increase metastatic potential.",
            "score": 5,
            "explanation": "The predicted answer identifies EMT as the process allowing detachment and circulation, matching the reference's mention of EMT. It discusses the pro-tumorigenic tumor microenvironment and genetic factors, aligning with the reference. However, while it doesn't focus on \"selection pressures,\" it sufficiently covers key aspects."
        },
        {
            "query_idx": 237,
            "query": "Which specific genetic alterations in oncolytic viruses contribute to selective tumor targeting and controlled replication, considering enhanced tumor specificity and functional mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    994,
                    993
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Genetic changes like a #TK gene# deficiency improve tumor specificity, and an #E2F-responsive element# insertion regulates replication in tumors with RB1 gene dysfunction.",
            "predicted_answer": "Genetic alterations like the deletion of the thymidine kinase (TK) gene in JX-594 and the insertion of an E2F-responsive element in VCN-01 enhance tumor specificity and controlled replication, targeting tumors with elevated TK or E2F levels.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions the deletion of the #TK gene# and the insertion of an #E2F-responsive element#. Both key facts emphasized in the reference are present, and the explanation of enhanced tumor specificity and controlled replication is consistent with the reference."
        },
        {
            "query_idx": 238,
            "query": "How do the outcomes of cord blood-derived CAR-NK therapy for B-cell malignancies compare to dual-targeting CD19xCD22 CAR-T therapy, specifically for relapsed B-cell acute lymphoblastic leukemia?",
            "retrieved_metrics": {
                "reference_idx": [
                    929,
                    941,
                    930
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #cord blood-derived CAR CD19-NK# therapy for B-cell malignancies showed a promising 48.6% response rate, whereas dual-targeting #SCRI-CAR19x22# in relapsed B-ALL achieved an #84.6% complete response rate#.",
            "predicted_answer": "Cord blood-derived CAR-NK therapy for B-cell malignancies showed a 48.6% overall response rate, with 1-year OS and PFS rates of 68% and 32%, respectively. Dual-targeting CD19xCD22 CAR-T therapy for relapsed B-ALL achieved an 84.6% complete response rate, with 95% MRD-.",
            "score": 3,
            "explanation": "The predicted answer includes the key outcomes and response rates for both the therapies, aligning with the reference: a 48.6% response for CAR-NK and 84.6% for dual-targeting CAR-T. However, it omits specific therapy names ('CAR CD19-NK' and 'SCRI-CAR19x22'), affecting completeness."
        },
        {
            "query_idx": 239,
            "query": "Which combination of theoretical concepts and modeling techniques supports understanding how the evolving nature of cancer complicates therapy development in light of continuous genetic variations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1637,
                    1639,
                    1588
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The integration of #tumor evolutionary theory# with PK/PD models helps address challenges posed by #genetic mutations# and the drug efficacy impact due to #tumor evolution#.",
            "predicted_answer": "The combination of tumor evolutionary theory and conventional PK/PD modeling supports understanding how continuous genetic variations in cancer complicate therapy development by influencing E-R relationships and treatment responses.",
            "score": 3,
            "explanation": "The predicted answer includes \"tumor evolutionary theory\" and mentions the impact of genetic variations on therapy, aligning with the reference's focus. However, it omits \"genetic mutations\" and \"drug efficacy impact,\" which are key emphasized facts in the reference, slightly affecting completeness."
        },
        {
            "query_idx": 240,
            "query": "What specific type of cell culture model shows increased resistance due to drug penetration limitations, and how does this model's predictive accuracy compare to traditional cell cultures when assessing animal model responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    1763,
                    1766
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #MGH-U1 spheroids# show increased resistance due to #limited drug penetration#, and #spheroid models# more accurately predict #in vivo chemosensitivity# compared to traditional 2D cultures.",
            "predicted_answer": "Spheroid cell cultures show increased resistance due to limited drug penetration in the inner core. This model more accurately predicts in vivo responses compared to traditional 2D monolayer cultures.",
            "score": 1,
            "explanation": "The predicted answer correctly identifies \"spheroid cell cultures\" and mentions \"limited drug penetration,\" capturing two key facts. However, it omits \"MGH-U1\" and \"in vivo chemosensitivity,\" missing two key elements, affecting completeness. The overall trend is aligned, with no contradictions."
        },
        {
            "query_idx": 241,
            "query": "What therapeutic process involves genetically modified cells used in tumor treatments that release active substances and use a receptor essential for targeting tumors?",
            "retrieved_metrics": {
                "reference_idx": [
                    924,
                    927,
                    939
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The therapeutic process #CAR# involves genetically engineered cells releasing #cytotoxic effector molecules# and utilizing the essential receptor #CD16# for targeting tumors.",
            "predicted_answer": "The therapeutic process involving genetically modified cells that release active substances and use a receptor for tumor targeting is Chimeric Antigen Receptor T-Cell Therapy (CAR-T). CAR-T cells are engineered to target specific tumor antigens, leading to the release of cytotoxic molecules and tumor cell death.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies Chimeric Antigen Receptor (CAR-T) Therapy, aligning with the reference's mention of \"CAR\". It notes the release of cytotoxic molecules, aligning with \"cytotoxic effector molecules\". However, it omits the specific receptor \"CD16\", affecting completeness."
        },
        {
            "query_idx": 242,
            "query": "How does sequential sampling through liquid biopsy contribute to the identification of DNA methylation biomarkers, and what is its relevance to the commercial availability of epigenetic treatments in oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    479,
                    491,
                    457
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Sequential sampling in #liquid biopsy# aids in monitoring #minimal residual disease#, involves #clinical trials# for DNA methylation biomarkers, and is relevant to #epigenetic biomarkers# and #epigenetic drugs# in oncology.",
            "predicted_answer": "Sequential sampling through liquid biopsy allows for repeated monitoring of DNA methylation biomarkers, which is crucial for tracking minimal residual disease and treatment response. This capability supports the development and commercial availability of epigenetic treatments in oncology by enabling more precise and dynamic patient management.",
            "score": 1,
            "explanation": "The predicted answer includes key ideas like \"sequential sampling,\" \"liquid biopsy,\" and \"monitoring of DNA methylation biomarkers.\" It mentions \"treatment response\" relevant to \"epigenetic treatments\" and their commercial availability. However, it lacks mention of \"clinical trials\" and \"epigenetic drugs,\" missing two crucial details."
        },
        {
            "query_idx": 243,
            "query": "Which therapeutic strategy uses certain agents to improve immunotherapy efficacy and is being evaluated in multiple clinical trials targeting different cancer types?",
            "retrieved_metrics": {
                "reference_idx": [
                    554,
                    557
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The strategy involves #HDACi agents# like vorinostat to enhance immunotherapy, paired with pembrolizumab, under evaluation in several #clinical trials# addressing diverse cancers.",
            "predicted_answer": "HDACi agents, such as vorinostat, are being evaluated in multiple clinical trials to improve immunotherapy efficacy by increasing PD-L1 expression and reducing regulatory T cells, enhancing T-cell tumor infiltration and survival.",
            "score": 3,
            "explanation": "The predicted answer mentions HDACi agents like vorinostat and their evaluation in multiple clinical trials, aligning with key facts in the reference answer. However, it misses the specific pairing with pembrolizumab. This omission affects the completeness of the information provided."
        },
        {
            "query_idx": 244,
            "query": "What are the physical and technical barriers that gene therapy must overcome to successfully integrate genetic material into target cells and improve its practice?",
            "retrieved_metrics": {
                "reference_idx": [
                    427,
                    952
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Gene therapy must surpass the #nuclear envelope# to integrate genetic material, while addressing #safety and delivery efficiency# challenges for improved practice.",
            "predicted_answer": "Gene therapy must overcome barriers such as passing the plasma membrane and nuclear envelope of target cells, ensuring safe and efficient delivery, and avoiding immune responses to successfully integrate genetic material.",
            "score": 5,
            "explanation": "The predicted answer covers all the key facts emphasized in the reference answer: overcoming the nuclear envelope (#nuclear envelope#), safety, and delivery efficiency (#safety and delivery efficiency#). The answer aligns with the reference, with no significant omissions or errors."
        },
        {
            "query_idx": 245,
            "query": "How do PDO models address the challenges of tumor heterogeneity representation, ensuring long-term stability in culture, and accurately capturing immune cell characteristics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1731,
                    1986,
                    1981
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "PDOs are derived from #single biopsies# which may not capture full tumor heterogeneity. Understanding the #tumor microenvironment# is essential for stability, while the #T-cell receptor spectrum# is accurately replicated.",
            "predicted_answer": "PDO models address tumor heterogeneity by faithfully representing both inter- and intratumoral diversity, though they may not fully encompass the original tumor. They maintain long-term stability through a deep understanding of the tumor microenvironment. PDOs also accurately capture immune cell characteristics, including T, B, NK cells, and macrophages, preserving the native TCR spectrum.",
            "score": 1,
            "explanation": "The Predicted Answer aligns with the general trend of the Reference Answer but omits specific key facts: it doesn't mention that PDOs are derived from single biopsies and doesn't explicitly connect immune cell characteristics with the accurate replication of the T-cell receptor spectrum. Therefore, the completeness is affected."
        },
        {
            "query_idx": 246,
            "query": "How do specific compounds influence the expression of a liver enzyme, and what additional pathway enhances this effect regarding metabolic diseases linked to fat metabolism?",
            "retrieved_metrics": {
                "reference_idx": [
                    1323,
                    1352,
                    1315
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#C75 and baicalin# directly enhance the enzyme's expression, while the #FGF21 pathway# further augments this, potentially improving conditions by boosting #CPT1A# expression in metabolic diseases.",
            "predicted_answer": "Specific compounds like C75 and baicalin can directly activate CPT1A, enhancing fatty acid oxidation. Additionally, FGF21 promotes CPT1A expression via the AMPK-ACC pathway and PPAR δ/γ signaling, further improving metabolic diseases linked to fat metabolism.",
            "score": 5,
            "explanation": "The Predicted Answer captures all key facts: C75 and baicalin directly enhance CPT1A expression. It explains FGF21's role in enhancing CPT1A through AMPK-ACC and PPAR δ/γ pathways. Both answers align well without discrepancies, covering all emphasized points consistently."
        },
        {
            "query_idx": 247,
            "query": "Modified multi-hop query:\nWhat techniques are employed to create advanced 3D tumor models that incorporate distinct tumor mutations and improve functionality through recent advancements?",
            "retrieved_metrics": {
                "reference_idx": [
                    1479,
                    2039,
                    1978
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modified answer:",
            "predicted_answer": "Recent advancements in 3D tumor modeling include the use of organoids, which can retain specific mutations and histological features. Techniques like 3D bioprinting, microfluidic systems, and novel extracellular matrix analogs enhance these models, improving their functionality and physiological relevance.",
            "score": 5,
            "explanation": "The predicted answer covers all key aspects: use of organoids retaining specific mutations, and techniques like 3D bioprinting, microfluidics, and extracellular matrix analogs improving model functionality and relevance. There are no significant omissions or contradictions with the reference."
        },
        {
            "query_idx": 248,
            "query": "What system uses microfluidics to replicate the biological environment, aid in drug efficacy assessments for tumoroid models, and control the tumor microenvironment's physical conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1404,
                    1483,
                    1494
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #organ-on-a-chip# system uses #microfluidic chips# to replicate #biological environments#, control the #tumor microenvironment#, and assess drug #toxicity and efficacy#.",
            "predicted_answer": "Microfluidic systems, particularly \"organ-on-a-chip\" models, use microfluidics to replicate the biological environment, control physical conditions, and facilitate drug efficacy assessments for tumoroid models.",
            "score": 3,
            "explanation": "The predicted answer captures the key concepts of \"organ-on-a-chip,\" \"microfluidics,\" \"replicate biological environment,\" and \"drug efficacy assessment for tumoroid models.\" However, it omits \"toxicity\" in drug assessments. Despite the omission, the overall trend aligns well, but a key detail is missing."
        },
        {
            "query_idx": 249,
            "query": "What are the specific roles and potential therapeutic applications of quercetin in cellular mechanisms and treatment strategies across various diseases?",
            "retrieved_metrics": {
                "reference_idx": [
                    824,
                    823,
                    822
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Quercetin #induces senescence# in cancer cells, shows #senolytic action# on senescent cell types, and demonstrates #senotherapeutic potential# in studies exploring its therapeutic applications.",
            "predicted_answer": "Quercetin induces cellular senescence in various cancer cells, inhibits HDACs, reactivates P53, and modulates the tumor microenvironment. It shows potential as a senotherapeutic agent and can protect against therapy-induced senescence.",
            "score": 3,
            "explanation": "The predicted answer correctly mentions quercetin inducing senescence and its senotherapeutic potential but misses the \"senolytic action\" emphasized in the reference. This omission affects completeness though overall aligns with trends and doesn't contradict the reference."
        },
        {
            "query_idx": 250,
            "query": "How does the compound mediate interactions in liver, breast, and cervical cancer cells, considering its roles in specific biosynthetic or signaling pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    832,
                    1690,
                    833
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The compound suppresses #cholesterol biosynthesis# in liver cancer, activates #AhR/CYP1A1 pathway# in breast cancer, and induces #apoptosis in cervical cancer# through specific pathways.",
            "predicted_answer": "Emodin mediates interactions in liver, breast, and cervical cancer cells by suppressing cholesterol and triglyceride biosynthesis, inhibiting AKT signaling, activating the AhR/CYP1A1 pathway, and inducing apoptosis through HPV E6/E7 suppression and glucose metabolism modulation.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts: the suppression of cholesterol biosynthesis, the activation of the AhR/CYP1A1 pathway, and the induction of apoptosis in respective cancer types. It adds extra detail about signaling pathways but aligns with the Reference Answer without omissions or contradictions."
        },
        {
            "query_idx": 251,
            "query": "How does the influence of a specific substance on ferroptosis and necroptosis contribute to its evaluation as a potential candidate for anti-tumor therapy in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    775,
                    776
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #induction# of #ferroptosis# and possible #necroptosis# by #Tanshinone IIA# highlights its #potential# as a viable #anti-tumor therapy# requiring comprehensive understanding for cancer treatment.",
            "predicted_answer": "Tanshinone IIA induces ferroptosis and necroptosis in cancer cells, leading to increased ROS, lipid peroxidation, and iron accumulation, and inhibiting tumor growth. Its multifaceted effects on cell death pathways make it a promising candidate for anti-tumor therapy.",
            "score": 5,
            "explanation": "The predicted answer covers key facts such as the induction of ferroptosis and necroptosis by Tanshinone IIA and its potential as an anti-tumor therapy. It mentions mechanisms like ROS and lipid peroxidation. These align with the reference, although \"possible necroptosis\" is more definitive."
        },
        {
            "query_idx": 252,
            "query": "Modify the multi-hop query:\nHow do the differences in experimental design and treatment protocols impact the evaluation of predictive accuracy across various cancer model responses and their alignment with patient outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1808,
                    1810
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "Differences in experimental design and treatment protocols, such as varying drug concentrations, exposure durations, and efficacy criteria, can lead to inconsistent results, affecting the evaluation of predictive accuracy across cancer models and their alignment with patient outcomes.",
            "score": 1,
            "explanation": "The predicted answer captures the essence of the query by noting that variations in experimental design and treatment protocols lead to inconsistent results, which affects the evaluation of predictive accuracy and alignment with patient outcomes. However, the key facts emphasized with # in the reference answer are not provided, as the reference itself is incomplete."
        },
        {
            "query_idx": 253,
            "query": "What are the individual interaction profiles of the compounds, specifically (8a) and (8b), with apoptosis-related proteins, nucleic acids, and tumor suppressor proteins, highlighting any notable binding scores?",
            "retrieved_metrics": {
                "reference_idx": [
                    231,
                    243,
                    239
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The compound #(8b)# interacted significantly with #apoptosis-related proteins#, while #(8a)# exhibited notable interactions with #nucleic acids# and #tumor suppressor proteins#, achieving specific binding scores.",
            "predicted_answer": "Compound (8b) showed strong interactions with apoptosis-related proteins, including caspase-3, with a docking score of -5.9 kcal/mol, and intercalated DNA. Compound (8a) inhibited p53 with a docking score of -5.7 kcal/mol and interacted with DNA at -5.1 kcal/mol.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference answer regarding Compound (8b) interacting with apoptosis-related proteins. However, it swaps the roles of Compounds (8a) and (8b) concerning nucleic acids and tumor suppressor proteins, leading to the omission of (8b)'s significant interaction with nucleic acids and (8a)'s with tumor suppressor proteins."
        },
        {
            "query_idx": 254,
            "query": "How does the adaptation of traditional 2D viability assays to 3D cancer models highlight the significance of using an ATP-based luminescent method like CTG-3D?",
            "retrieved_metrics": {
                "reference_idx": [
                    1737,
                    1740,
                    1742
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #ATP-based CTG-3D# luminescent assay is vital because it addresses the need for #optimization and validation# of 2D assays in 3D models and reflects the #importance of specialized 3D viability methods#.",
            "predicted_answer": "The adaptation of 2D viability assays to 3D cancer models often fails due to limited reagent penetration and reduced lytic activity. ATP-based luminescent methods like CTG-3D, designed for 3D structures, provide more accurate and reliable viability measurements, highlighting their significance.",
            "score": 1,
            "explanation": "The predicted answer includes the rationale for using ATP-based luminescent methods like CTG-3D in 3D models, aligning with the reference. However, it misses mentioning \"optimization and validation\" of 2D assays and the emphasis on \"specialized 3D viability methods.\" Thus, it omits more than one key fact."
        },
        {
            "query_idx": 255,
            "query": "How do differences in culture methods, genetic alterations, and technical variabilities affect the reproduction of spheroids in cancer research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1721,
                    1804,
                    1716
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Reproduction challenges arise from #heterogeneity# in spheroid properties, #morphological differences# due to culture methods, and #genetic modifications# within immortalized cell-derived spheroids.",
            "predicted_answer": "Differences in culture methods, genetic alterations, and technical variabilities can lead to variations in spheroid size, shape, cell density, and differentiation, affecting their therapeutic responses and the reliability of cancer research outcomes.",
            "score": 3,
            "explanation": "The predicted answer addresses heterogeneity in spheroid properties, morphological differences, and genetic alterations, aligning with the key facts of morphological differences and genetic modifications. However, it does not explicitly mention heterogeneity, affecting completeness."
        },
        {
            "query_idx": 256,
            "query": "What are the advancements in phage therapy research, and what evidence showcases its effectiveness in resistant infections? How have these developments influenced the interest in alternatives to antibiotics?",
            "retrieved_metrics": {
                "reference_idx": [
                    6,
                    34,
                    3
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Recent advancements in #phage-based drug development# address drug-resistant infections. #Personalized phage therapy# has treated cases like carbapenem-resistant infections, leading to a #renewed interest# given antibiotic resistance challenges.",
            "predicted_answer": "Recent advancements in phage therapy research, including personalized treatments and phage cocktails, have shown effectiveness against resistant infections like carbapenem-resistant Acinetobacter baumannii and biofilm-related conditions. These developments have increased interest in phage therapy as an alternative to antibiotics.",
            "score": 5,
            "explanation": "The predicted answer covers the key advancements in phage therapy, including personalized treatments and effectiveness against resistant infections, aligning with the reference's emphasis on \"phage-based drug development\" and \"personalized phage therapy.\" It also captures the overall trend of renewed interest due to antibiotic resistance."
        },
        {
            "query_idx": 257,
            "query": "What are the percentages of outcome observations for phage therapy targeting MRSA, and how many clinical studies have been conducted or are in progress for this approach in fighting drug resistance?",
            "retrieved_metrics": {
                "reference_idx": [
                    18,
                    19
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Phage therapy against #MRSA# showed effectiveness in #77.2%# improvement and #61.3%# bacteria eradication. It is one of the most #advanced and promising# fields with #14 studies# on MRSA.",
            "predicted_answer": "In a clinical study, 77.2% of cases showed clinical improvement, and 61.3% had eradication of MRSA. At least 14 clinical studies on phage therapy for Staphylococcus aureus, including MRSA, have been completed or are ongoing.",
            "score": 5,
            "explanation": "The predicted answer includes all the emphasized key facts from the reference answer: 77.2% improvement, 61.3% eradication, and 14 studies related to MRSA. The overall trend of emphasizing the effectiveness and advancement in phage therapy is consistent. There are no significant omissions or errors."
        },
        {
            "query_idx": 258,
            "query": "What factors, including genetic influences and variations in patient responses, pose challenges to determining optimal therapeutic dosing and developing new oncology drugs in clinical trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    716,
                    1640,
                    1586
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Genetic variations# influence pharmacokinetics, #tumor genetic characteristics# affect drug sensitivity, and patient response #heterogeneity# complicates dose optimization in oncology drug trials.",
            "predicted_answer": "Genetic variations, interpatient pharmacokinetic variability, and tumor heterogeneity pose significant challenges. These factors, along with patient characteristics and drug interactions, complicate optimal dosing and the development of new oncology drugs in clinical trials.",
            "score": 3,
            "explanation": "The predicted answer includes key points: genetic variations, tumor heterogeneity, and patient response variability, aligning with the reference. However, it does not specifically mention \"tumor genetic characteristics\" affecting drug sensitivity, which impacts completeness. Overall, the main trends are aligned with no contradictory information."
        },
        {
            "query_idx": 259,
            "query": "What methods and materials are used in establishing MCF-7 cell culture environments, and how are software tools applied for their spheroid analysis?",
            "retrieved_metrics": {
                "reference_idx": [
                    342,
                    344
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "MCF-7 cell environments use #penicillin/streptomycin and glutamine#, while spheroid analysis uses #ImageJ for volume calculations# and #Microsoft Excel for statistical analysis and plotting#.",
            "predicted_answer": "MCF-7 cells are cultured in phenol red-free DMEM with 10% FBS, bovine insulin, estradiol, and antibiotics. U-bottom, cell-repellent 96-well plates are used for spheroid culture. Spheroid analysis involves ImageJ for volume calculation and Excel for statistical analysis.",
            "score": 1,
            "explanation": "The Predicted Answer mentions antibiotics generally, capturing 'penicillin/streptomycin' indirectly, but omits 'glutamine', missing more than one key fact. It correctly includes 'ImageJ' for 'volume calculation' and 'Excel for statistical analysis', aligning with part of the Reference Answer."
        },
        {
            "query_idx": 260,
            "query": "What experimental models are used to analyze simultaneous cancer progression from the lungs to other organs and evaluate drug efficacy and toxicity during lung cancer development?",
            "retrieved_metrics": {
                "reference_idx": [
                    2204,
                    2212,
                    1472
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #in vivo metastasis model# simulates lung cancer spread. A #vascularized tumor model# studies specific organ metastasis and #3D models# evaluate drug efficacy and toxicity in lung cancer treatment.",
            "predicted_answer": "Experimental models like the lung-on-a-chip and vascularized tumor models are used to analyze simultaneous cancer progression and evaluate drug efficacy and toxicity. These models simulate physiological conditions and metastasis to organs such as the brain, bone, and liver.",
            "score": 1,
            "explanation": "The predicted answer mentions \"vascularized tumor models,\" aligning with one key fact. However, it omits \"in vivo metastasis model\" and \"3D models,\" both emphasized in the reference. Thus, two critical elements are missing, impacting completeness. Trends are aligned, but essential details are absent."
        },
        {
            "query_idx": 261,
            "query": "What therapeutic inhibitor plays a key role in targeting a critical enzyme involved in fatty acid oxidation, and was tested for effectiveness in a major cardiac condition but faced early trial termination?",
            "retrieved_metrics": {
                "reference_idx": [
                    1303,
                    1347,
                    1327
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The therapeutic inhibitor #Etomoxir# targets #CPT1A# involved in fatty acid oxidation, showing potential in treating #heart failure# but trials were terminated prematurely.",
            "predicted_answer": "Etomoxir, a CPT1A inhibitor, was tested for effectiveness in heart failure but faced early trial termination due to elevated liver transaminase in patients.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies \"Etomoxir\" and \"CPT1A\" as key points, aligns with the intended application for \"heart failure,\" and mentions trial termination. However, it adds \"elevated liver transaminase in patients\" which is supplementary, not contradictory. All key facts are covered."
        },
        {
            "query_idx": 262,
            "query": "What methods facilitate the systematic exploration and optimization of treatment regimens involving novel modalities, when clinical data is limited, and diverse dosing strategies are applied in phase I trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    1611,
                    1618,
                    1613
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The process involves #QSP virtual trial simulation# supporting #dose optimization with QSP models# and mapping #dose/E-R relationships# to improve treatment regimens in data-limited phase I trials.",
            "predicted_answer": "Quantitative Systems Pharmacology (QSP) modeling and digital twin simulations facilitate the systematic exploration and optimization of treatment regimens, especially when clinical data is limited and diverse dosing strategies are applied in phase I trials.",
            "score": 1,
            "explanation": "The predicted answer mentions \"QSP modeling\" and \"digital twin simulations,\" which correlate with \"QSP virtual trial simulation\" in the reference. However, it misses references to \"dose optimization with QSP models\" and \"dose/E-R relationships,\" resulting in incomplete coverage of key facts."
        },
        {
            "query_idx": 263,
            "query": "Which ADCs utilize microtubule-targeting agents for inducing apoptosis and demonstrate efficacy in pre-clinical models using a dual-payload system with potent nanomolar to picomolar effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    175,
                    182,
                    210
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Dual-payload ADCs exploit #MMAE and MMAF# for efficacy in pre-clinical models, exhibiting #IC50 in nanomolar to picomolar ranges# with #auristatins or maytansinoids# as microtubule-targeting agents.",
            "predicted_answer": "Auristatins and maytansinoids are microtubule-targeting agents used in ADCs that induce apoptosis. An example of a dual-payload ADC is an anti-HER2 ADC containing MMAE and MMAF, showing efficacy in pre-clinical models.",
            "score": 3,
            "explanation": "The predicted answer aligns well with the reference by mentioning auristatins and maytansinoids as microtubule-targeting agents, and it includes MMAE and MMAF in a dual-payload ADC. However, it lacks the detail about the IC50 ranges in nanomolar to picomolar, affecting completeness."
        },
        {
            "query_idx": 264,
            "query": "Which compound, identified through computational analysis based on binding energy and inhibitory efficiency, was found to be optimal for a specific health condition in various studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1659,
                    1660
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The compound #ZINC00936598# demonstrated #highest binding energy# and #lowest K\\_i#, leading to its identification as the #best PR antagonist for breast cancer treatment#.",
            "predicted_answer": "ZINC00936598 was identified as the optimal compound for breast cancer treatment, based on its highest binding energy and lowest inhibitory constant (K_i) among the analyzed PR antagonists.",
            "score": 5,
            "explanation": "The predicted answer fully captures all key facts emphasized in the reference answer: ZINC00936598 is identified, with highest binding energy and lowest K_i, confirming it as the best PR antagonist for breast cancer treatment. There are no significant omissions or errors in the predicted answer."
        },
        {
            "query_idx": 265,
            "query": "What limitations in lung cancer research methodologies affect the prediction of treatment efficacy, and how do these limitations impact the development of effective therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1440,
                    1478
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The prediction of treatment efficacy is affected by the #current preclinical models#' inability to mimic human responses, highlighting the need to account for #personalized differences#.",
            "predicted_answer": "Current lung cancer research methodologies often use models that do not accurately mimic human tumor biology, leading to false positive drug candidates and poor prediction of treatment efficacy. This disconnect hinders the development of effective therapies by failing to account for patient-specific responses.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by mentioning the limitations of current models and the importance of patient-specific responses, covering both key facts (#current preclinical models# and #personalized differences#). The explanation of the impact is detailed and consistent with the reference."
        },
        {
            "query_idx": 266,
            "query": "What therapeutic method enables precise control of gene expression without altering DNA, and what are its notable advantages over traditional therapies in terms of success rate and efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    375,
                    2119
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#siRNAs# provide gene silencing without DNA alteration, offering a high #development success rate# and #robust efficacy#, surpassing traditional therapies.",
            "predicted_answer": "RNA interference (RNAi) using siRNAs enables precise control of gene expression by silencing specific mRNAs without altering DNA. Its advantages include a high success rate, robust and long-lasting efficacy, and no risk of causing cancer, unlike gene therapy.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: RNA interference using #siRNAs# provides gene silencing without altering DNA, mentions a #high success rate#, and notes #robust efficacy#. These match the emphasized points in the reference. The predicted answer aligns well with the reference without omissions."
        },
        {
            "query_idx": 267,
            "query": "Which actions performed by the RING-type E3 ligase lead to the modification and subsequent degradation of a tumor suppressor protein, and what are its implications in various human cancers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1563,
                    1562
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "MDM2 #binds and ubiquitinates# the tumor suppressor #p53#, promoting its degradation. MDM2's overexpression in cancers leads to poor #patient outcomes#.",
            "predicted_answer": "The RING-type E3 ligase MDM2 ubiquitinates the tumor suppressor p53, leading to its nuclear export and proteasomal degradation. This repression of p53's activity is linked to poor survival in various cancers, including osteosarcoma, neuroblastoma, and lung cancer.",
            "score": 3,
            "explanation": "The predicted answer successfully mentions MDM2 ubiquitinating p53, linking it to degradation and negative outcomes in cancers, reflecting the reference's emphasis on MDM2's role. However, it misses \"binding\" to p53, a key fact. Overall, the trend is aligned but incomplete."
        },
        {
            "query_idx": 268,
            "query": "How do 3D printing technologies, tumor-on-a-chip platforms, and hydrogel structures collectively contribute to the development of patient-specific tumor models and the analysis of cellular dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    2228,
                    2227,
                    2040
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The integration of #3D printing# into #tumor-on-a-chip platforms# enables #patient-specific# modeling and analysis of cell dynamics with #porous hydrogels#.",
            "predicted_answer": "3D printing, tumor-on-a-chip platforms, and hydrogel structures collectively enable the creation of patient-specific tumor models that preserve heterogeneity and mimic the tumor microenvironment, facilitating the analysis of cellular dynamics and improving drug sensitivity predictions.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by mentioning 3D printing, tumor-on-a-chip platforms, and patient-specific models, as well as the analysis of cellular dynamics. However, it misses the key fact about \"porous hydrogels\" emphasized in the reference, impacting the completeness slightly."
        },
        {
            "query_idx": 269,
            "query": "Which type of cancer treatment is questioned for its effectiveness in treating head and neck cancer and presents increased gastrointestinal issues in prostate cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1000,
                    1004
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The treatment is #proton therapy#, with uncertain effectiveness in #head and neck cancer# and increased #gastrointestinal morbidity# observed in #prostate cancer#.",
            "predicted_answer": "Proton therapy is questioned for its effectiveness in treating head and neck cancer and presents increased gastrointestinal issues in prostate cancer.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies \"proton therapy\" as the treatment in question, its uncertain effectiveness for \"head and neck cancer,\" and increased \"gastrointestinal issues\" in \"prostate cancer,\" covering all key facts and maintaining consistency with the reference answer. No key facts are missing or contradicted."
        },
        {
            "query_idx": 270,
            "query": "What system is used for simulating organ growth interactions and enables the analysis of conditions affecting multiple organs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1456,
                    1455
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #OIC# system enables the simulation of organ growth with #fluid dynamics and tissue diversity# and allows analysis of #conditions affecting multiple organs#.",
            "predicted_answer": "Organ-in-chip (OIC) systems are used for simulating organ growth interactions and enable the analysis of conditions affecting multiple organs by incorporating fluid motion and multiple tissue types.",
            "score": 5,
            "explanation": "The Predicted Answer accurately mentions the \"OIC\" system and its ability to simulate organ growth interactions and analyze conditions affecting multiple organs. It also covers \"fluid motion\" and \"multiple tissue types,\" aligning with \"fluid dynamics and tissue diversity\" in the Reference Answer, thus fully capturing the key facts."
        },
        {
            "query_idx": 271,
            "query": "What is the effect of combining certain targeted therapies on the response rates in colorectal cancer associated with different KRAS mutations, and how does this differ between various mutation types?",
            "retrieved_metrics": {
                "reference_idx": [
                    881,
                    1043,
                    1417
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Combining #Adagrasib and Cetuximab# increases response in #KRAS G12C# colorectal cancer, whereas #Afatinib and selumetinib# show limited efficacy in other #KRAS mutant# types.",
            "predicted_answer": "Combining Adagrasib and Cetuximab in KRAS G12C-mutated colorectal cancer increased response rates from 19% to 46%. However, for other KRAS mutations, combinations like afatinib and selumetinib showed limited efficacy, only stalling the cell cycle without killing cells.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts about combining Adagrasib and Cetuximab increasing response in KRAS G12C cancer and afatinib and selumetinib's limited efficacy in other KRAS mutations. No contradictions or significant omissions in the predicted answer."
        },
        {
            "query_idx": 272,
            "query": "What process results in the production of a dioxygenase inhibitor in mutant IDH tumors, and which therapeutic agent is known to counteract this effect to promote cellular differentiation?",
            "retrieved_metrics": {
                "reference_idx": [
                    598,
                    599
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Mutant IDH tumors produce an inhibitor, #2HG#, affecting dioxygenases, which #enasidenib# counters by suppressing #2HG# and inducing differentiation.",
            "predicted_answer": "Gain-of-function mutations in IDH1/IDH2 produce 2-hydroxyglutarate (2HG), which inhibits dioxygenases. Enasidenib, an IDH inhibitor, suppresses 2HG production and promotes cellular differentiation.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key facts from the reference: gain-of-function mutations in IDH1/IDH2 produce 2HG, inhibiting dioxygenases, and enasidenib counters this by suppressing 2HG and promoting differentiation. All emphasized elements are present, maintaining the overall meaning and completeness."
        },
        {
            "query_idx": 273,
            "query": "Which compound inhibits thioredoxin reductase activities, delivered orally or intravenously, and is utilized in clinical trials for non-small-cell lung cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1874,
                    1875
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The compound #Ethaselen 20# inhibits thioredoxin reductase activities and is in a #Phase II clinical trial# specifically for non-small-cell lung cancer.",
            "predicted_answer": "Ethaselen, an analog of ebselen, inhibits thioredoxin reductase activities and is delivered orally or intravenously. It has been used in a phase II clinical trial for non-small-cell lung cancer.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the compound Ethaselen's ability to inhibit thioredoxin reductase and its use in oral or intravenous delivery and phase II clinical trials for non-small-cell lung cancer. Although it misses the \"20\" detail, this is not crucial for meaning or context."
        },
        {
            "query_idx": 274,
            "query": "What methodology leverages AI for integrating multiple data networks to improve predictions in the early stages of drug-target identification in anti-cancer drug design?",
            "retrieved_metrics": {
                "reference_idx": [
                    139,
                    141,
                    145
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #DDR method# uses #AI# to integrate networks, improving #drug-target identification# predictions crucial to early anti-cancer drug design steps.",
            "predicted_answer": "The methodology that leverages AI for integrating multiple data networks to improve predictions in early stages of drug-target identification in anti-cancer drug design is the DDR method, which combines various drug and target similarity networks to enhance prediction accuracy.",
            "score": 5,
            "explanation": "The predicted answer mentions the #DDR method#, use of #AI#, and #drug-target identification#, aligning well with the reference answer. It covers all key facts, numbers, and technical details without significant omissions or contradictions, despite variations in wording."
        },
        {
            "query_idx": 275,
            "query": "Which compound did researchers identify to effectively disrupt a specific protein interaction, and what was the intended effect on an enzyme activity related to melanoma progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    1661,
                    1662
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The compound #ZINC02578057# was identified to effectively disrupt the #BSG-TRAF6 interaction#, intended to control #MMP9 overexpression# in melanoma.",
            "predicted_answer": "Researchers identified ZINC02578057 to effectively disrupt the interaction between TRAF6 and BSG, aiming to control MMP9 overexpression, which is related to melanoma progression.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts and essential information: compound #ZINC02578057#, disruption of the #BSG-TRAF6 interaction#, and control of #MMP9 overexpression# related to melanoma progression. The phrasing is slightly different, but the meaning and details are consistent."
        },
        {
            "query_idx": 276,
            "query": "Which isolated compounds from marine sponges are evaluated for their cytotoxic effectiveness against U937 cells, particularly focusing on the comparative cytotoxicity of different compounds?",
            "retrieved_metrics": {
                "reference_idx": [
                    1279,
                    1285
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#BrBin# and #Compound 87# from marine sponges show significant cytotoxic effects on U937 cells, with #Compound 87# maintaining equivalent effectiveness in inducing apoptosis compared to #BrBin#.",
            "predicted_answer": "BrBin, along with compounds 85, 86, and 87, were evaluated for cytotoxicity against U937 cells. BrBin showed the highest cytotoxicity, while 87 was equivalent. Compounds 85 and 86 were less effective.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies BrBin and compound 87 as having high cytotoxicity against U937 cells, matching the reference answer. However, it omits the fact about compound 87 being equivalent in efficacy specifically regarding apoptosis, a key detail in the reference."
        },
        {
            "query_idx": 277,
            "query": "How does the first FDA-approved nanomedicine influence adverse effect management and its role in oncology drug delivery systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    1024,
                    1016
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The FDA-approved nanomedicine, #Doxil#, was pioneering in cancer therapy by improving #targeted drug delivery# and leading to the #mitigation of toxic side effects#.",
            "predicted_answer": "The first FDA-approved nanomedicine, Doxil, enhances drug concentration at tumor sites while reducing exposure to healthy tissues, thus mitigating toxic side effects and improving therapeutic efficiency in oncology.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"Doxil\" and its role in oncology, aligning with the reference by emphasizing reduced side effects and enhanced drug delivery targeting tumor sites. All key points, including improving targeted drug delivery and mitigating toxic side effects, are adequately covered."
        },
        {
            "query_idx": 278,
            "query": "What model provides a consistent representation of parental breast tumor characteristics and supports drug screening while addressing challenges like cell line-induced variability effectively?",
            "retrieved_metrics": {
                "reference_idx": [
                    2076,
                    2075,
                    2079
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #PDX models# effectively represent #parental breast tumor characteristics# and are consistent in drug screening, unlike #CDX#, which faces challenges with cell line-induced variability.",
            "predicted_answer": "Patient-derived xenograft (PDX) models provide a consistent representation of parental breast tumor characteristics, including genetic and molecular features, and support drug screening while addressing cell line-induced variability.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies PDX models as providing a consistent representation of parental breast tumor characteristics and supporting drug screening while addressing cell line-induced variability. It includes all key facts from the reference and maintains overall alignment with no significant omissions."
        },
        {
            "query_idx": 279,
            "query": "What are the key components and distinct features used in simulation models to replicate the spread of cancer cells through systems involved in cellular transport and interactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    2057,
                    2198
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The simulation uses #microfluidic chips# to model cellular transport, incorporating #lymphatic angiogenesis#, affecting tumor interactions and increasing cancer cell spread.",
            "predicted_answer": "Key components in simulation models include microfluidic chips, polysaccharide-cellulose-based microtubes, and collagen matrices. Distinct features involve mimicking lymphatic and vascular systems, tumor-endothelial cell interactions, and the effects of perfusion on tumor growth and drug delivery.",
            "score": 3,
            "explanation": "The predicted answer covers the use of microfluidic chips, aligning with the reference's mention of them in cellular transport modeling. Both emphasize features like tumor interactions, although 'lymphatic angiogenesis' is specifically mentioned only in the reference. The predicted answer mostly aligns but omits this key detail."
        },
        {
            "query_idx": 280,
            "query": "What mechanisms affect chromatin organization and transcription regulation, contributing to cancer progression, and how are they used in cancer diagnostic processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    464,
                    471,
                    528
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The alteration of #histone modifications# affects chromatin and #gene expression#, contributing to cancer, where processes like #histone acetylation# serve as #biomarkers# for identifying cancer presence.",
            "predicted_answer": "Histone modifications and DNA methylation affect chromatin organization and transcription, contributing to cancer. These epigenetic changes disrupt gene expression and cellular homeostasis. High-throughput technologies have identified cancer-specific epigenetic marks used as biomarkers for diagnosis, prognosis, and therapy response.",
            "score": 3,
            "explanation": "The predicted answer includes histone modifications affecting chromatin and transcription as well as identifying epigenetic biomarkers for cancer diagnosis, which aligns with the reference. However, it omits specific mention of histone acetylation and gene expression, impacting completeness."
        },
        {
            "query_idx": 281,
            "query": "What is the total number of lung cancer cell lines derived for study, and which in vivo models are used to retain the phenotypic features of primary lung tumors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1474,
                    1476
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #NCI panel# has over #200 lung cancer cell lines#, and #patient-derived tumor xenografts# are used to preserve #essential features# of primary human tumors.",
            "predicted_answer": "There are over 200 lung cancer cell lines derived for study. For in vivo models, patient-derived tumor xenografts (PDXs) are used to retain the phenotypic features of primary lung tumors.",
            "score": 3,
            "explanation": "The predicted answer correctly states there are over 200 lung cancer cell lines and mentions patient-derived tumor xenografts (PDXs) for retaining phenotypic features, accurately reflecting the key facts in the reference. However, it omits the mention of the #NCI panel# and #essential features#, but maintains overall trend alignment."
        },
        {
            "query_idx": 282,
            "query": "What are the financial and developmental advantages of repurposing drugs for cancer treatment, and what specific cellular characteristics do these drugs affect in the context of oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    755,
                    772,
                    2233
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Leveraging existing drugs in oncology is #cheaper# and #faster#, offering advantages in cancer treatment by targeting #cancer hallmarks# and affecting #cell death# mechanisms.",
            "predicted_answer": "Repurposing drugs for cancer treatment is cost-effective and accelerates development due to known safety profiles. These drugs target various cancer hallmarks, such as proliferative signaling, evading growth suppressors, and resisting cell death, and can activate multiple cell death pathways.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by noting the financial advantage of being \"cost-effective\" (cheaper) and the developmental benefit of \"accelerating development\" (faster). It matches the emphasis on targeting \"cancer hallmarks\" and affecting \"cell death\" mechanisms, capturing all key details effectively."
        },
        {
            "query_idx": 283,
            "query": "What biotechnological application involves using bacteriophages to effectively reduce protective bacterial formations and manage oral health issues such as dental plaque and periodontal disease?",
            "retrieved_metrics": {
                "reference_idx": [
                    30,
                    33
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The use of #bacteriophages# in biotechnology helps reduce #biofilms#, notably dental #biofilms#, and manage conditions like #periodontal disease#.",
            "predicted_answer": "Phage therapy is a biotechnological application that uses bacteriophages to target and reduce bacterial biofilms, effectively managing oral health issues like dental plaque and periodontal disease.",
            "score": 5,
            "explanation": "The predicted answer accurately captures all key elements: the use of bacteriophages, reduction of biofilms (including dental biofilms), and the management of oral health issues such as dental plaque and periodontal disease. There are no significant omissions, contradictions, or errors compared to the reference."
        },
        {
            "query_idx": 284,
            "query": "What are the specific regulatory and ethical considerations involved in deploying AI technologies for healthcare to ensure both innovative practices and safeguarding patient interests?",
            "retrieved_metrics": {
                "reference_idx": [
                    1225,
                    1229
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Deploying AI in healthcare involves #regulatory frameworks# ensuring safety, and #balancing innovation and patient safety# to address ethical considerations and protect patient interests.",
            "predicted_answer": "Regulatory considerations include FDA and EU MDR/IVDR frameworks for safety, efficacy, and data protection. Ethical considerations involve ensuring patient privacy, trust, and addressing ethical questions in diagnosis and treatment.",
            "score": 5,
            "explanation": "The Predicted Answer mentions regulatory frameworks (FDA and EU MDR/IVDR) and addresses safety, privacy, and ethical questions, aligning with the Reference Answer's emphasis on regulatory frameworks and balancing innovation with patient safety. Key facts are present, showing consistency without contradictions."
        },
        {
            "query_idx": 285,
            "query": "How do cancer PDOs exhibit diverse morphological features and respond to intrinsic and extrinsic factors, and what advanced cultural techniques are used to maintain their original characteristics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1395,
                    1726,
                    1969
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Cancer PDOs are cultivated as #cost-effective# models with #similarity to primary tumors#, displaying #morphological heterogeneity# from #intrinsic and extrinsic factors#, using advanced #3D structures# to maintain their #characteristics#.",
            "predicted_answer": "Cancer PDOs exhibit diverse morphological features, including cohesive and discohesive structures, which reflect the original tumor's histology. Their characteristics are maintained using 3D culturing techniques with specialized scaffolds and growth factors, preserving genetic and phenotypic traits.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference answer on morphological heterogeneity and 3D techniques. However, it misses key facts like the cost-effectiveness and similarity to primary tumors. Overall, the trend is maintained, but multiple key points are omitted, impacting completeness."
        },
        {
            "query_idx": 286,
            "query": "What innovative delivery system is employed to navigate resistance in pancreatic cancer caused by genetic heterogeneity and biological barriers, integrating different therapeutic strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    395,
                    426,
                    453
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "A #nanoparticle-based delivery system# is used to tackle #PC's genetic variability# and resistance, employing #combination therapy# to overcome biological obstacles effectively.",
            "predicted_answer": "Nanoparticle-based delivery systems are being developed to target genetically diverse subclones and overcome biological barriers in pancreatic cancer. These systems, combined with adaptive and combinational therapies, aim to personalize treatment and enhance efficacy.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts: \"nanoparticle-based delivery systems\" and \"combination therapy\", aligning well with the trend of addressing genetic variability and overcoming biological barriers effectively. However, it does not explicitly mention \"PC's genetic variability,\" which slightly impacts completeness."
        },
        {
            "query_idx": 287,
            "query": "Which mutation in the H3.3 histone variant is associated with poor prognosis in gliomas, leads to a significant tumor classification, and results in alterations to the epigenome?",
            "retrieved_metrics": {
                "reference_idx": [
                    530,
                    536,
                    531
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #H3K27M# mutation in the #H3.3# histone variant is linked to #short survival# in gliomas, crucial for #classifying diffuse midline glioma#, and represents an #oncohistone mutation# affecting the epigenome.",
            "predicted_answer": "The H3K27M mutation in the H3.3 histone variant is associated with poor prognosis in gliomas, leads to a significant tumor classification as diffuse midline glioma, and results in alterations to the epigenome by disrupting methylation and acetylation patterns.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts, including the H3K27M mutation in H3.3, its association with poor prognosis in gliomas, its role in classifying diffuse midline glioma, and its effect on the epigenome. However, it omits the term \"oncohistone mutation\" and \"short survival,\" affecting completeness."
        },
        {
            "query_idx": 288,
            "query": "How does the sustained initiation of new blood vessels, inadequate oxygen delivery due to tumor size, and irregular vessel configuration affect tumor environments and progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    791,
                    2182,
                    389
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Persistent angiogenesis# leads to a conducive environment for #tumor expansion#, inadequate supply causes #hypoxia#, and #irregular vessels# raise #interstitial pressure#, leading to an #acidic microenvironment#.",
            "predicted_answer": "Sustained initiation of new blood vessels, inadequate oxygen delivery, and irregular vessel configuration in tumors lead to hypoxia, necrosis, and a more acidic environment, promoting tumor progression, invasion, and the development of aggressive cancer cell clones.",
            "score": 3,
            "explanation": "The predicted answer covers several key facts: sustained angiogenesis (persistent initiation of blood vessels), hypoxia, and the development of an acidic environment. However, it misses the specific effects of high interstitial pressure due to irregular vessels, crucial for a comprehensive understanding."
        },
        {
            "query_idx": 289,
            "query": "What is the method that compares individual and dual gene disruptions to reveal interactions between gene pairs, particularly when linking these outcomes with genetic dependencies highlights synthetic lethal relationships?",
            "retrieved_metrics": {
                "reference_idx": [
                    1946,
                    1977,
                    1945
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The method involves #dual perturbation# to show unexpected effects, #simultaneous gene perturbation# to examine interactions, and linking #perturbation outcomes with genetic dependencies# to reveal synthetic lethal interactions.",
            "predicted_answer": "The method that compares individual and dual gene disruptions to reveal interactions, including synthetic lethal relationships, is called multiplexed or combinatorial CRISPR screening. This approach assesses the fitness effects of disrupting genes individually and in pairs to identify significant deviations.",
            "score": 1,
            "explanation": "The predicted answer mentions multiplexed or combinatorial CRISPR screening, which aligns with comparing individual and dual gene disruptions. However, it doesn't explicitly mention \"dual perturbation,\" \"simultaneous gene perturbation,\" or linking \"outcomes with genetic dependencies,\" which are key points emphasized in the reference."
        },
        {
            "query_idx": 290,
            "query": "What test is recommended in clinical guidelines for grade III and IV gliomas, and how does it impact the predicted effectiveness of alkylating chemotherapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    483,
                    508
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The guidelines recommend #MGMT promoter methylation# testing for grade III and IV gliomas as a #predictor# of their response to alkylating chemotherapy.",
            "predicted_answer": "MGMT promoter methylation testing is recommended for grade III and IV gliomas. This test predicts the effectiveness of alkylating chemotherapy, with methylation indicating a more favorable response.",
            "score": 5,
            "explanation": "The Predicted Answer successfully includes all key facts emphasized in the Reference Answer: \"MGMT promoter methylation,\" \"grade III and IV gliomas,\" and its role as a \"predictor\" of response to alkylating chemotherapy. The phrasing differs slightly but the meaning is consistent without any significant omissions or errors."
        },
        {
            "query_idx": 291,
            "query": "How does integrating multiple types of 'omics data contribute to AI-driven advancements in cancer screening, target identification, and drug response prediction?",
            "retrieved_metrics": {
                "reference_idx": [
                    1238,
                    1241,
                    156
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The integration of multi-omics data enhances #AI-driven cancer screening#, facilitates the identification of #therapeutic targets#, and aids in predicting #drug responses# for cancer treatment.",
            "predicted_answer": "Integrating multi-omics data enhances AI-driven cancer screening, target identification, and drug response prediction by providing comprehensive molecular insights. This improves accuracy, enables precision screening, and identifies effective therapeutic targets and drug combinations.",
            "score": 5,
            "explanation": "The 'Predicted Answer' covers all key aspects: enhanced AI-driven cancer screening, identification of therapeutic targets, and prediction of drug responses, as outlined in the 'Reference Answer'. The phrasing differs, but the meaning and key facts are consistent and complete, with no contradictions."
        },
        {
            "query_idx": 292,
            "query": "Which chemical treatment is used to analyze DNA methylation in the context of noninvasive cancer diagnosis through blood, urine, or other body fluids?",
            "retrieved_metrics": {
                "reference_idx": [
                    468,
                    478
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The treatment with #sodium bisulfite# is crucial for analyzing DNA methylation, enabling #liquid biopsy# as a noninvasive cancer diagnostic method using body fluids.",
            "predicted_answer": "Sodium bisulfite treatment is used to analyze DNA methylation in noninvasive cancer diagnosis through blood, urine, or other body fluids. This method converts unmethylated cytosines to uracil while leaving methylated cytosines intact.",
            "score": 3,
            "explanation": "The predicted answer includes the use of sodium bisulfite for analyzing DNA methylation, which aligns with the key fact of the reference. However, it lacks reference to the term \"liquid biopsy,\" omitting a specific aspect of the application. Overall, it aligns but is missing one emphasized key term."
        },
        {
            "query_idx": 293,
            "query": "How are anticancer orphan indications classified as ultra-rare in terms of prevalence and number of affected individuals in the US?",
            "retrieved_metrics": {
                "reference_idx": [
                    1060,
                    1074
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Anticancer orphan indications are classified as ultra-rare if the prevalence is #1 in 50000 US citizens# or if they affect fewer than #6600# individuals.",
            "predicted_answer": "Anticancer orphan indications are classified as ultra-rare if they affect fewer than 6,600 individuals in the US, corresponding to a prevalence rate of 1 in 50,000.",
            "score": 5,
            "explanation": "The predicted answer accurately covers both key facts from the reference: the prevalence rate of 1 in 50,000 and affecting fewer than 6,600 individuals in the US. The meaning and details are consistent with the reference."
        },
        {
            "query_idx": 294,
            "query": "Which compound, used in oncology to increase treatment efficiency, targets multiple signaling pathways, and influences protein expression changes related to inflammation modulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    803,
                    805,
                    814
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #compound enhances cancer therapy# by targeting the #NFκ B pathway#, inhibiting #COX-2#, increasing #PTEN protein expression#, and modulating #inflammatory processes# linked to cancer progression.",
            "predicted_answer": "Celecoxib, a selective COX-2 inhibitor, targets multiple signaling pathways including ERK1/2, P38, and NFκB, and influences protein expression related to inflammation modulation, enhancing treatment efficiency in oncology.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions Celecoxib, targeting NFκB and COX-2, and modulating inflammation. However, it omits PTEN protein expression, missing one key fact. Overall, it aligns with the reference but lacks completeness due to the PTEN omission."
        },
        {
            "query_idx": 295,
            "query": "What changes have occurred in the number of approved treatments since the adoption of the orphan drug act in 1983, and during what period after initial approval is FDA approval for new indications most likely?",
            "retrieved_metrics": {
                "reference_idx": [
                    2261,
                    2262
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Since 1983, approved treatments increased from #38# to over #350#. FDA approval likelihood for new drug indications peaks within #1-2 years# post-initial approval, before generics appear.",
            "predicted_answer": "Since the Orphan Drug Act of 1983, approved treatments for rare diseases have increased from 38 to over 350. The FDA is most likely to approve new indications for a drug within 1-2 years after its initial approval.",
            "score": 5,
            "explanation": "The predicted answer accurately includes both key facts: the increase in approved treatments from 38 to over 350 and the likelihood of FDA approval for new indications within 1-2 years after initial approval. No significant omissions or errors are present, and trends are correctly aligned."
        },
        {
            "query_idx": 296,
            "query": "What specific cellular structures and organ-level mechanisms complicate the delivery and effectiveness of therapeutic agents in the human body?",
            "retrieved_metrics": {
                "reference_idx": [
                    355,
                    359
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Delivering therapeutic agents is hindered by #biological barriers# like the #nuclear membrane# at cellular levels and challenges such as the #blood-brain barrier# and #genetic heterogeneity# at organ levels.",
            "predicted_answer": "Cellular structures like the nuclear membrane, organelle linings, and endosomal compartments, along with organ-level barriers such as the blood-brain barrier and mucosal/epithelial lining, complicate drug delivery and effectiveness.",
            "score": 3,
            "explanation": "The predicted answer includes the nuclear membrane and blood-brain barrier, aligning with the key points of the reference. However, it omits \"genetic heterogeneity\" and inaccurately mentions additional barriers that are not in the reference. This missing key fact affects completeness."
        },
        {
            "query_idx": 297,
            "query": "Which agents received FDA accelerated approvals for R/R peripheral T-cell lymphoma and R/R multiple myeloma between 2014-2015, and what were the clinical trial criteria supporting their approvals?",
            "retrieved_metrics": {
                "reference_idx": [
                    560,
                    571
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Agents #Belinostat# and #Panobinostat# received FDA accelerated approval in #2014 for R/R PTCL# and #2015 for R/R multiple myeloma#, respectively, based on #overall response rate# and #progression-free survival# criteria.",
            "predicted_answer": "Belinostat received FDA accelerated approval for R/R peripheral T-cell lymphoma in 2014, based on a single-arm trial with an ORR of 25.8%. Panobinostat, in combination with bortezomib and dexamethasone, was approved for R/R multiple myeloma in 2015, supported by superior PFS in the PANORAMA1 study.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference: Belinostat's approval in 2014 for R/R PTCL based on ORR, Panobinostat's approval in 2015 for R/R multiple myeloma based on PFS in PANORAMA1 study. The details are consistent with the emphasized information in the reference."
        },
        {
            "query_idx": 298,
            "query": "What structured modeling techniques and their processes are employed in oncology to optimize drug dosing decisions, and how do continuous data updates contribute to these processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1603,
                    1629,
                    1589
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Pharmacologically informed modeling# enhances #dose optimization# in oncology using #MIDD tools#. Continuous #quantitative knowledge base# updates are essential for effective #dose selection# and #program strategy development#.",
            "predicted_answer": "Model-informed drug development (MIDD) techniques, including data collection, synthesis, estimation, and simulation, are used in oncology to optimize drug dosing. Continuous data updates refine these models, improving dose-response and toxicity predictions, and enabling more adaptive clinical trial designs.",
            "score": 3,
            "explanation": "The Predicted Answer covers MIDD techniques and continuous data updates, aligning with the Reference Answer’s focus on pharmacologically informed modeling, dose optimization, and quantitative knowledge updates. However, it lacks mention of \"dose selection\" and \"program strategy development,\" which impacts completeness."
        },
        {
            "query_idx": 299,
            "query": "How do limitations in standard assays affect the accuracy of efficacy measurements, particularly over time, and what role do image-based techniques play in enhancing measurements in organoid research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1743,
                    1750,
                    1761
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Standard assays are limited by #cell subpopulation detection#, leading to #time-dependent efficacy metrics#, while image-based techniques address #growth measurement inconsistencies# in organoid research.",
            "predicted_answer": "Limitations in standard assays, like viability-based methods, can lead to inaccurate efficacy measurements over time as they fail to account for heterogeneity in organoid cultures. Image-based techniques enhance accuracy by providing detailed morphological data, enabling better assessment of treatment effects and growth rate inhibition.",
            "score": 1,
            "explanation": "The predicted answer covers the limitations of standard assays and the role of image-based techniques but misses specific key facts like \"cell subpopulation detection\" and the notion of \"time-dependent efficacy metrics.\" These omissions impact the completeness of the answer regarding the emphasized points."
        },
        {
            "query_idx": 300,
            "query": "How are models, derived from metastatic biopsies, applied to forecast treatment responses in a particular type of cancer through predictive testing?",
            "retrieved_metrics": {
                "reference_idx": [
                    1389,
                    1401,
                    1771
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Organoids# from #metastatic lesions# are used for #predictive testing# in #colorectal cancer# to assess chemotherapeutic responses.",
            "predicted_answer": "Metastatic biopsies are used to create organoids that reflect the genetic characteristics of the primary tumor. These organoids are then tested with various chemotherapeutic regimens to predict patient response, aiding in personalized treatment planning.",
            "score": 1,
            "explanation": "The predicted answer mentions \"organoids\" and their use in testing chemosensitivity, aligning with the reference. However, it lacks specificity, notably \"metastatic lesions\" and \"colorectal cancer.\" Thus, while no contradictions exist, it misses two key facts impacting completeness."
        },
        {
            "query_idx": 301,
            "query": "Which immune checkpoint inhibitors, highlighted for their cancer-fighting mechanism at the 2023 ASCO-GU Symposium, contribute to immune enhancement by targeting specific proteins on cancer and immune cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    900,
                    907,
                    1857
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Immune checkpoint inhibitors targeting #PD-1# and #PD-L1# were highlighted for #enhancing immune response# against cancer and prominently featured at the #2023 ASCO-GU Cancers Symposium#.",
            "predicted_answer": "Pembrolizumab, Nivolumab, Atezolizumab, and Avelumab, highlighted at the 2023 ASCO-GU Symposium, enhance the immune response by targeting PD-1 or PD-L1 proteins on cancer and immune cells.",
            "score": 5,
            "explanation": "The predicted answer mentions Pembrolizumab, Nivolumab, Atezolizumab, and Avelumab, all relevant to the PD-1/PD-L1 targets, aligning with the reference. It confirms the enhancement of immune response and the 2023 ASCO-GU Symposium context. All key facts with # are covered."
        },
        {
            "query_idx": 302,
            "query": "Which screening method uncovers specific synthetic lethal interactions between tumor suppressors and also offers advantages over cDNA methods due to its simplicity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1941,
                    2098
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#RNAi-based# screens find interactions with #SMARCA4/SMARCA2# and #MAGOH/MAGOHB#. Meanwhile, #CRISPR-based# screening surpasses cDNA methods due to reduced complexity.",
            "predicted_answer": "CRISPR-based screening, particularly CRISPR-Cas9, uncovers specific synthetic lethal interactions between tumor suppressors and offers advantages over cDNA methods due to its simplicity and robust on-target activity.",
            "score": 1,
            "explanation": "The predicted answer identifies CRISPR-based screening as uncovering synthetic lethal interactions and mentions its simplicity as an advantage over cDNA methods. It omits the specific RNAi-based interactions with SMARCA4/SMARCA2 and MAGOH/MAGOHB, thus missing key facts highlighted in the reference answer."
        },
        {
            "query_idx": 303,
            "query": "What impact do patient-derived organoids have on cancer treatment selection and effectiveness, and what challenges do they face in clinical trial validations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1983,
                    1995,
                    1779
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "PDOs help clinicians select treatments by providing a #predictive framework# and #improving patient care#, but they face validation challenges, showing limited significant responses in #clinical applications#.",
            "predicted_answer": "Patient-derived organoids (PDOs) enhance cancer treatment selection and effectiveness by providing personalized, predictive models that improve response rates and survival. However, challenges in clinical trial validations include ethical considerations, scaling up processes, and ensuring equitable access. Clinical trials have shown mixed results, with some patients not achieving significant responses.",
            "score": 3,
            "explanation": "The Predicted Answer captures the essence of using PDOs as a predictive framework to improve patient care, aligning with the Reference Answer. It mentions challenges such as scaling and equitable access but covers clinical application challenges like mixed trial results. It misses details on \"improving patient care\"."
        },
        {
            "query_idx": 304,
            "query": "What treatment in a study reported updated response rates for a type of lung cancer, where patients were not selected based on a specific protein expression?",
            "retrieved_metrics": {
                "reference_idx": [
                    193,
                    194
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The treatment #Dato-DXd# was analyzed for #NSCLC# without #TROP2 selection#, showing variations in #ORR# across dose levels.",
            "predicted_answer": "Dato-DXd treatment in the TROPION-PanTumor01 trial reported updated response rates for NSCLC, with patients not selected based on TROP2 expression. ORR ranged from 21% to 25% across different doses.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference answer: the treatment name \"Dato-DXd,\" the focus on NSCLC, the absence of TROP2 selection, and variations in ORR across doses. The prediction is consistent with the reference regarding the overall trend and details."
        },
        {
            "query_idx": 305,
            "query": "How are phage-based strategies used to improve outcomes by enhancing therapeutic efficacy and interacting with microbiota in the context of hematological malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    73,
                    76
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Phage therapy in hematological malignancies addresses #complications# like acute graft-versus-host disease and targets cancer-associated #microbiota# for enhanced therapeutic outcomes.",
            "predicted_answer": "Phage-based strategies in hematological malignancies enhance therapeutic efficacy through gene delivery, immunomodulation, and addressing drug resistance. They also modulate gut microbiota to improve chemotherapy responses and manage complications like aGVHD.",
            "score": 5,
            "explanation": "The predicted answer covers addressing complications such as aGVHD and targets cancer-associated microbiota, as mentioned in the reference answer. It also expands on enhancing efficacy through gene delivery, which aligns with the reference's emphasis on therapeutic enhancement. No key facts are missing or contradicted."
        },
        {
            "query_idx": 306,
            "query": "What was the statistical timeframe and specific method used to evaluate the racial group proportions against CiNA data in clinical trials, and how were representation differences determined?",
            "retrieved_metrics": {
                "reference_idx": [
                    1424,
                    1432,
                    1431
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The assessment conducted from #July 2021 to March 2022# employed #Pearson χ² tests# to evaluate racial group proportions. Differences in representation were calculated by comparing these #proportions# with corresponding data from CiNA for overrepresentation or underrepresentation.",
            "predicted_answer": "The statistical analysis was conducted from July 12, 2021, to March 15, 2022. A 2-sample test for equality of proportions with continuity correction was used to compare racial group proportions in trials to CiNA data. Differences were considered significant at P < .05.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference regarding the timeframe and the method of comparison to CiNA data. However, it mentions a 2-sample test with continuity correction instead of Pearson χ² tests, missing a key fact about the specific method, affecting completeness."
        },
        {
            "query_idx": 307,
            "query": "Which group of therapeutic drugs is associated with changes in clinical development times due to FDA special designations, and what statistical methods are used to study these changes?",
            "retrieved_metrics": {
                "reference_idx": [
                    621,
                    628,
                    646
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Oncology drugs with #cumulative FDA special designations# show altered #clinical development times#, examined using methods like #Kaplan-Meier curves# and #Cox proportional hazard regression#.",
            "predicted_answer": "Cancer drugs with cumulative special FDA designations are associated with changes in clinical development times. Statistical methods used include Kaplan-Meier curves, Cox proportional hazard regression, and Kruskal-Wallis tests.",
            "score": 3,
            "explanation": "The predicted answer accurately identifies the group of drugs as cancer/oncology drugs with cumulative special FDA designations, aligns with the key fact of altered clinical development times, and includes two key statistical methods: Kaplan-Meier curves and Cox proportional hazard regression, but omits Kruskal-Wallis tests."
        },
        {
            "query_idx": 308,
            "query": "Which proteins have been identified through experimental techniques as interacting with B7-H3, and why are these interactions significant in scientific research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1381,
                    1382
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The proteins #Angio-associated migratory cell protein (AAMP)# and #Interleukin-20 receptor alpha (IL-20RA)# have been identified as B7-H3 interaction partners through experimental techniques, aiding research into its biological roles.",
            "predicted_answer": "Experimental techniques have identified AAMP and IL-20RA as interacting with B7-H3. These interactions are significant because they may influence cellular processes like proliferation and could be potential targets for cancer treatment.",
            "score": 5,
            "explanation": "The predicted answer correctly lists AAMP and IL-20RA as proteins interacting with B7-H3, consistent with the key facts in the reference answer. It also aligns with the significance provided in the reference, focusing on research implications, without contradictions or significant omissions."
        },
        {
            "query_idx": 309,
            "query": "What is the name of the antibody identified using patient-derived organoids for colorectal cancer, which receptors does it bind on cancer stem cells, and what is the outcome on organoid development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1169,
                    1801
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The antibody #MCLA-158# binds to #LGR5# and #EGFR# receptors on cancer stem cells, resulting in #significant blockage of organoid growth#.",
            "predicted_answer": "MCLA-158 is the bispecific antibody identified. It binds to LGR5 and EGFR on cancer stem cells, leading to a robust blocking of organoid growth.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized in the reference answer: the identification of the antibody as MCLA-158, its binding to LGR5 and EGFR receptors, and the blocking of organoid growth. Both answers convey the same meaning without significant omissions."
        },
        {
            "query_idx": 310,
            "query": "What computational strategies and modern techniques are utilized to identify new chemical entities derived from plants in the field of anti-cancer drug discovery?",
            "retrieved_metrics": {
                "reference_idx": [
                    1655,
                    1702,
                    1688
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Computer-aided drug discovery utilizes #structure and ligand-based approaches#, including #molecular docking#, #dynamics#, and #QSAR#, with emerging #ML# and #network pharmacology# to identify #NCEs from plant sources#.",
            "predicted_answer": "In anti-cancer drug discovery, computational strategies include molecular docking, pharmacophore modeling, and QSAR. Modern techniques like machine learning and network pharmacology are also utilized to identify new chemical entities from plants.",
            "score": 3,
            "explanation": "The predicted answer covers most key facts such as molecular docking, QSAR, machine learning, and network pharmacology. However, it misses \"structure and ligand-based approaches\" and \"dynamics.\" Overall, it aligns with the trend but lacks completeness in capturing all emphasized points."
        },
        {
            "query_idx": 311,
            "query": "What cell line and plate format are used in the newly devised method for studying breast cancer drug effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    340,
                    349
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The evaluation method uses #MCF-7# cells with a novel approach in #ultra-low attachment 6-well# plates and a distinct #method# in #96-well low attachment# plates.",
            "predicted_answer": "The newly devised method for studying breast cancer drug effectiveness uses MCF-7 cells and 96-well low attachment plates.",
            "score": 3,
            "explanation": "The predicted answer mentions MCF-7 cells and 96-well low attachment plates, correctly reflecting two key elements. However, it misses the ultra-low attachment 6-well plates. Thus, it's generally aligned but lacks one critical detail affecting completeness."
        },
        {
            "query_idx": 312,
            "query": "Which signalling pathways require targeting in cancer treatment to overcome drug resistance, what role do these pathways play in cancer cell functions, and how can existing drugs address cancer holistically?",
            "retrieved_metrics": {
                "reference_idx": [
                    2252,
                    2255,
                    769
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #Renin-Angiotensin System# and its involvement with #CPT1# support cancer proliferation. Targeting these pathways alongside #drug repurposing# approaches addresses cancer’s #14 hallmarks#.",
            "predicted_answer": "Signalling pathways like RAS, Notch, Wnt/β-catenin, and Sonic Hedgehog are crucial in cancer cell functions and drug resistance. Targeting these pathways with a multi-target strategy can address cancer more effectively by disrupting cancer cell proliferation and survival, overcoming resistance.",
            "score": 1,
            "explanation": "The predicted answer mentions RAS, Notch, Wnt/β-catenin, and Sonic Hedgehog pathways, none of which are highlighted in the reference. It omits the Renin-Angiotensin System, CPT1, drug repurposing, and the hallmarks of cancer. These omissions affect completeness significantly."
        },
        {
            "query_idx": 313,
            "query": "How do infectious disease safety protocols impact surgical procedures for rapidly progressing thyroid tumors, and what non-surgical treatments are considered when surgery is not viable?",
            "retrieved_metrics": {
                "reference_idx": [
                    2157,
                    2159,
                    2158
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "During the #COVID-19# pandemic, #surgical procedures are impacted# by restrictions. For rapidly advancing thyroid cancers, if #surgery is not viable#, alternatives like #RAI or pharmacotherapy# are considered.",
            "predicted_answer": "Infectious disease safety protocols, like those during the COVID-19 pandemic, can lead to more cautious selection and potential postponement of surgery for thyroid tumors. For rapidly progressing tumors, a timely, safe environment is crucial. When surgery is not viable, non-surgical treatments such as radioactive iodine (RAI) therapy or pharmacotherapy are considered.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts: the impact of COVID-19 on surgical procedures, the necessity of safety protocols, and consideration of non-surgical treatments like RAI or pharmacotherapy. The information aligns with the reference, including conditions when surgery isn't viable."
        },
        {
            "query_idx": 314,
            "query": "How are selenium-based compounds currently being used in pharmaceutical development, and what diseases are targeted by ongoing research and future therapeutic applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    1865,
                    1904
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Selenium compounds are developed for #pharmaceuticals#, targeting #tumor and diabetes# treatment in ongoing research and future therapies.",
            "predicted_answer": "Selenium-based compounds are being researched for their antioxidant, anticancer, and antimicrobial properties. Ongoing studies target diseases such as cancer, diabetes, and neurodegenerative disorders, though most research is still in the preclinical stage.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference in the context of using selenium-based compounds for pharmaceutical development, highlighting research into cancer (tumor) and diabetes. However, it introduces neurodegenerative disorders and antimicrobial properties not emphasized in the reference, but no contradictions exist."
        },
        {
            "query_idx": 315,
            "query": "What treatment regimen involving Pembrolizumab is used for advanced cervical cancer, populations with PD-L1 CPS of 1 or greater, and early-stage TNBC, and what are their respective outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1032,
                    1033,
                    660
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Using #Pembrolizumab# with TP and optional #Bevacizumab# improves #OS and PFS# for advanced cervical cancer, reduces #mortality risk# by 40% for PD-L1 CPS ≥1, and boosts #complete response and event-free survival# in TNBC.",
            "predicted_answer": "For advanced cervical cancer with PD-L1 CPS ≥1, Pembrolizumab combined with chemotherapy (TP) and optional Bevacizumab is used, reducing mortality risk by 40%. For early-stage TNBC, Pembrolizumab with neoadjuvant chemotherapy followed by adjuvant Pembrolizumab improves pathologic complete response and event-free survival.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key points: the use of Pembrolizumab with chemotherapy (TP) and optional Bevacizumab, the reduction in mortality risk for PD-L1 CPS ≥1, and improvements in complete response and event-free survival in TNBC. The key facts and trends are present and aligned."
        },
        {
            "query_idx": 316,
            "query": "What trial phase is currently examining inhibitors in breast cancer with BRCA mutations, focusing on reducing specific side effects, and what foundational evidence supports this approach?",
            "retrieved_metrics": {
                "reference_idx": [
                    651,
                    665,
                    657
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phase III trials target #g BRCA mutations# in breast cancer, aiming to cut down #hematologic toxicity#, underpinned by #preclinical proof-of-concept# supporting BRCA-associated cancer treatment.",
            "predicted_answer": "Current phase III trials are examining PARP inhibitors like olaparib, niraparib, and talazoparib in BRCA-mutated breast cancer. Ongoing research, including trials with selective PARP1 inhibitors like AZD5305, aims to reduce hematologic toxicity. Foundational evidence is based on the synthetic lethality approach in tumors with deficient homologous recombination repair.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies phase III trials targeting BRCA mutations and mentions the aim to reduce hematologic toxicity, aligning with synthetic lethality, akin to the foundational preclinical proof-of-concept. It covers all key facts without significant omissions or contradictions."
        },
        {
            "query_idx": 317,
            "query": "What are the effects of different injection sites on the efficiency of bone metastasis in breast cancer models, and which specific cell lines achieve the highest success rates in these models?",
            "retrieved_metrics": {
                "reference_idx": [
                    2065,
                    2071,
                    2068
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Injection sites affect #bone metastasis efficiency#, with success rates for #4T1, E0771, and KEP# cell lines. #MDA MB-231 subtypes# show 95% success via tail injection.",
            "predicted_answer": "Different injection sites affect bone metastasis efficiency in breast cancer models. Intracardiac and intraosseous injections lead to higher bone metastasis, while tail vein injection often results in lung metastases. Cell lines like MDA MB-231 subtypes, 4T1, E0771, and KEP achieve high success rates, with MDA MB-231 showing 95% bone metastasis via tail artery injection.",
            "score": 3,
            "explanation": "The predicted answer mentions the effect of injection sites on bone metastasis and includes the same cell lines as the reference (4T1, E0771, KEP, MDA MB-231 subtypes). However, it inaccurately states \"95% bone metastasis via tail artery injection\" instead of \"tail injection,\" which could imply a different method."
        },
        {
            "query_idx": 318,
            "query": "Which compounds impact the acidification process in cancer cells that influences both drug resistance and immune evasion mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    843,
                    844
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#PPIs# impact the #acidification process# modulating #chemoresistance# and influencing #immune evasion mechanisms# in tumor cells.",
            "predicted_answer": "Proton pump inhibitors (PPIs) impact the acidification process in cancer cells, reducing V-ATPase activity and disrupting proton transport. This shifts the pH balance, increasing drug sensitivity and enhancing immune surveillance by influencing macrophage function.",
            "score": 5,
            "explanation": "The predicted answer mentions PPIs impacting the acidification process, aligning with the reference. It covers drug sensitivity, thus addressing chemoresistance, and mentions immune surveillance, aligning with immune evasion mechanisms. Key facts are present, and the overall trend is consistent."
        },
        {
            "query_idx": 319,
            "query": "What is the specific genetic mutation that FDA-approved irreversible inhibitors target, which compound was the first approved to address these mutations, and what structural challenges are associated with this gene?",
            "retrieved_metrics": {
                "reference_idx": [
                    880,
                    1110,
                    883
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "FDA-approved irreversible inhibitors target the #KRAS G12C# mutation. The first approved inhibitor is #Sotorasib#, known as #AMG 510#, with development challenges due to KRAS's smooth surface.",
            "predicted_answer": "The specific genetic mutation targeted by FDA-approved irreversible inhibitors is KRAS G12C. Sotorasib was the first approved compound for this mutation. The structural challenge is the relatively smooth surface of the KRAS protein, lacking obvious binding pockets.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes the key facts: KRAS G12C mutation, sotorasib as the first approved compound, and the challenge of KRAS's smooth surface. Although it lacks \"AMG 510,\" this does not significantly impact overall understanding or alignment with the 'Reference Answer'."
        },
        {
            "query_idx": 320,
            "query": "What comprehensive methodologies combine detailed molecular characterization and spatial analysis to address the diverse cellular composition in tumors and its implications for treatment resistance in clinical oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    608,
                    1052
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Multi-omics technologies# enable detailed #molecular characterization and spatial analysis#, addressing #intratumoral heterogeneity# challenges crucial for overcoming treatment resistance in clinical oncology.",
            "predicted_answer": "Multi-omics technologies, such as slide-DNA-seq and spatial proteomics, combine detailed molecular characterization with spatial analysis to address tumor heterogeneity and its implications for treatment resistance in clinical oncology.",
            "score": 5,
            "explanation": "The predicted answer includes \"Multi-omics technologies,\" \"detailed molecular characterization,\" and \"spatial analysis,\" which align with key details in the reference answer. It also refers to \"tumor heterogeneity,\" akin to \"intratumoral heterogeneity.\" No key facts are missing; thus, it thoroughly covers the reference details."
        },
        {
            "query_idx": 321,
            "query": "Which gene editing strategies are implemented to address immune rejection challenges in both CAR19-T cells and universal CAR-T cell therapies, and what specific targets do they focus on in each type?",
            "retrieved_metrics": {
                "reference_idx": [
                    935,
                    963,
                    2114
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Gene editing tools# like #TALENs# prevent immune rejection in #CAR19-T cells#, while #CRISPR-Cas9# targets #MHC related genes# in #universal CAR-T cells# to provide immunological advantages.",
            "predicted_answer": "Gene editing strategies to address immune rejection in CAR19-T and universal CAR-T cells include using TALENs, ZFNs, or CRISPR/Cas9 to knock out TCRs and MHC genes. In CAR19-T, TCR and CD52 are targeted, while in universal CAR-T, TRAC and MHC genes are knocked out to prevent host rejection.",
            "score": 3,
            "explanation": "The predicted answer covers the key points by mentioning TALENs and CRISPR/Cas9 gene editing tools, focusing on TCRs and MHC genes for immune rejection. However, it misses specific mention of MHC genes in CAR19-T cells, partly impacting completeness."
        },
        {
            "query_idx": 322,
            "query": "What therapeutic approach involves inhibiting specific proteins like CDK4 and CDK6 and is associated with discovering new therapeutic opportunities through understanding genetic interactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1959,
                    1962
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The therapeutic approach involves inhibiting #paralog members# like #CDK4 and CDK6#, leveraging #synthetic lethality# with #gene pairs#, promising new therapeutic opportunities.",
            "predicted_answer": "The therapeutic approach that involves inhibiting specific proteins like CDK4 and CDK6, and is associated with discovering new therapeutic opportunities through understanding genetic interactions, is the use of small-molecule inhibitors. This approach targets both members of a paralog pair, such as palbociclib for CDK4 and CDK6 in breast cancer.",
            "score": 1,
            "explanation": "The predicted answer covers the inhibition of CDK4 and CDK6 and the concept of discovering new therapeutic opportunities through understanding genetic interactions. However, it misses the specific mention of \"paralog members,\" \"synthetic lethality,\" and \"gene pairs,\" which are key facts in the reference."
        },
        {
            "query_idx": 323,
            "query": "What are the integrated components and specific resistance indicators analyzed in the newly developed in vitro model for testing immune checkpoint inhibitors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1492,
                    1497
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The model integrates an #immune-competent tumor model# with a #tumoroid and artificial lymph node#, analyzing #primary resistance indicators#, including #TILs and PD-L1 expression#.",
            "predicted_answer": "The in vitro model integrates patient-derived tumoroids with an artificial lymph node containing mature antigen-presenting cells. It analyzes PD-L1 expression and tumor-infiltrating lymphocytes (TILs) as resistance indicators.",
            "score": 3,
            "explanation": "The predicted answer includes the integration of a \"tumoroid and artificial lymph node,\" but omits the term \"immune-competent tumor model.\" It correctly identifies TILs and PD-L1 expression as resistance indicators, aligning with the reference on these points but missing one key fact."
        },
        {
            "query_idx": 324,
            "query": "Which PET ligands are used to measure an enzyme associated with Alzheimer's in the human brain and a phosphodiesterase isoform related to CNS disorders?",
            "retrieved_metrics": {
                "reference_idx": [
                    1539,
                    1538
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#[$^{18}$F]LSN3316612# measures an enzyme linked to Alzheimer's, while #PF-06445974# targets a phosphodiesterase isoform related to CNS disorders.",
            "predicted_answer": "[$^{18}$F]LSN3316612 is used to measure O-GlcNAcase, an enzyme associated with Alzheimer's, and PF-06445974 is used to image phosphodiesterase 4B (PDE4B) isoform, which is related to CNS disorders.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key facts in the reference answer: [$^{18}$F]LSN3316612 is used for an enzyme associated with Alzheimer's, and PF-06445974 is related to a phosphodiesterase isoform associated with CNS disorders. The technical details match those in the reference."
        },
        {
            "query_idx": 325,
            "query": "Describe the selenium-based compounds used in cancer treatment, specifying the cancer type each targets and the mechanism of action or measurement value associated with each.",
            "retrieved_metrics": {
                "reference_idx": [
                    1883,
                    1886,
                    1884
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Compound 36 targets breast cancer with an #IC₅₀ value of 1.5 µM#. Selenazoles target melanoma with #antitumor activity#. Selnocoxib-1 targets prostate cancer through #inhibition mechanism# downregulating p-AKT, COX-2, HIF-1a.",
            "predicted_answer": "Selenocyanate compounds, such as benzyl selenocyanate derivatives, target breast cancer by inhibiting tubulin polymerization and Akt phosphorylation. Selnocoxib-1 targets prostate cancer by downregulating p-AKT, COX-2, and HIF-1α. Phenylalkyl isoselenocyanates are effective against various tumors.",
            "score": 1,
            "explanation": "The predicted answer aligns with the overall trend of the reference answer. Both mention Selnocoxib-1 targeting prostate cancer and its downregulation pathways. However, the predicted answer misses key facts about Compound 36 for breast cancer (IC₅₀ value) and selenazoles targeting melanoma, impacting completeness."
        },
        {
            "query_idx": 326,
            "query": "What technological advancements are used to enhance the accuracy of cancer diagnosis and to tailor personalized cancer therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1213,
                    1627
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Deep learning# enhances cancer diagnosis accuracy, while #machine learning# tailors personalized therapies, improving both precision in diagnostics and treatment approaches.",
            "predicted_answer": "Deep learning algorithms and AI-powered digital pathology platforms enhance cancer diagnosis accuracy by automating slide scanning, image analysis, and identifying subtle histological features. Machine learning techniques analyze large patient datasets to tailor personalized cancer therapies.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of using #deep learning# for accuracy in diagnosis and #machine learning# for tailoring personalized therapies, both of which align with the reference. The explanation is complete and contains no contradictions or significant omissions."
        },
        {
            "query_idx": 327,
            "query": "What changes are necessary in both the approach for phage-based vaccination methodologies and the technical systems supporting these vaccines to improve their overall effectiveness in inducing an immune response?",
            "retrieved_metrics": {
                "reference_idx": [
                    64,
                    63
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Improvements are needed in the #targeted phage-based vaccination strategies# and the #optimization of phage display systems# to enhance the effectiveness of the immune response.",
            "predicted_answer": "To improve phage-based vaccine effectiveness, it is necessary to optimize antigen presentation and phage display systems for enhanced immunogenicity. Additionally, advancing technical systems, such as cold-free supply chains, and conducting rigorous clinical trials for safety and efficacy validation are crucial.",
            "score": 3,
            "explanation": "The predicted answer includes the optimization of phage display systems, aligning with the reference. However, it lacks mention of \"targeted phage-based vaccination strategies,\" meaning a key fact is missing. Other details about technical systems do not contradict but are not emphasized in the reference."
        },
        {
            "query_idx": 328,
            "query": "What cancer model, noted for its ability to reproduce original tumor features, provides enhanced transcriptional accuracy and is applied in NSCLC studies for evaluating drug effects?",
            "retrieved_metrics": {
                "reference_idx": [
                    1481,
                    1489,
                    1482
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The model used is the #lung tumoroids#, which #mimic primary tumor# features, offer #higher transcriptional accuracy#, and are used in #NSCLC tumoroid# studies to evaluate #drug toxicity# and efficacy.",
            "predicted_answer": "Patient-derived tumoroids, noted for their ability to reproduce original tumor features and enhanced transcriptional accuracy, are applied in NSCLC studies for evaluating drug effects. These models incorporate relevant healthy cells like CAFs to better mimic the tumor microenvironment.",
            "score": 3,
            "explanation": "The 'Predicted Answer' aligns with the 'Reference Answer' by mentioning #tumoroids, mimic of tumor features, transcriptional accuracy, and evaluation in NSCLC studies#. However, it does not specify \"lung\" tumoroids or focus on \"drug toxicity,\" which affects completeness."
        },
        {
            "query_idx": 329,
            "query": "How do different proton therapy techniques compare in terms of radiation dose delivery and adverse event rates for treating locally advanced and unresectable NSCLC, relative to photon radiation therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    1003,
                    1002
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#IMPT# offers lower radiation doses and fewer adverse events in locally advanced NSCLC, whereas #PSPT# demonstrates a reduced rate of adverse events in unresectable NSCLC compared to photon radiation.",
            "predicted_answer": "IMPT delivers lower radiation doses to surrounding organs and has a lower rate of adverse events compared to PSPT. IMRT and PSPT show no significant difference in radiation pneumonitis or local failure. PSPT has a decreased rate of adverse events compared to photon therapy.",
            "score": 5,
            "explanation": "The 'Predicted Answer' contains the key facts, mentioning that IMPT delivers lower radiation doses and has a reduced rate of adverse events, aligning with the reference. It also states PSPT's reduced adverse events compared to photon therapy. The overall trends and key facts are captured accurately."
        },
        {
            "query_idx": 330,
            "query": "How is the impact of drug exposure on cells within three-dimensional cultures assessed and quantified graphically to evaluate treatment potency?",
            "retrieved_metrics": {
                "reference_idx": [
                    1733,
                    1744
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #proportion of living cells# is assessed through viability assays and quantified in a #concentration-response curve# to gauge the drug's potency in 3D cultures.",
            "predicted_answer": "The impact of drug exposure on cells in 3D cultures is assessed using cell viability assays, which measure living cells or their signals. The results are graphically represented as concentration-response curves, from which metrics like IC50 and AUC are derived to evaluate treatment potency.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer, matching key elements such as using viability assays to assess the proportion of living cells and representing the data graphically with concentration-response curves. It also adds relevant metrics (IC50 and AUC), which do not contradict the reference."
        },
        {
            "query_idx": 331,
            "query": "What biological challenges affect the persistent effectiveness of gene therapy in non-native target cells, potentially leading to decreased expression of the therapy product over time?",
            "retrieved_metrics": {
                "reference_idx": [
                    448,
                    449
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The nature of #non-native transduced target cells# poses biological challenges, affecting the persistent effectiveness of Roctavian, as its #transgene expression decreases# over time.",
            "predicted_answer": "Biological challenges include the non-native target cells' limited capacity to produce the complex protein, lack of co-expression with chaperone proteins, and the fading transgene expression over time due to first-order elimination kinetics.",
            "score": 3,
            "explanation": "The predicted answer addresses key facts like biological challenges and decreased transgene expression over time in non-native target cells but omits the gene therapy product name \"Roctavian,\" a significant detail present in the reference answer. The overall trend aligns, with no contradictory information."
        },
        {
            "query_idx": 332,
            "query": "How is ubiquitin transferred in the ubiquitination process, and what classification is based on the N-terminal sequences of HECT-type E3s?",
            "retrieved_metrics": {
                "reference_idx": [
                    1553,
                    1554
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Ubiquitin transfer involves a #two-step reaction# from E2 to E3, then to substrates. HECT-type E3s are classified into #three groups# based on N-terminal sequences.",
            "predicted_answer": "In the ubiquitination process, ubiquitin is first transferred from E2 to the catalytic C site of HECT E3, forming a thioester intermediate, then ligated to the substrate. HECT-type E3s are classified into three groups based on their N-terminal sequences: Nedd4/Nedd4-like, HERC- and RLD-containing, and those without WW and RLD domains.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by describing ubiquitin transfer and classification of HECT-type E3s. However, it misses the specific mention of \"two-step reaction\" in the ubiquitin transfer process, affecting completeness. The classification into three groups is covered."
        },
        {
            "query_idx": 333,
            "query": "What investigational agents are currently being evaluated in clinical trials for their roles in treating SCLC, AML, and NSCLC, and what are their distinct evaluation criteria in these trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    587,
                    583,
                    202
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The agents under investigation include #CC -90011# in #SCLC trials#, showing #safety and efficacy of Iadademstat# in #AML#, and #Enfortumabvedotin# for #targeting Nectin 4 in NSCLC#.",
            "predicted_answer": "CC-90011 plus nivolumab and bomedemstat plus atezolizumab are being evaluated in SCLC. Iadademstat is in trials for AML. For NSCLC, CC-90011 with chemotherapy and nivolumab is under study. Evaluation criteria include efficacy, safety, and clinical response.",
            "score": 3,
            "explanation": "The predicted answer mentions CC-90011 for SCLC and Iadademstat for AML, covering some of the key facts. However, it misses Enfortumab vedotin for NSCLC, which impacts completeness. The trend is generally aligned, but missing a key agent for NSCLC affects the score."
        },
        {
            "query_idx": 334,
            "query": "What drug used in leukemia treatment incorporates longitudinal data and a tumor growth inhibition model to determine drug effectiveness and toxicity, and uses a specific model linking drug concentration to tumor response?",
            "retrieved_metrics": {
                "reference_idx": [
                    1622,
                    1630,
                    1811
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The drug #Asciminib# for #chronic myeloid leukemia# uses #longitudinal data# and #TGI-survival modeling# to assess #effectiveness# and #toxicity#, with the #Simeoni TGI model# relating concentration to #tumor inhibition#.",
            "predicted_answer": "Asciminib, a BCR::ABL1 inhibitor used in chronic myeloid leukemia treatment, uses longitudinal data and a tumor growth inhibition model to link drug concentration to tumor response, determining its effectiveness and toxicity.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies Asciminib for chronic myeloid leukemia and mentions the use of longitudinal data and a tumor growth inhibition model to determine effectiveness and toxicity. However, it omits the specific mention of TGI-survival modeling and the Simeoni TGI model, affecting completeness."
        },
        {
            "query_idx": 335,
            "query": "What legal pathway introduced by the US Congress in 2012 enhances the drug development process by allowing trial flexibility and approvals relying on non-traditional clinical trial endpoints?",
            "retrieved_metrics": {
                "reference_idx": [
                    1916,
                    1915,
                    644
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "In 2012, the #Breakthrough Therapy designation# was introduced, offering #trial design flexibility# and #approval based on surrogate endpoints# to expedite drug development for serious conditions.",
            "predicted_answer": "The Breakthrough Therapy designation, introduced by the US Congress in 2012, enhances drug development by allowing trial flexibility and approvals based on non-traditional endpoints like surrogate markers.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies the #Breakthrough Therapy designation#, #trial design flexibility#, and reliance on #surrogate endpoints# for approval, which are key facts emphasized in the Reference Answer. There are no significant omissions or contradictions in the given context."
        },
        {
            "query_idx": 336,
            "query": "What challenges exist in the treatment development for rare aggressive cancers, and how do inefficiencies in late-stage trials underscore the necessity for a specific pre-clinical study approach?",
            "retrieved_metrics": {
                "reference_idx": [
                    286,
                    304,
                    2270
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The development of therapies for #rare aggressive cancers# is hindered by unclear mechanisms. Inefficiencies in #late-stage trials# emphasize the need for #pre-clinical combination studies# to ensure effective clinical evaluations.",
            "predicted_answer": "Challenges in treating rare aggressive cancers include inadequate tumor exposure, intrinsic resistance, and complex tumor microenvironments. Inefficiencies in late-stage trials, such as poor early-stage evaluations and low patient participation, underscore the need for robust pre-clinical studies to identify effective combinations and reduce costs.",
            "score": 3,
            "explanation": "The predicted answer addresses challenges in treating rare aggressive cancers and mentions inefficiencies in late-stage trials. However, it doesn't explicitly mention the need for \"pre-clinical combination studies,\" which is a key point in the reference answer, thus missing a crucial detail affecting completeness."
        },
        {
            "query_idx": 337,
            "query": "What technology is utilized for the early detection of a specific pulmonary complication in lung cancer, and what primary therapy is used for this condition's management once detected?",
            "retrieved_metrics": {
                "reference_idx": [
                    205,
                    215
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#eNose technology# enables early detection of ILD, and #steroid treatment# serves as the primary management for #ILD#.",
            "predicted_answer": "eNose technology, which uses breath analysis, is utilized for the early detection of interstitial lung disease (ILD) in lung cancer. Once detected, corticosteroids are the primary therapy used for managing ILD.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies \"eNose technology\" for early detection and \"corticosteroids\" as the primary therapy for managing ILD, aligning with the key facts and overall trend of the Reference Answer. All emphasized points are covered without significant omissions or contradictions."
        },
        {
            "query_idx": 338,
            "query": "Which analytical method evaluates clinical trial activity disparities and investment distribution across various cancer types around the globe, and how does it address each type's specific research needs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1198,
                    1200
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The analysis employs a #unique global database# measuring clinical trial disparities for #rare and non-rare cancers#, addressing #inequity in R&D investment based on relative need#.",
            "predicted_answer": "The analytical method uses a global database of clinical trial activity and costs for 227 cancer types, measuring disparities in trial activity and R&D investment. It addresses specific research needs by proxying need with prevalence, incidence, and survival rates, identifying gaps in resource allocation.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference by discussing a global database and measuring disparities in clinical trials and R&D investment. However, it lacks specific emphasis on disparities for \"rare and non-rare cancers\" and \"inequity in R&D investment based on relative need,\" impacting completeness."
        },
        {
            "query_idx": 339,
            "query": "Which type of cancer, often requiring treatment as a second or third option and characterized by severe healthcare needs and fewer available therapies, is frequently recognized through special healthcare designations?",
            "retrieved_metrics": {
                "reference_idx": [
                    636,
                    640
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Hematologic cancers# frequently receive #special designations# due to #severe healthcare needs#, lower disease incidence, and being treated in advanced therapy lines with limited options.",
            "predicted_answer": "Hematologic cancers, often treated as second- or third-line monotherapies, are frequently recognized through special healthcare designations due to their severe nature and fewer available therapies.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as \"hematologic cancers,\" \"special healthcare designations,\" and \"severe nature\" (healthcare needs) of the cancer. However, it omits \"lower disease incidence\" and does not explicitly mention \"limited options\" as elements of advanced therapy lines."
        },
        {
            "query_idx": 340,
            "query": "What is the viral agent used in glioma treatment, what therapeutic combination is utilized, and how does this combination impact patient survival?",
            "retrieved_metrics": {
                "reference_idx": [
                    991,
                    992
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The agent #DNX-2401# targets #recurrent malignant glioma#, combined with an #immune checkpoint inhibitor#, resulting in a #survival benefit# for patients.",
            "predicted_answer": "DNX-2401, an adenovirus-based oncolytic virus, is used in glioma treatment. When combined with an immune checkpoint inhibitor, this therapeutic approach has shown initial results indicating a survival benefit in select patients.",
            "score": 3,
            "explanation": "The predicted answer includes key facts: \"DNX-2401,\" the combination with \"immune checkpoint inhibitor,\" and indicates a \"survival benefit.\" It lacks the specific detail about targeting \"recurrent malignant glioma,\" but aligns with the trend and doesn't contradict the reference answer."
        },
        {
            "query_idx": 341,
            "query": "Which compound extracted from R. chingii Hu demonstrates notable cytotoxic effects on tumor cells and is among the plant's key types of bioactive chemical structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    314,
                    317
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Tormentic acid#, extracted from R. chingii Hu, exhibits strong cytotoxic effects against cancer cells. It is classified among the plant’s main #terpenoids# with significant bioactivity.",
            "predicted_answer": "Tormentic acid, a terpenoid isolated from R. chingii Hu, demonstrates notable cytotoxic effects on tumor cells and is among the plant's key bioactive chemical structures.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions \"tormentic acid\" and its cytotoxic effects, aligning well with the reference. It also identifies it as a terpenoid, covering all key facts. There are no significant omissions or errors, ensuring consistency with the reference."
        },
        {
            "query_idx": 342,
            "query": "Which therapy received approval in 2023 for pediatric patients with a low-grade glioma mutation, and what therapy is the standard for melanoma involving a particular mutation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1025,
                    1040
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The therapy #Tafinlar + Mekinist# received #pediatric approval in 2023# for patients with #low-grade glioma#, while #standard treatment# for #melanoma# involves patients with the #BRAF V600E/K mutation#.",
            "predicted_answer": "In 2023, the combination therapy of Tafinlar (dabrafenib) and Mekinist (trametinib) was approved for pediatric patients with low-grade gliomas carrying the BRAF V600E mutation. For melanoma with BRAF V600E/K mutations, the standard therapy is also the combination of dabrafenib and trametinib.",
            "score": 5,
            "explanation": "The predicted answer accurately includes all key points from the reference answer: Tafinlar + Mekinist approval in 2023 for pediatric low-grade glioma and being standard therapy for melanoma with BRAF V600E/K mutations. No significant omissions or errors are present, reflecting complete alignment with the reference."
        },
        {
            "query_idx": 343,
            "query": "What are the factors escalating the production expenses of monoclonal antibodies and the implications of increasing production scale for clinical use?",
            "retrieved_metrics": {
                "reference_idx": [
                    908,
                    909
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The production expenses rise due to #high costs# linked with #complex production processes#, requiring #large quantities# of monoclonal antibodies for achieving the desired clinical outcomes.",
            "predicted_answer": "High production expenses of monoclonal antibodies are due to their complex structure, requiring advanced eukaryotic systems for mass production. Increasing production scale can further elevate costs, but alternative systems like microorganisms and plants are being explored to reduce expenses.",
            "score": 1,
            "explanation": "The predicted answer mentions complex structures and advanced systems, aligning with the reference's complex production processes. However, it misses the emphasis on \"high costs\" and \"large quantities\" needed for clinical outcomes, impacting completeness. No contradictory information is present."
        },
        {
            "query_idx": 344,
            "query": "How are patient-derived organoids from breast cancer used to predict tumor growth responses, particularly in gemcitabine resistance, and what statistical data supports their derivation and predictive accuracy?",
            "retrieved_metrics": {
                "reference_idx": [
                    1783,
                    1784,
                    1732
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Breast cancer PDxOs have an #85% success rate#, exhibit #TGI# in gemcitabine resistance, and show a predictive power with #accuracy# 86%, #positive value# 75%, and #negative value# 91%.",
            "predicted_answer": "Patient-derived organoids (PDOs) from breast cancer are used to predict tumor growth responses, including gemcitabine resistance, by mirroring in vivo outcomes. Statistical data shows that PDOs have an 86% accuracy in predicting PDX outcomes, with a positive predictive value of 75% and a negative predictive value of 91%.",
            "score": 3,
            "explanation": "The Predicted Answer encompasses the key facts from the Reference Answer, including the 86% accuracy, positive predictive value of 75%, and negative predictive value of 91%. While it misses explicitly mentioning 'TGI' in gemcitabine resistance, it aligns with the overall trend of tumor growth responses."
        },
        {
            "query_idx": 345,
            "query": "How are functional cell clusters developed and utilized to represent and investigate diverse tumor variations in cancer research and personalized medicine?",
            "retrieved_metrics": {
                "reference_idx": [
                    1393,
                    1802,
                    2038
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Functional cell clusters are developed into #3D structural models# using #tissue stem cells#, stored as a #biobank of tumor subtypes# to investigate and represent #tumor heterogeneity# for personalized medicine.",
            "predicted_answer": "Functional cell clusters, or organoids, are developed by inducing tissue stem cells to differentiate in vitro. They mimic tumor properties and are used to study tumor variations, test drug efficacy, and advance personalized medicine by representing patient-specific tumors.",
            "score": 1,
            "explanation": "The predicted answer addresses the use of tissue stem cells and discusses tumor variations and personalized medicine. However, it lacks the mention of \"3D structural models\" and \"biobank of tumor subtypes\" which are key aspects emphasized in the reference answer."
        },
        {
            "query_idx": 346,
            "query": "What is the name of the compound used in research that faces a challenge due to poor systemic absorption despite showing effects involving a specific enzyme associated with cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    788,
                    790,
                    789
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Epigallocatechin 3-gallate# (EGCG) targets cancer cells by #telomerase inhibition# but its #limited bioavailability# hinders effectiveness in trials.",
            "predicted_answer": "The compound is Epigallocatechin 3-gallate (EGCG), which faces a challenge due to its limited bioavailability despite showing effects on telomerase, an enzyme associated with cancer cells.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts: the compound #Epigallocatechin 3-gallate#, its challenge of #limited bioavailability#, and its effect on #telomerase#, aligning with the Reference Answer. It accurately reflects the meaning and facts without omissions or contradictions."
        },
        {
            "query_idx": 347,
            "query": "How does the effectiveness of the Colvera test compare with a common noninvasive biomarker in monitoring plasma elements for disease recurrence, and which specific elements does it analyze?",
            "retrieved_metrics": {
                "reference_idx": [
                    487,
                    489
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #Colvera test# shows a higher #odds ratio# compared to carcinoembryonic antigen, measuring the #methylation# of BCAT and IKZF1 in plasma to monitor disease recurrence.",
            "predicted_answer": "The Colvera test is more effective, with a higher odds ratio (14.4) and sensitivity for detecting recurrence compared to carcinoembryonic antigen (CEA). Colvera analyzes the methylation levels of BCAT and IKZF1 in plasma.",
            "score": 5,
            "explanation": "The predicted answer matches all the key details from the reference: it mentions the Colvera test, higher odds ratio (14.4), and methylation of BCAT and IKZF1. While it adds sensitivity details, these do not contradict the reference. All emphasized key facts are correctly included."
        },
        {
            "query_idx": 348,
            "query": "What is the 2020 global estimate for new breast cancer cases, and how does the suppression of a key enzyme affect two different metabolic processes in Myc-driven breast cancer and other cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1328,
                    1329,
                    1338
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "In 2020, there were #2.26 million# new breast cancer cases. CPT1A suppression alters #energy metabolism# in Myc-driven breast cancer and enhances #β-catenin# acetylation in other cancer cells.",
            "predicted_answer": "In 2020, there were 2.26 million new breast cancer cases globally. Suppressing CPT1A inhibits fatty acid oxidation (FAO) and reduces energy metabolism in Myc-driven breast cancer, while also impairing invasion and lymphangiogenesis in other cancer cells.",
            "score": 3,
            "explanation": "The predicted answer correctly states that there were 2.26 million new breast cancer cases in 2020, aligning with the reference. It mentions energy metabolism suppression but misses β-catenin acetylation in other cells, impacting completeness."
        },
        {
            "query_idx": 349,
            "query": "What pharmacokinetic factors influence the clinical impact of a specific TKI used in chronic myeloid leukemia, and how are these factors considered in treatment modifications?",
            "retrieved_metrics": {
                "reference_idx": [
                    712,
                    714
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The TKI #imatinib#'s #pharmacokinetic profile# affects its clinical impact, necessitating #treatment adjustments# in chronic myeloid leukemia based on patient response variability.",
            "predicted_answer": "Pharmacokinetic factors like age, BMI, compliance, concomitant drugs, diet, genetics, and organ function influence TKI impact in CML. AUC or steady-state concentrations guide efficacy and toxicity, informing dose adjustments to optimize treatment.",
            "score": 1,
            "explanation": "The predicted answer discusses general pharmacokinetic factors influencing TKI treatment in CML, aligning with the trend of the reference. However, it omits the specific mention of \"imatinib\" and its \"pharmacokinetic profile.\" No contradictions are present, but these omissions impact completeness."
        },
        {
            "query_idx": 350,
            "query": "How does a specific drug targeting lipid metabolism affect the growth of xenografts in prostate cancer, and what is the duration of its effect?",
            "retrieved_metrics": {
                "reference_idx": [
                    1332,
                    1333
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The drug #Etomoxir# targets #CPT1A# in lipid metabolism, reducing prostate cancer #xenograft growth# for #21 days#.",
            "predicted_answer": "Etomoxir, a CPT1A inhibitor, reduces xenograft growth in prostate cancer by affecting lipid metabolism. This effect lasts for 21 days, with reduced mTOR signaling and increased caspase-3 activation.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies Etomoxir as the drug and CPT1A as the target, mentions xenograft growth reduction, and indicates the duration of the effect as 21 days. All key facts marked with # in the reference are present in the predicted answer."
        },
        {
            "query_idx": 351,
            "query": "What specific dose-related factor influences the risk of severe complications in hemophilia gene therapy using AAV vectors and has led to concerns due to serious incidents?",
            "retrieved_metrics": {
                "reference_idx": [
                    447,
                    975
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #dosage# of AAV vectors impacts the risk of severe complications in hemophilia gene therapy, resulting in #controversy# due to serious incidents at high doses.",
            "predicted_answer": "The specific dose-related factor is the applied vector dose, which correlates with the risk of insertional mutagenesis and severe complications like liver function abnormalities. Reducing the AAV vector dose helps mitigate these risks.",
            "score": 5,
            "explanation": "The predicted answer covers the key fact that the dosage of AAV vectors influences the risk of severe complications. It mentions the specific risk of insertional mutagenesis and liver function abnormalities, aligning with the reference's mention of serious incidents at high doses, reflecting the controversy."
        },
        {
            "query_idx": 352,
            "query": "Which polymer-based nanoparticles are used in oncology for targeted drug delivery and show comparative effectiveness to soluble anti-PD-L1 monoclonal antibodies in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    854,
                    1023
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In oncology, #PLGA# nanoparticles are used for #targeted drug delivery# and have shown #effectiveness comparable to anti-PD-L1 monoclonal antibody treatments#, enhancing cancer care.",
            "predicted_answer": "PLGA nanoparticles are used in oncology for targeted drug delivery and have shown comparative effectiveness to soluble anti-PD-L1 monoclonal antibodies, particularly in reducing tumor growth in a subcutaneous model of MC38 colon cancer.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference answer, such as PLGA nanoparticles, their use in targeted drug delivery, and their effectiveness comparable to anti-PD-L1 monoclonal antibodies. It provides additional detail about effectiveness in a specific cancer model. This alignment warrants a full score."
        },
        {
            "query_idx": 353,
            "query": "Which genetic targets are disrupted for enhancing T-cell response in cancer therapy, and what specific cells are engineered to address mesothelin-positive tumors using new genetic technologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    2109,
                    2107,
                    964
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "CRISPR-Cas9 T-cells disrupt #TCR# and #PD-1# genes to improve response by altering #MHC class I# expression, while mesothelin-positive tumors use #PD-1# disrupted CAR T-cells.",
            "predicted_answer": "In cancer therapy, T-cells are engineered to target mesothelin-positive tumors by disrupting PD-1 and TCR genes using CRISPR-Cas9, enhancing their response. These CAR T-cells are used in trials for multiple solid tumors (NCT03545815).",
            "score": 3,
            "explanation": "The predicted answer identifies the disruption of TCR and PD-1 genes, aligning with the reference. It highlights the use of CAR T-cells for mesothelin-positive tumors. However, the reference mentions modifying MHC class I expression, which is omitted in the predicted answer, affecting completeness."
        },
        {
            "query_idx": 354,
            "query": "Which medication received regulatory approval for enhancing survival metrics and was compared with a different treatment in HER2-negative breast cancer trials to assess age-related response differences?",
            "retrieved_metrics": {
                "reference_idx": [
                    658,
                    663
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The U.S. FDA approved #olaparib# for improving #invasive disease-free survival#, with enhanced #effectiveness# in #hormone-positive and young patients# in HER2-negative breast cancer trials compared to carboplatin.",
            "predicted_answer": "Olaparib received FDA approval for enhancing survival metrics in HER2-negative breast cancer. It was compared with placebo, showing benefits in invasive disease-free and distant disease-free survival across all age groups.",
            "score": 1,
            "explanation": "The predicted answer mentions olaparib for survival metrics in HER2-negative breast cancer, covering key facts like the FDA approval, survival benefit, and age-related analysis. However, it misses comparison with carboplatin and the specific effectiveness in hormone-positive and young patients."
        },
        {
            "query_idx": 355,
            "query": "What is the name of the treatment approved for a type of lymphoma in 2009, later withdrawn due to unfulfilled study requirements, and related to a trial with a specific response rate in treating R/R PTCL?",
            "retrieved_metrics": {
                "reference_idx": [
                    553,
                    563,
                    561
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Romidepsin# received approval for #cutaneous T-cell lymphoma# in 2009. The U.S. withdrew approval due to incomplete required studies. Approval for #R/R PTCL# was based on a #25% ORR# trial.",
            "predicted_answer": "Romidepsin, approved in 2009 for treating R/R PTCL with a 25% ORR, was later withdrawn due to unfulfilled study requirements.",
            "score": 3,
            "explanation": "The predicted answer mentions Romidepsin and its withdrawal, matching the reference. It states approval for R/R PTCL with a 25% ORR, but misses that initial approval was for cutaneous T-cell lymphoma. Lacking this detail affects completeness but trends are aligned."
        },
        {
            "query_idx": 356,
            "query": "What role do specific biomarkers and endpoints play in early drug development when assessing drug efficacy and overcoming challenges related to tumor changes and predictive measures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1633,
                    1638,
                    1634
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#PD biomarkers# are critical for assessing drug efficacy, addressing #tumor resistance#, and utilizing #alternative endpoints# when standard metrics do not accurately predict clinical outcomes.",
            "predicted_answer": "Specific biomarkers and endpoints in early drug development help assess drug efficacy by indicating target engagement, pharmacological effects, and tumor resistance. They support dose optimization and provide early predictive measures, even as tumors evolve, guiding more effective treatment strategies.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference answer's overall trend and mentions tumor resistance and endpoints. However, it doesn't explicitly mention \"PD biomarkers\" or \"alternative endpoints,\" missing these key facts. Thus, while aligned, it omits two critical elements emphasized in the reference."
        },
        {
            "query_idx": 357,
            "query": "What expression is used as a predictive marker for breast cancer treatment efficacy, and what agents modulate the immune response?",
            "retrieved_metrics": {
                "reference_idx": [
                    558,
                    562
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#HDAC2 expression# predicts breast cancer treatment efficacy, and #HDACi# agents modulate the immune response.",
            "predicted_answer": "HDAC2 expression is a predictive marker for breast cancer treatment efficacy. Agents like vorinostat, an HDAC inhibitor, modulate the immune response by decreasing regulatory T cells.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts: #HDAC2 expression# as a predictive marker and #HDACi# agents (like vorinostat) that modulate the immune response. The alignment in meaning is clear, with no significant omissions or errors, ensuring full coverage."
        },
        {
            "query_idx": 358,
            "query": "How are physiological, drug-specific, and distribution challenges addressed in optimizing dosing for bispecific antibody therapies in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1616,
                    1620,
                    1624
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #PBPK# and #QSP# models addresses physiological factors, #receptor occupancy#, and optimizes dosing for #BiTEs# in cancer therapy.",
            "predicted_answer": "PBPK and QSP models address physiological, drug-specific, and distribution challenges by incorporating factors like tissue composition, blood flow, and T-cell activation. These models predict optimal doses and schedules, ensuring adequate exposure and receptor occupancy, even in poorly vascularized tumors.",
            "score": 3,
            "explanation": "The predicted answer includes the use of PBPK and QSP models and mentions receptor occupancy, aligning with the reference answer. However, it lacks a specific mention of BiTEs dosing optimization, which is a key component marked in the reference. Overall, it covers most but not all key facts."
        },
        {
            "query_idx": 359,
            "query": "What types of materials are utilized to enhance tissue emulation, and what factors play a significant role in influencing cell growth in organoid cultures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1156,
                    1452
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Hydrogel scaffolds# are used to enhance tissue emulation, and the #properties of the extracellular matrix# play a significant role in influencing growth in organoid cultures.",
            "predicted_answer": "Hydrogels, polymers, and decellularized extracellular matrices are used to enhance tissue emulation. Factors like scaffold stiffness, biomimicry, and the ability to culture at air-liquid interfaces significantly influence cell growth in organoid cultures.",
            "score": 3,
            "explanation": "The predicted answer includes \"hydrogels,\" which aligns with \"hydrogel scaffolds\" from the reference. However, it lacks the emphasis on \"properties of the extracellular matrix\" and instead lists factors like scaffold stiffness and biomimicry. Thus, it misses one key fact affecting completeness."
        },
        {
            "query_idx": 360,
            "query": "Which active agent is central to anti-angiogenic therapy in FDA-approved cancer treatment combinations, and how frequently is it included across these combinations?",
            "retrieved_metrics": {
                "reference_idx": [
                    898,
                    1042
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The central agent in anti-angiogenic therapy combinations approved by the FDA is #Bevacizumab#, appearing #14 times# in treatment combinations.",
            "predicted_answer": "Bevacizumab (Avastin) is central to anti-angiogenic therapy in FDA-approved cancer treatment combinations and is included 14 times across these combinations.",
            "score": 5,
            "explanation": "The Predicted Answer accurately identifies \"Bevacizumab\" as the central agent and correctly states it appears \"14 times\" in FDA-approved combinations, matching the key facts emphasized in the Reference Answer. The information is complete with no significant omissions or errors."
        },
        {
            "query_idx": 361,
            "query": "What adverse events were linked to a high dosage during clinical trials, and what was the subsequently advised dosage for future studies to enhance safety?",
            "retrieved_metrics": {
                "reference_idx": [
                    187,
                    196
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The adverse #ILD# and #fatal events# at a high #8 mg/kg dose# led to the #recommended dose# being revised to #6 mg/kg# for safer future trials.",
            "predicted_answer": "At the 8 mg/kg dose, higher frequencies of ILD were reported, with 12 out of 14 ILD cases and 3 fatal Grade 5 events. The 6 mg/kg dose was recommended for future studies to enhance safety.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized with # symbols: \"ILD,\" \"fatal events,\" \"8 mg/kg dose,\" and \"6 mg/kg recommended dose.\" It matches the reference answer in meaning and details, ensuring both accuracy and completeness without contradictions."
        },
        {
            "query_idx": 362,
            "query": "What protein interaction with ERAD E2s is crucial in tumor proliferation, and what effect does its inhibition have on the metastasis inhibitor accumulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1561,
                    1575
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The protein #Gp78# interacts with ERAD E2s, promoting #tumor metastasis#, and its inhibition leads to #KAI1# accumulation, reducing #tumor metastasis#.",
            "predicted_answer": "Gp78 interacts with ERAD E2s and promotes tumor proliferation. Inhibiting Gp78 increases the accumulation of the metastasis inhibitor KAI1, leading to reduced tumor metastasis.",
            "score": 3,
            "explanation": "The Predicted Answer correctly identifies Gp78's interaction with ERAD E2s and mentions KAI1's accumulation resulting from Gp78 inhibition. However, it incorrectly states that Gp78 promotes tumor proliferation instead of metastasis, a key fact emphasized in the Reference Answer, affecting accuracy."
        },
        {
            "query_idx": 363,
            "query": "How do anatomical differences, gene editing approaches, and the limitations of mouse models contribute to the challenges in predicting human responses to RNA-based preclinical drug interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1153,
                    2094,
                    2135
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Current #preclinical tests# struggle with predicting human responses due to anatomical differences, while #gene editing# may fail at efficacy prediction. Traditional #mouse model limitations# hinder RNA drug response extrapolation.",
            "predicted_answer": "Anatomical differences, gene editing approaches, and limitations of mouse models contribute to challenges in predicting human responses to RNA-based drugs. Mouse models have low predictive values due to anatomical and biological discrepancies, and RNA dose-response relationships from mice cannot be directly applied to humans.",
            "score": 5,
            "explanation": "The predicted and reference answers both mention anatomical differences, gene editing approaches, and limitations with mouse models. Key facts such as anatomical discrepancies and issues with RNA drug response extrapolation are present. Overall, the predicted answer aligns well with the reference in meaning, capturing all key aspects."
        },
        {
            "query_idx": 364,
            "query": "What are the mechanisms by which engineered phages target cancer cells, and what are the specific clinical translation challenges faced by these therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    68,
                    78
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Engineered #phages# specifically target tumor cells, but face clinical translation challenges like #consistent manufacturing# and #clinical evaluation#, affecting the success of phage-based cancer therapies.",
            "predicted_answer": "Engineered phages target cancer cells by displaying tumor-specific ligands, inducing cell death, and stimulating immune responses. Clinical translation challenges include consistent manufacturing, understanding side effects, and establishing dosing regimens.",
            "score": 3,
            "explanation": "The predicted answer includes \"engineered phages\" and \"consistent manufacturing,\" aligning with the reference. However, it mentions \"stimulating immune responses\" and \"dosing regimens,\" diverging slightly from \"clinical evaluation.\" The predicted answer misses the specific aspect of clinical evaluation. Thus, key ideas generally align but with some omission."
        },
        {
            "query_idx": 365,
            "query": "Which specific limitations in early-phase oncology trials hinder robust dose-response relationships, and which trial design is optimal for assessing multiple dosage-related safety and efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    1585,
                    1602
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Early-phase trials face #sample size limitations# that hinder dose-response assessment, while #randomized dose-response trials# are optimal for evaluating safety and efficacy across multiple dosages.",
            "predicted_answer": "Limitations in early-phase oncology trials include small sample sizes and short observation periods, hindering robust dose-response relationships. Optimal trial design for assessing multiple dosages is a randomized, parallel dose-response trial, as recommended by the FDA.",
            "score": 5,
            "explanation": "The predicted answer closely matches the reference answer by identifying \"sample size limitations\" and endorsing \"randomized dose-response trials\" as optimal. Both answers align on the limitations and optimal trial design, with no critical omissions or contradictions."
        },
        {
            "query_idx": 366,
            "query": "What biomarkers have been identified as important in selecting cancer treatments and improving detection accuracy for specific cancers, and what roles do they play in these applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    466,
                    506
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The use of #epigenetic biomarkers# aids in cancer treatment decisions and facilitates #high sensitivity# detection of prostate cancer.",
            "predicted_answer": "EZH2, IDH1, and IDH2 mutations are key biomarkers for cancer treatment and detection. They guide drug development and help in precise diagnosis, tumor subtyping, and monitoring residual disease, improving patient outcomes.",
            "score": 0,
            "explanation": "The predicted answer mentions specific genetic mutations (EZH2, IDH1, and IDH2), unrelated to the reference's focus on epigenetic biomarkers and prostate cancer detection. No key facts from the reference, like \"epigenetic biomarkers\" and \"high sensitivity detection,\" are covered."
        },
        {
            "query_idx": 367,
            "query": "What innovative method in tissue engineering involves removing elements after performing a pattern-forming process and utilizes specific solutions to establish intricate pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    2195,
                    2196
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The technique involves using #sacrificial elements# for #3D tissue structures#, removing them post-formation, with #specific solutions# like #calcium solutions# aiding in forming #intricate physical structures#.",
            "predicted_answer": "The innovative method involving removing elements after a pattern-forming process and using specific solutions to create intricate pathways is sacrificial bioprinting, where sacrificial inks are printed and later liquified or washed off, leaving hollow structures.",
            "score": 1,
            "explanation": "The predicted answer captures the concept of sacrificial elements being removed post-formation, aligning with the reference. It mentions creating intricate pathways but lacks details on \"3D tissue structures,\" \"specific solutions,\" and \"calcium solutions,\" resulting in missing key facts. Trends are aligned without contradictions."
        },
        {
            "query_idx": 368,
            "query": "What innovative method in drug repurposing, which contrasts with the traditional drug development timeline and budget, utilizes experimental and computational techniques to explore new drug applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    759,
                    767
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The innovative method of #high-throughput screening using sophisticated models# in drug repurposing contrasts with traditional drug development, which requires #10 -15 years and costs $1 -2 billion#.",
            "predicted_answer": "Drug repurposing uses experimental and computational techniques, such as induced pluripotent stem cell models, phenotypic screenings, and target-centric strategies, to find new applications for existing drugs, significantly reducing the timeline and budget compared to traditional drug development.",
            "score": 1,
            "explanation": "The predicted answer mentions experimental and computational techniques, aligning generally with the reference, but omits \"high-throughput screening using sophisticated models\" and specific timelines and costs (\"10-15 years and costs $1-2 billion\"). These omissions of key details affect the completeness and precision of the answer."
        },
        {
            "query_idx": 369,
            "query": "How do elevated interstitial fluid pressure and tumor-promoting conditions within the tumor microenvironment contribute to immune evasion and affect cancer treatment efficacy and macrophage behavior?",
            "retrieved_metrics": {
                "reference_idx": [
                    388,
                    2061,
                    2206
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "In #PC#, the #elevated interstitial fluid pressure# exacerbates a #tumor-promoting immunosuppressive environment#, affecting immune evasion, #reducing drug treatment effectiveness#, and influencing macrophage activity.",
            "predicted_answer": "Elevated interstitial fluid pressure and tumor-promoting conditions in the TME contribute to immune evasion by creating a physical barrier that hinders drug delivery and promotes an immunosuppressive environment. This affects cancer treatment efficacy and leads to M2 macrophage polarization, which supports tumor growth.",
            "score": 3,
            "explanation": "The predicted answer covers the elevated interstitial fluid pressure, tumor-promoting immunosuppressive environment, and macrophage polarization, aligning with the reference's trend. However, it lacks mention of specifically reducing drug treatment effectiveness, a key point in the reference."
        },
        {
            "query_idx": 370,
            "query": "What computational processes utilize both systematic high throughput datasets and diverse data inputs in drug repurposing?",
            "retrieved_metrics": {
                "reference_idx": [
                    766,
                    1841
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Computational approaches in drug repurposing# involve analyzing #systematic high throughput datasets# and integrating #diverse data inputs# like electronic health records.",
            "predicted_answer": "Computational processes in drug repurposing that utilize both systematic high throughput datasets and diverse data inputs include molecular docking, network analysis, data mining, similarity analysis, machine learning, and transcriptional signature techniques. These methods leverage large-scale omics data and varied inputs like electronic health records and proteomic data.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the reference by listing computational processes and mentioning the use of systematic high throughput datasets and diverse data inputs, such as electronic health records. No contradictory information is present, and all key concepts are covered."
        },
        {
            "query_idx": 371,
            "query": "What type of regulatory designation, overseen by a U.S. agency, considers development costs, provides trial design flexibility, and includes financial exemptions, for both rare and non-rare disease conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    639,
                    1057,
                    1072
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #FDA# evaluates costs and grants #orphan status# for rare or no-cost-recovery diseases, offering #trial flexibility# and #Orphan Drug Act benefits#, like #fee waivers# for varied conditions.",
            "predicted_answer": "The regulatory designation that considers development costs, provides trial design flexibility, and includes financial exemptions for both rare and non-rare disease conditions is the Orphan Drug Designation, overseen by the FDA.",
            "score": 5,
            "explanation": "The predicted answer captures elements such as the FDA's oversight, orphan designation, trial design flexibility, and financial exemptions/fee waivers. It covers the important aspects highlighted with # in the reference, despite not mentioning \"Orphan Drug Act benefits\" explicitly."
        },
        {
            "query_idx": 372,
            "query": "What factors increase the risk of complications from COVID-19 in thyroid cancer patients, and what was reported as a treatment approach involving an advanced thyroid cancer patient during their COVID-19 diagnosis?",
            "retrieved_metrics": {
                "reference_idx": [
                    2166,
                    2170
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In thyroid cancer patients, risk factors for COVID-19 complications include #MKI# treatments. A patient treated with #lenvatinib# during COVID-19 persisted in their therapy without additional adverse events.",
            "predicted_answer": "Factors increasing the risk of COVID-19 complications in thyroid cancer patients include MKI treatment, external beam radiation therapy, lung metastases, older age, and comorbidities. A case report described a lenvatinib-treated patient with DTC and lung metastases who continued lenvatinib during asymptomatic to mild COVID-19, recovering after 21 days.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: MKI treatment (specifically lenvatinib) and its use during COVID-19 without adverse events, as mentioned for thyroid cancer patients. The overall trend aligns well with the reference, despite more detailed context. No critical information is omitted or contradicted."
        },
        {
            "query_idx": 373,
            "query": "How do preclinical models for colorectal cancer and recent technological developments collectively influence patient-specific drug screening and therapy customization?",
            "retrieved_metrics": {
                "reference_idx": [
                    1414,
                    2000,
                    1994
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The integration of #CRC PDOs# assists in drug response prediction. Their potential in #personalized medicine# is boosted by #technological advancements# like gene editing and single-cell sequencing for tailored therapies.",
            "predicted_answer": "Preclinical models like CRC PDOs and PDXs, combined with recent technological advancements such as CRISPR-Cas9 and single-cell RNA sequencing, enhance patient-specific drug screening and therapy customization by predicting drug responses and improving treatment specificity.",
            "score": 5,
            "explanation": "The key facts from the reference answer, which include CRC PDOs, technological advancements like gene editing, and single-cell sequencing, are all present in the predicted answer. Both answers focus on personalized medicine through improved drug response prediction and therapy customization. The overall trend is aligned without any omissions."
        },
        {
            "query_idx": 374,
            "query": "What novel treatment option is proposed for a respiratory viral infection that utilizes a strong inhibitor targeting kinases like anaplastic lymphoma kinase and c-ros oncogene 1?",
            "retrieved_metrics": {
                "reference_idx": [
                    2172,
                    2174
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The proposed treatment is #Entrectinib#, suggested for #COVID-19#, functioning as a #potent inhibitor# of anaplastic lymphoma kinase, ROS1, and NTRK kinases.",
            "predicted_answer": "Entrectinib, a potent inhibitor of anaplastic lymphoma kinase and c-ros oncogene 1, is proposed as a novel treatment for respiratory viral infections like COVID-19, showing antiviral activity against SARS-CoV-2.",
            "score": 3,
            "explanation": "The predicted answer mentions Entrectinib as a potent inhibitor of anaplastic lymphoma kinase and c-ros oncogene 1, proposed for respiratory viral infections like COVID-19. However, it omits NTRK kinases mentioned in the reference, affecting completeness."
        },
        {
            "query_idx": 375,
            "query": "What are the reported response rates for lung cancer patients in the HER2-mutant NSCLC cohort of the DESTINY-Lung01 trial compared to those in the lower dose group of the DESTINY-Lung02 trial?",
            "retrieved_metrics": {
                "reference_idx": [
                    185,
                    1597
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #objective response rate# for the HER2-mutant NSCLC cohort in DESTINY-Lung01 was #55%#, while the lower dose group in DESTINY-Lung02 showed a rate of #53.8#%.",
            "predicted_answer": "In the HER2-mutant NSCLC cohort of DESTINY-Lung01, the confirmed objective response rate was 55%, while in the lower dose group of DESTINY-Lung02, it was 53.8%.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts from the Reference Answer: the objective response rates (55% for DESTINY-Lung01 and 53.8% for the lower dose group in DESTINY-Lung02). There are no discrepancies or missing details. The information aligns with the Reference Answer's essential points."
        },
        {
            "query_idx": 376,
            "query": "What cellular changes and mechanisms contribute to both the initial development of pancreatic cancer and its detection at advanced stages with resistance to treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    383,
                    384
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Mutagenesis# initiates cellular transformation into lesions, causing #late detection# and forming #barriers# that lead to #treatment resistance# in pancreatic cancer.",
            "predicted_answer": "Pancreatic cancer develops from mutagenesis in ductal cells, forming pancreatic intraepithelial neoplasia. Its late detection and aggressive growth, along with multiple biological barriers, contribute to treatment resistance and advanced-stage diagnosis.",
            "score": 5,
            "explanation": "The predicted answer includes the key concepts of #mutagenesis#, #late detection#, and #barriers# leading to #treatment resistance#. It effectively mirrors the reference answer, capturing the essential trends and details without any significant omissions or contradictions."
        },
        {
            "query_idx": 377,
            "query": "What is a not well-studied process involving a specific cell surface protein that is significant for the progression of cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1351,
                    1377
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #posttranslational modifications# of the specific cell surface protein #B7-H3# are under-researched and crucial for cancer progression.",
            "predicted_answer": "Posttranslational modifications (PTMs) of B7-H3, a cell surface protein, are not well-studied but are significant for cancer progression. Understanding these PTMs and their regulatory factors is crucial for advancing cancer research.",
            "score": 5,
            "explanation": "The Predicted Answer captures both key facts: \"posttranslational modifications\" and \"B7-H3,\" and aligns with the Reference Answer regarding their significance in cancer progression. It accurately reflects the meaning without significant omissions or errors. The overall trend is consistently covered."
        },
        {
            "query_idx": 378,
            "query": "What model is used to study the impact of combining anti-VEGF and anti-ANG2 treatments on cell viability in cancers with RAS mutations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1045,
                    1796
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #organoid# model is used to evaluate the impact of #anti-VEGF# and #anti-ANG2# treatments, notably improving viability in #RAS-mutated# cancers.",
            "predicted_answer": "Organoid cultures, particularly patient-derived organoids (PDOs), are used to study the impact of combining anti-VEGF and anti-ANG2 treatments on cell viability in cancers with RAS mutations.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized in the reference answer: the use of the \"organoid\" model, the focus on \"anti-VEGF\" and \"anti-ANG2\" treatments, and their application in cancers with \"RAS mutations.\" The predicted answer fully reflects the reference's meaning without contradictions."
        },
        {
            "query_idx": 379,
            "query": "What are the specific trial response rates of the drugs in clinical trials, and how do distinct action mechanisms like targeted and complementary effects contribute to cancer drug combination efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    2251,
                    2253,
                    2247
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The clinical trial of #Thalidomide# showed a 25% to 35% response rate. #Synergistic# effects improve outcomes by targeting distinct pathways, while #complementary# action mechanisms enhance therapeutic effectiveness in combination therapies.",
            "predicted_answer": "The context provides an example of thalidomide, with response rates ranging from 25% to 35% in multiple myeloma. Distinct action mechanisms, such as targeted and complementary effects, can enhance efficacy by acting on separate targets or pathways, leading to synergistic impacts and reduced resistance.",
            "score": 5,
            "explanation": "The Predicted Answer accurately captures the response rates of Thalidomide (25% to 35%) and describes distinct mechanisms, including synergistic and complementary effects, that enhance efficacy. All key points from the Reference Answer are present without significant omissions or contradictions."
        },
        {
            "query_idx": 380,
            "query": "What methodology is used to personalize cancer treatment, predict clinical drug responses, and identify therapeutic combinations for patients with specific mutations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1173,
                    1775,
                    1172
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The methodology involves implementing #PDO cultures# to guide treatment through #AUC# evaluations and identifying effective combinations for patients with rare mutations like those affecting #CFTR#.",
            "predicted_answer": "Patient-derived organoids (PDOs) are used to personalize cancer treatment, predict clinical drug responses, and identify therapeutic combinations for patients with specific mutations by subjecting them to transcriptomic profiling and therapeutic testing.",
            "score": 1,
            "explanation": "The predicted answer matches the overall trend of personalizing treatment using PDOs. However, it lacks specific detail on #AUC# and #CFTR# from the reference answer, impacting completeness as it omits important evaluative criteria and rare mutation specifications."
        },
        {
            "query_idx": 381,
            "query": "How is a scoring system used to categorize chemotherapy response levels, and what challenges are associated with its use in assessing FOLFOX and other drug regimens for CRC patients?",
            "retrieved_metrics": {
                "reference_idx": [
                    1773,
                    1776
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The scoring system categorizes response levels by dividing #AUCs# into three groups, predicting efficacy. It shows no correlation with #FOLFOX# but predicts outcomes accurately for other #combinations#.",
            "predicted_answer": "A scoring system categorizes chemotherapy response levels using AUCs from concentration-viability curves, classifying them into high, intermediate, and low responses. Challenges include inconsistent prediction accuracy, especially in pretreated patients, and varying correlations with clinical outcomes for FOLFOX.",
            "score": 3,
            "explanation": "The predicted answer reflects the key fact about AUCs being used in the scoring system. It mentions FOLFOX correlations but misses stating the lack of correlation and the accurate prediction for other combinations. Thus, it lacks completeness but doesn't contradict the reference."
        },
        {
            "query_idx": 382,
            "query": "How do bacterial metabolites and microorganisms like F. nucleatum together impact the tumor microenvironment to alter cancer progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    827,
                    846
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Certain bacterial #metabolites# alter tumor pH and oxygen, fostering cancer growth, while #F. nucleatum# specifically decreases CD4+ and CD8+ T cells, modulating the immune microenvironment and promoting tumor progression.",
            "predicted_answer": "F. nucleatum and bacterial metabolites can alter the tumor microenvironment by reducing CD4+ and CD8+ T cells, promoting an immunosuppressive state, and producing by-products that create conditions favorable for cancer growth.",
            "score": 3,
            "explanation": "The Predicted Answer captures the role of F. nucleatum in reducing CD4+ and CD8+ T cells and promoting an immunosuppressive state. However, it misses the detail about bacterial metabolites specifically altering tumor pH and oxygen, which is crucial. The overall trend is aligned but incomplete."
        },
        {
            "query_idx": 383,
            "query": "What are the key mechanisms involved in stabilizing both protein-ligand and DNA-cisplatin complexes, and what unique features are observed specifically in DNA-cisplatin interactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    244,
                    250
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Hydrogen bonding# is critical in both #protein-ligand# and #DNA-cisplatin# complexes, with DNA-cisplatin showing bond lengths at #2.92, 2.96, and 3.12 angstroms#, highlighting unique interaction features.",
            "predicted_answer": "Hydrogen bonding and hydrophobic interactions stabilize both protein-ligand and DNA-cisplatin complexes. In DNA-cisplatin, specific hydrogen bonds form with thymine residues, and hydrophobic interactions occur with thymine, deoxyadenosine, and deoxycytosine.",
            "score": 3,
            "explanation": "The 'Predicted Answer' aligns with the trend of the 'Reference Answer', mentioning hydrogen bonding and specific residues. However, it lacks details on bond lengths (2.92, 2.96, 3.12 angstroms), impacting completeness. No contradictory information is present, but a key fact is missing."
        },
        {
            "query_idx": 384,
            "query": "Modify the multi-hop query  \nHow have intellectual property developments influenced dosing innovations and chemical modifications in siRNA therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    2136,
                    2132,
                    2137
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer",
            "predicted_answer": "Intellectual property developments, such as the patent WO2016028649, have guided dosing innovations and chemical modifications in siRNA therapies, enhancing stability, specificity, and bioavailability while addressing challenges like immunogenicity and toxicity.",
            "score": 1,
            "explanation": "The predicted answer is generally aligned with the reference answer but lacks key specifics about intellectual property developments and precise innovations in siRNA therapies, affecting completeness. Critical components such as #specific patents, modifications impacting bioavailability#, are mentioned superficially without in-depth detail."
        },
        {
            "query_idx": 385,
            "query": "What measurements are necessary for determining receptor binding potential values, and what are the specific parameters in the distribution ratios that must be considered?",
            "retrieved_metrics": {
                "reference_idx": [
                    1515,
                    1516
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Determining receptor binding potentials requires the #measurement of arterial input function#, while the distribution ratio involves the #volume of distribution# with specific, non-specific bound, and free radioligand.",
            "predicted_answer": "To determine receptor binding potential values, measurements of the arterial input function for BP$_F$ and BP$_P$ are required, while BP$_{ND}$ does not need blood sampling. Parameters include volumes of distribution (V$_T$, V$_S$, V$_{ND}$) and kinetic rate constants.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts highlighted in the reference answer, namely \"measurement of arterial input function\" and \"volume of distribution\" in the context of receptor binding potentials. It also correctly mentions the types of volumes involved (V$_T$, V$_S$, V$_{ND}$) aligning with distribution ratio considerations. No significant omissions."
        },
        {
            "query_idx": 386,
            "query": "What nuclear reaction involves $^{18}$O water and results in the production of a radionuclide with a specific half-life and molar activity beneficial for PET imaging?",
            "retrieved_metrics": {
                "reference_idx": [
                    1517,
                    1519,
                    1520
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The reaction involves a #proton# with #$^{18}$O water# to produce #$^{18}$F# fluoride, featuring a #maximum half-life of 110 minutes# and #high molar activity# for PET imaging.",
            "predicted_answer": "The nuclear reaction involving $^{18}$O water that produces a radionuclide for PET imaging is $^{18}$O (p, n) $^{18}$F, resulting in fluorine-18 with a 110-minute half-life and high molar activity.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key details emphasized in the Reference Answer: the involvement of a proton with $^{18}$O water, resulting in $^{18}$F fluoride, features a 110-minute maximum half-life, and high molar activity. The alignment is precise, covering all essential details for PET imaging."
        },
        {
            "query_idx": 387,
            "query": "What are the roles of specific agents in the COVID-19 treatment process, particularly regarding viral attachment and inflammation?",
            "retrieved_metrics": {
                "reference_idx": [
                    2173,
                    2175
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Vemurafenib# disrupts #viral attachment#, and #vandetanib# decreases #inflammatory cytokines# in COVID-19 treatment.",
            "predicted_answer": "Vemurafenib and MKIs like vandetanib play roles in COVID-19 treatment by hindering viral attachment, replication, and reducing inflammation. Vemurafenib locks the SBD in a closed conformation, while vandetanib reduces inflammatory cytokines and immune cell infiltration in the lungs.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference: Vemurafenib's role in disrupting viral attachment and vandetanib's effect on reducing inflammatory cytokines. Additionally, it mentions reducing immune cell infiltration, supporting the overall trend without contradictions. All key facts are covered."
        },
        {
            "query_idx": 388,
            "query": "How do the linker types used in TDM1 compare to current favored designs in terms of stability and functionality within systemic circulation and tumor environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    174,
                    173,
                    916
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "TDM1 employs a #thioether-based# #non-cleavable linker# for stability in systemic circulation, differing from the #cleavable linkers# used currently to achieve enhanced bystander effects.",
            "predicted_answer": "TDM1 uses a non-cleavable thioether-based linker, which is stable in systemic circulation and releases the payload after antibody degradation in tumor cells. In contrast, current favored cleavable linkers are designed for stability in circulation and specific release in the tumor environment, often enabling a bystander effect.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: TDM1's use of a thioether-based non-cleavable linker and the distinction of cleavable linkers for achieving bystander effects. It covers all emphasized key facts in the reference answer and aligns with the overall trend, indicating no significant omissions or contradictions."
        },
        {
            "query_idx": 389,
            "query": "What specific combination therapies were evaluated in clinical studies for treating hepatocellular carcinoma and refractory metastatic colorectal cancer, and what impacts did these therapies have on their respective median overall survival times?",
            "retrieved_metrics": {
                "reference_idx": [
                    1027,
                    1046
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #combination of Atezolizumab and Bevacizumab# for hepatocellular carcinoma improved median overall survival to #19.2 months#, and #Trifluridine-Tipiracil plus Bevacizumab# for metastatic colorectal cancer increased it to #10.8 months#.",
            "predicted_answer": "For hepatocellular carcinoma, the combination of Atezolizumab and Bevacizumab (T + A) increased median overall survival to 19.2 months compared to 13.4 months with sorafenib. For refractory metastatic colorectal cancer, Trifluridine-Tipiracil plus Bevacizumab improved median overall survival to 10.8 months versus 7.5 months with Trifluridine-Tipiracil alone.",
            "score": 5,
            "explanation": "The predicted answer matches all key facts from the reference. It correctly identifies the combination therapies and their impact on median overall survival for both hepatocellular carcinoma and metastatic colorectal cancer. The trends and details are aligned with no omissions or contradictions."
        },
        {
            "query_idx": 390,
            "query": "Which specific cell type is utilized to generate organoids and what type of culture is established from these cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1157,
                    1446
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #use of tissue­-resident ASCs# results in the establishment of #long-term organoid cultures# from a single ASC.",
            "predicted_answer": "Adult stem cells (ASCs) are utilized to generate organoids. These cells, when isolated and cultured under specific conditions, establish long-term 3D cultures that resemble the structure of their native tissue.",
            "score": 3,
            "explanation": "The predicted answer identifies adult stem cells (ASCs) as the cell type, similar to the reference's \"tissue-resident ASCs,\" and mentions \"long-term 3D cultures,\" aligning with \"long-term organoid cultures.\" However, it omits the specific aspect of originating from a single ASC."
        },
        {
            "query_idx": 391,
            "query": "How do trial designs for orphan versus non-orphan indications statistically differ in terms of randomization, life expectancy impacts, and tumor response measurements?",
            "retrieved_metrics": {
                "reference_idx": [
                    1066,
                    1067,
                    1070
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Concurrent randomized controlled trials# occur less frequently for #orphan indications#. #Disability adjusted life years# are higher in #rare, ultra-rare orphan indications#. #Single arm trials# show increased #tumor response# for #ultra-rare orphan indications#.",
            "predicted_answer": "Trial designs for orphan indications are less likely to use concurrent randomized controlled trials and phase 3 designs, and less often assess overall survival. Tumor response rates in single-arm trials are higher for orphan indications, especially ultra-rare ones, compared to non-orphan indications.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by noting less frequent concurrent randomized trials for orphan indications and increased tumor response rates in single-arm trials for ultra-rare orphan indications. However, it misses the mention of \"disability adjusted life years\" for rare, ultra-rare orphan indications."
        },
        {
            "query_idx": 392,
            "query": "What methods are employed to quantify drug effects and evaluate growth and treatment responses in cancer spheroids?",
            "retrieved_metrics": {
                "reference_idx": [
                    1745,
                    1754
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "A combination of #fluorometric assays# is used for quantifying drug effects, while #image-based assays# evaluate growth and treatment responses in cancer spheroids.",
            "predicted_answer": "Methods to quantify drug effects and evaluate growth and treatment responses in cancer spheroids include fluorometric assays (e.g., CellTiter-Blue, Calcein AM), dye exclusion assays (Trypan Blue), and imaging techniques (brightfield microscopy, ImageJ software, fluorescent microscopy) to measure cell viability and spheroid size.",
            "score": 5,
            "explanation": "The predicted answer covers both #fluorometric assays# and #image-based assays#, which are the key facts in the reference answer. The predicted answer even goes further to specify examples of fluorometric assays and imaging methods, aligning well with the reference's intent and details."
        },
        {
            "query_idx": 393,
            "query": "How do personalized modeling techniques apply to specific cancer environments and how are these models validated for treatment response in oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1467,
                    1469
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Personalized modeling techniques recreate the #bone marrow microenvironment# for #castrate-resistant prostate cancer#, and use #predictive organoid models# validated for #rectal cancers# to predict treatment responses.",
            "predicted_answer": "Personalized modeling techniques, such as organoids and OIC, recreate specific cancer environments like bone marrow. These models are validated by testing treatment responses ex vivo, which helps in guiding personalized therapy and predicting both tumor and normal tissue reactions.",
            "score": 1,
            "explanation": "The predicted answer includes \"bone marrow,\" matching one key fact. It mentions \"OIC\" and \"organoids\" but not specifically for \"castrate-resistant prostate cancer\" or \"rectal cancers,\" missing key context about these specific cancer types. There is general alignment, but two key facts are missing."
        },
        {
            "query_idx": 394,
            "query": "What are the limitations of AI in developing drugs, and how is AI used to personalize and integrate cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    117,
                    163,
                    1048
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI has #limited explanation# in drug development, enhances #precision oncology#, and supports comprehensive #integration with cancer therapy#.",
            "predicted_answer": "AI in drug development faces limitations such as high data dependence and a lack of explainability, which can hinder understanding the logic behind predictions. In cancer treatment, AI is used to personalize therapies by analyzing vast amounts of patient data, enabling precision oncology and accelerating the discovery of new, more effective anti-cancer drugs.",
            "score": 3,
            "explanation": "The 'Predicted Answer' reflects the key facts in the 'Reference Answer' regarding limited explanation (lack of explainability) and precision oncology. However, it misses the emphasis on the comprehensive integration with cancer therapy, leading to incomplete coverage."
        },
        {
            "query_idx": 395,
            "query": "Which specific gene editing technologies are fundamental to the development of next-generation gene therapies, and through which processes do these technologies achieve precise DNA modification?",
            "retrieved_metrics": {
                "reference_idx": [
                    452,
                    957
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Next-generation gene therapies rely on #CRISPR/Cas9#, #ZFNs#, and #TALEN# for precise DNA modifications achieved through #NHEJ# and #HDR#.",
            "predicted_answer": "CRISPR/Cas9, ZFNs, and TALENs are fundamental to next-generation gene therapies. They achieve precise DNA modification through NHEJ and HDR processes, with CRISPR/Cas9 using RNA-guided Cas9 protein, ZFNs using zinc finger proteins, and TALENs using TALE molecules.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key facts emphasized in the reference answer, including CRISPR/Cas9, ZFNs, TALENs, and the processes NHEJ and HDR. It also provides additional details about the functionality of the technologies without contradicting the reference answer."
        },
        {
            "query_idx": 396,
            "query": "Which viral vector is recognized for its in vivo and ex vivo gene therapy use, with specific features like low immunogenicity and long-term transgene expression that make it suitable for medical purposes?",
            "retrieved_metrics": {
                "reference_idx": [
                    429,
                    431
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #AAV# vector is pivotal for gene therapy due to its #low immunogenicity#, #broad tropism#, and #long-term transgene expression#, making it suitable for #medical applications#.",
            "predicted_answer": "AAV (Adeno-Associated Virus) is recognized for its in vivo and ex vivo gene therapy use, with low immunogenicity and long-term transgene expression, making it suitable for medical purposes.",
            "score": 3,
            "explanation": "The predicted answer covers most key facts like AAV, low immunogenicity, and long-term transgene expression. However, it omits \"broad tropism\" from the reference answer, affecting completeness. The overall trend is aligned with no contradictions."
        },
        {
            "query_idx": 397,
            "query": "How do signaling pathway alterations integrate with metabolic process changes to support the enhanced energy needs of cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    777,
                    842
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The integration of the #PI3K/AKT/mTOR pathway# with altered #metabolic flux# supports the enhanced energy and synthesis requirements necessary for cancer cell proliferation.",
            "predicted_answer": "Signaling pathway alterations, such as the activation of PI3K/AKT/mTOR and oncoproteins like MYC, RAS, PKM2, and HIF-1, reprogram cancer cell metabolism to meet enhanced energy and synthesis demands, supporting tumor proliferation.",
            "score": 3,
            "explanation": "The predicted answer includes the key fact of the activation of the #PI3K/AKT/mTOR pathway# and its role in reprogramming cancer cell metabolism. However, it does not mention #altered metabolic flux#, affecting completeness. Overall, it aligns with the reference but omits one critical detail."
        },
        {
            "query_idx": 398,
            "query": "What challenges are encountered in quantifying monoclonal antibodies in clinical practice, in terms of bioanalytical limitations and genetic factors affecting their cellular mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    732,
                    730
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Quantifying #monoclonal antibodies# faces #bioanalytical challenges# and limits #TDM#, while #genetic predictors# like #FCGR polymorphisms# influence #ADCC activity#.",
            "predicted_answer": "Bioanalytical challenges in quantifying mAbs include complex pharmacokinetics and limited therapeutic drug monitoring (TDM) methods. Genetic factors, such as FCGR2A and FCGR3A polymorphisms, can affect antibody-dependent cellular cytotoxicity (ADCC) and overall response.",
            "score": 5,
            "explanation": "The Predicted Answer covers all key facts from the Reference Answer: bioanalytical challenges and limited TDM methods, along with genetic factors like FCGR polymorphisms affecting ADCC activity. The inclusion of specific polymorphisms (FCGR2A and FCGR3A) enhances the answer's precision without contradicting the original meaning."
        },
        {
            "query_idx": 399,
            "query": "What specific infectious disease is being targeted by recent therapeutic breakthroughs involving novel druggable targets, and what technological modality is being used to achieve this?",
            "retrieved_metrics": {
                "reference_idx": [
                    373,
                    454,
                    456
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The recent therapeutic focus targets #HIV#, utilizing new intervention #druggable targets# enabled through #RNAi-based therapeutics#.",
            "predicted_answer": "Recent therapeutic breakthroughs in HIV involve novel druggable targets and use technological modalities such as RNAi-based therapeutics and AAV-based gene therapy.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies #HIV# and mentions novel #druggable targets#. It also includes #RNAi-based therapeutics# and adds AAV-based gene therapy, which does not contradict but adds detail. All key facts from the reference are present, aligning closely with the reference."
        },
        {
            "query_idx": 400,
            "query": "What current strategy utilizes specific tools to assess genetic dependencies in human cell lines, and which computational method is used to predict synthetic lethality among gene pairs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1942,
                    1951,
                    1949
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The current strategy uses #CRISPR-Cas9# to assess genetic dependencies in cell lines. A #machine learning approach# predicts #complex genetic interactions# by ranking gene pairs for synthetic lethality.",
            "predicted_answer": "CRISPR-Cas9 is currently used to assess genetic dependencies in human cell lines. A machine learning approach has been developed to predict synthetic lethality among gene pairs, aiding in the prioritization of pairs for experimental testing.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies CRISPR-Cas9 and a machine learning approach, aligning with the reference answer. However, it omits the detail of \"complex genetic interactions\" and doesn't explicitly mention \"ranking\" gene pairs, which affects completeness."
        },
        {
            "query_idx": 401,
            "query": "What specific modifications are necessary for in vitro models to better replicate tumor physiology, particularly in terms of cellular interplay and the inclusion of diverse biological structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1718,
                    2194,
                    1441
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "In vitro models need #optimization of tumor-stromal cell ratios# and #media components#, inclusion of #multiple cell types#, addressing #traditional culture limitations# to #better replicate tumor physiological complexity#.",
            "predicted_answer": "To better replicate tumor physiology, in vitro models need co-cultures with optimized tumor-stromal cell ratios, inclusion of diverse cell types like endothelial and immune cells, and 3D structures such as spheroids or bioprinted tissues to mimic the tumor microenvironment.",
            "score": 3,
            "explanation": "The predicted answer covers key elements like optimizing tumor-stromal cell ratios and inclusion of multiple cell types. However, it misses details such as 'media components' optimization and 'addressing traditional culture limitations.' Despite alignment in trend, these omissions affect completeness."
        },
        {
            "query_idx": 402,
            "query": "Which enzymatic subunit of a transcription-silencing complex has mutations in certain cancers that correlate with advanced disease and leads to development as a therapeutic target?",
            "retrieved_metrics": {
                "reference_idx": [
                    532,
                    574
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The enzymatic subunit #EZH2# in a transcription-silencing complex has mutations in cancers, correlating with #advanced disease# and making #EZH2# a therapeutic target.",
            "predicted_answer": "EZH2, the enzymatic subunit of PRC2, has mutations in certain cancers that correlate with advanced disease. These mutations and overexpression make EZH2 a therapeutic target, leading to the development of EZH2-specific inhibitors.",
            "score": 5,
            "explanation": "The predicted answer includes all the emphasized key facts: it identifies the enzymatic subunit as EZH2, mentions its mutations in certain cancers, links these mutations to advanced disease, and identifies EZH2 as a therapeutic target. It aligns well with the reference, with no significant omissions."
        },
        {
            "query_idx": 403,
            "query": "Which compound influences both the balance of regulatory T cells/Th17 cells and the function of tumor suppressor genes, playing a role in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    783,
                    784
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Oleanolic acid# modulates #regulatory T cells/Th17 cells# and interacts with #tumor suppressor genes#, suggesting its role in cancer treatment.",
            "predicted_answer": "Oleanolic acid influences the balance of regulatory T cells/Th17 cells and has potential as an epigenetic modulator in cancer treatment, though its direct impact on tumor suppressor genes like P53 is not specified in the context.",
            "score": 3,
            "explanation": "The predicted answer identifies \"Oleanolic acid\" and its role in modulating \"regulatory T cells/Th17 cells,\" matching the reference. However, it does not affirmatively state the interaction with \"tumor suppressor genes,\" crucial for completeness. The overall trend aligns, but the omission impacts completeness."
        },
        {
            "query_idx": 404,
            "query": "What structural changes in staurosporine derivatives lead to increased performance against the MV4-11 leukemia cell line, and how does the efficacy of a specific derivative compare to a control against the SW-620 colorectal cell line?",
            "retrieved_metrics": {
                "reference_idx": [
                    1292,
                    1293
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Halogens at C-3# enhance activity against the #MV4-11 leukemia cell line#. #Compound 108# shows greater inhibition of the #SW-620 colorectal cell line# compared to #staurosporine#.",
            "predicted_answer": "Halogenation at the C-3 position in staurosporine derivatives, such as compound 138, enhances activity against MV4-11 cells. Compound 108 shows stronger inhibitory activity on SW-620 cells (IC50: 9.99 nM) compared to staurosporine (IC50: 25.10 nM).",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects all key facts from the Reference Answer: halogenation at C-3 enhances activity against MV4-11, Compound 108 is more effective against SW-620 than staurosporine. The data and trends in the Predicted Answer are consistent and complete with no omissions."
        },
        {
            "query_idx": 405,
            "query": "How do the chemical structures of Compounds 4, 3, 30, and 8b correlate with their IC50 values against breast cancer, HepG2, LNCAP, MDA-MB231, and MCF-7 cell lines, considering unique substituents?",
            "retrieved_metrics": {
                "reference_idx": [
                    1251,
                    1262,
                    224
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #IC50# of #Compound 4# and #3# signifies moderate activity against breast cancer and HepG2. #Compound 30#'s 4-chlorobenzyl group is effective on LNCAP. #Compound 8b#'s thiophene indicates promising #anticancer potential# in MDA-MB231 and MCF-7 cells.",
            "predicted_answer": "Compounds 4 and 3 show moderate anti-proliferative activity against breast cancer, with IC50 values of 10.7 and 17.5 µg/mL, respectively. Compound 30, with a 4-chlorobenzyl and 5-methoxy substituent, is effective against LNCAP (IC50 = 14.6 µM). Compound 8b, containing a thiophene ring, is more potent against MDA-MB231 and MCF-7.",
            "score": 3,
            "explanation": "The predicted answer includes key facts: moderate activity of Compounds 4 and 3, Compound 30's effectiveness with the 4-chlorobenzyl substituent, and the anticancer potential of Compound 8b against MDA-MB231 and MCF-7. However, it misses the detail about Compound 4 and 3's activity against HepG2."
        },
        {
            "query_idx": 406,
            "query": "How does the over-expression of a particular protein influence cancer stem cell populations and the mechanisms of resistance to therapies targeting cellular senescence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1370,
                    1372
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The over-expression of #B7-H3# enlarges the #cancer stem cell population# and hinders #cellular senescence and growth arrest#, leading to therapy #resistance#.",
            "predicted_answer": "Over-expression of B7-H3 increases cancer stem cell populations and enhances resistance to therapies targeting cellular senescence, such as doxorubicin, by preventing senescence and growth arrest through the AKT/TM4SF1/SIRT1 pathway.",
            "score": 5,
            "explanation": "The predicted answer accurately includes all key facts from the reference: over-expression of B7-H3, increase in cancer stem cell populations, and therapeutic resistance due to prevention of senescence and growth arrest. The AKT/TM4SF1/SIRT1 pathway detail enhances but doesn't contradict the reference."
        },
        {
            "query_idx": 407,
            "query": "Which advanced imaging methods are pivotal for efficient data generation in high-resolution disease models and complete structure visualization in challenging organoid cultures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1189,
                    1755
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Light-sheet fluorescence microscopy# excels in high-resolution data generation for disease models, while #Z-stack technology# captures complete 3D structures in organoid cultures.",
            "predicted_answer": "Light-sheet fluorescence microscopy and Z-stack technology are pivotal for high-resolution imaging and complete structure visualization in organoid cultures, enabling robust 3D data generation and analysis.",
            "score": 5,
            "explanation": "Both the 'Predicted Answer' and the 'Reference Answer' mention the key imaging methods: #light-sheet fluorescence microscopy# and #Z-stack technology#. The predicted answer aligns with the reference in terms of their application and significance in the context provided without any contradictions."
        },
        {
            "query_idx": 408,
            "query": "Modified multi-hop query:\n\nWhat specific AI methodologies are used to enhance diagnostic accuracy by integrating different data techniques, and how do these methodologies address errors in diagnostic prediction?",
            "retrieved_metrics": {
                "reference_idx": [
                    121,
                    1236,
                    1237
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modified answer:",
            "predicted_answer": "AI methodologies like machine learning and multi-modal data fusion integrate imaging, genomics, and clinical data to enhance diagnostic accuracy. These techniques address errors by reducing false positives and providing a more comprehensive patient health picture, leading to more precise and personalized diagnoses.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by mentioning AI methodologies such as machine learning, and their integration of various data (imaging, genomics, clinical) to enhance diagnostic accuracy. However, it omits specific methodologies that address errors in diagnostic prediction, such as detailing how errors are specifically corrected."
        },
        {
            "query_idx": 409,
            "query": "How does HIV-1 navigate environmental and structural defenses in the cervicovaginal tract to access immune cells and enhance its spread?",
            "retrieved_metrics": {
                "reference_idx": [
                    369,
                    370
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "HIV-1 overcomes #mucus# and #epithelial barriers# in the cervicovaginal tract, utilizing routes across #epithelial cells# and infecting #vaginal epithelial cells#, facilitating its #spread within the female genital tract#.",
            "predicted_answer": "HIV-1 navigates the cervicovaginal tract by overcoming mucus and epithelial barriers. It can pass through intercellular spaces and via transcytosis, reaching immune cells in the lamina propria. Vaginal epithelial cells also contribute to viral spread.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of overcoming mucus and epithelial barriers and mentions epithelial routes. However, it lacks specific mention of \"facilitating its spread within the female genital tract,\" impacting completeness. The overall trend is aligned, but one key aspect is missing."
        },
        {
            "query_idx": 410,
            "query": "What specific conjugate has proven effective for RNA delivery to liver cells, and what new areas are being explored for expanding siRNA applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    2145,
                    2146
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #GalNAc-siRNA conjugate# is effective for liver cell delivery; siRNA is expanding to target #chronic diseases# and delivery to areas like the central nervous system and eyes.",
            "predicted_answer": "The GalNAc-siRNA conjugate has proven effective for delivering RNA to liver cells. New areas being explored for expanding siRNA applications include the CNS, eye, muscle, lung, and fat tissues, as well as tumors.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the GalNAc-siRNA conjugate as effective for liver RNA delivery and mentions several new areas for siRNA applications. However, it omits the exploration of targeting chronic diseases. This affects the completeness of the response."
        },
        {
            "query_idx": 411,
            "query": "What biological marker is responsible for cellular changes in low-oxygen tumor microenvironments, and what tool can simulate these conditions to study cancer cell phenotype transformations?",
            "retrieved_metrics": {
                "reference_idx": [
                    837,
                    2059
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#HIF-1 α# is the marker indicating hypoxia leading to #EMT#, studied using a #microfluidic device# simulating tumor conditions affecting #cancer cell phenotype#.",
            "predicted_answer": "HIF-1α is the primary biological marker for cellular changes in low-oxygen tumor microenvironments. Microfluidic devices, such as those designed by Acosta et al., can simulate these conditions to study cancer cell phenotype transformations.",
            "score": 3,
            "explanation": "The predicted answer mentions HIF-1α and microfluidic devices as tools for simulating low-oxygen conditions, aligning with key facts in the reference. However, it does not explicitly mention EMT, an important transformation highlighted in the reference, affecting completeness."
        },
        {
            "query_idx": 412,
            "query": "What are the differences in the time requirement and dependency on external factors for breast cancer cell types to develop lesions in bone metastasis models?",
            "retrieved_metrics": {
                "reference_idx": [
                    2067,
                    2073
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "ER-cells #quickly form osteolytic lesions# in bone models, whereas ER-positive cells #take over 6 months to metastasize# without estradiol, highlighting different dependencies and time requirements.",
            "predicted_answer": "ER+ cells, like MCF-7, require over 6 months to develop mixed lesions in bone and need estradiol for growth. ER- cells, such as MDA-MB-231, create osteolytic lesions within 2-4 weeks, showing a faster and less dependent process.",
            "score": 5,
            "explanation": "The predicted answer reflects that ER- cells form osteolytic lesions within 2-4 weeks, capturing the idea of quicker lesion formation, consistent with the reference. ER+ cells' need for estradiol and taking over 6 months is correctly described. The overall alignment is strong."
        },
        {
            "query_idx": 413,
            "query": "How do co-culture systems with cancer organoids and three-dimensional scaffold models contribute to cancer research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1727,
                    2041
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Co-culture systems contribute by promoting #PDO growth#, while three-dimensional models assist in maintaining #metastasis potential#.",
            "predicted_answer": "Co-culture systems with cancer organoids and 3D scaffolds enhance cancer research by promoting tumor growth, preserving biological pathways, and enabling cell-cell and cell-matrix interactions that mimic the tumor microenvironment, thus improving the study of cancer progression and metastasis.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts of promoting tumor/PDO growth and facilitating metastasis, consistent with the Reference Answer’s focus on PDO growth and metastasis potential. Despite differing phrasing, key elements and the overall trend are well-aligned, ensuring completeness without contradictions."
        },
        {
            "query_idx": 414,
            "query": "How do monoclonal antibodies interact with tumor-associated macrophages to alter their polarization and activity in the treatment of cancers?",
            "retrieved_metrics": {
                "reference_idx": [
                    411,
                    904
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Agonistic #CD40# antibodies shift macrophage polarization to #M1#, while anti-#CD24# antibodies increase macrophage activity by blocking anti-phagocytic signals, supporting cancer treatment outcomes.",
            "predicted_answer": "Monoclonal antibodies, such as agonistic CD40 and anti-CD24, can alter the polarization of tumor-associated macrophages (TAMs) to a more favorable M1 phenotype, enhancing their phagocytic activity and promoting tumor cell apoptosis.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies the role of agonistic CD40 and anti-CD24 antibodies in altering macrophage polarization to the M1 phenotype. It also mentions enhanced phagocytic activity and tumor cell apoptosis, aligning with the overall trend. No contradictory information is present, and all key aspects are covered."
        },
        {
            "query_idx": 415,
            "query": "What kind of systematically collected data, when aligned with a regulatory initiative, informs dosage changes in cancer treatment trials involving specific targeted therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1644,
                    1645
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The collection of #fit-for-purpose PRO data# as part of the #FDA Oncology Center of Excellence# indicates that #up to 60% of patients# in trials with EGFR-targeting drugs face dosage changes due to tolerability.",
            "predicted_answer": "Systematically collected patient-reported outcomes (PROs) data, aligned with regulatory initiatives like the FDA's Patient-Focused Drug Development program, inform dosage changes in cancer treatment trials by providing insights into patient tolerance and symptomatic toxicities.",
            "score": 1,
            "explanation": "The predicted answer mentions patient-reported outcomes (PROs) and regulatory initiatives but misses critical details from the reference: the term \"fit-for-purpose,\" the specific involvement of the \"FDA Oncology Center of Excellence,\" and the specific statistic \"up to 60% of patients\" facing dosage changes."
        },
        {
            "query_idx": 416,
            "query": "How do M2a and M1 macrophages influence tumor cell behavior, particularly focusing on invasion/metastasis and the suppression of tumor growth and angiogenesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    2203,
                    2207
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The presence of #M2a macrophages# promotes tumor cell infiltration and potential metastasis, while #M1 macrophages# suppress tumor growth and fully inhibit angiogenesis.",
            "predicted_answer": "M2a macrophages promote tumor cell invasion and metastasis by facilitating the release of tumor cells from aggregates. M1 macrophages, in contrast, suppress tumor growth and angiogenesis, inhibiting tumor migration and invasion.",
            "score": 5,
            "explanation": "The predicted answer correctly highlights the roles of #M2a macrophages# in promoting tumor invasion and #M1 macrophages# in suppressing tumor growth and angiogenesis. It captures the overall trend and key facts, with minor differences in wording not affecting the meaning."
        },
        {
            "query_idx": 417,
            "query": "How many naturally occurring small molecules were evaluated initially, and how many inhibitors with certain characteristics were ultimately identified for a specific mutated protein target in a cancer study?",
            "retrieved_metrics": {
                "reference_idx": [
                    1664,
                    1667
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "From an initial evaluation of #152056# naturally occurring small molecules, #3 inhibitors# with the lowest binding free energy effectively targeted the double-mutated EGFR protein.",
            "predicted_answer": "Initially, 152,056 naturally occurring small molecules were evaluated. Ultimately, 3 inhibitors with specific binding characteristics were identified for the double mutated EGFR protein target.",
            "score": 5,
            "explanation": "The Predicted Answer includes all the key facts emphasized in the Reference Answer: \"152,056\" naturally occurring small molecules were evaluated, and \"3 inhibitors\" were identified for the \"double mutated EGFR protein\". There are no significant omissions or contradictions, and the meaning is consistent."
        },
        {
            "query_idx": 418,
            "query": "What biochemical pathway modifies the activity of CPT1A, and which structural component determines its affinity for malonyl-CoA through various conformational states?",
            "retrieved_metrics": {
                "reference_idx": [
                    1318,
                    1319
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #AMPK-ACC-CPT1A pathway# regulates CPT1A activity, while the #N-terminal state of CPT1A# determines malonyl-CoA affinity through its different conformational states.",
            "predicted_answer": "The AMPK-ACC-CPT1A pathway modifies CPT1A activity. The N-terminal state of CPT1A, specifically residues 1-42, determines its affinity for malonyl-CoA through conformational changes between inhibitory and non-inhibitory states.",
            "score": 5,
            "explanation": "The predicted answer fully covers all key facts emphasized in the reference answer: the involvement of the AMPK-ACC-CPT1A pathway and the role of the N-terminal state of CPT1A in determining malonyl-CoA affinity through conformational states. There are no significant omissions or errors."
        },
        {
            "query_idx": 419,
            "query": "Which compounds exhibit distinct mechanisms against cancer, one inhibiting multiple cancer types and the other specifically targeting prostate cancer via a kinase pathway?",
            "retrieved_metrics": {
                "reference_idx": [
                    1876,
                    1877
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Methylselenic acid# inhibits multiple cancers by inducing caspase pathways, while #methylimidoseleno carbamates# target prostate cancer via PI3K/Akt/mTOR inhibition.",
            "predicted_answer": "Methylselenic acid inhibits multiple cancer types, including pancreatic, breast, and prostate, by triggering caspase pathways and other mechanisms. Methylimidoseleno carbamates 21 specifically target prostate cancer via the PI3K/Akt/mTOR and ERK1/2 kinase pathways.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies both key compounds, #Methylselenic acid# and #methylimidoseleno carbamates#, and includes that they inhibit multiple cancers and specifically target prostate cancer, respectively. However, the pathway description for #methylimidoseleno carbamates# diverges from the reference, missing its focus on PI3K/Akt/mTOR."
        },
        {
            "query_idx": 420,
            "query": "What challenges do spheroids and 2D cell cultures present in terms of drug penetration and cell interaction, and how do these challenges impact the predictability of anticancer drug efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    1706,
                    1767
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Many anticancer compounds exhibit #reduced efficacy in spheroids# due to poor drug penetration, while #2D cultures poorly predict in vivo outcomes# due to cell interaction discrepancies, limiting drug efficacy evaluation.",
            "predicted_answer": "2D cell cultures have limited cell-cell interactions, leading to higher drug sensitivity and impaired predictability of anticancer drug efficacy. Spheroids, with their 3D structure, often show reduced drug penetration, particularly in the inner core, which can also decrease the predictability of drug efficacy.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts that spheroids have reduced drug penetration and 2D cell cultures have limitations in predicting in vivo outcomes due to cell interaction issues. Both answers align on these trends, covering the emphasized points in the reference."
        },
        {
            "query_idx": 421,
            "query": "What critical structural aspect enhances the cytotoxicity of specific compounds, and how does the cytotoxic efficacy of these compounds compare to standard chemotherapy agents like cisplatin?",
            "retrieved_metrics": {
                "reference_idx": [
                    1287,
                    1791
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #bridged sugar units# are vital for increasing cytotoxicity, and these compounds exhibit an #18-fold higher# cytotoxic potency than cisplatin, highlighting their therapeutic potential.",
            "predicted_answer": "Bridged sugar units are critical for enhancing cytotoxicity. Some compounds showed 18-fold higher cytotoxic potency than cisplatin, indicating superior efficacy compared to standard chemotherapy agents.",
            "score": 5,
            "explanation": "The predicted answer accurately captures both key facts from the reference: the significance of \"bridged sugar units\" for increased cytotoxicity and the \"18-fold higher\" cytotoxic potency of the compounds compared to cisplatin. The trend and details are consistent with the reference."
        },
        {
            "query_idx": 422,
            "query": "How does the unique regulatory process in PDAC facilitate tumor access to circulation, and what is the effect of cellular structure loss on cell replacement and programmed cell death in this context?",
            "retrieved_metrics": {
                "reference_idx": [
                    2218,
                    2219
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In PDAC, #angiogenesis# regulation uniquely allows microvessel development for tumor access to circulation and hampers chemotherapy reach; #endothelial# ablation leads to tumor cell linings with selective HUVEC apoptosis.",
            "predicted_answer": "In PDAC, tumor cells uniquely regulate angiogenesis, allowing early access to circulation. Cellular structure loss, particularly endothelial ablation, facilitates tumor cell replacement and can induce programmed cell death in endothelial cells, promoting tumor invasion.",
            "score": 1,
            "explanation": "The predicted answer includes the regulation of angiogenesis, mentioning early circulation access, aligning with the reference's emphasis on #angiogenesis#. However, it lacks details on #microvessel development# and #selective HUVEC apoptosis#, indicating the omission of key information related to endothelial effects."
        },
        {
            "query_idx": 423,
            "query": "How do specific advanced 3D cell culture models contribute to the evaluation of novel metal-based cancer treatments, and what unique benefits do they provide in testing these agents?",
            "retrieved_metrics": {
                "reference_idx": [
                    1785,
                    1786
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #spheroids and organoids# serve as advanced testing platforms in which #ruthenium complexes# can be screened. Their design mimics the tumor microenvironment, providing a more relevant assessment.",
            "predicted_answer": "Advanced 3D cell culture models, such as spheroids and organoids, provide a more in vivo-like environment, enabling better evaluation of novel metal-based cancer treatments. They help in screening and testing these agents by partially mimicking the tumor ECM, which is crucial for the activity of metal compounds like ruthenium complexes.",
            "score": 5,
            "explanation": "The predicted answer covers both #spheroids and organoids# and #ruthenium complexes#, aligning with the reference regarding 3D models mimicking the tumor microenvironment. However, the specific mention of \"tumor ECM\" instead of \"tumor microenvironment\" is not significant. Overall, the key facts and trends are effectively captured."
        },
        {
            "query_idx": 424,
            "query": "Which drugs, originally used for rheumatoid arthritis, psoriatic arthritis, and as anthelmintic agents, have shown potential in cancer therapy due to their effects on specific metabolic enzymes or cellular structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    778,
                    793
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Leflunomide#, used for rheumatoid and psoriatic arthritis, affects a metabolic enzyme, while #Mebendazole#, used as an anthelmintic, targets cellular microtubules, both showing anticancer potential.",
            "predicted_answer": "Leflunomide, used for rheumatoid and psoriatic arthritis, and mebendazole, an anthelmintic agent, have shown potential in cancer therapy. Leflunomide inhibits DHODH, while mebendazole interacts with microtubules.",
            "score": 5,
            "explanation": "The predicted answer successfully mentions Leflunomide and Mebendazole and aligns with the reference by stating their original uses and detailing their roles in cancer therapy by inhibiting DHODH and interacting with microtubules, respectively. No key facts are omitted, ensuring consistency and completeness."
        },
        {
            "query_idx": 425,
            "query": "Which two medications are associated with cancer treatment mechanisms involving new blood vessel growth inhibition and action against tumor cell gene deficiencies?",
            "retrieved_metrics": {
                "reference_idx": [
                    764,
                    786
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The medications #atorvastatin# and #simvastatin# are notable in cancer treatments for #inhibiting angiogenesis# and targeting #RB-deficient# tumor cells.",
            "predicted_answer": "Atorvastatin and simvastatin are associated with cancer treatment mechanisms, including inhibiting new blood vessel growth and acting against tumor cell gene deficiencies like RB.",
            "score": 5,
            "explanation": "The predicted answer includes both medications (atorvastatin and simvastatin) and the key mechanisms (inhibiting new blood vessel growth and acting against RB-deficient tumor cells) relevant to cancer treatment. All key facts from the reference answer are present without any contradictions or significant omissions."
        },
        {
            "query_idx": 426,
            "query": "What challenges affect minority group participation in clinical trials, and what statistical issue hinders the assessment of participant diversity in these studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1436,
                    1437
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The participation of minority groups in trials is affected by #social determinants of health#, while #32.2% of trials do not report race and ethnicity#, hindering diversity assessment.",
            "predicted_answer": "Challenges include lack of access to academic medical centers, social determinants like transportation and childcare. Statistical issues arise from insufficient reporting and standardization of sociodemographic data, limiting diversity assessment.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions the impact of \"social determinants\" on minority participation. However, it lacks the specific statistical fact that \"32.2% of trials do not report race and ethnicity,\" which is crucial for evaluating diversity. Thus, it's missing one important detail but aligns with the overall trend."
        },
        {
            "query_idx": 427,
            "query": "What method is applied to adjust drug concentration in patients taking oral therapies, and what are the criteria used to determine the need for implementing such a method?",
            "retrieved_metrics": {
                "reference_idx": [
                    718,
                    719
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Pharmacokinetic-guided interventions# are applied to adjust drug concentration based on #suitability criteria for TDM# in patients taking oral therapies.",
            "predicted_answer": "Pharmacokinetic-guided dosing is used to adjust drug concentration. Criteria for implementing this method include the absence of an easily measurable biomarker, long-term therapy, significant interpatient variability, and a narrow therapeutic range.",
            "score": 5,
            "explanation": "The Predicted Answer identifies \"pharmacokinetic-guided dosing,\" which aligns with \"pharmacokinetic-guided interventions\" in the Reference Answer. It also states criteria relevant to TDM, fulfilling the \"suitability criteria\" aspect. The overall trend and key facts are present, allowing for a precise match."
        },
        {
            "query_idx": 428,
            "query": "Which biological model is used for evaluating drug metabolism, maintaining genetic consistency with original tissues, and predicting treatment responses specifically in prostate cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1450,
                    1449,
                    1466
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Patient-derived organoids show #CYP3A4# expression near in vivo levels, retain #genetic similarity# to original tissues, and predict treatment responses in #prostate cancer#.",
            "predicted_answer": "Patient-derived organoids (PDOs) are used for evaluating drug metabolism, maintaining genetic consistency with original tissues, and predicting treatment responses specifically in prostate cancer.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies patient-derived organoids for evaluating drug metabolism and predicting treatment responses in prostate cancer, maintaining genetic consistency. However, it omits the specific expression of #CYP3A4#, which impacts completeness. The overall trend aligns, but one key fact is missing."
        },
        {
            "query_idx": 429,
            "query": "What are the specific activities exhibited by the phytochemicals of the ethnomedicinal plant used by Indian tribal communities, and what pharmaceutical assessments do they comply with?",
            "retrieved_metrics": {
                "reference_idx": [
                    1683,
                    1685
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The phytochemicals of #Selaginella repanda# have #anti-proliferative effects# on MCF7, HCT116, and A549 cell lines and comply with pharmaceutical standards through #Lipinski's rule of 5#.",
            "predicted_answer": "The phytochemicals of Selaginella repanda, used by Indian tribal communities, exhibit anti-proliferative activity against cancer cell lines. These compounds, including flavonoids and alkaloids, comply with ADMET assessments, showing good bioavailability and permeability.",
            "score": 1,
            "explanation": "The predicted answer mentions \"anti-proliferative activity\" and phytochemicals from \"Selaginella repanda,\" partially aligning with the reference. However, it fails to specify the exact cell lines (MCF7, HCT116, A549) and incorrectly substitutes \"Lipinski's rule of 5\" with different ADMET assessments. Critical details are missing, affecting completeness."
        },
        {
            "query_idx": 430,
            "query": "What alternative dosing strategy is proposed to achieve effective BTK receptor targeting while minimizing safety risks, differing from the conventional 3+3 dose design?",
            "retrieved_metrics": {
                "reference_idx": [
                    729,
                    735
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "A #personalized approach# to dosing is advocated to ensure effective #BTK receptor occupancy# and #safety#, differing from traditional methods like the 3 + 3 escalation design.",
            "predicted_answer": "A personalized pharmacology-driven dose optimization strategy is proposed, focusing on achieving the minimum effective and safe dose for each patient, rather than using the traditional 3+3 dose escalation design.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer by emphasizing a personalized dosing strategy focusing on safe and effective dosing. The reference highlights personalized dosing for effective BTK receptor occupancy and safety. Although the predicted answer doesn't explicitly mention \"BTK receptor occupancy,\" its focus on minimum effective and safe dosing implies this."
        },
        {
            "query_idx": 431,
            "query": "How can organoid technology and cellular integration enhance cancer treatment while addressing tumor microenvironment challenges?",
            "retrieved_metrics": {
                "reference_idx": [
                    1423,
                    1989
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The combination of #personalized therapeutic regimens# and organoid technology, integrating #immune and endothelial cells#, aids in overcoming tumor microenvironment challenges in cancer treatment.",
            "predicted_answer": "Organoid technology, by integrating immune and endothelial cells, enhances the representation of the tumor microenvironment. This integration helps in developing more effective cancer treatments, including immunotherapies, by better mimicking in vivo conditions and addressing challenges like drug resistance.",
            "score": 3,
            "explanation": "The predicted answer captures the integration of #immune and endothelial cells#, as emphasized in the reference answer. However, it misses the mention of #personalized therapeutic regimens#, which are critical to the reference answer's focus on addressing tumor microenvironment challenges."
        },
        {
            "query_idx": 432,
            "query": "What specific investigational treatments are being explored in clinical trials for advanced hematologic conditions associated with IDH1 mutations and IDH2-mutated relapsed/refractory acute myeloid leukemia?",
            "retrieved_metrics": {
                "reference_idx": [
                    606,
                    601
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The investigational therapies involve #ivosidenib# in trials for #IDH1-mutant conditions# and #enasidenib# in studies targeting #IDH2-mutated R/R AML#.",
            "predicted_answer": "Clinical trials are exploring ivosidenib, both as a single agent and in combination with azacitidine, for IDH1-mutant hematologic malignancies. For IDH2-mutated relapsed/refractory AML, enasidenib is being evaluated alone and in combination with azacitidine, venetoclax, or ruxolitinib.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions key facts from the reference: #ivosidenib# for #IDH1-mutant conditions# and #enasidenib# for #IDH2-mutated R/R AML#. The predicted answer expands on the combinations with other drugs but aligns fully with the reference without omission of critical details."
        },
        {
            "query_idx": 433,
            "query": "What is the ClinicalTrials.gov identifier for TEN-010 trials in solid tumors, and what is the objective response rate for its use with venetoclax and rituximab in a phase 1 DLBCL trial?",
            "retrieved_metrics": {
                "reference_idx": [
                    591,
                    593
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The identifier for solid tumors involving #TEN-010# is #NCT01987362#, and in combination with venetoclax and rituximab, the ORR for DLBCL is #38.5%#.",
            "predicted_answer": "The ClinicalTrials.gov identifier for TEN-010 trials in solid tumors is NCT01987362. In a phase 1 DLBCL trial with venetoclax and rituximab, the objective response rate (ORR) was 38.5%.",
            "score": 5,
            "explanation": "The predicted answer fully matches the key facts emphasized in the reference answer. It provides the correct ClinicalTrials.gov identifier for TEN-010 trials, NCT01987362, and mentions the objective response rate of 38.5% for DLBCL with venetoclax and rituximab, aligning accurately with the reference."
        },
        {
            "query_idx": 434,
            "query": "What biological system is involved in clearing foreign particles and contributes to difficulties in the systemic distribution of oncological treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    403,
                    851
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #Mononuclear Phagocyte System (MPS)# clears foreign particles, causing #uneven distribution of systemic oncological treatments#, leading to challenges in drug delivery.",
            "predicted_answer": "The mononuclear phagocyte system (MPS), including Kupffer cells in the liver and sinusoidal macrophages in the spleen, is involved in clearing foreign particles and can contribute to difficulties in the systemic distribution of oncological treatments.",
            "score": 3,
            "explanation": "The predicted answer successfully identifies the Mononuclear Phagocyte System (MPS) and its role in clearing foreign particles, which aligns with the reference. However, it does not explicitly mention the \"uneven distribution\" of treatments, affecting completeness. Overall, the key trend is captured despite this omission."
        },
        {
            "query_idx": 435,
            "query": "What recent genetic modification method has advanced cancer research applications, and why is it superior in precision and functionality to existing gene-editing technologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    959,
                    971
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Prime Editing# has advanced cancer research by offering #advantages# like high precision, enabling diverse base substitutions and small indels, surpassing the capabilities of CRISPR-Cas9 and other methods.",
            "predicted_answer": "Prime Editing is a recent genetic modification method that has advanced cancer research. It is superior in precision and functionality because it can execute various types of single-base substitutions, multiple-base substitutions, and small indels with high on-target accuracy, outperforming CRISPR-Cas9 and other base editing methods.",
            "score": 5,
            "explanation": "The predicted answer effectively captures all emphasized information from the reference answer. It mentions \"Prime Editing\" as the method, highlights its advantages in precision, and compares its superior functionality to CRISPR-Cas9 and other methods. All key facts are present without significant omissions or contradictions."
        },
        {
            "query_idx": 436,
            "query": "How is the classification of drug indications determined by both the approval timeline and the number of drugs used in the therapeutic approach?",
            "retrieved_metrics": {
                "reference_idx": [
                    625,
                    1062
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The classification involves the #distinction between original and supplemental approvals# and categorizing treatments as either #monotherapy or combination# based on the number of drugs involved.",
            "predicted_answer": "The classification of drug indications is determined by the FDA approval timeline, distinguishing between original and supplemental approvals, and the number of drugs in the treatment, categorizing them as monotherapy or combination treatments.",
            "score": 5,
            "explanation": "The predicted answer mentions both the distinction between original and supplemental approvals and the categorization into monotherapy or combination treatments based on the number of drugs, consistent with the key facts in the reference answer. No significant omissions or errors are present."
        },
        {
            "query_idx": 437,
            "query": "What metrics are used to evaluate the influence of cancer cell growth rate, and what specific methodological change was proposed in 2016 for assessing drug efficacy regarding these metrics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1748,
                    1747
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The metrics #GR50# and #GRAUC# evaluate cancer cell growth rate. In 2016, a change was proposed to use the #growth rate inhibition curve# instead of the viability curve.",
            "predicted_answer": "The metrics used are GR50 and GRAUC. In 2016, Hafner et al. proposed using the concentration-growth rate inhibition curve instead of the concentration-viability curve to better assess drug efficacy.",
            "score": 5,
            "explanation": "The predicted answer successfully includes both key metrics, GR50 and GRAUC, and accurately describes the proposed methodological change in 2016 by Hafner et al., involving a shift to the growth rate inhibition curve. No significant parts are missing or incorrect."
        },
        {
            "query_idx": 438,
            "query": "What effects are observed in preclinical models of cancer when utilizing DNMTi agents in combination with other antineoplastic therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    551,
                    552
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Combining DNMTi agents with antineoplastic therapies in preclinical models results in #improved anticancer activity# and #complete tumor regression#.",
            "predicted_answer": "In preclinical models, DNMTi agents in combination with other antineoplastic therapies show higher anticancer activity, complete tumor regression, and enhanced overall survival, particularly in AML. These combinations also have the potential to improve efficacy in solid tumors.",
            "score": 5,
            "explanation": "The predicted answer covers both key facts: #improved anticancer activity# and #complete tumor regression#. Additionally, it mentions enhanced overall survival, which complements the overall trend without contradiction. There are no significant omissions or errors, and it aligns well with the reference answer."
        },
        {
            "query_idx": 439,
            "query": "Which protein is involved both in promoting new blood vessel formation and altering glucose metabolism in cancer cells through distinct molecular pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1366,
                    1371
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The protein #B7-H3# promotes angiogenesis via increased #VEGF# through the #NF-κB pathway# and modifies glucose metabolism by enhancing #glycolysis# through upregulation of #HIF-1α# targets.",
            "predicted_answer": "B7-H3 is involved in promoting new blood vessel formation by stimulating VEGF secretion and altering glucose metabolism in cancer cells through the PI3K/Akt/mTOR pathway, supporting the Warburg effect.",
            "score": 1,
            "explanation": "The predicted answer mentions B7-H3 (key fact) and its role in angiogenesis through VEGF secretion, matching the reference. However, it incorrectly states the pathway as PI3K/Akt/mTOR and misses the emphasis on NF-κB and HIF-1α targets, impacting completeness and accuracy."
        },
        {
            "query_idx": 440,
            "query": "What delivery system offers promising solutions for overcoming targeting, immune reaction, and stability challenges of genome editing within the body, and what are its key characteristics?",
            "retrieved_metrics": {
                "reference_idx": [
                    966,
                    978
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#CRISPR# delivery faces targeting, immune, and stability challenges. #PNPs# offer solutions with controlled release, biocompatibility, and customization for in vivo genome editing.",
            "predicted_answer": "Polymer nanoparticles (PNPs) offer promising solutions for genome editing, providing controlled release, enhanced solubility, and targeted delivery. They are non-toxic, biocompatible, and can be engineered to address targeting, immune reactions, and stability challenges.",
            "score": 3,
            "explanation": "The predicted answer mentions polymer nanoparticles (PNPs) as a solution for genome editing challenges, similar to the reference. It includes aspects like controlled release, biocompatibility, and targeting issues. However, it omits \"CRISPR\" as the context, which affects completeness."
        },
        {
            "query_idx": 441,
            "query": "What is the role of B7-H3 in modulating immune cell populations and the suppression of T cell-mediated responses in tumor environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1362,
                    1379
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Elevated #B7-H3# expression is linked to #increased immune cell numbers# in tumors and #suppression of CD8+ T cell-dependent anti-tumor immunity#.",
            "predicted_answer": "B7-H3 in tumor environments can suppress T cell-mediated anti-tumor immunity by promoting IL-6 release from myeloid cells, which increases B7-H3 expression on tumors, inhibiting CD8+ T cell activity. Blocking B7-H3 can enhance protective T cell responses.",
            "score": 3,
            "explanation": "The Predicted Answer captures the key fact of #B7-H3# expression linked to the suppression of #CD8+ T cell activity#, fulfilling the reference's emphasis. However, it misses the point about #increased immune cell numbers# in tumors, impacting the completeness of the answer."
        },
        {
            "query_idx": 442,
            "query": "Which investigational therapeutic approach involves combining specific immune checkpoint inhibitors in trials for prostate cancer and also utilizes chemotherapy agents for NMC treatment in clinical studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    592,
                    590
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The investigational #ZEN -3694# is trialed with immune checkpoint inhibitors like #nivolumab#, #pembrolizumab# for prostate cancer, and with chemotherapy drugs #etoposide#, #cisplatin# for NMC treatment.",
            "predicted_answer": "The investigational therapeutic approach involves combining ZEN-3694 with immune checkpoint inhibitors like nivolumab and pembrolizumab for prostate cancer, and ZEN-3694 with chemotherapy agents etoposide and cisplatin for NMC treatment.",
            "score": 5,
            "explanation": "The predicted answer fully covers all key facts emphasized with # symbols in the reference answer. It mentions ZEN-3694, the immune checkpoint inhibitors nivolumab and pembrolizumab for prostate cancer, as well as the chemotherapy drugs etoposide and cisplatin for NMC treatment. No omissions or contradictions are present."
        },
        {
            "query_idx": 443,
            "query": "What is the name of the molecule currently under clinical investigation for solid tumors, and which overexpressed protein involved in cancer malignancy is it targeting?",
            "retrieved_metrics": {
                "reference_idx": [
                    1565,
                    1578
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #Smac mimic inhibitor# is being tested in clinical trials against solid tumors, aiming to inhibit the overexpressed protein #Skp2#, linked to cancer malignancy.",
            "predicted_answer": "Lcl161 is under clinical investigation for solid tumors, targeting the overexpressed protein Skp2, which is involved in cancer malignancy.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies \"Skp2\" as the target protein, aligning with the reference. However, it incorrectly names the molecule as \"Lcl161\" instead of the \"Smac mimic inhibitor.\" The discrepancy in the molecule's name is a key fact omission, impacting completeness."
        },
        {
            "query_idx": 444,
            "query": "What is the preclinical screening method used for therapies targeting genetic disorders, and what model is effective for testing immune checkpoint inhibitors?",
            "retrieved_metrics": {
                "reference_idx": [
                    2095,
                    2097
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #CRISPR-Cas9-edited zebrafish models# are used for testing therapies for genetic disorders, while #Efficient PDX models# are effective for immune checkpoint inhibitors.",
            "predicted_answer": "CRISPR-Cas9-edited zebrafish models are used for preclinical screening of therapies targeting genetic disorders. PDX models are effective for testing immune checkpoint inhibitors.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes both key facts: the use of CRISPR-Cas9-edited zebrafish models for genetic disorder therapies and PDX models for immune checkpoint inhibitors. Neither key fact is omitted, and terminology is consistent, aligning with the 'Reference Answer'."
        },
        {
            "query_idx": 445,
            "query": "What specific designations and associated pathways have cancer drugs received from the FDA between 2012 and 2022, and what factors are analyzed in their recognition process?",
            "retrieved_metrics": {
                "reference_idx": [
                    616,
                    1925
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Cancer drugs received #multiple special designations# and were analyzed through #special approval pathways# emphasizing aspects like clinical benefit within 2012-2022.",
            "predicted_answer": "Between 2012 and 2022, cancer drugs received FDA designations including orphan, fast track, accelerated approval, priority review, and breakthrough therapy. Factors analyzed for these designations include clinical benefit, unmet medical needs, trial evidence, and innovativeness.",
            "score": 5,
            "explanation": "The predicted answer correctly lists the special FDA designations and associated pathways for cancer drugs between 2012 and 2022, covering all key facts emphasized in the reference answer, such as multiple special designations and aspects like clinical benefit. No significant details are omitted."
        },
        {
            "query_idx": 446,
            "query": "What unique structural features in specific compounds correlate to their potency against different cancer cell lines, and what cellular processes do they affect?",
            "retrieved_metrics": {
                "reference_idx": [
                    1878,
                    1881,
                    1258
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #Phenylselenide tail# in compound 28 acts against T-lymphoma lines. Compound 27's #benzodiazepine scaffold# disrupts microtubules, while #bisindole thiophene compound 20# targets leukemic cell lines effectively.",
            "predicted_answer": "Selenium-containing compounds, such as selenides and bisindole thiophenes, show potent anticancer activity. Unique features like phenylselenide tails and benzodiazepine scaffolds correlate with their efficacy. These compounds affect cellular processes like microtubule organization and cell cycle arrest, leading to cell death.",
            "score": 3,
            "explanation": "The predicted answer includes key features like the phenylselenide tail and benzodiazepine scaffold, correctly relating them to anticancer activity. However, it misses associating bisindole thiophene specifically with leukemic cell lines. This omission slightly affects completeness but aligns with overall trends."
        },
        {
            "query_idx": 447,
            "query": "Which DNMT inhibitor was first FDA-approved in 2004 for a hematologic condition, what was its efficacy based on response rate, and what is the action mechanism of such inhibitors?",
            "retrieved_metrics": {
                "reference_idx": [
                    541,
                    535
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The first DNMT inhibitor approved by the FDA in 2004 was #azacitidine# for #myelodysplastic syndrome#, achieving a #15.7% response rate#. These inhibitors form #irreversible DNA-DNMT adducts#, causing epigenetic and cytotoxic effects.",
            "predicted_answer": "Azacitidine was the first DNMT inhibitor FDA-approved in 2004 for myelodysplastic syndrome, with an overall response rate of 15.7%. DNMT inhibitors work by forming covalent DNA-DNMT adducts, leading to epigenetic and cytotoxic effects.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts: azacitidine, myelodysplastic syndrome, 15.7% response rate, and the mechanism involving DNA-DNMT adducts. While it doesn't specify \"irreversible\" adducts, it aligns with the overall trend without contradiction. Hence, it provides nearly complete information with minor detail omission."
        },
        {
            "query_idx": 448,
            "query": "Which therapies were approved by the U.S. Food and Drug Administration in the 1990s specifically for different types of cancer impacting bladder and lymphatic systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    868,
                    872
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The U.S. Food and Drug Administration approved #BCG# for superficial #bladder cancer# and #Rituximab# for #B-cell lymphomas# in the 1990s, revolutionizing targeted cancer therapies.",
            "predicted_answer": "In the 1990s, the FDA approved BCG for superficial bladder cancer in 1990 and Rituximab for B-cell lymphomas in 1997.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized in the reference answer: BCG for bladder cancer and Rituximab for B-cell lymphomas, aligning with the trend of FDA approvals in the 1990s. There are no omissions or contradictions, ensuring a complete and consistent match."
        },
        {
            "query_idx": 449,
            "query": "Modify the multi-hop query:  \nWhat experimental antibody-drug conjugate treatment showed specific results in terms of progression-free survival for HER2-mutated advanced NSCLC, and which related treatment received approval for these patients?",
            "retrieved_metrics": {
                "reference_idx": [
                    179,
                    1617
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "Trastuzumab emtansine showed a median progression-free survival of 5 months in HER2-mutated advanced NSCLC. Trastuzumab deruxtecan received approval for these patients.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference: trastuzumab emtansine's progression-free survival in HER2-mutated advanced NSCLC and trastuzumab deruxtecan's approval. Since the key facts are covered without contradiction, the predicted answer fully aligns with the reference."
        },
        {
            "query_idx": 450,
            "query": "What processes influence the conversion of specific precursor cells into bone cells, and what factors contribute to the activation and movement of bone-degrading cells in the setting of cancer metastasis?",
            "retrieved_metrics": {
                "reference_idx": [
                    2026,
                    2030
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "A #biochemical or biomechanical stimulus# facilitates precursor cell conversion to bone cells, while #RANKL expression# affects the activation and movement of bone-degrading cells in cancer metastasis.",
            "predicted_answer": "Mesenchymal stem cells convert into osteoblasts upon biochemical or biomechanical stimuli. In cancer metastasis, factors like RANKL, TNF-α, and interleukins (IL-1, IL-6, IL-8) secreted by cancer cells activate and promote the movement of osteoclasts, leading to bone degradation.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference, emphasizing both #biochemical or biomechanical stimuli# and #RANKL# in bone cell conversion and osteoclast activation. It also includes additional factors like TNF-α, IL-1, IL-6, IL-8 involved in cancer metastasis, without contradicting the reference."
        },
        {
            "query_idx": 451,
            "query": "How many compounds were successfully identified after profiling based on adherence to ADMET properties and effectiveness against significant breast cancer targets, supported by documented evidence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1682,
                    1692
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#24 compounds# were identified post-#ADMET# profiling, and #68 phytochemicals# were determined to be effective against critical #breast cancer targets#.",
            "predicted_answer": "24 compounds were successfully identified after ADMET profiling and evaluation of their effectiveness against significant breast cancer targets, as documented in the evidence.",
            "score": 3,
            "explanation": "The predicted answer correctly mentions the key fact of \"24 compounds\" and aligns generally with the reference answer in terms of ADMET profiling and effectiveness against breast cancer targets. However, it omits the detail about \"68 phytochemicals,\" affecting completeness."
        },
        {
            "query_idx": 452,
            "query": "What methodology is used to identify and design novel inhibitors when the receptor's structural information is unavailable, and what process aids in recognizing crucial molecular features?",
            "retrieved_metrics": {
                "reference_idx": [
                    1657,
                    1665
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #ligand-based drug design# methodology identifies novel inhibitors when receptor structure is absent. It employs #pharmacophore modelling# to pinpoint essential molecular features necessary for biological activity.",
            "predicted_answer": "Ligand-based drug design (LBDD) is used, employing techniques like QSAR and pharmacophore modeling to identify and design novel inhibitors. Pharmacophore modeling helps recognize crucial molecular features, such as HBA, HBD, and HY, even without the receptor's structural information.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the use of ligand-based drug design and pharmacophore modeling, matching the key facts in the reference. It further elaborates on recognizing molecular features, aligning with the overall trend and essential points emphasized in the reference answer. No critical details are missing."
        },
        {
            "query_idx": 453,
            "query": "How does the tumor microenvironment in pancreatic cancer contribute to immune response challenges and therapy resistance?",
            "retrieved_metrics": {
                "reference_idx": [
                    392,
                    407
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The tumor microenvironment in pancreatic cancer causes #immune suppression# through signaling molecules and creates a #resistance to immunotherapy# due to poor T cell access and stromal barriers.",
            "predicted_answer": "The tumor microenvironment in pancreatic cancer produces signaling molecules that promote chronic inflammation and tumor growth, while also suppressing the anti-tumor immune response by inhibiting cytotoxic CD8+ T cell activity. This contributes to therapy resistance and immune evasion.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by highlighting immune suppression through signaling molecules. However, it misses the aspect of resistance to immunotherapy due to poor T cell access and stromal barriers, which impacts the completeness of the answer."
        },
        {
            "query_idx": 454,
            "query": "How do HECT and RBR type E3 ligases differ from RING-type E3 ligases in their ubiquitination mechanisms, specifically concerning the reaction steps and the involvement of zinc ions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1555,
                    1560
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "HECT and RBR ligases use a #two-step reaction# with a catalytic active site, while RING-type E3s enable #Ub transfer# directly, facilitated by a #zinc-dependent RING domain#.",
            "predicted_answer": "HECT and RBR E3 ligases use a two-step reaction involving a thioester intermediate, while RING-type E3s directly transfer Ub from E2 to substrates. RING-type E3s require Zn²⁺ ions for their function, unlike HECT and RBR types.",
            "score": 5,
            "explanation": "The predicted answer covers the #two-step reaction# of HECT and RBR ligases, and the #Ub transfer# of RING-type E3s. It also mentions that RING E3s function with Zn²⁺ ions, aligning with the reference's #zinc-dependent RING domain#. All key concepts are accurately captured."
        },
        {
            "query_idx": 455,
            "query": "What method is used to determine the origin of cancers of unknown primary and how does this determination affect the outcomes of targeted versus non-targeted treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    510,
                    517
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The method is #DNA methylation-based classification#, identifying primary cancer origin, leading to improved survival with #targeted therapy# compared to non-targeted, or empirical, treatment.",
            "predicted_answer": "DNA methylation-based classifiers, like EPICUP, are used to determine the origin of cancers of unknown primary. This method can predict the primary cancer, and patients receiving tumor type-specific therapy show improved overall survival compared to those on empiric therapy.",
            "score": 5,
            "explanation": "The predicted answer includes key facts: the use of DNA methylation-based classifiers and improved survival with targeted therapy. It aligns with the trend of the reference answer, mentioning both DNA classification and targeted therapy, thus covering all emphasized points."
        },
        {
            "query_idx": 456,
            "query": "What host responses over time need examination to ensure the prolonged effectiveness of phage therapies, given potential interactions and antibody development?",
            "retrieved_metrics": {
                "reference_idx": [
                    77,
                    93
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Phage therapies' success over time requires understanding host #immune system# interactions and potential #neutralizing antibodies#, impacting long-term treatment efficacy.",
            "predicted_answer": "Host responses to examine include immune system interactions, development of neutralizing antibodies, and potential off-target effects on the microbiome. These factors can impact the prolonged effectiveness and safety of phage therapies.",
            "score": 5,
            "explanation": "The Predicted Answer covers the necessary host responses, including #immune system interactions# and #neutralizing antibodies#, both crucial factors in the Reference Answer. Although the Predicted Answer adds extra considerations like off-target effects on the microbiome, it does not contradict the Reference Answer, maintaining alignment with its overall trend."
        },
        {
            "query_idx": 457,
            "query": "What agents are combined with aromatase inhibitors for breast cancer treatment, where one agent received a significant status in the US, and another received a national approval elsewhere?",
            "retrieved_metrics": {
                "reference_idx": [
                    564,
                    565
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The agents are #Entinostat#, given a breakthrough status in the US with exemestane, and #Chidamide#, approved in China combined with an aromatase inhibitor.",
            "predicted_answer": "Entinostat, which received FDA Breakthrough Therapy Designation, and chidamide, approved in China, are combined with aromatase inhibitors for breast cancer treatment.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key facts: Entinostat with FDA Breakthrough Therapy Designation in the US, and Chidamide approved in China, mentioned with aromatase inhibitors. These reflect the essential details and trend of the Reference Answer with no significant omissions or contradictions."
        },
        {
            "query_idx": 458,
            "query": "What are the advantages of a specific bioreactor model that supports a three-dimensional growth environment and offers variable culture conditions resembling natural settings?",
            "retrieved_metrics": {
                "reference_idx": [
                    2042,
                    2046
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #stirring bioreactors# provide a #three-dimensional growth environment# and feature #adjustable culture parameters#, making them effective in mimicking natural conditions.",
            "predicted_answer": "The bioreactor model supports 3D growth, mimics natural conditions with adjustable culture parameters, and enables control over dissolved oxygen, temperature, pH, and nutrients. It also provides mechanical stimuli and perfusion, enhancing cell-cell and cell-ECM interactions.",
            "score": 3,
            "explanation": "The predicted answer covers the three-dimensional growth and adjustable culture parameters, aligning with the reference. However, it omits the mention of \"stirring bioreactors,\" which is a key fact in the reference. No contradictory information is present."
        },
        {
            "query_idx": 459,
            "query": "How is the radiofluorination reaction used to synthesize a compound that crosses a protective barrier in imaging studies, and what receptor demonstrates notable uptake of a similar radiolabeled compound?",
            "retrieved_metrics": {
                "reference_idx": [
                    1532,
                    1542
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #Cu mediated radiofluorination# synthesizes $\\text{^{18}F}$-TRACK, allowing it to cross the #blood-brain barrier#. In studies, the #5-HT$_{1B}$# receptor exhibits high uptake of a related compound.",
            "predicted_answer": "The radiofluorination reaction, using Cu-mediated synthesis in DMF, produces $^{18}$F-TRACK, which crosses the blood-brain barrier. The 5-HT$_{1B}$ receptor shows notable uptake of a similar radiolabeled compound, AZ10419096.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference answer: it mentions the Cu-mediated radiofluorination reaction, the ability of $^{18}$F-TRACK to cross the blood-brain barrier, and notable uptake by the 5-HT$_{1B}$ receptor. It captures all essential points without discrepancies."
        },
        {
            "query_idx": 460,
            "query": "Which specific genetic variant impacts the metabolism of irinotecan, and what approach is used to assess its effect on the drug's metabolism and associated clinical outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    690,
                    710
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #UGT1A1# *28 allele impacts irinotecan metabolism, and #Modeling and Simulation methods# assess its effect on drug metabolism and clinical outcomes.",
            "predicted_answer": "The *28 allele of the UGT1A1 gene impacts irinotecan metabolism, reducing gene expression and increasing toxicity risk. Pharmacokinetic and pharmacodynamic modeling is used to assess its effect on drug metabolism and clinical outcomes like neutropenia.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions the UGT1A1 *28 allele's impact on irinotecan metabolism, aligning with the reference. However, it specifies \"pharmacokinetic and pharmacodynamic modeling\" rather than the broader \"Modeling and Simulation methods,\" missing one key detail affecting completeness."
        },
        {
            "query_idx": 461,
            "query": "What agents are explored to enhance outcomes in non-small-cell lung cancer and identify response predictors in head and neck squamous cell carcinoma treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    288,
                    290
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The agent #Ipilimumab# aids in improving outcomes in non-small-cell lung cancer, while #Cetuximab# is studied for response predictors in head and neck squamous cell carcinoma.",
            "predicted_answer": "In non-small-cell lung cancer, ipilimumab and nivolumab are explored to enhance outcomes. For head and neck squamous cell carcinoma, pembrolizumab and cetuximab are used, with window trials aiming to identify response predictors for these treatments.",
            "score": 1,
            "explanation": "The predicted answer correctly identifies ipilimumab for non-small-cell lung cancer, matching the reference. However, it incorrectly states nivolumab instead of focusing on cetuximab. Additionally, it refers to pembrolizumab and window trials not mentioned in the reference, introducing irrelevant details."
        },
        {
            "query_idx": 462,
            "query": "What are the distinct issues regarding physicians' decision-making roles and the potential for imbalanced treatment outcomes in AI-driven healthcare systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    1230,
                    1234
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Physicians should retain #control# in decision-making regarding AI healthcare applications, ensuring that #imbalanced treatment outcomes# from algorithmic biases are addressed to prevent inequities.",
            "predicted_answer": "In AI-driven healthcare, physicians face issues with algorithmic bias and transparency. Biased algorithms can lead to imbalanced treatment outcomes, while lack of transparency hinders informed decision-making. Physicians must retain control and be aware of AI limitations.",
            "score": 3,
            "explanation": "The predicted answer covers key facts like the need for physicians to retain control and the issue of imbalanced treatment outcomes due to algorithmic bias. However, it misses the emphasis on addressing biases to prevent inequities. Overall, it aligns with the reference but lacks completeness."
        },
        {
            "query_idx": 463,
            "query": "How do CAR-NK cells execute their tumor-eliminating function, and what unique features of NK92 cell lines contribute to the effectiveness of CAR-NK therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    936,
                    937
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "CAR-NK cells utilize #Perforin# and #Granzyme# for tumor elimination by #recognition#. #NK92 cell lines# in CAR-NK therapy offer #unlimited proliferation# and are sourced from #various options#.",
            "predicted_answer": "CAR-NK cells eliminate tumors by secreting cytotoxic granules, expressing tumor necrosis factors, and mediating ADCC. NK92 cell lines are favored for CAR-NK therapy due to their unlimited proliferation, ease of genetic modification, and availability without needing patient blood.",
            "score": 3,
            "explanation": "The predicted answer captures the concept of using cytotoxic granules, which includes #Perforin# and #Granzyme# for tumor elimination, aligning with the reference answer. However, it misses the detail of #recognition# and #sourced from various options#, reflected in sourcing without patient blood. Thus, it's slightly incomplete."
        },
        {
            "query_idx": 464,
            "query": "How does a widespread viral outbreak alter the standard treatment procedures for thyroid cancer, and what are the potential consequences on these procedures?",
            "retrieved_metrics": {
                "reference_idx": [
                    2155,
                    2149
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "During a #viral outbreak#, #surgical resection# remains a primary treatment for thyroid cancer, but #treatment strategies# adjust significantly due to the #impact on cancer management#.",
            "predicted_answer": "A widespread viral outbreak like COVID-19 can delay or alter thyroid cancer treatments, including surgical resections and radioiodine therapy. Cancer patients face higher risks of severe illness and death from SARS-CoV-2, complicating standard procedures. Further research is needed to understand the full impact.",
            "score": 5,
            "explanation": "The predicted answer acknowledges the impact of a viral outbreak on thyroid cancer procedures, mentioning delays and alterations in treatments, aligning with the reference's mention of adjusted treatment strategies. Surgical resection is specifically noted in both, maintaining the emphasis. Despite some phrasing differences, key facts are present."
        },
        {
            "query_idx": 465,
            "query": "What sequence of chemical transformations begins with 5-bromo-6-chloronicotinic acid and results in a final compound formed by coupling with (2-fluoro-6-hydroxyphenyl)potassium trifluoroborate?",
            "retrieved_metrics": {
                "reference_idx": [
                    1089,
                    1095
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The sequence starts with conversion to #bromonicotinamide 40#, progressing through steps resulting in #coupled compound 129# after coupling with (2-fluoro-6-hydroxyphenyl)potassium trifluoroborate using palladium(II).",
            "predicted_answer": "The sequence starts with 5-bromo-6-chloronicotinic acid, which is converted to a nicotinamide derivative. This undergoes further transformations, including cyclization and chlorination, before being coupled with (2-fluoro-6-hydroxyphenyl)potassium trifluoroborate to form the final compound.",
            "score": 1,
            "explanation": "The predicted answer identifies the starting compound correctly but fails to mention the specific transformation to \"bromonicotinamide 40.\" It also does not specify the use of palladium(II) for the final coupling, which are key details emphasized in the reference answer."
        },
        {
            "query_idx": 466,
            "query": "What critical components are missing from tumor models that decrease their effectiveness, and what substitution practice results in variability among experimental outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1453,
                    2077
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The effectiveness of tumor models is reduced by #absence of stromal components#, while #substituting with murine stroma# leads to variability in experimental results.",
            "predicted_answer": "Tumor models often lack stromal and microenvironment components, which are crucial for mimicking real tumor behavior. Substituting human stroma with murine stroma in PDX models introduces variability due to species-specific differences, affecting experimental outcomes.",
            "score": 5,
            "explanation": "The predicted answer captures both key facts: the absence of stromal components in tumor models and the substitution with murine stroma causing variability, mirroring the reference answer. Although phrasing differs, the essential details and overall trend align perfectly with the reference."
        },
        {
            "query_idx": 467,
            "query": "What limitations are associated with using lipid nanoparticles (LNPs) for delivering complex genetic materials, and how do their design and structural components help address these limitations?",
            "retrieved_metrics": {
                "reference_idx": [
                    976,
                    977
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The delivery system of #LNPs# faces #constraints in delivering complex genes# yet benefits from #design flexibility# and #enhanced targeting capabilities# to mitigate these challenges.",
            "predicted_answer": "LNPs have capacity limitations for delivering complex genetic materials and can cause liver burden, immune responses, and allergic reactions. Design adjustments, such as optimizing ionizable lipids, PEG-lipid, cholesterol, and helper lipid ratios, enhance stability, reduce toxicity, and mitigate these issues.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the constraint of LNPs in delivering complex genetic materials and mentions design flexibility. However, it does not mention enhanced targeting capabilities, as highlighted in the reference. This missing key fact affects completeness."
        },
        {
            "query_idx": 468,
            "query": "What are the differing results observed in the studies of adjuvant autogene cevumeran and mRNA-4650 involving early personalized mRNA-based vaccines with respect to tumor recurrence and clinical response?",
            "retrieved_metrics": {
                "reference_idx": [
                    419,
                    986
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In studies, the adjuvant autogene cevumeran #delayed tumor recurrence#, while mRNA-4650 showed #no objective clinical responses# despite eliciting T-cell responses.",
            "predicted_answer": "The Phase 1 study of adjuvant autogene cevumeran showed delayed tumor recurrence and poly-specific T-cell responses, while the Phase I/II study of mRNA-4650 in metastatic gastrointestinal cancer patients showed T-cell responses but no objective clinical responses.",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer by stating that autogene cevumeran delayed tumor recurrence and that mRNA-4650 showed no objective clinical responses despite eliciting T-cell responses. All key facts are present, and there are no significant omissions."
        },
        {
            "query_idx": 469,
            "query": "Which compound has been synthesized for its anti-proliferative effects and interaction with a kinase relevant to pancreatic cancer, while also exhibiting properties suitable for pharmacokinetics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1253,
                    1256
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #1,2,4-oxadiazole topsentin analogues# target #GSK3β#, while exhibiting #good pharmacokinetic properties# for potential investigation, demonstrating targeted anti-proliferative effects on pancreatic cancer cells.",
            "predicted_answer": "Derivative 16, a 1,2,4-oxadiazole topsentin analogue, has been synthesized for its anti-proliferative effects on pancreatic cancer cells, interacts with CDK1, and shows good pharmacokinetic properties.",
            "score": 1,
            "explanation": "The predicted answer mentions the synthesis of a 1,2,4-oxadiazole topsentin analogue with anti-proliferative effects and good pharmacokinetics, aligning with the reference. However, it incorrectly identifies the kinase as CDK1 instead of GSK3β, missing a critical fact."
        },
        {
            "query_idx": 470,
            "query": "Modify the multi-hop query:  \nWhat specific evaluation process must be confirmed before advancing cancer drugs to later stages, and which drugs are tested in randomized perioperative trials for certain brain tumor conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    287,
                    300
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modify the answer:",
            "predicted_answer": "Before advancing cancer drugs to later stages, the evaluation must confirm target engagement in tumor tissue and its association with molecular changes. For certain brain tumors, drugs like pembrolizumab and vorasidenib are tested in randomized perioperative trials.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the need to confirm target engagement in tumor tissue and mentions pembrolizumab and vorasidenib being tested in randomized perioperative trials for brain tumors. However, specific mention of 'molecular changes' as part of the evaluation process is not separately highlighted and seems to be implicitly covered."
        },
        {
            "query_idx": 471,
            "query": "How does metformin influence transcription factor levels and impact the abilities of cancer stem cells to self-renew?",
            "retrieved_metrics": {
                "reference_idx": [
                    810,
                    809
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Metformin decreases #HNF4 α# levels and inhibits #CSCs' self-renewal abilities# via AMPK pathway activation, impacting both the transcription factor and cellular regeneration capabilities.",
            "predicted_answer": "Metformin reduces transcription factors like HNF4α via AMPK activation, modulating WNT signaling and suppressing cancer stem cell self-renewal by decreasing CSC markers such as CD44 and CD133.",
            "score": 5,
            "explanation": "The predicted answer covers the key points: reduction of HNF4α via AMPK activation and suppression of cancer stem cells' self-renewal, aligning with the reference. It includes additional details about pathways and markers which do not contradict the core information in the reference."
        },
        {
            "query_idx": 472,
            "query": "How are specialized organic methodologies utilized alongside elemental target compositions in the production of radiotracers for medical imaging diagnostics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1531,
                    1527
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Specialized #organic methodologies# with C-C bond formations use #carbon-11 radionuclides# generated from nitrogen-based targets for creating PET radiotracers, aiding medical imaging diagnostics.",
            "predicted_answer": "Specialized organic methodologies, such as C-C bond formation and metal-catalyzed reactions, are used to incorporate carbon-11 into biomolecules, producing radiotracers for PET imaging. These methods include alkylation, carboxylation, and the use of [$^{11}$C]CH₃I, [$^{11}$C]CO, and [$^{11}$C]CN.",
            "score": 3,
            "explanation": "The predicted answer includes the use of specialized organic methodologies and C-C bond formations. It also specifies the utilization of carbon-11 in the production of radiotracers. However, it misses the mention of carbon-11 radionuclides being generated from nitrogen-based targets, which is a key fact."
        },
        {
            "query_idx": 473,
            "query": "What is a first-line treatment for an advanced type of cancer that involves a drug also used in other malignancies, including ovarian cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1013,
                    1044
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The first-line treatment for advanced #hepatocellular carcinoma (HCC)# is the combination of #Bevacizumab# and #Atezolizumab#, reflecting #Bevacizumab#’s expanded use in cancers like #ovarian cancer#.",
            "predicted_answer": "Bevacizumab, often combined with chemotherapy or other targeted therapies, is a first-line treatment for advanced cancers, including ovarian cancer.",
            "score": 1,
            "explanation": "The predicted answer mentions \"Bevacizumab\" and its use in \"advanced cancers, including ovarian cancer,\" aligning with the reference. However, it omits \"hepatocellular carcinoma (HCC)\" and \"Atezolizumab,\" missing two key facts from the reference."
        },
        {
            "query_idx": 474,
            "query": "What drugs approved by the FDA as of March 2024 have a complex operational mechanism involving multiple steps and offer benefits over chemotherapy in terms of reduced systemic toxicity?",
            "retrieved_metrics": {
                "reference_idx": [
                    169,
                    920
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #ADCs# class, with #15 FDA-approved drugs# as of March 2024, has a complex mechanism and offers #reduced systemic toxic side effects# compared to chemotherapy.",
            "predicted_answer": "As of March 2024, the FDA has approved 15 ADC drugs. These drugs have a complex mechanism involving antibody binding, internalization, and payload release, and they offer reduced systemic toxicity compared to chemotherapy.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes all key facts emphasized in the 'Reference Answer': ADCs, 15 FDA-approved drugs as of March 2024, complex operational mechanism, and reduced systemic toxicity compared to chemotherapy. The predicted answer aligns well with the reference answer in terms of meaning and facts without omissions."
        },
        {
            "query_idx": 475,
            "query": "Which enzyme ensures the preservation of DNA methylation patterns during replication, and which enzymes have antagonistic functions regarding the methylation status of histone tails?",
            "retrieved_metrics": {
                "reference_idx": [
                    459,
                    461
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The enzyme #DNMT1# maintains DNA methylation during replication, while #histone methyltransferases (HMTs)# and #histone demethylases (HDMs)# act in opposition to determine histone methylation status.",
            "predicted_answer": "DNMT1 ensures the preservation of DNA methylation patterns during replication. Histone methyltransferases (HMTs) and histone demethylases (HDMs) have antagonistic functions regarding the methylation status of histone tails.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies DNMT1 as the enzyme preserving DNA methylation during replication and HMTs and HDMs as those with antagonistic roles for histone methylation status. All key facts from the Reference Answer, including terms marked with #, are present and consistent."
        },
        {
            "query_idx": 476,
            "query": "What changes are being implemented in Europe to address regulatory frameworks for phage therapies, and what global initiatives are contributing to the harmonization of these regulations?",
            "retrieved_metrics": {
                "reference_idx": [
                    65,
                    100
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Europe is improving #regulatory accommodations for medicinal phages#, while global initiatives, like ICH, focus on #harmonization efforts worldwide#, streamlining processes, and ensuring consistent regulatory standards.",
            "predicted_answer": "Europe is evolving its regulatory framework to better accommodate medicinal phages, streamlining the approval process. Globally, the ICH is working on harmonizing guidelines to ensure consistent safety and efficacy standards, reducing the burden on developers.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized in the reference answer: the improvement of regulatory accommodations for medicinal phages in Europe, and the global harmonization efforts by ICH. Both answers align in context and intent, with no significant omissions or errors."
        },
        {
            "query_idx": 477,
            "query": "How did legislative initiatives by the US and EU specifically address economic challenges in developing treatments for low-incidence diseases, and what impact did these initiatives have on innovation for oncological conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1199,
                    1898
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #Orphan Drug# acts by the US and EU tackled economic barriers in developing #orphan drugs# for #rare diseases#, significantly boosting innovation in #oncological treatments# by offering financial and research incentives.",
            "predicted_answer": "The US and EU addressed economic challenges in developing treatments for low-incidence diseases through the Orphan Drug Act (1983) and Orphan Drug legislation (2000), respectively. These initiatives provided incentives like tax credits, market exclusivity, and fee waivers, which significantly boosted innovation for rare cancers and other rare diseases.",
            "score": 3,
            "explanation": "The predicted answer includes key elements such as the Orphan Drug Act/legislation, financial incentives, and their impact on rare diseases, aligning with the reference answer. However, it does not specifically mention \"orphan drugs\" and \"oncological treatments,\" affecting completeness. Overall, it reflects the trend but misses key specifics."
        },
        {
            "query_idx": 478,
            "query": "How are recent biomedical advancements improving disease modeling through innovative access to patient-derived biological materials?",
            "retrieved_metrics": {
                "reference_idx": [
                    1183,
                    1196
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "New biomedical advancements, like #living biobanks#, enhance disease modeling by addressing the #limited regenerative capacity# of traditional models.",
            "predicted_answer": "Recent biomedical advancements, such as 'living biobanks' and organ-on-chip models, provide access to patient-derived cells and organoids, enhancing disease modeling by improving clinical mimicry and overcoming initial limitations like cell diversity and tissue crosstalk.",
            "score": 3,
            "explanation": "The predicted answer includes \"living biobanks\" but does not mention the \"limited regenerative capacity\" of traditional models, which is emphasized in the reference. While it aligns with the trend of enhancing disease modeling, missing this key fact affects completeness."
        },
        {
            "query_idx": 479,
            "query": "How do advanced single-cell technologies and technological advances contribute to broadening the range of epigenetic biomarkers and developing new therapeutic strategies in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    613,
                    614
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The use of #state-of-the-art single-cell technologies# expands #epigenetic biomarkers# and advances #epidrugs development#, benefiting cancer therapy through #technological advancements#.",
            "predicted_answer": "Advanced single-cell technologies and technological advances broaden the range of epigenetic biomarkers by enabling detailed characterization of the cancer epigenome. This leads to the identification of novel biomarkers and improved patient stratification, facilitating the development of new therapeutic strategies and combination treatments in cancer.",
            "score": 3,
            "explanation": "The predicted answer aligns with the overall trend of the reference answer by acknowledging the contribution of advanced single-cell technologies and technological advancements to broader epigenetic biomarkers and cancer treatment. However, it misses the specific emphasis on \"epidrugs development,\" affecting comprehensiveness."
        },
        {
            "query_idx": 480,
            "query": "What are two categories of pharmacological agents known for targeting cell populations in oncology, one aiming at resistant cancer stem cells and the other at inflammatory pathways linked to cancer progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    2256,
                    2257
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Metformin# targets and eradicates resistant #cancer stem cells#; #NSAIDs#, especially #COX-2 inhibitors#, focus on reducing cancer progression by targeting #inflammatory pathways#.",
            "predicted_answer": "Two categories are cancer stem cell (CSC) inhibitors like thioridazine and metformin, targeting resistant CSCs, and anti-inflammatory drugs such as NSAIDs, which target inflammatory pathways linked to cancer progression.",
            "score": 3,
            "explanation": "The Predicted Answer covers the key facts regarding metformin targeting cancer stem cells and NSAIDs targeting inflammatory pathways. However, it lacks the specific mention of COX-2 inhibitors, which affects the completeness. Despite alignment in the overall trend, one key detail is missing."
        },
        {
            "query_idx": 481,
            "query": "What transformation facilitates metastasis in cells, and which specific factor influences this transformation in the context of breast cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    398,
                    2034
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The transformation that facilitates metastasis is #epithelial-mesenchymal transition#, with #TGF-β# serving as the influential factor in breast cancer.",
            "predicted_answer": "Epithelial-mesenchymal transition (EMT) facilitates metastasis in cells. In breast cancer, TGF-β is a key factor that influences this transformation.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies epithelial-mesenchymal transition (EMT) as the transformation facilitating metastasis and TGF-β as the influential factor in breast cancer, matching the key facts emphasized in the reference answer. The meaning and details are consistent."
        },
        {
            "query_idx": 482,
            "query": "What positron-emitting radiotracers are utilized in both PET molecular imaging applications and clinical research, contributing to improved biodistribution and advancements in drug development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1505,
                    1537
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The radiotracers #carbon-11# and #fluorine-18# are used in PET imaging applications, with #carbon-11# showing improved biodistribution in clinical research advancements.",
            "predicted_answer": "Carbon-11 and fluorine-18 radiotracers are widely used in PET molecular imaging for both clinical research and drug development, contributing to improved biodistribution and advancements in the field.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts, carbon-11 and fluorine-18, aligning with the reference answer. It mentions their usage in clinical research and drug development, consistent with the reference's emphasis on improved biodistribution with carbon-11. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 483,
            "query": "Which program established by a European medicine agency in 2004 facilitates the transformation of preliminary drug authorizations into permanent approvals under specific conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1922,
                    1923
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #EMA# established a #conditional approval program# in #2004#, allowing initial drug authorizations to become full approvals on average after #4 years#, subject to stringent conditions.",
            "predicted_answer": "The EMA's conditional approval program, established in 2004, facilitates the transformation of preliminary drug authorizations into permanent approvals under specific conditions.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as the #EMA#, #conditional approval program#, and its establishment in #2004#. However, it omits the detail that approvals occur on average after #4 years#, which is emphasized in the reference answer, affecting completeness."
        },
        {
            "query_idx": 484,
            "query": "Which antibody-drug conjugate uses a topoisomerase inhibitor payload and targets HER3, demonstrating significant efficacy specifically in breast cancer with low HER2 expression?",
            "retrieved_metrics": {
                "reference_idx": [
                    189,
                    918
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #HER3-directed ADC# uses a #topoisomerase I inhibitor payload#, achieving #significant efficacy# in breast cancer with #low HER2 expression#.",
            "predicted_answer": "Patritumab deruxtecan is the antibody-drug conjugate that uses a topoisomerase I inhibitor payload and targets HER3, showing significant efficacy in breast cancer with low HER2 expression.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the HER3-directed ADC as patritumab deruxtecan, includes the use of a topoisomerase I inhibitor payload, and mentions significant efficacy in breast cancer with low HER2 expression. All key facts and trends from the reference answer are covered without omission."
        },
        {
            "query_idx": 485,
            "query": "What non-invasive tests have shown specific performance levels for monitoring bladder-related conditions and received significant regulatory acknowledgment recently?",
            "retrieved_metrics": {
                "reference_idx": [
                    504,
                    502
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #Bladder EpiCheck test# shows sensitivity from 68.2% to 91.7% for #NMIBC monitoring# with 88% specificity, while #UriFind# gained #FDA BDD# for bladder cancer #screening#.",
            "predicted_answer": "The Bladder EpiCheck test, with a sensitivity of 68.2% and specificity of 88%, and UriFind, which obtained FDA BDD in July 2021, are non-invasive tests that have shown specific performance levels for monitoring bladder-related conditions.",
            "score": 1,
            "explanation": "The predicted answer contains the key facts regarding the Bladder EpiCheck test's sensitivity and specificity. It also mentions UriFind's FDA BDD but misses details about NMIBC monitoring and UriFind being for bladder cancer screening. Thus, two key facts are absent."
        },
        {
            "query_idx": 486,
            "query": "Which regulatory agencies are involved in the oversight of phage-based therapeutic products in both the United States and Europe, dictating the standards for their authorization?",
            "retrieved_metrics": {
                "reference_idx": [
                    97,
                    96
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In the U.S., phage-based therapeutics are regulated by the #FDA#, while Europe entrusts this responsibility to the #EMA#.",
            "predicted_answer": "In the United States, the FDA oversees phage-based therapeutics, while in Europe, the EMA regulates them through the centralized marketing authorization procedure. Both agencies ensure these products meet high standards of quality, safety, and efficacy.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions that in the U.S., the #FDA# regulates phage-based therapeutics, and in Europe, the #EMA# is responsible. It adds additional detail about the regulation process, but all key facts emphasized in the reference are present without contradiction."
        },
        {
            "query_idx": 487,
            "query": "Which method is used for detailed DNA methylation profiling in human cancer studies, and what associated dataset provides extensive information across numerous tumor types?",
            "retrieved_metrics": {
                "reference_idx": [
                    473,
                    475
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #bisulfite conversion-dependent methylation arrays# method is used, with #450K DNA methylation profiles of TCGA samples# providing extensive tumor-type data.",
            "predicted_answer": "Bisulfite conversion-dependent methylation arrays, specifically the Infinium HumanMethylation450 BeadChip, are used for detailed DNA methylation profiling. The associated dataset with extensive information across numerous tumor types is available in the TCGA via the Genomic Data Commons Data Portal.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the use of \"bisulfite conversion-dependent methylation arrays\" and specifies \"450K DNA methylation profiles\" from TCGA samples. Although phrasing varies, the key facts are present, trends aligned, with no significant omissions or contradictory details."
        },
        {
            "query_idx": 488,
            "query": "What trial method is utilized to study the effectiveness of investigational drugs for their penetration capacity in surgery-related recurring brain tumors?",
            "retrieved_metrics": {
                "reference_idx": [
                    295,
                    292
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "A #randomized design# in #perioperative trials# is utilized to evaluate investigational drugs for blood-brain barrier penetration in recurring brain tumors.",
            "predicted_answer": "Perioperative trials, often randomized, are used to study the penetration of investigational drugs in recurring brain tumors. These trials include patients receiving placebo or no drug before surgery to evaluate drug efficacy and penetration.",
            "score": 3,
            "explanation": "The predicted answer correctly mentions \"perioperative trials\" and that these trials are \"often randomized,\" aligning with the reference answer's emphasis on these terms. However, it does not explicitly mention \"blood-brain barrier penetration,\" which is a key fact. Thus, it is missing one important detail."
        },
        {
            "query_idx": 489,
            "query": "What are the challenges faced by AI systems in predicting protein structures used in developing anticancer drugs, and how do these challenges affect the identification of resistance mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    271,
                    275
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The AI system #fails to predict multi-domain proteins#, like #transmembrane receptors#, crucial for anticancer drugs, affecting #structure-based discovery# and understanding #resistance mechanisms#.",
            "predicted_answer": "AI systems like AlphaFold2 face challenges in accurately predicting structures of proteins with multiple domains, crucial for anticancer drugs. This limitation hinders the identification of resistance mechanisms, as incorrect predictions can lead to ineffective drug targets.",
            "score": 3,
            "explanation": "The predicted answer captures the challenge of predicting multi-domain protein structures but misses the specific mention of \"transmembrane receptors\" and lacks direct reference to \"structure-based discovery.\" While the overall trend related to resistance mechanisms is included, these omissions affect completeness."
        },
        {
            "query_idx": 490,
            "query": "What chemical modification enhances the absorption and bioavailability of drugs while overcoming challenges in drug development and approval for various medical treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1081,
                    1107
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #fluorination# process enhances drug absorption, increasing bioavailability, leading to the approval of #fluorinated drugs# despite development challenges.",
            "predicted_answer": "Fluorination enhances the absorption and bioavailability of drugs by increasing their lipophilicity, allowing them to pass through cell membranes more easily. This modification also improves drug potency and is beneficial in various medical treatments.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of fluorination enhancing absorption and bioavailability, mentioning its role in improving drug potency for treatments. However, it omits the aspect of fluorination leading to the approval of fluorinated drugs, which is a key fact in the reference answer."
        },
        {
            "query_idx": 491,
            "query": "What combination of inhibitors and immune-blocking antibodies is evaluated in PDOs to enhance the efficacy of immune-checkpoint therapies in cancer research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1175,
                    1176
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The development of #CDK4/6# inhibitors shows #synergy# with anti-PD-1 antibodies, enhancing T cell activation in PDOs to boost treatment efficacy.",
            "predicted_answer": "CDK4/6 inhibitors in combination with anti-PD-1 blocking antibodies are evaluated in PDOs to enhance the efficacy of immune-checkpoint therapies.",
            "score": 1,
            "explanation": "The predicted answer mentions CDK4/6 inhibitors and anti-PD-1 antibodies, aligning with the reference. However, it lacks the key fact of “synergy” and the detail about enhancing T cell activation, impacting the completeness of the comparison."
        },
        {
            "query_idx": 492,
            "query": "What are the specific structural and environmental challenges in in vitro systems that affect nutrient uptake and lead to cellular heterogeneity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1184,
                    2083
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Tissue geometry# is challenging to replicate, affecting #nutrient distribution# which causes non-uniform cell development.",
            "predicted_answer": "In vitro systems face challenges like non-uniform nutrient distribution, difficulty in replicating tissue-specific geometry, and high model variability. These issues lead to uneven cell growth and atypical gene and protein expression, contributing to cellular heterogeneity.",
            "score": 5,
            "explanation": "The predicted answer mentions challenges like non-uniform nutrient distribution and difficulty in replicating tissue-specific geometry, which are the key facts emphasized with # in the reference answer. The overall trend and meaning are consistent, and no important details are missing."
        },
        {
            "query_idx": 493,
            "query": "What receptor's expression level is critical for applying a specific combination of targeted inhibitors and chemotherapy in a form of breast cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    110,
                    1039
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The receptor #HER2# plays a key role in #HER2#-positive breast cancer, treated using #HER2# inhibitors like Trastuzumab plus Pertuzumab alongside chemotherapy.",
            "predicted_answer": "The expression level of HER2 is critical for applying a specific combination of targeted inhibitors and chemotherapy in the treatment of HER2-positive breast cancer.",
            "score": 5,
            "explanation": "The predicted answer accurately covers the key fact that the receptor HER2 is critical for applying targeted inhibitors and chemotherapy in the treatment of HER2-positive breast cancer. It aligns with the reference answer, despite not mentioning specific inhibitors, but maintains overall consistency."
        },
        {
            "query_idx": 494,
            "query": "What is the period during which anticancer drug approvals were examined, and how are these indications classified according to the number of affected individuals?",
            "retrieved_metrics": {
                "reference_idx": [
                    1059,
                    1073
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Anticancer drug approvals were analyzed from #1 January 2000 to 1 January 2022#, and indications are classified by affected individuals as #common, rare, and ultra-rare#.",
            "predicted_answer": "The anticancer drug approvals were examined from 1 January 2000 to 1 January 2022. Indications are classified as common (>200,000), rare (200,000-6,600), or ultra-rare (<6,600) based on the number of affected U.S. citizens.",
            "score": 5,
            "explanation": "The 'Predicted Answer' accurately provides the time period, \"1 January 2000 to 1 January 2022,\" and classifies indications as common, rare, and ultra-rare. It includes additional detail regarding the number of affected individuals, which complements but doesn't contradict the reference. All key facts are present."
        },
        {
            "query_idx": 495,
            "query": "Which in vitro model is used for predicting patient responses in personalized oncology and requires protocol standardization for acceptance in the drug development process?",
            "retrieved_metrics": {
                "reference_idx": [
                    1486,
                    1500
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The in vitro model #tumoroids# is vital for #predicting patient responses# in personalized oncology and requires #standardization# of protocols for widespread application in drug development.",
            "predicted_answer": "Tumoroids are used for predicting patient responses in personalized oncology. Standardization of protocols is necessary for their acceptance in the drug development process.",
            "score": 5,
            "explanation": "The 'Predicted Answer' accurately mentions \"tumoroids,\" their role in \"predicting patient responses,\" and the necessity for \"standardization of protocols,\" aligning with the key facts highlighted in the 'Reference Answer.' There are no significant omissions or contradictions, fully reflecting the reference's meaning."
        },
        {
            "query_idx": 496,
            "query": "Which treatment marked a significant advancement in breast cancer therapy by utilizing a targeted approach, and which protein does this treatment specifically address to achieve its effects?",
            "retrieved_metrics": {
                "reference_idx": [
                    111,
                    869
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The treatment #Trastuzumab# marked a significant advancement in breast cancer therapy by targeting the #HER-2# protein, making it a pioneering targeted therapy in this field.",
            "predicted_answer": "Trastuzumab (Herceptin) marked a significant advancement in breast cancer therapy by targeting the HER-2 protein, which is overexpressed in some breast cancers.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies Trastuzumab as the treatment and HER-2 as the targeted protein, consistent with the reference answer. It includes all key facts emphasized with # symbols without omissions or contradictions, aligning completely with the overall trend of the reference."
        },
        {
            "query_idx": 497,
            "query": "What specific tools and techniques have contributed to improvements in patient outcomes, and how do distinct predictive biomarkers facilitate this process in targeted therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    415,
                    467
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Implementing #personalized treatment# using #predictive genomic biomarkers# enhances #progression-free survival# and improves the effectiveness of #targeted therapies#.",
            "predicted_answer": "Next-generation sequencing (NGS), including whole-exome and single-cell sequencing, and liquid biopsy facilitate the identification of predictive biomarkers. These tools enable adaptive therapy by tracking tumor evolution, allowing for personalized treatment adjustments that improve patient outcomes.",
            "score": 3,
            "explanation": "The predicted answer mentions \"predictive biomarkers,\" similar to \"predictive genomic biomarkers,\" supporting personalized treatment. However, it lacks specific mentions of \"progression-free survival\" and \"effectiveness of targeted therapies,\" both crucial points in the reference, affecting completeness."
        },
        {
            "query_idx": 498,
            "query": "Which genetic screening technology is pivotal in modifying immune cells for enhancing cancer therapy, and what specific type of engineered cells shows efficacy in targeting cancer cells without MHC restrictions?",
            "retrieved_metrics": {
                "reference_idx": [
                    2108,
                    2112
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #CRISPR-Cas9# system is pivotal in enhancing T-cell therapies, while engineered #CAR-T cells# efficiently target cancer cells with MHC-independent antigen recognition.",
            "predicted_answer": "CRISPR-Cas9 is pivotal for modifying immune cells. CAR-T cells, engineered to target extracellular antigens without MHC restrictions, show efficacy in targeting cancer cells.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts: CRISPR-Cas9 as the genetic screening technology and CAR-T cells' targeting capabilities without MHC restrictions. Both responses reflect the overall trend of immune cell modification for cancer therapy enhancement, with no significant omissions or contradictions."
        },
        {
            "query_idx": 499,
            "query": "What technologies and methods support the advancement and refinement of targeted cancer therapies, considering both the creation of innovative molecular targets and the integration of patient-derived data?",
            "retrieved_metrics": {
                "reference_idx": [
                    270,
                    1217
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The advancement of targeted cancer therapies involves #AI# in #creating CRISPR-based targets# and #utilizing patient-specific data# to optimize #personalized treatment strategies#, enhancing precision oncology.",
            "predicted_answer": "AI-driven methods, including machine learning and neural networks, support the advancement of targeted cancer therapies by identifying molecular targets, designing drugs, and integrating patient-derived data to personalize treatments and optimize efficacy.",
            "score": 1,
            "explanation": "The predicted answer covers the use of AI and the integration of patient-derived data for personalization, aligning with the reference answer trends. However, it misses key facts like \"CRISPR-based targets\" and \"personalized treatment strategies,\" impacting completeness."
        },
        {
            "query_idx": 500,
            "query": "Which methylation-based assays are used in cervical cancer screening, and what specific genes do these assays analyze for hypermethylation?",
            "retrieved_metrics": {
                "reference_idx": [
                    495,
                    496
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #FAM19A4/miR124-2# and #PAX1 methylation# assays screen for cervical cancer. The #GynTect test# analyzes hypermethylation in #DLX1#, #ITGA4#, #RXFP3#, #SOX17#, and #ZNF671#.",
            "predicted_answer": "FAM19A4/miR124-2, PAX1, DLX1, ITGA4, RXFP3, SOX17, and ZNF671 are analyzed for hypermethylation in cervical cancer screening using assays like FAM19A4/miR124-2, Cervi-M, and GynTect.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts from the reference answer: it mentions the FAM19A4/miR124-2, PAX1 assays, and the genes DLX1, ITGA4, RXFP3, SOX17, and ZNF671 analyzed by the GynTect test for hypermethylation. All essential details are present, reflecting the reference answer accurately."
        },
        {
            "query_idx": 501,
            "query": "What is the effectiveness of Apatinib in treating a specific type of lung cancer, and which therapeutic category does this approach fall under?",
            "retrieved_metrics": {
                "reference_idx": [
                    870,
                    1015
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Apatinib shows a #76.7% disease control rate# in treating #NSCLC#, and this treatment falls under the category of #targeted therapies for non-small cell lung cancer#.",
            "predicted_answer": "Apatinib, a VEGFR-2 inhibitor, has shown a 76.7% disease control rate in treating non-small cell lung cancer (NSCLC) patients who did not respond to initial or follow-up treatments. This approach falls under the category of anti-angiogenic therapy.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions the 76.7% disease control rate and specifies the treatment of NSCLC, aligning with the key facts. However, it categorizes the approach as anti-angiogenic therapy, while the reference specifies targeted therapies, affecting the completeness."
        },
        {
            "query_idx": 502,
            "query": "How do a marine sponge-derived compound and 4-(R)-6'-debromohamacanthin A influence human cancer cell lines and cellular signaling pathways differently?",
            "retrieved_metrics": {
                "reference_idx": [
                    1252,
                    1270
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The marine sponge-derived #isobromodeoxytopsentin# targets five cancer cell lines, whereas #Compound 58# influences VEGF-induced MAPK and PI3K/AKT/mTOR signaling pathways.",
            "predicted_answer": "The marine sponge-derived compound, bromodeoxytopsentin, shows cytotoxicity against K562 and other cancer cell lines. In contrast, 4-(R)-6'-debromohamacanthin A has a weak inhibitory effect on HCT15 and can inhibit VEGF-induced MAPKs and the PI3K/AKT/mTOR pathway.",
            "score": 1,
            "explanation": "The predicted answer covers the cytotoxic effects on cancer cell lines and the inhibition of the VEGF-induced pathways but uses different compound names: bromodeoxytopsentin and 4-(R)-6'-debromohamacanthin A instead of isobromodeoxytopsentin and Compound 58. This results in two key factual discrepancies."
        },
        {
            "query_idx": 503,
            "query": "Which gene-editing method targets immunomodulatory genes to alter checkpoints, thereby boosting the efficacy of a certain cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    2106,
                    2113
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #CRISPR-Cas9# technique targets and disrupts genes impacting #immune checkpoints#, significantly boosting the #immunotherapy response# against cancer.",
            "predicted_answer": "CRISPR-Cas9 targets immunomodulatory genes like PD-1 and CTLA-4 to alter immune checkpoints, enhancing the effectiveness of cancer immunotherapy.",
            "score": 5,
            "explanation": "The predicted answer mentions \"CRISPR-Cas9,\" \"immune checkpoints,\" and \"immunotherapy,\" which align with the key facts in the reference answer (#CRISPR-Cas9#, #immune checkpoints#, #immunotherapy response#). It fully covers the emphasized details, reflecting consistency in meaning and information."
        },
        {
            "query_idx": 504,
            "query": "Which compound modulates gut microbiota, affects inflammatory and immune responses, utilizes tryptophan pathways in metabolism, and is associated with cancer prevention and treatment strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    849,
                    850
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The compound #EVO# modulates gut microbiota, #affects inflammatory and immune responses#, and via #tryptophan pathways influences metabolism#, impacting cancer #prevention and therapeutic strategies#.",
            "predicted_answer": "EVO modulates gut microbiota, affects inflammatory and immune responses, utilizes tryptophan pathways in metabolism, and is associated with cancer prevention and treatment strategies.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes all the key facts emphasized in the 'Reference Answer': the compound EVO, its effects on gut microbiota, inflammatory and immune responses, tryptophan pathways in metabolism, and its role in cancer prevention and treatment. There are no omissions or errors."
        },
        {
            "query_idx": 505,
            "query": "Based on the suggestions, the modified multi-hop query:\nHow do liposome carriers enhance drug delivery in cancer treatment, and which specific liposome formulations used for this purpose have regulatory approval for specific types of cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1017,
                    1018
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modified answer based on the suggestions:",
            "predicted_answer": "Liposome carriers enhance drug delivery by protecting drugs from degradation, extending their half-life, and controlling release, leveraging the EPR effect to target tumors. FDA-approved liposomal formulations include Doxil and Myocet for breast cancer and non-small cell lung cancer.",
            "score": 5,
            "explanation": "The predicted answer correctly aligns with the key facts in the reference answer: liposome carriers enhance drug delivery by shielding drugs, prolonging their half-life, and utilizing the EPR effect to specifically target tumors. It also identifies FDA-approved formulations like Doxil for cancers, covering the critical details without contradiction."
        },
        {
            "query_idx": 506,
            "query": "Which therapeutic interventions use CRISPR-Cas9 to manage a genetic condition by addressing protein misfolding and simultaneously employ it to reduce immune cell-related adverse effects?",
            "retrieved_metrics": {
                "reference_idx": [
                    965,
                    2100
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "CRISPR-Cas9 is applied in #gene knockout in T cells# to mitigate #immune cell toxicity# and via #NTLA-2001# therapy to address #protein misfolding# in hereditary #ATTR#.",
            "predicted_answer": "NTLA-2001, a CRISPR-Cas9 based therapy, targets misfolded TTR protein in hereditary transthyretin amyloidosis. A separate study uses CRISPR-Cas9 to knock out genes in T cells to reduce GvHD toxicity, addressing immune cell-related adverse effects.",
            "score": 5,
            "explanation": "The Predicted Answer covers all key facts from the Reference Answer: use of CRISPR-Cas9 for gene knockout in T cells reducing immune cell-related adverse effects, and NTLA-2001 targeting protein misfolding in hereditary ATTR. The details and trends align without significant omissions or contradictions."
        },
        {
            "query_idx": 507,
            "query": "Which pairs of genes are identified as synthetic lethal in melanoma, with each pair associated with a different mutation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1952,
                    1963
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #DUSP4/DUSP6# pair is synthetic lethal in #NRAS mutant melanoma#, and the #MAP2K1/MAP2K2# pair is synthetic lethal in #BRAF mutant melanoma#.",
            "predicted_answer": "In melanoma, the paralog pairs DUSP4/DUSP6 (NRAS mutant) and MAP2K1/MAP2K2 (BRAF mutant) are identified as synthetic lethal.",
            "score": 5,
            "explanation": "The predicted answer fully captures all key facts from the reference answer. It correctly identifies the DUSP4/DUSP6 pair with NRAS mutation and MAP2K1/MAP2K2 pair with BRAF mutation as synthetic lethal in melanoma. There are no omissions or contradictions."
        },
        {
            "query_idx": 508,
            "query": "How are economically disadvantaged regions with a high incidence of life-threatening diseases attempting to overcome the challenges of high treatment costs and limited accessibility to essential medications?",
            "retrieved_metrics": {
                "reference_idx": [
                    737,
                    745
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Biosimilars# are proposed in LMICs to mitigate the #prohibitive cost# of original biologics, confronting the #limited resources# amid a #high cancer burden#.",
            "predicted_answer": "Economically disadvantaged regions are tackling high treatment costs and limited medication access by promoting local clinical research, encouraging trials that benefit their populations, and developing generics and biosimilars as more affordable alternatives to expensive biologics.",
            "score": 3,
            "explanation": "The predicted answer includes the development of \"generics and biosimilars\" to address the challenge of \"high treatment costs,\" aligning with the reference answer's mention of \"biosimilars\" and \"prohibitive cost.\" However, it omits \"limited resources\" and \"high cancer burden,\" affecting completeness."
        },
        {
            "query_idx": 509,
            "query": "What molecular interaction impacts specific complexes in Ewing sarcoma, and what is the resultant effect of inhibiting one of these components on the immune characteristics of cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    584,
                    596
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In Ewing sarcoma, #EWS/FLI# affects LSD1 complexes, and inhibiting LSD1 enhances #immunogenicity#, boosting immune responses typically limited in some cancer therapies.",
            "predicted_answer": "In Ewing sarcoma, the interaction between LSD1 and EWS/FLI impacts specific complexes. Inhibiting LSD1 enhances tumor immunogenicity and T-cell infiltration, improving immune characteristics of cancer cells.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the interaction between LSD1 and EWS/FLI, as well as the inhibition of LSD1 enhancing tumor immunogenicity. However, it misses the aspect of boosting immune responses typically limited in cancer therapies, affecting the completeness slightly."
        },
        {
            "query_idx": 510,
            "query": "What experimental technique is used to assess interactions between compounds and cancer-related proteins, and to evaluate the repurposing potential of existing drugs for treating other cancer types?",
            "retrieved_metrics": {
                "reference_idx": [
                    262,
                    2243
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The technique is #molecular docking#, crucial for evaluating #non-covalent interactions# with cancer proteins, and essential for #drug repurposing# by analyzing drugs like #thalidomide# for treating various cancers.",
            "predicted_answer": "Molecular docking is used to assess interactions between compounds and cancer-related proteins, and to evaluate the repurposing potential of existing drugs for treating other cancer types.",
            "score": 1,
            "explanation": "The predicted answer correctly identifies \"molecular docking\" as the technique used to evaluate interactions with cancer proteins and drug repurposing. However, it lacks details about \"non-covalent interactions\" and the specific example of \"thalidomide,\" both key facts in the reference answer."
        },
        {
            "query_idx": 511,
            "query": "What material is essential for creating a single-cell environment in CRC organoid culture, and which biological factor has been pivotal in this methodology since 2009?",
            "retrieved_metrics": {
                "reference_idx": [
                    1399,
                    1403
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Matrigel# is essential for creating a suitable environment for single cells, and #Lgr5 stem cells# have been pivotal in CRC organoid culture since 2009.",
            "predicted_answer": "Matrigel is essential for creating a single-cell environment in CRC organoid culture. Lgr5 stem cells have been pivotal in this methodology since 2009, driving intestinal epithelial self-renewal.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions both \"Matrigel\" and \"Lgr5 stem cells,\" consistent with the key facts in the reference answer. It correctly identifies the importance of Matrigel in single-cell environments and the pivotal role of Lgr5 stem cells, aligning with the reference without omissions or errors."
        },
        {
            "query_idx": 512,
            "query": "Which compounds from the genus Spongosorites are characterized by specific structural features and tested for their IC₅₀ values on certain cancer cell lines, while others inhibit specific phosphatases?",
            "retrieved_metrics": {
                "reference_idx": [
                    1272,
                    1273
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Dragmacidin G# contains a #pyrazine ring# and #two indole rings#, effective on #PANC-1, MIA PaCa-2, BxPC-3, ASPC-1# with specific #IC₅₀ values#, while Dragmacidon A inhibits #PP1# and #PP2A# phosphatases.",
            "predicted_answer": "Dragmacidon A and Dragmacidin G from Spongosorites exhibit specific structural features. Dragmacidon A shows IC₅₀ values on A549, HT29, and MDA-MB-231 cell lines and inhibits PP1 and PP2A phosphatases. Dragmacidin G has IC₅₀ values on PANC-1, MIA PaCa-2, BxPC-3, and ASPC-1 cell lines.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts: Dragmacidin G's structural features (not mentioned but implied), its IC₅₀ values on specified cancer cell lines, and Dragmacidon A's effect on PP1 and PP2A phosphatases. No contradictions or omissions significantly impact completeness."
        },
        {
            "query_idx": 513,
            "query": "Modify the multi-hop query:\nHow does the FDA Modernization Act 2.0 impact the integration of specific in vitro cancer models within the drug discovery process, particularly concerning preclinical methods and alternative to animal testing?",
            "retrieved_metrics": {
                "reference_idx": [
                    1800,
                    1819
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modify the answer:",
            "predicted_answer": "The FDA Modernization Act 2.0 allows the use of 3D in vitro cancer models like spheroids and organoids as alternatives to animal testing, potentially improving preclinical methods and reducing animal use, though complete replacement is not yet feasible.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by mentioning the use of 3D in vitro cancer models as alternatives to animal testing, improving preclinical methods, and reducing animal use. However, without the reference, it's unknown if key emphasized facts are fully covered."
        },
        {
            "query_idx": 514,
            "query": "Which prodrugs undergo conversion into triphosphate forms to act as RNA polymerase inhibitors for the treatment of viral infections, specifically targeting SARS-CoV-2?",
            "retrieved_metrics": {
                "reference_idx": [
                    1103,
                    1105
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The prodrugs #Favipiravir# and #4'-Fluorouridine (4'-FIU)# are converted to triphosphate forms, enabling them to inhibit RNA polymerase and target SARS-CoV-2.",
            "predicted_answer": "Favipiravir and 4'-Fluorouridine (4'-FIU) are prodrugs that convert into their triphosphate forms, favipiravir-RTP and 4'-FIU-TP, respectively, to act as RNA polymerase inhibitors for SARS-CoV-2.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts emphasized in the reference: \"Favipiravir\" and \"4'-Fluorouridine (4'-FIU)\" as prodrugs, their conversion to triphosphate forms, and their role as RNA polymerase inhibitors targeting SARS-CoV-2. All essential details are present and trends are aligned."
        },
        {
            "query_idx": 515,
            "query": "How do iterative processes and holistic approaches contribute to optimizing drug dosing strategies for oncology treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1594,
                    1598
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "An #iterative process# ensures continual dose optimization, while a #holistic approach# using a ToE mindset optimizes oncology regimens, integrating comprehensive data for effective treatment.",
            "predicted_answer": "Iterative processes and holistic approaches in oncology optimize drug dosing by continuously updating dose selection based on new data, integrating multidimensional evidence, and considering various factors like disease, drug, patient, and trial-related elements.",
            "score": 3,
            "explanation": "The 'Predicted Answer' mentions both 'iterative processes' and 'holistic approaches,' aligning with the core concepts of the 'Reference Answer.' However, the specific mention of \"ToE mindset\" is missing, slightly affecting completeness, but the overall trend is maintained."
        },
        {
            "query_idx": 516,
            "query": "How are ADCs internalized and processed within cells, and how does this process alter the dynamics of antigens involved in combination therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    209,
                    917
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "ADCs undergo #endocytosis# where they are internalized, processed in lysosomes, and facilitate #antigen turnover or degradation#, impacting their dynamics in combination therapies.",
            "predicted_answer": "ADCs are internalized via endocytosis into endosomes, which then fuse with lysosomes. In lysosomes, ADCs are degraded, releasing the toxin to kill the tumor cell. This process can increase antigen turnover or degradation, potentially enhancing the efficacy of combination therapies.",
            "score": 5,
            "explanation": "The predicted answer includes key facts about ADCs being internalized via endocytosis, processed in lysosomes, and impacting antigen turnover or degradation. These match the reference answer, aligning with the overall trend about ADCs' role in combination therapies without any significant omissions."
        },
        {
            "query_idx": 517,
            "query": "What are the design challenges of bioink in 3D bioprinting for modeling tumor tissues, and how do these impact the ability to adjust specific properties of the tumor microenvironment?",
            "retrieved_metrics": {
                "reference_idx": [
                    2049,
                    2047
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In 3D bioprinting, #bioink# design addresses challenges in accurately modeling tumor tissues by adjusting properties such as #TME# stiffness, crucial for replicating the tumor environment.",
            "predicted_answer": "Design challenges of bioink in 3D bioprinting for tumor tissues include selecting appropriate bioink with suitable mechanical and physiological properties, ensuring cell survival, and achieving high resolution. These impact the ability to adjust tumor microenvironment properties like stiffness and biochemical factor distribution, which are crucial for modeling tumor behavior and interactions.",
            "score": 5,
            "explanation": "The Predicted Answer captures the key elements of bioink design challenges, including the importance of mechanical properties, and specifically mentions stiffness, which aligns with the reference regarding TME. Although it is more detailed, all critical concepts emphasized in the reference are addressed."
        },
        {
            "query_idx": 518,
            "query": "How do chemical modifications and amino acid alterations address the challenges associated with peptide cancer therapies, including their physicochemical limitations and administration route issues?",
            "retrieved_metrics": {
                "reference_idx": [
                    894,
                    895
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Chemical modifications# like acetylation improve peptide #stability#, while the use of #synthetic amino acids# and design strategies enhances #membrane permeability# and #oral bioavailability#.",
            "predicted_answer": "Chemical modifications like acetylation, methylation, and cyclization, along with the use of synthetic amino acids, enhance peptide stability, extend half-life, and improve membrane permeability, addressing physicochemical limitations and administration issues in cancer therapies.",
            "score": 1,
            "explanation": "The predicted answer and reference answer both mention chemical modifications and synthetic amino acids. The predicted answer includes peptide stability, but it only partially covers membrane permeability without oral bioavailability. Thus, the predicted answer is missing more than one key fact: oral bioavailability."
        },
        {
            "query_idx": 519,
            "query": "What technique is pivotal in discerning cellular targets and resistance mechanisms in drug development, and which comprehensive strategy evaluates gene influence on medication response and immune activation?",
            "retrieved_metrics": {
                "reference_idx": [
                    2090,
                    2102
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#CRISPR-Cas-mediated gene knockout# is crucial for discerning drug targets and resistance, while #genome-wide lentiviral CRISPR libraries# evaluate gene influence on drug response and immune activation.",
            "predicted_answer": "CRISPR-Cas9 gene knockout combined with high-throughput sequencing is pivotal for identifying cellular targets and resistance mechanisms. Genome-wide CRISPR libraries evaluate gene influence on drug response and immune activation, including antitumor elements.",
            "score": 5,
            "explanation": "The predicted answer includes both key elements highlighted in the reference: \"CRISPR-Cas-mediated gene knockout\" and \"genome-wide CRISPR libraries,\" matching the overall meaning. Although \"lentiviral\" is missing, it does not significantly affect the meaning or completeness of the answer."
        },
        {
            "query_idx": 520,
            "query": "What challenges related to economic viability and regulations hinder drug repurposing, and why do these challenges necessitate expanding available cancer treatment options?",
            "retrieved_metrics": {
                "reference_idx": [
                    859,
                    1830
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #limited return on investment# and #regulatory issues# obstruct drug repurposing innovation, necessitating #portfolio expansion# due to the #complex nature of cancer treatment#.",
            "predicted_answer": "Economic viability and regulatory challenges, such as limited return on investment for off-patent drugs and inadequate regulatory incentives, hinder drug repurposing. These challenges necessitate expanding cancer treatment options to address the complexity and variability of cancer.",
            "score": 5,
            "explanation": "The predicted answer effectively mentions the \"limited return on investment\" and \"regulatory challenges\" that obstruct drug repurposing. It also highlights the need to expand cancer treatment options due to \"complexity and variability of cancer,\" mirroring the \"portfolio expansion\" and \"complex nature\" points in the reference."
        },
        {
            "query_idx": 521,
            "query": "How can an analytical tool contribute to the development of evaluation criteria for drug efficacy in 3D spheroid and organoid models, and what are the implications for research practices?",
            "retrieved_metrics": {
                "reference_idx": [
                    1805,
                    1814
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Standardized evaluation methods# for drug efficacy in 3D models can be achieved through #mathematical modeling#, which aids analysis and reduces experimental trials.",
            "predicted_answer": "Analytical tools, especially mathematical modeling, can help develop standardized evaluation criteria for drug efficacy in 3D models by providing quantitative analysis and predictive simulations. This enhances research practices by reducing experimental costs and improving the accuracy of drug efficacy assessments.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of \"#standardized evaluation methods#\" and \"#mathematical modeling#\" and explains their role in aiding analysis and reducing experimental trials, aligning with the reference answer. There are no omissions or contradictory information, and the meaning is consistent."
        },
        {
            "query_idx": 522,
            "query": "How do insurers handle the complexities introduced by the lack of comprehensive clinical data when assessing drugs approved through accelerated processes, particularly concerning medical effectiveness and financial considerations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1912,
                    1929
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Insurers face difficulty with #clinical outcomes# assessment and uncertain #therapeutic value# due to accelerated #drug approval#, impacting financial decisions and coverage policies.",
            "predicted_answer": "Insurers face challenges in assessing drugs with accelerated approval due to limited clinical data, leading to difficulties in determining value, price, and coverage. They use managed entry agreements and other tools to manage financial and clinical uncertainties, especially in Europe.",
            "score": 1,
            "explanation": "The predicted answer captures the issues of limited clinical data affecting drug assessment and mentions financial considerations through managed entry agreements. However, it lacks specific reference to \"clinical outcomes\" and \"therapeutic value,\" focusing more on methods like \"managed entry agreements\" rather than the concept of \"drug approval.\""
        },
        {
            "query_idx": 523,
            "query": "What are the key electrical properties and simulation results that identify the compound showing the highest effectiveness in cancer treatment according to the research findings?",
            "retrieved_metrics": {
                "reference_idx": [
                    261,
                    267
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The compounds' #high ion-attracting capacity# suggests promising properties, while #Compound (8b)'s free-binding energy attributes# highlight its #greatest potential as an anticancer agent#.",
            "predicted_answer": "The key electrical properties include high ion-attracting capacity and structural stability. Simulation results, particularly from DFT calculations and Desmond simulations, showed Compound (8b) to have the highest potential as an anticancer agent.",
            "score": 3,
            "explanation": "The predicted answer covers the compound's high ion-attracting capacity and identifies Compound (8b) as having the highest potential as an anticancer agent, aligning with the reference answer. However, it misses the specific detail of \"free-binding energy attributes,\" impacting completeness."
        },
        {
            "query_idx": 524,
            "query": "What sophisticated adaptive strategies inherent in the receptor-binding mechanisms of bacteriophages orchestrate their targeted engagement and heightened operational efficacy in combating antibiotic-resistant bacterial strains?",
            "retrieved_metrics": {
                "reference_idx": [
                    7
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Phage specificity and efficiency are enhanced by #rapid evolution# of receptor-binding domains, enabling adaptation to bacterial surface variations and improving targeting of #antibiotic-resistant# strains.",
            "predicted_answer": "Bacteriophages use rapidly evolving receptor-binding proteins (RBPs) to adapt to bacterial surface variations, enhancing their specificity and efficiency. This adaptability is crucial for targeting and combating antibiotic-resistant bacterial strains.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts from the reference answer: the rapid evolution of receptor-binding proteins and targeting antibiotic-resistant strains. Both answers highlight adaptation to bacterial surface variations, indicating consistency in meaning and trends without significant omissions or contradictions."
        },
        {
            "query_idx": 525,
            "query": "What influence do the symphonic arrangements of replication gene clusters within bacteriophage genomic compositions exert in enhancing the intricate understanding of their diverse propagation blueprints?",
            "retrieved_metrics": {
                "reference_idx": [
                    8
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #modular arrangement# of replication genes in bacteriophage genomes enhances understanding of #DNA replication mechanisms#, illuminating diverse propagation strategies through phage-host interactions.",
            "predicted_answer": "The symphonic arrangements of replication gene clusters in bacteriophage genomes, as discussed by Weigel et al. (2006) and Salmond and Fineran (2015), enhance our understanding of diverse propagation strategies, including the switch between lytic and lysogenic cycles.",
            "score": 1,
            "explanation": "The predicted answer mentions \"symphonic arrangements\" of gene clusters, while the reference emphasizes \"modular arrangement.\" It discusses propagation strategies but omits the key aspect of \"DNA replication mechanisms\" and \"phage-host interactions.\" Despite trends being aligned, critical details are missing."
        },
        {
            "query_idx": 526,
            "query": "Within the symbiotic ballet of microbial engagement, what strategic maneuverings are undertaken by receptor-binding proteins (RBPs) as vigilant molecular custodians, and how do they refine the tactical precision and discriminatory competence of phages in surmounting the defenses of antibiotic-resistant bacterial fortresses?",
            "retrieved_metrics": {
                "reference_idx": [
                    9
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Receptor-binding proteins (RBPs) enhance phage #specificity# and #efficiency# by evolving to adapt to bacterial surface variations, enabling phages to overcome antibiotic-resistant bacteria defenses.",
            "predicted_answer": "Receptor-binding proteins (RBPs) mediate phage adsorption to bacterial surfaces, enhancing specificity and efficiency. They evolve rapidly to adapt to bacterial surface changes, refining the phages' ability to overcome antibiotic-resistant bacterial defenses.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of RBPs enhancing specificity and efficiency, as well as evolving to adapt to bacterial surface changes. The meaning and key facts match the reference answer without any omissions or contradictions, aligning with the overall trend."
        },
        {
            "query_idx": 527,
            "query": "What profound structural elucidations did the work of Hu et al. (2013) contribute to the comprehension of the bacteriophage T7 DNA translocation infrastructure, specifically in its adeptness at transcending and subduing microbial defensive constructs during the genetic encroachment phase?",
            "retrieved_metrics": {
                "reference_idx": [
                    10
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Hu et al. (2013) elucidated the #architecture# of bacteriophage #T7# DNA-injection machinery, revealing how phages overcome bacterial defenses during genome injection.",
            "predicted_answer": "Hu et al. (2013) revealed the detailed architecture of the bacteriophage T7 DNA-injection machinery, providing insights into how it overcomes bacterial defenses during genome injection.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions the architecture of the DNA-injection machinery and describes its role overcoming bacterial defenses, aligning closely with the reference answer. However, it is missing the specific mention of \"T7,\" which is a key detail in the reference."
        },
        {
            "query_idx": 528,
            "query": "What differential impacts on the intricate dance of genetic interchange and antibiotic resilience can be observed between modulated phages—sculpted through bioengineering—and their primal counterparts, which emerge through natural evolutionary processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    12
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Engineered phages, designed via #synthetic biology#, selectively remove resistance genes, minimizing harmful gene transfer, whereas natural phages navigate an evolutionary arms race impacting #therapy effectiveness#.",
            "predicted_answer": "Engineered phages, designed through synthetic biology, selectively target and remove resistance genes, reducing the risk of harmful gene transfer. In contrast, naturally evolved phages may contribute to horizontal gene transfer and antibiotic resistance.",
            "score": 3,
            "explanation": "The predicted answer covers the key concept of \"synthetic biology\" and contrasts engineered and natural phages with respect to gene transfer and resistance. However, it omits the impact on \"therapy effectiveness,\" a key detail from the reference answer. Thus, completeness is slightly affected."
        },
        {
            "query_idx": 529,
            "query": "Amidst the complex interplay of phages orchestrating bacterial genetic exchanges, what mechanisms do these viral agents employ to traverse the molecular conduits enhancing the challenge of antibiotic resistance, and through which stratagems do tailored phages propose to counteract this dissemination risk?",
            "retrieved_metrics": {
                "reference_idx": [
                    15
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Phages enhance #antibiotic resistance# through horizontal gene transfer, while #engineered phages# counteract this by specifically targeting and mitigating resistance gene spread.",
            "predicted_answer": "Phages use receptor-binding proteins for bacterial infection, injecting genetic material that can spread antibiotic resistance. Engineered phages aim to counteract this by degrading biofilms and lysing cells, reducing the dissemination of resistance genes.",
            "score": 3,
            "explanation": "The predicted answer captures the #antibiotic resistance# associated with phages and describes #engineered phages# counteractions, like targeting bacteria and reducing resistance spread. However, it omits the specific mechanism of \"horizontal gene transfer,\" missing a key detail from the reference."
        },
        {
            "query_idx": 530,
            "query": "What underlying advantage does the finely tuned bacteriophage application confer in addressing the intricate challenge of methicillin-resistant Staphylococcus aureus (MRSA) management, particularly regarding its selective affinity for bacterial hosts and the preservation of ecological microbial equilibrium?",
            "retrieved_metrics": {
                "reference_idx": [
                    17
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The finely tuned bacteriophage application offers #targeted treatment# for MRSA, reducing secondary infections and preserving #microbial equilibrium# without affecting beneficial bacteria.",
            "predicted_answer": "The finely tuned bacteriophage application offers selective targeting of MRSA, preserving beneficial microbiota and reducing the risk of secondary infections. Phages self-amplify at infection sites, providing sustained treatment and mitigating resistance development.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by emphasizing selective targeting (targeted treatment) of MRSA and preserving beneficial microbiota (microbial equilibrium). It also adds the phage self-amplification point, which does not contradict the reference. All key facts are present."
        },
        {
            "query_idx": 531,
            "query": "What central repository or information fountainhead was utilized in the curation of the anthology summarizing exploratory clinical endeavours involving microbe-targeting viral elements?",
            "retrieved_metrics": {
                "reference_idx": [
                    20
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The central repository utilized is the #ClinicalTrials.gov# database from the National Library of Medicine.",
            "predicted_answer": "The ClinicalTrials.gov database from the National Library of Medicine was utilized as the central repository for curating the anthology of exploratory clinical endeavors involving microbe-targeting viral elements.",
            "score": 5,
            "explanation": "The 'Predicted Answer' mentions the \"ClinicalTrials.gov database from the National Library of Medicine,\" exactly matching the key fact emphasized in the 'Reference Answer' with no contradictions or omissions. Therefore, it fully covers the key facts given."
        },
        {
            "query_idx": 532,
            "query": "Within the complex interplay of microbial resistance strategies and therapeutic interventions, what catalytic influence does the conjoint stratagem of phage and antibiotic infusion exert on the reclaimed vulnerabilities of Acinetobacter baumannii strains to the ceftazidime agent, particularly those initially displaying fortitude against phage intrusion?",
            "retrieved_metrics": {
                "reference_idx": [
                    24
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #phage-antibiotic# combination therapy resensitizes #Acinetobacter baumannii# strains to ceftazidime, showing improved effectiveness over phage-only treatment in reducing bacterial burden.",
            "predicted_answer": "The conjoint stratagem of phage and antibiotic infusion can resensitize phage-resistant Acinetobacter baumannii to ceftazidime, significantly reducing bacterial burden and disrupting biofilms more effectively than either treatment alone.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference, covering key facts such as the #phage-antibiotic# combination resensitizing #Acinetobacter baumannii# to ceftazidime. It includes additional detail about disrupting biofilms, enhancing the completeness without contradictions. No key facts are missing."
        },
        {
            "query_idx": 533,
            "query": "In the orchestration of microbially mediated defenses, which enzymatic conductors within the biofilm symphony precipitate the liberation of viral sentinels embedded in the biocompatible protective fabric?",
            "retrieved_metrics": {
                "reference_idx": [
                    31
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The enzymatic conductors are #biofilm-associated enzymes# that trigger the release of phages from the biocompatible polymer matrix.",
            "predicted_answer": "Biofilm-associated enzymes trigger the release of bacteriophages from a biocompatible polymer matrix, acting as enzymatic conductors to liberate viral sentinels for targeted biofilm disruption.",
            "score": 5,
            "explanation": "The predicted answer contains all the key facts emphasized by the # symbols in the reference answer, such as \"biofilm-associated enzymes\" and the release from a \"biocompatible polymer matrix.\" The meaning and key concepts are consistent and correctly portrayed, with no significant omissions or errors."
        },
        {
            "query_idx": 534,
            "query": "What intricate interplay of diverse microbial methodologies is essential for orchestrating the ongoing dissolution of bacterial fortifications and maintaining equilibrium among microbial entities to thwart the rise of phage-resistant strains?",
            "retrieved_metrics": {
                "reference_idx": [
                    36
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate interplay involves using a cocktail of bacteriophages with #different physiological characteristics# to lyse bacteria continuously and prevent the rise of #phage-resistant strains#.",
            "predicted_answer": "The interplay of diverse bacteriophage methodologies, including the use of phage cocktails with different physiological characteristics and advanced delivery systems like hydrogels, is essential for sustained bacterial lysis and preventing the emergence of phage-resistant strains.",
            "score": 5,
            "explanation": "The predicted answer includes the use of phage cocktails with different physiological characteristics and preventing phage-resistant strains, aligning with the reference. However, it also adds advanced delivery systems like hydrogels, which isn't emphasized in the reference. Key facts are present, but with slight expansion."
        },
        {
            "query_idx": 535,
            "query": "How does the pre-neck appendage entity known as Dpo7 orchestrate the modulation within the complex matrix of host immunological defenses, specifically amid the stalwart presence of biofilm-related bacterial incursions?",
            "retrieved_metrics": {
                "reference_idx": [
                    39
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Dpo7 disrupts and inhibits biofilm formation of #staphylococcal species#, potentially aiding the #immune response# against biofilm-associated infections.",
            "predicted_answer": "Dpo7, a pre-neck appendage protein from phage vB_SepiS-phiIPLA7, disrupts and inhibits biofilm formation, potentially modulating the host's innate immune response by degrading biofilm structures, thus aiding in the clearance of biofilm-embedded bacteria.",
            "score": 3,
            "explanation": "The predicted answer mentions \"biofilm formation\" and the \"innate immune response,\" aligning with the reference's emphasis on \"immune response\" and biofilm inhibition. However, it omits the specific mention of \"staphylococcal species\" as found in the reference. This omission affects completeness but doesn't contradict the reference."
        },
        {
            "query_idx": 536,
            "query": "What architectural paradigm involving the utilization of dendritic mesoporous silica nanoparticles has been conceptualized as a strategic vector to augment phage efficacy in the microbial stronghold against Mycobacterium tuberculosis?",
            "retrieved_metrics": {
                "reference_idx": [
                    47
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Beitzinger et al. (2021) conceptualized utilizing #dendritic mesoporous silica nanoparticles# as a strategic #vector to augment phage efficacy# against Mycobacterium tuberculosis.",
            "predicted_answer": "The architectural paradigm involves using dendritic mesoporous silica nanoparticles to enhance phage delivery and activity against intracellular Mycobacterium tuberculosis, as suggested by Beitzinger et al. (2021).",
            "score": 5,
            "explanation": "The predicted answer covers both key facts from the reference answer: the use of dendritic mesoporous silica nanoparticles and their role as a vector to augment phage efficacy against Mycobacterium tuberculosis. The key points and trends are aligned without any significant omissions or errors."
        },
        {
            "query_idx": 537,
            "query": "In the strategic narrative of combating drug-resistant Chlamydia trachomatis, what are the specific enhancements and potential research pathways that the engineered pGFPΦ CPG1 phage offers over the archetype Φ CPG1 in terms of its groundbreaking utility and investigational opportunities in confronting antibiotic resistance and facilitating vaccine discoveries?",
            "retrieved_metrics": {
                "reference_idx": [
                    46
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #engineered pGFPΦ CPG1# phage enhances research on #CT drug resistance# and vaccine development, expanding investigational opportunities beyond the archetype Φ CPG1 in combating antibiotic-resistant Chlamydia trachomatis.",
            "predicted_answer": "The engineered pGFPΦ CPG1 phage enhances the archetype Φ CPG1 by providing a visual marker for tracking infection, enabling precise monitoring and facilitating research on drug resistance and vaccine development.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the reference, mentioning visual tracking and research facilitation. It addresses the engineered pGFPΦ CPG1 phage and its role in enhancing research on drug resistance and vaccines, aligning well with the reference answer, without contradicting it or omitting significant details."
        },
        {
            "query_idx": 538,
            "query": "What is the symphonic interaction between the molecular architects of bacteriophages and the innate immunological network that propels their function as biological conveyors in the context of self-adjuvanting effects?",
            "retrieved_metrics": {
                "reference_idx": [
                    50
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #capsid proteins# and genetic elements of bacteriophages interact with Toll-like receptors, priming the innate #immune response# by serving as pathogen-associated molecular patterns (PAMPs).",
            "predicted_answer": "The symphonic interaction involves phage components like capsid proteins and nucleic acids acting as PAMPs, which bind to TLRs on innate immune cells, priming the immune response and enhancing their function as biological conveyors.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"#capsid proteins#\" and the role of PAMPs and TLRs for priming the \"#immune response#,\" aligning with the # innate immune response# mentioned in the reference. Despite slight wording differences, the overall trend is consistent with no major omissions."
        },
        {
            "query_idx": 539,
            "query": "What catalytic interactions within cellular signaling cascades initiate the phosphorylation sequence of the IKK molecular consortium, thereby facilitating the translocation narrative of NFκB into the nuclear domain and orchestrating the cellular symphony of pro-inflammatory cytokines and interferons' emergence?",
            "retrieved_metrics": {
                "reference_idx": [
                    54
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "PAMPs binding to TLRs activate the #Myd88 pathway#, which phosphorylates the #IKK complex# (IKKα, IKKβ, NEMO), enabling NFκB nuclear translocation and pro-inflammatory cytokine, interferon expression.",
            "predicted_answer": "The binding of PAMPs to TLRs activates the MyD88 pathway, leading to phosphorylation of the IKK complex. This phosphorylation releases NFκB, enabling its translocation to the nucleus and subsequent expression of pro-inflammatory cytokines and interferons.",
            "score": 5,
            "explanation": "The predicted answer correctly mentions PAMPs binding to TLRs, the activation of the MyD88 pathway, and phosphorylation of the IKK complex, aligning with the reference. Although it omits specific components (IKKα, IKKβ, NEMO), it covers all key concepts without contradictions."
        },
        {
            "query_idx": 540,
            "query": "What nuanced mechanisms guide the symphony of immune modulation via phage-guided immunological navigators, resulting in the aligned activation of both CD4+ helper and CD8+ cytotoxic T cell agents?",
            "retrieved_metrics": {
                "reference_idx": [
                    59
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Phage-presented antigens crucially activate #CD4+# helper and #CD8+# cytotoxic T cells, promoting proliferation, differentiation, and subsequent immune responses via phage-based vaccines.",
            "predicted_answer": "Phage-presented antigens activate antigen-specific T cells, leading to the proliferation and differentiation of CD4+ helper and CD8+ cytotoxic T cells. CD4+ T cells aid B cells in antibody production, while CD8+ T cells eliminate infected cells, enhancing immune modulation.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer in discussing the activation of CD4+ helper and CD8+ cytotoxic T cells by phage-presented antigens. However, it omits the crucial role of phage-based vaccines, which is a key detail. Thus, the predicted answer is incomplete."
        },
        {
            "query_idx": 541,
            "query": "In what orchestrated symphony do bacteriophages partake, as deciphered by contemporary scholarship, to both conceal their presence and reveal their potential as strategic allies in the uncharted territories of oncological therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    69
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Bacteriophages engage in an orchestrated #immune-mediated attack# against tumors and aid in #tumor detection#, enhancing cancer therapy precision and efficacy.",
            "predicted_answer": "Contemporary scholarship indicates that bacteriophages partake in an orchestrated symphony by activating tumor-associated macrophages and using engineered phages for targeted detection and treatment, thereby concealing their presence and revealing their potential as strategic allies in oncological therapy.",
            "score": 3,
            "explanation": "The predicted answer includes \"aiding in tumor detection\" which aligns with the reference's \"#tumor detection#\". However, the predicted answer mentions \"activating tumor-associated macrophages\" instead of an \"#immune-mediated attack#\", overlooking a key detail on immune involvement. The trend is aligned, but one key fact is missing."
        },
        {
            "query_idx": 542,
            "query": "What strategies are employed by the enigmatic architectures of phage capsids that enable them to act as formidable sentinels, ensuring the unyielding resilience and safeguarded trajectory of medicinal compounds through the intricate passages of drug delivery systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    83
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Phage capsids provide a #protective environment# for payloads, shielding them from degradation and enzymes, ensuring effective therapeutic delivery and minimizing off-target effects.",
            "predicted_answer": "Phage capsids employ strategies such as providing a stable and protective environment that shields medicinal compounds from degradation and enzymatic activity, ensuring effective delivery to target sites. Encapsulation in liposomes further enhances stability and protection.",
            "score": 5,
            "explanation": "The Predicted Answer mentions a “stable and protective environment” and shields from “degradation and enzymatic activity”, aligning with the Reference Answer's “protective environment” and shielding payloads from “degradation and enzymes”. The mention of liposomes introduces related but non-contradictory detail. Overall, key facts are present."
        },
        {
            "query_idx": 543,
            "query": "Within the intricate dance of molecular architecture, what is the influence exerted by the phage display methodology upon the creation of bispecific fusion proteins designed to counteract MERS-CoV, as depicted in the exploration by Wang et al. (2019)?",
            "retrieved_metrics": {
                "reference_idx": [
                    89
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Phage display influences the creation of bispecific fusion proteins against MERS-CoV by facilitating the design of antibodies with #enhanced# properties like higher #affinity# and specificity, as shown by Wang et al. (2019).",
            "predicted_answer": "Phage display methodology, as used by Wang et al. (2019), facilitates the engineering of bispecific fusion proteins with enhanced properties, specifically targeting MERS-CoV, demonstrating its utility in creating effective therapeutic candidates.",
            "score": 3,
            "explanation": "The predicted answer captures the overarching impact of phage display in engineering bispecific fusion proteins for MERS-CoV. However, it omits specific details like \"enhanced properties\" being higher \"affinity\" and specificity, which are key facts highlighted. Thus, it aligns with the trend but lacks completeness."
        },
        {
            "query_idx": 544,
            "query": "What are the possible longitudinal consequences within the immune ecosystem from repetitive phage interactions that might influence the evolving therapeutic potency of phage-based interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    92
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Repetitive phage interactions may lead to the development of #neutralizing antibodies#, potentially reducing the #efficacy# of phage-based interventions over time.",
            "predicted_answer": "Repetitive phage interactions can lead to the development of neutralizing antibodies, potentially reducing the efficacy of phage-based interventions over time. This may influence the evolving therapeutic potency by diminishing the phages' ability to combat bacterial infections.",
            "score": 5,
            "explanation": "The predicted answer aligns closely with the reference answer, mentioning both the development of neutralizing antibodies and the reduction in efficacy of phage-based interventions. These are the key facts highlighted in the reference, with no significant omissions or errors."
        },
        {
            "query_idx": 545,
            "query": "What are the comparative proportions of nations residing across the spectrum of affluence that engage in the realms of holistic oncological care, projecting therapeutic completeness, versus those encumbered by economic limitations, navigating varied medical landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    107
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#90%# of high-income countries have comprehensive holistic oncological care, compared to #15%# of low-income countries.",
            "predicted_answer": "High-income countries, with 90% having comprehensive cancer treatment, widely offer holistic oncological care. In contrast, only 15% of low-income countries can provide such comprehensive treatment, often due to economic limitations.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key statistics of #90%# for high-income countries and #15%# for low-income countries, matching the reference in meaning and key facts. Both answers reflect the disparity in access to comprehensive oncological care due to economic differences."
        },
        {
            "query_idx": 546,
            "query": "In the context of elucidating transformative therapeutic avenues within the complex realm of cancer pharmacotherapy, what strategic functions do interconnected computational frameworks imbued with network topologies and machine learning dynamics employ in navigating the intricate challenges associated with the multifaceted molecular characteristics of oncological drugs?",
            "retrieved_metrics": {
                "reference_idx": [
                    108
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Interconnected computational frameworks using #network topologies# and #machine learning# address intricate challenges in cancer pharmacotherapy by exploring polypharmacological drug effects and multifaceted molecular characteristics.",
            "predicted_answer": "Interconnected computational frameworks use network topologies and machine learning to model complex protein-drug interactions, predict polypharmacological effects, and identify novel therapeutic targets in cancer, enhancing the discovery of multifaceted oncological drugs.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key facts emphasized with # symbols—namely, \"network topologies\" and \"machine learning.\" It also aligns with the overall trend of the reference by discussing polypharmacological effects and drug discovery in cancer pharmacotherapy. There are no significant omissions or errors."
        },
        {
            "query_idx": 547,
            "query": "What are the intricate pathways that machine learning systems might traverse to enhance the refinement of clinical attribute prognosis within precision oncology, considering the nuanced interplay of methodological challenges and the enigmatic utility of experimental preclinical paradigms as elaborated in the context?",
            "retrieved_metrics": {
                "reference_idx": [
                    109
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Machine learning enhances #clinical prognosis# in precision oncology by utilizing #population-scale data# and optimizing patient feature mixes, but preclinical models' efficacy remains uncertain.",
            "predicted_answer": "Machine learning systems in precision oncology use population-scale data and molecular annotations to refine clinical attribute prognosis. They define optimal patient feature mixes, including non-genetic tumor traits, and leverage preclinical models like patient-derived xenografts, though their efficacy for precision oncology is still uncertain.",
            "score": 3,
            "explanation": "The predicted answer captures the key concepts of utilizing population-scale data and refining clinical prognosis. It also mentions the uncertainty regarding the efficacy of preclinical models. However, it doesn't specify \"clinical prognosis\" directly, which impacts the completeness slightly."
        },
        {
            "query_idx": 548,
            "query": "What intrinsic element can be seen as the cornerstone of enlightenment, guiding artificial intelligence's prowess in decrypting the intricate tapestry of data generated within the realm of healthcare, thus unlocking pathways to enhanced human welfare?",
            "retrieved_metrics": {
                "reference_idx": [
                    114
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Integration of Big Data# is the cornerstone of AI's ability to decode healthcare data, unlocking pathways to enhanced #human welfare#.",
            "predicted_answer": "The cornerstone of enlightenment in AI for healthcare is machine learning, which enables the analysis of large, complex datasets to uncover valuable patterns and insights, enhancing patient outcomes and advancing medical practices.",
            "score": 3,
            "explanation": "The predicted answer focuses on \"machine learning,\" omitting the key fact of \"integration of Big Data\" from the reference answer. It correctly mentions enhanced patient outcomes and advancing medical practices, aligning with \"human welfare,\" but lacks completeness by missing one critical fact."
        },
        {
            "query_idx": 549,
            "query": "In the context of embracing the symbiosis of artificial intelligence with cancer recognition, what veiled complexities and ethical conundrums emerge at the intersection of technological infiltration and diagnostic imperatives?",
            "retrieved_metrics": {
                "reference_idx": [
                    122
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #ethical conundrums# include data privacy, algorithm interpretability, standardization, bias, and #equal access# to AI-driven diagnostic tools in cancer recognition.",
            "predicted_answer": "Integrating AI in cancer recognition brings complexities like data privacy, algorithm interpretability, and standardization. Ethical concerns include bias in algorithms and ensuring equitable access to these diagnostic tools.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts such as data privacy, algorithm interpretability, standardization, and bias, but it mentions equitable access instead of equal access. The overall trend is aligned with the reference answer as there are no contradictions and only slight wording differences."
        },
        {
            "query_idx": 550,
            "query": "In what manner do algorithmic entities engage in the intricate strategic process of elevating precision within the broader oncological domain, through the sophisticated molecular classification of tumorigenic structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    118
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Algorithmic entities enhance precision in #oncology# by employing molecular #classification# of tumors, using machine learning on proteomics, metabolomics, and genomes, enabling specialized and individualized treatment plans.",
            "predicted_answer": "Algorithmic entities elevate precision in oncology by using machine learning to classify tumors based on molecular data, enabling tailored treatments that target specific genetic compositions and improve patient outcomes.",
            "score": 1,
            "explanation": "The Predicted Answer covers the emphasis on \"oncology\" and \"classification\" but lacks specific details about \"proteomics, metabolomics, and genomes\" used in molecular classification. While aligned in trend, the absence of these details affects completeness concerning the full spectrum of data types used."
        },
        {
            "query_idx": 551,
            "query": "What roles do prognostic frameworks play as guiding lights in the orchestration of tailored interventions and vigilance schemes to address the nuanced needs of populations preconditioned to distinct health outcomes within the intricate dynamics of healthcare provision?",
            "retrieved_metrics": {
                "reference_idx": [
                    129
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Prognostic frameworks #identify# high-risk groups, guiding #tailored interventions# and vigilance schemes, thereby optimizing screening, interventions, and follow-up care for populations with distinct health outcomes.",
            "predicted_answer": "Prognostic frameworks guide tailored interventions and vigilance schemes by identifying high-risk subgroups through demographic, genetic, and environmental factors, enabling customized screening, prevention, and more intense monitoring for better health outcomes.",
            "score": 3,
            "explanation": "The predicted answer aligns well with the reference answer by covering key aspects: identifying high-risk groups and guiding tailored interventions to optimize health outcomes. However, the phrase \"more intense monitoring\" in the predicted answer implies rather than explicitly states \"follow-up care,\" leading to a minor omission."
        },
        {
            "query_idx": 552,
            "query": "How do cognitive augmentation technologies influence the dynamics of collaborative autonomy, empowering individuals to immerse themselves in the coalescent pathways of innovation and treatment within the oncological domain?",
            "retrieved_metrics": {
                "reference_idx": [
                    132
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cognitive augmentation technologies empower individuals by enhancing #patient engagement# and #shared decision-making#, enabling active participation in oncology innovation and treatment pathways.",
            "predicted_answer": "Cognitive augmentation technologies, like AI, enhance collaborative autonomy in oncology by providing personalized treatment information and supporting shared decision-making, thus empowering patients to actively participate in their care and innovation.",
            "score": 5,
            "explanation": "The predicted answer closely aligns with the reference by mentioning #shared decision-making# and empowering patients to participate actively, which corresponds to #patient engagement#. No contradictory information is present, thus maintaining the primary trend and key elements of the reference answer."
        },
        {
            "query_idx": 553,
            "query": "In the unfolding narrative of skill enlightenment and equitable access transmission, what pivotal influence do educational beacons wield in harmonizing the infusion of algorithmic paradigms into diverse therapeutic ecosystems?",
            "retrieved_metrics": {
                "reference_idx": [
                    134
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Educational #beacons# play a pivotal role in harmonizing algorithmic paradigms by providing #education# and training to ensure healthcare personnel effectively utilize AI technologies, enhancing equitable access.",
            "predicted_answer": "Educational programs are crucial for harmonizing the integration of AI into diverse therapeutic ecosystems by ensuring healthcare personnel have the necessary skills and fostering trust through evidence-based practices.",
            "score": 3,
            "explanation": "The Predicted Answer reflects the significance of educational programs in integrating AI into healthcare. It covers key themes such as the educational role and skill enhancement, aligning with the Reference Answer. However, it lacks the explicit mention of \"enhancing equitable access.\""
        },
        {
            "query_idx": 554,
            "query": "Through the prism of precision-focused therapeutic innovations and immune system harnessing strategies, what metamorphosis occurred within the chronological survival journey of lung cancer patients over the timeframe spanning 2014 to 2021, as perceived and communicated by the institution named the American Cancer Society?",
            "retrieved_metrics": {
                "reference_idx": [
                    135
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #three-year survival# rate for lung cancer patients increased from #21% to 31%# between 2014 and 2021, according to the American Cancer Society.",
            "predicted_answer": "From 2014 to 2021, the American Cancer Society reported a significant increase in the three-year survival rate for lung cancer patients, rising from 21% to nearly 31%, attributed to advancements in targeted therapies and immunotherapeutics.",
            "score": 5,
            "explanation": "The predicted answer from the LLM includes all the key facts emphasized in the reference answer: the increase in the three-year survival rate from 21% to nearly 31% between 2014 and 2021. It also aligns with the trend described, with no significant details missing."
        },
        {
            "query_idx": 555,
            "query": "Within the vast tapestry of computational explorations that seek to unveil drug-target interactions, in what manner does the end-to-end learning mechanism inherent in the EEG-DTI paradigm cultivate an enriched canvas of predictive refinement, especially when devoid of explicit spatial configurations, thus offering a nuanced augmentation over traditional methods absent of neural complexities?",
            "retrieved_metrics": {
                "reference_idx": [
                    142
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #EEG-DTI# paradigm uses #graph convolutional networks# to learn feature representations and predict DTIs effectively without needing 3D structures, enhancing prediction over traditional methods.",
            "predicted_answer": "The EEG-DTI paradigm uses end-to-end learning with graph convolutional networks to learn low-dimensional feature representations of drugs and targets, enabling accurate DTI predictions without explicit 3D structures, thus enhancing predictive refinement over traditional methods.",
            "score": 5,
            "explanation": "The Predicted Answer incorporates all the key facts emphasized in the Reference Answer: the use of the EEG-DTI paradigm, graph convolutional networks, and the advantage of not requiring 3D structures for DTI prediction. The trend and intent are consistent with the Reference Answer."
        },
        {
            "query_idx": 556,
            "query": "What was the fundamental aspiration of Shao et al. when contemplating the transformation of drug-target interaction forecasting into a paradigm of inferential connectivity assessment?",
            "retrieved_metrics": {
                "reference_idx": [
                    143
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Shao et al. aimed to transform DTI prediction into an #inferential connectivity assessment paradigm# using a #heterogeneous graph with attention mechanism# to improve prediction performance.",
            "predicted_answer": "Shao et al. aimed to transform drug-target interaction forecasting into a link prediction problem, proposing an end-to-end model (DTI-HETA) that improved prediction performance without using 3D structures.",
            "score": 3,
            "explanation": "The Predicted Answer captures the transformation into a link prediction problem, aligning with the inferential connectivity assessment in the Reference. However, it overlooks the emphasis on a \"heterogeneous graph with attention mechanism,\" which is crucial for full context."
        },
        {
            "query_idx": 557,
            "query": "What overarching objective does the AI system known as DrugnomeAI aim to achieve within the domain of druggable target identification, and through what probabilistic scaffold of cognition and learning is its existence architected?",
            "retrieved_metrics": {
                "reference_idx": [
                    144
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "DrugnomeAI's objective is to predict the #druggability# of drug targets using a #stochastic semi-supervised# machine learning framework.",
            "predicted_answer": "DrugnomeAI aims to predict the druggability of drug targets in the human exome, particularly for oncology diseases, using a stochastic semi-supervised machine learning framework.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer. It covers the key facts: the #druggability# of drug targets and the use of a #stochastic semi-supervised# machine learning framework. Although it adds context about the human exome and oncology, there are no significant omissions or errors."
        },
        {
            "query_idx": 558,
            "query": "How does the integrative molecular fingerprinting stratagem formulated by Hutter synthesize various molecular structures into a cohesive data enhancement mechanism, contrasting with traditional approaches that employ an isolated molecular blueprint?",
            "retrieved_metrics": {
                "reference_idx": [
                    146
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Hutter's integrative molecular fingerprinting synthesizes structures into a cohesive mechanism by #improving utilization# of data, unlike traditional approaches that use isolated molecular blueprints.",
            "predicted_answer": "Hutter's integrative molecular fingerprinting stratagem synthesizes various molecular structures by incorporating all available structural data, enhancing data utilization and cohesion. This contrasts with traditional methods that use isolated molecular blueprints, leading to potential data waste.",
            "score": 5,
            "explanation": "The predicted answer reflects the key fact of \"#improving utilization#\" of molecular data, aligning with the reference answer. It captures the synthesis of structures into a cohesive mechanism and correctly contrasts with the isolated blueprint approach. No key details are missing, and the trend is consistent."
        },
        {
            "query_idx": 559,
            "query": "In the intricate tapestry of chemical exploration, what conceptual divergences delineate the AI-driven molecular genesis from the established pathway of employing extensive compound catalogues, particularly with respect to their unified aim yet distinctly varied methodologies in traversing the chemical cosmos?",
            "retrieved_metrics": {
                "reference_idx": [
                    149
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "AI-driven molecular genesis, through #de novo drug design#, generates molecules with AI, contrasting with traditional #high-throughput screening#, which screens existing compound libraries to identify suitable molecules.",
            "predicted_answer": "AI-driven molecular genesis creates and optimizes new molecules using artificial intelligence, whereas traditional methods like high-throughput screening and virtual screening evaluate existing compounds in large libraries. Both aim to find molecules with specific properties but differ in their methodologies.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer as it mentions AI-driven molecular creation and contrasts it with traditional methods of evaluating existing compounds. It captures both key concepts: AI-driven design and traditional screening methods. No significant omissions or errors are noted."
        },
        {
            "query_idx": 560,
            "query": "What are the trio of synthetic transmutation strategies synergistically intertwined with the RNN fabrication framework devised by Moret et al., which enable the forging of molecular constructs encapsulating desired attributes?",
            "retrieved_metrics": {
                "reference_idx": [
                    150
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The synthetic transmutation strategies synergistically intertwined with the RNN fabrication framework by Moret et al. are #data augmentation#, #temperature sampling#, and transfer learning.",
            "predicted_answer": "The trio of synthetic transmutation strategies integrated with the RNN framework by Moret et al. are data augmentation, temperature sampling, and transfer learning. These methods enable the creation of molecules with desired properties using limited data.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts of #data augmentation# and #temperature sampling# and mentions transfer learning, which is not emphasized in the reference. There are no contradictions, but one key fact (transfer learning) is not emphasized as critical in the reference."
        },
        {
            "query_idx": 561,
            "query": "What metaphorical approach does the Mol-Cycle GAN method undertake using the alchemist's philosophy embedded in generative models to traverse the complex landscape of molecular harmonic convergence, especially regarding challenging synthesis routes and structural similitude in novel drug creation?",
            "retrieved_metrics": {
                "reference_idx": [
                    151
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Mol-Cycle GAN# method metaphorically traverses the #complex landscape# of molecular synthesis by optimizing challenging synthesis routes and generating structurally similar molecules in novel drug creation.",
            "predicted_answer": "Mol-Cycle GAN uses the metaphor of an alchemist's philosophy, transforming and optimizing molecular structures through a cycle of generation and refinement, akin to the alchemical process, to navigate complex synthesis routes and achieve structural similitude in novel drug creation.",
            "score": 5,
            "explanation": "The predicted answer includes key elements such as \"Mol-Cycle GAN,\" \"complex synthesis routes,\" and \"structural similitude,\" aligning with the reference's emphasis on \"Mol-Cycle GAN,\" \"complex landscape,\" and \"structurally similar molecules.\" The metaphorical approach and purpose match well with the reference."
        },
        {
            "query_idx": 562,
            "query": "What navigational schematics do cognitive predictive frameworks employ within the artificial intelligence domain to maneuver the reallocation of pharmacological constructs, particularly through a dual-lens approach, contemplating the convergence of target-centric and disease-centric paradigms of interaction?",
            "retrieved_metrics": {
                "reference_idx": [
                    154
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cognitive predictive frameworks in AI utilize #target-centric# and #disease-centric# paradigms to navigate the reallocation of pharmacological constructs.",
            "predicted_answer": "Cognitive predictive frameworks in AI use machine learning algorithms and computational modeling to navigate the reallocation of pharmacological constructs. They employ a dual-lens approach, integrating both target-centric and disease-centric paradigms for drug repositioning.",
            "score": 5,
            "explanation": "The predicted answer includes both the #target-centric# and #disease-centric# paradigms crucial to the reference answer and aligns with the overall trend of integrating both paradigms for drug repositioning. All key facts emphasized with # in the reference are present in the predicted answer."
        },
        {
            "query_idx": 563,
            "query": "What underlying qualities embodied in the strategic maneuvering of pharmaceutical repurposing pathways suggest this route might transcend the uncertainties and prolonged undertakings typical of the exploratory journey involved in the genesis of novel oncologic molecular innovations?",
            "retrieved_metrics": {
                "reference_idx": [
                    153
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Repurposing drugs is #faster#, #safer#, and less expensive than developing new cancer drugs, suggesting it can overcome uncertainties and lengthy timelines.",
            "predicted_answer": "Pharmaceutical repurposing, by leveraging existing drugs, can be faster, safer, and more cost-effective. It reduces uncertainties and accelerates the development timeline compared to novel molecular innovations, making it a promising pathway in oncology.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference answer: pharmaceutical repurposing is suggested to be faster, safer, and less expensive. The trend and key points about reducing uncertainties and accelerating timelines in oncology are well captured, with no significant omissions or errors."
        },
        {
            "query_idx": 564,
            "query": "What pioneering orchestration does ReLeaSE utilize in the sculpting and crafting of therapeutic compounds with oncological potential, leveraging the convergence of computational paradigms and decision sciences?",
            "retrieved_metrics": {
                "reference_idx": [
                    152
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "ReLeaSE orchestrates compound design by integrating #deep learning# and #reinforcement learning# in generative and predictive neural networks to create molecules with specified oncological properties.",
            "predicted_answer": "ReLeaSE utilizes deep reinforcement learning, combining deep learning for molecular generation and reinforcement learning for optimization, to design novel therapeutic compounds with oncological potential.",
            "score": 5,
            "explanation": "The predicted answer mentions the use of deep reinforcement learning, combining deep learning and reinforcement learning, which aligns with the key aspects of the reference answer that highlights integrating deep learning and reinforcement learning. Both answers focus on molecular generation with oncological potential. No key facts are missing."
        },
        {
            "query_idx": 565,
            "query": "Within the theoretical constructs Precily and DRUML, which sophisticated methodologies or esoteric frameworks were harnessed to navigate the predictive landscape of drug sensitivity and the hierarchical assessment of anti-neoplastic drug effectiveness, correspondingly?",
            "retrieved_metrics": {
                "reference_idx": [
                    157
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Precily uses #gene expression# and drug structural properties. DRUML uses #omics data# for ranking anti-cancer drugs by efficacy.",
            "predicted_answer": "Precily uses a deep neural network combining drug structural properties and gene expression pathway specificity. DRUML ranks over 400 anti-cancer drugs using omics data for efficacy.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the reference's key facts: Precily using \"gene expression\" and \"drug structural properties\" and DRUML using \"omics data\" to rank anti-cancer drugs. The terminology aligns with the reference regarding the importance of gene expression and omics data, ensuring consistency without omissions."
        },
        {
            "query_idx": 566,
            "query": "What sophisticated paradigm did Zhao et al. cultivate to navigate the complexities of pharmacological adverse effect manifestation frequencies, setting it apart from traditional methodologies fixated on mere occurrence prediction?",
            "retrieved_metrics": {
                "reference_idx": [
                    158
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Zhao et al. developed a novel #graphical attention model# to predict drug side effect #frequency# using multi-view data, distinguishing it from traditional occurrence-focused methodologies.",
            "predicted_answer": "Zhao et al. developed a novel graphical attention model that predicts drug side effect frequency using multi-view data, distinguishing it from traditional methods that focus only on predicting the occurrence of adverse reactions.",
            "score": 5,
            "explanation": "The predicted answer includes all key elements from the reference: the use of a graphical attention model and the focus on predicting drug side effect frequency with multi-view data. It aligns with the reference, with no omissions or contradictions."
        },
        {
            "query_idx": 567,
            "query": "Amidst the complex symphony of cellular metabolic harmonies orchestrated in the expanse of lung adenocarcinomas, which specific orchestral sections and interwoven movements are subtly influenced by Ouabain's therapeutic presence, as mapped out by the algorithmic insights of GPSnet?",
            "retrieved_metrics": {
                "reference_idx": [
                    155
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ouabain specifically influences #HIF1 α /LEO1-mediated# cellular metabolic pathways in #lung adenocarcinomas#, as identified by GPSnet.",
            "predicted_answer": "Ouabain influences the HIF1α/LEO1-mediated cellular metabolic pathways in lung adenocarcinomas, as identified by GPSnet, showing potential anti-tumor effects.",
            "score": 5,
            "explanation": "The predicted answer covers all the emphasized key facts: the HIF1α/LEO1-mediated pathways, the influence of Ouabain, and its context within lung adenocarcinomas. The GPSnet identification is also mentioned, aligning with the reference, with no significant omissions or contradictions."
        },
        {
            "query_idx": 568,
            "query": "How did Recursion's AI-powered synthesis unveil REC-2282 as an auspicious prospect for mitigating ailments entwined with NF2 gene irregularities, within the intricate theater of anti-oncogenic compound development?",
            "retrieved_metrics": {
                "reference_idx": [
                    160
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Recursion's AI-driven #Recursion OS# identified #REC-2282# as a potential treatment for NF2 gene mutation-related diseases.",
            "predicted_answer": "Recursion's AI-driven platform, Recursion OS, identified REC-2282 as a potential candidate for treating NF2 gene mutation-related diseases by analyzing vast datasets and predicting its efficacy.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts: \"Recursion's AI-driven platform,\" \"Recursion OS,\" and \"REC-2282\" as a potential candidate for treating NF2 gene mutation-related diseases. The overall trend and meaning align with the Reference Answer, with no significant omissions or contradictions."
        },
        {
            "query_idx": 569,
            "query": "What are the triumvirate of structural underpinnings involving molecular recognition agents, lethality conveyors, and molecular bridges, which collectively bolster ADCs in the precise pursuit of tumor cell engagement?",
            "retrieved_metrics": {
                "reference_idx": [
                    167
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The triumvirate involves #monoclonal antibodies# for targeting, a #cytotoxic drug payload# for lethality, and a cleavable or non-cleavable linker as a molecular bridge in ADCs.",
            "predicted_answer": "The triumvirate of structural underpinnings in ADCs includes: (1) a monoclonal antibody for selective binding, (2) a cytotoxic drug payload, and (3) a cleavable or non-cleavable linker, which together enable precise tumor cell targeting.",
            "score": 5,
            "explanation": "The Predicted Answer accurately identifies all key components emphasized in the Reference Answer: #monoclonal antibodies#, #cytotoxic drug payload#, and the linker. The descriptions given in the Predicted Answer are consistent with the Reference Answer's meaning and lack omissions or contradictions."
        },
        {
            "query_idx": 570,
            "query": "In the realm of ADC-influenced oncological pursuits, how does the nuanced affinity of lysine-based conjugation intricately reshape the bystander whisper, guiding the therapeutic narrative within targeted cellular domains?",
            "retrieved_metrics": {
                "reference_idx": [
                    170
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The nuanced affinity of #lysine-based conjugation# reshapes the bystander whisper by promoting drug retention within targeted cells, influencing the #therapeutic narrative# in ADC applications.",
            "predicted_answer": "Lysine-based conjugation in ADCs can reduce the bystander effect by promoting drug retention within targeted tumor cells, thus enhancing specificity and minimizing toxicity to non-targeted cells.",
            "score": 3,
            "explanation": "The predicted answer captures the key fact of lysine-based conjugation promoting drug retention within targeted cells, aligning with the therapeutic narrative in ADC applications. However, the reference's implication of reshaping the 'bystander whisper' is not fully articulated."
        },
        {
            "query_idx": 571,
            "query": "What unique confluence of physiological harmonies and molecular predispositions inherent in the IgG1 subclass formulates a preeminent design matrix, elevating it above its sibling subclasses in the sophisticated orchestration of contemporary ADCs?",
            "retrieved_metrics": {
                "reference_idx": [
                    171
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #IgG1# subclass combines optimal #solubility#, long serum half-life, and high binding affinity to Fc γ receptors, making it superior for contemporary ADC development.",
            "predicted_answer": "IgG1's optimal solubility, long serum half-life, and strong binding affinity to Fc γ receptors make it superior for ADC design, enhancing its efficacy and therapeutic potential.",
            "score": 5,
            "explanation": "The key facts of \"IgG1,\" \"optimal solubility,\" \"long serum half-life,\" and \"high binding affinity to Fc γ receptors\" are all present in the predicted answer. The overall trend and meaning align well with the reference answer without significant omissions or contradictory information."
        },
        {
            "query_idx": 572,
            "query": "What is the environmental catalyst threshold required to initiate the liberation of molecular contents within enzymatic vaults via a hydrazone interface?",
            "retrieved_metrics": {
                "reference_idx": [
                    172
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #pH threshold# required to initiate liberation is #pH 4.8# using a hydrazone interface.",
            "predicted_answer": "The environmental catalyst threshold for initiating the release of molecular contents via a hydrazone interface is typically a pH of 4.8, which triggers hydrolysis and payload release in lysosomes.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts emphasized in the reference answer: the threshold being a #pH# level of #pH 4.8#. The additional detail about lysosomes does not contradict the reference. The meaning and key facts are consistent throughout."
        },
        {
            "query_idx": 573,
            "query": "Within the constellation of HDAC inhibitors, by what confluence of patient attunement and potential adverse manifestations does REC-2282 distinguish itself, particularly considering its prolonged orchestration and cardiological implications?",
            "retrieved_metrics": {
                "reference_idx": [
                    161
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "REC-2282 distinguishes itself by being #well tolerated# even when used over years, with potential #reduced cardiotoxicity# compared to other HDAC inhibitors.",
            "predicted_answer": "REC-2282 distinguishes itself with prolonged use and reduced cardiotoxicity, making it well-tolerated for patients with NF2-mutated meningiomas.",
            "score": 5,
            "explanation": "The predicted answer reflects the key facts emphasized in the reference: REC-2282's prolonged use and reduced cardiotoxicity, which contributes to it being well-tolerated. There are no significant omissions or errors, and the trend is fully aligned with the reference."
        },
        {
            "query_idx": 574,
            "query": "In what distinct orchestration do immune-stimulating antibody conjugates engage the immune response choreography, diverging from the harmonic execution observed in the checkpoint blockade approach?",
            "retrieved_metrics": {
                "reference_idx": [
                    176
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Immune-stimulating antibody conjugates (#ISACs#) activate myeloid #antigen-presenting cells# and stimulate the immune system differently from checkpoint blockade, focusing on tumor anti-immunity.",
            "predicted_answer": "ISACs engage the immune response by activating myeloid antigen-presenting cells, promoting tumor regression and antiimmunity, which differs from the checkpoint blockade approach.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: ISACs, activation of myeloid antigen-presenting cells, and a focus on tumor anti-immunity, reflecting their distinction from checkpoint blockade. There are no contradictions or significant omissions, ensuring alignment with the reference answer."
        },
        {
            "query_idx": 575,
            "query": "How does the engagement of TLR8 by the intricate molecular entity SBT6050 choreograph the intricate interplay of lymphocytic activation and the emission of cytokine signals within the tapestry of the innate immune system?",
            "retrieved_metrics": {
                "reference_idx": [
                    177
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "SBT6050 engages #TLR8#, inducing #lymphocytic activation# and cytokine secretion via NFκ B pathway activation within the innate immune system.",
            "predicted_answer": "Engagement of TLR8 by SBT6050 triggers a signaling cascade, activating NFκB and leading to cytokine and chemokine secretion. This process also activates lymphocytes, enhancing the innate immune response.",
            "score": 5,
            "explanation": "The predicted answer accurately describes the engagement of TLR8 by SBT6050 and the activation of the NFκB pathway, leading to cytokine secretion and lymphocytic activation. While the wording is slightly different, the meaning and key facts emphasized in the reference are fully captured without omissions."
        },
        {
            "query_idx": 576,
            "query": "Within the intricate signaling cascades of oncogenic receptor families, what initiates the synergistic formation of HER receptor dyads in the specialized context of lung cancer pathology?",
            "retrieved_metrics": {
                "reference_idx": [
                    178
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ligand binding to #HER1#, #HER3#, or HER4 initiates the synergistic formation of HER receptor dyads in lung cancer pathology.",
            "predicted_answer": "Ligand binding to HER1, HER3, or HER4 initiates the dimerization and synergistic formation of HER receptor dyads, including HER2, which is overexpressed in lung cancer.",
            "score": 5,
            "explanation": "The predicted answer covers ligand binding to HER1 and HER3 as mentioned in the reference. It also adds HER4 and explains the resulting dimerization, aligning with the overall trend. The HER2 detail, while extra, does not contradict but adds context. Key facts present, minor additional information."
        },
        {
            "query_idx": 577,
            "query": "What is the numerical portion of the participant population that exhibited HER2 IHC as graded 2+, discerned within the sphere of their commencement into the evaluative phase?",
            "retrieved_metrics": {
                "reference_idx": [
                    183
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#79.6%# of the participants exhibited HER2 IHC graded #2+ at commencement.",
            "predicted_answer": "79.6% of the participants exhibited HER2 IHC as graded 2+ at the start of the evaluative phase.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts highlighted in the reference answer: namely, \"79.6%\" and \"HER2 IHC graded 2+ at commencement.\" The details presented match those emphasized in the reference, and there are no significant omissions or contradictions."
        },
        {
            "query_idx": 578,
            "query": "What contrasting manifestations of resonance amplification were encountered among individuals presenting disparate patterns of signal strength in their biological marker overexpression scales, particularly when comparing the groups delineated as IHC 3+ versus IHC 2+?",
            "retrieved_metrics": {
                "reference_idx": [
                    184
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Patients with #IHC 3+# had a 20.0% ORR and 6.0-month median DOR. IHC 2+ had a 25.6% ORR; DOR not specified.",
            "predicted_answer": "In the study, IHC 3+ and IHC 2+ groups showed different response rates, with IHC 3+ at 20.0% and IHC 2+ at 25.6%. The IHC 3+ group had a median DOR of 6.0 months and a DCR of 69.4%, indicating varying resonance amplification effects.",
            "score": 3,
            "explanation": "The predicted answer includes the ORR for both IHC 3+ (20.0%) and IHC 2+ (25.6%), and the median DOR for IHC 3+ (6.0 months) but incorrectly mentions DCR instead of ORR. The key facts are present, though not completely aligned due to the mention of DCR."
        },
        {
            "query_idx": 579,
            "query": "What role does the auxiliary biomarker, embodied by nuanced variations in HER3 levels, play in the labyrinthine context of resistance phenomena, when tasked with the potentially nebulous endeavor of distinguishing categorical treatment outcomes as one might isolate a signal from overwhelming static?",
            "retrieved_metrics": {
                "reference_idx": [
                    190
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #auxiliary biomarker#, with nuanced HER3 variations, does not clearly distinguish treatment #outcomes# in the context of EGFR TKI resistance phenomena.",
            "predicted_answer": "HER3 levels do not clearly distinguish between responders and non-responders in the context of resistance to EGFR TKI treatments, suggesting limited utility as an auxiliary biomarker for treatment outcomes.",
            "score": 5,
            "explanation": "The predicted answer captures both key facets: HER3's role as an auxiliary biomarker and its limited ability to distinguish treatment outcomes in the context of EGFR TKI resistance, as emphasized in the reference. The overall meaning and trend are consistent, with no significant omissions."
        },
        {
            "query_idx": 580,
            "query": "In the realm of pulmonary neoplastic transformations, how prominently do adenocarcinoma and squamous cell carcinoma variants express Trop2 as a pivotal molecular signature, and what implications arise from this altered cellular narrative in terms of survival dynamics and cellular resistance?",
            "retrieved_metrics": {
                "reference_idx": [
                    195
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Adenocarcinoma expresses #Trop2# in 64% and squamous cell carcinoma in 75%, linked to #reduced survival# and potential chemotherapy resistance.",
            "predicted_answer": "In lung cancer, Trop2 is overexpressed in up to 64% of adenocarcinoma and 75% of squamous cell carcinoma, linked to reduced survival and potential resistance to chemotherapy and CD8+ T-cell apoptosis.",
            "score": 5,
            "explanation": "The predicted answer contains all key facts emphasized in the reference answer: it mentions the expression of Trop2 in 64% of adenocarcinoma and 75% in squamous cell carcinoma, along with its links to reduced survival and resistance to treatment, aligning closely with the provided trends."
        },
        {
            "query_idx": 581,
            "query": "What constitutes the molecular concordance measure reflective of the conjugated balance within the pharmaceutical constellation of sacituzumab govitecan (SG)?",
            "retrieved_metrics": {
                "reference_idx": [
                    197
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #molecular concordance measure# of sacituzumab govitecan is reflected in its #high DAR ratio# of 7.6, indicating its efficient conjugated balance.",
            "predicted_answer": "The molecular concordance measure in sacituzumab govitecan (SG) reflects the balance between the humanized anti-Trop2 monoclonal antibody and the topoisomerase I inhibitor SN-38, linked via a hydrolysable cleavable linker.",
            "score": 1,
            "explanation": "The predicted answer mentions the balance between the antibody and inhibitor in sacituzumab govitecan but misses the specific key fact of the \"high DAR ratio of 7.6,\" which is crucial in the reference answer. This omission affects the answer's completeness regarding the molecular concordance measure."
        },
        {
            "query_idx": 582,
            "query": "In the pursuit of pioneering therapeutic avenues within the domain of NSCLC, what discreet molecular hallmark, distinguished by its amplified presentation amidst advanced disease phases, is under active investigation as a prospective axis for targeted treatment approaches?",
            "retrieved_metrics": {
                "reference_idx": [
                    203
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The discreet molecular hallmark under active investigation for NSCLC targeted treatment is #tissue factor#, noted for its #amplified presentation# in advanced disease phases.",
            "predicted_answer": "Tissue factor (TF) is a molecular hallmark under active investigation for targeted treatment in advanced NSCLC, noted for its amplified expression in later disease stages.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions \"tissue factor\" and its \"amplified expression in later disease stages,\" both key facts emphasized in the reference answer. The meaning and key details are consistent and fully covered, with no significant omissions or inconsistencies."
        },
        {
            "query_idx": 583,
            "query": "What enigmatic interactions and undisclosed pathways within the cellular environment are responsible for the distinctive respiratory perturbations seen with trastuzumab-linked constructs such as deruxtecan and duocarmycin, while the comparable T-DM1 exhibits significantly fewer such perturbations?",
            "retrieved_metrics": {
                "reference_idx": [
                    204
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Trastuzumab-linked constructs, #deruxtecan# and #duocarmycin#, cause pulmonary toxicities through unknown mechanisms, differing from T-DM1, which shows fewer respiratory perturbations.",
            "predicted_answer": "Trastuzumab-linked constructs like deruxtecan and duocarmycin cause pulmonary toxicities through unknown mechanisms, while T-DM1 shows fewer such effects. The specific interactions and pathways remain undetermined.",
            "score": 5,
            "explanation": "Both answers recognize #deruxtecan# and #duocarmycin# as causing pulmonary toxicities through unknown mechanisms and note that T-DM1 exhibits fewer such effects. The predicted answer aligns well with the reference in key facts and meaning, with no significant omissions or errors."
        },
        {
            "query_idx": 584,
            "query": "In what manner might bispecific antibody constructs manifest their inherent potential to refine the precision and enhance the multi-layered biological synergy of antibody-drug conjugates, particularly in their nuanced engagement with tumor-specific antigens?",
            "retrieved_metrics": {
                "reference_idx": [
                    208
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Bispecific antibody constructs can enhance #precision# and #synergy# by improving receptor aggregation and accelerating target internalization when engaging with tumor-specific antigens in ADCs.",
            "predicted_answer": "Bispecific antibody constructs can enhance the precision and biological synergy of ADCs by targeting different sites on the same tumor antigen, improving receptor aggregation, and accelerating target internalization, thus increasing tumor specificity.",
            "score": 5,
            "explanation": "The predicted answer fully covers key facts of enhancing \"precision\" and \"synergy\" through improving receptor aggregation and accelerating target internalization when engaging with tumor-specific antigens, as stated in the reference. The predicted answer adds detail without contradiction or omission."
        },
        {
            "query_idx": 585,
            "query": "Amidst the evolving landscape of clinical ADC evaluations, what conceptualized strategic synthesis and collaborative frameworks are envisaged to amplify the potency of these therapeutics in overcoming the elusive resistance dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    207
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rationale combination strategies and collaborative frameworks focusing on #predictive biomarkers# and #assays# are envisaged to enhance ADC efficacy against resistance dynamics.",
            "predicted_answer": "Strategic synthesis and collaborative frameworks include prescreening patients for target expression, developing validated assays and cutoffs, and employing rationale combination strategies to enhance ADC activity and overcome resistance.",
            "score": 3,
            "explanation": "The Predicted Answer includes key concepts such as combination strategies and the development of assays. However, it misses the specific mention of \"predictive biomarkers,\" which is emphasized in the Reference Answer as a critical element. Overall, the answer is aligned, but one key fact is missing."
        },
        {
            "query_idx": 586,
            "query": "What is the process through which the ensemble of catalytic intrinsics, led by pseudomonas exotoxin A, orchestrates the cessation of cellular functions through its engagement with elongation factor-2, within the conceptual arena of LMB-100’s apoptotic initiative?",
            "retrieved_metrics": {
                "reference_idx": [
                    211
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "LMB-100, with #pseudomonas exotoxin A#, induces apoptosis by #inhibiting elongation factor-2#, ceasing cellular functions through its catalytic mechanism.",
            "predicted_answer": "LMB-100 uses pseudomonas exotoxin A to induce apoptosis by inhibiting elongation factor-2, leading to the cessation of cellular functions.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of the reference answer, such as the use of pseudomonas exotoxin A, inhibition of elongation factor-2, and induction of apoptosis. It aligns with the overall trend and does not miss any crucial details emphasized in the reference."
        },
        {
            "query_idx": 587,
            "query": "What enduring dilemmas in the oncological landscape perpetuate the demand for groundbreaking therapeutic innovations, notwithstanding significant advancements in cancer treatment methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    213
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The persistence of #drug resistance# and #toxicity# in cancer treatments perpetuates the demand for groundbreaking therapeutic innovations despite significant advancements.",
            "predicted_answer": "Drug resistance, toxicity, and ineffectiveness, along with the tendency of cancer to spread, continue to drive the need for innovative oncological treatments, despite advancements in cancer therapies.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts emphasized in the reference answer: \"drug resistance\" and \"toxicity.\" It adds additional context with \"ineffectiveness\" and the spread of cancer, but these do not contradict or omit the key facts. The overall trend aligns with the reference."
        },
        {
            "query_idx": 588,
            "query": "Considering the advances in understanding molecular conformation via sophisticated structural elucidation techniques over recent years, what are the macromolecular engagement loci within DNA that frequently serve as the nexus of covalent interaction for anticancer compounds?",
            "retrieved_metrics": {
                "reference_idx": [
                    216
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #DNA atomic sites# often targeted for covalent interaction by anticancer compounds are those identified using #high-resolution techniques# like X-ray diffraction and nuclear magnetic resonance.",
            "predicted_answer": "Particular DNA atomic sites, often in the grooves or between base pairs, serve as frequent targets for covalent interactions with anticancer compounds, acting as macromolecular engagement loci.",
            "score": 3,
            "explanation": "The predicted answer identifies \"particular DNA atomic sites\" as the loci for interaction, matching the key detail of \"#DNA atomic sites#\" from the reference. However, it lacks mention of the \"#high-resolution techniques#\" such as X-ray or NMR, missing a key fact. Thus, completeness is affected."
        },
        {
            "query_idx": 589,
            "query": "What are the prominent atomic loci within the DNA macromolecule that consistently partake in covalent engagements with therapeutic entities aimed at oncological intervention?",
            "retrieved_metrics": {
                "reference_idx": [
                    218
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #prominent atomic loci# in DNA that frequently engage in #covalent actions# with anticancer drugs are specific targeted sites on the DNA macromolecule.",
            "predicted_answer": "Prominent atomic loci within DNA that engage covalently with anticancer drugs include nitrogen atoms in purine and pyrimidine bases, and phosphate groups. These interactions are critical for the therapeutic effect of many oncological treatments.",
            "score": 3,
            "explanation": "The predicted answer mentions \"prominent atomic loci\" and \"covalent engagements\" with anticancer drugs, aligning with the reference answer’s emphasis. However, it introduces extraneous details about nitrogen atoms and phosphate groups not highlighted in the reference answer, lacking specificity in the mentioned \"targeted sites.\""
        },
        {
            "query_idx": 590,
            "query": "What complex interplays of molecular tapestry are illuminated when the nuanced sulfonamide motifs supplant the traditional carboxylic configurations, considering their comparable aqueous-bound intrinsic structures and the saga of crossing cellular fortresses?",
            "retrieved_metrics": {
                "reference_idx": [
                    217
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #sulfonamide motif# mirrors the carboxylic group's hydrogen bonding network, reducing passive diffusion issues and offering diverse biological activities like #anti-bacterial# and anti-cancer.",
            "predicted_answer": "Sulfonamide motifs can form a hydrogen bond network similar to carboxylic groups, with nearly identical oxygen atom distances. This allows them to avoid limitations like poor membrane permeability and metabolic instability, while offering diverse biological activities.",
            "score": 3,
            "explanation": "The predicted answer captures the similarity in hydrogen bonding networks (#sulfonamide motif# mirrors carboxylic groups). It mentions reduced membrane permeability limitations but omits specific biological activities like #anti-bacterial# capabilities, which affects completeness. Overall, trends are aligned but missing one key fact."
        },
        {
            "query_idx": 591,
            "query": "Within the convoluted realm of anti-cancer pursuits centered around sulphonamide derivatives, what are the inferred strategic roles of the genomic custodian known as p53, the orchestrators of apoptosis identified as caspases, and the transcriptional regulator called NFκ B in discerning the compounds' potential for therapeutic innovation?",
            "retrieved_metrics": {
                "reference_idx": [
                    219
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "p53 targets mutations in cancer, serving as a #therapeutic# target. Caspases induce apoptosis, crucial for cell death. NFκB is involved in transcription regulation, influencing anti-cancer strategies.",
            "predicted_answer": "p53, caspases, and NFκB are key in evaluating sulphonamide derivatives' anti-cancer potential. p53 targets mutations in cancer, caspases induce apoptosis, and NFκB regulates transcription, all crucial for therapeutic innovation.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer, mentioning p53's role in targeting mutations, caspases inducing apoptosis, and NFκB's role in transcription regulation. The term \"therapeutic\" is explicitly emphasized in the reference answer but is implied as \"therapeutic innovation\" in the prediction."
        },
        {
            "query_idx": 592,
            "query": "In what manner do the intricate engagements between pro-apoptotic caspases and sulphonamide compounds facilitate the modulation of cellular demise pathways, contributing to the multidimensional stratagem of oncological interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    220
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate engagement between pro-apoptotic #caspases# and #sulphonamide# compounds potentially modulates apoptosis, facilitating programmed cell death and contributing to oncological interventions.",
            "predicted_answer": "Sulphonamide compounds interact with pro-apoptotic caspases, enhancing their activation and promoting apoptosis. This interaction is part of a broader strategy in oncological interventions, targeting key proteins like p53 and NFκB to modulate cellular demise pathways.",
            "score": 5,
            "explanation": "The predicted answer captures the key elements of the interaction between pro-apoptotic caspases and sulphonamide compounds facilitating apoptosis and contributing to oncological interventions, aligning with the reference. Both answers emphasize caspases and sulphonamides' role in modulating cellular death pathways without contradictions."
        },
        {
            "query_idx": 593,
            "query": "What role does the intricate choreography of molecular dynamic simulations play in deciphering the stability tapestry of protein-ligand complexes, ultimately facilitating the exploration of potential anticancer lead compounds within their biochemical symphony?",
            "retrieved_metrics": {
                "reference_idx": [
                    221
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Molecular dynamic simulations reveal time-dependent changes in protein-ligand interactions, deciphering the #stability# and facilitating exploration of potential #anticancer# lead compounds.",
            "predicted_answer": "Molecular dynamic simulations elucidate the stability of protein-ligand complexes by revealing time-dependent interaction changes, which aids in identifying potential anticancer lead compounds.",
            "score": 5,
            "explanation": "The Predicted Answer contains the key facts emphasized in the Reference Answer, specifically addressing \"stability\" and \"anticancer lead compounds.\" It also aligns with the overall meaning, focusing on changes in protein-ligand interactions revealed by molecular dynamics simulations. No significant omissions or errors are present."
        },
        {
            "query_idx": 594,
            "query": "Regarding the intrinsic characteristics and interactive potential of compound (8a), what specific quantitative measure reflects its electron-attracting inclination as discerned in the comprehensive evaluation?",
            "retrieved_metrics": {
                "reference_idx": [
                    225
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The specific quantitative measure reflecting compound #8a#'s electron-attracting inclination is its electron #accepting power# of 0.246.",
            "predicted_answer": "The electron-accepting power, measured as 0.246, reflects compound (8a)'s electron-attracting inclination.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized in the reference answer: mentions of \"compound (8a)\", \"electron-attracting inclination\", \"electron-accepting power\", and the value \"0.246\". There are no omissions, errors, or contradictions, and it aligns perfectly with the reference's meaning."
        },
        {
            "query_idx": 595,
            "query": "How does the central orchestrator NF-B facilitate the nuanced interplay of cellular mechanisms, thereby sculpting responses pivotal to the paradigms of cancer research?",
            "retrieved_metrics": {
                "reference_idx": [
                    229
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "NF-B regulates #inflammation#, cell survival, and proliferation, crucial for cellular responses, making it central in #cancer research# to assess drug interactions with cancer proteins.",
            "predicted_answer": "NF-B, a transcription factor, regulates inflammation, cell survival, and proliferation. In cancer research, it orchestrates cellular responses by modulating gene expression, making it pivotal for understanding and developing therapeutic strategies.",
            "score": 3,
            "explanation": "The predicted answer mentions NF-B's regulation of inflammation and its role in cancer research, aligning with key facts in the reference answer. However, it omits the assessment of drug interactions with cancer proteins, a crucial aspect. Thus, while mostly aligned, it misses one key detail."
        },
        {
            "query_idx": 596,
            "query": "What are the understated molecular dialogues and nuanced relational tapestries that delineate the suboptimal embrace of NFκB-cisplatin, Caspase 3-cisplatin, and DNA-cisplatin complexes, as perceived through their subdued affinity landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    233
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #NFκB-cisplatin#, #Caspase 3-cisplatin#, and DNA-cisplatin complexes exhibit suboptimal binding affinity due to fewer hydrogen bonding and hydrophobic interactions, necessitating ligand or target protein optimization.",
            "predicted_answer": "The NFκB-cisplatin, Caspase 3-cisplatin, and DNA-cisplatin complexes exhibit weak binding affinities due to fewer hydrogen bonding and hydrophobic interactions, suggesting they may not be ideal drug targets. Further optimization is needed to enhance their anticancer potential.",
            "score": 3,
            "explanation": "The predicted answer maintains the key facts regarding the weak binding affinities due to fewer hydrogen and hydrophobic interactions for NFκB-cisplatin and Caspase 3-cisplatin mentioned in the reference. There is no contradictory information, but it omits the point about ligand or target protein optimization."
        },
        {
            "query_idx": 597,
            "query": "What is the spatial distance discerned between the molecular entities Gln241 and Lys221, reflecting the quintessential dimensions characteristic of conventional intermolecular hydrogen connections?",
            "retrieved_metrics": {
                "reference_idx": [
                    237
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The spatial distance discerned between Gln241 and Lys221 for hydrogen bonds is #3.4 Å# and #2.4 Å#.",
            "predicted_answer": "The spatial distances between Gln241 and Lys221, reflecting conventional intermolecular hydrogen bonds, are 3.4 Å and 2.4 Å.",
            "score": 5,
            "explanation": "The predicted answer accurately captures both key spatial distances—3.4 Å and 2.4 Å—highlighted in the reference answer regarding typical hydrogen bonding between Gln241 and Lys221. There are no omissions or errors, and the overall meaning and important details are consistent."
        },
        {
            "query_idx": 598,
            "query": "In the intricate dance of molecular interactions, what elusive molecular characteristics contribute to the reduced interactive synergy of compound (8b) with the p53 protein framework, in comparison to compound (8a)?",
            "retrieved_metrics": {
                "reference_idx": [
                    240
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #reduced interactive synergy# of compound (8b) with p53 is due to the absence of key hydrogen bonding residues and shorter #hydrogen bond length#.",
            "predicted_answer": "The reduced interactive synergy of compound (8b) with p53, compared to (8a), is due to the absence of key hydrogen bonding residues and a shorter hydrogen bond length, leading to a weaker binding affinity.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts: \"reduced interactive synergy\" and \"shorter hydrogen bond length,\" as well as the absence of key hydrogen bonding residues. It aligns well with the reference answer without contradictions or significant omissions."
        },
        {
            "query_idx": 599,
            "query": "In what manner might the nuanced dance of molecular forces initiated by Compound 8b's affinity for particular amino acid residues and the resulting shifts in binding dynamics influence the core functional paradigm of the p53 structural entity?",
            "retrieved_metrics": {
                "reference_idx": [
                    238
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compound 8b may impair p53's core function through interactions involving #hydrogen bonds# with Arg203, Tyr92, Glu89 and #hydrophobic interactions# with various residues, potentially affecting p53's structural integrity.",
            "predicted_answer": "The hydrogen bonds and hydrophobic interactions between Compound 8b and key p53 residues, such as Arg203, Tyr92, and Glu89, may alter the protein's binding dynamics, potentially impairing its core functional activity.",
            "score": 5,
            "explanation": "The predicted answer includes both #hydrogen bonds# and #hydrophobic interactions#, as well as mentions the key residues (Arg203, Tyr92, Glu89) referenced. It aligns with the potential impact on p53's function. No key facts are missing and there are no contradictions present."
        },
        {
            "query_idx": 600,
            "query": "In the molecular ballet orchestrated amidst the Caspase-3 -8b complex, what influence do the intricate molecular tendrils and hydrophobic veils hold over the observed structural coherence as outlined by the MD simulations?",
            "retrieved_metrics": {
                "reference_idx": [
                    251
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Hydrophobic #interactions# and #hydrogen bonds# are crucial for maintaining structural coherence in the Caspase-3 -8b complex during MD simulations.",
            "predicted_answer": "The intricate molecular tendrils and hydrophobic veils significantly contribute to the structural coherence of the Caspase-3 -8b complex, as evidenced by the stable RMSD and hydrogen bond interactions observed in MD simulations.",
            "score": 3,
            "explanation": "The 'Predicted Answer' mentions \"hydrogen bond interactions,\" aligning with the reference's emphasis on \"#hydrogen bonds#.\" It also references \"hydrophobic veils,\" partially aligning with \"#hydrophobic interactions#.\" However, \"interactions\" are more precise and missing, warranting a slightly lower score for completeness."
        },
        {
            "query_idx": 601,
            "query": "Within the interpretive ballet of molecular architecture, what insights emerge concerning the adaptive vicissitudes of the p53-(8a) complex's configurational landscape from a modulation in RMSD spanning 1.8 Å to 2.8 Å throughout the simulation period?",
            "retrieved_metrics": {
                "reference_idx": [
                    252
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #RMSD# increase from #1.8 Å# to 2.8 Å reflects conformational changes in the p53-(8a) complex, maintaining overall stability during the simulation.",
            "predicted_answer": "The increase in RMSD from 1.8 Å to 2.8 Å indicates conformational changes in the p53-(8a) complex, suggesting adaptive structural adjustments. Despite these fluctuations, the complex maintained overall stability throughout the simulation.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts emphasized in the reference answer, including the RMSD increase and conformational changes. Both answers mention the RMSD range (1.8 Å to 2.8 Å) and maintain overall stability. The trend and meaning are consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 602,
            "query": "What convoluted sequence of methodological orchestrations ceases the biochemical interplay, and by what systematic avenues is the emergent optical discernment translated within the assay's interpretative paradigm?",
            "retrieved_metrics": {
                "reference_idx": [
                    257
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The assay ceases biochemical interplay with #sodium dodecyl sulfate#. Optical discernment is translated through #absorbance measurement# at 575 nm using a microplate reader.",
            "predicted_answer": "The biochemical interplay is ceased by adding 10% sodium dodecyl sulfate. The optical discernment is translated through measuring the optical density at 575 nm and calculating background absorbance at 625 nm using a microplate reader.",
            "score": 5,
            "explanation": "The predicted answer includes the key fact of using sodium dodecyl sulfate to cease biochemical interplay and mentions the optical measurement at 575 nm with a microplate reader. However, it adds unnecessary detail about the background absorbance at 625 nm, which isn't in the reference."
        },
        {
            "query_idx": 603,
            "query": "How was the degree of transparency and clarity in the genetic essence harvested from Herring sperm evaluated through the analysis of spectral light interactions, specifically within the framework of molecular binding phenomena?",
            "retrieved_metrics": {
                "reference_idx": [
                    258
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #transparency# and #clarity# of Herring sperm DNA were evaluated by examining the 260/280 absorbance ratio, confirming sufficient purity for spectrophotometric analysis.",
            "predicted_answer": "The transparency and clarity of the genetic essence from Herring sperm were evaluated using UV-visible spectrophotometry, assessing the 260/280 absorbance ratio to ensure DNA purity before analyzing molecular binding.",
            "score": 5,
            "explanation": "The Predicted Answer includes key terms \"transparency,\" \"clarity,\" and \"260/280 absorbance ratio,\" aligning with the Reference Answer. It addresses DNA purity and spectrophotometric analysis, though it adds UV-visible spectrophotometry without disrupting alignment. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 604,
            "query": "What transformations within the photonic profiles hint at molecular dialogues between investigational entities and the genomic tapestry, and through what deciphering methods are the patterns of affinity and their vigor unveiled?",
            "retrieved_metrics": {
                "reference_idx": [
                    259
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Transformations in photonic profiles, indicated by changes in #spectra#, suggest molecular dialogues, with #binding constants# and interaction modes deciphered through UV absorption spectra analysis.",
            "predicted_answer": "Changes in UV absorption spectra after incubation of investigational compounds with DNA indicate molecular interactions. Binding constants and interaction modes are determined from these spectral changes, revealing patterns of affinity and their strength.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer, correctly capturing changes in UV absorption spectra and the determination of binding constants and interaction modes. It matches all key facts, such as spectra analysis for molecular dialogue and deciphering interaction patterns, with consistent meaning throughout."
        },
        {
            "query_idx": 605,
            "query": "What algorithmic frameworks and elemental coordinate systems were orchestrated to refine molecular architectures and analyze the equilibrium proclivities of N-ethyl toluene-4-sulphonamide and 2,5-Dichlorothiophene-3-sulfonamide within the realm of electronic properties exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    260
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #DFT# calculations using the #B3LYP# functional and 6-31G* basis set optimized geometries and analyzed stability of N-ethyl toluene-4-sulphonamide and 2,5-Dichlorothiophene-3-sulfonamide.",
            "predicted_answer": "DFT calculations with the B3LYP functional and 6-31G* basis set were used to optimize geometries and evaluate stability. Electron density, reactivity descriptors, and frontier molecular orbitals were analyzed for electronic properties.",
            "score": 5,
            "explanation": "The predicted answer successfully captures all the key facts from the reference answer, including the use of DFT calculations, B3LYP functional, and 6-31G* basis set. It effectively addresses the optimization and stability analysis of the specified molecules, consistent with the electronic properties exploration context."
        },
        {
            "query_idx": 606,
            "query": "How do the dynamics of protonation alterations act as pivotal determinants in the web of electrostatic orchestration, affecting the molecular handshake's affinity and specificity calibration during the multidimensional analyses of docking simulations?",
            "retrieved_metrics": {
                "reference_idx": [
                    263
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Protonation alterations modulate #electrostatic interactions#, significantly influencing #binding affinity# and specificity in docking simulations by affecting the protonation states of amino acids in the active site.",
            "predicted_answer": "Protonation alterations influence electrostatic interactions, affecting the binding affinity and specificity between ligand and protein. These changes are crucial for accurate docking simulations, as they refine the molecular handshake's precision.",
            "score": 3,
            "explanation": "The predicted answer captures the influence of protonation alterations on \"electrostatic interactions\" and their impact on \"binding affinity\" and specificity in docking simulations, aligning with the reference. However, the mention of \"protonation states of amino acids\" is missing, impacting completeness."
        },
        {
            "query_idx": 607,
            "query": "What comprehensive array of molecular fine-tuning techniques and electrostatic adaptations were executed on the PDB-sourced proteins to ensure seamless incorporation into the structured confines of the docking matrix as detailed in the scientific investigation?",
            "retrieved_metrics": {
                "reference_idx": [
                    264
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Proteins underwent #fine-tuning# by removing water, adding polar hydrogens, and incorporating #Gasteiger charges# to integrate smoothly into the docking matrix.",
            "predicted_answer": "The proteins were prepared by removing water and hetero-atoms, adding polar hydrogen atoms, and incorporating Gasteiger charges to ensure seamless incorporation into the docking matrix.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts marked with # in the reference, including the addition of polar hydrogens and incorporation of Gasteiger charges. The phrase \"fine-tuning\" is omitted but implied in the detailed preparation steps, aligning with the reference's overall trend."
        },
        {
            "query_idx": 608,
            "query": "What conceptual benchmarks facilitate the determination of success in the molecular coupling strategy relative to the spatial validation of the synthesized co-crystal construct?",
            "retrieved_metrics": {
                "reference_idx": [
                    265
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The success in the molecular coupling strategy is determined by an #RMSD# of fewer than #two angstroms# between the original and rebuilt positions during docking validation.",
            "predicted_answer": "The success of the molecular coupling strategy is determined by the RMSD between the original and rebuilt positions of the co-crystal ligand, with a threshold of fewer than two angstroms indicating success.",
            "score": 5,
            "explanation": "The predicted answer correctly includes the key facts: RMSD as a measure and the threshold of fewer than two angstroms, aligning with the reference answer. Both the trend and critical details, such as the significance of these benchmarks, are captured without contradiction or omission."
        },
        {
            "query_idx": 609,
            "query": "In the landscape of calculated boundaries and repeating domains, what was the inaugural methodology applied to harmonize systemic energies and circumvent elemental convergence prior to the main sequence of dynamic equilibrium establishment?",
            "retrieved_metrics": {
                "reference_idx": [
                    266
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The inaugural methodology was #2000 steps# for #minimizing energy# to harmonize systemic energies and circumvent elemental convergence.",
            "predicted_answer": "The inaugural methodology involved 2000 steps of energy minimization to prevent atomic collisions, followed by equilibration in an NPT ensemble at 300 K and 1.01 bar using a Nose-Hoover thermostat and Martyna-Tobias-Klein barostat.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts of \"2000 steps\" and \"minimizing energy\" mentioned in the Reference Answer. It includes additional details about equilibration and specific conditions, but there are no significant omissions or contradictions. The main points are fully addressed."
        },
        {
            "query_idx": 610,
            "query": "Amidst the intricate process of scientific revelation, what role do vector-based algorithmic frameworks play in unraveling the complexities of pharmacokinetic conduits and systemic gatekeeping mechanisms for therapeutics in oncological pharmacology?",
            "retrieved_metrics": {
                "reference_idx": [
                    272
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Vector-based algorithmic frameworks help predict #pharmacokinetic properties# and #blood-brain barrier permeability#, aiding the understanding of drug behaviors in oncological pharmacology.",
            "predicted_answer": "Vector-based algorithmic frameworks, such as support vector machines, play a crucial role in predicting pharmacokinetic properties and systemic absorption for anticancer drugs, aiding in the optimization of therapeutic efficacy.",
            "score": 3,
            "explanation": "The predicted answer covers the prediction of #pharmacokinetic properties# but does not mention #blood-brain barrier permeability#. While the prediction aligns with the overall trend of vector-based algorithms aiding drug efficacy analysis, it omits a critical aspect from the reference answer."
        },
        {
            "query_idx": 611,
            "query": "What serendipitous intersections of unforeseen observations and scientific inquiry delineated the path leading to the transformative recognition of cisplatin and valproic acid as pivotal compounds in their respective therapeutic realms during the 1960s?",
            "retrieved_metrics": {
                "reference_idx": [
                    273
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #unforeseen observations# of valproic acid's ability to reduce seizures and cisplatin's inhibition of E. coli division catalyzed their recognition as pivotal therapeutic compounds.",
            "predicted_answer": "In the 1960s, valproic acid, used as a solvent in cough syrups, was observed to reduce seizures in epileptic patients. Cisplatin was discovered when platinum electrodes unexpectedly inhibited E. coli division, leading to its use in oncology.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts emphasized in the reference: the unforeseen observation of valproic acid reducing seizures and cisplatin inhibiting E. coli division. It aligns with the trend of serendipity in their therapeutic recognition. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 612,
            "query": "In the landscape of oncological exploration, what strands of molecular tapestry underscore the precedence of Compound 8b as a potent adversary, illustrating a distinct chemistry in binding loci, while deftly contrasting its stability and interactive dynamic with both the time-honored cisplatin and the venerable Doxorubicin in therapeutic pursuits?",
            "retrieved_metrics": {
                "reference_idx": [
                    268
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compound #8b# has a strong affinity for #Caspase-3#, exhibiting better docking scores than cisplatin and comparable docking scores to Doxorubicin, indicating potential as an anticancer compound.",
            "predicted_answer": "Molecular docking and DFT calculations show Compound 8b binds strongly to Caspase-3, with good chemical reactivity and stability. It outperforms cisplatin and matches Doxorubicin in binding scores, highlighting its potential as an anticancer agent.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference answer: Compound 8b's strong binding to Caspase-3, better performance than cisplatin, and comparable affinity to Doxorubicin as an anticancer agent. The overall meaning and key details are consistent without significant omissions."
        },
        {
            "query_idx": 613,
            "query": "What are the implications of applying virtual pharmacological simulacra to explore the nuanced interstice between novel synthesis and derivative replication in the evolution of echo pharmaceuticals, especially when evaluated against conventional empirical methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    277
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Applying #virtual pharmacological simulacra# can improve drug development by using #in silico trials#, enhancing treatment design and addressing the limitations of me-too drugs versus empirical methodologies.",
            "predicted_answer": "Applying virtual pharmacological simulacra can enhance the exploration of novel synthesis and derivative replication, offering more precise and efficient drug development. This approach, compared to conventional methods, leverages AI and in silico trials to improve therapeutic outcomes and innovation.",
            "score": 3,
            "explanation": "The predicted answer includes the key concepts of \"virtual pharmacological simulacra\" and \"in silico trials,\" aligning with the reference. It also touches upon improved drug development and treatment design. However, it omits the emphasis on addressing \"limitations of me-too drugs.\" This omission affects completeness."
        },
        {
            "query_idx": 614,
            "query": "What are the intrinsic conceptual bottlenecks encountered in the evolving blueprints of oncologic defense strategies, as they manifest in the intricate dance of stakeholders orchestrating expeditions through the therapeutic frontiers of immunological checkpoint inhibition?",
            "retrieved_metrics": {
                "reference_idx": [
                    278
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intrinsic conceptual bottlenecks are trial design #redundancy# and complex stakeholder #interactions# in the development of immunological checkpoint inhibition strategies.",
            "predicted_answer": "In oncologic defense strategies, particularly with immunological checkpoint inhibition, key bottlenecks include trial design redundancy, complex interactions among stakeholders, and the need for robust clinical validation of AI-generated algorithms.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key conceptual bottlenecks of \"#trial design redundancy#\" and \"#complex stakeholder interactions#\" highlighted in the Reference Answer. Although it adds extra information about \"robust clinical validation,\" this does not contradict the reference but rather supplements it."
        },
        {
            "query_idx": 615,
            "query": "What intrinsic difficulties are encountered by traditional methodological frameworks in therapeutic exploration when attempting to unearth synergistic combinations of pharmaceutical regimens within the confines of limited participant availability in the field of immunotherapeutic trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    279
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Traditional frameworks face difficulties like inadequate rules, limited #participants#, and risk of missing active combinations when exploring #synergistic combinations# in immunotherapeutic trials.",
            "predicted_answer": "Traditional methodological frameworks struggle with limited participant availability, potentially missing active drug combinations due to the vast number of possible regimens to test in immunotherapy trials.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of limited participants and the risk of missing active combinations, aligning generally with the reference answer. However, it does not explicitly mention \"synergistic combinations,\" which is a critical point emphasized in the reference. Overall, the content is aligned but missing one key detail."
        },
        {
            "query_idx": 616,
            "query": "What are the potential pathways through which digital avatars, born from the confluence of data and algorithmic intelligence, might abbreviate the temporal and financial horizons of oncological treatment explorations?",
            "retrieved_metrics": {
                "reference_idx": [
                    282
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Digital avatars# aggregate and structure data to create 'real simulated patients,' potentially reducing the #duration and cost# of therapeutic trials in oncology.",
            "predicted_answer": "Digital avatars, created using patient data and AI, can identify eligible clinical trial participants, reducing the time and cost of oncological treatment trials. This accelerates the exploration and approval of new therapies.",
            "score": 3,
            "explanation": "The predicted answer mentions \"digital avatars\" and focuses on reducing the time and cost of trials, aligning closely with the reference. However, it lacks the specific concept of \"real simulated patients\" from the reference. This missing detail slightly affects completeness."
        },
        {
            "query_idx": 617,
            "query": "How does the grand design for integrating cognitive automata aim to intricately stitch a novel paradigm into the fabric of pharmaceutical oversight and foster dialogues with critical orchestras resembling ultimate adjudicators?",
            "retrieved_metrics": {
                "reference_idx": [
                    283
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The grand design integrates cognitive automata through #digital innovation#, facilitating engagement with #regulators# like the FDA, promoting a new paradigm in pharmaceutical oversight and stakeholder dialogues.",
            "predicted_answer": "The grand design aims to integrate cognitive automata into pharmaceutical oversight by leveraging AI for decision-making, engaging with key regulators, and fostering dialogue among stakeholders. It emphasizes the need for reliable and interpretable AI systems to enhance accuracy and usefulness.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by discussing integration into pharmaceutical oversight and engagement with regulators. However, it does not explicitly mention \"digital innovation,\" which is critical to the reference. Overall, it captures the general trend but misses one emphasized key fact."
        },
        {
            "query_idx": 618,
            "query": "What intrinsic barriers and systemic detriments have coalesced at the crossroads of scientific inquiry and industry objectives, thwarting the progressive advancement of treatment modalities for CNS WHO grade 4 glioblastoma as per recent delineations?",
            "retrieved_metrics": {
                "reference_idx": [
                    285
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intrinsic barriers include the #heterogeneity# of gliomas, while systemic detriments involve focusing on expanding existing therapies over developing new agents for #glioblastoma# treatment.",
            "predicted_answer": "Intrinsic barriers include the heterogeneity and infiltrative nature of glioblastoma. Systemic detriments involve a lack of effective new agents and a focus on repurposing existing therapies rather than developing novel treatments.",
            "score": 5,
            "explanation": "The Predicted Answer covers both the \"heterogeneity\" (#heterogeneity#) as an intrinsic barrier and the emphasis on existing therapies over novel treatments for #glioblastoma#, addressing the systemic detriment mentioned in the Reference Answer. The meaning is preserved, and no facts are contradicted."
        },
        {
            "query_idx": 619,
            "query": "Through what multidimensional synthesis inherent in the jinkō trial simulation's orchestrated rehearsal did it catalyze an expedited unveiling of the prospective timelines for AstraZeneca's phase III investigation of FLAURA2?",
            "retrieved_metrics": {
                "reference_idx": [
                    281
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #jinkō trial simulation# predicted AstraZeneca's FLAURA2 timelines in one month, expediting the process compared to the actual 3-year clinical trial.",
            "predicted_answer": "The jinkō trial simulation's multidimensional synthesis, using totally simulated patients and adjusting key parameters, expedited the unveiling of prospective timelines for AstraZeneca's FLAURA2 phase III investigation, completing in one month what would take years in real trials.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the #jinkō trial simulation# and its role in predicting AstraZeneca's FLAURA2 timelines rapidly, completing in one month versus the real trial's three years. The key fact of the simulation process and duration is included and aligned with the reference."
        },
        {
            "query_idx": 620,
            "query": "In the intricate dance of pharmacological exploration, how do the conceptual trajectories and ultimate aspirations of window-of-opportunity trials manifestly contrast with those of phase 0 endeavors, particularly regarding their stationing within the developmental symphony and their envisioned outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    291
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Window-of-opportunity trials occur #post-phase I# and assess biologic effects, while phase 0 trials, positioned between preclinical and phase I, focus on #microdosing# and pharmacokinetics.",
            "predicted_answer": "Window-of-opportunity trials, conducted post-phase I, aim to assess target engagement and pharmacodynamics at specific time points. Phase 0 trials, occurring pre-phase I, use microdosing to evaluate human pharmacokinetics and drug suitability for further development.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies that window-of-opportunity trials occur post-phase I and focus on assessing effects, aligning with the reference answer. It also correctly notes that phase 0 trials involve microdosing to evaluate pharmacokinetics. All key facts are present and trends align with no omissions."
        },
        {
            "query_idx": 621,
            "query": "What underlying dimensions could manifest as navigational impediments influencing the temporal crossroads in the relay of therapeutic potentials while orchestrating the prelude exploration of an investigational entity?",
            "retrieved_metrics": {
                "reference_idx": [
                    289
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Potential delays# in providing therapies and ensuring #biologically meaningful# results are impediments influencing the temporal crossroads in the relay of therapeutic potentials.",
            "predicted_answer": "Navigational impediments include potential delays in providing other effective therapies and the need for robust, biologically meaningful results, which depend on relevant controls and reliable pharmacodynamic assays.",
            "score": 5,
            "explanation": "The predicted answer mentions \"potential delays\" and \"biologically meaningful results,\" which match the key facts highlighted in the reference answer. The phrasing differs slightly, but the meaning and key impediments are consistent and no critical information is missing."
        },
        {
            "query_idx": 622,
            "query": "Within the intricate theater of perioperative neurooncological inquiries, what conceptual assemblages and comparative stratagems are paramount to architect a formidable investigational architecture, thereby distilling critical and illuminating insights?",
            "retrieved_metrics": {
                "reference_idx": [
                    294
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The paramount conceptual assemblages and comparative stratagems include the incorporation of #controls#, such as earlier resection comparisons, external samples, or a placebo arm, in perioperative neurooncology.",
            "predicted_answer": "In perioperative neurooncology, key concepts include the use of robust controls such as earlier tumor resections, archival samples, and placebo arms. These strategies help in generating reliable and insightful data.",
            "score": 5,
            "explanation": "The predicted answer includes the key concept of using controls such as earlier tumor resections, archival samples, and placebo arms, which aligns with the reference answer. No significant omissions or contradictions are present, and the key facts are covered. Thus, it mirrors the reference meaning."
        },
        {
            "query_idx": 623,
            "query": "What are the dual strategic benefits imbued within the application of stochastic methodologies during the initial preparatory phase of the clinical investigation?",
            "retrieved_metrics": {
                "reference_idx": [
                    296
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #random assignment# in the preparatory phase ensures consistent treatment protocols and enhances #confidence# in results, allowing effective tissue-based comparisons and clinical efficacy assessments.",
            "predicted_answer": "The dual strategic benefits of stochastic methodologies in the initial phase include ensuring similar treatment and conditions across groups, and enhancing confidence in results through random assignment, which also allows for clinical efficacy comparison.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of \"random assignment\" and \"enhancing confidence in results\" from the reference answer. While it mentions similar treatment conditions, it lacks the specific detail about \"tissue-based comparisons.\" Overall, the alignment is strong but missing one critical detail."
        },
        {
            "query_idx": 624,
            "query": "Within the structured confines of an experimentally altered setting, what significant revelations were observed from deploying PD-1 antibody therapy pertaining to the evaluations that succeed surgery, which potentially indicated a remarkable enlargement in patient survival timelines?",
            "retrieved_metrics": {
                "reference_idx": [
                    297
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The postoperative evaluations revealed #doubling of survival# in patients receiving #PD-1 monoclonal antibody# therapy in the neoadjuvant setting.",
            "predicted_answer": "The study revealed that PD-1 antibody therapy, when used in the neoadjuvant setting, doubled patient survival times as observed in postoperative efficacy evaluations.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts from the reference answer: \"doubling of survival\" and \"PD-1 antibody therapy in the neoadjuvant setting\" are clearly mentioned. The overall trend is aligned without contradictions or significant omissions. Completeness and accuracy are maintained."
        },
        {
            "query_idx": 625,
            "query": "In the grand orchestrations of perioperative inquiry, what were the nuanced intentions nestled in the quest to unravel the enigma of the central nervous system's permeability and the subsequent molecular metamorphosis incited by the antitumor agents, specifically within IDH-mutated glioma scenarios?",
            "retrieved_metrics": {
                "reference_idx": [
                    298
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The study aimed to assess #CNS permeability# of agents, reduce #2-hydroxyglutarate# levels, restore DNA function, reverse gene expression changes, and reduce tumor proliferation in IDH-mutated gliomas.",
            "predicted_answer": "The study aimed to assess the agents' ability to penetrate the CNS, reduce 2HG levels, restore 5hmC, reverse gene expression associated with mIDH, and inhibit tumor cell proliferation in IDH-mutated gliomas.",
            "score": 5,
            "explanation": "The predicted answer includes CNS permeability, reduction of 2-HG (2-hydroxyglutarate), restoration of DNA function as \"restore 5hmC\", reversal of gene expression changes, and tumor proliferation reduction. All key facts from the reference are present, indicating high consistency with no significant omissions."
        },
        {
            "query_idx": 626,
            "query": "What catalytic element instigated an intensified wave of scholarly drive to navigate the uncharted paths of mIDH inhibitor exploration, even as it remained unintegrated with standard paradigms applied to glioma investigational traditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    301
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The catalytic element was the #determination of tumor growth rates#, which sparked increased enthusiasm for mIDH inhibitor exploration but remains unintegrated with #standard glioma evaluation#.",
            "predicted_answer": "The observed gradual but sustained shrinkage or stabilization of tumors in early clinical evaluations of mIDH inhibitors, even without meeting standard response criteria, catalyzed an intensified wave of scholarly interest in exploring these inhibitors.",
            "score": 1,
            "explanation": "The predicted answer addresses the effect observed in tumors as a catalyst for interest in mIDH inhibitors but misses the specific catalyst emphasized: the #determination of tumor growth rates#. Additionally, it misses the point about #standard glioma evaluation# integration, affecting completeness."
        },
        {
            "query_idx": 627,
            "query": "How does the existing evaluative paradigm within neuro-oncological assessments metaphorically fail to unearth pharmacological beacons for glioblastoma, as illuminated by the stagnation in survival statistics and the surplus of non-affirmative drug trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    293
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #existing evaluative paradigm# fails to identify effective treatments for #glioblastoma#, evidenced by stagnant survival rates and numerous unsuccessful drug trials.",
            "predicted_answer": "The existing evaluative paradigm in neuro-oncology, such as RANO criteria, fails to effectively identify active or inactive agents, as shown by the lack of new drug approvals for glioblastoma and numerous negative phase III trials, leading to minimal improvement in survival rates.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: it discusses the evaluative paradigm's failure, mentions glioblastoma, and highlights stagnant survival rates and unsuccessful drug trials. It also includes the specific mention of RANO criteria and negative phase III trials, harmonizing with the reference answer's trends and details without omissions or contradictions."
        },
        {
            "query_idx": 628,
            "query": "What intricate arrangement methodology is suggested to unveil the impact of each therapeutic entity and their collective orchestration on the tumor microenvironment, deliberately excluding any unproductive autonomous interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    299
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The suggested methodology is a #factorial design# to unveil the impact of each therapeutic entity and their #combination# on the tumor microenvironment, excluding ineffective single-agent treatments.",
            "predicted_answer": "A factorial design is suggested to reveal the impact of each therapeutic entity and their collective effect on the tumor microenvironment, while avoiding unproductive single-agent interventions.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the use of a #factorial design# and addresses the combination effect on the tumor microenvironment, as in the reference. However, it omits mentioning the exclusion of \"ineffective\" interventions specifically, though the intent is implied. All key facts are present with aligned trends."
        },
        {
            "query_idx": 629,
            "query": "How does analyzing initial proliferation pathways of tumorigenic masses potentially refine the intellectual approach to therapeutic orchestration, particularly in calibrating dosage, timing, and patient subgroup partitioning within solid neoplasm studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    303
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Analyzing #initial proliferation pathways# can refine therapeutic approaches by enhancing #sensitivity# in identifying treatment impacts, optimizing dose, timing, and patient subgroup selection in solid tumor studies.",
            "predicted_answer": "Analyzing initial proliferation pathways refines therapeutic approaches by enhancing sensitivity to treatment impacts, aiding in better decision-making for dosage, timing, and patient subgroup identification. Functional imaging like PET helps characterize tumor biology and monitor treatment responses.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the initial proliferation pathways and their role in refining therapeutic approaches, including dosage, timing, and subgroup identification. It aligns with the reference answer's emphasis on sensitivity but adds detail about functional imaging, which does not affect completeness. All key facts are covered."
        },
        {
            "query_idx": 630,
            "query": "What emergent benefits could stem from harnessing theoretically advanced surrogate comparators in unilateral investigative frameworks, particularly in propelling the terminal phase progression of therapeutic regimes for exceedingly rare and therapeutically complex cancers, exemplified by glioblastoma multiforme?",
            "retrieved_metrics": {
                "reference_idx": [
                    306
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Harnessing #synthetic controls# in single-arm trials can provide #preliminary evidence# of activity, offering cost-effectiveness, rapid enrollment, and patient preference, aiding late-stage development for rare cancers.",
            "predicted_answer": "Harnessing advanced surrogate comparators, such as synthetic controls, in unilateral frameworks can accelerate the development of therapies for rare, complex cancers like glioblastoma by providing robust preliminary evidence, reducing costs, and speeding up patient enrollment.",
            "score": 5,
            "explanation": "The predicted answer includes the key points of using \"synthetic controls\" (#synthetic controls#) and providing \"preliminary evidence\" (#preliminary evidence#) necessary for developing therapies for rare cancers. The benefits such as cost reduction and speeding enrollment are present, aligning well with the reference answer."
        },
        {
            "query_idx": 631,
            "query": "What intricate ripple effects manifest in GBM pharmacological advancements when experimental constructs lack statistical vigor or misapply numerical strategies, potentially skewing the perception of treatment impact?",
            "retrieved_metrics": {
                "reference_idx": [
                    305
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #misapplication of numerical strategies# in GBM studies can lead to #overestimation# or underestimation of treatment effects, affecting the rationale for RCTs or hindering further testing.",
            "predicted_answer": "In GBM pharmacological advancements, lack of statistical rigor or misuse of numerical strategies can lead to overestimation or underestimation of treatment effects, causing misguided further trials or abandonment of potentially effective therapies.",
            "score": 3,
            "explanation": "The Predicted Answer includes key facts such as the misapplication of numerical strategies and the over/underestimation of treatment effects in GBM studies. It aligns with the Reference Answer trend, though it doesn't explicitly mention \"affecting the rationale for RCTs,\" which slightly impacts completeness."
        },
        {
            "query_idx": 632,
            "query": "Within the intricate odyssey of advancing therapies for cerebral malignancies, what catalytic advantages could potentially be unveiled by the synergistic fusion of intrinsic oversight mechanisms with external evaluative constructs during the clinical trials' multi-layered pursuit?",
            "retrieved_metrics": {
                "reference_idx": [
                    308
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The synergistic fusion enables prospective bias evaluation and enhances #efficiency# in trials, increasing chances of timely discontinuing ineffective treatments while avoiding premature halting of effective therapies.",
            "predicted_answer": "The synergistic fusion of intrinsic oversight mechanisms with external evaluative constructs, like endpoint committees (ECs), can enhance clinical trial efficiency, reduce bias, and improve the accuracy of interim analyses, potentially leading to more effective and timely therapeutic advancements.",
            "score": 3,
            "explanation": "The predicted answer includes the key fact of enhancing \"efficiency\" in clinical trials, aligning with the reference's emphasis on efficiency and bias evaluation. However, it lacks specific references to evaluating bias and the impact on halting treatments, which affects completeness, but no contradictory information is present."
        },
        {
            "query_idx": 633,
            "query": "What methodologies of temporal layer modifications and legacy data incorporation act to dynamically fortify the evaluative distinctions between the established reference arm and the investigational contingents within the study's operational schema?",
            "retrieved_metrics": {
                "reference_idx": [
                    311
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The methodologies include #temporal adjustments# to the control arm's effect, leveraging #legacy data# from prior studies to enhance power and evaluative distinctions.",
            "predicted_answer": "The context describes methodologies such as adjusting the control arm over time and incorporating prior study data to enhance comparisons. These modifications and data incorporation dynamically strengthen the evaluative distinctions between the reference and investigational arms.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of #temporal adjustments# (\"adjusting the control arm over time\") and #legacy data# (\"incorporating prior study data\"), maintaining alignment with key ideas in the reference. Despite different wording, no crucial detail is omitted or contradicted."
        },
        {
            "query_idx": 634,
            "query": "What are the dual phases inherent in the GBM AGILE architectural framework, and through what intricate mechanisms do they underpin its registration efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    310
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #two stages# in GBM AGILE are screening and confirmation, ensuring detailed evaluation of #three subtypes# of GBM for registration efficacy.",
            "predicted_answer": "GBM AGILE includes two stages: an initial screening phase to identify effective treatments and a confirmatory phase to validate these treatments, ensuring registration efficacy through adaptive Bayesian methods.",
            "score": 3,
            "explanation": "The predicted answer identifies the two stages (screening and confirmation) similar to the reference. However, it misses the specific emphasis on the evaluation of \"three subtypes\" of GBM. The broader mechanism of adaptive Bayesian methods is mentioned which aligns with registration efficacy."
        },
        {
            "query_idx": 635,
            "query": "In what manner do sophisticated adaptive platforms like GBM AGILE recalibrate the methodological paradigm of pharmaceutical explorations in glioblastoma trials, enabling concurrent multifaceted inquiries and dynamic longitudinal evaluations?",
            "retrieved_metrics": {
                "reference_idx": [
                    312
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Sophisticated adaptive platforms like #GBM AGILE# recalibrate pharmaceutical explorations by enabling concurrent multifaceted inquiries and dynamic longitudinal evaluations, exploring multiple #subtypes# and study arms efficiently within trials.",
            "predicted_answer": "GBM AGILE recalibrates pharmaceutical explorations by enabling multiple concurrent inquiries and dynamic evaluations, improving efficiency and accuracy in both preliminary and market approval phases, thus benefiting patients with glioblastoma.",
            "score": 1,
            "explanation": "The predicted answer mentions \"GBM AGILE,\" concurrent inquiries, and dynamic evaluations, aligning with the reference. However, it lacks mention of multiple \"subtypes\" and specific \"study arms,\" missing two key facts that impede completeness."
        },
        {
            "query_idx": 636,
            "query": "How do the multifaceted biochemical symphonies inherent in Rubus chingii Hu shape its profound impact on various human health functionalities?",
            "retrieved_metrics": {
                "reference_idx": [
                    313
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rubus chingii Hu's #bioactive components# significantly impact human health by providing #anti-oxidant#, anti-inflammatory, and antitumor benefits.",
            "predicted_answer": "The multifaceted biochemical components in Rubus chingii Hu, including terpenoids, flavonoids, and alkaloids, contribute to its antioxidant, anti-inflammatory, and antitumor properties, enhancing various health functionalities.",
            "score": 5,
            "explanation": "The predicted answer covers the key fact of Rubus chingii Hu’s bioactive components (terpenoids, flavonoids, alkaloids) and their roles in antioxidant, anti-inflammatory, and antitumor functionalities. There are no significant omissions or contradictions to the reference answer, maintaining alignment and completeness."
        },
        {
            "query_idx": 637,
            "query": "Within the symphony of enzymatic expressions found in the genetic landscape of R. chingii, how do the orchestrations of the CXE and UGT gene-directed pathways contribute to the emergence and diversification of hydrolysable tannin structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    315
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #CXE# and #UGT# gene-directed pathways contribute to hydrolysable tannin diversification through tannin hydrolase and gallic acid glycosyltransferase functions, respectively.",
            "predicted_answer": "In R. chingii, CXE and UGT genes in the tandem cluster on chromosome 02 contribute to hydrolysable tannin (HT) biosynthesis. CXE enzymes act as tannin hydrolases, while UGTs function as gallic acid glycosyltransferases, facilitating the emergence and diversification of HT structures.",
            "score": 5,
            "explanation": "The predicted answer accurately includes both key facts: the roles of CXE as tannin hydrolases and UGT as gallic acid glycosyltransferases in the biosynthesis and diversification of hydrolysable tannins. All important details marked with # in the reference are present, with no omissions or errors."
        },
        {
            "query_idx": 638,
            "query": "What symphony of biochemical engagement do oleanolic acid and ursolic acid conduct within the intricate theatre of prostate malignancy cellular assemblages as contemplated by Li et al.?",
            "retrieved_metrics": {
                "reference_idx": [
                    318
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Oleanolic acid (#OA#) inhibits prostate cancer cell viability and proliferation, promotes apoptosis, and causes #G0/G1 phase# cell cycle arrest.",
            "predicted_answer": "Li et al. demonstrated that oleanolic acid inhibits cell viability and proliferation, promotes apoptosis, and induces G0/G1 phase cell cycle arrest in prostate cancer cells.",
            "score": 5,
            "explanation": "The predicted answer includes the key information that oleanolic acid inhibits cell viability and proliferation, promotes apoptosis, and induces cell cycle arrest at the G0/G1 phase. This matches all the key emphasized facts in the reference answer, showing complete alignment in meaning and details."
        },
        {
            "query_idx": 639,
            "query": "Regarding the intricate repertoires of neurobehavioral outcomes, how do amplified proportions of raspberry extractions orchestrate amelioration within cognitive compromise frameworks precipitated by multifarious chemical inducers in biological test subjects?",
            "retrieved_metrics": {
                "reference_idx": [
                    323
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Amplified proportions of #raspberry extractions# improve #cognitive compromise# in test subjects by reducing brain free radical injury and enhancing cholinergic function, particularly against scopolamine and sodium nitrite.",
            "predicted_answer": "Raspberry extracts, particularly in high doses, improve memory and cognitive function in models of chemically-induced cognitive impairment, such as those caused by scopolamine, sodium nitrite, and ethanol.",
            "score": 3,
            "explanation": "The predicted answer contains key elements of raspberry extracts improving cognitive impairment caused by scopolamine and sodium nitrite, aligning with the reference's \"cognitive compromise.\" However, it omits details about mechanisms like reducing brain free radical injury or enhancing cholinergic function, affecting completeness."
        },
        {
            "query_idx": 640,
            "query": "In what manner do the intricate communication networks, governed by transcriptional maestros, interface with cellular orchestrations to manifest the antineoplastic harmonies elicited by alkaloid interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    322
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Alkaloids interface with cellular orchestrations by modifying #transcription factors# such as NFκ B, MYC, FOS, CREB, and mTOR, influencing signal pathways to elicit #antineoplastic# effects.",
            "predicted_answer": "Alkaloids interface with cellular processes by modulating transcription factors and signaling pathways, such as downregulating VEGF, AKT, and NFκB, leading to antineoplastic effects and inhibiting tumor growth and metastasis.",
            "score": 3,
            "explanation": "The predicted answer touches on transcription factors and antineoplastic effects, aligning with the reference's emphasis on transcription factors like NFκB and antineoplastic outcomes. However, it omits key transcription factors MYC, FOS, CREB, and mTOR, resulting in a loss of completeness."
        },
        {
            "query_idx": 641,
            "query": "Through what intricate mechanisms does EA partake in modulating the dynamic equilibrium of liver enzyme kinetics and fortifying the biochemical sentinel against oxidative agitators, within the nuanced landscape of free radical-induced hepatic ailment?",
            "retrieved_metrics": {
                "reference_idx": [
                    325
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "EA modulates liver enzyme kinetics and fortifies biochemical defenses through #Nrf2# activation, reducing serum liver enzymes and bilirubin levels, thus counteracting oxidative stress in #free radical-induced liver# ailments.",
            "predicted_answer": "EA modulates liver enzyme kinetics by reducing serum liver enzyme activity and bilirubin levels. It fortifies the biochemical defense against oxidative stress by activating Nrf2, enhancing its anti-oxidant capacity and alleviating liver injury from free radicals.",
            "score": 5,
            "explanation": "The predicted answer includes key points from the reference: activation of Nrf2, reduction of serum liver enzymes, bilirubin levels, and defense against oxidative stress. It covers the #free radical-induced liver# ailment context, fully aligning with the reference answer."
        },
        {
            "query_idx": 642,
            "query": "In what manner do the sophisticated molecular pathways within the cellular tapestry of BV2 microglia become orchestrated by tiliroside, effectuating a diminution of neuroinflammatory responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    324
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tiliroside orchestrates #neuroinflammation# reduction in BV2 microglia through TRAF6-mediated activation of NFκ B and p38 MAPK signaling #pathways#, likely due to its antioxidant properties.",
            "predicted_answer": "Tiliroside orchestrates molecular pathways in BV2 microglia by inhibiting TRAF6-mediated activation of NFκB and p38 MAPK, thereby reducing neuroinflammatory responses, likely due to its anti-oxidant properties.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts #neuroinflammation# and #TRAF6-mediated activation of NFκB and p38 MAPK signaling pathways# as present in the reference answer. It also mentions the anti-oxidant properties of tiliroside, aligning in overall trend and completeness with the reference."
        },
        {
            "query_idx": 643,
            "query": "In what nuanced manner does quercetin navigate and subtly disrupt the orchestrating influence of seminal genetic promoters that are crucial in the nascent phase of prostate cancer genesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    321
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Quercetin indirectly disrupts prostate cancer genesis by blocking the activity of promoters for crucial genes such as #AR# and #PSA#.",
            "predicted_answer": "Quercetin disrupts the activity of genetic promoters, such as AR and PSA, which are critical in the early stages of prostate cancer, thereby preventing its initiation.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized in the reference answer, specifically the disruption of #AR# and #PSA# promoters. The meaning of blocking these genetic promoters aligns with the reference, and no contradictory information is present."
        },
        {
            "query_idx": 644,
            "query": "What complex interplays characterize the transformations of kaempferol 3-rutinoside, and how do these manifest in enhancing the antioxidative defense matrix amidst oxidative perturbations?",
            "retrieved_metrics": {
                "reference_idx": [
                    326
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The complex interplay of #kaempferol 3-rutinoside# increases #antioxidant capacity# and enzyme activities, reducing MDA content, thus enhancing antioxidative defense amidst oxidative perturbations.",
            "predicted_answer": "Kaempferol 3-rutinoside, when metabolized and absorbed as glycosides, enhances the antioxidative defense by increasing T-AOC, SOD, GSH-Px activity, and GSH content, while decreasing MDA, thereby mitigating oxidative stress.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"kaempferol 3-rutinoside\" increasing \"antioxidant capacity\" and reducing \"MDA content,\" aligning well with the reference. It elaborates on specific enzyme activities, maintaining overall trend consistency, with no significant omissions or contradictions."
        },
        {
            "query_idx": 645,
            "query": "In the realm of biochemical interplay, what distinguishes the molecular adhesion propensity of ursolic acid in orchestrating superoxide dismutase activity from the parallel enzyme interaction paradigm presented by quercetin?",
            "retrieved_metrics": {
                "reference_idx": [
                    328
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ursolic acid's #binding affinity# to SOD is higher compared to quercetin, providing enhanced #antioxidant activity# through SOD inhibition.",
            "predicted_answer": "Ursolic acid has a higher binding affinity for inhibiting SOD (-5.4 kcal/mol) compared to quercetin, and it may protect against oxidative brain injury, suggesting a stronger molecular adhesion and antioxidant activity.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts: the higher binding affinity of ursolic acid to SOD and its enhanced antioxidant activity, as emphasized in the reference through the inhibition of SOD. While the phrasing differs, the key points are consistent and aligned with the reference."
        },
        {
            "query_idx": 646,
            "query": "In the realm of metabolic symphony, what transformative influence does the multifarious compound, ellagic acid, exert on the expression rhythm of UCP1, the brown adipose herald, within the storage matrix of lipid-laden rodent physiology?",
            "retrieved_metrics": {
                "reference_idx": [
                    329
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ellagic acid #improved expression# of the #UCP1 gene# in white adipose tissue of obese rats, promoting browning and addressing obesity-related conditions.",
            "predicted_answer": "Ellagic acid promotes the browning of white adipose tissue in obese rodents by enhancing the expression of UCP1, a key protein in brown adipose tissue, thereby improving obesity-related conditions.",
            "score": 3,
            "explanation": "The predicted answer conveys the enhancement of UCP1 expression, promoting browning of white adipose tissue in obese rodents—key points mirrored in the reference. However, it generalizes \"improved expression\" to \"enhancing,\" missing the specific \"UCP1 gene\" detail, though aligning with the trend."
        },
        {
            "query_idx": 647,
            "query": "How does the ethanol-derived phytochemical infusion from R. chingii foliage engage with circulatory and metabolic pathways to exert its pharmacological influence in both empirical laboratory conditions and dynamic biological systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    332
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The ethanol-derived phytochemical infusion from R. chingii foliage exhibits #α-glucosidase# inhibition and has potential #anti-thrombotic effects#, impacting metabolic and circulatory pathways in laboratory and biological systems.",
            "predicted_answer": "The ethanol-derived phytochemicals from R. chingii foliage, including oleanolic and ursolic acids, inhibit α-glucosidase, which helps manage diabetes and metabolic disorders. Additionally, they exhibit anti-thrombotic effects, supporting circulatory health.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts from the reference answer: α-glucosidase inhibition and anti-thrombotic effects. It aligns with the trend of affecting metabolic and circulatory pathways, as mentioned in the reference. There are no significant omissions or errors."
        },
        {
            "query_idx": 648,
            "query": "Within the landscape of genetic pathways and empirical inquiry led by Tang et al., what investigative approaches were employed to affirm the genomic equilibrium of R. chingii Hu, specifically through exploratory trials on mice?",
            "retrieved_metrics": {
                "reference_idx": [
                    334
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tang et al. used the #micronucleus test#, #Ames test#, and sperm abnormality test to affirm the genomic equilibrium of R. chingii Hu in mice.",
            "predicted_answer": "Tang et al. used acute toxicity tests, bone marrow cell micronucleus tests, Ames tests, and sperm abnormality tests in mice to affirm the genomic equilibrium of R. chingii Hu.",
            "score": 5,
            "explanation": "The predicted answer includes the micronucleus test, Ames test, and sperm abnormality test, which are all emphasized in the reference. Additionally, it mentions the acute toxicity tests and bone marrow cell micronucleus tests, providing extra details without contradicting the reference."
        },
        {
            "query_idx": 649,
            "query": "What insights are gleaned from the TEAC assay by Arts et al. in relation to the relative prowess of quercetin in its custodial safeguarding of plasma anti-oxidant capacity vis-à-vis the baseline established by trolox?",
            "retrieved_metrics": {
                "reference_idx": [
                    327
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Arts et al. found quercetin's contribution to plasma anti-oxidant capacity to be #6.24 times# greater than #trolox#, significantly boosting endogenous anti-oxidant protection.",
            "predicted_answer": "The TEAC assay by Arts et al. revealed that quercetin enhances plasma anti-oxidant capacity 6.24 times more effectively than trolox, indicating its superior protective prowess.",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer in key aspects, including the numerical value \"6.24 times\" and the comparison to \"trolox.\" It effectively conveys that quercetin significantly enhances plasma antioxidant capacity, aligning with the trend of the reference answer without omissions or contradictions."
        },
        {
            "query_idx": 650,
            "query": "What is the conjectured biochemical essence harbored within the R. chingii extract that is deemed to impart its significant anti-fungal attributes against pathogenic fungal entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    333
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The conjectured biochemical essence in the R. chingii extract attributed to its significant anti-fungal attributes are the #triterpenoid# components.",
            "predicted_answer": "The conjectured biochemical essence in R. chingii extract with significant anti-fungal properties is likely its triterpenoid components.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key fact emphasized in the Reference Answer, which is the \"triterpenoid\" components responsible for the anti-fungal attributes of R. chingii extract. The information is consistent with the Reference Answer with no significant omissions or errors."
        },
        {
            "query_idx": 651,
            "query": "In the 2015 edition of the pharmacopeial manuscript dedicated to R. chingii Hu, which symbolic molecular entities are entrusted with the task of representing compositional benchmarks for its profound evaluation?",
            "retrieved_metrics": {
                "reference_idx": [
                    335
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The symbolic molecular entities representing compositional benchmarks for R. chingii Hu in 2015 are #ellagic acid# and #kaempferol-3o-rutoside#.",
            "predicted_answer": "In the 2015 edition of the Chinese Pharmacopoeia, ellagic acid and kaempferol-3-o-rutoside are used as the index components for the quality control of R. chingii Hu.",
            "score": 5,
            "explanation": "The 'Predicted Answer' accurately identifies #ellagic acid# and #kaempferol-3o-rutoside# as the symbolic molecular entities, consistent with the 'Reference Answer'. Both answers align on the key facts without contradictions or omissions, covering compositional benchmarks effectively."
        },
        {
            "query_idx": 652,
            "query": "What statistical ensemble, reflecting underlying epidemiological dynamics, represents the probability that a woman will face the emergence of invasive mammary carcinoma throughout her lifespan?",
            "retrieved_metrics": {
                "reference_idx": [
                    337
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The statistical ensemble representing the probability that a woman will face invasive #breast cancer# throughout her lifespan is #1 in 8#.",
            "predicted_answer": "The statistical ensemble that represents the probability of a woman developing invasive mammary carcinoma throughout her lifespan is based on epidemiological data, indicating about 1 in 8 women will develop this cancer.",
            "score": 5,
            "explanation": "The predicted answer captures the key fact that the likelihood is about \"1 in 8\" women, aligning with the statistical ensemble's representation in the reference. However, it uses \"invasive mammary carcinoma\" instead of \"breast cancer,\" which is a synonymous difference, not affecting the overall meaning."
        },
        {
            "query_idx": 653,
            "query": "Within the intricate tapestry of estrogenic modulation in oncological treatments, which potential avenue remains a largely untraversed frontier, particularly reflecting upon catalysts of estrogenic equilibrium yet to be thoroughly exploited in therapeutic paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    338
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The largely untraversed frontier in oncological treatments is targeting #estrogen sulfotransferase# (SULT1E1), which is not yet thoroughly exploited in therapeutic paradigms.",
            "predicted_answer": "Estrogen sulfotransferase (SULT1E1) remains a largely unexplored therapeutic target in estrogen-dependent cancers, offering a potential new avenue for modulating estrogenic equilibrium.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"estrogen sulfotransferase (SULT1E1)\" as the untraversed frontier and aligns with the reference answer regarding its potential as a therapeutic target. No significant details are missing or contradictory; the answer is complete and consistent with the reference."
        },
        {
            "query_idx": 654,
            "query": "What methodical choreography governs the dexterous extraction and infusion process of the nutrient abyss from the cultured matrices, designed to maintain the sanctity of cellular tranquility while orchestrating the unruffled replenishment?",
            "retrieved_metrics": {
                "reference_idx": [
                    343
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The method involves #slow# removal and addition of medium using a #200 ml multichannel pipette# at a 90-degree angle, ensuring no disturbance to the plates.",
            "predicted_answer": "The choreography involves centrifuging plates at 1000 RPM for 5 minutes, carefully removing and replacing three-quarters of the medium every two days with a 200 ml multichannel pipette, ensuring minimal disturbance to maintain cellular tranquility.",
            "score": 3,
            "explanation": "The predicted answer includes using a 200 ml multichannel pipette and ensuring minimal disturbance, matching parts of the reference answer. However, it omits the \"slow\" aspect and the \"90-degree angle,\" which are key details emphasized in the reference. These omissions affect completeness."
        },
        {
            "query_idx": 655,
            "query": "Within the elaborate framework of cellular microcosms, what cascading biochemical influences does STX64 exert upon the autonomously configured cell collectives, particularly when bearing in mind their affinity-driven interactions modulated through the lens of estrogen synthesis and subsequent activity inhibition?",
            "retrieved_metrics": {
                "reference_idx": [
                    345
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "STX64 inhibits #STS# activity, reducing the conversion of inactive estrogen sulfates into #active estrogens# in MCF-7 cell spheroids.",
            "predicted_answer": "STX64 inhibits STS, preventing the activation of inactive estrogen sulfates into active estrogens, thus reducing estrogen activity in MCF-7 cell spheroids. This modulation impacts estrogen-driven cellular processes.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts that STX64 inhibits STS and prevents the conversion of inactive estrogen sulfates into active estrogens, impacting estrogen activity in MCF-7 cell spheroids. It aligns with the reference answer and contains all the crucial details mentioned."
        },
        {
            "query_idx": 656,
            "query": "What quantitative spectrum and chronological sequence delineate the capacity of PPT to exert a discernible influence on the proliferation kinetics of MCF-7 cellular spheroids, as substantiated through methodological findings derived from the t-Test analytical framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    348
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "PPT does not significantly inhibit MCF-7 spheroid growth for 0.05 to 5.0 µM after #two weeks#, but moderately inhibits growth at these concentrations beyond this period.",
            "predicted_answer": "PPT moderately inhibits MCF-7 spheroid growth after two weeks at concentrations between 0.05 to 5.0 µM, as shown by t-Test results. No significant inhibition was observed within the first two weeks.",
            "score": 0,
            "explanation": "The predicted answer correctly indicates the time frame as two weeks and the concentration range of 0.05 to 5.0 µM. However, it inaccurately states that moderate inhibition occurs after two weeks, conflicting with the reference, which specifies that significant effects occur only beyond two weeks."
        },
        {
            "query_idx": 657,
            "query": "What are the dual strategic imperatives of chemical warfare employed against breast malignancy, as articulated within the explanatory framework provided?",
            "retrieved_metrics": {
                "reference_idx": [
                    352
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The dual strategic imperatives are killing unseen #cancer cells# post-surgery (adjuvant) and shrinking tumors pre-surgery (neoadjuvant) for less extensive removal.",
            "predicted_answer": "The dual strategic imperatives of chemical warfare against breast malignancy are adjuvant chemotherapy, to eliminate residual cancer cells and prevent recurrence, and neoadjuvant chemotherapy, to shrink tumors before surgery.",
            "score": 3,
            "explanation": "The 'Predicted Answer' mentions adjuvant and neoadjuvant chemotherapy as strategies, aligning with the 'Reference Answer'. However, it misses the key fact of \"less extensive removal\" related to neoadjuvant therapy, affecting completeness. Overall, it generally follows the trend without contradicting information."
        },
        {
            "query_idx": 658,
            "query": "How do the enzymatic artisans known as SULT1E1 and STS choreograph the biochemical relay of sulfonate transformation and hydrolytic revival, which captures the imagination of pioneers in the realm of estrogen-centric breast cancer therapeutic evolution?",
            "retrieved_metrics": {
                "reference_idx": [
                    351
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "SULT1E1 #sulfates# estrogens for solubility; STS #hydrolyzes# them to active forms, impacting estrogen receptor activity crucial in breast cancer therapy.",
            "predicted_answer": "SULT1E1 sulfates estrogens for circulation, while STS hydrolyzes estrogen sulfates to regenerate active estrogens in target tissues. This interplay influences estrogen-dependent breast cancer, guiding therapeutic strategies.",
            "score": 3,
            "explanation": "The predicted answer covers key processes: SULT1E1 sulfates estrogens and STS hydrolyzes them, affecting breast cancer therapy—consistent with the reference answer. It misses mentioning 'solubility' and 'estrogen receptor activity' explicitly but captures the essence of therapeutic influence."
        },
        {
            "query_idx": 659,
            "query": "In the analysis of spheroidal response within MCF-7 cultures, how do the divergent efficacious signatures and alternative inhibitory pathways of TAM and STX64 manifest in terms of their impact on spheroid integrity and cellular viability?",
            "retrieved_metrics": {
                "reference_idx": [
                    353
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "TAM leads to #spheroid breakdown# and cell death, while STX64 inhibits #spheroid growth# without causing death.",
            "predicted_answer": "TAM causes spheroid breakdown and cell death, while STX64 inhibits spheroid growth by decreasing active estrogens without causing spheroid death. Their divergent mechanisms result in different impacts on spheroid integrity and cellular viability.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts: TAM leads to \"spheroid breakdown\" and cell death, while STX64 inhibits \"spheroid growth\" without causing death. The meanings are consistent, with no key omissions or contradictions regarding spheroid integrity and cellular viability."
        },
        {
            "query_idx": 660,
            "query": "What are the quartet of existential pathways reflected within the HIV-1 genomic panorama, each embodying an odyssey of autonomous interspecies narrative transformations mapped within the central western African milieu?",
            "retrieved_metrics": {
                "reference_idx": [
                    357
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The quartet of existential pathways within the HIV-1 genomic panorama are #lineages M#, #N#, O, and P, each from independent cross-species transmission in central western Africa.",
            "predicted_answer": "The quartet of existential pathways in the HIV-1 genomic panorama refers to the four lineages (M, N, O, and P), each arising from independent interspecies transmissions in central western Africa.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects each of the key lineages: M, N, O, and P, as emphasized in the reference answer. It conveys the same meaning regarding their independent interspecies transmissions in central western Africa, aligning precisely with the reference."
        },
        {
            "query_idx": 661,
            "query": "In the grand design of the HIV-1 M virus, how do the dual outer-layer sentinels, abstractly coined as the signal conduit gp120 and the fusion archetype gp41, manifest within the viral architecture to mediate engagement with the cellular interface of its host?",
            "retrieved_metrics": {
                "reference_idx": [
                    360
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #gp120# glycoprotein acts as a signal conduit, while #gp41# serves as a fusion archetype, both mediating interaction with host cell receptors in HIV-1 M virus.",
            "predicted_answer": "In the HIV-1 M virus, gp120 and gp41 are surface glycoproteins on the outer lipid membrane. Gp120 binds to host cell receptors, while gp41 facilitates the fusion of the viral and cellular membranes, enabling viral entry.",
            "score": 5,
            "explanation": "The predicted answer includes both gp120 and gp41, correctly identifying gp120's role in receptor binding and gp41's role in membrane fusion. This aligns with the reference, covering all key facts without significant omissions or errors. The overall trend is consistent."
        },
        {
            "query_idx": 662,
            "query": "Within the intricate dance of molecular adaptation, what underlying complexities in genomic fluidity and mechanistic evolution contribute to HIV-1's expansive diversity and its profound resonance across global socio-economic landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    362
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "HIV-1's #genetic heterogeneity# is driven by high reverse transcription #error rates#, extensive recombination, and prolific virion generation, enhancing its global socio-economic impact.",
            "predicted_answer": "HIV-1's diversity arises from its high error rate during reverse transcription, extensive recombination, and rapid replication, allowing it to adapt and spread globally, impacting socio-economic landscapes.",
            "score": 3,
            "explanation": "The predicted answer covers most key facts such as high error rates in reverse transcription and recombination. However, it omits the term \"genetic heterogeneity\" present in the reference, which is needed for full completeness. Overall, the trend and impact on socio-economic landscapes are consistent."
        },
        {
            "query_idx": 663,
            "query": "During the final tableau of HIV's existential cycle, what dynamic interplay does the proteolytic architecture constructed by PR invoke in the unleashing of viral assemblies, and in what manner does this interplay critically undermine the stalwart defenses of host cellular immunity?",
            "retrieved_metrics": {
                "reference_idx": [
                    363
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The proteolytic architecture of #PR# releases viral assemblies, depleting #CD4+ T-cells#, leading to the collapse of host cellular immunity.",
            "predicted_answer": "In the final step, PR cleaves viral polyproteins into functional units, enabling mature viral particle assembly. This process is critical for viral infectivity and undermines host immunity by depleting CD4+ T-helper cells, weakening the immune response.",
            "score": 5,
            "explanation": "The predicted answer mentions the role of PR in cleaving polyproteins and the resulting depletion of CD4+ T-helper cells, aligning with the reference's key points on PR, CD4+ T-cell depletion, and weakening host immunity. Thus, it fully covers the emphasized key facts."
        },
        {
            "query_idx": 664,
            "query": "What are the essential challenges that serve as barriers to the optimal functioning of prophylactic strategies, such as pre-exposure and post-exposure pharmacological measures, when operating within the economic and societal terrains of developing regions?",
            "retrieved_metrics": {
                "reference_idx": [
                    365
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The main barriers to effective prophylactic strategies like #PrEP# and #PEP# in developing regions are lack of compliance and challenging affordability.",
            "predicted_answer": "The essential challenges include lack of compliance, high costs making them unaffordable, and the need for consistent, long-term use, which can be difficult in developing regions.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference by identifying lack of compliance and affordability as key challenges. However, it does not mention specific prophylactic strategies like PrEP and PEP, which are critical details highlighted in the reference. Thus, it misses more than one key fact."
        },
        {
            "query_idx": 665,
            "query": "In what ways do innovative immunological frameworks seek to unravel the enigma of carbohydrate-heavy barriers that shroud HIV's protective coat, aiming to forge potent counteroffensive strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    367
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Innovative immunological frameworks focus on inducing #broadly neutralizing antibodies# or using #cytomegalovirus vectors# to target glycosylated barriers of HIV for effective counteroffensive strategies.",
            "predicted_answer": "Innovative immunological frameworks aim to overcome HIV's carbohydrate-heavy barriers by designing immunogens that induce broadly neutralizing antibodies (bnABs) to target conserved epitopes, or by using cytomegalovirus vectors to stimulate CD8+ T-cell responses.",
            "score": 5,
            "explanation": "The predicted answer includes inducing broadly neutralizing antibodies and using cytomegalovirus vectors, both key facts from the reference answer. It also adds the specific targets of these strategies and immune responses. There are no contradictory statements and all key facts are covered."
        },
        {
            "query_idx": 666,
            "query": "What nuanced defensive architectures within the intricate landscape of vaginal mucosa serve as guardian structures, adeptly countering the potential transmission vectors of HIV and other sexually communicated infections?",
            "retrieved_metrics": {
                "reference_idx": [
                    368
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #vaginal mucosa# features a protective #mucus layer#, stratified squamous epithelium, and intercellular connections like tight junctions and desmosomes, guarding against infections.",
            "predicted_answer": "The vaginal mucosa features a stratified squamous epithelium, protective mucus, and tight junctions that reduce permeability, serving as key defensive structures against HIV and other sexually transmitted infections.",
            "score": 3,
            "explanation": "The predicted answer includes the vaginal mucosa, stratified squamous epithelium, protective mucus, and tight junctions, which aligns with the reference. However, it omits \"desmosomes,\" a key detail marked in the reference answer. The overall trend is consistent but lacks completeness."
        },
        {
            "query_idx": 667,
            "query": "What convoluted biological mechanisms underpin the formidable barriers thwarting the realization of a globally effective HIV vaccine, considering the virus's perpetual genomic transformation and its adept evasion of immune fortifications through latent viral repositories?",
            "retrieved_metrics": {
                "reference_idx": [
                    366
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The formidable barriers to a globally effective HIV vaccine include #high mutation rate# causing diversity in HIV strains and #latent viral reservoirs# enabling immune evasion.",
            "predicted_answer": "The high mutation rate of HIV during reverse transcription leads to diverse strains, making it a moving target. Additionally, HIV evades adaptive immune responses and forms latent reservoirs in immune cells, complicating vaccine development.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference answer, such as the #high mutation rate# leading to diverse HIV strains and #latent viral reservoirs# complicating vaccine development. There are no significant omissions or contradictory information, and the overall meaning is preserved."
        },
        {
            "query_idx": 668,
            "query": "What trio of biological artificers does HIV-1 cunningly recruit to execute its ongoing biological integration within the protective realm of host cellular defenders?",
            "retrieved_metrics": {
                "reference_idx": [
                    361
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "HIV-1 recruits the trio of biological artificers: #reverse transcriptase# (RT), #integrase# (IN), and protease (PR) for integration within host cells.",
            "predicted_answer": "HIV-1 recruits reverse transcriptase, integrase, and protease to execute its integration within host cells.",
            "score": 3,
            "explanation": "The Predicted Answer includes reverse transcriptase and integrase but omits protease, which is one of the key facts emphasized in the Reference Answer. The answer aligns with the overall trend of the Reference Answer but lacks completeness due to this omission."
        },
        {
            "query_idx": 669,
            "query": "What enzymatic catalysts are incapacitated through pharmacological interventions to unravel the replication apparatus of HIV, aiming to mitigate its viral signature?",
            "retrieved_metrics": {
                "reference_idx": [
                    364
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Antiretroviral drugs incapacitate #reverse transcriptase#, #integrase#, and protease to paralyze HIV's replication machinery and mitigate its viral signature.",
            "predicted_answer": "Pharmacological interventions target and incapacitate HIV's reverse transcriptase, integrase, and protease, disrupting the virus's replication and reducing its viral load.",
            "score": 5,
            "explanation": "The predicted answer includes all key enzymes (#reverse transcriptase# and #integrase#) mentioned in the reference answer. It accurately reflects the impact on replication and viral load, maintaining alignment with the reference's overall trend without significant omissions or contradictions."
        },
        {
            "query_idx": 670,
            "query": "What mechanisms do vaginal epithelial cells employ as custodians of microbial equilibrium to ensure the perpetuation of an acidic ecological niche within the cervicovaginal domain, acting both as barriers and metabolic supporters?",
            "retrieved_metrics": {
                "reference_idx": [
                    380
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Vaginal epithelial cells maintain microbial equilibrium by producing glycogen, which aids lactobacilli fermentation, and form a #physical barrier# comprising multiple layers, fostering an #acidic niche#.",
            "predicted_answer": "Vaginal epithelial cells produce and store glycogen, which lactobacilli ferment to produce lactic acid, maintaining an acidic pH that inhibits pathogens. The stratified squamous epithelium also acts as a physical barrier against microbial invasion.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as glycogen production for lactobacilli fermentation, the creation of lactic acid for maintaining acidity, and the role of the stratified squamous epithelium as a physical barrier. All essential elements from the reference are present, with no omissions or contradictions."
        },
        {
            "query_idx": 671,
            "query": "What multifarious and territorially entrenched aspects of the anatomical layout associated with pancreatic tumors are responsible for rendering surgical navigations exceedingly arduous, exacerbated by the tumor's invasive synergy with contiguous organ systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    382
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #location# of pancreatic tumors in the #abdominal retroperitoneal space# and their infiltration into neighboring organs make surgical navigation exceedingly arduous.",
            "predicted_answer": "Pancreatic tumors are deeply embedded in the retroperitoneal space, surrounded by vital organs and vessels. Their invasive growth into neighboring structures makes surgical navigation extremely challenging.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts from the reference: the #location# of pancreatic tumors in the #retroperitoneal space# and their invasive growth into nearby structures, making surgery challenging. Key details are present, the trend is aligned, and accuracy is maintained."
        },
        {
            "query_idx": 672,
            "query": "In the elaborate symphony of oncogenic advancement, how do tumor-associated neutrophils (TANs), as polarized harmonizers in the immunological ensemble, influence the metamorphosis and metastatic journey of cancerous entities through their transformational attributes and molecular harmonics within the intricate tapestry of the tumor's microcosmic environment?",
            "retrieved_metrics": {
                "reference_idx": [
                    390
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tumor-associated neutrophils (#TANs#) in the #tumor# microenvironment enhance cancer progression and metastasis by promoting an immunosuppressive phenotype and secreting cytokines and proteases.",
            "predicted_answer": "Tumor-associated neutrophils (TANs), when polarized to an N2 phenotype, promote tumor progression and metastasis by secreting cytokines and proteases that remodel the tumor microenvironment and enhance immunosuppression.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of TANs, tumor microenvironment, immunosuppression, cytokine, and protease secretion as indicated in the reference. It provides an accurate and comprehensive response to the question, fully aligning with the critical elements of the reference."
        },
        {
            "query_idx": 673,
            "query": "In what manner do regulatory architects craft a covert suppressive ecosystem that subtly alters the operational dynamics of cytotoxic agents within the complex contours of tumor domains, thereby affecting their infiltration and functional capacity?",
            "retrieved_metrics": {
                "reference_idx": [
                    391
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Regulatory architects create a #covert suppressive ecosystem# by secreting cytokines like TGF-ß and IL-10, inhibiting cytotoxic agents and #facilitating immune evasion# within tumor domains.",
            "predicted_answer": "Regulatory T cells (Tregs) secrete cytokines like TGF-β and IL-10, inhibiting cytotoxic CD8+ T cells, CD4+ T-helper cells, and NK cells. This creates an immunosuppressive environment that hinders the infiltration and function of these cytotoxic agents in tumor domains.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of creating an immunosuppressive environment using cytokines TGF-β and IL-10, aligning with the reference answer. However, it misses explicitly mentioning \"facilitating immune evasion,\" impacting the completeness due to one missing key fact."
        },
        {
            "query_idx": 674,
            "query": "What particular genomic contingents, belonging to the viral entity and its cellular residing partners, found themselves at the focal point of strategic molecular choreography, contrived through the application of cholesterol-bound genetic silencers, to hinder HSV-2's invasive endeavor in the murine model?",
            "retrieved_metrics": {
                "reference_idx": [
                    377
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The chol-siRNAs targeted #HSV-2# viral genes and #EC host genes# required for viral entry to inhibit infection in mice.",
            "predicted_answer": "The focal genomic targets included HSV-2 viral genes and endothelial cell (EC) host genes required for viral entry, which were inhibited using cholesterol-conjugated siRNAs (chol-siRNAs) in a murine model.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts: #HSV-2# viral genes and #EC host genes# necessary for viral entry, and their inhibition using chol-siRNAs. The phrasing aligns with the reference, maintaining completeness and consistency with no omissions or contradictions."
        },
        {
            "query_idx": 675,
            "query": "In the complex orchestration of pharmacological itineraries, what intrinsic obstacles complicate the transit of medicinal compounds to skeletal strongholds, and how do these diverge, akin to contrasting courses, from the formidable barriers encountered when penetrating the cerebral bastions of neural metastasis?",
            "retrieved_metrics": {
                "reference_idx": [
                    400
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #blood-bone barrier# and #dense bone matrix# impede drug transit to bones, unlike the blood-brain barrier, which challenges drug delivery to cerebral metastasis.",
            "predicted_answer": "Intrinsic obstacles for drug delivery to bones include the blood-bone barrier, dense bone matrix, and poor drug solubility. For brain metastasis, the primary barrier is the blood-brain barrier, which restricts drug entry.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as the \"blood-bone barrier\" and \"dense bone matrix\" for obstacles in delivering drugs to bones, similar to the reference. It also mentions the \"blood-brain barrier\" for brain metastasis, fully aligning with the reference. No significant details are missing."
        },
        {
            "query_idx": 676,
            "query": "In the evolving landscape of oncological sciences, what are the intricate trademarks of pancreatic cancer that construct formidable fortresses around therapeutic efficacy, thereby obstructing the seamless progress of treatment paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    401
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate trademarks of pancreatic cancer obstructing treatment include its #specific TME# and #broad genetic diversity#, which hinder therapeutic efficacy.",
            "predicted_answer": "The hallmarks of pancreatic cancer, such as its specific tumor microenvironment (TME), broad genetic diversity, and high metastatic potential, create significant barriers to effective treatment, hindering the progress of therapeutic strategies.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts emphasized with # in the reference answer: the \"specific TME\" and \"broad genetic diversity.\" Additionally, it introduces \"high metastatic potential\" as a further challenge, which aligns with the overall negative impact on therapeutic efficacy without contradicting the reference."
        },
        {
            "query_idx": 677,
            "query": "In what manner does the labyrinthine diversity of clonal entities within a tumor mold the dependability of singular histological evaluations in capturing the holistic genetic portrait necessary for crafting oncologic therapeutic avenues and prospective prognostic insights?",
            "retrieved_metrics": {
                "reference_idx": [
                    402
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #diversity# of clonal entities within a tumor limits the accuracy of singular histological evaluations in capturing its complete genetic portrait necessary for #treatment# and prognostic guidance.",
            "predicted_answer": "The diverse clonal entities within a tumor, driven by continuous genetic and epigenetic changes, lead to a highly dynamic and heterogeneous environment. This makes single histological evaluations insufficient for capturing the full genetic profile, complicating accurate treatment and prognosis.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the clonal diversity in tumors affecting the completeness of singular histological evaluations, aligning with treatment and prognostic challenges. Both answers mention the impact of genetic heterogeneity on treatment and prognosis. No significant details are missing, matching the key points."
        },
        {
            "query_idx": 678,
            "query": "What mechanisms do the emissarial cellular constructs from neoplasm sites employ to refine distant ecological sanctuaries, thereby nurturing the ascension of colonizing cellular insurgents in unprepared anatomical domains?",
            "retrieved_metrics": {
                "reference_idx": [
                    399
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Emissarial cellular constructs utilize #exosomes# from primary tumors to induce a #premetastatic niche#, enhancing colonization by metastatic cells in distant anatomical sites.",
            "predicted_answer": "Neoplasm-derived exosomes, carrying tumorigenic micro-RNAs like miR-200, help create a premetastatic niche in distant tissues, facilitating the colonization of circulating tumor cells. Changes in the primary tumor's microenvironment can also mobilize more potent cells for metastasis.",
            "score": 5,
            "explanation": "The predicted answer includes the key elements of \"exosomes\" and \"premetastatic niche,\" aligning with the reference. It enhances details by discussing micro-RNAs and primary tumor microenvironment changes. No significant omissions or contradictory information affect the overall trend and meaning."
        },
        {
            "query_idx": 679,
            "query": "What life prolongation dynamics, metaphorically illustrating the augmentation of the horizon of being, are associated with the intricate regimen of FOLFIRINOX as aligned against the singular trajectory of gemcitabine treatment in the realm of advanced pancreatic cancer patients?",
            "retrieved_metrics": {
                "reference_idx": [
                    405
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "FOLFIRINOX extends median #overall survival# in advanced pancreatic cancer patients by #4 months# compared to gemcitabine alone.",
            "predicted_answer": "FOLFIRINOX, a combination of folinic acid, fluorouracil, irinotecan, and oxaliplatin, extends life by about 4 months compared to gemcitabine alone in advanced pancreatic cancer patients.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts from the reference: FOLFIRINOX extends life \"by about 4 months\" and applies this to \"advanced pancreatic cancer patients,\" clearly matching the emphasis on \"overall survival\" and \"4 months\" extension. Phrasing differences do not alter the meaning."
        },
        {
            "query_idx": 680,
            "query": "What process of molecular enhancement involves the metaphorical adornment of therapeutic substances with an adaptive polymer sheath, stepping up their persistence within the circulatory expanse?",
            "retrieved_metrics": {
                "reference_idx": [
                    404
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The process is #pegylation#, involving the attachment of polyethylene glycol, enhancing therapeutic substances' persistence within the circulation.",
            "predicted_answer": "The process involves pegylation, where therapeutic substances are metaphorically adorned with a polyethylene glycol sheath, enhancing their persistence in the circulatory system.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts emphasized in the reference answer: the process being \"pegylation\" and the role of \"polyethylene glycol\" in enhancing persistence within the circulatory system. The phrasing might differ slightly, but the core information is present and consistent."
        },
        {
            "query_idx": 681,
            "query": "Within the intricate tapestry of the tumorous domain, what inherent function do the pancreatic architectural weavers fulfill in reinforcing the complex stromal matrix, and by what pathways might molecular modulators such as losartan intervene in reshaping these cellular dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    410
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Pancreatic #stellate cells# produce collagen and hyaluronan, reinforcing the stromal matrix. #Losartan# targets these cells, inhibiting their proliferation and reshaping tumor dynamics.",
            "predicted_answer": "Pancreatic stellate cells (PSCs) produce collagen and hyaluronan, reinforcing the stromal matrix. Losartan, an angiotensin inhibitor, can intervene by inhibiting PSC proliferation, thus reducing tumor-promoting effects.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies pancreatic stellate cells (PSCs) and their role in producing collagen and hyaluronan, reinforcing the stromal matrix, and mentions losartan as a modulator inhibiting PSC proliferation. All key facts marked with # in the reference answer are present in the prediction, with consistent meaning."
        },
        {
            "query_idx": 682,
            "query": "Within the complex framework of strategic therapeutic endeavors targeting malignancies, what tactical advantage does verapamil provide in navigating the molecular defense mechanisms constituted by efflux-pump-associated multidrug resistance barriers?",
            "retrieved_metrics": {
                "reference_idx": [
                    413
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Verapamil offers a tactical advantage by #inhibiting efflux pumps#, potentially overcoming #multidrug resistance# and enhancing chemotherapy effectiveness.",
            "predicted_answer": "Verapamil, as an efflux pump inhibitor, helps overcome multidrug resistance by blocking P-gp, preventing cancer cells from expelling chemotherapeutics and thus enhancing treatment efficacy.",
            "score": 5,
            "explanation": "The Predicted Answer captures the key facts from the Reference Answer by indicating that verapamil inhibits efflux pumps and addresses multidrug resistance, enhancing chemotherapy effectiveness. The main concepts are aligned, with no significant omissions or contradictory information."
        },
        {
            "query_idx": 683,
            "query": "In the nuanced landscape of precision oncology, what strategic function does the Know Your Tumor ® paradigm fulfill as a cartographer in delineating the intricate map of individually-tailored therapeutic strategies, and how does it influence the evolutionary journey towards optimized therapeutic endpoints for individuals confronting pancreatic malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    414
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Know Your Tumor®# program serves as a strategic #cartographer#, utilizing molecular tumor profiling to personalize therapy and improve outcomes for pancreatic cancer patients by identifying actionable mutations.",
            "predicted_answer": "The Know Your Tumor ® paradigm serves as a cartographer by profiling tumors genetically to tailor personalized therapies. It identifies actionable mutations in about half of pancreatic cancer patients, guiding the selection of targeted treatments and optimizing therapeutic outcomes.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts emphasized in the reference answer: the Know Your Tumor® program acts as a cartographer through molecular tumor profiling, identifies actionable mutations, and aims to improve outcomes. All emphasized points are present with consistent meaning, although with different phrasing."
        },
        {
            "query_idx": 684,
            "query": "What is the symbiotic immunological orchestrating required to facilitate a harmonized cellular and humoral defense within a therapeutic oncological vaccine designed to target an ensemble of tumorigenic signatures?",
            "retrieved_metrics": {
                "reference_idx": [
                    417
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #therapeutic# vaccine requires orchestrating both #humoral# and T-cell responses, activating CD4+ T-helper cells and CD8+ cytotoxic T lymphocytes, targeting multiple tumorigenic antigens.",
            "predicted_answer": "A therapeutic oncological vaccine requires a symbiotic immunological orchestration that activates both humoral and cellular responses, including the generation of neutralizing antibodies and the activation of CD4+ T-helper and CD8+ cytotoxic T lymphocytes, to target multiple tumorigenic antigens.",
            "score": 5,
            "explanation": "The Predicted Answer accurately covers all key aspects emphasized in the Reference Answer. It mentions the requirement for orchestrating humoral and T-cell responses and specifies the activation of CD4+ T-helper and CD8+ cytotoxic T lymphocytes, along with the targeting of multiple tumorigenic antigens. The overall trend and key facts are aligned."
        },
        {
            "query_idx": 685,
            "query": "What intricately convoluted anatomical systems predispose the hepatic domain to preferential colonization by pancreatic neoplastic cells, and how do these spatial and structural complexities contrast with the elevated surgical hurdles faced when addressing cerebral metastatic challenges?",
            "retrieved_metrics": {
                "reference_idx": [
                    418
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Pancreatic cancer cells metastasize to the #liver# due to the portal vein connection, whereas #brain# metastasis is rarer and more challenging surgically, lacking regenerative capabilities.",
            "predicted_answer": "The hepatic domain is predisposed to colonization by pancreatic neoplastic cells due to the portal vein, which directly connects the pancreas to the liver. In contrast, cerebral metastases are rare and pose greater surgical challenges due to the brain's complex and sensitive anatomy.",
            "score": 3,
            "explanation": "The predicted answer covers the key fact of the portal vein connection predisposing the liver to pancreatic cancer cell metastasis, and it recognizes the surgical challenge of cerebral metastases. However, it misses the detail of the brain's lack of regenerative capabilities, which slightly impacts completeness."
        },
        {
            "query_idx": 686,
            "query": "What emergent effects might arise from employing agents designed to obscure the cryptic dialogue within oncogenic landscapes, specifically through Hedgehog signaling inhibitors, in the endeavor to attenuate the relentless tide of cancerous proliferation?",
            "retrieved_metrics": {
                "reference_idx": [
                    422
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The use of Hedgehog #inhibitors# is likely to #slow down# cancer progression by affecting the tumor microenvironment and metastasis.",
            "predicted_answer": "Employing Hedgehog signaling inhibitors may reduce cancer proliferation and metastasis by altering the tumor microenvironment. These agents, such as vismodegib and sonidegib, are in clinical trials and show potential in slowing down cancer progression.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of using Hedgehog inhibitors to slow cancer progression by affecting the tumor microenvironment and metastasis. It aligns with the reference answer and includes additional detail about specific agents and clinical trials, without any contradiction."
        },
        {
            "query_idx": 687,
            "query": "What distinct junctures in the voyage of neoplastic cellular transitions, characterized by shifts in identity and spatial engagements, elucidate potential interventional loci promising for therapeutic modulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    421
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The distinct junctures include #epithelial-mesenchymal transformation# at the primary tumor, migration as #circulating tumor cells#, and formation of metastatic colonies in distant organs.",
            "predicted_answer": "The distinct junctures in neoplastic cellular transitions include epithelial-mesenchymal transformation, migration as circulating tumor cells, and formation of metastatic colonies, each offering potential interventional loci for therapeutic modulation.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized by # symbols in the reference answer: \"epithelial-mesenchymal transformation,\" \"circulating tumor cells,\" and \"formation of metastatic colonies.\" The overall meaning aligns well, and there are no contradictions or significant omissions."
        },
        {
            "query_idx": 688,
            "query": "What intricate interplay exists within the oncogenic biosphere when the mechanistic catalyst known as mTOR is modulated, ensuing in a potential bifurcation of chemotherapy resilience and susceptibility among malignant cellular contingencies?",
            "retrieved_metrics": {
                "reference_idx": [
                    423
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The modulation of #mTOR# influences an intricate interplay, potentially leading to bifurcation by fostering #chemotherapy resistance# and simultaneously increasing chemosensitivity in certain cancer cell populations.",
            "predicted_answer": "mTOR modulation can both increase and decrease chemotherapy sensitivity in cancer cells. Inhibiting mTOR may promote resistance, while activation in some resistant cells can enhance chemosensitivity, highlighting the complex role of mTOR in cancer treatment.",
            "score": 5,
            "explanation": "The Predicted Answer captures the essential points from the Reference Answer: mTOR's modulation leads to both increased chemotherapy resistance and sensitivity in different cancer cells. Both answers emphasize the complex interplay of mTOR modulation in cancer treatment without contradicting each other, maintaining accuracy and completeness."
        },
        {
            "query_idx": 689,
            "query": "What paradigm of therapeutic intervention, utilizing biomimetic nanostructures cloaked in platelet-like membranes, was evidenced to disrupt the metastatic trajectory orchestrated by CTCs and simultaneously orchestrate the assembly of immune sentinels within a rodent oncological framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    425
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #paradigm# utilizes #platelet-coated# nanoparticles to prevent metastasis formation and recruit T cells to CTCs, as demonstrated in a rodent cancer model.",
            "predicted_answer": "The paradigm of therapeutic intervention involves using platelet membrane-cloaked nanoparticles to deliver drugs like PD-L1 antibodies and sorafenib, which disrupt CTC-mediated metastasis and recruit T cells, enhancing immune surveillance in a rodent cancer model.",
            "score": 5,
            "explanation": "The predicted answer mentions \"platelet membrane-cloaked\" nanoparticles, aligning with \"platelet-coated\" in the reference, and correctly describes disrupting metastasis and T cell recruitment. There is a minor addition about specific drugs, which does not contradict the reference. All key aspects are reflected, reflecting consistent trends."
        },
        {
            "query_idx": 690,
            "query": "In what manner do primary molecular access points and additional cellular channels orchestrate the intricate engagement process of AAV serotype 2 with the cellular microenvironment?",
            "retrieved_metrics": {
                "reference_idx": [
                    433
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Primary molecular access points like #heparan sulfate proteoglycans# coordinate with secondary receptors such as #FGFR# and c-Met to mediate AAV2's engagement with cellular environments.",
            "predicted_answer": "AAV2 engages with the cellular microenvironment through primary attachment to heparan sulfate proteoglycans and secondary interactions with FGFR, integrin, and c-Met, facilitating its entry into cells.",
            "score": 5,
            "explanation": "The predicted answer includes key facts about AAV2 engagement with heparan sulfate proteoglycans, FGFR, and c-Met, aligning with the reference. However, it omits integrin, which is not emphasized in the reference. The overall trends and key facts are well-represented in the predicted answer."
        },
        {
            "query_idx": 691,
            "query": "Amidst the intricate dance of cellular safeguard and genetic augmentation, wherein viral vectors are meticulously harnessed as agents of genetic restoration, what array of pathophysiological phenomena is presently under systematic investigation within the context of clinical trial enterprises exploring these viral avenues for gene transfer therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    432
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Viral vectors are being investigated in clinical trials for treating #cardiovascular# diseases, muscular, metabolic, neurological, hematological, ophthalmological diseases, infectious disorders, and #cancers#.",
            "predicted_answer": "Clinical trials are investigating the use of viral vectors, such as adenovirus, AAV, retroviral, and lentiviral vectors, to treat a range of diseases including cardiovascular, muscular, metabolic, neurological, hematological, ophthalmological, infectious disorders, and cancers.",
            "score": 5,
            "explanation": "The predicted answer closely matches the reference answer, covering all the key facts: cardiovascular diseases and cancers, along with other diseases mentioned. The overall trend and details are consistent with the reference. There are no significant omissions or errors, fulfilling the criteria for full coverage."
        },
        {
            "query_idx": 692,
            "query": "What critical juncture marked the cessation of uninhibited zeal for genetic therapy explorations at the tail end of the 20th century?",
            "retrieved_metrics": {
                "reference_idx": [
                    434
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The critical juncture was the #1999# death of an #18-year-old# receiving gene therapy, which resulted in a lethal immune reaction.",
            "predicted_answer": "The critical juncture was in 1999 when an 18-year-old patient died due to a lethal immune reaction to the viral vector used in gene therapy, which significantly dampened enthusiasm for genetic therapy explorations.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference: the year (1999), the patient's age (18 years old), the event (a death during gene therapy), and the cause (a lethal immune reaction). It accurately captures and expands on these details without introducing contradictions."
        },
        {
            "query_idx": 693,
            "query": "What transformative episode catalyzed a significant alteration in the pathway of gene-therapy innovations, inducing a notable hiatus in the realm of biomedical exploration, eventually leading to a rejuvenation period?",
            "retrieved_metrics": {
                "reference_idx": [
                    436
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The transformative episode was the activation of an #oncogene# in five SCID-X1 children causing #leukemia#, halting gene-therapy development until a recent renaissance.",
            "predicted_answer": "The transformative episode was the development of leukemia in children with SCID-X1 following gene therapy, which caused a significant hiatus in gene-therapy research due to the risk of oncogenesis, before a renaissance occurred.",
            "score": 3,
            "explanation": "The predicted answer accurately reflects the transformative episode involving the development of leukemia in SCID-X1 children, referencing the oncogenesis risk that led to a hiatus in gene-therapy research and a subsequent renaissance. However, it omits the specific mention of the \"#oncogene#\" activation, which was a crucial detail in the reference answer."
        },
        {
            "query_idx": 694,
            "query": "Which pioneering intervention, delivered by a molecular chariot and marking a significant milestone in the authoritative quest to rectify an inherited metabolic conundrum, emerged as the foremost sanction of its kind within the domain of rAAV-transported solutions?",
            "retrieved_metrics": {
                "reference_idx": [
                    437
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The pioneering intervention is #alipogene tiparvovec# (Glybera), an #EMA-approved# gene therapy using rAAV to treat familial lipoprotein lipase deficiency, approved in 2012.",
            "predicted_answer": "Alipogene tiparvovec (Glybera), delivered via an rAAV vector, was the pioneering intervention approved by EMA in 2012 for treating familial lipoprotein lipase deficiency.",
            "score": 5,
            "explanation": "The Predicted Answer accurately includes all key facts emphasized in the Reference Answer: \"alipogene tiparvovec,\" \"EMA-approved,\" and the approval year \"2012.\" It also aligns with the overall trend, covering gene therapy using an rAAV vector and targeting familial lipoprotein lipase deficiency, with no significant omissions."
        },
        {
            "query_idx": 695,
            "query": "In the context of a transgenic murine conduit simulating the visceral journey of prostate carcinoma towards osseous territories, what sophisticated biochemical confrontation was employed to avert the skeletal ensnarement by malignant cells, and through what intricate cellular ballet did it execute its preventive quest?",
            "retrieved_metrics": {
                "reference_idx": [
                    424
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Atelocollagen-delivered #miR-16# was used to prevent skeletal metastasis by regulating #cell-cycle control# genes in a prostate cancer murine model.",
            "predicted_answer": "In the murine model, atelocollagen-delivered miR-16 was used to inhibit bone metastasis by regulating cell-cycle control genes, preventing the establishment of a favorable tumor microenvironment.",
            "score": 5,
            "explanation": "The predicted answer correctly mentions the use of atelocollagen-delivered miR-16 to prevent metastasis, aligns with the reference on regulating cell-cycle control genes, and addresses the use of a murine model. It covers all key facts emphasized in the reference answer."
        },
        {
            "query_idx": 696,
            "query": "What conceptual frameworks or strategic insights inspire the advent of gene therapy as a paradigm-shifting solution for hemophilia A, considering the intricate balance of its therapeutic promise against the enduring complexities of existing treatment modalities?",
            "retrieved_metrics": {
                "reference_idx": [
                    443
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The advent of #gene therapy# as a paradigm-shifting solution for hemophilia A is inspired by the promise of a curative approach and reducing the #bleeding phenotype# substantially.",
            "predicted_answer": "The advent of gene therapy for hemophilia A is inspired by the need to address the limitations of existing treatments, such as the high cost and frequent administration of emicizumab. Gene therapy aims to provide a curative approach by raising factor VIII levels above 10-15%, significantly reducing bleeding and improving patient outcomes.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by mentioning the advent of gene therapy and its curative promise for hemophilia A. It correctly addresses reducing bleeding and improving outcomes. However, it lacks explicit mention of the \"bleeding phenotype,\" despite covering the overall trend well."
        },
        {
            "query_idx": 697,
            "query": "What are the dual impediments that manifest as fading echoes of transgene presence within the vector-borne genetic blueprint in rAAV-mediated therapeutic ventures?",
            "retrieved_metrics": {
                "reference_idx": [
                    439
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Transgene presence fades due to #episomal loss# during cell division, and #epigenetic silencing# of vector genomes, necessitating redosing in rAAV-mediated therapies.",
            "predicted_answer": "The dual impediments are the loss of episomes during cell division and epigenetic silencing of transgene expression, leading to a decline in therapeutic efficacy over time.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies both key factors: the #episomal loss# and #epigenetic silencing# of the transgene, which are pivotal in the reference answer. It aligns with the overall trend and does not miss any critical detail essential for understanding the therapeutic challenge."
        },
        {
            "query_idx": 698,
            "query": "Within the hepatic microcosm, which cellular architects primarily oversee the liberation of factor VIII, and what ripple effects do these entities engender in the clinical symphony of hemophilia A's characteristic manifestations?",
            "retrieved_metrics": {
                "reference_idx": [
                    442
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Factor VIII is primarily released by #sinusoidal endothelial# cells in the liver, and its deficiency in hemophilia A leads to joint and muscle bleeding, causing significant morbidity.",
            "predicted_answer": "Sinusoidal endothelial cells in the liver primarily oversee the liberation of factor VIII. A deficiency in this factor leads to hemophilia A, characterized by joint and muscle bleeding, which can cause arthropathy and, in severe cases, fatal intracranial bleeds.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies sinusoidal endothelial cells as the primary release source of factor VIII and notes its deficiency leads to joint and muscle bleeding, aligning with the reference. Both accounts reflect the clinical manifestations of hemophilia A. Additional details in the prediction don't contradict the reference."
        },
        {
            "query_idx": 699,
            "query": "In the intricate symphony of genetic engineering aimed at addressing hemophilia A, what nuanced alteration within the AAV5 molecular conveyance mechanism enabled it to encapsulate and convey the recontextualized blueprint of the coagulation FVIII gene, surmounting inherent dimensional limitations?",
            "retrieved_metrics": {
                "reference_idx": [
                    445
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #AAV5 vector# encapsulates the #B-domain deleted# version of the coagulation FVIII gene, reducing its size to 4.9 kb to fit within packaging constraints.",
            "predicted_answer": "The AAV5 vector in Roctavian was modified to carry a B-domain deleted version of the FVIII gene, reducing its size to 4.9 kb to fit within the packaging capacity, enabling effective gene delivery.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference answer: it mentions the AAV5 vector, the B-domain deleted version of the FVIII gene, and the reduction in size to 4.9 kb. These details align with the reference's emphasis, ensuring accuracy and completeness."
        },
        {
            "query_idx": 700,
            "query": "What potential metamorphoses within the chronicle of managing congenital coagulopathies do prolonged-release medical agents herald, especially when juxtaposed with the enduring tribulations of perpetual therapeutic regimens?",
            "retrieved_metrics": {
                "reference_idx": [
                    446
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Prolonged-release agents in congenital coagulopathy management could ease #therapeutic burden# by reducing the frequency of intravenous injections and improving #bioavailability# of clotting factors.",
            "predicted_answer": "Prolonged-release agents in managing congenital coagulopathies, like hemophilia, reduce dosing frequency and improve bioavailability, potentially easing the burden of perpetual therapeutic regimens.",
            "score": 5,
            "explanation": "The predicted answer successfully covers the key facts emphasized in the reference answer, specifically the reduction in dosing frequency (#therapeutic burden#) and improvement in #bioavailability#. Both answers align on the major trend of easing the perpetual therapeutic burden through these benefits."
        },
        {
            "query_idx": 701,
            "query": "What intrinsic factor enables Hemgenix to perpetuate enduring genetic presence, whereas Roctavian contends with diminishing molecular continuity within circulatory networks?",
            "retrieved_metrics": {
                "reference_idx": [
                    451
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "An intrinsic factor enabling #Hemgenix#'s enduring genetic presence is the #FIX-Padua variant#, which provides sustainable higher activity, unlike Roctavian's declining plasma FVIII levels.",
            "predicted_answer": "Hemgenix enables enduring genetic presence through stable transgene expression of FIX in hepatocytes, which natively produce FIX. The FIX-Padua variant also has higher specific activity. Roctavian faces declining FVIII levels in the bloodstream.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts of Hemgenix's enduring genetic presence via the FIX-Padua variant, which has higher activity. It also acknowledges Roctavian's declining FVIII levels. The key information from the Reference Answer is fully reflected in the Predicted Answer without omissions or errors."
        },
        {
            "query_idx": 702,
            "query": "What are the inherent attributes and biological nuances that lend extracellular vesicles superiority as conveyors of therapeutic genetic blueprints when juxtaposed against the conventional viral entities within gene therapy paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    455
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Extracellular vesicles are superior due to their #non-immunogenic# nature, #biodegradability#, universal availability, and ability to cross biological barriers, including the blood-brain barrier.",
            "predicted_answer": "Extracellular vesicles (EVs) are non-immunogenic, inert, and biodegradable. They can pass through biological barriers, including the blood-brain barrier, making them superior for delivering therapeutic genetic material compared to immunogenic viral vectors.",
            "score": 3,
            "explanation": "The predicted answer includes key facts of \"non-immunogenic\" and \"biodegradable\" nature, and the ability to cross biological barriers, like the blood-brain barrier. However, it omits the \"universal availability\" attribute, indicating a minor gap in completeness."
        },
        {
            "query_idx": 703,
            "query": "How do the intricate refinements within the architecture of AAV vectors orchestrate the amplified efficacy of gene therapy 2.0, heralding a substantial departure from the foundational limitations of its antecedent iteration?",
            "retrieved_metrics": {
                "reference_idx": [
                    450
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate refinements in #AAV vectors# lead to #amplified efficacy# by enabling targeted transgene delivery and optimizing packaging, reducing risks like insertional mutagenesis compared to gene therapy 1.0.",
            "predicted_answer": "The intricate refinements in AAV vectors, such as targeted cellular delivery and optimized transgene packaging, enhance gene expression and safety, significantly improving the efficacy of gene therapy 2.0 over its predecessor.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts of \"AAV vectors\" and \"amplified efficacy\" through targeted delivery and optimized packaging. However, it omits the specific reduction of risks such as \"insertional mutagenesis\" from the reference answer, affecting completeness."
        },
        {
            "query_idx": 704,
            "query": "In the intricate ballet of molecular change, what role do the evolving architectures of DNA methylation blueprints play in weaving the tale of tumor advancement and the enigmatic journey of metastasis?",
            "retrieved_metrics": {
                "reference_idx": [
                    458
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Evolving #DNA methylation# architectures orchestrate tumor #progression# and metastasis by altering methylation patterns, impacting gene expression in tumors.",
            "predicted_answer": "DNA methylation blueprints, through their evolving architectures, orchestrate tumor progression and metastasis by altering gene expression patterns, which are crucial for these processes.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts: evolving DNA methylation architectures, their role in tumor progression, and metastasis through gene expression alteration, aligning with the reference answer. However, it lacks explicit mention of \"altering methylation patterns,\" slightly affecting completeness. Overall, the trend is maintained."
        },
        {
            "query_idx": 705,
            "query": "In the grand chessboard of cellular transformation, how does the fluidity of epigenomic modulation enhance its appeal for novel therapeutic avenues, juxtaposed with the unyielding nature of genomic alterations in crafting anticancer strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    460
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #fluidity# of epigenomic modulation enhances therapeutic appeal through its #reversibility# compared to the unyielding nature of permanent genomic alterations in anticancer strategies.",
            "predicted_answer": "The fluidity of epigenomic modulation, through reversible changes in DNA methylation and histone marks, offers dynamic therapeutic targets. This contrasts with the unyielding nature of genomic alterations, making epigenetic approaches more appealing for flexible and adaptable anticancer strategies.",
            "score": 5,
            "explanation": "The predicted answer encompasses key facts from the reference, such as the #fluidity# and #reversibility# of epigenomic modulation, contrasting it with genomic alterations, aligning with the reference’s overall theme on therapeutic appeal. No significant omissions or errors are present."
        },
        {
            "query_idx": 706,
            "query": "What nuanced divergence manifests within the cellular microcosms of life, when juxtaposing the cryptic silencing rituals of promoter-anchored CpG islands with the ubiquitous yet subtly structured methylation of gene bodies, across the dualistic nature of oncogenic and physiologic cellular realities?",
            "retrieved_metrics": {
                "reference_idx": [
                    463
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Promoter-anchored CpG #hypermethylation# silences tumor suppressor genes in #cancer# cells, while gene body methylation maintains active gene expression in normal physiology, but diminishes in cancer.",
            "predicted_answer": "Promoter-anchored CpG island hypermethylation silences tumor suppressor genes in cancer, while gene body methylation is common in active genes in normal cells. Cancer exhibits global hypomethylation, leading to chromosomal instability and reactivation of transposable elements.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts of promoter-anchored CpG hypermethylation silencing tumor suppressor genes in cancer and gene body methylation's role in active gene expression. However, it misses the diminished gene body methylation in cancer, affecting completeness. Overall trend alignment is present."
        },
        {
            "query_idx": 707,
            "query": "What mechanisms do the consortiums of bromodomain and extraterminal segment components and methyl-CpG-binding domain factions employ to decode the epigenetically marked lexicon on histone filaments, thereby modulating chromatin architecture?",
            "retrieved_metrics": {
                "reference_idx": [
                    462
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Bromodomain# proteins recognize acetylated lysines, while #Methyl-CpG-binding# domain proteins bind methylated DNA, modulating chromatin architecture to influence transcriptional activation or repression.",
            "predicted_answer": "BET proteins recognize acetylated lysines, while MBD proteins bind to methylated DNA. These interactions decode the epigenetic marks on histone tails, leading to chromatin remodeling and modulating gene expression.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions that BET proteins recognize acetylated lysines and MBD proteins bind methylated DNA, similar to the reference answer’s \"bromodomain\" and \"Methyl-CpG-binding\" domains. Both align with the trend of decoding epigenetic marks to modulate chromatin structure. No significant omissions or contradictions exist."
        },
        {
            "query_idx": 708,
            "query": "What role did the chemical allure of bisulfite-treated strands play as a navigational compass in elucidating the epigenetic alchemy of methyl motifs, thereby unveiling hidden patterns embedded within the molecular tapestry of oncogenesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    469
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #chemical allure# of bisulfite-treated strands enabled #genome-wide# mapping of methylated cytosines, revealing crucial patterns in cancer epigenetics.",
            "predicted_answer": "Bisulfite-treated strands served as a navigational compass by highlighting sequence differences, enabling the detection of methylated cytosines and revealing hidden methylation patterns crucial for understanding oncogenesis.",
            "score": 1,
            "explanation": "The predicted answer captures the role of bisulfite-treated strands in detecting methylated cytosines and highlighting hidden patterns, aligning with the reference answer's emphasis on these aspects. However, it does not mention the #chemical allure# or #genome-wide# mapping, omitting two key facts."
        },
        {
            "query_idx": 709,
            "query": "What are the salient molecular architectures or functional motifs deployed in the intricate dance of capturing epigenetic signatures, marked notably by their selective engagement with methyl-laden cytosine epitopes?",
            "retrieved_metrics": {
                "reference_idx": [
                    470
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Antibodies# against methylated DNA and #MBD proteins# are key motifs for capturing epigenetic signatures, specifically targeting methylated cytosine epitopes.",
            "predicted_answer": "The key molecular architectures include antibodies in MeDIP and methyl-CpG-binding domain proteins (MBDs) in MBD-seq, which selectively bind to methylated cytosines for profiling DNA methylation.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts—use of antibodies and MBD proteins to bind methylated cytosines for profiling—as indicated in the reference answer. Both answers focus on capturing epigenetic signatures via these molecular motifs, with no omissions or contradictions."
        },
        {
            "query_idx": 710,
            "query": "What is the transformative influence of the Human MethylationEPIC BeadChip in the sophisticated landscape of tumor genome decryption, specifically through its synergistic alignment with enhancer sites discovered by ambitious genomic cartography endeavors like ENCODE and FANTOM5, as elucidated in modern characterization efforts?",
            "retrieved_metrics": {
                "reference_idx": [
                    474
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Human MethylationEPIC BeadChip# enhances tumor genome decoding by integrating CpG sites in enhancer regions identified by #ENCODE# and FANTOM5, improving epigenomic characterization of tumors.",
            "predicted_answer": "The Human MethylationEPIC BeadChip enhances tumor genome decryption by interrogating nearly a million CpGs, including enhancer sites from ENCODE and FANTOM5, providing a more thorough epigenomic characterization and enabling the development of clinically relevant methylation signatures.",
            "score": 5,
            "explanation": "The Predicted Answer matches the key facts: it mentions the Human MethylationEPIC BeadChip's role in enhancing tumor genome analysis through CpG sites in enhancer regions identified by ENCODE and FANTOM5, aligned with the Reference Answer. All critical points are covered without contradictions or omissions."
        },
        {
            "query_idx": 711,
            "query": "What is the inherent superiority of nanopore sequencing in altering the landscape of methylation detection through its unique electric signal modulation as compared to the traditional chemical transformations employed by bisulfite treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    476
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Nanopore sequencing's #electric current intensity# detection directly identifies DNA methylation, unlike bisulfite treatment's #chemical transformations#, offering a more direct and potentially simpler method.",
            "predicted_answer": "Nanopore sequencing directly detects DNA methylation by measuring changes in electric current, offering a more streamlined and real-time approach compared to the chemical transformations required by bisulfite treatment.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: the detection of DNA methylation via electric current, contrasting with bisulfite treatment's chemical transformations, aligning well with the reference. Although phrasing differs, the central facts and trends are correctly represented with no significant omissions."
        },
        {
            "query_idx": 712,
            "query": "How does the steadfast nature of epigenetic whispers — specifically DNA methylation — bestow upon it a notable advantage in the complex orchestration of specimen transitions and analytic endeavors within clinical paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    477
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #stability# of #DNA methylation# ensures its reliability in clinical specimen transitions and analyses, unaffected by sample processing or storage conditions.",
            "predicted_answer": "The stability of DNA methylation, unaffected by sample processing or storage, makes it a reliable marker for clinical applications, ensuring consistent and accurate results in specimen transitions and analyses.",
            "score": 5,
            "explanation": "The predicted answer fully captures the essence of the reference answer by detailing the stability and reliability of DNA methylation in clinical contexts. It mentions stability, DNA methylation, and its unaffected nature by sample processing or storage, aligning with key facts in the reference. No significant omissions or errors are present."
        },
        {
            "query_idx": 713,
            "query": "What detective procedure effectively illuminates a substantial spectrum of CpG archipelagos by deploying a methylation-unaffected cleavage instrument in the intricate matrix of genomic exploration, and which paramount cog is customarily engaged in this scientific odyssey?",
            "retrieved_metrics": {
                "reference_idx": [
                    472
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Reduced-representation bisulfite sequencing effectively illuminates a substantial spectrum of #CpG islands# by using a #methylation-insensitive# restriction endonuclease, typically MspI.",
            "predicted_answer": "Reduced-representation bisulfite sequencing uses a methylation-insensitive CpG restriction endonuclease, typically MspI, to enrich for CpG islands, capturing 85% of them and reducing overall sequencing costs.",
            "score": 5,
            "explanation": "The predicted answer successfully mentions \"reduced-representation bisulfite sequencing\" and \"a methylation-insensitive restriction endonuclease, typically MspI,\" aligning with the reference. While it adds extra detail about cost reduction and capture percentage, the key points in the reference are fully covered without contradiction."
        },
        {
            "query_idx": 714,
            "query": "What triadic constructs serve as the scaffolding for the stratification of experimental inquiries centered on the diagnostic and prognostic utility of epigenetic modulation through DNA methylation?",
            "retrieved_metrics": {
                "reference_idx": [
                    481
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The triadic constructs are: #market#, #investigative#, and exploratory categories of clinical trials involving DNA methylation-based strategies.",
            "predicted_answer": "The triadic constructs are market, investigative, and exploratory clinical trials, which assess the diagnostic and prognostic utility of DNA methylation-based strategies.",
            "score": 5,
            "explanation": "The predicted answer includes \"market,\" \"investigative,\" and \"exploratory\" components, which align with the key facts marked in the reference answer. The terms used are consistent with the categories mentioned, ensuring no significant omissions or contradictions."
        },
        {
            "query_idx": 715,
            "query": "What foundational dynamics govern the intricate variability observed in ctDNA amidst the cfDNA continuum, and what drives the necessity for utilizing bespoke containment to safeguard the integrity of diagnostic evaluations?",
            "retrieved_metrics": {
                "reference_idx": [
                    482
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The variability in ctDNA amidst the cfDNA continuum is governed by factors like #tumor volume# and #cancer stage#, necessitating bespoke containment to prevent masking of ctDNA signals.",
            "predicted_answer": "The variability in ctDNA within cfDNA is influenced by tumor volume, localization, vascularization, and type. This necessitates highly sensitive assays and specialized collection tubes to prevent cell lysis and ensure the integrity of diagnostic evaluations.",
            "score": 3,
            "explanation": "The predicted answer mentions \"tumor volume,\" aligning with the reference's emphasis, but misses the #cancer stage#. The necessity of bespoke containment is addressed, but additional details (e.g., cell lysis prevention) are not specified in the reference. Overall, aligned but missing a key fact."
        },
        {
            "query_idx": 716,
            "query": "What embodies the unique diagnostic signature among individuals, within the experimental continuum denoted NCT01397747, whose prognostic pathways exhibit either subdued or void developments?",
            "retrieved_metrics": {
                "reference_idx": [
                    485
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The unique diagnostic signature is embodied by #nonadvanced/negative findings# with higher specificity in #FIT# (86.6% vs. 94.9%), within the NCT01397747 trial.",
            "predicted_answer": "The unique diagnostic signature in NCT01397747 is characterized by the specificity of FIT (Fecal Immunochemical Test) for detecting nonadvanced or negative findings, with a higher rate of 94.9% compared to other methods.",
            "score": 3,
            "explanation": "The predicted answer reflects the key facts: #nonadvanced/negative findings#, #FIT#, and the specificity value of 94.9% in NCT01397747. While the predicted answer omits the comparison (86.6% vs. 94.9%) present in the reference, it does not contradict the reference and maintains the overall trend."
        },
        {
            "query_idx": 717,
            "query": "How is the temporal framework for CRC diagnostic revival intervals crafted by the trio of health governance bodies—NCCN, ACS, and FDA—within their sanctioned protocols?",
            "retrieved_metrics": {
                "reference_idx": [
                    486
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #NCCN# and #ACS# recommend CRC rescreening every 3 years, aligning with FDA approval.",
            "predicted_answer": "The NCCN and ACS recommend CRC rescreening every 3 years, aligning with FDA approval. The USPSTF suggests a range of 1-3 years for testing intervals.",
            "score": 5,
            "explanation": "The predicted answer mentions the #NCCN# and #ACS# recommendation of CRC rescreening every 3 years, aligning with FDA approval, covering the key facts. However, it introduces USPSTF intervals not present in the reference, which neither contradicts nor directly affects the alignment with main points."
        },
        {
            "query_idx": 718,
            "query": "In the domain of post-therapeutic biochemical landscapes, what is the quantified advancement propensity, manifesting as hazard potential, associated with the presence of genetic disturbance markers compared to their absence, specifically concerning the trajectory of deterioration?",
            "retrieved_metrics": {
                "reference_idx": [
                    488
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The presence of #BCAT1/IKZF1-methylated# ctDNA after treatment increases the hazard potential for disease progression by a #hazard ratio of 9.7# compared to its absence.",
            "predicted_answer": "The presence of BCAT1-methylated or IKZF1-methylated ctDNA post-therapy is associated with a 9.7 times higher hazard ratio for disease progression compared to their absence.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer, capturing all key facts: the presence of BCAT1/IKZF1-methylated ctDNA post-therapy and the associated hazard ratio of 9.7 for disease progression. The meaning and essential details are consistent without any contradictions or omissions."
        },
        {
            "query_idx": 719,
            "query": "What roles do the complex architectures of epigenetic frameworks play in guiding the transformation journey from initial latent cervical epithelial stages to advanced precursors of malignancy, thereby supporting the innovation of diagnostic pathways for in vitro medical exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    492
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #epigenetic frameworks# guide the transformation from #CIN1 to CIN3#, supporting innovation in diagnostic pathways for developing in vitro diagnostic medical devices.",
            "predicted_answer": "Epigenetic frameworks guide the transformation from latent cervical epithelial stages to advanced precursors of malignancy, enabling the development of epigenetic biomarkers for in vitro diagnostic tools to identify women at risk of cervical cancer.",
            "score": 3,
            "explanation": "The Predicted Answer includes the presence of \"epigenetic frameworks\" and their role in guiding transformation to malignancy, akin to the process described from \"CIN1 to CIN3.\" However, it lacks the specificity of \"CIN1 to CIN3\" stages, impacting completeness despite maintaining alignment with the overall trend."
        },
        {
            "query_idx": 720,
            "query": "Within the landscape of negative outcomes from prevalent viral diagnostics, what role do the identified molecular signatures play as epigenetic hallmarks in discerning the profound intricacies that distinguish severe intra-cervical lesions from mere inflammatory or minor dysplastic presentations?",
            "retrieved_metrics": {
                "reference_idx": [
                    498
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Molecular signatures of #EPB41L3 and JAM3# methylation identify severe intra-cervical lesions by differentiating ≥CIN2 from inflammation/CIN1 in cases negative for #hrHPV#.",
            "predicted_answer": "Molecular signatures, such as EPB41L3 and JAM3 methylation, serve as epigenetic hallmarks to differentiate severe intra-cervical lesions (≥ CIN2) from inflammation or minor dysplasia, even in hrHPV-negative cases.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the molecular signatures of EPB41L3 and JAM3 methylation as markers to differentiate severe intra-cervical lesions from minor dysplastic presentations, including in hrHPV-negative cases. All key facts highlighted in the reference are present and the meanings coincide."
        },
        {
            "query_idx": 721,
            "query": "In what manner does QIAsure employ its advanced methodological framework to transcend standard genomic limitations and uncover diverse cervical cancer manifestations, including those elusive to hrHPV-based identification protocols?",
            "retrieved_metrics": {
                "reference_idx": [
                    500
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "QIAsure examines #methylation# of FAM19A4 and hsa-mir124-2, detecting >98% of cervical cancers, including rare cases and those missed by hrHPV identification protocols.",
            "predicted_answer": "QIAsure transcends standard genomic limitations by analyzing the methylation status of FAM19A4 and hsa-mir124-2, detecting over 98% of cervical cancers, including rare histotypes and hrHPV-negative cases.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key information about examining methylation of FAM19A4 and hsa-mir124-2, detecting over 98% of cervical cancer cases, including rare histotypes and hrHPV-negative cases. All key facts emphasized in the Reference Answer are present without significant omissions or contradictions."
        },
        {
            "query_idx": 722,
            "query": "What is the characteristic temporal endurance median for patients manifesting overt clinical symptoms in the advanced progression stage of hepatocellular carcinoma?",
            "retrieved_metrics": {
                "reference_idx": [
                    497
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The characteristic temporal endurance median for patients with overt clinical symptoms in advanced-stage hepatocellular carcinoma is #12-18 months#.",
            "predicted_answer": "The median survival for patients with symptomatic, advanced-stage hepatocellular carcinoma is 12-18 months.",
            "score": 5,
            "explanation": "The 'Predicted Answer' accurately reflects the key fact emphasized in the 'Reference Answer', which is the median survival of 12-18 months for patients with advanced-stage symptomatic hepatocellular carcinoma. There are no omissions or errors in this alignment; thus, it is highly consistent."
        },
        {
            "query_idx": 723,
            "query": "In the realm of genetic diagnostics, what particular epigenetic signatures does the EsoGuard assay examine to elucidate the concealed affliction of Barrett esophagus within its molecular confines?",
            "retrieved_metrics": {
                "reference_idx": [
                    505
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "EsoGuard examines epigenetic signatures of hypermethylation in #CCNA1# and #VIM# genes to detect Barrett esophagus.",
            "predicted_answer": "The EsoGuard assay examines hypermethylation events in CCNA1 and VIM genes to detect Barrett esophagus.",
            "score": 5,
            "explanation": "The predicted answer fully captures the key facts emphasized in the reference answer. It correctly identifies the epigenetic signatures of hypermethylation in the CCNA1 and VIM genes as part of the EsoGuard assay's examination of Barrett esophagus, with no significant omissions or contradictions."
        },
        {
            "query_idx": 724,
            "query": "Within the context of the DOCUMENT examination, what delineated interval demarks the probability permutation indicator when esteemed as an autonomous forecasting element by the epigenetic scrutiny lens?",
            "retrieved_metrics": {
                "reference_idx": [
                    509
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #DOCUMENT# study identified the interval as #OR 2.69, 95% CI 1.60-4.51# for the epigenetic assay as an autonomous forecasting element.",
            "predicted_answer": "The 95% confidence interval (1.60-4.51) delineates the probability permutation indicator for the epigenetic assay as an independent forecasting element in the DOCUMENT examination.",
            "score": 3,
            "explanation": "The predicted answer captures the 95% confidence interval (1.60-4.51) but omits the odds ratio (OR 2.69). Thus, while aligned with the reference's trend, a crucial detail is missing, affecting completeness."
        },
        {
            "query_idx": 725,
            "query": "What are the perceptual precision and forecast reliability statistics of the neoplastic categorization apparatus when discerning the complexities of CUP biopsy analyses, as depicted in validation metrics?",
            "retrieved_metrics": {
                "reference_idx": [
                    511
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #neoplastic categorization apparatus# shows #99.6% specificity# and 97.7% sensitivity in CUP biopsy analyses, with 88.6% PPV and 99.9% NPV across 7691 tumors in validation metrics.",
            "predicted_answer": "The neoplastic categorization apparatus demonstrated 99.6% specificity, 97.7% sensitivity, 88.6% positive predictive value (PPV), and 99.9% negative predictive value (NPV) in validating CUP biopsy analyses.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts emphasized in the Reference Answer: neoplastic categorization apparatus, 99.6% specificity, 97.7% sensitivity, 88.6% PPV, and 99.9% NPV. Although it doesn't mention \"7691 tumors,\" the main metrics are fully covered, ensuring trend alignment and completeness."
        },
        {
            "query_idx": 726,
            "query": "What level of predictive precision characterizes the alignment of diagnostic signals in determining the specific oncological categorization, expressed in terms of reliability percentages?",
            "retrieved_metrics": {
                "reference_idx": [
                    514
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The predictive precision of diagnostic signals for cancer categorization is characterized by a #97%# accuracy.",
            "predicted_answer": "The diagnostic signals for identifying specific cancer types have a predictive precision of 97% accuracy.",
            "score": 5,
            "explanation": "The predicted answer accurately reproduces the key fact emphasized in the reference answer, namely the \"97% accuracy\" of the diagnostic signals in cancer categorization. There are no omissions, errors, or contradictions in the predicted answer compared to the reference."
        },
        {
            "query_idx": 727,
            "query": "In what manner does the Therascreen PITX2 RGQ PCR assay function as a critical instrument for prognostic analysis, especially regarding its influence on therapeutic expectations and decisions for breast cancer patients classified as high-risk undergoing chemotherapy regimens?",
            "retrieved_metrics": {
                "reference_idx": [
                    516
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The Therascreen PITX2 RGQ PCR assay is a #robust# test predicting the outcome of #anthracycline#-based chemotherapy in high-risk breast cancer patients, aiding prognostic analysis and therapeutic decisions.",
            "predicted_answer": "The Therascreen PITX2 RGQ PCR assay determines PITX2 promoter methylation status, predicting outcomes for high-risk breast cancer patients undergoing anthracycline-based chemotherapy, thus guiding therapeutic expectations and decisions.",
            "score": 5,
            "explanation": "The predicted answer includes key facts: it identifies the assay type and matches \"PITX2 promoter methylation status\" for high-risk breast cancer patients on anthracycline chemotherapy, aligning with the reference's emphasis on anthracycline-based chemotherapy's outcome prediction. Both include guiding therapeutic expectations and decisions, covering all highlighted points."
        },
        {
            "query_idx": 728,
            "query": "What genomic custodians undergo methylation status discernment in biopsies that are bereft of malignant confirmation, thereby informing the clinician's strategic decision regarding subsequent biopsy procedures?",
            "retrieved_metrics": {
                "reference_idx": [
                    507
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #methylation status# of #GSTP1#, APC, and RASSF1 genes is analyzed in biopsies lacking malignant confirmation to guide decisions on repeat prostate biopsies.",
            "predicted_answer": "GSTP1, APC, and RASSF1 genes undergo methylation status discernment in biopsies without confirmed malignancy, guiding clinicians on whether to repeat a prostate biopsy.",
            "score": 5,
            "explanation": "The predicted answer contains all key facts emphasized in the reference answer: methylation status, GSTP1, APC, and RASSF1 genes, biopsy context without malignancy, and guidance for repeat prostate biopsy decisions. The phrasing is slightly different but does not affect the consistency and completeness of the information."
        },
        {
            "query_idx": 729,
            "query": "How does the employment of DNA methylation profiling as a diagnostic paradigm transform the landscape of accurately discerning and classifying enigmatic malignant entities characterized by petite azure cellular formations?",
            "retrieved_metrics": {
                "reference_idx": [
                    521
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "DNA #methylation profiling# enhances precise #classification# of challenging tumors with small blue round cell histology, transforming cancer diagnosis and improving clinical management.",
            "predicted_answer": "DNA methylation profiling enhances the accuracy of diagnosing and classifying challenging tumors, such as those with small blue round cell histology, by providing a precise classification tool that improves clinical management.",
            "score": 5,
            "explanation": "The predicted answer adequately covers the key facts: \"DNA methylation profiling,\" \"enhances the accuracy,\" and \"classification\" of tumors with small blue round cell histology. It aligns with the transformation in diagnosis and clinical management emphasized in the reference, with no significant details missing."
        },
        {
            "query_idx": 730,
            "query": "How does PanSeer demonstrate its foresight and analytical clarity over the three-to-four-year interlude preceding the conventional horizon of tumor emergence detection?",
            "retrieved_metrics": {
                "reference_idx": [
                    520
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "PanSeer demonstrates foresight with #83.9%-95.7% sensitivity# for cancer detection 3-4 years before conventional diagnosis, highlighting its #analytical clarity#.",
            "predicted_answer": "PanSeer demonstrates foresight and analytical clarity by achieving high sensitivity in detecting cancer 3-4 years before conventional diagnosis, with rates of 83.9%-95.7%, and maintaining strong specificity.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized with # in the reference answer: \"83.9%-95.7% sensitivity\" and \"analytical clarity\" for detecting cancer 3-4 years before conventional diagnosis. It fully aligns with the reference answer without omissions or contradictions, maintaining the trend and meaning."
        },
        {
            "query_idx": 731,
            "query": "What innovative paradigm, leveraging a technologically guided symphonic interaction, is being scrutinized in the BRAINFUL initiative to intensify the transmission of neoplastic genetic markers into the circulatory realm?",
            "retrieved_metrics": {
                "reference_idx": [
                    522
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #BRAINFUL# initiative explores using #magnetic resonance-guided focused ultrasound# to transiently disrupt the blood-brain barrier for enhanced release of tumor DNA into circulation.",
            "predicted_answer": "The BRAINFUL initiative is examining the use of magnetic resonance-guided focused ultrasound to transiently disrupt the blood-brain barrier, enhancing the release of tumor DNA into circulation for better detection of DNA methylation signatures.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key aspects of the BRAINFUL initiative, such as utilizing magnetic resonance-guided focused ultrasound and disrupting the blood-brain barrier to release tumor DNA into circulation. It even adds extra detail about DNA methylation signatures, aligning with the reference answer without contradiction or omission."
        },
        {
            "query_idx": 732,
            "query": "Amidst the vast analysis of population health dynamics, what variety of organic substrate is characteristically utilized for the detection of oncological transformations pertaining to the cervix?",
            "retrieved_metrics": {
                "reference_idx": [
                    524
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Exfoliative #cytology# samples are characteristically utilized for the detection of oncological transformations pertaining to the #cervix#.",
            "predicted_answer": "Exfoliative cytology samples are characteristically utilized for the detection of oncological transformations pertaining to the cervix.",
            "score": 5,
            "explanation": "The Predicted Answer contains the key facts emphasized in the Reference Answer, namely \"cytology\" and \"cervix\". The phrasing is consistent with the meaning of the Reference Answer, with no omissions or errors in the key information."
        },
        {
            "query_idx": 733,
            "query": "In what capacity do cerebrospinal molecular blueprints, characterized by epigenetic landscapes, contribute to steering the vigilance over therapeutic effectiveness and the re-emergence of oncogenic specters in the pediatric medulloblastoma sphere?",
            "retrieved_metrics": {
                "reference_idx": [
                    523
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cerebrospinal molecular blueprints, through #DNA methylation profiles#, help monitor #treatment response# and tumor recurrence in pediatric medulloblastoma, offering insights into therapeutic effectiveness and oncogenic resurgence.",
            "predicted_answer": "Cerebrospinal molecular blueprints, through DNA methylation profiles, help monitor treatment response and detect tumor recurrence in pediatric medulloblastoma, enhancing therapeutic effectiveness and vigilance against cancer relapse.",
            "score": 5,
            "explanation": "The Predicted Answer captures the core elements of the Reference Answer, including \"DNA methylation profiles\" and \"treatment response,\" and aligns with its overall meaning. Although the language varies slightly, no key facts are omitted, and there is no contradictory information."
        },
        {
            "query_idx": 734,
            "query": "In the realm of oropharyngeal cancer inquiry, what is the cardinal purpose underpinning the PROMEO trial's analytical endeavor to decipher comparative molecular signatures from salivary samples of affected individuals against those of a control group?",
            "retrieved_metrics": {
                "reference_idx": [
                    526
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #PROMEO trial# aims to identify #biomarkers# for noninvasive diagnosis by comparing proteomic and methylation profiles in saliva from oropharyngeal cancer patients with controls.",
            "predicted_answer": "The PROMEO trial aims to identify robust biomarkers for noninvasive diagnosis by comparing proteomic and methylation profiles in saliva from oropharyngeal cancer patients and a control group.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference answer: the PROMEO trial's aim, the identification of biomarkers, and the comparison of proteomic and methylation profiles in saliva. The phrasing is consistent, with no omissions or errors affecting comprehension."
        },
        {
            "query_idx": 735,
            "query": "What influence do the orchestrated fluctuations of H3K9 and H3K27 chromatin adaptors exert in the cessation of gene expression dialogues, and in what manner do these epigenetic harmonics play as ambiguous harbingers for the prognostic narrative across various cancer frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    527
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Orchestrated #fluctuations# of H3K9 and H3K27 chromatin adaptors lead to #aberrant# gene silencing, influencing prognosis narratives across various cancers.",
            "predicted_answer": "Alterations in H3K9 and H3K27 methylation patterns lead to aberrant gene silencing, influencing gene expression. These epigenetic changes serve as predictors of prognosis and cancer recurrence across various types, acting as ambiguous indicators in the prognostic narrative.",
            "score": 5,
            "explanation": "The predicted answer captures the key concepts of \"fluctuations\" leading to \"aberrant gene silencing\" and the influence on \"prognosis narratives,\" aligning well with the reference. It mentions H3K9 and H3K27 methylation patterns and their role as prognostic indicators, effectively covering all key facts."
        },
        {
            "query_idx": 736,
            "query": "What aggregate sum of participant entities do the EC-METHY2 and EC-METHY3 trials propose to converge upon in the pursuit of illuminating the precision evaluation of CDO1 and CELF4 methylation analysis, amidst the broader exploration of these methodologies in cervical cytology samples?",
            "retrieved_metrics": {
                "reference_idx": [
                    525
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #EC-METHY2# and #EC-METHY3# trials propose to recruit a total of 17,000 cases for evaluating CDO1 and CELF4 methylation in cervical cytology samples.",
            "predicted_answer": "The EC-METHY2 and EC-METHY3 trials propose to recruit a total of 17,000 participants to evaluate the accuracy of CDO1 and CELF4 methylation in cervical cytology samples.",
            "score": 5,
            "explanation": "The predicted answer accurately captures all key facts: the trials are EC-METHY2 and EC-METHY3, the total number of participants is 17,000, and the focus is on evaluating CDO1 and CELF4 methylation in cervical cytology samples. There are no significant omissions or errors in meaning."
        },
        {
            "query_idx": 737,
            "query": "What biological imprint is strategically utilized in clinically orchestrated inquiries to decode the modulation impact exerted by EZH2-particularized agents on the spectrum of therapeutic response dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    533
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The biological imprint strategically utilized is #H3K27me3#, employed as a #biomarker# to decode the modulation impact of EZH2-specific agents on therapeutic response dynamics.",
            "predicted_answer": "H3K27me3 levels in blood are analyzed before and after EZH2 inhibitor treatment to evaluate the therapeutic response, serving as a potential biomarker.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the biological imprint \"H3K27me3\" and its role as a \"biomarker\" for assessing the impact of EZH2-specific agents on therapeutic response. Both key facts from the reference are present, and the overall trend is maintained without any contradictions."
        },
        {
            "query_idx": 738,
            "query": "What alteration within the epigenetic framework, resembling a molecular fingerprint, serves as a diagnostic compass to differentiate melanoma linked to childhood congenital melanocytic nevi from its benign proliferative counterparts?",
            "retrieved_metrics": {
                "reference_idx": [
                    529
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #loss of H3K27me3# expression serves as a diagnostic marker to differentiate melanoma from benign proliferative nodules linked to congenital melanocytic nevi.",
            "predicted_answer": "The loss or complete lack of H3K27me3 expression, as detected by immunohistochemistry, serves as a diagnostic marker to differentiate melanoma linked to childhood congenital melanocytic nevi from benign proliferative nodules.",
            "score": 5,
            "explanation": "The predicted answer captures the key fact, which is the \"loss of H3K27me3\" expression as the diagnostic marker. This aligns with the reference answer. Both describe using this loss to differentiate melanoma from benign proliferative nodules, maintaining the intended meaning without contradictions."
        },
        {
            "query_idx": 739,
            "query": "What are the mechanisms through which the infusion of azacitidine into RNA frameworks instigates a series of cascading effects that disrupt the physiological balance in individuals undergoing treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    539
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Azacitidine incorporates into #RNA#, causing ribosomal disassembly and translation prevention, disrupting physiological balance by impairing normal cellular processes in both cancer and normal cells.",
            "predicted_answer": "Azacitidine incorporates into RNA, causing ribosomal disassembly and preventing translation. This disrupts normal cellular processes, affecting both cancer and healthy cells, leading to increased side effects.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts such as azacitidine's incorporation into RNA, ribosomal disassembly, and prevention of translation, consistent with the reference answer. However, it does not explicitly mention \"impairing normal cellular processes\" and \"physiological balance,\" impacting completeness."
        },
        {
            "query_idx": 740,
            "query": "What are the complex biochemical paradigms utilized to navigate the methodical breakdown of enzymatic constructs, such as those belonging to HDAC and BET classes, through the implementation of chimeric dismantlers and adhesive molecular orchestrators within the intricate molecular tapestry of cellular systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    538
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "PROTACs and molecular glues utilize the #ubiquitin proteasome# system to degrade #HDACs and BET# proteins within cellular systems.",
            "predicted_answer": "Complex biochemical paradigms, such as PROTACs and molecular glues, are used to degrade HDAC and BET proteins by hijacking the ubiquitin proteasome system, facilitating targeted enzymatic breakdown within cellular systems.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: the use of PROTACs and molecular glues, the involvement of the ubiquitin proteasome system, and the degradation of HDAC and BET proteins within cellular systems. The meaning is consistent with the reference answer with no significant omissions."
        },
        {
            "query_idx": 741,
            "query": "Within the intricate dance of genomic choreography, which specific archetypes of molecular orchestrators stand as focal points for synthetic modulating agents aiming to recalibrate the trajectories of genetic expression through strategic engagements with the epigenetic framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    545
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Specific archetypes of molecular orchestrators as focal points include #epigenetic writers# like DNMTs and #epigenetic erasers# such as LSD1/KDM1A, targeted by synthetic modulating agents.",
            "predicted_answer": "Key molecular orchestrators include DNA methyltransferases (DNMTs), histone methyltransferases (EZH2, DOT1L), histone demethylase (LSD1/KDM1A), histone deacetylases (HDACs), and bromodomain and extraterminal domain (BET) proteins. These are targeted by synthetic modulating agents to alter genetic expression.",
            "score": 3,
            "explanation": "The predicted answer includes DNMTs and LSD1/KDM1A, aligning with the reference's epigenetic writers and erasers. However, additional details such as EZH2, DOT1L, HDACs, and BET proteins are mentioned, which are not in the reference. No contradictory information is present, so overall alignment is maintained."
        },
        {
            "query_idx": 742,
            "query": "What was the achievement rate of the therapeutic alliance comprising venetoclax and azacitidine within the ambit of the investigative pursuit identified as VIALE-A?",
            "retrieved_metrics": {
                "reference_idx": [
                    543
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The achievement rate of the therapeutic alliance in VIALE-A was #37%# for the venetoclax and azacitidine group.",
            "predicted_answer": "The venetoclax plus azacitidine group achieved a complete remission (CR) rate of 37% in the VIALE-A study.",
            "score": 5,
            "explanation": "The predicted answer accurately reports the key fact from the reference answer: a 37% achievement rate for the venetoclax plus azacitidine group in the VIALE-A study. There are no omissions or inconsistencies with the reference, and the detail is preserved."
        },
        {
            "query_idx": 743,
            "query": "What intricate epigenetic dialogue differentiates GSK3685032 from its pyrimidine predecessors in its selective interplay with DNMT1, crafting a transient yet impactful narrative in DNA's methylation and transcriptional landscape, while demonstrating superior in vivo resilience?",
            "retrieved_metrics": {
                "reference_idx": [
                    548
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "GSK3685032 is a #non-nucleoside# DNMT1 inhibitor that selectively penetrates hemimethylated DNA, inducing rapid hypomethylation and transcription activation, with superior #in vivo# resilience compared to pyrimidine analogs.",
            "predicted_answer": "GSK3685032, unlike its pyrimidine predecessors, selectively and reversibly inhibits DNMT1 by competing with the active-site loop, leading to rapid DNA hypomethylation and robust transcriptional activation, with superior in vivo resilience.",
            "score": 3,
            "explanation": "The predicted answer captures the selective inhibition of DNMT1 and mentions in vivo resilience, consistent with the reference. However, it omits the key fact that GSK3685032 is a \"non-nucleoside\" inhibitor and does not explicitly mention penetrating hemimethylated DNA, affecting completeness."
        },
        {
            "query_idx": 744,
            "query": "What spheres of therapeutic and safety exploration are intricately examined in the first phase of the OMNIVERSE endeavor, involving the amalgamation of ONUREG and venetoclax, specifically targeting the spectrum of newly diagnosed, relapsed, or resistant states within the realm of acute myeloid leukemia?",
            "retrieved_metrics": {
                "reference_idx": [
                    546
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #OMNIVERSE# phase 1 study examines the #safety# and tolerability of ONUREG with venetoclax in newly diagnosed, relapsed, or refractory acute myeloid leukemia (AML).",
            "predicted_answer": "The OMNIVERSE phase 1 study examines the safety, tolerability, and preliminary efficacy of ONUREG combined with venetoclax in newly diagnosed, relapsed, and refractory acute myeloid leukemia (AML).",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts from the Reference Answer, covering \"OMNIVERSE,\" \"safety,\" \"tolerability,\" and the context of \"newly diagnosed, relapsed, or refractory AML.\" It adds \"preliminary efficacy,\" which doesn't contradict and complements the Reference. No significant omissions exist."
        },
        {
            "query_idx": 745,
            "query": "Within the symphonic exploration merging the essence of guadecitabine with immune arbiters, which oncological spectra are subjected to scrutiny in the diverse tapestry of corporeal afflictions?",
            "retrieved_metrics": {
                "reference_idx": [
                    549
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The combination of guadecitabine with immune arbiters is explored in #lung cancer#, #melanoma#, renal cell carcinoma, and urothelial tumors.",
            "predicted_answer": "The oncological spectra under scrutiny include lung cancer, melanoma, renal cell carcinoma, and urothelial tumors, where guadecitabine is combined with immune checkpoint inhibitors.",
            "score": 5,
            "explanation": "The predicted answer includes lung cancer, melanoma, renal cell carcinoma, and urothelial tumors, as stated in the reference answer. It aligns with the reference's overall trend and details, covering all key facts emphasized with # in the reference. There are no omissions or contradictions."
        },
        {
            "query_idx": 746,
            "query": "How do the orchestration dynamics of DNMTi agents function as integral conductors in the complex interplay of immune checkpoint activation scenarios, thereby potentially enhancing the perceptual acuity of neoplastic cellular entities within the realm of therapeutic synergy?",
            "retrieved_metrics": {
                "reference_idx": [
                    550
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "DNMTi agents enhance #tumor visibility# by re-expressing silenced genes, thus potentially improving immune checkpoint inhibitor efficacy and #therapeutic synergy# in cancer treatments.",
            "predicted_answer": "DNMTi agents enhance the visibility of cancer cells to the immune system by reactivating silenced genes, including tumor surface antigens and proteins from the major histocompatibility complex, thereby improving the efficacy of immune checkpoint inhibitors.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts about DNMTi agents enhancing tumor visibility by reexpressing silenced genes and their impact on immune checkpoint inhibitor efficacy, aligning with the reference answer's emphasis on #tumor visibility# and #therapeutic synergy#. There are no significant omissions or errors."
        },
        {
            "query_idx": 747,
            "query": "Within the intricate symphony of chromatin sculptors, what pivotal non-metallic agent underpins the functional disarmament choreography unique to the subset of histone deacetylases that diverge from zinc-dependent choreography, thereby facilitating their specialized biochemical performance?",
            "retrieved_metrics": {
                "reference_idx": [
                    555
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The pivotal non-metallic agent for sirtuins' unique functionality is #nicotinamide adenine dinucleotide (NAD+)#.",
            "predicted_answer": "Nicotinamide adenine dinucleotide (NAD+) is the pivotal non-metallic agent that underpins the functional disarmament of class III histone deacetylases, or sirtuins, facilitating their specialized biochemical performance.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies #nicotinamide adenine dinucleotide (NAD+)# as the pivotal non-metallic agent for sirtuins' functionality, fully covering the key fact emphasized in the reference answer. It aligns well in terms of meaning and detail, with no omissions or errors."
        },
        {
            "query_idx": 748,
            "query": "In the realm of therapeutic exploration pitting radiological and pharmacological forces against neuroblastoma, what was the quantified measure of therapeutic success when MIBG harmonized with vorinostat within the nuanced phase of clinical exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    559
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #ORR# when MIBG was combined with vorinostat in the phase 2 trial was #32%#.",
            "predicted_answer": "In the phase 2 trial, MIBG combined with vorinostat showed the highest overall response rate (ORR) of 32% (95% CI, 18%-51%) after the first course, compared to 14% in other arms.",
            "score": 5,
            "explanation": "The predicted answer captures all the key facts emphasized in the reference answer. It mentions the ORR of 32% when MIBG was combined with vorinostat in the phase 2 trial. There is additional detail present, but it does not contradict the reference. All key facts are present."
        },
        {
            "query_idx": 749,
            "query": "Within the domain of investigational treatment paradigms for malignancies shielded from endocrine influence, what quantifiable response rate coalesced from the phase 2 exploration of the molecular interplay between the apoptosis-inducing vorinostat and the estrogen-interfering tamoxifen?",
            "retrieved_metrics": {
                "reference_idx": [
                    556
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #ORR# of the phase 2 study combining vorinostat and tamoxifen was #19%#.",
            "predicted_answer": "The phase 2 study combining vorinostat with tamoxifen in hormone therapy-resistant breast cancer patients showed an overall response rate (ORR) of 19%.",
            "score": 5,
            "explanation": "The predicted answer accurately includes both key facts from the reference answer: the \"overall response rate (ORR)\" and the value \"19%\". The meaning is consistent with the reference answer, fully covering the essential information without omissions or errors."
        },
        {
            "query_idx": 750,
            "query": "What statistical metric articulates the deviation in resilience prognostication within the therapeutic amalgamation as opposed to the singular regimen paradigm?",
            "retrieved_metrics": {
                "reference_idx": [
                    566
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The statistical metric articulating deviation in resilience prognostication is the #hazard ratio# (#HR# = 0.59), showing improved survival in the combination over the singular regimen.",
            "predicted_answer": "The statistical metric that articulates the deviation in resilience prognostication is the Hazard Ratio (HR), which in this case is 0.59, indicating a reduced risk of an event in the combination arm compared to the singular regimen.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the key statistical metric, the Hazard Ratio (HR), and accurately provides the value (0.59), which corresponds to improved survival in the combination regimen. All key facts and the overall trend of the reference answer are captured without any contradictions or omissions."
        },
        {
            "query_idx": 751,
            "query": "What implications might the documented instance of a partial acknowledgement in an individual exhibiting endocrine disruption-resistant characteristics have on the prospective horizons of epigenetic therapeutic application?",
            "retrieved_metrics": {
                "reference_idx": [
                    568
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The instance suggests that individuals with #hormone-resistant# characteristics may benefit from #epigenetic therapy#, potentially expanding therapeutic applications in this area.",
            "predicted_answer": "The documented instance suggests that individuals with endocrine disruption-resistant characteristics may benefit from epigenetic therapies, potentially expanding treatment options and improving outcomes in hormone-resistant cancers.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts such as \"hormone-resistant characteristics\" and \"epigenetic therapies\" as mentioned in the reference, preserving the meaning and trend of the reference answer without contradictions. No significant omissions were identified in the key facts."
        },
        {
            "query_idx": 752,
            "query": "In what manner does the temporal tapestry of life expectancy and individual triumphs unfold amidst the structured symphony of epigenetic interventions administered to NSCLC patients, with particular emphasis on the resultant median temporal span of survival and distinctive patient journeys?",
            "retrieved_metrics": {
                "reference_idx": [
                    567
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #median survival# for NSCLC patients receiving epigenetic therapy is #6.4 months#, with one patient achieving CR/PR and surviving without progression for 2 years post-therapy.",
            "predicted_answer": "Epigenetic interventions, like combined low-dose azacitidine and entinostat, in NSCLC patients have shown a median survival of 6.4 months, with some achieving long-term disease control, highlighting varied patient journeys.",
            "score": 3,
            "explanation": "The 'Predicted Answer' correctly mentions the #median survival# of #6.4 months#. It addresses varied patient outcomes but omits specific details like one patient achieving CR/PR and surviving progression-free for 2 years, which impacts completeness."
        },
        {
            "query_idx": 753,
            "query": "What are the cascading repercussions on the molecular symphony within the cellular microcosm of epithelioid sarcoma, emerging from the orchestrated molecular dynamics shaped by the absence of INI1/SMARCB1 and its subsequent epigenetic modulations?",
            "retrieved_metrics": {
                "reference_idx": [
                    573
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The absence of #INI1/SMARCB1# in epithelioid sarcoma leads to constitutive and oncogenic activation of #EZH2#, influencing molecular dynamics and epigenetic modulations.",
            "predicted_answer": "The loss of INI1/SMARCB1 in epithelioid sarcoma leads to the oncogenic activation of EZH2, disrupting normal chromatin remodeling and epigenetic regulation, which alters gene expression and cellular behavior.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of INI1/SMARCB1 loss and EZH2 activation, matching the reference's emphasis. It aligns with the trend of molecular dynamic influence and epigenetic modulation described. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 754,
            "query": "What distinct biochemical ligand conjoins with the HDAC6-focused modulator, Nexturastat A, to devise the construction of molecular catalysts endowed with antiproliferative capabilities within the context of multiple myeloma cellular environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    570
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The biochemical ligand that conjoins with the HDAC6 modulator Nexturastat A is #pomalidomide#, forming molecular catalysts with #antiproliferative capabilities# in multiple myeloma cells.",
            "predicted_answer": "The distinct biochemical ligand that conjoins with Nexturastat A to create antiproliferative molecular catalysts in multiple myeloma is pomalidomide, an E3 ligase ligand.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts from the reference: 'pomalidomide' and 'antiproliferative capabilities in multiple myeloma'. It aligns with the reference's focus on forming molecular catalysts without any contradictions or significant omissions regarding key facts or trends."
        },
        {
            "query_idx": 755,
            "query": "Within the therapeutic venture involving tazemetostat against malignancies defined by BAP1 anomalies, what fraction of the cohort achieved a refined condition of status quo stability during the investigative pursuit of mesothelioma management?",
            "retrieved_metrics": {
                "reference_idx": [
                    578
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In the study on #tazemetostat# for BAP1-anomalous mesothelioma, #64%# of the cohort achieved disease stability.",
            "predicted_answer": "In the clinical trial, 64% of patients with BAP1-inactivated mesothelioma achieved disease stabilization when treated with tazemetostat.",
            "score": 5,
            "explanation": "The Predicted Answer accurately mentions the use of tazemetostat and the specific figure of 64%, which corresponds with the key facts emphasized in the Reference Answer. There are no significant omissions or errors, and the trend is aligned."
        },
        {
            "query_idx": 756,
            "query": "In the intricate landscape of therapeutic endeavors targeting a range of solid tumor pathologies, what is the codified distinction ascribed to the collaborative exploration of tazemetostat and durvalumab?",
            "retrieved_metrics": {
                "reference_idx": [
                    579
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #collaborative exploration# of tazemetostat and durvalumab is referred to as a phase #2 clinical trial# (ClinicalTrials.gov identifier NCT04705818) targeting multiple solid tumors.",
            "predicted_answer": "The collaborative exploration of tazemetostat and durvalumab is codified as a phase 2 clinical trial (ClinicalTrials.gov identifier NCT04705818) targeting multiple solid tumors.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects all key facts emphasized in the reference answer: the collaborative nature (\"collaborative exploration\"), the stage (\"phase 2 clinical trial\"), and the ClinicalTrials.gov identifier, as well as the target (\"multiple solid tumors\"). No information is missing or contradictory."
        },
        {
            "query_idx": 757,
            "query": "In the intricate choreography of cellular genetic frameworks, what underlying mechanisms enable the singular histone architect to influence the discordant expression of pivotal regulators within domains reshaped by MLL gene rearrangement in acute myeloid malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    580
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #DOT1L# histone methyltransferase influences gene expression in acute myeloid malignancies by promoting #ectopic expression# of genes through recruitment by chimeric MLL proteins.",
            "predicted_answer": "In acute myeloid malignancies with MLL gene rearrangements, the histone methyltransferase DOT1L is recruited by chimeric MLL proteins to aberrant sites, leading to ectopic expression of genes like HOXA9 and MEIS1, thus influencing cellular genetic frameworks.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"DOT1L\" and \"ectopic expression\" as key elements in acute myeloid malignancies influenced by MLL gene rearrangements, consistent with the reference. The primary facts and overarching trend align, covering the key concepts and mechanisms accurately."
        },
        {
            "query_idx": 758,
            "query": "What transmutation affects the catalytic paradigm of LSD1 during its nexus with the androgen receptor, and through what mechanisms does this influence propagate across the genomic tapestry of androgen-responsive target sequences?",
            "retrieved_metrics": {
                "reference_idx": [
                    581
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Transmutation# of LSD1 alters its catalytic paradigm through #H3K9me1/2# demethylation, influencing androgen-responsive gene expression by de-repressing AR target sequences.",
            "predicted_answer": "The transmutation involves LSD1's enzymatic specificity shifting from demethylating H3K4me1/2 to H3K9me1/2 when associated with the androgen receptor, leading to de-repression of androgen-responsive genes.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by identifying the transmutation of LSD1 impacting its enzymatic specificity to demethylate H3K9me1/2, leading to de-repression of androgen-responsive genes. It covers the key facts: transmutation, catalytic change, and influence on AR target sequences."
        },
        {
            "query_idx": 759,
            "query": "What is the prevalence metric of chronological endurance observed in patients with neuroendocrine neoplasms within the scope of the pulrodemstat trial, specifically exceeding a temporal stability threshold of more than half a year?",
            "retrieved_metrics": {
                "reference_idx": [
                    582
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#30%# of patients with neuroendocrine neoplasms showed #stable disease# exceeding six months in the pulrodemstat trial.",
            "predicted_answer": "In the pulrodemstat trial, 30% of patients with neuroendocrine neoplasms showed stable disease for more than 6 months.",
            "score": 5,
            "explanation": "The predicted answer correctly includes the #30%# figure and the term #stable disease#, matching the key facts of the reference answer. It is consistent in terms of the timeframe of #exceeding six months#. No significant facts are missing or incorrect."
        },
        {
            "query_idx": 760,
            "query": "In what manner does the orchestrated demethylation action stimulated by LSD1 serve as a conductor in preserving the intricate equilibrium and operational essence of DNMT1’s presence in a cellular context?",
            "retrieved_metrics": {
                "reference_idx": [
                    586
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "LSD1-dependent demethylation #stabilizes# DNMT1, #maintaining# global DNA methylation, crucial for preserving DNMT1's equilibrium and operational essence in a cellular context.",
            "predicted_answer": "LSD1-dependent demethylation stabilizes DNMT1, which is essential for maintaining global DNA methylation, thus preserving the intricate equilibrium and operational essence of DNMT1 in a cellular context.",
            "score": 5,
            "explanation": "The predicted answer accurately captures all key facts emphasized in the reference answer, including LSD1-dependent demethylation stabilizing DNMT1 and maintaining global DNA methylation crucial for DNMT1's equilibrium and operational essence. The meaning is consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 761,
            "query": "What is the intricate framework of the clinical investigative endeavor currently orchestrating the assessment of seclidemstat in subjects diagnosed with R/R Ewing sarcoma, particularly in terms of the layered therapeutic strategies and the delineated phases of study exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    585
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #phase 1/2 study# of seclidemstat involves #monotherapy or combination# with topotecan and cyclophosphamide for patients with R/R Ewing sarcoma featuring FET-family translocations (NCT03600649).",
            "predicted_answer": "The clinical study (NCT03600649) is assessing seclidemstat, either alone or with topotecan and cyclophosphamide, in R/R Ewing sarcoma patients. It includes phase 1/2 exploration to evaluate safety and efficacy. A rollover protocol (NCT05266196) allows continued access for benefiting patients.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference, mentioning the key points of the study being in phase 1/2, involving seclidemstat in monotherapy or combination with topotecan and cyclophosphamide for R/R Ewing sarcoma. The reference's detail on FET-family translocations is missing but does not significantly impact completeness."
        },
        {
            "query_idx": 762,
            "query": "In the layered architecture of cellular dynamics contributing to malignancy genesis, what mechanisms do bromodomain and extraterminal domain proteins employ as critical navigators in chromatin ecosystems to conduct the symphony of oncogenic scripts or potentially broader transcriptional narratives?",
            "retrieved_metrics": {
                "reference_idx": [
                    588
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#BET proteins# recognize acetylated lysines, triggering chromatin remodeling and transcriptional activation. They control super enhancers regulating oncogenes like #MYC# and globally regulate transcription elongation.",
            "predicted_answer": "BET proteins recognize acetylated lysines, facilitating chromatin remodeling and transcriptional activation. They regulate oncogenes by controlling super enhancers and act as master regulators of global transcription elongation.",
            "score": 3,
            "explanation": "The 'Predicted Answer' covers most key facts, noting BET proteins' role in recognizing acetylated lysines and chromatin remodeling. It mentions oncogene regulation and transcription elongation. However, it omits the specific mention of the oncogene 'MYC', affecting completeness."
        },
        {
            "query_idx": 763,
            "query": "In the domain of clinical investigations tied to archetype NCT01587703, engaging the investigative agent molibresib, what is the quantifiable fraction of participants bearing the medical condition termed NMC who underwent a discernible journey towards a partial reversion, either corroborated or speculative, relative to their cancer progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    589
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Of the #19# NMC patients, #4# experienced a confirmed or unconfirmed partial reversion in the molibresib trial NCT01587703.",
            "predicted_answer": "In the NCT01587703 trial, 4 out of 19 NMC patients achieved a confirmed or unconfirmed partial response, indicating a 21.1% fraction.",
            "score": 5,
            "explanation": "The Predicted Answer includes all the key facts emphasized in the Reference Answer: 19 NMC patients (number), 4 experienced a partial response (number), confirmed or unconfirmed, and from the molibresib trial NCT01587703. The completeness and correctness are maintained with consistent trends."
        },
        {
            "query_idx": 764,
            "query": "What complex synergisms and strategic blockade methodologies are invoked by BETi agents to counteract adaptive resistance mechanisms, thereby magnifying treatment effectiveness, specifically within the sophisticated environments of TNBC and BRAF-mutant melanoma when conjoined with additional molecular inhibitors?",
            "retrieved_metrics": {
                "reference_idx": [
                    594
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "BETi agents prevent transcription of resistance-driving kinases, enhancing treatment effectiveness in #TNBC# and #BRAF-mutant melanoma# by overcoming kinase reprogramming and resistance mechanisms.",
            "predicted_answer": "BETi agents, such as JQ1 and I-BET151, suppress the transcription of alternative tyrosine kinase receptors and proteins, preventing adaptive resistance. In TNBC and BRAF-mutant melanoma, this enhances the effectiveness of combined treatments with molecular inhibitors.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes the key facts of enhancing effectiveness in #TNBC# and #BRAF-mutant melanoma#, matching the emphasis in the 'Reference Answer'. It captures the overall trend of combating adaptive resistance by preventing transcription of specific kinases. Thus, it is highly consistent with the reference."
        },
        {
            "query_idx": 765,
            "query": "What exploratory endeavor is being undertaken in the intermediary phase to elucidate the interaction of synergistic modalities for ovarian cancer patients who have ventured past the confines of preceding PARPi therapy advancement?",
            "retrieved_metrics": {
                "reference_idx": [
                    595
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A #phase 2 trial# is testing the efficacy of #ZEN-3694 and talazoparib# in ovarian cancer patients who progressed on prior PARPi therapy.",
            "predicted_answer": "A phase 2 trial is assessing the efficacy of combining ZEN-3694 (a BET inhibitor) and talazoparib (a PARP inhibitor) in ovarian cancer patients who have progressed on prior PARPi therapy.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference answer, including the #phase 2 trial#, #ZEN-3694 and talazoparib#, and the application to ovarian cancer patients progressed on prior PARPi therapy. The information is consistent and complete, aligning fully with the reference."
        },
        {
            "query_idx": 766,
            "query": "What are the representative numerical codes assigned to the research inquiries involving the molecular disruptors FHD-609 and CFT8634, as they embark upon clinical explorations for synovial sarcoma and SMARCB1-deficient solid tumors?",
            "retrieved_metrics": {
                "reference_idx": [
                    597
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The research inquiries for FHD-609 and CFT8634 have identifiers #NCT04965753# and #NCT05355753#, respectively, for clinical exploration in synovial sarcoma and SMARCB1-deficient tumors.",
            "predicted_answer": "The numerical codes for the research inquiries are NCT04965753 for FHD-609 and NCT05355753 for CFT8634.",
            "score": 5,
            "explanation": "The predicted answer accurately replicates the key facts from the reference answer, specifically the numerical codes NCT04965753 and NCT05355753 for FHD-609 and CFT8634. The predicted answer is fully aligned with the reference, without omissions or errors."
        },
        {
            "query_idx": 767,
            "query": "What essential culmination in managing persistent suppression of abnormal cellular advancements was manifested through the strategic orchestration of intermittent epigenetic inhibition alongside perpetual oncological duotherapy, juxtaposed against the deleterious triad's regimen?",
            "retrieved_metrics": {
                "reference_idx": [
                    602
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intermittent #BETi# with continuous #BRAFi/MEKi# treatment was tolerable and improved durable tumor inhibition compared to the toxic triple combination regimen.",
            "predicted_answer": "The strategic orchestration of intermittent BET inhibition with continuous BRAF/MEK inhibition improved tumor suppression and was more tolerable, leading to a phase 1 trial for solid tumors.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"intermittent BET inhibition\" and \"continuous BRAF/MEK inhibition,\" aligning with the reference answer's focus on improved tumor suppression and tolerability compared to the toxic combination. The inclusion of a phase 1 trial detail matches the overall trend, ensuring completeness."
        },
        {
            "query_idx": 768,
            "query": "In the context of molecular interventions targeting chromatin dynamic regulators, what impact does the ARV-771 entity, functioning as a pan-BET disruptor, have on reshaping the oncogenic equilibrium within experimental murine models of androgen-independent prostatic cellular deviations?",
            "retrieved_metrics": {
                "reference_idx": [
                    605
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #pan-BET degrader# ARV-771 demonstrates #antitumor potential# by suppressing AR signaling and levels in castration-resistant PCa mouse models.",
            "predicted_answer": "ARV-771, a pan-BET degrader, disrupts oncogenic equilibrium in androgen-independent prostatic cellular deviations by suppressing AR signaling and levels in castration-resistant PCa mouse models.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies ARV-771 as a pan-BET degrader and mentions its role in disrupting oncogenic equilibrium by suppressing AR signaling in castration-resistant PCa models, consistent with the reference's emphasis on antitumor potential. All key facts are present, with trends aligned."
        },
        {
            "query_idx": 769,
            "query": "How has the chromatin landscape been orchestrated to form a unified directive that alleviates the endurance depletion of pivotal immune informants within the realm of basal cell carcinoma, as discerned through the sophisticated lens of scATAC-seq chromatin probing?",
            "retrieved_metrics": {
                "reference_idx": [
                    611
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #shared regulatory program# identified via #scATAC-seq# controls T-cell exhaustion, aiding endurance in basal cell carcinoma by coordinating chromatin landscapes in immune informants.",
            "predicted_answer": "scATAC-seq has identified chromatin regulators in T-cell subsets, revealing a shared program that controls T-cell exhaustion in basal cell carcinoma, which helps in understanding the endurance depletion of key immune cells.",
            "score": 5,
            "explanation": "The Predicted Answer includes key facts from the Reference Answer, such as the use of scATAC-seq, the identification of a shared regulatory program, and its impact on T-cell exhaustion in basal cell carcinoma. The meaning is consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 770,
            "query": "In the scope of the NOA-16 trial that navigated the peptide vaccine realm specifically for the IDH1(R132H) alteration, what were the discernible observational milestones at the juncture of biennial and triennial temporal scrutiny phases?",
            "retrieved_metrics": {
                "reference_idx": [
                    609
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In the NOA-16 trial, the #2-year# PFS rate was 82%, and the #3-year# PFS rate was 63%.",
            "predicted_answer": "In the NOA-16 trial, the 2-year and 3-year progression-free survival (PFS) rates were 82% and 63%, respectively.",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects both key facts emphasized with # symbols in the Reference Answer: the 2-year and 3-year PFS rates of 82% and 63%, respectively. The meaning and details are fully consistent, with no omissions or errors."
        },
        {
            "query_idx": 771,
            "query": "What is the proportional fiscal alleviation uncovered by the orphan designation for ventures in experimental drug development endeavors?",
            "retrieved_metrics": {
                "reference_idx": [
                    619
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #orphan designation# provides a proportional fiscal alleviation through #tax credits# of #25%# on qualified R&D expenditures for drug development.",
            "predicted_answer": "The orphan designation offers a 25% tax credit on qualified R&D expenditures, providing fiscal alleviation for experimental drug development.",
            "score": 5,
            "explanation": "The predicted answer includes all the essential facts: the \"orphan designation,\" \"tax credits,\" and \"25%\" are mentioned. Both answers align in meaning regarding fiscal alleviation for experimental drug development, with no significant omissions or contradictions."
        },
        {
            "query_idx": 772,
            "query": "What intricate paradigms underpinned the curation of cancer-targeted therapeutic agents, considering the temporal framework post-FDA sanctioning from the beginning of 2013, ensuing the legislative enactment of the Breakthrough Therapy Designation in 2012?",
            "retrieved_metrics": {
                "reference_idx": [
                    622
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #curation paradigm# of cancer-targeted therapeutic agents post-2013 involved excluding non-oncology and supportive care drugs, focusing on anti-cancer indications approved post-FDA sanctioning of #Breakthrough Therapy Designation#.",
            "predicted_answer": "The curation of cancer-targeted therapies post-2013 was influenced by the Breakthrough Therapy Designation, focusing on drugs with substantial improvement over existing treatments. Data from FDA approvals, clinical trials, and scientific publications were used to identify and evaluate these agents.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by mentioning the influence of the Breakthrough Therapy Designation on cancer-targeted therapies post-2013. However, it lacks specificity on excluding non-oncology and supportive care drugs as part of the curation paradigm, missing this key fact."
        },
        {
            "query_idx": 773,
            "query": "How do the foundational parameters distinguish the molecular imprint statuses, embraced as confirmatory or dismissive, regarding their stipulated confines in usage considerations?",
            "retrieved_metrics": {
                "reference_idx": [
                    624
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Foundational parameters distinguish molecular imprint statuses based on #biomarker# status, categorized as positive or negative, affecting their use in specified disease conditions.",
            "predicted_answer": "The context is not directly relevant to the query about molecular imprint statuses. Foundational parameters in molecular imprinting distinguish between confirmatory and dismissive statuses by evaluating binding specificity, selectivity, and affinity, ensuring they meet the stipulated usage criteria.",
            "score": 1,
            "explanation": "The Predicted Answer mentions parameters like binding specificity, selectivity, and affinity, which are not in the Reference Answer. It lacks the key fact of #biomarker# status impacting usage in disease conditions. Thus, the key fact is missing, albeit without contradictory information."
        },
        {
            "query_idx": 774,
            "query": "Amidst the labyrinth of regulatory transitions, how do these sequential accreditations, ordained by the FDA, subtly modulate the dimensional tapestry of patient vitality, as discerned through Chambers et al.'s lens of quality-adjusted prognostic evolution?",
            "retrieved_metrics": {
                "reference_idx": [
                    620
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Patient #health benefit# increases as #FDA designations# accumulate, enhancing quality-adjusted life years according to Chambers et al.'s study.",
            "predicted_answer": "Chambers et al. found that the cumulative number of FDA designations increases patient health benefits, measured by incremental quality-adjusted life years (QALYs).",
            "score": 5,
            "explanation": "The predicted answer includes key facts: \"FDA designations\" and \"health benefits\" measured by \"quality-adjusted life years,\" consistent with the reference. The alignment of trends and absence of contradictions justify a high score."
        },
        {
            "query_idx": 775,
            "query": "How does the evaluative construct articulated by Lanthier et al. classify therapeutic agents into the pioneering, emerging, or supplementary categories within their respective domains, considering their distinctive modus operandi and typological attributes?",
            "retrieved_metrics": {
                "reference_idx": [
                    623
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Lanthier et al. classify therapeutic agents into #pioneering#, #emerging#, or supplementary categories based on their first-in-class, advance-in-class, or addition-to-class status and #distinctive modus operandi#.",
            "predicted_answer": "Lanthier et al. classify therapeutic agents based on their innovativeness: first-in-class (pioneering), advance-in-class (emerging), or addition-to-class (supplementary), using their mechanism of action and product type.",
            "score": 5,
            "explanation": "The Predicted Answer includes the classifications of pioneering, emerging, and supplementary, which correspond to first-in-class, advance-in-class, and addition-to-class, respectively. It also mentions the mechanism of action, aligning with \"distinctive modus operandi.\" All key facts from the Reference Answer are present."
        },
        {
            "query_idx": 776,
            "query": "What structural determinants are operationalized to stratify experimental therapeutic investigations within the dataset, and how do these intricate categorizations articulate the distinctions among the principal investigative objectives for each inquiry?",
            "retrieved_metrics": {
                "reference_idx": [
                    626
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Clinical trials are stratified by #phase#, #design#, blinding, and number of arms to clarify distinctions in primary endpoints: OS, PFS, and tumor response.",
            "predicted_answer": "The dataset categorizes trials by phase, design, blinding, and number of arms. Primary endpoints include OS, PFS, and tumor response, distinguishing the main investigative objectives for each trial.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference: categorization by phase and design, along with primary endpoints like OS (Overall Survival), PFS (Progression-Free Survival), and tumor response. All critical components are included, with no significant omissions or contradictions."
        },
        {
            "query_idx": 777,
            "query": "What complex inferences regarding the latent therapeutic deficits of a malignancy can be elucidated by examining the therapeutic modalities' abundance in conjunction with the systemic health burden metrics as delineated by the GBD study?",
            "retrieved_metrics": {
                "reference_idx": [
                    627
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Examining #therapeutic modalities' abundance# and #DALYs# data reveals latent therapeutic deficits, indicating high unmet needs for cancers with few treatment options and substantial systemic health burdens.",
            "predicted_answer": "By analyzing the abundance of therapeutic modalities alongside GBD metrics like DALYs, one can infer the unmet therapeutic needs for specific malignancies. Cancers with high DALYs and few treatment options indicate significant latent therapeutic deficits.",
            "score": 5,
            "explanation": "The predicted answer accurately includes key elements from the reference: \"therapeutic modalities' abundance\" and \"DALYs.\" It reflects the trend of uncovering unmet therapeutic needs where treatment options are limited. The essence and key facts are preserved without omissions or contradictions."
        },
        {
            "query_idx": 778,
            "query": "How does the intricate interplay between the relative effectiveness measures of pharmaceutical treatments (HRs/RRs/ORRs) and the array of distinguished endorsements in clinical contexts relate to the augury of life-prolongation significance intertwined with these endorsements as elucidated through advanced statistical explorations such as meta-regressions and in-depth interpretative analyses?",
            "retrieved_metrics": {
                "reference_idx": [
                    629
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate interplay between #HRs/RRs/ORRs# and special designations relates to the #survival benefit# through meta-regressions and interpretative analyses, highlighting their significance in clinical contexts.",
            "predicted_answer": "Advanced statistical methods, such as meta-regressions and weighted-least squares regressions, are used to evaluate the relationship between the effectiveness measures (HRs/RRs/ORRs) of pharmaceutical treatments and special designations, assessing their impact on survival benefits.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized with # in the reference answer, such as HRs/RRs/ORRs, survival benefit, and statistical methods like meta-regressions. The trend aligns with an emphasis on evaluating relationships in clinical contexts. No significant omissions or errors are apparent."
        },
        {
            "query_idx": 779,
            "query": "What was the central ratio of distinctive accolades granted per therapeutic milestone within the sphere of FDA-sanctioned oncology endeavors over the decade spanning 2013 to 2022?",
            "retrieved_metrics": {
                "reference_idx": [
                    630
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The central ratio of distinctive accolades granted per therapeutic milestone was #2.4# special designations for each FDA-approved cancer indication between #2013 and 2022#.",
            "predicted_answer": "The central ratio of distinctive accolades per therapeutic milestone in FDA-approved oncology from 2013 to 2022 was 2.4 special designations per indication.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized with # in the reference answer: the ratio is #2.4#, and it pertains to FDA-approved cancer indications between #2013 and 2022#. The predicted answer is fully aligned with the reference in meaning and detail."
        },
        {
            "query_idx": 780,
            "query": "What intricate interplay of ripple effects does each successive accolade, granted by a regulatory body, introduce upon the multifaceted calculus of survival metrics, thereby modulating the undertones of hazard dynamics and their subsequent temporal medians?",
            "retrieved_metrics": {
                "reference_idx": [
                    632
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Each FDA accolade decreases OS and PFS hazard ratios by #-0.04# and #-0.08#, enhancing median improvements by #3.0# and 1.8 months, respectively.",
            "predicted_answer": "Each successive accolade from a regulatory body, like the FDA, introduces a reduction in hazard ratios for overall survival (OS) and progression-free survival (PFS), along with potential increases in their median values.",
            "score": 1,
            "explanation": "The predicted answer aligns with the general trend of the reference answer, noting reductions in hazard ratios and potential increases in median values. However, it omits the specific numerical changes (-0.04, -0.08) and median improvements (3.0, 1.8 months), missing two key facts."
        },
        {
            "query_idx": 781,
            "query": "In what manner does the intricate tapestry of therapeutic innovation endow certain pharmacological and clinical designations with an aura of distinction within the diverse realms of patient demographics encountered in advanced disease intervention?",
            "retrieved_metrics": {
                "reference_idx": [
                    635
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Innovativeness# and the specific #patient population# treated endow pharmacological and clinical designations with distinction in advanced disease intervention.",
            "predicted_answer": "Innovative therapies in advanced disease settings are distinguished by their unique designations, targeting specific patient demographics with unmet needs. These treatments, often used when first-line options fail, are recognized for their novel approaches and the specialized populations they serve.",
            "score": 5,
            "explanation": "The predicted answer captures the concepts of \"innovativeness\" and \"specific patient population\" by noting unique designations, unmet needs, and serving specialized populations. The overall trend aligns with the reference answer without omissions or contradictions, ensuring completeness and consistency."
        },
        {
            "query_idx": 782,
            "query": "What potential distortions in the collective interpretation of therapeutic benefit might arise from clinical evaluation architectures that lack foundational robustness for uniquely-labeled medical conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    638
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Non-robust, biased clinical trial designs for #special-designated indications# may cause #overestimation# of efficacy outcomes, leading to distorted interpretations of therapeutic benefit.",
            "predicted_answer": "Clinical evaluation architectures lacking robustness for uniquely-labeled conditions may overestimate efficacy, leading to potential distortions in the collective interpretation of therapeutic benefits. This can occur due to non-robust and biased trial designs.",
            "score": 3,
            "explanation": "The predicted answer captures the general trend and most key facts of overestimation of efficacy and potential distortions due to non-robust, biased trial designs. However, it misses the specific context of \"special-designated indications,\" affecting the completeness and precise alignment with the reference."
        },
        {
            "query_idx": 783,
            "query": "What is the variance in the continuum of lifespan extension for therapeutic scenarios possessing quintuple distinguished merits of recognition against scenarios lacking any form of conferred distinction?",
            "retrieved_metrics": {
                "reference_idx": [
                    637
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #lifespan extension# for indications with five special designations is #11.8 months#, compared to 3.7 months without any designation.",
            "predicted_answer": "The variance in lifespan extension between therapeutic scenarios with five special designations and those without is 8.1 months, reflecting a significant difference in treatment outcomes.",
            "score": 1,
            "explanation": "The predicted answer provides an 8.1-month variance but does not specify the #lifespan extension# values of #11.8 months# for scenarios with five designations and 3.7 months for scenarios lacking designations. It lacks two key specific lifespan figures, affecting completeness."
        },
        {
            "query_idx": 784,
            "query": "In what ways could the inclination towards showcasing selectively positive experimental outcomes distort the collective perception of therapeutic value for oncology-based treatment solutions that achieve regulatory endorsement?",
            "retrieved_metrics": {
                "reference_idx": [
                    642
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The inclination towards showcasing #positive experimental outcomes# may distort perceptions by #overestimating efficacy# of oncology treatments that achieve regulatory endorsement.",
            "predicted_answer": "The selective presentation of positive outcomes from oncology trials can lead to an overestimation of a treatment's efficacy, potentially distorting the perceived therapeutic value and influencing clinical decisions, pricing, and reimbursement.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of showcasing positive outcomes and overestimating efficacy, as highlighted in the reference. Both discuss distortion in perceived therapeutic value and its broader effects. No significant omissions or contradictions are present, demonstrating high alignment."
        },
        {
            "query_idx": 785,
            "query": "In what manner does the transformation of evidentiary thresholds dictated by pharmaceutical governance impact the ratification of anticancer therapeutics that possess a panoply of selective commendations?",
            "retrieved_metrics": {
                "reference_idx": [
                    643
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The transformation leads to #lowered evidentiary standards#, resulting in anticancer drugs often being approved based on #poor clinical trial design#.",
            "predicted_answer": "The lowering of evidentiary standards through special designations allows for more flexible clinical trial designs, but often results in approvals based on less rigorous evidence, such as non-RCTs or trials with placebo comparators.",
            "score": 3,
            "explanation": "The predicted answer covers the key fact of \"#lowered evidentiary standards#\" but misses the specific notion of \"#poor clinical trial design#\". It mentions flexible trial designs and less rigorous evidence, aligning generally with the trend but lacking one specific detail."
        },
        {
            "query_idx": 786,
            "query": "What constituted the central thematic inquiry in the exploration of FDA-endorsed oncological treatment designations from 2012 to 2022 within this analytical examination, particularly through the prism of regulatory deliberations, treatment efficacy, and dynamic healthcare needs?",
            "retrieved_metrics": {
                "reference_idx": [
                    634
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The central thematic inquiry focused on #FDA#-endorsed treatment #efficacy#, examining drugs with special designations to address unmet medical needs in oncology from 2012 to 2022.",
            "predicted_answer": "The central thematic inquiry focused on the efficacy, clinical evidence, and the role of FDA special designations in expediting oncological treatments, addressing unmet medical needs from 2012 to 2022.",
            "score": 3,
            "explanation": "The Predicted Answer includes key aspects such as treatment efficacy and addressing unmet medical needs, aligning with the Reference Answer. However, it lacks a specific reference to \"FDA.\" This missing detail slightly affects completeness but does not contradict the reference."
        },
        {
            "query_idx": 787,
            "query": "What are the complex ramifications entailed by the FDA's sophisticated strategies, as they orchestrate a delicate equilibrium through specialized evaluative frameworks, for pharmaceuticals aimed at existential therapeutic deficiencies?",
            "retrieved_metrics": {
                "reference_idx": [
                    645
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The FDA's strategies include #incentivizing# pharmaceutical development, #expediting# patient access, designing ethical trials, and ensuring drug safety and effectiveness for serious conditions with unmet medical needs.",
            "predicted_answer": "The FDA's strategies balance stakeholder interests, incentivize drug development for unmet medical needs, expedite patient access, ensure ethical trials, and guarantee drug safety and efficacy, leading to treatments for previously untreatable conditions.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference, such as incentivizing drug development, expediting patient access, and ensuring ethical trials and drug safety/efficacy. The trends are aligned, and all critical elements are covered without contradictions."
        },
        {
            "query_idx": 788,
            "query": "For those navigating the hereditary spectrums characterized by von Hippel-Lindau disease, how does the orchestration of belzutifan as a hypoxia-inducible factor 2 alpha inhibitor manifest into an extracted advantage, altering the clinical bearings and potentially resonating as treatment echoes across their therapeutic horizon?",
            "retrieved_metrics": {
                "reference_idx": [
                    647
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Patients with von Hippel-Lindau disease may benefit from #belzutifan#, a #hypoxia-inducible# factor 2 alpha inhibitor, enhancing therapeutic options by targeting the underlying pathological mechanisms.",
            "predicted_answer": "Belzutifan, as a hypoxia-inducible factor 2 alpha inhibitor, targets the VHL gene alteration in von Hippel-Lindau disease, potentially reducing tumor growth and offering a new therapeutic advantage for these patients.",
            "score": 5,
            "explanation": "The Predicted Answer identifies belzutifan as a hypoxia-inducible factor 2 alpha inhibitor, aligning with the Reference Answer's emphasis. It captures the therapeutic advantage for von Hippel-Lindau disease by addressing underlying mechanisms, consistent with key reference details. No significant facts are omitted."
        },
        {
            "query_idx": 789,
            "query": "What intrinsic genetic architecture's primordial shift within the lineal cohort designated as Family G has been validated to precipitate a sequence of sequence-specific genetic oscillations, consequently engendering a heightened predisposition towards colorectal carcinoma vulnerability?",
            "retrieved_metrics": {
                "reference_idx": [
                    650
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The primordial shift in Family G's intrinsic genetic architecture is a germline mutation in the #MSH2 gene#, causing #microsatellite instability# and increased susceptibility to colorectal cancer.",
            "predicted_answer": "The primordial shift in Family G, validated through sequencing 929 descendants, is a germline mutation in the MSH2 gene, causing microsatellite instability and increased susceptibility to colorectal cancer.",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects the key facts emphasized in the Reference Answer: the germline mutation in the MSH2 gene and the resulting microsatellite instability leading to increased susceptibility to colorectal cancer. No significant details are missing, and there are no contradictions."
        },
        {
            "query_idx": 790,
            "query": "What were the predominant manifestations of substantial consequence, graded within the higher echelons of severity, as discerned across the trio of clinical investigations employing PARPi as a solitary therapeutic intervention?",
            "retrieved_metrics": {
                "reference_idx": [
                    653
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The predominant grade #3-4# manifestations of consequence were #hematologic toxicity#, necessitating close monitoring and management during the trials.",
            "predicted_answer": "The most common grade 3-4 events across the three trials with PARPi as a monotherapy were hematologic toxicities. Close monitoring and management of these severe side effects are necessary.",
            "score": 5,
            "explanation": "The predicted answer includes both key points: the severity grade (3-4) and hematologic toxicity, which are present in the reference answer. Additionally, it acknowledges the need for monitoring and management. All essential elements are covered without contradictions."
        },
        {
            "query_idx": 791,
            "query": "In the realm of inherited complexities, dissected through the insightful lens of the triad Collins, Hippel, and Lindau, which particular proliferative phenomena ingrained in the variegated bodily landscapes serve as the quintessential manifestations of the von Hippel-Lindau constellation?",
            "retrieved_metrics": {
                "reference_idx": [
                    648
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Retinal #hemangioblastomas# and cerebellar and spinal #hemangioblastomas# are quintessential manifestations of von Hippel-Lindau syndrome.",
            "predicted_answer": "Retinal, cerebellar, and spinal hemangioblastomas are the quintessential manifestations of von Hippel-Lindau syndrome, as identified by Drs. Collins, Hippel, and Lindau.",
            "score": 5,
            "explanation": "The key facts, \"retinal, cerebellar, and spinal hemangioblastomas\" as quintessential manifestations of von Hippel-Lindau syndrome, are present in the predicted answer. The predicted answer includes all key emphasized details from the reference without error or omission."
        },
        {
            "query_idx": 792,
            "query": "What proportion of individuals traversing the intricate journey of the MEDIOLA exploration, dealing with the quandary of metastatic HER2-negative breast malignancy while inheriting the legacy of BRCA1/2 genetic variations, exhibited a meaningful clinical echo after a span of twelve weeks?",
            "retrieved_metrics": {
                "reference_idx": [
                    654
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "63% of individuals with metastatic #HER2-negative# breast cancer and #BRCA1/2# mutations exhibited an objective response rate (ORR) after twelve weeks in the MEDIOLA trial.",
            "predicted_answer": "In the MEDIOLA trial, 80% of patients with metastatic HER2-negative breast cancer and BRCA1/2 mutations achieved disease control after 12 weeks.",
            "score": 0,
            "explanation": "The predicted answer incorrectly states 80% achieved disease control, while the reference mentions 63% had an objective response rate after 12 weeks. Both mention metastatic HER2-negative breast cancer and BRCA1/2 mutations, but the percentage and response type are significant discrepancies."
        },
        {
            "query_idx": 793,
            "query": "What vital aspects must be judiciously navigated when orchestrating suitable movement regimes in the presence of concurrent therapy-induced erythrocytic and thrombocyte deficiencies?",
            "retrieved_metrics": {
                "reference_idx": [
                    659
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Caution must be taken to #determine activity level# when orchestrating exercise regimes in the presence of #anemia or thrombocytopenia# due to concurrent therapy.",
            "predicted_answer": "When orchestrating movement regimes, carefully assess and adjust activity levels to avoid exacerbating anemia or thrombocytopenia, ensuring safety and efficacy.",
            "score": 5,
            "explanation": "The predicted answer captures both key elements: the need to determine activity level and the consideration of anemia or thrombocytopenia. The answer is consistent with the reference in terms of safety and careful adjustment, thus covering all emphasized details effectively."
        },
        {
            "query_idx": 794,
            "query": "What quantitative representation exists for individuals whose engagement with olaparib was curtailed by adverse physiological responses, and in what manner does this align with the cessation metrics within the assemblage devoid of active therapeutic agents?",
            "retrieved_metrics": {
                "reference_idx": [
                    661
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "10% of patients discontinued olaparib due to toxicity, compared to #4%# in the #placebo# arm.",
            "predicted_answer": "10% of patients discontinued olaparib due to toxicity, compared to 4% on placebo. This metric indicates a higher cessation rate due to adverse effects in the olaparib group.",
            "score": 5,
            "explanation": "The Predicted Answer accurately includes all key facts and numbers emphasized with # symbols in the Reference Answer, specifically the 4% discontinuation rate in the placebo group. The alignment between both answers is maintained without any omissions or contradictions."
        },
        {
            "query_idx": 795,
            "query": "Within the NeoTALA 55 clinical scenario, designed to explore the effects of regimented exposure to talazoparib at a consistent dosage of 1 mg/day over a period of 24 weeks on the pathophysiological journey of TNBC patients, what proportional culmination of pathologic responses was predominantly attained?",
            "retrieved_metrics": {
                "reference_idx": [
                    664
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The predominant pathologic response attained was a #49%# #pathologic complete response# in TNBC patients exposed to talazoparib at 1 mg/day for 24 weeks.",
            "predicted_answer": "In the NeoTALA 55 trial, the pathologic complete response rate was 49% among TNBC patients receiving 1 mg/day of talazoparib for 24 weeks.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer, covering all key facts such as the 49% pathologic complete response rate, the patient group (TNBC), and the talazoparib dosage and duration. There are no significant omissions or errors, and the meaning is consistent."
        },
        {
            "query_idx": 796,
            "query": "What proportion of pancreatic ductal adenocarcinoma stakeholders embody inherent genetic blueprint alterations indicative of germline BRCA mutations that manifest as homologous recombination disruption within their cellular matrices?",
            "retrieved_metrics": {
                "reference_idx": [
                    666
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Up to #9%# of pancreatic ductal adenocarcinoma stakeholders have #germline BRCA mutations# causing homologous recombination defects.",
            "predicted_answer": "Up to 9% of pancreatic ductal adenocarcinoma patients have germline BRCA mutations, leading to homologous recombination defects.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized in the reference answer: \"up to 9%,\" \"germline BRCA mutations,\" and \"homologous recombination defects.\" The meaning and facts align fully with the reference answer, with no omissions or contradictions."
        },
        {
            "query_idx": 797,
            "query": "In the realm of genetic architectures and their economic viability, what is it about the molecular blueprints of hereditary anomalies like BRCA mutations that underscores the necessity for their targeted discovery in the orchestration of robust cancer mitigation strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    670
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The identification of #BRCA mutations# is crucial due to their impact on #cancer control# as revealed by the genetic economics of frequency penetrance.",
            "predicted_answer": "The genetic economics of frequency and penetrance highlight that identifying carriers of mutations like BRCA is crucial for effective cancer control, making targeted discovery economically and clinically impactful.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of identifying BRCA mutations and their importance for cancer control, which are emphasized in the reference answer. It also touches on the economic and clinical impact, aligning with the genetic economics of frequency penetrance mentioned in the reference."
        },
        {
            "query_idx": 798,
            "query": "In the sphere of pancreatic ductal adenocarcinoma, what profound ripple effect might the exploration of inherited BRCA mutation conundrums yield, surpassing the conventional therapeutic resonance attributed to olaparib utilization?",
            "retrieved_metrics": {
                "reference_idx": [
                    669
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The exploration of inherited #BRCA mutations# could lead to improved #survival# by recognizing hereditary syndromes, enabling targeted follow-ups, reducing second tumor incidence and mortality.",
            "predicted_answer": "Exploring inherited BRCA mutations in pancreatic ductal adenocarcinoma could lead to broader genetic testing, improved family risk management, and potentially greater survival benefits, surpassing the impact of olaparib alone.",
            "score": 3,
            "explanation": "The predicted answer mentions improved survival benefits linked to broader genetic testing and family risk management, similar to how the reference highlights improved survival by recognizing hereditary syndromes. However, it misses details on targeted follow-ups and reducing second tumor incidence and mortality."
        },
        {
            "query_idx": 799,
            "query": "What prospective strategic directions might be considered for those embodying the multifaceted genomic landscape of TNBC coupled with g BRCA anomalies, particularly when the journey does not culminate in a pathologic complete transformation?",
            "retrieved_metrics": {
                "reference_idx": [
                    673
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Combining #olaparib# and #pembrolizumab# might be a future option for TNBC patients with g BRCA mutation who do not achieve a pathologic complete response.",
            "predicted_answer": "For TNBC patients with g BRCA mutations who do not achieve a pathologic complete response, potential strategic directions include exploring the combination of olaparib and pembrolizumab, as suggested by recent research. Early g BRCA testing is crucial for selecting optimal treatment.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts of combining olaparib and pembrolizumab for TNBC patients with g BRCA mutations who don't achieve a complete response, aligning with the reference answer. Early testing is an added detail but doesn't contradict the reference. No key facts are missing."
        },
        {
            "query_idx": 800,
            "query": "What nuanced molecular dance, dictated by transformations in proline attributes within an oxygen-modulated domain, orchestrates the convergence between von Hippel-Lindau stewards and regulators of hypoxia?",
            "retrieved_metrics": {
                "reference_idx": [
                    674
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #hydroxylation of proline# residues on HIFs' oxygen-dependent degradation domain facilitates the interaction between von Hippel-Lindau protein and regulators of hypoxia.",
            "predicted_answer": "The nuanced molecular dance involves the hydroxylation of proline residues on HIFs' oxygen-dependent degradation domain, which dictates the interaction between von Hippel-Lindau protein and hypoxia regulators.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key detail of the \"hydroxylation of proline\" residues on HIFs' oxygen-dependent degradation domain. It aligns with the reference answer, capturing the essence of the molecular interaction without omissions or contradictions."
        },
        {
            "query_idx": 801,
            "query": "Within the complex choreography of cellular expansion spurred by dysfunctional genetic symphonies, what specific role do tyrosine kinase inhibitors fulfill in modulating the aberrant expression of genes associated with Von Hippel-Lindau syndrome and sporadic manifestations of renal cell carcinoma?",
            "retrieved_metrics": {
                "reference_idx": [
                    676
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tyrosine kinase inhibitors #target VEGF receptors# to modulate #gene overexpression# associated with VHL syndrome and renal cell carcinoma.",
            "predicted_answer": "Tyrosine kinase inhibitors target vascular endothelial growth factor receptors, suppressing the overproduction of genes like VEGF that contribute to tumorigenesis in Von Hippel-Lindau syndrome and sporadic clear cell renal cell carcinoma.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts emphasized in the reference: tyrosine kinase inhibitors target VEGF receptors and suppress the overproduction of genes, associated with Von Hippel-Lindau syndrome and renal cell carcinoma. The core concepts are present, showing consistency without significant omissions."
        },
        {
            "query_idx": 802,
            "query": "Within the framework of the pazopanib investigation, what fraction of the participant demographic required modification in their dosing strategy due to perturbations in hepatic biochemical indicators?",
            "retrieved_metrics": {
                "reference_idx": [
                    678
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#67%# of participants required dosing modification due to #elevated transaminases#.",
            "predicted_answer": "In the pazopanib study, 67% of the patients required a dose reduction due to elevated transaminases.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the key facts: #67%# of participants and #elevated transaminases# as reasons for dosing modification. The information is consistent with the reference answer, with no significant omissions or errors."
        },
        {
            "query_idx": 803,
            "query": "What latent architectural element within the configurational tapestry of the HIF2a PAS-B domain catalyzed the pioneering creation of initial HIF2a inhibitive agents?",
            "retrieved_metrics": {
                "reference_idx": [
                    680
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #290-Å 3 internal cavity# within the HIF2a PAS-B domain catalyzed the creation of initial #HIF2a inhibitors#.",
            "predicted_answer": "The identification of a 290-Å³ internal cavity within the HIF2a PAS-B domain catalyzed the creation of the first HIF2a inhibitive agents.",
            "score": 5,
            "explanation": "The predicted answer mentions the #290-Å³ internal cavity# and #HIF2a inhibitive agents#, aligning with the reference's emphasis on the domain's cavity and its role in creating #HIF2a inhibitors#. Both key facts are present, with no significant omissions or errors."
        },
        {
            "query_idx": 804,
            "query": "What proportion of individuals, identified with the specific vascular irruption within the cerebral complex, manifested a notable beneficial interaction in alignment with the investigative outcomes presented?",
            "retrieved_metrics": {
                "reference_idx": [
                    682
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#100%# of patients with retinal hemangioblastoma showed improvement according to the study outcomes.",
            "predicted_answer": "Among 50 patients with central nervous system hemangioblastoma, 30% showed a notable beneficial interaction, as indicated by the overall response rate (ORR).",
            "score": 0,
            "explanation": "The predicted answer states 30% of patients with central nervous system hemangioblastoma showed improvement, whereas the reference states 100% of patients with retinal hemangioblastoma showed improvement. The facts are inconsistent; there are differences in percentage and disease type, leading to a contradictory interpretation."
        },
        {
            "query_idx": 805,
            "query": "What cascade of cellular events and recognition failures emerge when the catalytic 'engines' of prolyl hydroxylases are rendered inactive, unable to transform proline into its hydroxylated counterpart amidst an oxygen-deprived milieu, influencing broader physiological pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    686
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "When #prolyl hydroxylases# are inactive in hypoxia, HIFs aren't hydroxylated, preventing pVHL recognition, leading to #HIFs accumulation# and disrupted ubiquitination, affecting physiological pathways.",
            "predicted_answer": "In an oxygen-deprived environment, inactive prolyl hydroxylases fail to hydroxylate HIFs, preventing pVHL recognition and subsequent degradation. This leads to HIF accumulation, triggering adaptive responses and potentially pathological conditions like VHL syndrome.",
            "score": 3,
            "explanation": "The predicted answer captures both key facts: inactive prolyl hydroxylases and HIF accumulation. It mentions HIFs aren't hydroxylated, preventing pVHL recognition, aligning with the reference answer. Although it omits \"disrupted ubiquitination,\" it generally aligns with the overall trend without contradictions."
        },
        {
            "query_idx": 806,
            "query": "What particular inherited biochemical script has been identified as the conductor of the unique molecular choreography affecting the energetic transformations experienced by debrisoquine and sparteine?",
            "retrieved_metrics": {
                "reference_idx": [
                    688
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#CYP2D6# gene has been identified as the conductor of the unique molecular choreography affecting #debrisoquine# and sparteine metabolism.",
            "predicted_answer": "The cytochrome P450 2D6 (CYP2D6) gene has been identified as the key inherited biochemical factor affecting the metabolism of debrisoquine and sparteine.",
            "score": 3,
            "explanation": "The 'Predicted Answer' includes the key facts emphasized in the 'Reference Answer': #'CYP2D6'# gene and #'debrisoquine'#. It accurately presents the inherited biochemical factor affecting metabolism, although it does not repeat \"sparteine,\" the overall meaning and key facts remain intact."
        },
        {
            "query_idx": 807,
            "query": "What potential repercussions on the toxicological profile of fluorouracil might emerge when the intrinsic catalytic mechanism of dihydropyrimidine dehydrogenase finds its operational vigor significantly subdued or compromised within the patient’s metabolic spectrum during treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    691
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #toxicological profile# of fluorouracil may show increased #significant toxicity# due to prolonged half-life from subdued dihydropyrimidine dehydrogenase activity.",
            "predicted_answer": "A significant reduction in dihydropyrimidine dehydrogenase activity can lead to a prolonged half-life of fluorouracil, increasing its cytotoxic effects and potentially causing severe toxicity, including diarrhea, mucositis, and leucopenia.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key points from the reference answer: the toxicological profile of fluorouracil is affected with increased toxicity, linked to its prolonged half-life due to reduced dihydropyrimidine dehydrogenase activity. Additional details like specific toxic effects highlight alignment, without contradicting the reference."
        },
        {
            "query_idx": 808,
            "query": "How does the unique molecular signature crafted by genetic variability modulate the intricate balance of efficacy and safety within the framework of anticancer pharmacotherapy, specifically with respect to compounds like fluorouracil?",
            "retrieved_metrics": {
                "reference_idx": [
                    689
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The unique #genetic variability# modulates the balance of #efficacy and safety# in anticancer pharmacotherapy, influencing treatment outcomes with compounds like fluorouracil.",
            "predicted_answer": "Genetic variability influences the efficacy and safety of anticancer drugs like fluorouracil by altering metabolic pathways, which can lead to varying therapeutic responses and toxicity levels among patients.",
            "score": 5,
            "explanation": "The predicted answer captures the influence of genetic variability on the efficacy and safety of drugs like fluorouracil, consistent with the reference answer. It references altered metabolic pathways, which aligns with the modulation of treatment outcomes but does not contradict or miss key emphasized facts."
        },
        {
            "query_idx": 809,
            "query": "Within the realm of exploratory dose-escalation trials (NCT02974738), pursuing the control of complex neoplastic conditions, what pivotally determined quantum of administration crystallized from this prior investigation, guiding its influx into the subsequent evaluative echelon, unencumbered by toxicity-inflicted constraints?",
            "retrieved_metrics": {
                "reference_idx": [
                    684
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #recommended phase II dose# for the study was determined as #120-mg once daily#.",
            "predicted_answer": "The pivotal determination from the dose-escalation trial (NCT02974738) was that 120 mg once daily was the recommended phase II dose, as no dose-limiting toxicities were observed up to 160 mg.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the #recommended phase II dose# as #120 mg once daily#, which matches the key information emphasized in the reference answer. There are no significant omissions or contradictions, and the overall meaning is consistent."
        },
        {
            "query_idx": 810,
            "query": "In the intricate landscape of medicinal guidance, wherein genomic storylines intertwine with treatment paradigms, what portfolio of pharmacological agents is documented with germline genetic directionality within official regulatory narratives, despite the tangible impediments confronting the complete integration of such personalized pharmacological scripting?",
            "retrieved_metrics": {
                "reference_idx": [
                    693
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The portfolio of pharmacological agents documented with germline genetic directionality includes #belinostat#, #tamoxifen#, dabrafenib, and others, according to FDA drug labeling, despite integration impediments.",
            "predicted_answer": "The FDA includes germline pharmacogenomic information for drugs like belinostat, capecitabine, and tamoxifen, among others, in their labels. However, barriers still hinder the full integration of personalized pharmacological practices.",
            "score": 3,
            "explanation": "The 'Predicted Answer' aligns with the 'Reference Answer' by mentioning #belinostat# and #tamoxifen#. However, it omits #dabrafenib#, a key fact from the reference, affecting completeness. The trend aligns, with no contradictory information present."
        },
        {
            "query_idx": 811,
            "query": "What constitutes the central theme of the preliminary therapeutic inquiry into the discovery phase of treatment potency calibration within the realm of oncology, particularly concerning the navigation of initial pharmacological cycles?",
            "retrieved_metrics": {
                "reference_idx": [
                    697
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The central theme is identifying the #MTD# via monitoring for #DLTs# during the first treatment cycle to maximize clinical benefit.",
            "predicted_answer": "The central theme involves identifying the Maximum Tolerated Dose (MTD) or Highest-Tested Dose (HTD) by monitoring for Dose-Limiting Toxicities (DLTs) in the first treatment cycle, aiming to maximize antitumor effects while ensuring safety.",
            "score": 5,
            "explanation": "The predicted answer includes identifying the MTD via monitoring for DLTs during the first treatment cycle, aligning with the reference. The predicted answer adds \"Highest-Tested Dose (HTD)\" and \"antitumor effects,\" which, although additional, do not contradict the reference information."
        },
        {
            "query_idx": 812,
            "query": "What potential destabilizing influences could jeopardize the sequential innovation phases when the dose determination is subtly swayed by individuals with intrinsic susceptibilities to adverse reactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    702
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Intrinsic susceptibilities# to toxicity could lead to #sub-optimal dose# selection, potentially delaying drug development and risking the innovation process due to safety concerns.",
            "predicted_answer": "Genetic predispositions to toxicity can lead to early observation of DLTs, causing sub-optimal dose selection and potential delays or halts in drug development. Small sample sizes may also result in doses that are not tolerated by a wider population in later trials.",
            "score": 5,
            "explanation": "The predicted answer captures the key fact of \"intrinsic susceptibilities\" (genetic predispositions) impacting \"sub-optimal dose\" selection, aligning with the reference's focus on dose and development delays. Both emphasize the jeopardy to drug development. However, the predicted answer includes \"small sample sizes,\" not emphasized in the reference, affecting completeness."
        },
        {
            "query_idx": 813,
            "query": "In the initial examination of the selective mesenchymal-epithelial transition modulator's journey in Japan, which nuanced genetic stratification approach was employed to delineate participants by their cytochrome enzymatic pathway variations?",
            "retrieved_metrics": {
                "reference_idx": [
                    704
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Participants were delineated by #CYP2C19# genetic stratification into normal metabolizers (#NMs#) with two *1 alleles and poor metabolizers with *2 and/or *3 alleles.",
            "predicted_answer": "The study employed CYP2C19 genotyping to stratify participants, dividing them into normal metabolizers (NMs) with two *1 alleles and poor metabolizers (PMs) with *2 and/or *3 alleles.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies CYP2C19 genotyping as the method for stratification and distinguishes between normal and poor metabolizers based on alleles, matching all key facts emphasized with # in the reference. No significant information is missing or contradicts the reference."
        },
        {
            "query_idx": 814,
            "query": "What role does the examination of genetic blueprints play in steering the metabolic choreography and consequential risk modulation of antibody-bound therapeutic constructs?",
            "retrieved_metrics": {
                "reference_idx": [
                    705
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The examination of #genetic blueprints# is crucial for modulating #antibody-drug conjugate# metabolism, affecting payload transport, and modifying the toxicity profile.",
            "predicted_answer": "The examination of genetic blueprints helps tailor the use of antibody-bound therapeutic constructs by identifying genetic variants that influence metabolism and toxicity, thereby modulating treatment risks.",
            "score": 1,
            "explanation": "The predicted answer mentions tailoring antibody-bound therapeutic constructs through genetic blueprints but omits specifics like affecting payload transport, and modifying the toxicity profile of antibody-drug conjugates. It aligns generally but misses more than one key element emphasized in the reference."
        },
        {
            "query_idx": 815,
            "query": "In the intricate choreography of therapeutic pathway calibrations for emergent oncological formulations, what synergistic frameworks and nuanced analytical constructs might underpin the refinement of dosing protocols during the nascent investigational phases and the exploration of dosage spectrums?",
            "retrieved_metrics": {
                "reference_idx": [
                    707
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Individualized dosing approaches leveraging #pharmacogenomics# and #pharmacodynamics# are crucial for refining dosing protocols, especially in early trials and dose-ranging studies, enhancing drug development and clinical outcomes.",
            "predicted_answer": "Pharmacogenomics, therapeutic drug monitoring (TDM), and pharmacodynamics are key frameworks for refining dosing protocols. These tools help individualize dosing, optimize efficacy, and minimize adverse effects in early clinical trials and dose-ranging studies.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"pharmacogenomics\" and \"pharmacodynamics\" as critical components for refining dosing protocols, aligning well with the reference answer. It adds \"therapeutic drug monitoring,\" which does not contradict but complements the reference's focus. All key facts are present with no significant omissions."
        },
        {
            "query_idx": 816,
            "query": "In the realm of calculated molecule delivery, particularly sotorasib at a milieu of 960 mg, directed towards entities specified by a genetic hallmark in the oncological continuum, what was the emergent pattern observed in relation to therapeutic efficacy during the second tier of methodological trial assessment?",
            "retrieved_metrics": {
                "reference_idx": [
                    706
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The emergent pattern observed was a #36% response rate# and an #81% disease control rate# in patients with KRAS G12C-positive NSCLC during Phase 2 trial of sotorasib 960 mg.",
            "predicted_answer": "In the Phase 2 trial, sotorasib at 960 mg showed a 36% response rate and 81% disease control rate in KRAS G12C-positive NSCLC patients. No dose-response relationship was observed, suggesting higher doses did not improve efficacy but may increase adverse events.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes all key facts from the 'Reference Answer': a 36% response rate and an 81% disease control rate in KRAS G12C-positive NSCLC patients during the Phase 2 trial of sotorasib at 960 mg. All important details match without contradiction or omission."
        },
        {
            "query_idx": 817,
            "query": "In contemplating Milligan's thorough analysis, how could the strategic foresight bestowed by M&S have illuminated the intricate web of exposure-response dynamics, mechanistic pathways, and intervention strategies within distinct populations, potentially circumventing the foundational missteps that led to the cessation of the 68 clinical evaluations?",
            "retrieved_metrics": {
                "reference_idx": [
                    708
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "M&S could have revealed crucial #exposure-response# dynamics and #mechanistic pathways# in specific populations, potentially preventing the failed clinical trials by informing design and strategy.",
            "predicted_answer": "M&S could have provided critical insights into exposure-response relationships, mechanistic pathways, and tailored intervention strategies, potentially preventing the 68 clinical trial failures by informing better design and execution.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: #exposure-response# relationships and #mechanistic pathways#. It aligns well with the reference answer's trend by mentioning preventing clinical trial failures and informing design and execution. All crucial elements emphasized in the reference are covered without omissions or contradictions."
        },
        {
            "query_idx": 818,
            "query": "Within the complex domain of therapeutic fine-tuning, what pivotal functions are ascribed to the analytical frameworks of pharmacometrics and the methodological intricacies of M&S models in steering dosage modulation in light of the genetic variegation landscape?",
            "retrieved_metrics": {
                "reference_idx": [
                    711
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Pharmacometrics and #M&S models# play pivotal roles in #dose optimization# by analyzing genetic variations and clinical data, influencing decisions on drug interactions, age, body weight, and organ functions.",
            "predicted_answer": "Pharmacometrics and M&S models analyze clinical data to optimize dosages, considering factors like genetic variants, drug interactions, and patient demographics, thus informing personalized dose adjustments.",
            "score": 3,
            "explanation": "The predicted answer captures the key roles of pharmacometrics and M&S models in dose optimization, acknowledging factors like genetic variants and drug interactions. However, it omits specific details like age, body weight, and organ functions mentioned in the reference answer, affecting completeness."
        },
        {
            "query_idx": 819,
            "query": "What delineated biochemical indices function as the dual augury of both enhanced survival prognostics and adverse physiological manifestations when subjected to imatinib therapeutic protocols?",
            "retrieved_metrics": {
                "reference_idx": [
                    713
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Imatinib# plasma concentrations serve as indicators: >#1000 ng/mL# improves survival outcomes, while >1685 ng/mL predicts toxicities.",
            "predicted_answer": "Imatinib plasma concentrations above 1000 ng/mL predict improved survival, while those above 1685 ng/mL indicate toxicities like diarrhea and edema.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes both key details: imatinib plasma concentrations above 1000 ng/mL predict improved survival and levels above 1685 ng/mL indicate toxicities, aligning with the 'Reference Answer'. No significant details are missing or contradictory."
        },
        {
            "query_idx": 820,
            "query": "To what extent can modeling and simulation be viewed as instruments of computational insight, refining the complex tapestry of decision paradigms within anticancer drug genesis, with explicit regard to the nuanced articulation of dosage determination and the subsequent clinical trajectory?",
            "retrieved_metrics": {
                "reference_idx": [
                    709
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Modeling and simulation (#M&S#) serve as instrumental tools in dose selection for anticancer drugs, enhancing #clinical decision-making# by predicting exposure and effects through PK/PD analyses.",
            "predicted_answer": "Modeling and simulation are essential in anticancer drug development, particularly for dose optimization. They integrate PK/PD analyses to predict exposure and effects, informing decisions on dosage and clinical outcomes, thus refining the decision-making process.",
            "score": 5,
            "explanation": "The predicted answer includes key elements such as modeling and simulation, PK/PD analysis, dose optimization, and their role in clinical outcomes. It captures the main idea of enhancing decision-making in anticancer drug development, aligning well with the emphasized aspects in the reference answer."
        },
        {
            "query_idx": 821,
            "query": "In the intricate landscape of pharmacological endeavors, what specialized roles do the genetic architects CYP2D6, DPYD, NUDT15, and TPMT assume within the regulatory symphonies to orchestrate the calibration of drug dosing efficacy, as elucidated by the pivotal frameworks provided by the FDA and the Clinical Pharmacogenetics Implementation Consortium?",
            "retrieved_metrics": {
                "reference_idx": [
                    720
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CYP2D6, DPYD, NUDT15, and TPMT are crucial for optimizing #dose selection# to reduce #drug toxicity# and improve efficacy as per the FDA and CPIC guidelines.",
            "predicted_answer": "CYP2D6, DPYD, NUDT15, and TPMT are key enzymes that influence drug metabolism. Guidelines from the FDA and Clinical Pharmacogenetics Implementation Consortium recommend using these genetic markers to optimize drug dosing, reducing toxicity and enhancing efficacy.",
            "score": 5,
            "explanation": "The Predicted Answer adequately covers essential roles such as optimizing drug dosing (aligned with \"dose selection\") and reducing toxicity as per the guidelines. It captures the spirit and key facts emphasized in the Reference Answer, maintaining overall consistency without significant omissions or contradictions."
        },
        {
            "query_idx": 822,
            "query": "What fundamental catalyst necessitates the pursuit of exhaustive exploration into the pharmacokinetic and pharmacodynamic interplay amidst the foundational stages of novel targeted therapeutic creation, as it relates to optimizing patient-specific dosing paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    721
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The fundamental catalyst is the #exposure-response# relationship, crucial for understanding #inter-patient variability# and optimizing patient-specific dosing paradigms in early drug development.",
            "predicted_answer": "The fundamental catalyst is the need to understand inter-patient variability and the exposure-response relationship, which informs optimal dosing and potential use of therapeutic drug monitoring for personalized treatment.",
            "score": 5,
            "explanation": "The predicted answer covers both the key facts emphasized in the reference answer: the \"exposure-response\" relationship and \"inter-patient variability.\" These elements are present and aligned with the overall trend of optimizing patient-specific dosing paradigms. No significant omissions or errors are noted."
        },
        {
            "query_idx": 823,
            "query": "In the intricate tapestry of pharmacokinetics, by what unique trajectory of chemical conversion does afatinib chart its distinct course, setting it apart from the metabolic pathways navigated by gefitinib, erlotinib, and osimertinib?",
            "retrieved_metrics": {
                "reference_idx": [
                    726
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Afatinib is #not metabolized# by #cytochrome P450s#, distinguishing its metabolic pathway as it is primarily excreted through feces, unlike gefitinib, erlotinib, and osimertinib.",
            "predicted_answer": "Afatinib is not metabolized by cytochrome P450 enzymes and is primarily excreted through the feces, distinguishing it from gefitinib, erlotinib, and osimertinib, which are metabolized by CYP3A4 and other CYP enzymes.",
            "score": 5,
            "explanation": "The predicted answer successfully captures all the key facts emphasized in the reference answer: afatinib is not metabolized by cytochrome P450 enzymes and is mainly excreted through feces. It accurately contrasts this with the metabolism through CYPs for other drugs, aligning precisely with the reference."
        },
        {
            "query_idx": 824,
            "query": "What configurations of allelic expression enveloped in the single nucleotide polymorphism rs4143815, within the intricate framework of the PD-L1 genetic realm, align with augmented durations of progression-free survival, particularly among NSCLC patients under the regimen of nivolumab's remedy?",
            "retrieved_metrics": {
                "reference_idx": [
                    733
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Patients with #CC# and #CG# genotypes of rs4143815 in the PD-L1 gene have longer progression-free survival when treated with nivolumab for NSCLC compared to the GG genotype.",
            "predicted_answer": "In NSCLC patients treated with nivolumab, the CC and CG genotypes of SNP rs4143815 in the PD-L1 gene are associated with longer progression-free survival compared to the GG genotype.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts emphasized in the reference answer: the CC and CG genotypes of SNP rs4143815 in the PD-L1 gene are linked to longer progression-free survival for NSCLC patients treated with nivolumab, compared to the GG genotype. All key points and trends are well covered."
        },
        {
            "query_idx": 825,
            "query": "What intrinsic genetic trajectories are charted by polymorphic shifts in FCGR2A and FCGR3A, and in what manner do they entwine with the paradigm of ADCC potentials? Moreover, within the realm of cetuximab's kinetic odyssey, how does the structural motif embedded within the FcRn promoter region orchestrate its systemic traversal and tenure?",
            "retrieved_metrics": {
                "reference_idx": [
                    739
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Polymorphic shifts in #FCGR2A# and #FCGR3A# alter ADCC activity. Within cetuximab's kinetics, FcRn promoter VNTR affects distribution, clearance, and half-life.",
            "predicted_answer": "Polymorphic shifts in FCGR2A and FCGR3A, such as C > T (rs1801274) and T > G (rs396991), alter ADCC activity. In cetuximab, FcRn promoter VNTRs, particularly three repeats, reduce distribution, increase half-life, and affect systemic traversal.",
            "score": 3,
            "explanation": "The predicted answer correctly references polymorphic shifts in FCGR2A and FCGR3A affecting ADCC activity and addresses the role of the FcRn promoter in cetuximab's pharmacokinetics, covering half-life and systemic traversal. However, it misses the detail about clearance, which affects completeness."
        },
        {
            "query_idx": 826,
            "query": "Through what mechanisms do the smoke-born aromatic hydrocarbons from cigarettes trigger an enhancement in the enzymatic expression of CYP1A2, thus evolving the metabolic processing of erlotinib into a pathway of increased expurgation and diminished therapeutic exposure?",
            "retrieved_metrics": {
                "reference_idx": [
                    728
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Aromatic hydrocarbons in #cigarette smoke# induce #CYP1A2# expression, increasing erlotinib metabolism and clearance, resulting in reduced drug exposure and efficacy.",
            "predicted_answer": "Cigarette smoke contains polycyclic aromatic hydrocarbons that induce CYP1A2 expression, increasing erlotinib clearance and reducing its therapeutic exposure.",
            "score": 3,
            "explanation": "The Predicted Answer mirrors the Reference Answer by identifying #cigarette smoke# and #CYP1A2# induction, which enhances erlotinib clearance, thus reducing therapeutic exposure. However, it doesn't explicitly mention reduced drug efficacy, though the trend is consistent. Therefore, a key fact (efficacy) is missing, affecting completeness."
        },
        {
            "query_idx": 827,
            "query": "What intricate procedural constructs and thresholds potentially contribute to the augmentation of financial outlays when transitioning medicinal breakthroughs from economically constrained to affluent territories?",
            "retrieved_metrics": {
                "reference_idx": [
                    743
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The augmentation of financial outlays is due to increased #development costs# from rigorous #regulatory requirements# and compliance issues in high-income countries (HICs).",
            "predicted_answer": "Regulatory requirements, rigorous safety and efficacy tests, and compliance issues in affluent territories increase the developmental costs of transitioning medicinal breakthroughs from economically constrained areas.",
            "score": 5,
            "explanation": "The predicted answer successfully identifies \"increased developmental costs\" and \"rigorous regulatory requirements\" as key contributors, aligning well with the reference. However, it also mentions \"safety and efficacy tests,\" which are implicit but not explicitly mentioned with \"#\" in the reference. Critical information is adequately covered."
        },
        {
            "query_idx": 828,
            "query": "To what extent do the multifaceted drivers, such as economic efficiency and prevailing health conditions, render lower- and middle-income regions as prime landscapes for high-income countries’ exploratory medical inquiries?",
            "retrieved_metrics": {
                "reference_idx": [
                    744
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Economic efficiency# and #higher incidence rates# make LMICs attractive for HICs' medical inquiries, reducing costs and time for patient recruitment in clinical trials.",
            "predicted_answer": "Lower- and middle-income regions, with their larger treatment-naive populations and higher disease incidence, offer cost and time efficiencies for high-income countries conducting medical research, making them prime locations for clinical trials.",
            "score": 5,
            "explanation": "The predicted answer reflects the key facts from the reference: both mention \"economic efficiency\" (cost and time efficiencies) and \"higher disease incidence\" (higher incidence rates) impacting medical research in LMICs. No key facts are missing, and the trends are aligned, ensuring completeness and consistency."
        },
        {
            "query_idx": 829,
            "query": "In the collective embrace of biosimilar trastuzumab by the distinguished constellation of EU5 countries, what expansive spectrum of fiscal reverberations, articulated as a harmonious convergence of economic liberation, might unfurl?",
            "retrieved_metrics": {
                "reference_idx": [
                    746
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #EU5 countries# could achieve #cost-savings# ranging from €19 million to €172 million with the use of biosimilar trastuzumab.",
            "predicted_answer": "The adoption of biosimilar trastuzumab in EU5 countries could lead to significant cost savings, ranging from €19 million to €172 million, enhancing economic efficiency and patient access to affordable cancer treatments.",
            "score": 5,
            "explanation": "The key facts in the Reference Answer, \"EU5 countries\" and \"cost-savings ranging from €19 million to €172 million,\" are present in the Predicted Answer. The predicted response also aligns with the overall economic benefit trend emphasized in the reference. No significant details are missing."
        },
        {
            "query_idx": 830,
            "query": "How might the intricate interplay of procedural dynamics within the biochemical synthesis tapestry of biosimilar production manifest as a domino effect, potentially giving rise to emergent hypersensitivity reactions and altered therapeutic efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    747
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #procedural dynamics# in biosimilar production can lead to #hypersensitivity reactions# and reduced therapeutic effectiveness due to minor manufacturing alterations affecting antibody response.",
            "predicted_answer": "The intricate interplay in biosimilar production can lead to slight variations, potentially triggering antibody responses and hypersensitivity reactions, as well as altering therapeutic efficacy. These changes can have a domino effect, impacting patient safety and treatment outcomes.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of the reference, noting the role of procedural dynamics in biosimilar production leading to hypersensitivity reactions and altered efficacy, along with the potential for a domino effect. However, it misses explicitly mentioning “procedural dynamics,” impacting completeness."
        },
        {
            "query_idx": 831,
            "query": "What fraction of the globe's cancer-related fiscal allocation is channeled toward economically constrained regions, whose substantial cancer fatality figures underscore a striking asymmetry in resource deployment?",
            "retrieved_metrics": {
                "reference_idx": [
                    742
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Only #5%# of global cancer-related fiscal allocation is spent in economically constrained regions, despite these regions witnessing #64%# of global cancer deaths.",
            "predicted_answer": "Only 5% of global resources for cancer are allocated to low- and middle-income countries, despite these regions accounting for 64% of global cancer deaths.",
            "score": 5,
            "explanation": "The Predicted Answer matches the Reference Answer closely. Both mention that only 5% of resources for cancer are allocated to low- and middle-income countries, despite these regions accounting for 64% of global cancer deaths. All key facts are present, and the overall trend is consistent."
        },
        {
            "query_idx": 832,
            "query": "How might navigators of medical ethics recalibrate their stance when faced with a conduit for medicinal progression that leans towards accelerated pharmacological affirmation, as illustrated by the LIGHTHOUSE initiative?",
            "retrieved_metrics": {
                "reference_idx": [
                    748
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Navigators of medical ethics should prioritise #patient benefit# and take a firm stance against trials aiming solely for #expedited drug approval# like the LIGHTHOUSE initiative.",
            "predicted_answer": "Navigators of medical ethics should prioritize patient benefit over expedited drug approval. In initiatives like LIGHTHOUSE, they must ensure trials focus on improving patient care and quality of life, advocating for transparent and ethical practices.",
            "score": 3,
            "explanation": "The Predicted Answer includes the key fact of \"prioritizing patient benefit.\" However, it does not explicitly emphasize the need to oppose expedited drug approval, which is a key point in the Reference Answer. Despite mentioning the importance of ethical practices, this omission affects completeness."
        },
        {
            "query_idx": 833,
            "query": "What intricate ethical and regulatory calculations led to the scenario where atezolizumab was removed from therapeutic use in high-income nations for triple-negative breast cancer, while it continues to be distributed across less financially affluent regions globally?",
            "retrieved_metrics": {
                "reference_idx": [
                    749
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Atezolizumab was removed due to #ineffectiveness# in HICs but remains available in LMICs despite ethical concerns over #global use# with no proven benefits.",
            "predicted_answer": "The decision to remove atezolizumab for triple-negative breast cancer in high-income countries was due to lack of benefits shown in trials. However, it remains available in less affluent regions, raising ethical concerns about unequal treatment standards.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of ineffectiveness and ethical concerns regarding global use with unequal treatment standards, which aligns with the reference. It effectively communicates the core issues surrounding ethical dilemmas without significant omissions or contradictions."
        },
        {
            "query_idx": 834,
            "query": "What navigational obstacles do economic thresholds and regulatory mazes present for nations with emerging marketplaces in their pursuit of crafting viable and cost-accessible biosimilar entities and strategically recontextualized medicinal compounds?",
            "retrieved_metrics": {
                "reference_idx": [
                    751
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Economic thresholds and regulatory mazes pose #investment# hurdles and patent policy #obstacles# for emerging markets developing biosimilars and repurposed drugs.",
            "predicted_answer": "Economic thresholds and regulatory mazes create significant hurdles, including high investment costs and restrictive patent policies, which can impede the development and accessibility of cost-effective biosimilars and repurposed drugs in emerging markets.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key points of the reference answer, specifically highlighting the #investment# hurdles and #patent policy# obstacles. It captures these challenges in developing biosimilars and repurposed drugs in emerging markets without any contradictions or significant omissions."
        },
        {
            "query_idx": 835,
            "query": "How do the intertwined perceptual barriers and logistical disparities within academic channels contribute to the distortion of a just global knowledge ecology in cancer research, especially when considering the storytelling potential from regions systematically positioned at the margins of the epistemic community?",
            "retrieved_metrics": {
                "reference_idx": [
                    752
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intertwined #perceptual barriers# and #logistical disparities# in academic channels distort global knowledge ecology by limiting publication opportunities and mentorship for LMICs in cancer research.",
            "predicted_answer": "Perceptual barriers and logistical disparities, such as publication bias and lack of resources, limit the visibility and impact of research from marginalized regions, distorting a just global knowledge ecology in cancer research. Addressing these issues requires equitable support and mentorship.",
            "score": 1,
            "explanation": "The predicted answer includes perceptual barriers and logistical disparities, consistent with the reference. It mentions publication bias and resource limitations, aligning with \"publication opportunities.\" However, it lacks reference to #mentorship# and #LMICs#, missing critical details that impact completeness."
        },
        {
            "query_idx": 836,
            "query": "What multifaceted hindrances arise within the substratum of international endeavors aiming to augment therapeutic access across the layered terrains of LMICs, entailing the nuanced interconnection of cultural variances, fiscal disparities, and the quandary of shared yet individualistic scientific recognition on the global stage?",
            "retrieved_metrics": {
                "reference_idx": [
                    754
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cultural differences, #lack of adequate funding#, communication barriers, and inadequate #representation in scientific publications# hinder international efforts to improve therapeutic access in LMICs.",
            "predicted_answer": "Cultural differences, inadequate funding, communication barriers, and lack of global representation in scientific publications hinder international efforts to improve therapeutic access in LMICs.",
            "score": 5,
            "explanation": "The Predicted Answer includes all the key facts from the Reference Answer: cultural differences, inadequate funding, communication barriers, and lack of global representation in scientific publications. The details and overall trend of both answers align well, with no significant omissions or contradictions."
        },
        {
            "query_idx": 837,
            "query": "Amidst the intricate ballet of molecular pathways and cellular dynamics, what abstracts of influence do the selective modulations by calcium influx perturbers, notably those channeling the L-type variances, impart on the morphogenetic architecture of filopodial extensions and the thwarting of oncogenic cellular encroachments, as unveiled through the lens of phenotypic exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    765
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "L-type calcium channel blockers, like #amlodipine#, inhibit #filopodia# formation and prevent cancer cell invasion, crucially regulating calcium entry and filamentous pore stabilization in cancer cells.",
            "predicted_answer": "L-type calcium channel blockers, such as amlodipine besylate and felodipine, inhibit filopodia formation and prevent cancer cell invasion, highlighting their role in regulating calcium influx and cellular dynamics.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer. It includes key facts such as the role of L-type calcium channel blockers (amlodipine mentioned) in inhibiting filopodia formation and preventing cancer cell invasion. The key technical component about filamentous pore stabilization is implied but not explicit."
        },
        {
            "query_idx": 838,
            "query": "In what manner does the omission of cellular entities, metaphorically viewed as the 'architectural symphony directors' within the mesenchymal tapestry, neural pathways, and immune surveillance systems, inhibit the comprehensive re-creation of oncological intricacies in tumoroid paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    763
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The omission of #mesenchymal tissues#, #neural cells#, and immune cells in tumoroid models restricts their capacity to replicate the full oncological intricacies.",
            "predicted_answer": "The omission of cellular entities like mesenchymal, neural, and immune cells in tumoroids limits their ability to fully replicate the complex structure and functionality of tumors, hindering the accurate re-creation of oncological intricacies.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts of omitting mesenchymal (referred to as \"cellular entities like mesenchymal\"), neural, and immune cells, aligning with the reference's mention of their roles in replication challenges. No contradictory information is present; however, the term \"tissues\" is omitted."
        },
        {
            "query_idx": 839,
            "query": "In what manner does the intricate choreography of evaluative methodologies function to discern which epigenetic modulators rise as candidates of discernible potential within the complex ecosystem surrounding breast cancer organoids?",
            "retrieved_metrics": {
                "reference_idx": [
                    768
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate choreography of evaluative methodologies identifies epigenetic modulators like #BML-210#, #GSK-LSD1#, and CUDC-101 through high-throughput screening with patient-derived breast cancer organoids and cytotoxic T cells.",
            "predicted_answer": "High-throughput screening of patient-derived breast cancer organoids interacting with tumor-specific cytotoxic T cells identifies epigenetic inhibitors like BML-210, GSK-LSD1, and CUDC-101 with significant antitumor effects.",
            "score": 5,
            "explanation": "The predicted answer successfully identifies the key epigenetic modulators, #BML-210# and #GSK-LSD1#, as well as the involvement of patient-derived breast cancer organoids and cytotoxic T cells, matching all key facts in the reference answer without any significant omissions or errors."
        },
        {
            "query_idx": 840,
            "query": "Within the molecular theater of cellular conduct, what abstract roles does salidroside undertake to potentially subvert cellular expansion and migration schemes in prostate and HeLa cells, particularly by interacting with pivotal biochemical cascades and signaling harmonics?",
            "retrieved_metrics": {
                "reference_idx": [
                    770
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Salidroside #suppresses# prostate and HeLa cell proliferation by inhibiting the #PI3K/AKT# pathway, triggering apoptosis and hampering migration, indicating its potential as an anticancer agent.",
            "predicted_answer": "Salidroside inhibits cellular proliferation, colony formation, and migration in prostate and HeLa cells by suppressing the PI3K/AKT pathway and activating apoptosis, thereby subverting expansion and migration.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer. It covers all key facts: salidroside's suppression of cell proliferation and migration in prostate and HeLa cells, the inhibition of the PI3K/AKT pathway, and induction of apoptosis. Both answers share the same overall trend without omissions or contradictions."
        },
        {
            "query_idx": 841,
            "query": "Within the spectrum of cellular cessation, how does the genetically choreographed symphony of structured cellular conclusion delineate itself from the spontaneous termination that unfolds devoid of genetic orchestration?",
            "retrieved_metrics": {
                "reference_idx": [
                    771
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Regulated cell death# involves a genetically encoded process, whereas #accidental cell death# is an uncontrolled, spontaneous termination without genetic orchestration.",
            "predicted_answer": "Regulated cell death (RCD) is genetically orchestrated and maintains tissue homeostasis, while accidental cell death (ACD) is spontaneous and uncontrolled. RCD includes apoptotic and non-apoptotic subcategories, each with specific genetic pathways.",
            "score": 5,
            "explanation": "The predicted answer covers all the key facts from the reference answer: \"regulated cell death\" as a genetically controlled process and \"accidental cell death\" as spontaneous and uncontrolled. It adds detail without contradiction, maintaining alignment and completeness."
        },
        {
            "query_idx": 842,
            "query": "In the intricate dance of oncological evolution, what cascade of orchestrated outcomes unfolds as a result of the attenuation of the cellular gatekeeper β-catenin, especially in terms of autophagic gateway formations and the symphonic orchestration of terminal cellular transformations?",
            "retrieved_metrics": {
                "reference_idx": [
                    774
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The attenuation of #β-catenin# leads to #autophagic vacuole# formation, increased apoptosis, and induces autophagic cell death.",
            "predicted_answer": "The attenuation of β-catenin leads to the formation of autophagic vacuoles, including autophagosomes and autolysosomes, and increases apoptosis, ultimately inducing autophagic cell death.",
            "score": 5,
            "explanation": "The predicted answer accurately presents the key facts emphasized in the reference answer. It mentions the attenuation of β-catenin leading to autophagic vacuole formations, increased apoptosis, and autophagic cell death. The phrasing differs slightly but captures all essential elements without omission."
        },
        {
            "query_idx": 843,
            "query": "In the mysterious dance of cellular transformations dictated by the influence of Triptolide, which structural reconfigurations materialize within these microscopic realms, and how do the orchestrators gasdermin E and gasdermin B engage in the tapestry of this cellular evolution?",
            "retrieved_metrics": {
                "reference_idx": [
                    773
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cells exposed to #Triptolide# experience non-apoptotic death with cytoplasmic swelling, membrane disruption, and increased expression of #gasdermin E# and gasdermin B.",
            "predicted_answer": "Triptolide induces non-apoptotic cell death, causing cytoplasmic swelling and membrane disruption. It also elevates the expression of gasdermin E (GSDME) and GSDMB, which contribute to these structural reconfigurations.",
            "score": 5,
            "explanation": "The predicted answer is aligned with the reference answer, covering all key facts such as \"Triptolide,\" non-apoptotic cell death, cytoplasmic swelling, membrane disruption, and the elevation of gasdermin E and gasdermin B. The meaning is consistent, and there are no significant omissions."
        },
        {
            "query_idx": 844,
            "query": "Within the complex realm of molecular interplay, what specific sequence of biochemical obstructions implemented by leflunomide facilitates the stalling of proliferative advancement in human A375 melanoma cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    780
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Leflunomide #suppresses melanoma# growth in A375 cells by causing nucleotide depletion, reducing chromatin occupancy of the RNA helicase protein #DDX21#, thereby impeding transcription elongation.",
            "predicted_answer": "Leflunomide stalls proliferative advancement in A375 melanoma cells by inhibiting de novo pyrimidine biosynthesis, leading to nucleotide depletion and reduced chromatin occupancy of the RNA helicase protein DDX21, thus impeding transcription elongation.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts from the reference answer, such as leflunomide's impact on nucleotide depletion, DDX21 reduction, and transcription inhibition. It adds detail about de novo pyrimidine biosynthesis but maintains consistent meaning without contradictions or omissions."
        },
        {
            "query_idx": 845,
            "query": "What multifaceted interplay of dynamic intracellular processes does TPL's interaction with prostate oncocytes orchestrate, inducing autophagic sequences through nuanced modulation of cellular communication pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    779
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "TPL's interaction with prostate oncocytes induces autophagy by #activating# the CAMKKb-AMPK pathway, inhibiting mTOR, and activating beclin-1 and #ULK1#.",
            "predicted_answer": "TPL's interaction with prostate cancer cells stimulates free calcium release, endoplasmic reticulum stress, and activates the CAMKKβ-AMPK pathway, inhibiting mTOR and activating beclin-1 and ULK1, thus promoting autophagy.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts emphasized in the reference answer: activation of the CAMKKβ-AMPK pathway, inhibition of mTOR, and activation of beclin-1 and ULK1. It aligns well with the reference by accurately describing the induction of autophagy without omitting significant details."
        },
        {
            "query_idx": 846,
            "query": "What avenue within the multifaceted domain of enzymatic inhibition positions simvastatin to exhibit unparalleled efficacy among its statin kin in the orchestration of therapeutic responses across an array of cancer phenotypes?",
            "retrieved_metrics": {
                "reference_idx": [
                    785
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Simvastatin exhibits unparalleled efficacy in cancer therapy through #activation of mutant P53#, providing therapeutic responses across various cancer phenotypes by targeting deregulated cancer cell growth pathways.",
            "predicted_answer": "Simvastatin exhibits unparalleled efficacy in cancer therapy by inhibiting HMGCR, reducing cholesterol production and impacting by-products essential for cancer cell growth. Its anticancer potential is further enhanced through the activation of mutant P53.",
            "score": 3,
            "explanation": "The predicted answer partially aligns with the reference by mentioning the activation of mutant P53, but it lacks emphasis on how simvastatin provides therapeutic responses across various cancer phenotypes by targeting deregulated growth pathways, a critical aspect of the reference."
        },
        {
            "query_idx": 847,
            "query": "What influence do catalytic particles exert in the molecular symphony of DHA to disentangle the endoperoxide nexus, thereby unlocking potential therapeutic pathways in the realm of disease eradication and regulation of cell growth?",
            "retrieved_metrics": {
                "reference_idx": [
                    792
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Catalytic particles, like #iron ions#, cleave the endoperoxide bridge in DHA, releasing #cytotoxic ROS# and facilitating therapeutic pathways for disease eradication and cell growth regulation.",
            "predicted_answer": "Catalytic particles, like iron ions, cleave the endoperoxide bridge in DHA, releasing cytotoxic ROS. This mechanism underpins DHA's anti-malarial and antitumor properties, unlocking therapeutic pathways for disease eradication and cell growth regulation.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized in the reference answer: the role of catalytic particles like iron ions and the release of cytotoxic ROS. It aligns closely with the reference, covering therapeutic pathways without omissions or contradictions."
        },
        {
            "query_idx": 848,
            "query": "In what manner does the phenomenon of epithelial-mesenchymal transmutation influence the expansive cellular journey involving pervasive tissue infiltration and the distant orchestration of oncological demise?",
            "retrieved_metrics": {
                "reference_idx": [
                    795
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The phenomenon of epithelial-mesenchymal transition (#EMT#) influences tumor invasion and #metastasis#, contributing to increased tumor-related mortality by enabling pervasive tissue infiltration and distant cancer spread.",
            "predicted_answer": "Epithelial-mesenchymal transition (EMT) enhances cancer cells' ability to invade surrounding tissues and metastasize, contributing to the spread and progression of cancer.",
            "score": 3,
            "explanation": "The predicted answer covers the key concepts of EMT and metastasis, aligning with the reference's mention of tissue infiltration and cancer spread. However, it omits \"increased tumor-related mortality.\" Overall, it aligns with the reference but misses a critical detail related to mortality."
        },
        {
            "query_idx": 849,
            "query": "In what diverse and integrative manner does human telomerase reverse transcriptase (hTERT) act as a critical conductor in the persistent replication and intricate modulation of signaling pathways within cancerous cells, thereby surpassing conventional checkpoints of cellular aging and programmed cell death?",
            "retrieved_metrics": {
                "reference_idx": [
                    787
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Human telomerase reverse transcriptase (#hTERT#) acts as a transcriptional regulator in cancer cells, activating crucial genes for proliferation and survival via #WNT/β-catenin# and NFκB signaling pathways.",
            "predicted_answer": "hTERT acts as a critical conductor in cancer cells by evading growth constraints, modulating WNT/β-catenin and NFκB signaling pathways, and activating genes essential for tumor proliferation and survival, thus surpassing cellular aging and apoptosis.",
            "score": 3,
            "explanation": "The predicted answer covers the role of hTERT in activating genes for tumor proliferation and survival, and mentions the modulation of WNT/β-catenin and NFκB signaling pathways. However, it lacks the detail of hTERT acting as a transcriptional regulator, leading to a slight inconsistency in completeness."
        },
        {
            "query_idx": 850,
            "query": "In the complex interplay of biochemical signals within the realm of human epithelial MDA-MB-231 breast cancer cells, what is the nuanced effect of simvastatin on the expression dynamics of the deviant sentinel protein and the transmutation marker of cellular migration potential?",
            "retrieved_metrics": {
                "reference_idx": [
                    794
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Simvastatin increases #mutant P53# expression and represses #CD44# expression, reducing migratory and invasive abilities of MDA-MB-231 breast cancer cells.",
            "predicted_answer": "Simvastatin reduces the migratory and invasive abilities of MDA-MB-231 cells by increasing mutant P53 expression and repressing CD44, a marker essential for cell migration.",
            "score": 5,
            "explanation": "The predicted answer fully aligns with the reference answer by indicating that simvastatin increases mutant P53 expression and represses CD44 expression, leading to reduced migratory and invasive abilities of MDA-MB-231 cells. No key facts or trends are missing or contradicted."
        },
        {
            "query_idx": 851,
            "query": "What multifaceted strategies do tumor cells deploy to convolute and dampen the vigilance of lymphoid warriors during the relentless march of oncogenic evolution?",
            "retrieved_metrics": {
                "reference_idx": [
                    796
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tumor cells express #PD-L1# to bind #PD-1# on lymphocytes, inhibiting their activity and suppressing anti-tumor immunity during tumor progression.",
            "predicted_answer": "Tumor cells deploy strategies like expressing PD-L1, which binds to PD-1 on lymphocytes, inhibiting their activity and dampening the immune response. This helps them evade detection and elimination by the body's lymphoid warriors.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts in the reference answer, mentioning PD-L1's role in engaging PD-1 on lymphocytes to inhibit their activity. It aligns with the overall trend of immune evasion and suppression but does not explicitly mention \"suppressing anti-tumor immunity during tumor progression\"."
        },
        {
            "query_idx": 852,
            "query": "What molecular or structural anomalies function as the triggers for the orchestration of genomic stability assurance systems during the progression of neoplastic cellular dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    798
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#DNA damage# such as germline or somatic defects, oncogene-induced #replication stress#, and flawed mitotic chromosome segregation trigger genomic stability assurance systems.",
            "predicted_answer": "Molecular or structural anomalies such as germline or somatic defects in DNA repair, oncogene-induced replication stress, flawed mitotic chromosome segregation, and clashes between replication and transcription machinery trigger the activation of genomic stability assurance systems during neoplastic cellular dynamics.",
            "score": 5,
            "explanation": "The predicted answer covers key facts from the reference answer, including DNA damage (germline or somatic defects), replication stress, and mitotic chromosome segregation issues. It includes additional details, like clashes between replication and transcription, without contradicting the reference, aligning well with the overall trend."
        },
        {
            "query_idx": 853,
            "query": "What role does the intricate convergence of genistein with diverse cancer therapy paradigms play as the principal axis in scrutinizing its clinical efficacy through trial investigations?",
            "retrieved_metrics": {
                "reference_idx": [
                    801
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate convergence of genistein with diverse cancer therapy paradigms plays a #synergistic# role, enhancing its potential as a #chemopreventive# agent in clinical trials.",
            "predicted_answer": "The convergence of genistein with various cancer therapies, such as radiotherapy and chemotherapy, is crucial for evaluating its clinical efficacy. Clinical trials aim to validate its potential as a chemopreventive agent when combined with other treatments.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer in identifying the role of genistein in conjunction with other therapies to evaluate its clinical efficacy. However, it does not explicitly mention the \"synergistic\" aspect, missing a key fact emphasized in the reference answer."
        },
        {
            "query_idx": 854,
            "query": "In the grand cosmic choreography of cellular processes, what role does DHA play in the orchestration of VEGFR1’s expression, and through which mechanistic blockade does it induce a state of cellular self-digestion in the endothelial realm of HUVECs?",
            "retrieved_metrics": {
                "reference_idx": [
                    804
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "DHA enhances #VEGFR1# expression by upregulating ETS-1 and induces autophagy in HUVECs by blocking the #AKT/mTOR# signaling pathway.",
            "predicted_answer": "DHA enhances VEGFR1 expression via ETS-1 upregulation and induces autophagy in HUVECs by suppressing the AKT/mTOR pathway.",
            "score": 5,
            "explanation": "The predicted answer accurately captures both key facts emphasized in the reference: upregulation of VEGFR1 expression and induction of autophagy by blocking the AKT/mTOR pathway. The phrasing is slightly different, but the meaning and details are fully consistent with the reference."
        },
        {
            "query_idx": 855,
            "query": "In what manner do the tripartite processes of cellular dynamism, each interfering in their unique capacity with the path of cellular specialization, manifest themselves during the intricate tapestry of organismal development?",
            "retrieved_metrics": {
                "reference_idx": [
                    806
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The tripartite processes in cellular dynamism manifest as #dedifferentiation#, #blocked differentiation#, and transdifferentiation, disrupting cellular specialization during organismal development.",
            "predicted_answer": "During organismal development, cellular dynamism manifests through dedifferentiation, blocked differentiation, and transdifferentiation, each interfering with the path of cellular specialization and potentially leading to tumor formation.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts: dedifferentiation, blocked differentiation, and transdifferentiation, consistent with the reference answer. There's an additional detail about potential tumor formation, but it does not contradict the reference. The key facts and trends are fully covered."
        },
        {
            "query_idx": 856,
            "query": "What pathways might the intricate symphony of SMAD4's genetic echoes unfurl in modulating the proliferative dance induced by WNT signals amidst tumor resilience, and how could the inventive recycling of therapeutic compounds herald novel medical revelations?",
            "retrieved_metrics": {
                "reference_idx": [
                    808
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate interplay of #SMAD4# can potentially suppress #WNT-induced# proliferation, and drug repurposing, like using metformin, may lead to novel therapeutic breakthroughs.",
            "predicted_answer": "SMAD4 promotes differentiation and suppresses WNT-induced proliferation, countering tumor resistance. Repurposing drugs like metformin could offer novel therapeutic approaches by leveraging these mechanisms.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts of SMAD4 suppressing WNT-induced proliferation and mentions drug repurposing with metformin, aligning with the Reference Answer. The meaning and key trends are consistent, covering the emphasized points without significant omissions."
        },
        {
            "query_idx": 857,
            "query": "What insight does the probabilistic risk modulation vector afford when elucidating the nuanced role of metformin as a transformative agent within the oncological narrative of ovarian cancer prevalence, particularly when juxtaposed with other therapeutic modalities?",
            "retrieved_metrics": {
                "reference_idx": [
                    811
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #risk modulation vector# reveals metformin's transformative role, showing a lower #ovarian cancer# prevalence (HR = 0.47) compared to other therapies.",
            "predicted_answer": "The probabilistic risk modulation vector highlights metformin's potential to reduce ovarian cancer risk, with a hazard ratio of 0.47 (95% CI: 0.27-0.82), suggesting it may be more effective than other therapies by modulating metabolic pathways.",
            "score": 5,
            "explanation": "The predicted answer contains key facts from the reference answer, such as the use of the risk modulation vector and the hazard ratio (HR = 0.47) indicating metformin's role in reducing ovarian cancer prevalence. While it lacks the phrase \"compared to other therapies,\" the overall trend and details are consistent."
        },
        {
            "query_idx": 858,
            "query": "How do the intricate bioactive agents originating from Oroxylum indicum, notably the flavonoid intervention, execute the modulation of hypoxia-induced cellular resilience mechanisms, thereby impacting tamoxifen resistance in breast cancer cell populations confronted by diminished oxygen levels?",
            "retrieved_metrics": {
                "reference_idx": [
                    812
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The flavonoid #Baicalein# helps reverse tamoxifen resistance in hypoxic breast cancer cells by #downregulating HIF-1 α# levels.",
            "predicted_answer": "Baicalein from Oroxylum indicum downregulates HIF-1α levels, reversing hypoxia-induced tamoxifen resistance in breast cancer cells.",
            "score": 5,
            "explanation": "The Predicted Answer includes all the key facts emphasized in the Reference Answer: \"Baicalein,\" \"downregulates HIF-1α levels,\" and \"reversing hypoxia-induced tamoxifen resistance in breast cancer cells.\" The interpretations are consistent, with no significant omissions or contradictions."
        },
        {
            "query_idx": 859,
            "query": "How does the molecular fulcrum, known as Fusobacterium adhesin A embedded in Fusobacterium nucleatum, orchestrate its influence under the confluence of biochemical signals that shape the neoplastic narrative in colorectal cancer advancement?",
            "retrieved_metrics": {
                "reference_idx": [
                    816
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Fusobacterium adhesin A in #Fusobacterium nucleatum# influences colorectal cancer progression via the #E-cadherin/WNTβ-catenin# signaling pathway under biochemical signals.",
            "predicted_answer": "Fusobacterium adhesin A in F. nucleatum promotes colorectal cancer progression by influencing the E-cadherin/WNT-β-catenin signaling pathway, contributing to tumor development.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies Fusobacterium adhesin A and Fusobacterium nucleatum, as well as the E-cadherin/WNT-β-catenin signaling pathway, aligning with the key facts in the reference answer. No key information, as emphasized by #’s, is missing from the provided details."
        },
        {
            "query_idx": 860,
            "query": "What function does the enzymatic conduit involving 6-phosphogluconate dehydrogenase play in orchestrating the molecular blueprint transformations, specifically involving histone modulation and DNA epigenetic alterations, as cells journey through the tumor advancement phase?",
            "retrieved_metrics": {
                "reference_idx": [
                    815
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #6-phosphogluconate dehydrogenase# facilitates histone H3K9 and #DNA methylation# reshaping, upregulating N-cadherin transcription, promoting EMT, and distant metastasis during tumor progression.",
            "predicted_answer": "The 6-phosphogluconate dehydrogenase-driven pathway facilitates reshaping of histone H3K9 and DNA methylation, upregulating N-cadherin transcription and promoting metastasis during tumor progression.",
            "score": 3,
            "explanation": "The predicted answer includes key functions of 6-phosphogluconate dehydrogenase in histone H3K9 and DNA methylation reshaping, upregulation of N-cadherin transcription, and promotion of metastasis during tumor progression. However, it omits EMT, a crucial detail in the Reference Answer."
        },
        {
            "query_idx": 861,
            "query": "What revelations emanated from the inaugural experimental foray using 211 BE amidst the battlefields of hormone-resistant prostate malignancy—in terms of both its healing promise and its safety perimeter?",
            "retrieved_metrics": {
                "reference_idx": [
                    813
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #phase 1 trial# of #211 BE# revealed promising therapeutic efficacy and safety in hormone-refractory prostate cancer patients. Further studies are needed for comprehensive understanding.",
            "predicted_answer": "The phase 1 clinical trial in 2008 revealed that 211 BE, a component of PCSPES, showed promising therapeutic efficacy and safety for hormone-refractory prostate cancer, though further studies are needed to understand its mechanisms.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts from the reference answer, mentioning the \"phase 1 trial,\" \"211 BE,\" its \"promising therapeutic efficacy and safety\" in \"hormone-refractory prostate cancer.\" The overall meaning aligns well with no significant omissions or errors."
        },
        {
            "query_idx": 862,
            "query": "What enigmatic dance do senescent cells engage in within the malignant sphere, wherein they simultaneously act as both sentinels against and instigators of oncogenic transformations, illustrating their Janus-faced nature in the realm of tumor dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    821
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Senescent cells engage in a #paradoxical role# by providing a barrier against cancer but also #promoting tumor growth# through mechanisms like the senescence-associated secretory phenotype.",
            "predicted_answer": "Senescent cells exhibit a dual role in tumor dynamics. They can prevent cancer by arresting the cell cycle and removing damaged cells, but they also promote tumor growth through the senescence-associated secretory phenotype (SASP), illustrating their Janus-faced nature.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of senescent cells having a paradoxical role by both preventing cancer and promoting tumor growth via the senescence-associated secretory phenotype. The meaning is consistent with the reference, aligning with its overall trend and details."
        },
        {
            "query_idx": 863,
            "query": "In what manner does the incorporation of inulin gel as an exemplary modulator within the intricate biological micro-ecosystem influence the symbiotic mechanisms of immune system enhancement and the intricate dynamics of neoplastic growth containment as interpreted from the context's exposition?",
            "retrieved_metrics": {
                "reference_idx": [
                    820
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Inulin gel #invigorates immune# response and #inhibits tumor# proliferation by reformulating gut microbiota, enhancing immune checkpoint therapy efficacy, and extending oncogenesis latency phase.",
            "predicted_answer": "Inulin gel modulates the gut microbiota, enhancing immune system function and inhibiting tumor growth. It amplifies the efficacy of immune checkpoint therapy, invigorates the immune response, and extends the latency phase of oncogenesis.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized in the reference answer: inulin gel invigorates the immune response, inhibits tumor growth, reformulates gut microbiota, enhances immune checkpoint therapy, and extends oncogenesis latency. The information is consistent and complete, with no key omissions."
        },
        {
            "query_idx": 864,
            "query": "In the realm of oncological transformation, what intrinsic systemic barriers must be surmounted to enable quercetin's expansive integration, and what novel mechanistic solutions have emerged to deftly traverse these formidable challenges?",
            "retrieved_metrics": {
                "reference_idx": [
                    826
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intrinsic systemic barriers include #limited bioavailability# and instability. Novel solutions involve using #lipid nanoparticles# and chitosan nanoparticles to enhance quercetin's bioavailability for oncological integration.",
            "predicted_answer": "Intrinsic barriers include limited bioavailability, instability, and lack of precise tumor targeting. Novel solutions involve using lipid and chitosan nanoparticles to enhance quercetin's bioavailability and efficacy.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized with # symbols: \"limited bioavailability\" and \"lipid nanoparticles\". The overall trend of addressing instability and novel mechanistic solutions aligns with the reference. No conflicting information is present."
        },
        {
            "query_idx": 865,
            "query": "In the complex ecological interactions and molecular choreography of the tumor's surrounding environment, what pivotal roles do the constituents of this intricate system play in potentially directing and modulating therapeutic outcomes in oncological treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    828
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Constituents of the #tumor microenvironment# regulate #therapeutic outcomes# by supporting cancer cell survival, proliferation, and modifying molecule interactions, making it crucial for developing cancer therapies.",
            "predicted_answer": "The constituents of the tumor microenvironment (TME), including immune cells, metabolic factors, and gut microbiota, play pivotal roles by either promoting or inhibiting tumor growth. Understanding these interactions is crucial for developing effective oncological treatments.",
            "score": 3,
            "explanation": "The 'Predicted Answer' covers the concept of the tumor microenvironment and its role in influencing therapeutic outcomes, aligning with the 'Reference Answer'. However, it misses mentioning specific regulatory roles, such as supporting cancer cell survival and modifying molecule interactions, affecting completeness."
        },
        {
            "query_idx": 866,
            "query": "What elaborate interactions define the role of apigenin in altering the molecular exhibition of PD-L1, as prompted by IFN-γ's influence, especially when considering the intricate dynamics of its effect within particular breast cancer and melanoma tumor participants?",
            "retrieved_metrics": {
                "reference_idx": [
                    829
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Apigenin effectively negates #IFN-γ-induced# PD-L1 upregulation in breast cancer and melanoma cell lines, highlighting its potential as an #immunomodulator# in cancer therapy.",
            "predicted_answer": "Apigenin, a flavonoid, negates the upregulation of PD-L1 induced by IFN-γ in specific breast cancer and melanoma cell lines, suggesting its potential as an immunomodulator in cancer therapy.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects key facts from the reference, including that apigenin negates IFN-γ-induced PD-L1 upregulation in specific cancer types and suggests its role as an immunomodulator. It is consistent with the reference answer, with no significant omissions or errors."
        },
        {
            "query_idx": 867,
            "query": "What is the intricate mechanism by which tadalafil orchestrates its influence in the layered framework of immune modulation, focusing on its synergistic role against myeloid-derived suppressor cells during the controlled, preliminary stage of clinical exploration involving perioperative intramuscular influenza vaccination?",
            "retrieved_metrics": {
                "reference_idx": [
                    830
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tadalafil, a #phosphodiesterase-5 inhibitor#, is used to counteract myeloid-derived suppressor cell inhibition of NK cells, enhancing immune modulation in preliminary clinical exploration with #influenza vaccination#.",
            "predicted_answer": "Tadalafil, a phosphodiesterase-5 inhibitor, enhances NK cell activity by counteracting the suppression caused by myeloid-derived suppressor cells during perioperative intramuscular influenza vaccination, as explored in a phase 1 clinical trial.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts that tadalafil is a phosphodiesterase-5 inhibitor and targets myeloid-derived suppressor cells. It also mentions its role in enhancing NK cell activity during influenza vaccination, aligning with the reference description. All key elements are present and consistent."
        },
        {
            "query_idx": 868,
            "query": "How do the architects of vascular structures engage in the absorption of fermentation derivatives to instigate the expansion of malignancies through metabolic adaptation?",
            "retrieved_metrics": {
                "reference_idx": [
                    831
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Architects of vascular structures, like endothelial cells, engage in #lactate uptake#, enhancing angiogenesis and #tumor growth# by increasing IL-8, VEGF, VEGFR2 expression, and AKT phosphorylation.",
            "predicted_answer": "Endothelial cells absorb lactate, a fermentation derivative, which induces angiogenesis and promotes tumor growth by increasing the expression of factors like VEGF and IL-8, supporting metabolic adaptation.",
            "score": 3,
            "explanation": "The predicted answer captures the uptake of lactate by endothelial cells and its role in promoting angiogenesis and tumor growth. However, it lacks the mention of AKT phosphorylation, which is a key fact in the reference answer, affecting completeness."
        },
        {
            "query_idx": 869,
            "query": "What symphonic interplays and covert molecular dialogues by the elusive CAF conductors initiate the structural renaissance of ECM and facilitate cellular metamorphosis, potentially via arcane emissary proteins or cryptic signaling orchestrations?",
            "retrieved_metrics": {
                "reference_idx": [
                    834
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #CAFs# initiate ECM restructuring and cellular transformation through the secretion of #MMPs# or activating Yes-associated protein, which promotes ECM degradation and remodeling.",
            "predicted_answer": "CAFs initiate ECM remodeling and cellular metamorphosis through secreting MMPs and activating signaling pathways like integrin, Rho, and Hippo, which facilitate EMT and enhance cell survival.",
            "score": 3,
            "explanation": "The Predicted Answer aligns with the overall trend of the Reference Answer and includes key facts such as CAFs and MMPs. However, it omits \"Yes-associated protein\" linked to ECM degradation, instead referencing integrin, Rho, and Hippo, which affects completeness."
        },
        {
            "query_idx": 870,
            "query": "What nuanced interplay of transcriptional governance orchestrated by curcumin articulates the down-regulation of TFAP2A pathways in the specialized sphere of LGR5(+) colorectal cancer stemness, affecting the cellular epicenter at a molecular dimension?",
            "retrieved_metrics": {
                "reference_idx": [
                    836
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Curcumin orchestrates #down-regulation# of TFAP2A pathways by promoting autophagy and repressing TFAP2A-regulated ECM in LGR5(+) colorectal cancer stem cells.",
            "predicted_answer": "Curcumin down-regulates TFAP2A, suppressing the proliferation of LGR5(+) colorectal cancer stem cells by promoting autophagy and repressing the oncogenic TFAP2A-regulated ECM pathway.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference by capturing the key facts: \"down-regulation\" of TFAP2A, \"promoting autophagy,\" and \"repressing TFAP2A-regulated ECM.\" It also accurately relates to the context of LGR5(+) colorectal cancer stem cells, ensuring precision and completeness."
        },
        {
            "query_idx": 871,
            "query": "What is the role of ascorbic acid in the biochemical orchestration with HIF-1α, as they together navigate the cellular landscape under duress, especially when considering the avant-garde paradigms of anticancer strategies that harness the symphony of genetic choreography and immune ballet?",
            "retrieved_metrics": {
                "reference_idx": [
                    838
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ascorbic acid contributes to #anticancer strategies# by engaging with #HIF-1α# in tumor hypoxia, supporting epigenetics, immunomodulation, and selective cytotoxicity in innovative treatments.",
            "predicted_answer": "Ascorbic acid, as an antioxidant, plays a role in novel cancer treatments by interacting with HIF-1α in the hypoxic tumor microenvironment, contributing to epigenetic changes, immunomodulation, and selective cytotoxicity.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer, capturing all key concepts including the role of ascorbic acid, its interaction with HIF-1α, and its involvement in epigenetics, immunomodulation, and selective cytotoxicity. The specific reference to \"anticancer strategies\" is implicit in the description of its role in novel cancer treatments."
        },
        {
            "query_idx": 872,
            "query": "In the labyrinthine dynamics of the mechanical matrix surrounding tumorous formations, what are the discrete strands of genetic articulation and production choreography that curcumin intricately influences to unveil its formidable antitumor virtuosity?",
            "retrieved_metrics": {
                "reference_idx": [
                    835
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Curcumin influences #α-SMA# and #COX-2# gene expression and reduces PGE2 production in CAFs to exhibit its antitumor effects.",
            "predicted_answer": "Curcumin influences the mechanical tumor microenvironment by attenuating the expression of α-SMA and COX-2 genes and reducing PGE2 production in cancer-associated fibroblasts, showcasing its antitumor properties.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key facts: the influence of curcumin on α-SMA and COX-2 gene expression, and the reduction of PGE2 production in cancer-associated fibroblasts, matching the antitumor effects outlined in the reference answer. There are no significant omissions or errors."
        },
        {
            "query_idx": 873,
            "query": "What are the potential ramifications on the dissemination propensity and molecular signal variations that suggest markers of cellular transition in melanoma cells subject to an externally imposed acidic microenvironment over a 24-hour period?",
            "retrieved_metrics": {
                "reference_idx": [
                    841
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Exposure of melanoma cells to an #acidic microenvironment# for 24 hours may increase the expression of #EMT markers# and enhance their invasiveness.",
            "predicted_answer": "Exposure to an acidic microenvironment for 24 hours can increase the expression of EMT markers and enhance the invasiveness of melanoma cells, indicating a transition in cellular behavior. This may also reduce the effectiveness of antitumor immune responses.",
            "score": 5,
            "explanation": "The predicted answer includes key facts from the reference: exposure to an acidic microenvironment and increased expression of EMT markers leading to enhanced invasiveness. However, it introduces additional information about the antitumor immune response impact, which is not in the reference but is not contradictory."
        },
        {
            "query_idx": 874,
            "query": "How might β-adrenergic antagonists, through a repurposed alliance in therapeutic symphonies, act as transformative agents within the complex tapestry of cancer treatment, potentially amplifying the overall impact against stubborn neoplastic resilience?",
            "retrieved_metrics": {
                "reference_idx": [
                    847
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "β-adrenergic antagonists may #reverse resistance# to therapies like trastuzumab, improving #cancer treatment# efficacy, but larger clinical trials are necessary for conclusive evidence.",
            "predicted_answer": "β-adrenergic antagonists, like ICI-118,551, can block catecholamine-induced malignancy and reverse resistance to targeted therapies, enhancing their efficacy in cancer treatment. More extensive clinical trials are needed to confirm these benefits.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts of β-adrenergic antagonists reversing resistance and improving cancer treatment efficacy. It mentions the need for more clinical trials, aligning with the reference answer. Both emphasize reversing resistance and treatment efficacy, ensuring consistency with the reference's key points."
        },
        {
            "query_idx": 875,
            "query": "What intricate correlation is delineated, within the intricate environment of MSI-high colorectal cancer habitats, between the genomic presence of F. nucleatum and the variable abundance of immunological cells, specifically the suppressive ensemble of FOXP3-positive T cells contrasted against M2-skewed macrophages?",
            "retrieved_metrics": {
                "reference_idx": [
                    848
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The genomic presence of #F. nucleatum# in MSI-high CRC is inversely correlated with FOXP3-positive T cells and positively correlated with #M2-like TAMs# abundance.",
            "predicted_answer": "In MSI-high colorectal cancer, F. nucleatum presence is inversely correlated with FOXP3+ T cell density and positively correlated with M2-like macrophage ratios, indicating its role in promoting suppressive immune cells.",
            "score": 5,
            "explanation": "The predicted answer accurately captures both key facts: the inverse correlation with FOXP3-positive T cells and the positive correlation with M2-like macrophages (#F. nucleatum# and #M2-like TAMs#). The overall trend and key information from the reference answer are consistently reflected."
        },
        {
            "query_idx": 876,
            "query": "What transformations within each oncogenic phase could modulate the diverse potentialities exhibited by recontextualized pharmacological agents when interfacing with the intricate milieu of cancer's evolving narrative?",
            "retrieved_metrics": {
                "reference_idx": [
                    852
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Transformations within each #oncogenic phase# may affect #repurposed drugs# by influencing their efficacy through cancer's evolving stages, due to diverse microenvironments and mechanisms.",
            "predicted_answer": "Cancer evolves through multiple stages, and repurposed drugs may have different effects at each phase. Understanding the unique anticancer mechanisms and conducting more nuanced preclinical and clinical trials are essential to modulate their potential in various oncogenic phases.",
            "score": 3,
            "explanation": "The predicted answer captures the key concepts of \"oncogenic phase\" and \"repurposed drugs,\" reflecting their varying effects across cancer's stages. It emphasizes the need for understanding anticancer mechanisms and trials, aligning with the reference but lacking explicit mention of microenvironments and mechanisms."
        },
        {
            "query_idx": 877,
            "query": "Through which mechanistic pathways does the nanocarrier interventional approach alter the augmentation of bioavailability and the equilibrium of cytological destruction, contrasting it with the phenomena manifested by the unconjugated fenbendazole/rapamycin ensemble within ovarian neoplastic treatment landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    855
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #M-FR system# enhances cytotoxicity and bioavailability by re-engineering RAPA into a tumoricidal agent, unlike the unconjugated #fenbendazole/rapamycin# combination.",
            "predicted_answer": "The nanocarrier interventional approach, such as the M-FR system, enhances bioavailability and cytotoxicity by improving drug delivery to ovarian cancer cells. This contrasts with unconjugated fenbendazole/rapamycin, which shows lower bioavailability and antitumor effects.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts of the #M-FR system# and the unconjugated #fenbendazole/rapamycin# while discussing improved bioavailability and cytotoxicity. However, it misses the detail about re-engineering RAPA into a tumoricidal agent, affecting the completeness. Overall, the trend is consistent."
        },
        {
            "query_idx": 878,
            "query": "What are the ethereal constructs and inherent molecular symphonies of silk fibroin that underpin its capacity to serve as a fundamental framework within synergistic medicinal delivery paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    853
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #biocompatible# and #biodegradable# properties of silk fibroin, along with its unique scaffolding abilities, underpin its capability as a framework in medicinal delivery systems.",
            "predicted_answer": "Silk fibroin's biocompatibility, biodegradability, and unique scaffolding properties enable it to serve as an effective framework for drug delivery systems, enhancing its potential in medicinal applications.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts highlighted in the reference answer—biocompatibility, biodegradability, and unique scaffolding properties of silk fibroin. These aspects are precisely aligned with the reference. There are no omissions or contradictions."
        },
        {
            "query_idx": 879,
            "query": "Within the dynamic architecture of pharmacological endeavors, how do the innate augmentation capabilities and diverse adaptability of polymeric micelles position them as superior vessels for the strategic conveyance of reengineered compounds such as rapamycin, across a spectrum of administration routes?",
            "retrieved_metrics": {
                "reference_idx": [
                    856
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Polymeric micelles (#PMs#) are superior for drug delivery due to their enhanced #adaptability#, biocompatibility, and advanced pharmacokinetics, facilitating varied administration routes for compounds like rapamycin.",
            "predicted_answer": "Polymeric micelles (PMs) are superior for delivering reengineered compounds like rapamycin due to their enhanced biocompatibility, advanced pharmacokinetics, and adaptability. They enable better absorption and reduced side effects across various administration routes, including parenteral, oral, nasal, and ocular.",
            "score": 5,
            "explanation": "The predicted answer successfully includes all key elements, such as polymeric micelles (PMs), adaptability, biocompatibility, advanced pharmacokinetics, and the ability to work across varied administration routes for compounds like rapamycin. No significant omissions or errors are present."
        },
        {
            "query_idx": 880,
            "query": "What biochemical complexities and systemic hurdles in the realm of pharmacodynamics contribute to the potential diminution of efficacy in redirecting pharmacological entities towards innovative therapeutic avenues?",
            "retrieved_metrics": {
                "reference_idx": [
                    857
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Biochemical complexities in drug repurposing include #pharmacological challenges# where original drugs may not achieve #clinical efficacy# for new therapeutic purposes, affecting efficacy in novel treatments.",
            "predicted_answer": "Pharmacological challenges, such as receptor specificity and high effective concentrations, can diminish efficacy. Systemic hurdles include legal, regulatory issues, and dosing challenges, which complicate the redirection of drugs for new therapeutic uses.",
            "score": 3,
            "explanation": "The predicted answer mentions \"pharmacological challenges,\" which aligns with the reference's mention of biochemical complexities. However, it does not specifically address the issue of achieving \"clinical efficacy\" in new therapeutic purposes, which is a key point marked in the reference."
        },
        {
            "query_idx": 881,
            "query": "How might the innovative redirection of medicaments such as simvastatin and metformin within the cancer treatment paradigm illuminate unforeseen molecular pathways and elicit unanticipated biological consequences, particularly in the domains of lipid regulation and glycemic stability?",
            "retrieved_metrics": {
                "reference_idx": [
                    858
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #repurposing# of simvastatin and metformin for cancer might disrupt #lipid regulation# and glycemic stability, potentially causing hypolipidemia and hypoglycemia due to unforeseen molecular interactions.",
            "predicted_answer": "Repurposing simvastatin and metformin for cancer may reveal new molecular pathways and side effects, such as hypolipidemia and hypoglycemia, due to off-target binding and altered dosages.",
            "score": 5,
            "explanation": "The predicted answer covers the key concepts of repurposing, lipid regulation, and glycemic stability effects like hypolipidemia and hypoglycemia, similar to the reference. It mentions molecular pathways and side effects, aligning well with the reference. Key facts are present and trends are consistent."
        },
        {
            "query_idx": 882,
            "query": "How does the orchestration of the mevalonate biochemical cascade act as a pivotal catalyst in modulating the therapeutic potential of statin compounds amidst the complex molecular landscapes of gastric, pancreatic, and colon cancers?",
            "retrieved_metrics": {
                "reference_idx": [
                    864
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #mevalonate# cascade's orchestration enhances statins' therapeutic potential by targeting dysregulated lipid metabolism in #gastric, pancreatic, and colon cancers#.",
            "predicted_answer": "The mevalonate pathway is crucial for cholesterol synthesis and is often dysregulated in gastric, pancreatic, and colon cancers. Statins, like simvastatin, inhibit HMG-CoA reductase, blocking this pathway and potentially modulating cancer cell growth and survival.",
            "score": 3,
            "explanation": "The predicted answer covers the #mevalonate# pathway's role and its link to #gastric, pancreatic, and colon cancers#. However, it lacks the specific mention of \"enhancing statins' therapeutic potential by targeting dysregulated lipid metabolism,\" a key fact in the reference. Hence, it affects completeness."
        },
        {
            "query_idx": 883,
            "query": "What are the predominant frameworks of conceptual strategies that serve as navigational pathways in the process of pharmacological reconfiguration, integrating genomic insights with clinical data to synergistically enhance tumoral mitigation within the sphere of contemporary oncological practices?",
            "retrieved_metrics": {
                "reference_idx": [
                    863
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The predominant frameworks are #experimental# and computational approaches, utilizing clinical symptoms, genome, and transcriptome data for drug repurposing to enhance tumor treatment.",
            "predicted_answer": "The predominant frameworks include drug repurposing, which integrates genomic and clinical data. These strategies often involve combining repurposed drugs with first-line anticancer treatments to target new mechanisms and enhance tumor mitigation.",
            "score": 1,
            "explanation": "The predicted answer mentions drug repurposing and integration of clinical and genomic data but omits key details such as #experimental# and computational approaches. This omission affects completeness, though the overall trend is somewhat aligned with the reference. Thus, essential parts of the process are not covered."
        },
        {
            "query_idx": 884,
            "query": "What are the primary challenges associated with the in-depth evaluation processes regarding the enduring effects and assurance of safety for novel nanoparticle drug delivery systems repurposed for cancer therapy trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    862
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The primary challenges are the lack of #safety testing# and unknown #long-term toxicity# of nanocarrier materials in cancer therapy trials.",
            "predicted_answer": "The primary challenges include the unknown long-term toxicity and safety of many nanocarrier components, despite their promising tumor targeting and therapeutic properties in preclinical models.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"unknown long-term toxicity\" and \"safety\" concerns, aligning with the reference answer's emphasis on lack of \"safety testing\" and \"long-term toxicity.\" All critical elements are covered with consistent meaning, demonstrating complete alignment."
        },
        {
            "query_idx": 885,
            "query": "When reevaluating therapeutic paradigms to align with the differentiated molecular landscapes and environmental dynamics of distinct cancer manifestations, what critical complexities and strategic frameworks must be thoroughly examined?",
            "retrieved_metrics": {
                "reference_idx": [
                    865
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "When reevaluating therapeutic paradigms, consider the complexity of #genetic backgrounds# and the need for optimizing #dosages# and administration frequencies based on distinct cancer characteristics.",
            "predicted_answer": "Critical complexities include genetic diversity, biomarker specificity, and microenvironment interactions. Strategic frameworks must consider pharmacodynamics, pharmacokinetics, and tailored dosing to optimize efficacy and minimize toxicity.",
            "score": 1,
            "explanation": "The predicted answer includes \"genetic diversity\" but omits \"dosages\" and \"administration frequencies.\" Though it addresses pharmacokinetics related to dosing, it lacks explicit mention of optimizing dosage and administration frequency, impacting completeness."
        },
        {
            "query_idx": 886,
            "query": "Within the context of neural infiltration and its synergistic dance with the oncologic milieu, what intricate role does β-adrenergic signaling assume in modulating cellular metamorphosis and augmenting metastatic trajectories through its engagement with complex biochemical orchestrations as illuminated in cutting-edge scientific discourse?",
            "retrieved_metrics": {
                "reference_idx": [
                    845
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "β-adrenergic signaling promotes #EMT# and increases metastatic potential via #VEGF/MMP# and STAT3/ERK/MAPK pathways, and enhances macrophage migration into tumor tissue.",
            "predicted_answer": "β-adrenergic signaling promotes epithelial-mesenchymal transition (EMT) and enhances metastatic potential in cancer cells through VEGF/MMP and STAT3/ERK/MAPK pathways, also facilitating macrophage migration into tumor tissue.",
            "score": 5,
            "explanation": "The predicted answer fully covers all the key facts emphasized in the reference: EMT, VEGF/MMP pathways, STAT3/ERK/MAPK pathways, and macrophage migration. The information is consistent, with no significant omissions or errors, aligning well with the reference answer's meaning."
        },
        {
            "query_idx": 887,
            "query": "What theoretical constructs and strategic blueprints could be contemplated as guides for surmounting the intricate clinical conundrums linked with precision-based molecular agents, peptide-centric regimens, immune system enhancers, cellular strategies, and genetic alteration techniques in the evolution of novel cancer therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    866
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Understanding the #merits/limitations# of precision-based therapies like peptide drugs and genetic alteration can guide researchers in overcoming clinical challenges in #cancer therapies# development.",
            "predicted_answer": "Theoretical constructs and strategic blueprints include understanding the merits and limitations of small molecule targeted drugs, peptide drugs, antibody drugs, cell therapy, and gene therapy. Addressing their development status, clinical challenges, and potential solutions can guide the advancement of novel cancer therapies.",
            "score": 5,
            "explanation": "The predicted answer captures the key concepts of understanding the merits and limitations of precision-based therapies, including peptide drugs and genetic alteration, in the context of cancer therapy development. It aligns with the trend of the reference answer without omissions or contradictions."
        },
        {
            "query_idx": 888,
            "query": "In the intricate evolution of therapeutic frontiers, what groundbreaking and paradigm-shifting development did Carl June orchestrate that marked a defining moment in the 2011 landscape of oncological innovations?",
            "retrieved_metrics": {
                "reference_idx": [
                    871
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In #2011#, Carl June's #CAR-T cell therapy# for leukemia marked a groundbreaking and paradigm-shifting development in oncological innovations.",
            "predicted_answer": "In 2011, Carl June successfully applied CAR-T cell therapy for leukemia treatment, marking a significant step forward in immunotherapy.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of #2011# and #CAR-T cell therapy# for leukemia, which match the emphasized details in the reference answer. The overall trend aligns with the groundbreaking and paradigm-shifting nature mentioned. There are no significant omissions or errors."
        },
        {
            "query_idx": 889,
            "query": "What innovative strategic pivot in the oncology pharmacopeia emphasizes the orchestration of innate immune symphonies over the classical siege and surrender of neoplastic fortresses?",
            "retrieved_metrics": {
                "reference_idx": [
                    874
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #strategic pivot# in oncology highlights #regulating self-immune activation# over traditional inhibition of tumor cell functions.",
            "predicted_answer": "The strategic pivot in oncology emphasizes regulating self-immune activation, such as with Antibody-Drug Conjugates (ADCs), over directly inhibiting tumor cell functions.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts: the \"strategic pivot\" and \"regulating self-immune activation,\" aligning with the reference answer. Although the method by Antibody-Drug Conjugates is mentioned, it doesn't contradict the core facts. Thus, the main points are covered."
        },
        {
            "query_idx": 890,
            "query": "How does the symbiotic melding of macrostructural biological frameworks and atomically resolved cartography facilitate the embryonic conceptualization of potent molecular archetypes for initial lead substance discernment in the realm of targeted inhibitory agents?",
            "retrieved_metrics": {
                "reference_idx": [
                    876
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #symbiotic melding# of biological structures and atomic cartography aids the conceptualization of molecular archetypes, aiding initial lead substance discovery for targeted #inhibitory agents#.",
            "predicted_answer": "The integration of macrostructural biology and atomic-level cartography enables precise targeting and design of molecular archetypes, facilitating the identification of potent lead compounds for targeted inhibitory agents by leveraging detailed structural information.",
            "score": 5,
            "explanation": "The predicted answer captures the symbiotic melding of biological structures and atomic-level cartography, as well as aiding in the identification of lead compounds for targeted inhibitory agents. It matches the key points of the reference answer, maintaining trend and completeness."
        },
        {
            "query_idx": 891,
            "query": "What complex barriers within the realm of molecular therapeutics arise in the pursuit of developing refined pharmacological agents, especially when negotiating with proteins frequently regarded as beyond the clasp of conventional intervention, thereby complicating endeavors in the domain of cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    879
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Developing refined pharmacological agents in cancer treatment is complicated by #undruggable proteins# and limited efficacy on #membrane proteins# and secretory proteins.",
            "predicted_answer": "Complex barriers in molecular therapeutics include targeting undruggable proteins, limited inhibitory effects on membrane and secretory proteins, and the difficulty in adjusting dosages due to metabolic influences, complicating cancer treatment.",
            "score": 5,
            "explanation": "The predicted answer covers key points mentioned in the reference: undruggable proteins, membrane proteins, and secretory proteins, which impede cancer treatment. No contradictory information is present, and the overall trend is aligned. Despite differing wording, the key facts are fully represented."
        },
        {
            "query_idx": 892,
            "query": "What are the dual intricate barriers confronting the orchestration of molecular symphonies by allosteric inhibitors that invoke the pursuit of enhanced intellectual alchemy and experimental refinement?",
            "retrieved_metrics": {
                "reference_idx": [
                    886
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The dual barriers are #computational power# shortcomings for allosteric site identification and issues with #drug-resistant mutations#, necessitating more research to maintain effectiveness.",
            "predicted_answer": "Allosteric inhibitors face two main challenges: the need for advanced computational methods to identify allosteric sites and the potential for drug resistance due to mutations or species differences, necessitating further research.",
            "score": 5,
            "explanation": "The predicted answer accurately captures both key facts: the need for \"advanced computational methods\" aligns with \"computational power shortcomings,\" and \"drug resistance due to mutations or species differences\" aligns with \"drug-resistant mutations.\" The meaning is consistent, with no significant omissions or contradictions."
        },
        {
            "query_idx": 893,
            "query": "What sophisticated method does Asciminib utilize to circumvent the formidable drug-resistant mutation T315I in chronic myeloid leukemia, subtly transforming the conformational state of associated protein structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    885
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Asciminib uses #allosteric inhibition# by binding to the #myristoyl pocket#, locking BCR-ABL1 in an inactive conformation to overcome the drug-resistant T315I mutation in chronic myeloid leukemia.",
            "predicted_answer": "Asciminib utilizes allosteric inhibition, binding to the myristoyl pocket of BCR-ABL1 and locking it in an inactive conformation, thereby overcoming the T315I mutation.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized in the reference answer: #allosteric inhibition#, #myristoyl pocket#, and overcoming the T315I mutation with no significant omissions or errors. The trend and key information are fully captured in the predicted answer."
        },
        {
            "query_idx": 894,
            "query": "In what manner does the strategic embedding of enduring chemical enlaces in molecular architectures enable the unlocking of cellular vaults for proteinaceous structures bereft of typical conformational landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    884
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #strategic embedding# of covalent bonds enables targeting proteins without surface pockets, effectively unlocking cellular vaults by altering protein function through stable #chemical enlaces#.",
            "predicted_answer": "Covalent modulation enables the strategic embedding of enduring chemical bonds in molecular architectures, allowing for the alteration of protein activity and function, even in those lacking typical binding sites.",
            "score": 3,
            "explanation": "The predicted answer captures the concepts of \"strategic embedding\" and \"enduring chemical bonds\" (equivalent to \"covalent bonds\") from the reference answer. However, it omits the specific mention of \"unlocking cellular vaults\" and \"proteins without surface pockets.\" These omissions affect the completeness of the answer."
        },
        {
            "query_idx": 895,
            "query": "What encapsulates the evolutionary likelihood of resistance emergence within the temporal framework of an annual therapeutic protocol, specifically during the molecular intervention trajectory utilizing inaugural and successive iterations of EGFR tyrosine kinase modulations in patients harboring EGFR mutations?",
            "retrieved_metrics": {
                "reference_idx": [
                    891
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Patients with EGFR mutations treated with #first-# and #second-generation# EGFR tyrosine kinase inhibitors have a 50-60% chance of developing resistance within one year.",
            "predicted_answer": "The context indicates that patients with EGFR mutations treated with first and second-generation EGFR tyrosine kinase inhibitors have a 50-60% chance of developing resistance within one year.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized with # in the reference answer, specifically referencing first and second-generation EGFR tyrosine kinase inhibitors and a 50-60% resistance chance within one year. The overall trend and details are fully aligned."
        },
        {
            "query_idx": 896,
            "query": "Within the sophisticated landscape of peptide tracer visualizations for neuroendocrine delineations, what sophisticated modalities harness the synergy of radioactive canvas to elucidate cellular landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    892
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The sophisticated modalities are #Peptide Scintigraphy# and #PRRT#, which use radiolabeled peptides with isotopes like 111In and 68Ga for cellular visualization.",
            "predicted_answer": "Peptide Scintigraphy and Peptide Receptor Radionuclide Therapy (PRRT) use radioactive isotopes like 111In and 68Ga, attached to peptides, to visualize and treat neuroendocrine tumors via SPECT or PET imaging.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized in the reference: \"Peptide Scintigraphy\", \"PRRT\", \"radioactive isotopes like 111In and 68Ga\", and the functional usage for cellular visualization. The predicted answer further expands on treatment applications, consistent with the reference's context."
        },
        {
            "query_idx": 897,
            "query": "In the realm of molecular navigation and cellular orchestration, what intricate role does the technetium-99m labeled peptide GX1 assume in the nuanced mapping and visualization of vascular characteristics within the tumor landscapes of gastric, colorectal, and glioma malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    893
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #technetium-99m labeled peptide GX1# plays a crucial role in mapping and visualizing #vascular characteristics# in gastric, colorectal, and glioma tumors by specifically binding to tumor vessels.",
            "predicted_answer": "Technetium-99m labeled peptide GX1 specifically binds to tumor vessels in gastric, colorectal, and glioma tumors, serving as a promising imaging biomarker for visualizing vascular characteristics within these malignancies.",
            "score": 5,
            "explanation": "The predicted answer captures the key elements of the reference: it mentions \"technetium-99m labeled peptide GX1,\" \"binding specifically to tumor vessels,\" and \"visualizing vascular characteristics\" in the specified tumors. The overall trend and facts are well-aligned, with no significant omissions or contradictions."
        },
        {
            "query_idx": 898,
            "query": "In what manner does the molecular choreography facilitated by MGDs culminate in a superior pharmacokinetic narrative compared to PROTACs, in the realms of cellular ingress, systemic permeation, and cerebral reach?",
            "retrieved_metrics": {
                "reference_idx": [
                    890
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "MGDs exhibit superior pharmacokinetic properties over PROTACs, with enhanced #membrane permeability# and #blood-brain barrier penetration#, improving cellular uptake and systemic and cerebral distribution.",
            "predicted_answer": "MGDs offer superior pharmacokinetic properties, including better membrane permeability, cellular uptake, and blood-brain barrier penetration, compared to PROTACs, enhancing their efficacy in cellular ingress, systemic permeation, and cerebral reach.",
            "score": 5,
            "explanation": "The predicted answer fully captures the key facts emphasized in the reference, such as enhanced membrane permeability and blood-brain barrier penetration, improving cellular uptake, systemic permeation, and cerebral reach. There are no significant omissions, and both answers are consistent in trends and details."
        },
        {
            "query_idx": 899,
            "query": "What complex amalgamations of molecular partnerships and pathway facilitators are employed to optimize both the temporal robustness and systemic conveyance capabilities of therapeutic peptides in medical applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    899
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Combining peptides with protease inhibitors and #permeation enhancers# like #citric acid# and EDTA increases oral delivery efficiency and systemic conveyance of therapeutic peptides.",
            "predicted_answer": "To optimize therapeutic peptides, protease inhibitors and permeation enhancers like citric acid and EDTA are used for oral delivery. Binding with plasma proteins, such as albumins, increases size to reduce renal clearance and extend half-life.",
            "score": 5,
            "explanation": "The predicted answer contains the key facts of using protease inhibitors and the example permeation enhancers \"citric acid\" and \"EDTA\" to improve oral delivery, aligning with the reference. There is no contradictory information and all key details are present, indicating high consistency."
        },
        {
            "query_idx": 900,
            "query": "What inherent molecular attributes and strategic therapeutic advantages endow IgG1 and IgG4 isotypes with a privileged status in the realm of monoclonal antibody construction for oncological interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    896
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#IgG1# and #IgG4# are favored in monoclonal antibody development for cancer due to their extended half-life and high affinity, enhancing their therapeutic effectiveness.",
            "predicted_answer": "IgG1 and IgG4 isotypes are favored in monoclonal antibody construction for oncology due to their extended half-life, high affinity, and potent efficacy in targeting specific cancer antigens, making them effective therapeutic agents.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: both #IgG1# and #IgG4#, extended half-life, and high affinity. However, the reference does not mention \"potent efficacy in targeting specific cancer antigens,\" which is an additional detail and not contradictory. Thus, all critical facts are present."
        },
        {
            "query_idx": 901,
            "query": "In the intricate interplay of molecular defenses against unchecked cellular proliferation, which pivotal surface sentinels are undermined by the agents trastuzumab and cetuximab, and across which specific oncological domains do these molecular disruptions yield pronounced therapeutic outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    897
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Trastuzumab targets #HER-2#, and cetuximab targets #EGFR#, primarily affecting HER2+ breast cancer, metastatic colorectal cancer, and advanced head and neck cancer.",
            "predicted_answer": "Trastuzumab and cetuximab target HER-2 and EGFR, respectively. These agents yield significant therapeutic outcomes in HER2+ breast cancer, metastatic colorectal cancer, and advanced head and neck cancer.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the key receptors (#HER-2# and #EGFR#) targeted by trastuzumab and cetuximab, and includes all specific cancer types where therapeutic outcomes are significant, matching the reference answer fully in terms of meaning and key facts."
        },
        {
            "query_idx": 902,
            "query": "Within the sphere of the HIMALAYA clinical exploration, what temporal augmentation in survival emerges from the synergistic clinical interplay between tremelimumab and durvalumab as juxtaposed with the singular sorafenib pathway in hepatic carcinoma patients?",
            "retrieved_metrics": {
                "reference_idx": [
                    901
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #HIMALAYA clinical trial# shows a survival benefit of #2.63 months# with tremelimumab and durvalumab compared to sorafenib alone in liver cancer patients.",
            "predicted_answer": "In the HIMALAYA clinical trial, the combination of tremelimumab and durvalumab resulted in a median overall survival of 16.43 months, compared to 13.8 months for sorafenib alone in liver cancer patients.",
            "score": 5,
            "explanation": "The predicted answer references the HIMALAYA trial and provides a survival duration of 16.43 months for the combination and 13.8 months for sorafenib, demonstrating the 2.63-month survival advantage. All key facts from the reference are present, and no critical details are missing."
        },
        {
            "query_idx": 903,
            "query": "Within the paradigm where targeted oncological interventions coexist with conventional cellular warfare, what specific privileges do monoclonal antibodies confer in terms of precision-tuned targeting and mitigation of inadvertent systemic toxicity, especially when contrasted with traditional modalities like chemotherapy and radiotherapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    906
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Monoclonal antibodies offer #precision-tuned targeting# by specifically recognizing antigens, minimizing damage to normal cells and reducing #systemic toxicity# compared to chemotherapy and radiotherapy.",
            "predicted_answer": "Monoclonal antibodies offer high specificity and reduced toxicity to healthy cells, targeting specific antigens or proteins on cancer cells. This precision minimizes damage to normal cells, unlike chemotherapy and radiotherapy, which can harm both tumor and healthy tissues.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the high specificity of monoclonal antibodies in targeting specific antigens and mentions reduced toxicity to healthy cells, aligning with the reference's emphasis on precision targeting and reduced systemic toxicity. Therefore, it captures the key facts highlighted in the reference."
        },
        {
            "query_idx": 904,
            "query": "How does the molecular sentinel referred to as TIM-3 curate the ensemble of cellular defense mechanisms, and what underlies its pivotal designation within therapeutic advancements, despite its absence from the commercial pharma stage?",
            "retrieved_metrics": {
                "reference_idx": [
                    902
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "TIM-3 curates cellular defense by suppressing Th1 and proinflammatory responses. Its pivotal role in #immunotherapy# advancements remains despite the lack of commercial #drugs#.",
            "predicted_answer": "TIM-3, a transmembrane protein on immune cells, curates defense mechanisms by suppressing Th1 and proinflammatory responses. Despite its significant role in immune checkpoint inhibition, no TIM-3-targeting drugs have reached the commercial market yet.",
            "score": 5,
            "explanation": "The predicted answer successfully captures the key facts emphasized in the reference answer: TIM-3's role in suppressing Th1 and proinflammatory responses and its significance in immunotherapy (immune checkpoint inhibition). The absence of commercial drugs is also noted. There are no critical omissions or errors."
        },
        {
            "query_idx": 905,
            "query": "What architectural blueprints are employed to magnify the therapeutic spectrum of monoclonal antibodies by reconfiguring the molecular interaction dance with Fc receptors, thus navigating complex augmentation pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    910
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Architectural blueprints include #mutagenesis# of the Fc region and the use of alternative antibody #isotypes#, such as IgG2, to enhance monoclonal antibody therapeutic effectiveness through improved Fc receptor interaction.",
            "predicted_answer": "Engineering the Fc region through mutagenesis, such as producing defucosylated mAbs, and exploring alternative antibody isotypes like IgG2, can enhance Fc receptor affinity and augment therapeutic effectiveness.",
            "score": 5,
            "explanation": "The predicted answer mentions \"mutagenesis\" and \"alternative antibody isotypes like IgG2,\" which are key facts highlighted in the reference answer. Both answers align in meaning and trends, as they discuss enhancing effectiveness through Fc receptor interaction. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 906,
            "query": "What foundational properties and molecular complexities elevate the IgG1 molecular framework to a pivotal stature within the orchestrated deployment of antibody-drug conjugates, particularly in terms of target engagement and functionality?",
            "retrieved_metrics": {
                "reference_idx": [
                    915
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #IgG1# framework is pivotal due to its prolonged half-life, high specificity, enhanced Fc γ R binding, potent #ADCC# and CDC effects, and reduced immunogenicity and oligomer formation.",
            "predicted_answer": "IgG1's prolonged blood half-life, enhanced Fc γ R binding, potent ADCC and CDC effects, and low immunogenicity make it ideal for ADCs, enabling effective target engagement and payload delivery to tumor cells.",
            "score": 3,
            "explanation": "The Predicted Answer captures most key points from the Reference Answer, like IgG1’s extended half-life, enhanced Fc γ R binding, potent ADCC and CDC effects, and low immunogenicity. However, it omits #oligomer formation#, a key detail, impacting completeness."
        },
        {
            "query_idx": 907,
            "query": "What emergent benefits do bispecific ADCs reveal within the domain of preclinical therapeutic investigations, particularly involving the molecular duality of EGFR/c-MET and HER2/PRLR, as understood from their preliminary study results?",
            "retrieved_metrics": {
                "reference_idx": [
                    921
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Bispecific ADCs targeting #EGFR/c-MET# and #HER2/PRLR# reveal benefits of improved internalization, increased affinity, and decreased toxicity in preclinical therapeutic investigations.",
            "predicted_answer": "Bispecific ADCs for EGFR/c-MET and HER2/PRLR show improved internalization, increased affinity, and decreased toxicity in preclinical studies. These benefits highlight their potential in targeted cancer therapy.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized with # symbols in the reference answer, specifically mentioning the targeting of EGFR/c-MET and HER2/PRLR along with emergent benefits like improved internalization, increased affinity, and decreased toxicity. The overall trend and key details are aligned."
        },
        {
            "query_idx": 908,
            "query": "What intricate array of interwoven factors delineates the differential molecular stability and complex metabolic transformations in ADCs, given their convergence on an identical antigenic target yet varied systemic manifestations?",
            "retrieved_metrics": {
                "reference_idx": [
                    922
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "ADCs targeting the same antigen show differential #molecular stability# and metabolic transformations due to variations in #antigen epitope# recognition, linker sites, coupling chemistry, and small molecule toxins.",
            "predicted_answer": "The differential molecular stability and metabolic transformations in ADCs, despite targeting the same antigen, are influenced by variations in antigen epitope recognition, linker sites, coupling chemistry, and the choice of small molecule toxins. These factors lead to differences in plasma stability, in vivo metabolism, and toxicity profiles.",
            "score": 5,
            "explanation": "The 'Predicted Answer' closely aligns with the 'Reference Answer'. It includes key factors such as molecular stability, antigen epitope recognition, linker sites, coupling chemistry, and small molecule toxins, reflecting the differential stability and metabolism trends of ADCs. Thus, it fully covers the essential points."
        },
        {
            "query_idx": 909,
            "query": "In the intricate molecular framework of chimeric antigen receptors, how does the intermediary passage that bridges external antigen acknowledgment with internal signal propagation manifest its operational capacity?",
            "retrieved_metrics": {
                "reference_idx": [
                    923
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intermediary passage in chimeric antigen receptors manifests its operational capacity through the #transmembrane domain#, linking the extracellular domain to the #intracellular signaling# domain.",
            "predicted_answer": "The intermediary passage in CARs is the transmembrane domain, which connects the extracellular antigen recognition (scFv) to the intracellular signaling domain, enabling the transmission of signals from external antigen binding to internal cellular responses.",
            "score": 5,
            "explanation": "The predicted answer accurately covers both key facts from the reference: the transmembrane domain and connecting the extracellular to the intracellular signaling domain. It aligns with the reference answer's overall trend, ensuring consistency in meaning without omissions."
        },
        {
            "query_idx": 910,
            "query": "Within the complex paradigm of immune system orchestration in CAR-T cell therapy, what is the paramount benefit rendered by these chronicle sentinels in maintaining an enduring safeguard against malignant relapse?",
            "retrieved_metrics": {
                "reference_idx": [
                    925
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The paramount benefit of CAR-T cell therapy is the #memory T cells# that provide #long-term protection# against malignant relapse.",
            "predicted_answer": "The paramount benefit of CAR-T cell therapy is the formation of memory T cells, which persist in the body and provide long-term protection against tumor recurrence, ensuring a sustained anti-tumor effect.",
            "score": 5,
            "explanation": "The predicted answer effectively covers the key facts highlighted in the reference answer: the role of #memory T cells# and #long-term protection# against relapse. The predicted phrasing mentions both these aspects, aligning closely with the reference without any significant omissions or contradictions."
        },
        {
            "query_idx": 911,
            "query": "In the transformative journey of individuals grappling with the intricate patterns of refractory-relapsed B-acute lymphoblastic landscapes, what enigmatic fraction of the assembly attained the summit of molecular negativity aligned with the intricate dance of complete or near-complete recovery?",
            "retrieved_metrics": {
                "reference_idx": [
                    931
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Among the #50 patients#, #47# (94%) achieved molecular negativity aligned with complete or near-complete recovery.",
            "predicted_answer": "Among the 50 refractory-relapsed B-ALL patients, 47 (94%) achieved molecular negativity, aligning with complete or near-complete recovery.",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects all key facts emphasized in the Reference Answer, including the total number of patients (50) and the number of those who achieved molecular negativity (47). The information is consistent and complete with the Reference Answer."
        },
        {
            "query_idx": 912,
            "query": "What transformative paradigms are employed to enhance the efficacy of CAR-T cells as they traverse the suppressive tumor milieu and surmount the structural impediments analogous to fortifications within solid tumor landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    934
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Transformative paradigms include combining #CAR-T cells# with immune checkpoint inhibitors and genetically modifying CAR-T cells to enhance their #immune response# and resistance to inhibitory factors.",
            "predicted_answer": "To enhance CAR-T cell efficacy in solid tumors, strategies include combining them with immune checkpoint inhibitors, genetically modifying CAR-T cells for better immune response, and using alternative delivery routes like intrathoracic injection to improve tumor infiltration.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts of combining CAR-T cells with immune checkpoint inhibitors and genetically modifying them for enhanced immune response, aligning with the reference. However, it omits specific details about overcoming structural impediments in solid tumors, leading to minor incompleteness."
        },
        {
            "query_idx": 913,
            "query": "In what ways do the strategies of architectural alteration in chimeric antigen receptor constructs and the orchestrated targeting of cytokine cascades serve to mitigate the entwined adversities of toxicity and potent cytokine surges within CAR-T cell therapeutic applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    932
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Architectural alterations in CAR constructs #reduce immunogenicity#, improving safety. Targeting cytokine cascades, especially #IL-6#, helps to diminish cytokine surges without impairing CAR-T functionalities.",
            "predicted_answer": "Modifying CAR structures and humanizing antibody fragments reduce immunogenicity. Targeting specific cytokines like IL-6 and IL-1 with drugs such as tocilizumab and siltuximab, and inhibiting GM-CSF, help mitigate CRS and toxicity without impairing CAR-T function.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts: architectural alterations reduce immunogenicity and targeting specific cytokines like IL-6 helps mitigate cytokine surges and toxicity without impairing CAR-T function. These align with the Reference Answer. Thus, it fully covers the key points."
        },
        {
            "query_idx": 914,
            "query": "Within the discussed narrative, what representational impediments challenge the strategic expansion of CAR-T therapeutics from the fluidic aberrations to the more rigid cellular terrains, focusing on the scarceness of distinguishable cellular markers and the implications on essential anatomical entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    933
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #scarcity of tumor-specific antigens# limits CAR-T expansion to solid tumors, as common antigens are present on #essential organs#, hindering strategic development.",
            "predicted_answer": "The main impediments include the scarcity of tumor-specific antigens in solid tumors and the expression of common tumor-associated antigens on vital organs, which limits CAR-T application and risks damage to essential anatomical entities.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts: the scarcity of tumor-specific antigens and their presence on vital or essential organs. It aligns with the reference answer's overall trend, covering essential information about challenges in expanding CAR-T therapy to solid tumors without contradictions."
        },
        {
            "query_idx": 915,
            "query": "Within the intricate dynamics of the tumor's biological symphony, in what manner do the modulatory agents Tregs, MDSCs, and M2 macrophages orchestrate the suppression of CAR-T cell robustness against solid neoplasms?",
            "retrieved_metrics": {
                "reference_idx": [
                    938
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tregs, MDSCs, and M2 macrophages suppress CAR-T cell robustness by releasing #cytokines# like TGF-β and IL-10, reducing CAR-T cell effectiveness against #solid tumors#.",
            "predicted_answer": "Tregs, MDSCs, and M2 macrophages in the tumor microenvironment release cytokines like TGF-β and IL-10, which suppress CAR-T cell activity and effectiveness against solid tumors.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts emphasized in the reference answer: the role of cytokines and the suppression of CAR-T cell effectiveness against solid tumors. The meaning is consistent, with no omissions or contradictions."
        },
        {
            "query_idx": 916,
            "query": "What implicit barriers reminiscent of CAR-T might the chimeric emissaries of CAR-M encounter within the adversarial milieu of tumor microenvironments, and how might novel insights from the artistry of macrophage generation via induced pluripotent stem constructions offer covert pathways to surmount such challenges?",
            "retrieved_metrics": {
                "reference_idx": [
                    951
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CAR-M may face #migration# and #inhibition# challenges within the tumor microenvironment, similar to CAR-T. Induced pluripotent stem cells offer potential to overcome cell population limitations.",
            "predicted_answer": "CAR-M may face challenges such as migration and inhibition within the tumor microenvironment, similar to CAR-T. Novel insights from generating CAR-iM via iPSCs offer a potential solution, providing a renewable source of cells and possibly overcoming these barriers.",
            "score": 5,
            "explanation": "The predicted answer includes key facts of \"migration\" and \"inhibition\" challenges, both of which are highlighted in the reference answer. It also mentions novel insights via iPSCs which aligns with overcoming barriers, including cell population limitations. Overall, the predicted content matches the reference without omissions."
        },
        {
            "query_idx": 917,
            "query": "What was the observed favorable manifestation prevalence resulting from the deployment of immune-modulating cellular therapy targeting the viral protein HPV-16 E7 in the expansive landscape of metastatic HPV-induced neoplastic disorders?",
            "retrieved_metrics": {
                "reference_idx": [
                    950
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The observed favorable manifestation prevalence was #50%# for patients receiving immune-modulating cellular therapy targeting the viral protein #HPV-16 E7# in metastatic HPV-induced neoplastic disorders.",
            "predicted_answer": "In a clinical trial using viral protein HPV-16 E7 TCR-T cell treatment for metastatic HPV-associated cancers, 50% of patients showed a positive response.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts: a favorable manifestation of 50% and targeting HPV-16 E7. It aligns with the overall trend and meaning of the reference answer, with no significant omissions or errors."
        },
        {
            "query_idx": 918,
            "query": "What are the transformative molecular symphonies conducted by mRNA platforms that harmonize with oncological initiatives as illustrated within the referential boundaries of the context?",
            "retrieved_metrics": {
                "reference_idx": [
                    955
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "mRNA platforms conduct #oncological symphonies# by encoding #neoantigens for cancer vaccines#, activating T-cells, inhibiting tumor progression, and enabling gene therapy through innovative mRNA applications.",
            "predicted_answer": "mRNA platforms orchestrate the encoding of neoantigens, tumor-associated antigens, and tumor suppressor factors, enhancing cancer vaccine efficacy and T-cell therapies, while also enabling gene editing for oncological treatments.",
            "score": 3,
            "explanation": "The predicted answer covers key elements like encoding of neoantigens and T-cell activation, aligning with the oncological symphonies described in the reference. #Tumor-associated antigens# and #tumor suppressor factors# are also mentioned, suggesting alignment but missing details like #inhibiting tumor progression#. Overall, it captures most points but lacks some specifics."
        },
        {
            "query_idx": 919,
            "query": "What was the observed manifestation of Carisma Therapeutics' macrophage-driven cellular innovation within the experimental framework targeting the SKOV3 ovarian cancer biological model, and how did it reflect in the overall survival metrics?",
            "retrieved_metrics": {
                "reference_idx": [
                    956
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CAR-M demonstrated #effective tumor killing# and extended #overall survival# in the SKOV3 human ovarian cancer mouse model.",
            "predicted_answer": "In the SKOV3 ovarian cancer model, Carisma Therapeutics' CAR-M therapy showed effective tumor killing and significantly extended overall survival in mice.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the key facts of \"effective tumor killing\" and \"extended overall survival,\" which align with the information highlighted in the reference answer. It also correctly identifies the involvement of the SKOV3 ovarian cancer model, maintaining consistency and completeness."
        },
        {
            "query_idx": 920,
            "query": "Amid the extensive chronicle of investigational pursuits from May 2005 to the dawn of 2024, which segment of the mRNA pharmacological exploration undertook its journey fueled by the transformative wave of the COVID-19 epoch?",
            "retrieved_metrics": {
                "reference_idx": [
                    954
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The segment of #mRNA pharmacological exploration# that was notably accelerated by the #COVID-19# epoch includes neoantigen research and mRNA drug studies.",
            "predicted_answer": "The segment of mRNA pharmacological exploration that saw significant growth fueled by the COVID-19 era is the development of mRNA drugs, with 53.9% of studies seeing increased activity since the pandemic's onset.",
            "score": 3,
            "explanation": "The predicted answer mentions mRNA drug studies but omits neoantigen research, which is a key component emphasized in the reference answer. While there is alignment with the COVID-19 era influence, the lack of neoantigen research affects the completeness, warranting a score of 3."
        },
        {
            "query_idx": 921,
            "query": "How do the labyrinthine dynamics intrinsic to the architectural assembly of zinc finger nucleases, in terms of their elaborate and costly genomic targeting endeavors, compare with the streamlined design ease associated with the CRISPR paradigm in the context of cancerous therapeutic strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    960
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #CRISPR system# offers a more #streamlined# and cost-effective design compared to the complex and costly synthesis of zinc finger nucleases for cancer therapeutic strategies.",
            "predicted_answer": "Zinc finger nucleases (ZFNs) require complex and costly protein engineering for genomic targeting, whereas CRISPR offers a more streamlined and modular design, making it easier and more cost-effective for cancer therapeutic strategies.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts and aligns with the overall trend of the reference answer, emphasizing CRISPR's streamlined, cost-effective design compared to the complexity of zinc finger nucleases for cancer therapies. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 922,
            "query": "In the realm of genomic artistry where cellular scripts are meticulously altered, what advanced mechanistic strategies do zinc finger nucleases deploy to orchestrate targeted modifications within the genetic framework of eukaryotic organisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    958
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Zinc finger nucleases leverage #double-strand DNA breaks# and cellular repair mechanisms like #nonhomologous end joining# or homology-directed repair to orchestrate targeted genetic modifications in eukaryotic cells.",
            "predicted_answer": "Zinc finger nucleases (ZFNs) induce double-strand DNA breaks at specific loci, leveraging cellular repair mechanisms like nonhomologous end joining (NHEJ) or homology-directed repair (HDR) to achieve targeted genetic modifications in eukaryotic organisms.",
            "score": 5,
            "explanation": "The predicted answer includes all the emphasized key facts from the reference: \"double-strand DNA breaks\" and the cellular repair mechanism \"nonhomologous end joining.\" The overall meaning is consistent and there are no significant omissions or errors. Important details are complete and accurate."
        },
        {
            "query_idx": 923,
            "query": "Within the intricate framework of genomic customization, what intrinsic obstacles surface when utilizing lentivirus-based delivery mechanisms for TALEN frameworks, especially when contrasted with the vector dynamics offered by adenovirus-based delivery paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    962
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intrinsic obstacles using #lentivirus# for TALENs include #instability# in tandemly repeated sequences, recombination during reverse transcription, and constrained co-delivery packaging capacity.",
            "predicted_answer": "Intrinsic obstacles for lentivirus-based TALEN delivery include limited packaging capacity and recombination during reverse transcription, whereas adenoviral vectors offer better stability and efficiency for TALEN delivery.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies limited packaging capacity and recombination during reverse transcription as intrinsic obstacles using lentivirus for TALEN delivery but fails to mention instability in tandemly repeated sequences. The overall trend aligns, but one key fact is missing."
        },
        {
            "query_idx": 924,
            "query": "Within the molecular architecture of the TALEN mechanism, how do the 12th and 13th elemental amino architects of the TALE module dictate the precision of the genomic interaction dance, influencing the specificity of the DNA accord?",
            "retrieved_metrics": {
                "reference_idx": [
                    961
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #12th and 13th# amino acids in each TALE module of TALEN dictate the DNA binding site's precision, allowing high #specificity# by recognizing almost any sequence.",
            "predicted_answer": "The 12th and 13th amino acids in each TALE module determine the specific DNA base it binds to, enabling precise targeting. Altering these amino acids allows TALENs to recognize and bind to virtually any desired DNA sequence with high specificity.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts from the reference answer regarding the role of the 12th and 13th amino acids in determining DNA binding specificity. Both answers highlight that these amino acids allow TALENs to recognize and bind various DNA sequences with high precision."
        },
        {
            "query_idx": 925,
            "query": "In the intricate choreography of genome modulation employed by Prime Editing, what is the function of the spacetime anchor motif in harmonizing the realignment of DNA sequences during the subtle molecular undertaking of mutation rectification?",
            "retrieved_metrics": {
                "reference_idx": [
                    967
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #spacetime anchor motif# anchors the pegRNA to the DNA, ensuring precise #realignment# of sequences during mutation rectification in Prime Editing.",
            "predicted_answer": "The context does not mention a \"spacetime anchor motif.\" In Prime Editing, the pegRNA's spacer and primer binding site guide the Cas nickase to the target DNA, and the RT domain synthesizes the corrected sequence.",
            "score": 1,
            "explanation": "The predicted answer does not mention the \"spacetime anchor motif\" and its role in realigning sequences, which are the key facts in the reference answer. It instead focuses on pegRNA and Cas nickase functions, indicating more than one critical omission."
        },
        {
            "query_idx": 926,
            "query": "What functional capacities do the molecular variants BE3-Gam and BE4-Gam fulfill within the intricate framework of nucleotide transformation to ensure the diminution of unintended DNA interruptions and the elevation of molecular synthesis precision?",
            "retrieved_metrics": {
                "reference_idx": [
                    968
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "BE3-Gam and BE4-Gam utilize the #Gam# protein to reduce unintended #indels# and enhance product purity in nucleotide transformation.",
            "predicted_answer": "BE3-Gam and BE4-Gam incorporate the Gam protein to protect DNA double-strand breaks, reducing unintended indels and enhancing the precision of molecular synthesis.",
            "score": 3,
            "explanation": "The 'Predicted Answer' includes the use of the #Gam# protein and mentions reducing unintended #indels#, aligning with the key facts in the 'Reference Answer'. However, it does not explicitly mention 'product purity', affecting completeness slightly. Overall trends align well."
        },
        {
            "query_idx": 927,
            "query": "What is perceived as the foundational visionary goal underlying the integration of CRISPR within the sophisticated landscape of ex vivo T-cell modification, particularly in the strategic confrontation with cancerous anomalies?",
            "retrieved_metrics": {
                "reference_idx": [
                    970
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The foundational visionary goal of integrating #CRISPR# in ex vivo T-cell modification is to #enhance anti-cancer properties# by refining gene editing techniques.",
            "predicted_answer": "The foundational visionary goal is to enhance T-cell anti-cancer properties by using CRISPR to eliminate PD1 expression, thereby improving cancer treatment effectiveness.",
            "score": 3,
            "explanation": "The predicted answer captures the key goal of using CRISPR to enhance anti-cancer properties in T-cells, aligning with the reference answer's trend. However, it specifically mentions \"eliminate PD1 expression,\" missing the broader aspect of \"refining gene editing techniques.\""
        },
        {
            "query_idx": 928,
            "query": "Within the realm of AAV's genetic conveyance, how do the enigmatic architects, Rep and Cap, facilitate the complex orchestration required for synthesizing and structuring the viral entities through precise replication, assembly, and packaging?",
            "retrieved_metrics": {
                "reference_idx": [
                    972
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Rep# proteins mediate viral #replication#, while Cap proteins are crucial for viral assembly and packaging, enabling efficient synthesis and structuring of AAV entities.",
            "predicted_answer": "Rep and Cap proteins are crucial for AAV replication, assembly, and packaging. Rep facilitates viral DNA replication, while Cap forms the capsid, ensuring the viral genome is correctly packaged into the viral particle.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts emphasized in the reference answer: Rep proteins' role in viral replication and Cap proteins' role in assembly and packaging. Both answers align in meaning and detail without significant omissions or contradictions."
        },
        {
            "query_idx": 929,
            "query": "What symphonic nuance do trans-splicing vectors introduce in the complex choreography of gene expression protocols within AAV vector frameworks, specifically through their splice donor sequences, to achieve meticulous protein synthesis reconstitution?",
            "retrieved_metrics": {
                "reference_idx": [
                    974
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Trans-splicing vectors introduce splice donor sequences to achieve #precise# and #controlled# gene expression, facilitating meticulous protein synthesis reconstitution within AAV vector frameworks.",
            "predicted_answer": "Trans-splicing vectors, through their splice donor sequences, introduce a precise and controlled nuance in gene expression within AAV frameworks, enabling the reconstitution of meticulous protein synthesis.",
            "score": 5,
            "explanation": "The predicted answer covers all the key facts emphasized in the reference answer, such as \"precise\" and \"controlled\" gene expression and \"meticulous protein synthesis reconstitution\" within AAV frameworks. The wording is slightly different, but the meaning is consistent with the reference."
        },
        {
            "query_idx": 930,
            "query": "What multifaceted biological approach, diverging from algorithmic foresight, facilitates the acquisition of immune-reactive neoantigenic moieties through the engagement of intrinsic antigen-presenting frameworks with tumoral derivatives?",
            "retrieved_metrics": {
                "reference_idx": [
                    980
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "An alternative approach involves #loading autologous antigen-presenting cells# with tumor lysates to facilitate the acquisition of #immune-reactive neoantigenic moieties#.",
            "predicted_answer": "The alternative approach involves loading autologous antigen-presenting cells, like dendritic cells, with tumor lysates and validating them ex vivo by co-culturing with T cells, which facilitates the acquisition of immune-reactive neoantigens.",
            "score": 5,
            "explanation": "The predicted answer contains the key facts: \"loading autologous antigen-presenting cells\" and \"immune-reactive neoantigens,\" aligning with the reference answer. It slightly expands with validation methods and mechanisms (ex vivo co-culture with T cells), but does not contradict the reference. Both cover the alternative approach effectively."
        },
        {
            "query_idx": 931,
            "query": "What underlying technological constellations and predictive mechanisms form the scaffold for the preliminary in silico discernment of emergent neoantigen signatures in neoplastic cellular entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    979
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The scaffold for in silico neoantigen discernment includes #next-generation sequencing# and #multi-omics# technologies, using tumor genome or transcriptome comparisons to normal ones.",
            "predicted_answer": "Next-generation sequencing and mass spectrometry are key technologies for identifying neoantigens. By comparing tumor and normal genomes or transcriptomes, potential neoantigens are predicted in silico, forming the basis for their preliminary discernment.",
            "score": 3,
            "explanation": "The predicted answer includes the key fact of \"next-generation sequencing\" but omits \"multi-omics\" technologies, which is marked with # in the reference. Both answers discuss comparing tumor and normal genomes for neoantigen prediction, aligning overall trends without contradiction."
        },
        {
            "query_idx": 932,
            "query": "What extent of reduction in the HepG2-driven oncological proliferation symphony was harmonized through the collaborative deployment of the sg-VEGFR2 and Cas9 molecular partnership encapsulated in the PNPs concerted framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    981
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #sg-VEGFR2# and Cas9 molecular partnership within PNPs achieved over #70%# suppression of HepG2-induced HCC tumor progression.",
            "predicted_answer": "The collaborative deployment of sg-VEGFR2 and Cas9 within the PNPs framework led to over 70% suppression of HepG2-induced tumor progression.",
            "score": 5,
            "explanation": "The predicted answer accurately presents all key facts from the reference: it mentions the collaborative involvement of sg-VEGFR2 and Cas9 within the PNPs, delivering a suppression rate of over 70% for HepG2-induced progression. The meaning and trend match precisely with the reference answer."
        },
        {
            "query_idx": 933,
            "query": "In the realm of malignancies impacting the ovaries, what evolutions transpired in the nuanced fabric of the immune defense system subsequent to the administration of a genetic blueprint targeting IGFBP-2?",
            "retrieved_metrics": {
                "reference_idx": [
                    985
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #DNA vaccine# targeting IGFBP-2 enhanced the #T helper-1 immune response#, increasing IFN γ-secreting and T-bet positive T cells in ovarian cancer patients.",
            "predicted_answer": "The administration of a genetic blueprint targeting IGFBP-2 in ovarian cancer patients led to an increased activation of the T helper-1 immune response, marked by a rise in IFN γ-secreting T cells and T-bet positive T cells.",
            "score": 3,
            "explanation": "The 'Predicted Answer' aligns well with the 'Reference Answer', covering the enhancement of the T helper-1 immune response with increased IFN γ-secreting and T-bet positive T cells. The only omission is the specific mention of the intervention being a 'DNA vaccine'. However, the overall meaning is retained."
        },
        {
            "query_idx": 934,
            "query": "How do the unique surface identifiers orchestrate the navigational and interactional pathways of oncolytic viral particles to target and dismantle anomalously overexpressed cellular topographies within neoplastic entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    987
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Oncolytic viral particles recognize #surface markers# abnormally overexpressed on cancer cells, enabling navigation and interaction to target and dismantle #neoplastic entities#.",
            "predicted_answer": "Oncolytic viruses recognize and target surface markers abnormally overexpressed on cancer cells, allowing them to enter and destroy these cells. This specific recognition helps navigate and interact with the tumor, leading to selective destruction of neoplastic entities.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies the recognition of \"surface markers\" and targeting of \"neoplastic entities,\" which align with the emphasis in the Reference Answer. It covers all key facts such as recognition, targeting, and destruction without omissions or contradictions."
        },
        {
            "query_idx": 935,
            "query": "Within the nuanced paradigm of oncological immunotherapy, by what means do the supportive molecular constituents in peptide-based vaccination frameworks sculpt the immunological landscape to enhance resistance to cancerous entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    982
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Supportive molecular constituents in peptide-based vaccination frameworks, such as #immunoadjuvants#, shape the immunological landscape by enhancing the #immune response# against cancerous entities.",
            "predicted_answer": "Peptide-based vaccines, often combined with immunoadjuvants, enhance the immunological landscape by inducing tumor-specific immunity and long-term immune memory, thus improving resistance to cancer.",
            "score": 5,
            "explanation": "The predicted answer includes \"immunoadjuvants,\" which matches the emphasis of \"immunoadjuvants\" in the reference answer. It conveys enhancing the immune response by mentioning \"tumor-specific immunity\" and \"long-term immune memory,\" aligning with \"enhancing immunity\" in the reference. All key facts are present, with no significant omissions."
        },
        {
            "query_idx": 936,
            "query": "What unique cellular insurgency was catalyzed in breast carcinoma subjects who participated in the 2014 preliminary phase analysis involving the mammaglobin-A inscribed genomic schema, as noted in reported outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    984
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #2014# study showed the mammaglobin-A DNA vaccine effectively elicited cytotoxic #antigen-specific T cells# in breast carcinoma patients, leading to prolonged progression-free survival (PFS).",
            "predicted_answer": "The 2014 Phase I study reported that the mammaglobin-A DNA vaccine elicited cytotoxic antigen-specific T cells in breast cancer patients, leading to prolonged progression-free survival.",
            "score": 5,
            "explanation": "The predicted answer accurately covers all key facts emphasized in the reference answer, such as the \"2014\" study, \"mammaglobin-A DNA vaccine,\" and \"cytotoxic antigen-specific T cells.\" There are no significant omissions, with the overall meaning and context remaining consistent."
        },
        {
            "query_idx": 937,
            "query": "Within the complex interplay of immune orchestration against advanced lung malignancies, what specific indicators of enhanced therapeutic potency were revealed by the T-cell response mechanistic evaluation during the Neo-DCVac pilot exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    988
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Neo-DCVac# pilot exploration revealed enhanced therapeutic potency through a strong increase in T-cell #IFN γ# secretion and cytotoxicity.",
            "predicted_answer": "The T-cell response mechanistic evaluation during the Neo-DCVac pilot study revealed a strong increase in IFN-γ secretion and cytotoxicity, indicating enhanced therapeutic potency.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes key facts from the 'Reference Answer': mention of the Neo-DCVac pilot study, T-cell IFN-γ secretion, and increased cytotoxicity indicating enhanced therapeutic potency. All critical points emphasized with # symbols are present in the 'Predicted Answer'."
        },
        {
            "query_idx": 938,
            "query": "What intricate molecular choreography orchestrates the infiltration of tumor cells by herpes simplex viruses, and how does this complex pathway differ from the distinctive cellular ingress mechanism favored by measles viruses?",
            "retrieved_metrics": {
                "reference_idx": [
                    989
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Herpes simplex viruses use #HVEM# and #nectin-1# for tumor cell entry, while measles viruses recognize CD46 upregulated on tumor cells for infiltration.",
            "predicted_answer": "Herpes simplex viruses use HVEM and nectin-1 for tumor cell entry, differing from measles viruses which recognize CD46. This molecular specificity allows each virus to infiltrate cells via distinct pathways.",
            "score": 5,
            "explanation": "The predicted answer mentions both \"HVEM\" and \"nectin-1\" for herpes simplex viruses, aligning with the reference. It also mentions \"CD46\" for measles viruses, consistent with the reference. It covers all key facts with no omissions or contradictions."
        },
        {
            "query_idx": 939,
            "query": "Within the delicate interplay of genetic engineering, what specific molecular embellishment embedded in Talimogene laherparepvec facilitates the metamorphic amplification of the immune orchestra, targeting the stubborn adversary of recurrent unresectable melanoma?",
            "retrieved_metrics": {
                "reference_idx": [
                    990
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Talimogene laherparepvec's #insertion of GM-CSF# facilitates immune activation by recruiting antigen-presenting cells, thereby targeting recurrent unresectable melanoma.",
            "predicted_answer": "The insertion of the human granulocyte macrophage colony-stimulating factor (GM-CSF) gene in Talimogene laherparepvec facilitates the immune response by recruiting antigen-presenting cells and inducing T-cell activation.",
            "score": 5,
            "explanation": "The predicted answer covers the key fact of the \"#insertion of GM-CSF#\" in Talimogene laherparepvec and its role in immune response activation by recruiting antigen-presenting cells. Both the predicted and reference answers convey the same meaning, and there are no significant omissions or errors."
        },
        {
            "query_idx": 940,
            "query": "Which couple of cellular constructs, depicted as intricate biological vessels within the narrative, assumes the role of delivering viral composites, and what designated viral identities are they crafted to ferry?",
            "retrieved_metrics": {
                "reference_idx": [
                    995
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Neural stem cells# deliver #CRAd-S-pk7# and bone marrow-derived mesenchymal stem cells carry #Icovir-5#.",
            "predicted_answer": "Neural stem cells and mesenchymal stem cells (MSCs) are used as delivery systems. They carry adenovirus-based CRAd-S-pk7 and Icovir-5, respectively, to target and deliver these viruses to tumor sites.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the cells ('Neural stem cells' and 'mesenchymal stem cells') and their relevant viral deliveries ('CRAd-S-pk7' and 'Icovir-5'). However, the predicted answer incorrectly identifies mesenchymal stem cells as not being bone marrow-derived, which constitutes a missing key fact."
        },
        {
            "query_idx": 941,
            "query": "Following the revelation of a serendipitous interaction entailing reduction of tumor presence alongside erysipelas affliction, what specific amalgamation did William Coley employ in his endeavor to address sarcoma, informed by his observation of this peculiar phenomenon?",
            "retrieved_metrics": {
                "reference_idx": [
                    996
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "William Coley used a specific amalgamation of #Streptococcus erysipelas# and #Bacillus prodigiosus# toxins, known as Coley's toxins, to treat sarcoma.",
            "predicted_answer": "William Coley used a mixture of toxins from Streptococcus erysipelas and Bacillus prodigiosus, known as Coley's toxins, to treat sarcoma after observing tumor regression in a patient with both sarcoma and erysipelas.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies both key components, \"Streptococcus erysipelas\" and \"Bacillus prodigiosus\" toxins, as well as the fact that they are known as Coley's toxins to treat sarcoma. All key facts from the reference are present without any contradictions or omissions."
        },
        {
            "query_idx": 942,
            "query": "What potential orchestration of immune system dynamics, influenced by the biological catalyst Bacillus Calmette-Guérin (BCG), might contribute to the eventual demise of malignant formations in the context of bladder cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    997
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "BCG may #activate# NK cells, induce cytokine secretion, and promote #immune cell# infiltration, contributing to the destruction of malignant formations in bladder cancer.",
            "predicted_answer": "BCG activates the innate immune system, inducing proinflammatory cytokine secretion and immune cell infiltration, including NK cell activation, which collectively contribute to the anti-tumor effect in bladder cancer.",
            "score": 5,
            "explanation": "The Predicted Answer includes all the key facts emphasized in the Reference Answer: it mentions BCG activating NK cells, inducing cytokine secretion, and promoting immune cell infiltration. There are no significant omissions or errors, and the overall trend aligns with the Reference Answer."
        },
        {
            "query_idx": 943,
            "query": "Through what mechanisms do the sentinel-like modulators within the antigen-presenting cellular framework orchestrate the interlinked complexities of adaptive response pathways in the context of T cells’ immune activation?",
            "retrieved_metrics": {
                "reference_idx": [
                    998
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Sentinel-like modulators, like #Toll-like receptors#, orchestrate adaptive response pathways by activating antigen-presenting cells, inducing proinflammatory cytokines, and stimulating adaptive immunity in #T cells#.",
            "predicted_answer": "Toll-like receptors (TLRs) in antigen-presenting cells, like macrophages and dendritic cells, activate and secrete proinflammatory cytokines, which stimulate adaptive immunity in T cells, orchestrating the immune response.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference answer: it mentions \"Toll-like receptors\" and their role in activating antigen-presenting cells and stimulating adaptive immunity in \"T cells.\" All critical aspects are aligned with the reference answer."
        },
        {
            "query_idx": 944,
            "query": "How does the orchestration of the synthetic compound G100 in orchestrating within the realms of a malignant cellular peculiarity initiate a sequence of defensive immune orchestrations culminating in an oncological withdrawal for participants in the initial phase of investigation?",
            "retrieved_metrics": {
                "reference_idx": [
                    999
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "G100, a synthetic #TLR4# agonist, initiates immune responses by increasing #T cell# infiltration and activation, resulting in sustained tumor regression in a phase I study on Merkel Cell Carcinoma.",
            "predicted_answer": "G100, a synthetic TLR4 agonist, when injected intratumorally, activates the immune response, increases T cell infiltration, and leads to sustained tumor regression in patients with Merkel Cell Carcinoma.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies G100 as a TLR4 agonist and mentions it being injected intratumorally, which aligns with the reference's emphasis on TLR4 and T cell infiltration and activation. Both discuss increased T cell action and resulting tumor regression, aligning with key points."
        },
        {
            "query_idx": 945,
            "query": "How do the multi-dimensional quests for crafting and operationalizing biomedical synergy amplifiers and elemental immune catalysts unfold, particularly in the context of achieving targeted influence while navigating the hazards of uncontrolled inflammatory surges and potential habituation over extensive horizons?",
            "retrieved_metrics": {
                "reference_idx": [
                    1001
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Developing #biomedical synergy# and immune modulators involves ensuring safety and efficacy while addressing inflammation and habituation risks in complex immune environments over time.",
            "predicted_answer": "The quests for crafting and operationalizing biomedical synergy amplifiers and elemental immune catalysts involve balancing targeted influence with the risks of excessive inflammation and habituation. Careful development is essential to ensure specificity, safety, and long-term efficacy.",
            "score": 3,
            "explanation": "The Predicted Answer covers the concepts of \"biomedical synergy amplifiers\" but lacks the specific mention of \"immune modulators\" as key elements. It aligns with the Reference Answer's themes of targeted influence, inflammation, and habituation risks, yet misses a key fact about complex immune environments over time."
        },
        {
            "query_idx": 946,
            "query": "Over the span of a year following therapeutic engagement, what were the deciphered outcomes from histopathological assessments, correlating to the ability of light-reactive metallic particulates to eradicate neoplastic tissue within prostate oncological sites?",
            "retrieved_metrics": {
                "reference_idx": [
                    1006
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "After 12 months, histopathological assessments showed that #13 of 15# patients were #cancer-free# at the ablation zones following light-activated goldsilica nanoshell therapy in prostate cancer sites.",
            "predicted_answer": "In a pilot study, 13 out of 15 prostate cancer patients were cancer-free at the ablation zones after 12 months, following treatment with gold-silica nanoshells and near-infrared laser illumination.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts emphasized in the reference answer: #13 of 15# patients were #cancer-free# at the ablation zones after 12 months following treatment. The overall trend, details, and meaning are consistent without omissions or errors."
        },
        {
            "query_idx": 947,
            "query": "What architectural discrepancies and distinctive dynamic phenomena characterize the vascular development within malignant growths as opposed to the harmonized and regulated vascular proliferation witnessed in typical biological processes such as embryogenesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    1010
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Tumor angiogenesis# is characterized by a #disordered structure#, high permeability, and absence of pericytes and smooth muscle cells, unlike the regulated process in normal angiogenesis.",
            "predicted_answer": "Malignant growths exhibit disordered vascular structures, high permeability, and a lack of pericytes and smooth muscle cells, contrasting with the harmonized and regulated vascular development in typical processes like embryogenesis.",
            "score": 3,
            "explanation": "The predicted answer captures the main points such as disordered vascular structures, high permeability, and lack of pericytes and smooth muscle cells. It aligns with the reference answer but misses the specific mention of \"tumor angiogenesis,\" which is a key fact."
        },
        {
            "query_idx": 948,
            "query": "How do the intricate dynamics of photonic energy navigation through corporeal domains pose challenges to the strategic effectiveness of light-initiated cellular ablation methodologies, particularly in relation to voluminous or subterranean neoplastic configurations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1009
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #depth of light penetration# in PTT and PDT limits their effectiveness against #voluminous or subterranean neoplastic# configurations, posing challenges in targeting and treatment efficacy.",
            "predicted_answer": "The primary challenge is the limited depth of light penetration, which can reduce the effectiveness of PTT and PDT in treating larger or deeper tumors. Precise control and potential side effects also pose significant hurdles.",
            "score": 5,
            "explanation": "The predicted answer includes the key fact about the limited depth of light penetration affecting the effectiveness of PTT and PDT and mentions larger or deeper tumors, aligning with \"voluminous or subterranean neoplastic\" from the reference. No facts are omitted or contradicted."
        },
        {
            "query_idx": 949,
            "query": "What dynamic influence do the fibroblast growth factors and their receptor interactions wield within the complex tapestry of tumor vascular proliferation, and how crucial are these biomolecular conversations in the context of oncological prognostic assessments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1011
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Fibroblast growth factors (#FGFs#) and their receptor interactions play a significant role in tumor #angiogenesis#, with prognostic significance, although mechanisms are not fully understood.",
            "predicted_answer": "Fibroblast growth factors (FGFs) and their receptors significantly influence tumor vascular proliferation, with their overexpression observed in various malignancies. These interactions are crucial for oncological prognostic assessments, though the exact mechanisms remain partially understood.",
            "score": 5,
            "explanation": "The predicted answer mentions FGFs and their influence on tumor vascular proliferation, aligning with the role in angiogenesis. It acknowledges prognostic importance but lacks the specific term \"angiogenesis.\" Despite this, the overall trend matches, with no contradictions or significant omissions."
        },
        {
            "query_idx": 950,
            "query": "In the ethereal landscape of tumor vascular origination, what principal orchestrated symphonies are initiated by the binding interaction of VEGF-A with VEGFR2, setting off the cellular cascade, as expounded through a mechanistic framework of molecular symphony and signaling choreography in the provided context?",
            "retrieved_metrics": {
                "reference_idx": [
                    1014
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The binding of #VEGF-A# to #VEGFR2# initiates tumor angiogenesis through endothelial cell reprogramming, proliferation, and migration by activating RAS, ERK-MAPK, and PI3K-AKT pathways.",
            "predicted_answer": "The binding of VEGF-A to VEGFR2 initiates dimerization and activates downstream pathways such as RAS, ERK-MAPK, and PI3K-AKT, promoting endothelial cell reprogramming, proliferation, and migration in tumor angiogenesis.",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer in terms of key facts: the binding of VEGF-A to VEGFR2, initiation of tumor angiogenesis, and activation of RAS, ERK-MAPK, and PI3K-AKT pathways. No contradictory information and all emphasized details are captured."
        },
        {
            "query_idx": 951,
            "query": "What role does the molecular symphony conducted by the epidermal growth factor clan play in the orchestration of vascular proliferation within a neoplastic context, considering both direct receptor-mediated interactions and auxiliary extracellular signaling pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1012
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #epidermal growth factor# family promotes #tumor angiogenesis# by directly stimulating endothelial cell proliferation via EGFR and indirectly increasing VEGF secretion from smooth muscle cells.",
            "predicted_answer": "The EGF family promotes vascular proliferation in tumors by binding to EGFR, stimulating endothelial cell growth, and increasing VEGF secretion, thus enhancing angiogenesis through direct and indirect mechanisms.",
            "score": 5,
            "explanation": "The predicted answer accurately covers the key facts from the reference answer: the involvement of the epidermal growth factor in promoting tumor angiogenesis, the direct effect on endothelial cell growth, and the indirect mechanism involving VEGF secretion. Although no explicit mention of \"smooth muscle cells,\" it captures the overall meaning."
        },
        {
            "query_idx": 952,
            "query": "How do the minuscule entities composed of iron oxide operate as instrumental amplifiers within the diagnostic landscape, enriching the intricate visualization of neoplastic formations during the pursuit of oncological discernment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1019
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Iron oxide nanoparticles, like #Fe3O4#, act as #contrast agents# in MRI, enhancing visualization of tumors for better diagnostic precision in oncology.",
            "predicted_answer": "Iron oxide nanoparticles act as contrast agents in MRI, enhancing the visualization of tumors by improving the contrast and detail in imaging, which aids in the detection and diagnosis of neoplastic formations.",
            "score": 3,
            "explanation": "The predicted answer successfully captures the key facts from the reference answer, such as the role of iron oxide nanoparticles as contrast agents in MRI for tumor visualization, with a focus on detection and diagnosis of neoplastic formations. However, the specific mention of #Fe3O4# is missing."
        },
        {
            "query_idx": 953,
            "query": "What was the magnitude of change observed in the fundamental parameter of lesion activity subsequent to a series of three administrations of synthetic hypericin, as documented in the comprehensive Snapshot inquiry targeting the preliminary spectrum of MF/CTCL treatment methodology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1008
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #ILRR# increased to #49%# after three administrations of synthetic hypericin.",
            "predicted_answer": "The ILRR increased to 49% after three administrations of synthetic hypericin in the treatment of early-stage MF/CTCL, as documented in the FLASH study.",
            "score": 5,
            "explanation": "The Predicted Answer fully covers all the key facts and numbers emphasized in the Reference Answer. It mentions the increase to 49% in ILRR after three administrations of synthetic hypericin, which matches the Reference Answer's key information. The details and trends are aligned without significant omissions."
        },
        {
            "query_idx": 954,
            "query": "What roles do naturally occurring liposome-like vesicular envoys, particularly those secreted by phagocytic cells, play in optimizing the distribution and effectiveness of anticancer compounds utilized against malignant breast tissues?",
            "retrieved_metrics": {
                "reference_idx": [
                    1020
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Exosomes# secreted by macrophages optimize #anticancer drug# delivery like Doxorubicin in malignant breast tissues by enhancing cell communication and carrying therapeutic molecules.",
            "predicted_answer": "Naturally occurring exosomes, especially those from phagocytic cells like macrophages, enhance the delivery of anticancer drugs such as Doxorubicin to breast cancer tissues, improving treatment effectiveness and distribution.",
            "score": 3,
            "explanation": "The Predicted Answer covers the key facts: \"exosomes,\" \"anticancer drugs,\" and \"delivery of Doxorubicin to breast cancer tissues.\" It aligns with the overall trend of optimizing drug delivery. However, it omits \"enhancing cell communication and carrying therapeutic molecules,\" affecting completeness."
        },
        {
            "query_idx": 955,
            "query": "In the multifaceted orchestration of cellular alchemy, what transformational roles do the constructs of TiO2 and ZnO assume in the genesis of reactive oxygen species, as they choreography their selective incursion on malign cellular architectures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1021
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#TiO2# and #ZnO# generate reactive oxygen species (ROS) under light exposure to selectively kill tumor cells.",
            "predicted_answer": "TiO2 and ZnO generate reactive oxygen species (ROS) under light exposure, which selectively target and kill tumor cells.",
            "score": 5,
            "explanation": "The predicted answer covers all the key facts emphasized in the reference answer. It includes TiO2 and ZnO's role in generating ROS under light to target and kill tumor cells. There are no significant omissions or contradictory information, demonstrating alignment and completeness."
        },
        {
            "query_idx": 956,
            "query": "What quantifiable enhancement in median longevity metrics is discernible with the innovative therapeutic paradigm when positioned against the survival parameters established by sorafenib within the bounds of the Chinese patient cohort?",
            "retrieved_metrics": {
                "reference_idx": [
                    1026
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The innovative therapeutic paradigm extends median overall survival to #two years# compared to #11.4 months# with sorafenib in the Chinese patient cohort.",
            "predicted_answer": "In the Chinese patient cohort, the median overall survival (mOS) was extended to two years with the new therapeutic paradigm, compared to 11.4 months with sorafenib.",
            "score": 5,
            "explanation": "The Predicted Answer correctly states the key facts: extension of median overall survival to \"two years\" and comparison to \"11.4 months\" with sorafenib. Both these key points emphasized in the Reference Answer are present, with no omissions or contradictions."
        },
        {
            "query_idx": 957,
            "query": "Within the intricate narrative woven by the SPOTLIGHT study, what is the quantitative measure by which zolbetuximab coupled with mFOLFOX6 recalibrates the course of advanced gastric cancer's progression or demise, contrasted with the traditional placebo-assisted mFOLFOX6 methodology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1028
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Zolbetuximab with mFOLFOX6 reduces the risk of #disease progression# or #death# by 24.9% compared to placebo with mFOLFOX6 in advanced gastric cancer.",
            "predicted_answer": "The SPOTLIGHT study showed that zolbetuximab with mFOLFOX6 reduced the risk of disease progression or death by 24.9% compared to placebo plus mFOLFOX6, with a median PFS of 10.61 months versus 8.67 months.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key facts of the reference answer, specifically the reduction in risk of disease progression or death by 24.9% with zolbetuximab plus mFOLFOX6. It also provides additional contextual details about the median PFS, enhancing comprehensiveness without contradictions."
        },
        {
            "query_idx": 958,
            "query": "Through what intricate dance do ions of iron, unfurling from the porous architecture of mesoporous Prussian blue constructs camouflaged within macrophage facades, propel the transformation of tumor-associated macrophage allegiances, whilst concurrently influencing the fervent activation of cytotoxic T cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1022
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Iron ions from mesoporous Prussian blue induce M1-like macrophage differentiation via the #IRF5 pathway#, stimulating cytotoxic #T cells# for antitumor effects.",
            "predicted_answer": "Iron ions from mesoporous Prussian blue constructs, camouflaged within macrophage membranes, promote M1-like tumor-associated macrophage differentiation via the IRF5 pathway and stimulate cytotoxic T cells, enhancing antitumor effects.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as iron ions from mesoporous Prussian blue promoting M1-like macrophage differentiation via the IRF5 pathway and stimulating cytotoxic T cells for antitumor effects, consistent with the reference. All emphasized information is present without significant omissions or errors."
        },
        {
            "query_idx": 959,
            "query": "In the context of orchestrating the strategic navigation of genetic elements, what favorable attributes do specialized polymer-enhanced nanocarriers exhibit that distinguish them during their mission to transport the p53 tumor suppressor blueprint, contrasting with the unrestricted journey of the unadulterated gene?",
            "retrieved_metrics": {
                "reference_idx": [
                    1029
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Specialized #dendrimer-functionalized nanocarriers# improve #antiproliferative effects# and enhance stability, bioavailability, and circulation time compared to the free p53 gene.",
            "predicted_answer": "Specialized polymer-enhanced nanocarriers, like dendrimer-functionalized nanoparticles, improve the targeted delivery and antiproliferative effect of the p53 tumor suppressor gene, offering better stability, bioavailability, and reduced off-target interactions compared to the unadulterated gene.",
            "score": 3,
            "explanation": "The predicted answer mentions \"dendrimer-functionalized nanoparticles,\" aligning with the key detail in the reference. It covers \"antiproliferative effect,\" \"stability,\" and \"bioavailability.\" The only omission is \"circulation time,\" resulting in overall alignment but missing one key fact."
        },
        {
            "query_idx": 960,
            "query": "In the context of comprehensive clinical explorations, what is the harvested chronicle of longevity among those facing the daunting resurgence or far-reaching expansion of nasopharyngeal carcinoma, as they embark on a therapeutic journey entwined with tislelizumab and its chemotherapeutic counterpart, as chronicled by the esteemed JUPITER-02 exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1030
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #JUPITER-02# study showed that treatment with #tislelizumab# and chemotherapy improved overall survival for recurrent or metastatic nasopharyngeal carcinoma, with a 3-year OS rate of 64.5%.",
            "predicted_answer": "The JUPITER-02 study found that tislelizumab combined with chemotherapy significantly improved overall survival in patients with recurrent or metastatic nasopharyngeal carcinoma, achieving a 3-year OS rate of 64.5%.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized in the reference: it specifies the JUPITER-02 study, discusses the combination of tislelizumab and chemotherapy, and mentions the 3-year OS rate of 64.5%. The overall trend and details accurately reflect the reference answer."
        },
        {
            "query_idx": 961,
            "query": "What archetype of malignant cellular emergence finds itself at the forefront of therapeutic focus through the convergence of Nivolumab and Ipilimumab, within the analytical breadth provided by studies spanning from 2006 to March 20, 2024?",
            "retrieved_metrics": {
                "reference_idx": [
                    1031
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The combination of #Nivolumab and Ipilimumab# focuses primarily on treating #melanoma# among various cancers.",
            "predicted_answer": "The combination of Nivolumab and Ipilimumab, both immune checkpoint inhibitors, is primarily focused on treating melanoma, renal cell carcinoma (RCC), mesothelioma, and non-small cell lung cancer (NSCLC).",
            "score": 5,
            "explanation": "The key facts in the reference answer emphasize the combination of Nivolumab and Ipilimumab primarily treating melanoma. The predicted answer mentions melanoma but also includes other cancers, aligning generally with the focus on melanoma without contradiction. The key fact is present."
        },
        {
            "query_idx": 962,
            "query": "What profound interwoven hindrances and multifaceted constraints are obstructing the seamless transition of nanoparticle nanomedicinal innovations from auspicious laboratory frameworks to practical therapeutic arenas?",
            "retrieved_metrics": {
                "reference_idx": [
                    1034
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Biological challenges#, regulatory hurdles, and #high cost# hinder the transition of nanoparticle nanomedicines from lab innovations to practical therapies, compounded by safety, efficacy, manufacturing, and IP issues.",
            "predicted_answer": "Key hindrances include unclear distribution, metabolism, and clearance mechanisms, long-term health and environmental risks, biocompatibility and safety concerns, large-scale manufacturing challenges, regulatory hurdles, intellectual property issues, and high costs.",
            "score": 5,
            "explanation": "The predicted answer covers all the key facts: biological challenges (clearance mechanisms), high cost, and regulatory hurdles. It also addresses safety, manufacturing, and intellectual property issues. The overall trend and meaning align well with the reference answer. No significant omissions or contradictions exist."
        },
        {
            "query_idx": 963,
            "query": "What is the emblematic primary intervention recommended within the intricate protocols for addressing the advanced atypical pathology of non-clear cell renal carcinoma, considering the therapeutic results delineated in the provided exposition?",
            "retrieved_metrics": {
                "reference_idx": [
                    1035
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The recommended primary intervention for advanced atypical #non-clear cell# renal carcinoma is #Pembrolizumab and Lenvatinib# as first-line treatment.",
            "predicted_answer": "The emblematic primary intervention recommended for advanced non-clear cell renal carcinoma is the combination of Pembrolizumab and Lenvatinib, supported by promising survival outcomes.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer, identifying Pembrolizumab and Lenvatinib as the recommended intervention for advanced non-clear cell renal carcinoma. It correctly emphasizes the essential aspects mentioned with #, covering all key facts without contradiction or omission."
        },
        {
            "query_idx": 964,
            "query": "What measure of temporal elongation within the structured pathway of disease progression was discerned in the context of RELATIVITY-047's trial when synthesizing Relatlimab and Nivolumab in the therapeutic domain addressing metastatic melanoma?",
            "retrieved_metrics": {
                "reference_idx": [
                    1037
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #median PFS# for Relatlimab and Nivolumab increased from #4.6 months# to 10.1 months in the RELATIVITY-047 trial for metastatic melanoma.",
            "predicted_answer": "The median progression-free survival (PFS) increased from 4.6 months to 10.1 months in the RELATIVITY-047 trial, indicating a significant temporal elongation in disease progression with the Relatlimab and Nivolumab combination.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized in the reference answer: both the \"median PFS\" and the metrics \"4.6 months\" and \"10.1 months\" are present. The information is consistent, with no significant omissions or contradictions."
        },
        {
            "query_idx": 965,
            "query": "What underlying transformational dynamic is catalyzed within the PD-1 + TCF-1 + progenitor-like CD8 + T cell population in response to the orchestrated synergy of PD-1 plus IL-2 interactive treatment strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1038
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The PD-1 + IL-2 combination therapy #significantly alters# the differentiation program of #PD-1 + TCF-1 + stem-like# CD8 + T cells.",
            "predicted_answer": "The PD-1 + IL-2 combination therapy significantly alters the differentiation program of PD-1 + TCF-1 + stem-like CD8 + T cells, enhancing their potential for cancer treatment.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer, conveying that PD-1 + IL-2 therapy significantly alters the differentiation of PD-1 + TCF-1 + stem-like CD8 + T cells. It captures both the impact on differentiation and the specific cell population involved, with no omissions or contradictions."
        },
        {
            "query_idx": 966,
            "query": "Which synergistic alliance identified in Zheng et al.'s study exemplifies a strategic convergence of molecular inhibition and targeted genetic intervention, manifesting as synthetic lethality within the landscape of hepatic oncogenesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    1041
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The synergistic alliance identified is #GSK-J4# exhibiting synthetic lethality with #donafenib# in liver cancer.",
            "predicted_answer": "The synergistic alliance identified in Zheng et al.'s study is the combination of GSK-J4 and donafenib, which demonstrates synthetic lethality in liver cancer.",
            "score": 5,
            "explanation": "The predicted answer includes both key components, #GSK-J4# and #donafenib#, as exhibiting synthetic lethality in liver cancer, aligning with the reference answer. There are no significant omissions or errors, as the key facts and overall meaning are accurately captured."
        },
        {
            "query_idx": 967,
            "query": "Within the context of a meticulously structured investigational pursuit involving the fusion of Bevacizumab and Erlotinib as counteractive forces against the advancement of ovarian pathology, what temporal oasis, quantified as the median span of progression-free resilience, emerged from this clinical synergy?",
            "retrieved_metrics": {
                "reference_idx": [
                    1047
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The median span of progression-free resilience for the #Bevacizumab# and #Erlotinib# combination in advanced ovarian cancer was 25.6 months.",
            "predicted_answer": "The median progression-free survival (mPFS) for the combination of Bevacizumab and Erlotinib in advanced ovarian cancer was 25.6 months.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies #Bevacizumab# and #Erlotinib# as the drugs used in the combination and accurately states the median progression-free survival as 25.6 months, matching the key facts and trend in the reference answer, with no omissions or contradictions."
        },
        {
            "query_idx": 968,
            "query": "In the enigmatic dance of cervix-related diagnostic intricacies, what emerges as the degree of discernment showcased by Huawei's AI paradigm concerning the interpretative clarity for slides devoid of pathological manifestations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1049
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Huawei's AI paradigm shows a remarkable interpretative clarity with an accuracy exceeding #99%# for slides devoid of #pathological manifestations#.",
            "predicted_answer": "Huawei's AI-assisted model, developed with KingMed Diagnostic, shows over 99% accuracy in interpreting negative slides for cervical cancer screening.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts highlighted in the reference: an accuracy of over 99% and interpretation of negative slides (those without pathological manifestations) for cervical cancer screening. The information is consistent, with no significant omissions or errors, aligning with the reference answer's intent."
        },
        {
            "query_idx": 969,
            "query": "What distinct pathological state, marked by intrinsic HRR genetic anomalies in an advanced physiological arena resistant to hormone deprivation, was the strategic amalgamation of talazoparib and enzalutamide officially sanctioned to address in the concluding phase of 2023?",
            "retrieved_metrics": {
                "reference_idx": [
                    1050
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The talazoparib and enzalutamide combination was approved to treat #HRR gene-mutated# metastatic #castration-resistant prostate cancer# in November 2023.",
            "predicted_answer": "The combination of talazoparib and enzalutamide was approved in November 2023 for treating HRR gene-mutated metastatic castration-resistant prostate cancer.",
            "score": 5,
            "explanation": "The Predicted Answer includes all the key facts emphasized in the Reference Answer: “HRR gene-mutated” and “castration-resistant prostate cancer”. It also mentions the correct approval timing, November 2023. The wording might differ slightly, but all critical information is captured."
        },
        {
            "query_idx": 970,
            "query": "How do the intricacies of lipid-based energetic frameworks command the proliferative and migratory tendencies of neoplastic cells, particularly through the orchestration of membrane architecture and electrochemical homeostasis?",
            "retrieved_metrics": {
                "reference_idx": [
                    1054
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Fatty acid metabolism# supports tumor cell growth and #metastasis# by aiding membrane synthesis, signal transduction, β-oxidation for energy, and NADPH for redox balance.",
            "predicted_answer": "Lipid-based frameworks influence neoplastic cell proliferation and migration by shaping membrane architecture and maintaining electrochemical homeostasis. Fatty acids support tumor growth and metastasis through structural roles, energy provision via β-oxidation, and redox balance.",
            "score": 3,
            "explanation": "The predicted answer encompasses key elements such as the role of fatty acids in tumor growth, metastasis, structure, energy provision, and redox balance, which align with the reference. However, it lacks explicit mention of \"signal transduction\" and \"NADPH,\" slightly impacting completeness."
        },
        {
            "query_idx": 971,
            "query": "In what manner does the identity of Helicobacter as a preeminent microbial architect influence oncogenic terrains, as reflected in its standing within global health adjudications concerning cancer genesis pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1055
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Helicobacter, identified as a #Group 1 carcinogen# by WHO, influences oncogenic terrains by associating with primary liver and gastric cancers, impacting global cancer genesis pathways.",
            "predicted_answer": "Helicobacter, identified as a Group 1 carcinogen by the WHO, influences oncogenic terrains by its association with primary liver and gastric cancers, impacting global health policies on cancer genesis.",
            "score": 5,
            "explanation": "The Predicted Answer successfully includes the key facts that Helicobacter is a Group 1 carcinogen, recognized by the WHO, and its association with primary liver and gastric cancers, as highlighted in the Reference Answer. The overall trend and meaning are consistent without omissions or contradictions."
        },
        {
            "query_idx": 972,
            "query": "To what degree have the monetary escalations of proprietary pharmaceutical formulations for less prevalent maladies diverged when juxtaposed with those targeting more ubiquitous conditions throughout the era beginning in the 2000s to the contemporary timeframe?",
            "retrieved_metrics": {
                "reference_idx": [
                    1056
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Monetary escalations of proprietary formulations for #orphan indications# rose by #94%#, while those for non-orphan indications increased by 50% from 2005 to 2023.",
            "predicted_answer": "Prices for pharmaceuticals targeting less prevalent maladies, especially ultra-rare orphan indications, have increased more significantly (94%) compared to those for more common conditions (50%) from 2005 to 2023.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts from the reference answer: the price increase for orphan indications is 94%, and for non-orphan indications, it's 50%, from 2005 to 2023. Both answers present the same trend without any contradictions or omissions."
        },
        {
            "query_idx": 973,
            "query": "In the complex biochemical theatre of tumorigenic dynamics, what is the contributory essence of phosphoenolpyruvate carboxykinase 1's catalytic prowess, as a conductor of lipid biosynthesis harmonies in the relentless expansion of cancerous cells, as elucidated in the academic explorations of Lu Zhimin's research activities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1053
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Phosphoenolpyruvate carboxykinase 1 catalyzes lipid biosynthesis by using #GTP# as a phosphate donor, stimulating #tumor lipid synthesis# and promoting cancer cell expansion.",
            "predicted_answer": "PCK1, as studied by Lu Zhimin, catalyzes reactions that stimulate tumor lipid synthesis, promoting cancer cell growth and progression. This enzyme's activity highlights its role in metabolic pathways critical for tumor expansion.",
            "score": 3,
            "explanation": "The predicted answer captures the general idea of PCK1's role in stimulating tumor lipid synthesis and promoting cancer cell growth, aligning with the reference answer. However, it lacks mention of the use of #GTP# as a phosphate donor, which is a key detail in the reference."
        },
        {
            "query_idx": 974,
            "query": "What strategic resolution mechanisms were implemented to ensure alignment of divergent perspectives in the intricate process of elucidating data from FDA label sources?",
            "retrieved_metrics": {
                "reference_idx": [
                    1061
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Disagreements were resolved by #consensus# between reviewers or by consulting an experienced oncologist (#TB#) to align divergent perspectives.",
            "predicted_answer": "To ensure alignment of divergent perspectives, disagreements were resolved through consensus between reviewers or by consulting an experienced oncologist.",
            "score": 5,
            "explanation": "The Predicted Answer fully captures the key facts in the Reference Answer. It includes resolving disagreements through consensus and consulting an experienced oncologist. There are no significant omissions or errors, and the overall trend is aligned with the Reference Answer."
        },
        {
            "query_idx": 975,
            "query": "What part does the revelation of complex molecular compositions through spatial proteomics data play in empowering the nuanced architecture of precision-designed therapeutic regimes, nestled in the overarching analysis of clinical trial landscapes, particularly for B-cell Non-Hodgkin's Lymphoma?",
            "retrieved_metrics": {
                "reference_idx": [
                    1051
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The revelation of #complex molecular compositions# via spatial proteomics empowers precision-designed therapeutic regimes by guiding precision trials and tailoring targeted therapy for #B-cell Non-Hodgkin's Lymphoma#.",
            "predicted_answer": "The revelation of complex molecular compositions through spatial proteomics data enhances the design of precision therapies by identifying specific tumor microenvironment changes, which can predict therapeutic effects and drive targeted treatments in B-cell Non-Hodgkin's Lymphoma.",
            "score": 3,
            "explanation": "The predicted answer captures the key concept of \"complex molecular compositions\" and its role in enhancing precision therapies. However, it misses the specific emphasis on \"precision trials\" from the reference. The trend is aligned, focusing on B-cell Non-Hodgkin's Lymphoma, but one key fact is missing."
        },
        {
            "query_idx": 976,
            "query": "What analytical mechanism was enlisted to illuminate contrasts between these niche therapeutic frameworks known as orphan designations and the broader spectrum of non-orphan counterparts?",
            "retrieved_metrics": {
                "reference_idx": [
                    1063
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Cochran's Q test# was used to illuminate contrasts between #orphan# and non-orphan therapeutic frameworks.",
            "predicted_answer": "A Cox regression model, Fisher's exact tests, Kruskal-Wallis tests, random effects regressions, and Cochran's Q test were used to analyze differences between orphan and non-orphan drug designations.",
            "score": 5,
            "explanation": "The Predicted Answer includes the #Cochran's Q test# and mentions both #orphan# and non-orphan drug designations. However, it lists additional tests not emphasized in the Reference Answer. Despite this, the key facts required are present, and there is no contradictory information."
        },
        {
            "query_idx": 977,
            "query": "What fraction of therapeutic constructs tailored for commonly acknowledged orphan disease typologies consists of intricately formulated small molecules engaging in a purposefully directed molecular interaction framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1065
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Therapeutic constructs for common orphan disease typologies primarily consist of #80%# small molecules with a #targeted mechanism# of action.",
            "predicted_answer": "80% of therapeutic constructs for common orphan diseases are intricately formulated small molecules engaging in targeted molecular interactions.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects both key facts emphasized in the reference answer: the fraction of therapeutic constructs being #80%# and the #targeted mechanism# of small molecules. The wording differs slightly, but the essential information and meaning are intact without any contradictory elements."
        },
        {
            "query_idx": 978,
            "query": "What intricate criteria are utilized to conceptually derive the designation of rare classification for therapeutic agents targeting the BRAF mutation, encompassing the whole gamut of neoplastic conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1075
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The designation of rare classification for therapeutic agents targeting the #BRAF mutation# requires fewer than #200,000 patients# with the mutation across all cancer types.",
            "predicted_answer": "The designation of rare classification for therapeutic agents targeting the BRAF mutation considers the total number of patients with BRAF mutations across all cancer types. If this number is fewer than 200,000, the drug qualifies for orphan status.",
            "score": 5,
            "explanation": "The predicted answer accurately covers the key facts such as the focus on the BRAF mutation and the criterion of fewer than 200,000 patients across all cancer types for orphan status designation, aligning well with the reference answer without omissions."
        },
        {
            "query_idx": 979,
            "query": "What intricate reformative pathway could Medicare and Medicaid theorize to enact, flanked by stakeholder negotiation chessboard strategies, to recalibrate the market dynamics of highly valued pharmaceutical innovations within the niche of orphan drug delineations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1076
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Medicare and Medicaid could implement #value based pricing# for orphan drugs using #cost effectiveness analyses# and negotiating strategies, extending powers to include ultra-rare disease assessments.",
            "predicted_answer": "Medicare and Medicaid could negotiate value-based prices for orphan drugs, using bargaining power and cost-effectiveness analyses from independent agencies. This reform would include a special assessment pathway for ultra-rare diseases, aligning prices with clinical benefits and unmet needs.",
            "score": 5,
            "explanation": "The predicted answer includes both #value-based pricing# and #cost-effectiveness analyses#, aligning with the Reference Answer. It also mentions negotiation and ultra-rare disease assessments, fully covering key facts without contradictions or omissions."
        },
        {
            "query_idx": 980,
            "query": "What instrumentalities ought to be forged within the symphony of trial designs for navigating the uncharted waters of ultra-rare diseases, especially when the pursuit of participant accrual is a formidable endeavor and endpoints are intangible specters?",
            "retrieved_metrics": {
                "reference_idx": [
                    1077
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "To navigate ultra-rare diseases, instrumentalities like #synthetic control arms# and #natural history studies# should be employed, encouraging diverse and innovative trial designs.",
            "predicted_answer": "To navigate trials for ultra-rare diseases, leverage public-private partnerships, synthetic control arms, and natural history studies. These tools help address participant accrual challenges and intangible endpoints, facilitating more effective trial designs.",
            "score": 5,
            "explanation": "The predicted answer includes both #synthetic control arms# and #natural history studies#, matching the key facts emphasized in the reference answer. While the predicted answer adds elements like public-private partnerships, it aligns overall without contradiction, showing strong alignment with the reference. No key facts are missing."
        },
        {
            "query_idx": 981,
            "query": "What complex molecular deterrents exhibiting fluorinated functionality undertake an orchestrated engagement with viral and cellular components, and how do these interactions harmonize with the overarching framework of pandemic mitigation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1080
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Fluorinated drugs# target viral or host proteins, significantly contributing to #pandemic mitigation# by controlling COVID-19 through these interactions.",
            "predicted_answer": "Fluorinated drugs, such as those used in COVID-19 treatment, interact with viral and cellular proteins or RNA. These interactions disrupt viral replication and host cell mechanisms, contributing to pandemic control by reducing virus spread and severity.",
            "score": 5,
            "explanation": "The predicted answer mentions \"fluorinated drugs\" and their interaction with viral and cellular targets, aligning with the reference's key facts about such drugs targeting viral or host proteins. It also touches on their role in pandemic control, consistent with \"pandemic mitigation.\" All key facts are present."
        },
        {
            "query_idx": 982,
            "query": "What conceptual framework might the Centers for Medicare and Medicaid Services employ to cultivate a perpetual loop of evaluative re-examination concerning the advantageous potentials of ultra-scarce medicinal entities following their inaugural approval in the commercial pharmaceutical domain?",
            "retrieved_metrics": {
                "reference_idx": [
                    1078
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The Centers for Medicare and Medicaid Services might use #Coverage with Evidence Development# to reassess ultra-scarce medicines' benefits after a #pre-defined period#.",
            "predicted_answer": "The Centers for Medicare and Medicaid Services could use a Coverage with Evidence Development program to collect outcome data, enabling periodic reassessment of the benefits of ultra-scarce medicinal entities after their initial approval.",
            "score": 3,
            "explanation": "The predicted answer includes the key concept of \"Coverage with Evidence Development\" but lacks the specific detail of a \"pre-defined period\" noted in the reference answer. Both answers align in overall trend concerning reassessment but miss this important temporal detail."
        },
        {
            "query_idx": 983,
            "query": "In what manner do the transformative potentials of adaptable molecular architectures orchestrate the biofunctional interactions with macromolecular entities, shaping the innovative trajectories of therapeutic developments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1082
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #conformational flexibility# of adaptable molecular architectures changes ligand properties, optimizing #biofunctional interactions# with macromolecules, thus advancing therapeutic developments.",
            "predicted_answer": "The transformative potentials of adaptable molecular architectures orchestrate biofunctional interactions by altering ligand conformations, which in turn change biological properties and influence the recognition abilities of biomacromolecules, driving innovative therapeutic developments.",
            "score": 5,
            "explanation": "The predicted answer encompasses the key facts from the reference: it mentions \"altering ligand conformations\" and \"biofunctional interactions,\" which are consistent with \"conformational flexibility\" and \"biofunctional interactions\" in the reference. Both answers convey the effect on therapeutic developments, with no significant omissions or errors."
        },
        {
            "query_idx": 984,
            "query": "Through what mechanisms does the infusion of $^{18}$F-laden constructs reshape the investigative framework of positron emission tomography, thereby enriching the narrative of biochemical dynamics and metabolic odysseys?",
            "retrieved_metrics": {
                "reference_idx": [
                    1084
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The infusion of #^{18}#F-laden constructs in PET enables studying #biochemical transformations#, enhancing noninvasive diagnostic capabilities for surveying living tissue and functional processes.",
            "predicted_answer": "The infusion of $^{18}$F-laden constructs in PET enhances the visualization of biochemical transformations and pharmacokinetics, providing a noninvasive method to study metabolic processes and functional dynamics in living tissues.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the reference by addressing the enhancement of biochemical transformation studies, noninvasive nature, and focus on metabolic processes, similarly emphasizing on visualizing dynamics in living tissues, though with slight wording variation. All key facts are present without contradictions or significant omissions."
        },
        {
            "query_idx": 985,
            "query": "What latent dynamics are set in motion by the incorporation of fluorine into the molecular tapestry of synthetic glycoform replicas and structural proteins, and how do these dynamics recalibrate their intrinsic and extrinsic interaction paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1083
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The incorporation of #fluorine# enhances #hydrophobicity#, stabilizing proteins against unfolding and improving binding affinities in glycoform replicas and structural protein interactions.",
            "predicted_answer": "Incorporating fluorine into synthetic glycoform replicas and structural proteins enhances their stability and hydrophobicity, improving binding affinities and pharmacokinetics. This recalibrates their intrinsic and extrinsic interactions, making them more effective and durable.",
            "score": 3,
            "explanation": "The key facts, such as #fluorine# enhancing #hydrophobicity# and improving binding affinities, are present in the predicted answer. The predicted answer aligns with the overall trend of stabilization and interaction recalibration expressed in the reference answer. However, stability specifically against unfolding is not explicitly mentioned."
        },
        {
            "query_idx": 986,
            "query": "How does the application of $^{19}$F MRI technology enable the decoding of intricate molecular dialogues among diverse macromolecular structures such as proteins, enzymes, and lipid matrices, thus illuminating their recognition narratives?",
            "retrieved_metrics": {
                "reference_idx": [
                    1085
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The application of #$^{19}$F MRI# technology enables the understanding of the recognition behavior of #ligands# with proteins, enzymes, and lipid matrices.",
            "predicted_answer": "$^{19}$F MRI technology, using fluorinated tracers like perflubron, enables the visualization and analysis of interactions between ligands and macromolecules such as proteins, enzymes, and lipids, providing insights into their recognition mechanisms.",
            "score": 5,
            "explanation": "The Predicted Answer mentions $^{19}$F MRI technology's use with ligands and macromolecules (proteins, enzymes, lipids) for understanding recognition mechanisms, aligning with the Reference Answer. Both emphasize $^{19}$F MRI, ligand interaction, and recognition behavior, covering all key facts and trends without significant omissions."
        },
        {
            "query_idx": 987,
            "query": "What are the molecular intricacies of Scemblix™-ABL001's chiral center and difluorinated components that guide its strategic interference in the pathological ensemble of chronic myeloid leukemic activity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1086
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Scemblix™-ABL001's #chiral center# at (R)-configuration and #difluorinated moiety# strategically interfere with BCR-ABL1 protein activity in chronic myeloid leukemia.",
            "predicted_answer": "Scemblix™-ABL001, a chiral compound with an (R)-configuration at its secondary carbon center and a difluorinated moiety, targets the BCR-ABL1 protein, inhibiting its kinase activity and disrupting CML progression.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts in the reference answer: the chiral center with (R)-configuration and the difluorinated moiety, as well as their role in targeting BCR-ABL1 protein in CML. No key facts are missing, and there is no contradictory information."
        },
        {
            "query_idx": 988,
            "query": "What are the intricate biochemical dialogues and multi-faceted molecular engagements through which BCR-ABL1 kinase domain inhibitors facilitate the redefinition of chronic myelogenous leukemia into a state characterized by enduring manageability?",
            "retrieved_metrics": {
                "reference_idx": [
                    1087
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "BCR-ABL1 kinase inhibitors, like #imatinib#, target the #ATP-binding site#, disrupting BCR-ABL1 activity, thereby managing CML through altered cell growth and survival signaling.",
            "predicted_answer": "BCR-ABL1 kinase inhibitors, like imatinib, dasatinib, and nilotinib, target the ATP-binding site of BCR-ABL1, blocking its activity and inhibiting abnormal signaling pathways. This transforms CML into a manageable chronic condition.",
            "score": 5,
            "explanation": "The predicted answer covers all the key facts emphasized with # in the reference, including #imatinib#, #ATP-binding site#, and the management of CML through inhibition of BCR-ABL1. It aligns with the reference answer's overall trend of how inhibitors make CML manageable by disrupting signaling."
        },
        {
            "query_idx": 989,
            "query": "Within the complex realm of molecular interactions, what are the ramifications of the trifluorobenzene component's presence in atogepant next to its structurally unembellished counterpart regarding their respective interaction propensities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1090
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #trifluorobenzene# component in atogepant results in higher #affinity# (Kᵢ = 0.015 nM) compared to its unsubstituted counterpart (Kᵢ = 0.067 nM).",
            "predicted_answer": "The trifluorobenzene component in atogepant increases its affinity for the target, with a K\\(_i\\) of 0.015 nM, compared to 0.067 nM for its unsubstituted counterpart, enhancing its interaction propensity.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the #trifluorobenzene# component, higher #affinity#, and the specific K\\(_i\\) values (0.015 nM for trifluorobenzene and 0.067 nM for the unsubstituted counterpart) mentioned in the reference answer. No key facts or figures are omitted or contradicted."
        },
        {
            "query_idx": 990,
            "query": "What intricate encounter, as revealed by X-ray diffraction studies, does the fluorine entity of asciminib engage in with the carbonyl arrangement of leucine L359 within the multifaceted spatial conformation of the BCR-ABL1 oncoprotein framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1088
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The fluorine atom of asciminib #interacts# with the #carbonyl carbon# of leucine L359 in the deep pocket of the BCR-ABL1 oncoprotein.",
            "predicted_answer": "X-ray diffraction studies reveal that the fluorine atom of asciminib interacts with the carbonyl carbon of leucine L359 in the deep pocket of the BCR-ABL1 oncoprotein.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts \"#interacts#\" and \"#carbonyl carbon#\" emphasized in the reference. It aligns with the reference answer's trend and meaning, without significant omissions or errors, providing a complete depiction of the interaction between fluorine and the carbonyl group."
        },
        {
            "query_idx": 991,
            "query": "What intricate series of molecular adjustments and architectural shifts catalyze the genesis of the intricate spirocyclic architecture described as compound 61 within the synthesis continuum delineated?",
            "retrieved_metrics": {
                "reference_idx": [
                    1091
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The spirocyclic architecture of compound #61# is formed through mesylation of diol #59# and base-catalyzed alkylation with SEM-protected azaoxindole 60.",
            "predicted_answer": "The spirocyclic architecture of compound 61 is formed through mesylation of diol 59, followed by base-catalyzed alkylation with SEM-protected azaoxindole 60.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key elements of the reference answer. It includes the mesylation of diol 59 and the base-catalyzed alkylation with SEM-protected azaoxindole 60, as described in the reference. The key facts (#61#, #59#) are present and aligned."
        },
        {
            "query_idx": 992,
            "query": "In the intricate design of cabotegravir's molecular structure, what pivotal role do the fluorine atoms assume as both stabilizing columns and dynamic influencers in shaping its overall pharmacological efficacy and adaptability through modulated molecular interactions and optimized metabolic characteristics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1093
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Fluorine atoms in #cabotegravir# enhance #metabolic stability#, affecting pharmacological efficacy through optimized lipophilicity and permeability.",
            "predicted_answer": "Fluorine atoms in cabotegravir enhance metabolic stability and optimize pharmacological parameters such as lipophilicity and permeability, contributing to its overall efficacy and adaptability.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference: fluorine in cabotegravir, enhancement of metabolic stability, and optimization of pharmacological parameters (lipophilicity and permeability). All aspects align with the reference without contradiction, maintaining the overall meaning and trend."
        },
        {
            "query_idx": 993,
            "query": "In the grand biochemical symphony, what quintessential molecular distinctions of the chiral construct known as Ukoniq orchestrate its dual functionality as a modulator of PI3K-delta and CK1-epsilon signal transductions, particularly within the cellular theaters of distinct lymphatic oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1097
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ukoniq's #chiral# structure with #three mono F-atoms# on phenyl moieties enables its functionality as a kinase inhibitor of PI3K-delta and CK1-epsilon in lymphatic oncology.",
            "predicted_answer": "Ukoniq, a chiral compound with three mono F-atoms, modulates PI3K-delta and CK1-epsilon by inhibiting their kinase activity, affecting signal transduction in lymphatic oncology.",
            "score": 5,
            "explanation": "The predicted answer covers key facts, including Ukoniq's chiral structure, its function as a kinase inhibitor, and the presence of three mono F-atoms. It aligns with the reference answer, despite slightly different phrasing, with no significant omissions or contradictions."
        },
        {
            "query_idx": 994,
            "query": "What unique differentiation markers delineate Vericiguat's position as an avant-garde therapeutic innovation within the orchestration of the nitric oxide-soluble guanylate cyclase-cyclic GMP cascade, impacting various cellular frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1096
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Vericiguat is characterized as the #first-in-class# stimulator of soluble guanylate cyclase (#sGC#), restoring the defective NO-sGC-cGMP pathway across various cell types.",
            "predicted_answer": "Vericiguat uniquely stimulates soluble guanylate cyclase (sGC) to restore the NO-sGC-cGMP pathway, differentiating it as an innovative therapy. It targets various cell types, including cardiomyocytes and smooth muscle cells, enhancing its impact on cellular frameworks.",
            "score": 3,
            "explanation": "Both the predicted and reference answers identify Vericiguat as targeting the sGC to restore the NO-sGC-cGMP pathway across various cell types. However, the predicted answer omits that Vericiguat is the \"first-in-class\" stimulator, a critical differentiation marker stated in the reference."
        },
        {
            "query_idx": 995,
            "query": "In the intricate scheme of molecular alterations progressing from compound 154 to the stereoisomerically distinct alcohol 170 (S), what orchestrating function does R-alpine borane undertake in facilitating the enantioselective conversion of molecular architecture?",
            "retrieved_metrics": {
                "reference_idx": [
                    1098
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "R-alpine borane orchestrates the #enantioselective reduction# of keto derivative 169 to #alcohol 170 (S)#, aiding the stereoisomeric conversion process.",
            "predicted_answer": "R-alpine borane facilitates the enantioselective reduction of the keto group in compound 169 to form the stereoisomerically distinct alcohol 170 (S).",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts from the Reference Answer: \"enantioselective reduction\" and the conversion to \"alcohol 170 (S)\". Both answers similarly describe the role of R-alpine borane in facilitating the stereoisomeric conversion. There are no significant omissions or errors."
        },
        {
            "query_idx": 996,
            "query": "What intricate sequence does the automated reactor's chamber perform to achieve the $^{18}$F-fortified metamorphosis of pylarify, with a spotlight on the molecular choreography transfiguring compound 184 through its critical alchemical phases to achieve its ultimate formation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1100
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The automated reactor's chamber performs a sequence of drying, activation of [$^{18}$F]fluoride, nucleophilic substitution into compound #184#, followed by protecting group removal for final radiolabeled #pylarify#.",
            "predicted_answer": "The automated reactor's chamber performs a three-step process: drying and activating [$^{18}$F]fluoride, incorporating it into compound 184 via nucleophilic substitution, and removing tert-butyl groups with HCl, followed by HPLC purification to yield the final product.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by detailing drying and activation of [$^{18}$F]fluoride, nucleophilic substitution into compound 184, and protecting group removal. It expands on purification steps with HPLC and specifies tert-butyl removal with HCl, with no contradictions or significant omissions."
        },
        {
            "query_idx": 997,
            "query": "What constitutes the pivotal element driving the energetic transmutation within the radiolabelled investigative apparatus dedicated to positron-mediated diagnostic exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1099
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The pivotal element is #Piflufolastat $^{18}$F#, driving energetic transmutation within the radiolabelled investigative apparatus for positron emission tomography imaging.",
            "predicted_answer": "The pivotal element driving the energetic transmutation is the radioactive isotope $^{18}$F, which emits positrons and enables the diagnostic imaging in positron emission tomography.",
            "score": 1,
            "explanation": "The predicted answer refers to the radioactive isotope $^{18}$F, while the reference answer specifies #Piflufolastat $^{18}$F#. The key fact about Piflufolastat is missing in the predicted answer, affecting completeness. Overall trend is aligned without contradiction."
        },
        {
            "query_idx": 998,
            "query": "What is the nature of the temporal attenuation phase observed in simian and canine subjects concerning its enteral assimilation capability and the enduring continuity within hepatic enzymatic interactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1102
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The temporal #attenuation phase# in simian and canine subjects showcases long elimination half-life due to high #metabolic stability#, indicating strong enteral assimilation and enduring hepatic enzymatic interactions.",
            "predicted_answer": "The temporal attenuation phase in simian and canine subjects is characterized by a long elimination half-life (t₁/₂ ≈ 10 and 30 h, respectively), indicating sustained hepatic enzymatic interactions and enteral assimilation.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of the temporal attenuation phase with long elimination half-lives and sustained hepatic interactions. However, it omits the mention of \"high metabolic stability,\" a key fact highlighted in the reference. Overall, it aligns well but lacks one critical detail."
        },
        {
            "query_idx": 999,
            "query": "What process does the corrective agent, Sofosbuvir, utilize as a strategic mechanism within the molecular fabric to establish a defense stronghold against the incursion of the Hepatitis C Virus?",
            "retrieved_metrics": {
                "reference_idx": [
                    1104
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Sofosbuvir acts as an #RNA-dependent RNA polymerase# inhibitor, blocking Hepatitis C Virus replication and establishing a defense mechanism.",
            "predicted_answer": "Sofosbuvir, a pro-antiviral drug, acts as an RNA-dependent RNA polymerase (RdRp) inhibitor. It integrates into the viral RNA, causing premature termination and preventing the replication of the Hepatitis C Virus.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies Sofosbuvir as an RNA-dependent RNA polymerase inhibitor, a key fact emphasized in the reference answer. It also explains how it prevents Hepatitis C Virus replication, thus reflecting the overall trend and strategic mechanism described in the reference."
        },
        {
            "query_idx": 1000,
            "query": "What contemporary inventive frameworks have materialized that revisit conventional charge-mediated interactions, surpassing the standard lexicon of electrophilic and nucleophilic approaches, to enable the creation of fluorine-enriched molecular assemblies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1106
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Radical fluorination#, along with #thermal and photochemical# approaches, revisits conventional charge-mediated interactions for creating fluorine-enriched molecular assemblies.",
            "predicted_answer": "Recent advancements include radical fluorination, thermal, and photochemical approaches, which expand beyond traditional electrophilic and nucleophilic methods to create fluorine-enriched molecular assemblies.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized in the reference answer: radical fluorination, and thermal and photochemical approaches for creating fluorine-enriched molecular assemblies. The meaning and overall trend align perfectly between the two answers, with no omissions or errors."
        },
        {
            "query_idx": 1001,
            "query": "How does Ensitrelvir, as a nonpeptidic and noncovalent actor in the realm of antiviral interventions, distinguish itself in its orchestrative approach towards neutralizing SARS-CoV-2 across diverse protease-targeting methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1101
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ensitrelvir distinguishes itself as the first #nonpeptidic# and #noncovalent# oral 3CL$^{pro}$ inhibitor, targeting SARS-CoV-2 by working on various variants and coronavirus families.",
            "predicted_answer": "Ensitrelvir distinguishes itself as the first nonpeptidic, noncovalent, oral 3CL$^{pro}$ inhibitor, effectively targeting SARS-CoV-2 and its variants by inhibiting a key viral protease, setting it apart in antiviral strategies.",
            "score": 3,
            "explanation": "The Predicted Answer includes the key facts of being nonpeptidic and noncovalent, and it mentions targeting SARS-CoV-2 through 3CL$^{pro}$ inhibition. However, it does not clearly mention working on various coronavirus families. Thus, it is missing one key fact, affecting completeness."
        },
        {
            "query_idx": 1002,
            "query": "How does the quintessential RAS molecule, via its strategic interaction with the mechanistic catalyst GAP, conduct an orchestration leading to the quelling of its communicative endeavors by enabling a pivotal transition in its molecular state?",
            "retrieved_metrics": {
                "reference_idx": [
                    1109
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The quintessential RAS molecule, via interaction with #GAP#, facilitates GTP hydrolysis, transitioning RAS-GTP to #RAS-GDP#, thereby halting signaling.",
            "predicted_answer": "The RAS molecule interacts with GAP, which enhances GTP hydrolysis, converting RAS-GTP to RAS-GDP. This transition changes RAS conformation and halts its signaling activity.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts from the reference answer: the interaction with GAP and the conversion of RAS-GTP to RAS-GDP, leading to a halt in signaling. The meaning is consistent with the reference answer, and no significant omissions are apparent."
        },
        {
            "query_idx": 1003,
            "query": "In the molecular symphony orchestrated by the protein architecture of GAP, which residue elements specifically participate in the amphiphobic ensemble that interacts with the cycloheptane segment of the compound's enigmatic construct?",
            "retrieved_metrics": {
                "reference_idx": [
                    1126
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #cycloheptane# segment interacts with the hydrophobic sidechains of #L787#, F788, M891, V895, and L902 residues from the GAP protein.",
            "predicted_answer": "The residues L787, F788, M891, V895, and L902 from the α 13 and α 19 helices of GAP participate in the amphiphobic ensemble that interacts with the cycloheptane segment.",
            "score": 5,
            "explanation": "The predicted answer includes the interaction of L787, F788, M891, V895, and L902 residues with the cycloheptane segment, which aligns with key facts in the reference. The amphiphobic/hydrophobic terminology difference doesn't significantly affect the meaning. No crucial information is missing or incorrect."
        },
        {
            "query_idx": 1004,
            "query": "What multidimensional evidence and systemic indicators converge to affirm the hypothesis that compound 14, administered at a dosage of 6 mg/kg, preserves physiological equilibrium in laboratory organisms within diverse experimental frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1119
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compound 14 at #6 mg/kg# shows #nontoxicity#, evidenced by stable body weight and liver weight-body weight ratios, confirming physiological equilibrium in laboratory organisms.",
            "predicted_answer": "The evidence includes no significant changes in body weight and liver weight-body weight ratios, indicating nontoxicity of compound 14 at 6 mg/kg, which supports its role in preserving physiological equilibrium.",
            "score": 5,
            "explanation": "The predicted answer includes key emphasized facts from the reference: compound 14 at 6 mg/kg, its nontoxicity, stable body weight, and liver weight-body weight ratios, supporting physiological equilibrium. The overall trend aligns well, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1005,
            "query": "Amidst the ecosystem of cellular propagation, which distinct nurturing substrate is designated for the perennial support of the endothelial lineage termed HUVEC-TERT?",
            "retrieved_metrics": {
                "reference_idx": [
                    1134
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "HUVEC-TERT cells are cultured in #Endothelial# cell #basal medium-2# (EBM-2).",
            "predicted_answer": "The distinct nurturing substrate for the perennial support of HUVEC-TERT is Endothelial cell basal medium-2 (EBM-2).",
            "score": 5,
            "explanation": "The predicted answer accurately mentions \"Endothelial cell basal medium-2 (EBM-2)\" as the nurturing substrate for HUVEC-TERT, aligning precisely with the key facts emphasized in the reference answer. No significant details are missing or contradict the reference."
        },
        {
            "query_idx": 1006,
            "query": "What are the elaborate compositional divergences in nutrient frameworks observed between the RPMI/IMDM mediums enriched with fundamental serum symphonies, and the bespoke nurturing tapestries fashioned for the CCD-986Sk and HUVEC-TERT cellular environments, inclusive of their unique supplemental intricacies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1135
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #RPMI/IMDM mediums# contain 10% FBS and 1% Penicillin/Streptomycin, while #CCD-986Sk# uses 20% FBS; HUVEC-TERT employs an EGM-2 kit, highlighting nutrient framework differences.",
            "predicted_answer": "RPMI and IMDM mediums contain 10% FBS and 1% Penicillin/Streptomycin. CCD-986Sk cells use 20% FBS, while HUVEC-TERT cells are supplemented with EGM-2, which includes specific growth factors and supplements for endothelial cells.",
            "score": 5,
            "explanation": "The Predicted Answer fully captures all the key facts emphasized in the Reference Answer: RPMI/IMDM mediums have 10% FBS and 1% Penicillin/Streptomycin, CCD-986Sk uses 20% FBS, and HUVEC-TERT involves EGM-2 with specified supplements. It maintains consistency and completeness with the Reference Answer."
        },
        {
            "query_idx": 1007,
            "query": "In the elaborate dance of docking algorithms, what primary dynamic attribute within the FRIGATE digital framework facilitates the diminishment of energetic amalgamation across the protein-ligand conglomerate amid the docking sequence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1137
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The primary dynamic attribute is the ability to rotate #all rotational bonds#, facilitating energetic minimization of the protein-ligand complex during docking in the FRIGATE framework.",
            "predicted_answer": "The primary dynamic attribute in the FRIGATE framework that facilitates the diminishment of energetic amalgamation is the allowance for rotational bond flexibility in the small molecules during the docking sequence.",
            "score": 3,
            "explanation": "The predicted answer captures the trend of facilitating rotational flexibility to diminish energy during docking. However, it specifies \"rotational bond flexibility in small molecules\" rather than rotating \"all rotational bonds\" in the complex. The omission of \"all rotational bonds\" is a key detail affecting completeness."
        },
        {
            "query_idx": 1008,
            "query": "What multi-dimensional computational construct is employed to derive the volumetric expansion representation of the BxPC3 cellular mass, utilizing paired axial calibrations in the context of the investigative regimen described?",
            "retrieved_metrics": {
                "reference_idx": [
                    1143
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The multi-dimensional computational construct employed is the formula #V = ab² × π / 6#, using paired axial calibrations of tumor length and width.",
            "predicted_answer": "The volumetric expansion of the BxPC3 cellular mass is calculated using the formula V = ab² × π /6, where a and b are the longest and shortest diameters measured with a digital caliper.",
            "score": 5,
            "explanation": "The predicted answer fully includes the key fact emphasized with # in the reference answer, namely the formula V = ab² × π / 6. The focus on diameters as measurements aligns with the reference's implied use of axial calibrations, maintaining consistency in overall meaning."
        },
        {
            "query_idx": 1009,
            "query": "What methodological assessment is employed for deriving the vitality quotient after the alchemical transition of purple precipitates in a dichotomous solvent medium, followed by their optical quantification at a wavelength of 570 nm, specifically considering static comparisons with baseline parallels?",
            "retrieved_metrics": {
                "reference_idx": [
                    1138
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #vitality quotient# is derived by measuring absorbance at #570 nm#, subtracting background absorbance, and comparing treated wells to the control baseline, set at 100% viability.",
            "predicted_answer": "The methodological assessment involves dissolving purple formazan crystals in a DMSO-ethanol solution, measuring absorbance at 570 nm, and comparing it to baseline controls to determine cell viability.",
            "score": 3,
            "explanation": "The predicted answer captures the main elements of the reference answer, including measuring absorbance at 570 nm and comparing it to baseline controls. However, it misses the steps of subtracting background absorbance and setting the control baseline at 100% viability, which are key for deriving the vitality quotient."
        },
        {
            "query_idx": 1010,
            "query": "What diverse intensities of molecular cocktails were orchestrated to navigate the biological paradigms of pancreatic carcinoma constructs and normal cellular assemblies in the depicted experimental choreography?",
            "retrieved_metrics": {
                "reference_idx": [
                    1139
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cells were treated with molecular cocktails at concentrations ranging from #15 nM# to #100 µM# to study pancreatic carcinoma and normal cell interactions.",
            "predicted_answer": "The cells were treated with various concentrations of compounds ranging from 15 nM to 100 µM, dissolved in DMSO, to study their effects on pancreatic cancer and normal cell lines.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts from the reference answer, including the concentration range (#15 nM# to #100 µM#), and maintains consistency in the context of treating pancreatic cancer and normal cells. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 1011,
            "query": "In probing the tangible and nuanced repercussions of compound 14 on the experimental mice ensemble, what refined collection of biological metrics was employed to unravel the intricacies of its toxicological profile, especially concerning their longevity, hepatic health, observable conduct alterations, and corporeal mass dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1142
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The refined biological metrics included evaluations of #lifespan#, #liver toxicity#, behavior, appearance, and body weight of the experimental mice over 15 days.",
            "predicted_answer": "The study evaluated the toxicity of compound 14 by monitoring the lifespan, liver health, behavior, appearance, and body weight of the mice over 15 days.",
            "score": 5,
            "explanation": "The predicted answer closely matches the reference answer. It includes #lifespan# and #liver health#, aligning with #liver toxicity#. The phrasing differs slightly, but all key facts are covered: lifespan, liver health, behavior, appearance, and body weight over 15 days. No important details are missing."
        },
        {
            "query_idx": 1012,
            "query": "In the intricate orchestration of the differential scanning fluorimetry inquiry, what scientific choreography unraveled the thermal nous of the proteins to elucidate their melting thresholds?",
            "retrieved_metrics": {
                "reference_idx": [
                    1147
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #differential scanning fluorimetry# elucidated proteins' #melting thresholds# by determining melting points from the first negative derivative of melting curves.",
            "predicted_answer": "Differential scanning fluorimetry used SYPRO Orange to monitor protein unfolding. Samples were heated from 25 to 85°C, and fluorescence was detected. Melting points were determined from the first negative derivative of the melting curves.",
            "score": 5,
            "explanation": "The predicted answer effectively captures the key elements of the reference answer, specifically the use of differential scanning fluorimetry to determine proteins' melting thresholds, and mentions the use of the first negative derivative of the melting curves. No significant omissions or contradictions exist."
        },
        {
            "query_idx": 1013,
            "query": "Which intricate analytical paradigm was employed to elucidate the nuanced biosystemic perturbations instigated by the experimental compound within the scope of the investigation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1148
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The analytical paradigm employed was #nonlinear fitting# to determine the growth-rate coefficient of the tumor and average doubling time for each group.",
            "predicted_answer": "The context partially addresses the query. Nonlinear fitting and toxicity evaluations were used to analyze the effects of the experimental compound, but the specific analytical paradigm for biosystemic perturbations is not detailed.",
            "score": 3,
            "explanation": "The Predicted Answer mentions \"nonlinear fitting\" but lacks detail about its application to the \"growth-rate coefficient of the tumor and average doubling time.\" This omission impacts completeness, as understanding these specifics is crucial to the original analytical paradigm's explanation."
        },
        {
            "query_idx": 1014,
            "query": "What inferential architecture was employed to evaluate inter-group disparities, and how are the outcomes encapsulated via luminescent inscriptions within the analytical tapestry?",
            "retrieved_metrics": {
                "reference_idx": [
                    1149
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Welch's correction# t-test analyzed inter-group disparities, with luminescent inscriptions represented by symbols *, **, ***, and **** indicating significance levels from #p ≤ 0.05# to p ≤ 0.0001.",
            "predicted_answer": "The inferential architecture used was a two-tailed unpaired t-test with Welch's correction. Outcomes are encapsulated using symbols (*, **, ***, ****) to denote significance levels at p ≤ 0.05, p ≤ 0.01, p ≤ 0.001, and p ≤ 0.0001, respectively.",
            "score": 5,
            "explanation": "The predicted answer and the reference answer both describe the use of Welch's correction in a t-test and mention significance levels denoted by symbols *, **, ***, **** from p ≤ 0.05 to p ≤ 0.0001. The key facts emphasized with # in the reference answer are fully covered."
        },
        {
            "query_idx": 1015,
            "query": "In what manner was the integrity of the molecular assemblage evaluated amidst the procedural cascade, and what delineation did the foundational benchmark of refinement achieve in the analytical aftermath?",
            "retrieved_metrics": {
                "reference_idx": [
                    1146
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The purity of the molecular assemblage was evaluated using #SDS PAGE# analysis, achieving a foundational benchmark of refinement with purity levels exceeding #95%#.",
            "predicted_answer": "The integrity of the molecular assemblage was evaluated using SDS-PAGE, achieving a purity of >95%. The foundational benchmark of refinement ensured high purity in the analytical results.",
            "score": 5,
            "explanation": "The predicted answer successfully captures both key facts: the method of evaluation, SDS-PAGE analysis, and the purity level exceeding 95%. The key details are accurately represented, aligning well with the reference answer, and there are no significant omissions or errors."
        },
        {
            "query_idx": 1016,
            "query": "In what ways do the results of genetic intervention, influenced by the sophisticated interaction of intrinsic species traits and ethical-pharmacological dilemmas, manifest differently across the liver terrains of rodent and primate genetic models when deploying base editing methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1152
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Base editing methodologies in liver terrains yield #61% efficacy# in rodents and #26%# in primates, influenced by species-specific gene sequences and therapeutic efficacy differences.",
            "predicted_answer": "Base editing in the liver shows higher efficacy in mice (61%) compared to primates (26%), reflecting differences in genetic sequences and therapeutic responses between these species.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts marked with # in the reference: 61% efficacy in rodents and 26% in primates. It reflects differences due to genetic sequences and therapeutic responses, maintaining alignment with the reference without omissions or contradictions."
        },
        {
            "query_idx": 1017,
            "query": "What nuanced capability do lung fibroblast assemblages in a three-dimensional architectural framework exhibit over those in a planar configuration, especially in the context of the manifestation of TNF conduits and the subsequent NF-κB orchestral activation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1155
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Lung fibroblast #3D cultures# mimic in vivo #TNF receptor# expression and NF-κB activation patterns more closely than 2D configurations, enhancing their capability in these areas.",
            "predicted_answer": "Lung fibroblast assemblages in 3D frameworks exhibit more accurate TNF receptor expression and NF-κB activation patterns, closely mimicking in vivo conditions compared to 2D configurations.",
            "score": 5,
            "explanation": "The predicted answer captures the key aspects of lung fibroblast assemblages in 3D cultures, including better TNF receptor expression and NF-κB activation patterns compared to 2D configurations. The meaning aligns well with the reference without significant omissions or contradictions."
        },
        {
            "query_idx": 1018,
            "query": "In the multifaceted realm of drug evolution, what is the prevailing role played by models grounded in human biology, particularly in the domain of gauging substance safety, despite their inherent intricacies and nascent exploitation in swift throughput methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1159
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The prevailing role of #human-based models# is in #toxicity testing# during preclinical and clinical research, despite their complexity and limited use in high-throughput methods.",
            "predicted_answer": "Human-based models are crucial for assessing drug safety and toxicity, despite their complexity limiting high-throughput use. They are essential in preclinical and clinical stages but are still emerging in broader applications.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer in identifying human-based models' roles in drug safety and toxicity testing during preclinical and clinical stages. However, it omits mentioning their nascent use in broader high-throughput methods, affecting completeness."
        },
        {
            "query_idx": 1019,
            "query": "What impediments confront planar biological constructs in their quest to mirror the sequential maturation phenomena innate to stratified epithelial layers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1158
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Planar #biological constructs# struggle to replicate #epithelial differentiation# stages of stratified layers, such as skin, in 2D cultures.",
            "predicted_answer": "2D cell cultures cannot fully replicate the sequential maturation of stratified epithelial layers, limiting their ability to mimic the complex differentiation stages.",
            "score": 1,
            "explanation": "The predicted answer captures the key idea that planar (2D) biological constructs face challenges in replicating the sequential maturation/differentiation stages of stratified epithelial layers. However, it does not mention \"biological constructs,\" and lacks specificity regarding \"epithelial differentiation,\" thus missing more than one key fact."
        },
        {
            "query_idx": 1020,
            "query": "What is the systemic impact of the mechanical disturbances orchestrated by SARS-CoV-2 on the concerted integrity and signaling nexus of endothelial constructs within the simulated vascular milieu?",
            "retrieved_metrics": {
                "reference_idx": [
                    1161
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "SARS-CoV-2 disrupts endothelial constructs by impairing #endothelial barrier# function and increasing #pro-inflammatory cytokine# release, affecting vascular integrity and signaling.",
            "predicted_answer": "SARS-CoV-2 disrupts endothelial barrier function by perturbing vascular endothelial-cadherin junctions and increasing pro-inflammatory cytokine release, leading to systemic impacts on vascular integrity and signaling.",
            "score": 5,
            "explanation": "The predicted answer successfully captures both key facts emphasized in the reference: it mentions the disruption of \"endothelial barrier function\" and the increase of \"pro-inflammatory cytokine release.\" The overall meaning and trend align with the reference's intent, with no significant omissions."
        },
        {
            "query_idx": 1021,
            "query": "How do the intrinsic biological divergences within rodent-derived investigative frameworks impose constraints on the elucidation of Zika virus pathogenic pathways, contrasting with the enriched cerebral stratification intrinsic to human models?",
            "retrieved_metrics": {
                "reference_idx": [
                    1163
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rodent models are limited in studying #Zika virus# pathogenic pathways due to lack of an additional cortical layer with #radial glial cells# found in the human brain.",
            "predicted_answer": "Rodent models are limited in elucidating Zika virus pathogenic pathways, especially microcephaly, due to the absence of an additional cortical layer with radial glial cells, which is present in human brains.",
            "score": 5,
            "explanation": "The Predicted Answer captures all key facts emphasized in the Reference Answer, including the Zika virus, the limitation of rodent models, and the lack of radial glial cells in the additional cortical layer present in humans. The meaning is consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 1022,
            "query": "Considering the subdued presence of conventional portals like ACE2 in brain-like structures, what supplementary pathways validate their significance in enabling the invasion and amplifying the proliferation of viral elements within these neural analogs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1162
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In brain-like structures, alternative receptors #CD147# and #DPP4# enable SARS-CoV-2 invasion and proliferation, compensating for low ACE2 levels.",
            "predicted_answer": "In brain-like structures, alternative receptors such as CD147 and DPP4 play a significant role in enabling viral invasion and amplifying proliferation, supplementing the limited presence of ACE2.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key receptors #CD147# and #DPP4# as mentioned in the reference answer, which are essential in viral invasion and proliferation in brain-like structures. The overall meaning and details are consistent without omissions or contradictions."
        },
        {
            "query_idx": 1023,
            "query": "In what manner might the deployment of organ-on-chip technologies serve as a revealing lens into the complex symphony of biochemical dialogues shared between the intestinal, hepatic, and neural corridors, thereby offering novel insights into the modulation of neurodegenerative chronicles such as those observed in Parkinsonian spectrums?",
            "retrieved_metrics": {
                "reference_idx": [
                    1164
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The deployment of #organ-on-chip# technologies can elucidate biochemical interactions in the gut-liver-brain axis, offering insights into #Parkinsonian# disease modulation.",
            "predicted_answer": "Organ-on-chip technologies can model the gut-liver-brain axis, revealing how intestinal microbiome metabolites, like short-chain fatty acids, influence neurodegeneration in Parkinson's disease, providing new insights into disease mechanisms.",
            "score": 5,
            "explanation": "The predicted answer effectively captures the key facts emphasized in the reference answer, such as \"organ-on-chip technologies,\" \"gut-liver-brain axis,\" and \"Parkinsonian disease.\" It extends these by providing details about metabolites and disease mechanisms, aligning well with the reference answer's overall trend."
        },
        {
            "query_idx": 1024,
            "query": "In what manner does an endogenous feature inherent to the two-dimensional phenotypic diagnostic landscape enable the exploration and revelation of therapeutic pathways for neurodegenerative afflictions characterized by motor neuron degeneration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1166
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #2D phenotypic diagnostic landscape# facilitates the discovery of #therapeutic pathways# by enabling the identification of drugs through alterations in diseased cell phenotypes without known specific targets.",
            "predicted_answer": "The two-dimensional phenotypic diagnostic landscape enables the exploration of therapeutic pathways by screening for alterations in disease phenotypes, leading to the discovery of drugs like risdiplam and branaplam for motor neuron degeneration.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the 2D phenotypic diagnostic landscape and its role in discovering therapeutic pathways through phenotype alterations. It includes the discovery of drugs like risdiplam and branaplam, aligning with the reference's key facts, even if some details differ."
        },
        {
            "query_idx": 1025,
            "query": "Which triad of biochemically active formulations demonstrates their unparalleled capability in sophisticated tri-dimensional biological constructs, effectively halting viral penetration via a regulated gradient of concentrations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1167
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The triad of biochemically active formulations is #amodiaquine#, #toremifene#, and #clomiphene#, demonstrating capability in 3D constructs to halt viral penetration.",
            "predicted_answer": "Amodiaquine, toremifene, and clomiphene have shown effectiveness in 3D organ-on-chip cultures, demonstrating their capability in halting viral penetration.",
            "score": 5,
            "explanation": "The predicted answer lists the triad of #amodiaquine#, #toremifene#, and #clomiphene#, and notes their capability to halt viral penetration in 3D constructs. It aligns with the reference answer without omissions or contradictions, thus covering all key facts."
        },
        {
            "query_idx": 1026,
            "query": "What cascade of biological reverberations initiated by the Zika virus influences cerebral precursor entities and consequently impacts the developmental blueprint for cognitive potential, culminating in a condition of reduced cranial parameters?",
            "retrieved_metrics": {
                "reference_idx": [
                    1165
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Zika virus# targets neural progenitor cells, increasing neural cell death and reducing proliferation, thereby impacting #neurogenesis# and causing microcephaly.",
            "predicted_answer": "The Zika virus infects neural progenitor cells, increasing cell death and reducing proliferation. This hampers neurogenesis and leads to microcephaly, a condition characterized by reduced cranial parameters.",
            "score": 5,
            "explanation": "The predicted answer fully captures the key facts emphasized in the reference answer: the Zika virus targets neural progenitor cells, increases cell death, reduces proliferation, and impacts neurogenesis leading to microcephaly. Both answers are consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 1027,
            "query": "How does the complex endeavor of pinpointing potential candidates for CFTR modulator therapies manifest challenges when navigating the multifaceted genetic tapestries of cystic fibrosis individuals, especially those distinguished by uncommon mutational fabrications?",
            "retrieved_metrics": {
                "reference_idx": [
                    1171
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Pinpointing candidates for CFTR modulator therapies is challenging due to #rare mutations# in cystic fibrosis, complicating the identification of potential #responders#.",
            "predicted_answer": "Identifying potential candidates for CFTR modulator therapies is challenging due to the diverse and rare genetic mutations in cystic fibrosis patients, making it difficult to predict who will respond effectively to these treatments.",
            "score": 5,
            "explanation": "The predicted answer addresses the challenge of identifying candidates for CFTR modulator therapies due to rare genetic mutations in cystic fibrosis, capturing the essence of \"rare mutations\" and \"responders.\" The meaning aligns with the reference, covering the emphasized key facts."
        },
        {
            "query_idx": 1028,
            "query": "In what manner did the initial exploratory methodologies, traversing the intricate domain of molecular targeting, manifest the therapeutic potential of amivantamab within patient-derived cellular structures containing the EGFR Exon20ins mutation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1170
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The initial methods successfully tested #amivantamab#'s efficacy using patient-derived cells with #EGFR Exon20ins# mutations, enhancing therapeutic potential and leading to clinical trial replication and approval.",
            "predicted_answer": "Initial exploratory methodologies, including preclinical tests in patient-derived cells and organoids with EGFR Exon20ins mutations, demonstrated amivantamab's therapeutic potential by showing its efficacy where standard tyrosine kinase inhibitors were ineffective.",
            "score": 3,
            "explanation": "The Predicted Answer covers amivantamab's therapeutic potential evaluated in patient-derived cells with EGFR Exon20ins mutations. It aligns with the Reference Answer but lacks details on clinical trial replication and approval. Overall, it reflects key facts but misses one critical detail."
        },
        {
            "query_idx": 1029,
            "query": "Through what mechanisms did the biochemical agent azeliragon exert its dampening effect on intensified pro-inflammatory cascades observed within the alveolar biomimetic systems in the context of severe COVID-19 manifestations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1168
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Azeliragon exerted its dampening effect by #suppressing# the overshooting of inflammatory responses via inhibition of the receptor for advanced glycation end products (#RAGE#).",
            "predicted_answer": "Azeliragon exerted its dampening effect by inhibiting the RAGE receptor, thereby suppressing the overshooting of inflammatory responses in alveolar biomimetic systems during severe COVID-19.",
            "score": 5,
            "explanation": "The predicted answer includes the suppression of inflammatory responses and identifies the RAGE receptor as the target, aligning with the reference answer. All key facts, such as \"suppressing\" and \"RAGE,\" are present, with no significant omissions or contradictions. The overall trend is consistent."
        },
        {
            "query_idx": 1030,
            "query": "What are the nuanced mechanisms through which ephemeral carbon compounds subtly influence the orchestration of oxidative death pathways within cerebral constructs pertaining to Parkinsonian perturbations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1174
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ephemeral carbon compounds, such as #short-chain fatty acids#, subtly influence oxidative death pathways by increasing the expression of pathways related to #ferroptosis# in Parkinson disease models.",
            "predicted_answer": "Short-chain fatty acids, as ephemeral carbon compounds, influence oxidative death pathways in Parkinson's disease by increasing the expression of ferroptosis-related pathways, leading to dopaminergic cell death.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies both key points from the reference: \"short-chain fatty acids\" and \"ferroptosis-related pathways\" relevant to Parkinson's disease. The information is consistent, contains no contradictions, and fully covers the emphasized details."
        },
        {
            "query_idx": 1031,
            "query": "In what manner can the skewed gender dynamics within the nascent phase of clinical experimentation impede the balance of pharmacological insights, and how might bespoke paradigms of disease modeling serve to rectify these inherent disparities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1177
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Skewed #gender dynamics# in early clinical trials impair #pharmacological# balance, as differences in drug metabolism are overlooked. Bespoke disease modeling can address these disparities by highlighting individual differences.",
            "predicted_answer": "Skewed gender dynamics in early clinical trials, with women often underrepresented due to reproductive toxicity risks, can lead to imbalanced pharmacological insights. Bespoke disease models from both sexes and diverse ethnicities can help identify inter-individual differences, improving drug efficacy and safety.",
            "score": 3,
            "explanation": "The predicted answer captures the key aspects of skewed gender dynamics in early clinical trials and their impact on pharmacological insights, as emphasized in the reference. It mentions bespoke disease models addressing individual differences. However, it doesn't detail drug metabolism differences, missing a key fact."
        },
        {
            "query_idx": 1032,
            "query": "How do the ineffable waves of temporal variability resist harmonization within the conceptual frameworks of direct and allometric dimensional adjustments, thereby complicating the task of aligning the rhythmic symphony of physiological model simulations with real-world temporal cadences?",
            "retrieved_metrics": {
                "reference_idx": [
                    1178
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #ineffable waves# of temporal variability resist harmonization because #direct and allometric scaling# do not account for time scale, complicating physiological model simulation alignment with real-world temporal cadences.",
            "predicted_answer": "Temporal variability resists harmonization because direct and allometric scaling methods do not account for time scales, leading to inaccuracies in simulating physiological processes' real-world temporal dynamics.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts of \"ineffable waves,\" \"temporal variability,\" \"direct and allometric scaling,\" and the issue of time scale alignment with real-world dynamics. It aligns with the reference and contains no significant omissions or contradictions."
        },
        {
            "query_idx": 1033,
            "query": "What underlying mechanisms intrinsic to organ-on-chip constructs allow for a nuanced orchestration of interconnected human system analogs, enabling them to transcend conventional paradigms in replicating intricate disease phenomena in vitro?",
            "retrieved_metrics": {
                "reference_idx": [
                    1160
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #interconnected human organs# in organ-on-chip constructs enable nuanced orchestration, allowing them to emulate intricate disease phenomena through #complex communication and interactions#.",
            "predicted_answer": "Organ-on-chip constructs use interconnected human system analogs and automated biophysical processes like chip perfusion to monitor tissue function in real time, enabling a nuanced replication of complex disease phenomena in vitro.",
            "score": 3,
            "explanation": "The predicted answer includes \"interconnected human system analogs,\" aligning with \"interconnected human organs\" in the reference. It also involves replicating \"complex disease phenomena,\" but lacks mention of \"complex communication and interactions.\" Therefore, it misses one key detail but generally aligns with the trend."
        },
        {
            "query_idx": 1034,
            "query": "What biological simulation parameters are typically employed within the frameworks of functional scaling to ensure that these miniaturized biological echoes achieve a level of physiological mimicry with their larger organ counterpart, particularly in terms of essential operational metrics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1179
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Miniaturized biological models require careful calculation of #perfusion, diffusion, permeation, nutrient, and metabolic rates# to match key functional indices like drug clearance or filtration rates for physiological mimicry.",
            "predicted_answer": "In functional scaling, parameters such as perfusion, diffusion, permeation, nutrient and metabolic rates, and their dosages are carefully calculated to match key functional indices, like drug clearance rate for the liver or filtration rate for the kidney, ensuring physiological mimicry.",
            "score": 5,
            "explanation": "The predicted answer effectively captures all key facts emphasized in the reference answer, such as perfusion, diffusion, permeation, nutrient, and metabolic rates, and the need to match key functional indices, aligning with the reference's intent. There are no omissions or contradictions."
        },
        {
            "query_idx": 1035,
            "query": "In what manner do the orchestrated symbiosis of physiological mechanical forces refine the harmonic orchestration of cellular contractions and the accelerated relay of electrical currents in artificially crafted myocardial replicas?",
            "retrieved_metrics": {
                "reference_idx": [
                    1181
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #contractility# and #conduction velocity# of bioengineered heart tissue are improved by mechanical forces mimicking cardiac preload and afterload.",
            "predicted_answer": "Mechanical forces refine cellular contractions and electrical conduction in bioengineered heart tissue by improving contractility, cell alignment, and conduction velocity, mimicking natural cardiac conditions.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"contractility\" and \"conduction velocity,\" aligning with the reference answer. It also mentions the overall trend of mechanical forces mimicking natural cardiac conditions. Thus, all key aspects are present, with no significant omissions, matching the reference's intent."
        },
        {
            "query_idx": 1036,
            "query": "What strategies does the similarity scaling paradigm employ, utilizing the interconnected tapestry of algebraic constructs, to reconcile the fluidic orchestration in OoC architectures with the temporal coordination required for drug administration scenarios?",
            "retrieved_metrics": {
                "reference_idx": [
                    1180
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The similarity scaling paradigm employs #dimensional analysis# and #similitude# to reconcile fluidic orchestration with temporal coordination in OoC architectures, using algebraic constructs to balance input variables and parameters.",
            "predicted_answer": "The similarity scaling paradigm uses dimensional analysis and similitude to balance competing key indices in multi-OoC setups, ensuring proper metabolic rates and drug exposure times by systematically linking algebraic constructs.",
            "score": 5,
            "explanation": "The Predicted Answer successfully includes the key facts emphasized with # symbols: \"dimensional analysis\" and \"similitude,\" as used in the Reference Answer. While the wording differs, the fundamental concepts and their roles in the similarity scaling paradigm are accurately conveyed without contradictory information."
        },
        {
            "query_idx": 1037,
            "query": "Through what complex interplay do modifications in the structural codes of the desmoplakin gene steer the methodological symphony of biomechanical determinants in the crafted landscapes of myocardial disruptions, further impacting the nuanced calibrations involved in electing prototypical model archetypes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1182
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Modifications in the #desmoplakin gene# cause cardiomyopathy, emphasizing the need for biomechanical cues in model selection, impacting prototypical model archetypes for myocardial disruptions.",
            "predicted_answer": "Mutations in the desmoplakin gene lead to cardiomyopathy, characterized by heart muscle thickening and stiffening, causing cardiac dysfunction. These changes influence the selection of bioengineered models that can integrate relevant biomechanical cues.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the role of the desmoplakin gene in causing cardiomyopathy and mentions the influence on model selection. However, it misses the nuance of how these modifications emphasize the need for biomechanical cues, impacting prototypical model archetypes. One key fact is missing."
        },
        {
            "query_idx": 1038,
            "query": "How do the interconnected predicaments presented by the employment of zoological proxies and sophisticated synthetic human constructs surface, especially in the enigmatic endeavor of mapping human physiological distortions, amid the shared anatomical features and complex biological architectures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1185
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Interconnected predicaments arise due to #translational failure# in animal models and uncertainty in bioengineered constructs' #predictive# capacity for human pathophysiology despite shared anatomical features.",
            "predicted_answer": "The use of zoological proxies and synthetic human constructs in biomedical research faces challenges in accurately mapping human physiological responses due to differences in biological complexity and translational failures, despite shared anatomical features.",
            "score": 3,
            "explanation": "The predicted answer captures the overall trend of challenges with translational failures and limitations of synthetic constructs, consistent with the reference. However, it misses the specific mention of \"predictive capacity,\" affecting completeness. While aligned in trend, it lacks one key fact."
        },
        {
            "query_idx": 1039,
            "query": "What are the mechanistic frameworks through which the intensified expression of transcriptional orchestrators like ETV2 and NGN1 recalibrates the biological programming needed to expedite the metamorphosis of pluripotent cellular terrains into structured tissue matrices?",
            "retrieved_metrics": {
                "reference_idx": [
                    1186
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The overexpression of #ETV2# and #NGN1# activates rapid cell differentiation, expediting the formation of multicellular and spatially patterned organoids without external cues.",
            "predicted_answer": "The overexpression of transcription factors like ETV2 and NGN1 rapidly activates specific genetic programs, guiding pluripotent cells to differentiate into structured tissues such as endothelial cells or neurons, thus expediting the formation of organized tissue matrices.",
            "score": 3,
            "explanation": "The predicted answer captures the overexpression of ETV2 and NGN1 and their role in cell differentiation and tissue formation. However, it omits the reference's detail about the formation of organoids without external cues, which is a key fact impacting completeness."
        },
        {
            "query_idx": 1040,
            "query": "What nuanced impediments impede the seamless integration of tailored biomedical constructs such as PDOs into the broad spectrum of clinical methodologies, considering their establishment efficiency and expansion duration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1187
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #low efficiency# of PDO establishment and their #lengthy generation# and expansion times impede integration into clinical methodologies.",
            "predicted_answer": "The main impediments include low establishment efficiencies (60-70% success rate) and lengthy generation and expansion times, which can span several weeks or months. These factors hinder the seamless integration of PDOs into clinical methodologies.",
            "score": 5,
            "explanation": "The Predicted Answer fully covers the key facts from the Reference Answer: #low efficiency# and #lengthy generation# times are both mentioned, with additional detail provided on establishment efficiency percentages. There are no omissions or contradictions, and the overall trend is consistent."
        },
        {
            "query_idx": 1041,
            "query": "Within the intricate tapestry of bioengineering practices, what pivotal act of diligent scrutiny, central to verifying the primacy or equivalence of anthropogenic constructs vis-à-vis natural forms, remains frequently eclipsed though critical?",
            "retrieved_metrics": {
                "reference_idx": [
                    1188
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rigorous #disease model validation# is pivotal for verifying the #equivalence# or superiority of anthropogenic constructs over natural forms, yet often remains neglected.",
            "predicted_answer": "Rigorous disease model validation, essential for verifying the equivalence or superiority of human disease models over animal-based counterparts, is a critical yet frequently neglected task in bioengineering.",
            "score": 5,
            "explanation": "The predicted answer includes \"rigorous disease model validation\" and the concept of verifying \"equivalence or superiority\" of anthropogenic constructs, aligning well with the reference. There are no omissions or contradictory information. All key information in the reference answer is present in the predicted answer."
        },
        {
            "query_idx": 1042,
            "query": "Within the spectrum of engineered emulations for physiological simulation, what intrinsic barriers and operational confines inhibit commercially sourced organotypic platforms from effectively encapsulating tridimensional biological matrices and tailoring models for investigatory pathology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1191
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Commercially# available organotypic platforms are costly, lack #customization#, focus on preclinical safety, and predetermined chips limit integration and dimensions, inhibiting effective 3D tissue modeling.",
            "predicted_answer": "Commercially sourced organotypic platforms face barriers such as high costs, limited customization, and preset chip configurations that restrict the types and dimensions of tissues. These constraints hinder effective 3D biological matrix encapsulation and tailored disease modeling.",
            "score": 3,
            "explanation": "The predicted answer includes several key facts from the reference answer, such as costliness, lack of customization, and limitations due to predetermined chip configurations. However, it misses mention of the focus on preclinical safety. Given this omission, the score reflects missing one key detail."
        },
        {
            "query_idx": 1043,
            "query": "What intrinsic scholarly reservations are there that discourage the adoption of microenvironmental platforms by the scientific community, and how might the creation of centralized hubs of innovation alleviate such impediments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1194
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Scholarly reservations include #high costs# and lack of ready-to-use systems. #Centralized hubs# offering training and models can help reduce these barriers and promote adoption.",
            "predicted_answer": "Scholarly reservations include lack of ready-to-use systems, high entry barriers, and costs. Centralized hubs can alleviate these by providing hands-on training, accessible tissue models, and scientific support, thus lowering barriers and promoting wider adoption.",
            "score": 5,
            "explanation": "The Predicted Answer includes key facts like \"lack of ready-to-use systems\" and \"high costs,\" both highlighted in the Reference Answer. It also mentions \"centralized hubs\" providing solutions, aligning with the Reference Answer's trend. The prediction explains the solutions in more detail without contradictions."
        },
        {
            "query_idx": 1044,
            "query": "What are the pivotal waypoints in the intricate journey of integrating human disease simulation constructs within the realms of preclinical and clinical drug crafting, ensuring their transformative essence is harnessed effectively?",
            "retrieved_metrics": {
                "reference_idx": [
                    1195
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Meeting key milestones such as #validation criteria#, benchmarking, regulatory approval, and standardized manufacturing processes are pivotal in integrating human disease simulation constructs in drug development effectively.",
            "predicted_answer": "Key waypoints include defining robust validation criteria, benchmarking against in vivo data, obtaining regulatory approval, and establishing scalable, standardized manufacturing processes. Different models like organoids and OoCs are suited for various applications, from high-throughput screenings to safety and efficacy testing.",
            "score": 5,
            "explanation": "The Predicted Answer covers all key facts: validation criteria, benchmarking, regulatory approval, and standardized manufacturing processes. It aligns with the Reference Answer, with additional context on different models' applications, which does not contradict the reference. All key points emphasized with # are present."
        },
        {
            "query_idx": 1045,
            "query": "What orchestrated endeavor, conceived in the year 2013, seeks to transform the landscape of scrutinizing new pharmaceuticals' arrhythmogenic risks, and which entities comprise its collective genius?",
            "retrieved_metrics": {
                "reference_idx": [
                    1193
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #CiPA initiative#, conceived in #2013#, aims to improve assessing arrhythmogenic risks of new drugs, involving regulatory authorities, pharmaceutical companies, and academics.",
            "predicted_answer": "The CiPA initiative, launched in 2013, aims to improve the assessment of new drugs' arrhythmogenic risks. It includes regulatory authorities like the FDA and EMA, pharmaceutical companies, and academics.",
            "score": 5,
            "explanation": "The 'Predicted Answer' matches the 'Reference Answer' on key facts: the CiPA initiative, launched in 2013, aims to improve arrhythmogenic risk assessment of new drugs and involves regulatory authorities, pharmaceutical companies, and academics. All key facts are present, and no significant details are missing."
        },
        {
            "query_idx": 1046,
            "query": "What sophisticated genomic deciphering technique empowers the molecular landscape cartography needed for unveiling elusive cellular ensembles and unraveling pivotal cellular genetic catalysts within disease genesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    1190
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Single-cell RNA-seq# empowers genomic deciphering by profiling individual cells, identifying #rare cell populations#, and detecting cell type-specific driver genes in disease.",
            "predicted_answer": "Single-cell RNA-seq is a sophisticated technique that enables whole-transcriptome profiling of individual cells, identifying rare cell populations and cell type-specific driver genes crucial for understanding disease genesis.",
            "score": 5,
            "explanation": "The predicted answer and reference answer both highlight single-cell RNA-seq as the technique in question. Both answers mention its role in profiling individual cells, identifying rare cell populations, and detecting cell type-specific driver genes in disease, covering all the key facts. Therefore, there are no significant omissions."
        },
        {
            "query_idx": 1047,
            "query": "What nuanced limitations curtail the forward trajectory of single-cell proteomics in its endeavor to decode the elaborate symphonies of cellular individuality, in contrast to the encompassing scope of bulk-level proteomic methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1192
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Single-cell proteomics face limitations such as #expensive# and time-consuming measurements and a #limited dynamic range#, resulting in low throughput compared to bulk-level methodologies.",
            "predicted_answer": "Single-cell proteomics faces limitations such as high costs, time-consuming measurements, and a limited dynamic range, which restrict its throughput and ability to capture cellular heterogeneities compared to bulk-level methods.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts from the reference answer: \"expensive\" and \"time-consuming measurements\" as well as a \"limited dynamic range.\" Both answers also align on the theme of low throughput in single-cell proteomics, thus reflecting a complete and accurate match."
        },
        {
            "query_idx": 1048,
            "query": "What emblematic indicators operate as surrogates representing the spectrum of research and development exertions contained within the oncological dataset's analysis of malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1201
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Clinical trials per year#, the #number of enrolled patients#, and the duration of clinical trials represent R&D efforts in the oncological dataset's analysis.",
            "predicted_answer": "Emblematic indicators include the number of clinical trials, enrolled patients, and trial durations, which represent R&D efforts. Need-related variables like prevalence, incidence, and survival rates also provide context for the oncological dataset's analysis.",
            "score": 3,
            "explanation": "The predicted answer closely aligns with the reference answer by mentioning the key facts of \"#number of enrolled patients#\" and \"#trial durations#\". However, it lacks the specific reference to \"#clinical trials per year#\", thus missing one key fact emphasized in the reference."
        },
        {
            "query_idx": 1049,
            "query": "What are the intricate roles of each foundational strand within the diverse tapestry of data amalgamation, which collectively construct the analytical paradigm for cancer type exploration, conceived within the temporal investigation spectrum of 1996 to 2016?",
            "retrieved_metrics": {
                "reference_idx": [
                    1202
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Each #foundational strand# provides data: Clinicaltrial.gov on #trial numbers#, Orpha.net on rare cancer trials, and Rarecarenet.eu on epidemiological stats for 2007, collectively informing cancer type analysis.",
            "predicted_answer": "The foundational strands include Clinicaltrial.gov for clinical trial registries, Orpha.net for rare cancer trials, and Rarecarenet.eu for epidemiological data, collectively enabling comprehensive cancer type analysis from 1996 to 2016.",
            "score": 1,
            "explanation": "The predicted answer captures the foundational strands mentioned in the reference, but it does not mention \"trial numbers\" for Clinicaltrial.gov or specify \"epidemiological stats for 2007\" for Rarecarenet.eu. These omissions impact the completeness of the answer, but the overall trend is aligned."
        },
        {
            "query_idx": 1050,
            "query": "What reconfiguration of focus trajectories for clinical trials delineating rare oncology phenomena can be discerned across each investigatory echelon subsequent to legislative enactment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1205
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "After the legislation, clinical trials maintained #pro-low need# inequity for non-rare cancers, but transitioned to #pro-high need# focus in all phases for rare cancers.",
            "predicted_answer": "After the legislation, clinical trials for rare cancers shifted focus towards high-need areas across all phases, while non-rare cancers maintained pro-low need inequity, except in phases 2 and 3.",
            "score": 3,
            "explanation": "The predicted answer captures the shift towards \"pro-high need\" focus for rare cancers in all phases, aligning with the reference. However, it states non-rare cancers maintained \"pro-low need\" inequity but incorrectly suggests an exception in phases 2 and 3, slightly misaligning with the reference."
        },
        {
            "query_idx": 1051,
            "query": "What implication arises from an empirical measure indicating maximal deviation towards the lesser necessity spectrum within oncological investigative frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1203
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The implication is a #pro-low need inequality#, meaning research is heavily focused on #low-need cancers#, as indicated by the maximal deviation in the empirical measure.",
            "predicted_answer": "An empirical measure indicating maximal deviation towards the lesser necessity spectrum suggests a pro-low need inequality, where research is heavily concentrated on cancers with lower prevalence, incidence, or survival needs.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts: \"pro-low need inequality\" and the focus on \"low-need cancers.\" It mirrors the implication derived from the empirical measure as stated in the reference. The information is consistent and no critical details are missing."
        },
        {
            "query_idx": 1052,
            "query": "What are the multifarious obstacles to the pursuit of novel trajectories in oncology innovation, considering the intricate web of technical complexities and disparities that manifest within clinical investigation landscapes and therapeutic formulation odysseys?",
            "retrieved_metrics": {
                "reference_idx": [
                    1207
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The pursuit of novel oncology trajectories faces obstacles like #technical complexity# in disease understanding and inequities in clinical trial distribution and investment.",
            "predicted_answer": "Obstacles in oncology innovation include technical complexities, disparities in clinical trial distribution, and varying levels of disease understanding. These factors, along with the imperfect measures of unmet cancer needs, contribute to the challenges in developing novel therapeutic approaches.",
            "score": 5,
            "explanation": "The predicted answer captures \"technical complexities\" and \"disparities in clinical trial distribution,\" which are emphasized in the reference. Although it adds elements like \"varying levels of disease understanding\" and \"imperfect measures,\" it does not contradict key facts. Both answers focus on hurdles in oncology innovation."
        },
        {
            "query_idx": 1053,
            "query": "What strategies do intelligence-enhanced decision ecosystems adopt in harnessing immediate clinical data flows to refine therapeutic pathways and foster patient compliance landscapes using prognosis-centric analytical frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1221
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intelligence-enhanced decision ecosystems use #AI# to integrate real-time clinical data to adapt therapeutic interventions, ensuring timely treatment modifications for improved #patient compliance#.",
            "predicted_answer": "Intelligence-enhanced decision ecosystems use real-time clinical data, such as treatment toxicities and patient-reported outcomes, to direct adaptive interventions. AI-driven systems detect complications early, allowing for timely treatment adjustments and improving patient adherence and comfort.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer by recognizing the use of real-time clinical data and AI-driven adjustments to interventions. It covers the emphasis on AI, data integration, adaptation, and improved patient adherence (compliance), without contradictions or significant omissions."
        },
        {
            "query_idx": 1054,
            "query": "What sophisticated frameworks and methodological blueprints should healthcare entities orchestrate to preserve the sanctity of patient information, thereby ensuring these defensive structures synergize with existing legislative tenets like HIPAA, amidst the transformative influences of AI in healthcare?",
            "retrieved_metrics": {
                "reference_idx": [
                    1223
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Healthcare entities should implement #encryption# and #anonymization# methods along with access controls to safeguard patient data, ensuring compliance with HIPAA and addressing AI-related challenges like algorithmic bias and accountability.",
            "predicted_answer": "Healthcare entities should implement encryption, anonymization, and access controls to protect patient data. They must also adhere to HIPAA and other legal requirements, ensuring that these measures align with ethical standards and evolving AI regulations.",
            "score": 3,
            "explanation": "The predicted answer includes key facts of encryption, anonymization, and access controls, aligning generally with the reference. However, it omits the specific mention of \"algorithmic bias and accountability,\" which affects completeness. It aligns with the overall trend without contradictions."
        },
        {
            "query_idx": 1055,
            "query": "What complex and perhaps unforeseen paradigms might manifest from the intertwining of artificial cognition into the sanctified tapestry of healthcare decision-making, stepping beyond the realm of algorithmic impartiality and the limitations of representational datasets?",
            "retrieved_metrics": {
                "reference_idx": [
                    1226
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The integration of #AI# in healthcare may raise concerns about #algorithmic bias#, challenge medical norms, and question accountability, autonomy, and fairness in decision-making processes.",
            "predicted_answer": "The intertwining of artificial cognition in healthcare decision-making may lead to complex paradigms, including algorithmic bias, accountability issues, and challenges to professional autonomy. It could also perpetuate disparities and raise ethical concerns about fairness and liability.",
            "score": 5,
            "explanation": "The predicted answer captures key facts such as \"algorithmic bias,\" \"accountability,\" and \"autonomy,\" aligning with the reference answer's emphasis on these risks. Additional details concerning disparities and ethical concerns are contextually relevant, enhancing the overall alignment without contradicting the reference."
        },
        {
            "query_idx": 1056,
            "query": "What mechanisms of cognitive convergence, enabled by digital harmonization strategies, influence the orchestration of innovative data conduits within clinical trial ecosystems, particularly in fostering dynamic trial blueprints and participatory recruitment paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1227
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Digital harmonization mechanisms, like #Federated Learning#, enable collaboration, ensuring #privacy# and enhancing clinical trials through dynamic designs and participatory recruitment while integrating real-world data effectively.",
            "predicted_answer": "Federated learning and AI integration with real-world data, such as from wearables and EHRs, enable dynamic trial blueprints and enhance participatory recruitment by improving data sharing, privacy, and real-time monitoring.",
            "score": 5,
            "explanation": "The predicted answer covers key facts like \"federated learning\", ensuring \"privacy\", and enhancing clinical trials through \"dynamic trial blueprints\" and \"participatory recruitment\" with real-world data. All significant points in the reference are addressed, aligning well with the overall trend."
        },
        {
            "query_idx": 1057,
            "query": "Within the intricate weave of digital equitability, what pivotal systemic conundrum must be unraveled to prevent digital architectures from exacerbating well-being imbalances across oncological realms, particularly concerning marginalized cohorts dwelling within the societal health spectrum?",
            "retrieved_metrics": {
                "reference_idx": [
                    1228
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A pivotal systemic conundrum is addressing #algorithmic bias# to prevent AI-driven healthcare disparities among #marginalized# groups, ensuring equitable access and fairness.",
            "predicted_answer": "The pivotal systemic conundrum is algorithmic bias and fairness. Addressing this ensures that digital architectures, especially AI in oncology, do not exacerbate well-being imbalances for marginalized groups.",
            "score": 3,
            "explanation": "The predicted answer mentions both \"algorithmic bias\" and the impact on \"marginalized groups,\" which are the key points emphasized in the reference answer. However, it misses \"AI-driven healthcare disparities\" and the aspect of ensuring \"equitable access.\" Thus, it is complete but missing an important detail."
        },
        {
            "query_idx": 1058,
            "query": "In the intricate interplay of artificial intelligence and oncological exploration, what role does the synthesis of diverse biomolecular spectra play in unraveling the concealed genesis and acceleration of neoplastic conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1231
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The synthesis of diverse biomolecular spectra in AI-assisted cancer research aids in unveiling the #genesis# and #progression# of neoplastic conditions through multi-omics integration.",
            "predicted_answer": "The synthesis of diverse biomolecular spectra, through multi-omics integration, plays a crucial role in uncovering the complex mechanisms driving cancer initiation and progression, enabling more precise and effective treatment strategies.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by recognizing the importance of multi-omics integration. It covers the key concepts, \"genesis\" and \"progression\" of cancer, although with different wording. No significant details are missing or contradictory, ensuring completeness and consistency with the reference."
        },
        {
            "query_idx": 1059,
            "query": "How might the composite realignment of trust toward AI-empowered diagnostic architectures be nurtured in the intricate weave of clinical practice, especially amidst the prevailing reservations concerning their analytic fidelity and operational pertinence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1240
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "To nurture trust in AI-diagnostic systems, clinicians need #education# and evidence of #effectiveness#, alongside collaboration and training to enhance integration into clinical practice.",
            "predicted_answer": "To nurture trust in AI-empowered diagnostics, clinicians should be educated on the technology's accuracy and clinical utility, provided with evidence of its effectiveness, and encouraged to collaborate. Support and training are essential to address their reservations.",
            "score": 5,
            "explanation": "The Predicted Answer captures the key facts such as the importance of education, evidence of effectiveness, collaboration, and training, which align well with the Reference Answer. The trends are aligned, and there are no significant omissions or contradictions."
        },
        {
            "query_idx": 1060,
            "query": "What role does the metaphorical 'battlefront' of rampant cellular upheaval play in magnifying both the inherent deadliness of cancer and the labyrinthine obstacles encountered by therapeutic endeavors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1242
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The metaphorical 'battlefront' of #cellular upheaval# magnifies cancer's #deadliness# and complicates therapeutic efforts by contributing to metastasis and treatment challenges like drug resistance.",
            "predicted_answer": "The 'battlefront' of cellular upheaval in cancer refers to the rapid, uncontrolled growth and spread of abnormal cells. This not only increases cancer's deadliness through metastasis but also complicates treatment by creating barriers like drug resistance and high toxicity.",
            "score": 5,
            "explanation": "The predicted answer includes key concepts from the reference: 'cellular upheaval,' cancer's 'deadliness' through metastasis, and treatment challenges like 'drug resistance.' The overall meaning aligns with the reference, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1061,
            "query": "Amidst the intricate tapestry of marine-sourced pharmaceutical innovations, celebrated for their therapeutic diversity, what is the particular proportion attributable to these compounds that actively engage in the suppression of oncogenic cell expansion?",
            "retrieved_metrics": {
                "reference_idx": [
                    1244
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#11# out of #20# clinically used drugs derived from marine sources exhibit antitumor effects, representing the proportion actively engaging in the suppression of oncogenic cell expansion.",
            "predicted_answer": "Of the 20 marine-sourced drugs used clinically, 11 exhibit antitumor effects, which is 55% of the total.",
            "score": 5,
            "explanation": "The predicted answer contains all the key facts highlighted by the # symbols in the reference answer, including \"11 out of 20\" and the proportion of marine-sourced drugs with antitumor effects, i.e., 55%. The prediction aligns well with the reference without omissions or contradictions."
        },
        {
            "query_idx": 1062,
            "query": "In what manner do the technological constructs of AI-enhanced liquid biopsy systems partake in the symphony of medical anticipation, interpreting genomic narratives and biological exchanges to recalibrate therapeutic pathways for those contending with cancer's manifold transformations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1249
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "AI-enhanced liquid biopsy systems interpret genomic and biological changes, tracking #tumor biology# and #genomic evolution#, enabling early intervention and adaptive cancer treatment strategies.",
            "predicted_answer": "AI-enhanced liquid biopsy systems analyze ctDNA, CTCs, and other biomarkers in blood to track treatment response, detect minimal residual disease, and identify resistance mechanisms, enabling timely adjustments in cancer therapy.",
            "score": 3,
            "explanation": "The Predicted Answer is aligned with the overall trend of the Reference Answer. It mentions tracking treatment response, identifying resistance mechanisms, and adjusting cancer therapy, which correlates with enabling early intervention and adaptive treatment. However, it misses explicit mention of tracking #tumor biology# and #genomic evolution#."
        },
        {
            "query_idx": 1063,
            "query": "How does the presence of the interlocking carbonyl component enhance the adaptive interplay of topsentin compounds as they navigate the molecular landscape of the CDK1 enzymatic core?",
            "retrieved_metrics": {
                "reference_idx": [
                    1255
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #carbonyl# component enhances topsentin compounds' #flexibility#, allowing better adaptation and interaction with the CDK1 enzymatic core through hydrogen bonding at the ATP binding site.",
            "predicted_answer": "The interlocking carbonyl component in topsentin compounds enhances their flexibility and adaptability, allowing them to better fit the ATP binding site of CDK1 and interact with amino acid residues, improving their effectiveness.",
            "score": 5,
            "explanation": "The predicted answer includes the #carbonyl# component and #flexibility# as in the reference, highlighting its role in adapting and interacting with the CDK1 ATP binding site. While not explicitly mentioning hydrogen bonding, it describes interactions with amino acid residues. No key facts are missing."
        },
        {
            "query_idx": 1064,
            "query": "Among the synthesized derivatives engaged in the biochemical odyssey of enhancing cellular adversity, which entity achieves the pinnacle of extermination capacity against P388 cellular life, as discerned through comparative subjugation indices?",
            "retrieved_metrics": {
                "reference_idx": [
                    1254
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Analogue #8# achieves the pinnacle of extermination capacity against P388 cells with an IC$\\_{50}$ value of #0.3 µg/mL#.",
            "predicted_answer": "Among the analogues, compound 8 with an IC50 value of 0.3 µg/mL shows the highest extermination capacity against P388 cells.",
            "score": 5,
            "explanation": "The predicted answer identifies compound 8 and specifies its IC50 value as 0.3 µg/mL for P388 cells, directly aligning with the key facts emphasized in the reference. Both key facts, analogue number and IC50 value, are correctly reflected without contradictions or omissions."
        },
        {
            "query_idx": 1065,
            "query": "In the nuanced orchestration of molecular transformations within human mammary carcinoma expressions, which processes are intricately interwoven with the symphonic cessation of cellular vitality, prompted by extrinsic catalysts and evidenced through phenomena such as membrane phosphatidylserine externalization, chromatin textural condensation, and cellular cycle phase modulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1267
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The processes intricately involved are #apoptosis# promotion, involving phosphatidylserine externalization, chromatin condensation, and cell cycle modulation to the #G0-G1 phase#.",
            "predicted_answer": "The processes intricately involved include apoptosis, characterized by phosphatidylserine externalization and chromatin condensation, and cell cycle arrest at the G0-G1 phase, all triggered by extrinsic factors.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts of apoptosis, phosphatidylserine externalization, chromatin condensation, and cell cycle arrest at the G0-G1 phase, as denoted by # symbols in the reference. It aligns well with the overall trend with no significant omissions or contradictions."
        },
        {
            "query_idx": 1066,
            "query": "What mechanistic symphony do the molecular virtuosos numbered 49, 50, and 51 conduct upon the cyclical cadence of the MCF-7 cell populace's proliferative journey?",
            "retrieved_metrics": {
                "reference_idx": [
                    1269
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Derivatives #49#, #50#, and 51 promote apoptosis, disrupt the cell cycle, reduce G0/G1 and S phase cells, and increase G2/M phase cells in MCF-7 cells.",
            "predicted_answer": "Compounds 49, 50, and 51 disrupt the MCF-7 cell cycle by reducing G0/G1 and S phase cells, increasing G2/M phase cells, and promoting apoptosis, effectively inhibiting cell proliferation.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized in the reference answer: promoting apoptosis, disrupting the cell cycle, reducing G0/G1 and S phase cells, and increasing G2/M phase cells. The overall trend of inhibiting cell proliferation is consistent in both answers."
        },
        {
            "query_idx": 1067,
            "query": "What precise quantitative threshold characterizes the subtle inhibitory discourse of Dendridine A when engaging with the cellular domain of murine leukemia L1210 specimens?",
            "retrieved_metrics": {
                "reference_idx": [
                    1281
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Dendridine A exhibits weak cytotoxicity to mouse leukemia L1210 cells, characterized by an IC$\\_{50}$ of #32.5 µg/mL#.",
            "predicted_answer": "Dendridine A exhibits weak cytotoxicity to murine leukemia L1210 cells, with an IC50 of 32.5 µg/mL.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key numerical detail emphasized in the reference answer, specifically the IC50 value of 32.5 µg/mL. Both answers describe the same weak cytotoxicity effect on murine leukemia L1210 cells, maintaining consistency in the overall trend and key information."
        },
        {
            "query_idx": 1068,
            "query": "Through which intricate biochemical symphony does staurosporine attenuate a molecular pathway, thus modulating the intrinsic resistance mechanisms of neoplastic cells to bolster their susceptibility to cisplatin's cytotoxic impact?",
            "retrieved_metrics": {
                "reference_idx": [
                    1284
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Staurosporine attenuates molecular pathways by #down-regulating# the #p62# mechanism, enhancing cancer cell susceptibility to cisplatin's cytotoxic effects.",
            "predicted_answer": "Staurosporine sensitizes cancer cells to cisplatin by down-regulating the p62 mechanism, which helps overcome cisplatin resistance and enhances its cytotoxic impact.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies staurosporine down-regulating the p62 mechanism, aligning with the reference answer. Both discuss enhancing susceptibility to cisplatin, maintaining the trend without omissions. Key facts are fully covered, with no contradictions."
        },
        {
            "query_idx": 1069,
            "query": "Within the spectrum of molecular engagements and cellular interplay, what represent the quantitative determinations of efficacy for compounds 100 and 101 in the cellular microenvironment of human cervical neoplasms? Moreover, do these molecular forms induce any perturbations within the intrinsic stability of HEK-293 cellular frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1282
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compounds 100 and 101 have #IC₅₀ values# of 4.6 µM and #1.3 µM# in human cervical cancer cells, respectively, showing no cytotoxicity in HEK-293 cell lines.",
            "predicted_answer": "Compounds 100 and 101 show significant antiproliferative activity against human cervical cancer cell lines, with IC50 values of 4.6 and 1.3 µM, respectively. They do not induce cytotoxic effects on HEK-293 cells, indicating no perturbations in their intrinsic stability.",
            "score": 5,
            "explanation": "The predicted answer adequately covers the key facts from the reference answer, including the IC50 values (4.6 µM and 1.3 µM) and the lack of cytotoxic effects on HEK-293 cells. The meaning and key facts align with the reference, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1070,
            "query": "How do the cytostatic thresholds embodied in the IC₅₀ values of biochemical entities dubbed A and B elucidate their varying potency in breaching the cellular defenses of KB cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1283
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Chondriamide #A# exhibits greater potency with an IC₅₀ of 0.5 µg/mL, indicating stronger capability in breaching KB cell defenses compared to chondriamide #B#.",
            "predicted_answer": "The IC₅₀ values indicate that chondriamide A (0.5 µg/mL) is more potent than chondriamide B (<1 µg/mL) in inhibiting KB cells, suggesting A more effectively breaches cellular defenses.",
            "score": 5,
            "explanation": "The key facts are present: chondriamide A is more potent, with an IC₅₀ of 0.5 µg/mL, in breaching KB cell defenses compared to chondriamide B. The predicted answer accurately conveys these details, aligning well with the reference, with no significant omissions or errors in meaning."
        },
        {
            "query_idx": 1071,
            "query": "Within the complex theater of cellular interactions, what convoluted sequence of molecular disruptions culminates in the unraveling of TET1's structural integrity amidst the B-ALL cell environment, specifically under the influence of the biochemical orchestrators: staurosporine and ATM inhibitory compounds?",
            "retrieved_metrics": {
                "reference_idx": [
                    1286
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Staurosporine and ATM inhibitors inhibit #phosphorylation#, causing #TET1 instability# and a synergistic killing effect in B-ALL cells.",
            "predicted_answer": "Staurosporine and ATM inhibitory compounds, like AZD0156, inhibit TET1 phosphorylation, leading to TET1 protein instability and a synergistic effect that kills B-ALL cells.",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer in key aspects: it mentions inhibition of phosphorylation and TET1 instability, which are crucial details. The overall trend of synergistic killing in B-ALL cells is consistent. No significant omissions are identified, and no contradictions present."
        },
        {
            "query_idx": 1072,
            "query": "In the dynamic realm of intracellular symphonies, what distinct molecular motifs are subdued by UCN-01, and which critical catalyst in the orchestration of kinases does it decisively counteract?",
            "retrieved_metrics": {
                "reference_idx": [
                    1288
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "UCN-01 subdues molecular motifs #thymidylate synthase# and #E2F-1#, and decisively counteracts the DNA damage checkpoint kinase #Chk1#.",
            "predicted_answer": "UCN-01 selectively inhibits protein kinase C and the DNA damage checkpoint kinase Chk1, while also suppressing the expression of thymidylate synthase and E2F-1.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions the subduing of thymidylate synthase and E2F-1, and the counteraction of Chk1, aligning with the reference. All key facts emphasized in the reference answer are present in the prediction. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 1073,
            "query": "What is the role of UCN-01 in modulating the intricate molecular networks to ultimately facilitate the initiation of programmed cell demise within neuroblastoma cellular frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1289
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "UCN-01 #inhibits# cell proliferation and induces #apoptosis# in neuroblastoma cells through caspase activation and PARP cleavage.",
            "predicted_answer": "UCN-01 facilitates programmed cell death in neuroblastoma by inhibiting PDK1, leading to Akt inactivation, and inducing apoptosis through caspase activation and PARP cleavage.",
            "score": 5,
            "explanation": "The predicted answer includes the key components of the reference answer: UCN-01 induces apoptosis in neuroblastoma through caspase activation and PARP cleavage. It additionally mentions PDK1 inhibition and Akt inactivation, which aligns with the reference answer without contradiction. No key facts are missing."
        },
        {
            "query_idx": 1074,
            "query": "In what capacity does lestaurtinib function as a conductor in the molecular ballet of prostate cancer cellular systems, altering the intricate choreography that governs SRF activity activated by androgenic influences?",
            "retrieved_metrics": {
                "reference_idx": [
                    1290
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Lestaurtinib functions by inhibiting #PKN1#, which affects #SRF activity# induced by androgens in prostate cancer cells.",
            "predicted_answer": "Lestaurtinib functions by inhibiting PKN1, which in turn affects SRF activity induced by androgens in prostate cancer cells, altering the cellular processes that govern SRF's role in cancer progression.",
            "score": 5,
            "explanation": "The predicted answer successfully includes all key facts marked with # in the reference answer: the inhibition of PKN1 and the influence on SRF activity induced by androgens in prostate cancer cells. It aligns fully with the reference answer's meaning and details without omissions."
        },
        {
            "query_idx": 1075,
            "query": "Through what nuanced molecular ballet do the entities AZD2461 and UCN-01 guide the cellular fate towards programmed demise and autophagic engagement, delineating uniquely tailored pathways within the disparate terrains of multiple myeloma versus primary effusion lymphoma cellular environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1291
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "AZD2461 and UCN-01 orchestrate #cellular demise# via CHK1 inhibition, downregulating xbp1, inducing UPR imbalance, leading to apoptosis and autophagy in MM and PEL cells.",
            "predicted_answer": "AZD2461 and UCN-01 inhibit PARP and CHK1, downregulating c-Myc and upregulating CHOP, leading to UPR imbalance and cell death. They trigger autophagy via PERK/eIF2alpha in multiple myeloma and IRE1alpha/JNK1/2 in primary effusion lymphoma.",
            "score": 3,
            "explanation": "The predicted answer includes CHK1 inhibition and UPR imbalance but misses the downregulation of xbp1. Both answers mention apoptosis/autophagy, with detailed pathways for distinct cell types in the prediction. This partially aligns but misses one key fact (xbp1 downregulation)."
        },
        {
            "query_idx": 1076,
            "query": "In what manner does the elusive entity designated as compound 138 harmonize the intricate web of signaling conduits within the microenvironment of MDA-MB-231 cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1294
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compound #138# harmonizes signaling conduits in MDA-MB-231 cells by regulating #ERK1/2#, Akt, and p38 MAPK pathways, and downregulating myc.",
            "predicted_answer": "Compound 138 harmonizes the intricate web of signaling conduits in MDA-MB-231 cells by regulating ERK1/2, Akt, and p38 MAPK pathways and downregulating myc.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized with # in the reference answer: it mentions compound 138, the regulation of ERK1/2, Akt, and p38 MAPK pathways, and the downregulation of myc. The meaning and details are consistent with the reference."
        },
        {
            "query_idx": 1077,
            "query": "In the context of Rhopaladin B's interaction with cyclin-dependent kinase 4 and the c-erbB-2 kinase, how do the delineated half maximal inhibitory concentration values illuminate its inherent capacity to perturb molecular stability within oncogenic frameworks, and what extrapolative assertions can be made about its cytotoxic potentialities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1295
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rhopaladin B's #IC₅₀ values# of 12.5 and 7.4 µg/mL suggest notable #cytotoxic potential# against oncogenic pathways, impacting molecular stability within tumor cells.",
            "predicted_answer": "Rhopaladin B's IC50 values of 12.5 µg/mL for CDK4 and 7.4 µg/mL for c-erbB-2 kinase suggest it can disrupt oncogenic pathways, indicating significant potential for cytotoxicity against human tumor cells.",
            "score": 5,
            "explanation": "The predicted answer includes the key IC₅₀ values of 12.5 µg/mL and 7.4 µg/mL, indicating Rhopaladin B's potential to disrupt oncogenic pathways. It effectively reflects the reference answer's meaning about cytotoxic potential and impact on tumor cells, covering all key facts."
        },
        {
            "query_idx": 1078,
            "query": "What are the quantifiable indices of inhibition potency, specifically concerning the molecular entities termed luteoalbusins A and B, as they navigate the biological complexes of SF-268 and NCI-H460 cellular structures, in terms of their interactive physiological thresholds?",
            "retrieved_metrics": {
                "reference_idx": [
                    1297
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Luteoalbusins A and B show #cytotoxicity# against SF-268 cancer cells with IC$\\_{50}$ values of 0.23-2.39 µM and #anti-proliferative# effects on NCI-H460 with IC$\\_{50}$ of 1.15-1.31 µM.",
            "predicted_answer": "The quantifiable indices of inhibition potency for luteoalbusins A and B in SF-268 and NCI-H460 cells are their IC50 values, which range from 0.23 to 2.39 µM for SF-268 and 1.15 to 1.31 µM for NCI-H460.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference answer: IC50 values for both SF-268 (0.23-2.39 µM) and NCI-H460 (1.15-1.31 µM). Terms like \"cytotoxicity\" and \"anti-proliferative\" were implied in the context. Thus, the answer successfully captures the essential information."
        },
        {
            "query_idx": 1079,
            "query": "What are the quantified lethality thresholds for the molecular entity identified as Hyrtinadine A, as well as its precursor molecular form, compound 156, when evaluated against the complex cellular assemblies designated as HCT116?",
            "retrieved_metrics": {
                "reference_idx": [
                    1296
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The IC$\\_{50}$ value for #Hyrtinadine A# against #HCT116# is >10 µM, while for compound 156, it is 3.7 µM.",
            "predicted_answer": "Hyrtinadine A shows weak cytotoxicity against HCT116 with IC50 > 10 µM, while its precursor, compound 156, has an IC50 of 3.7 µM against HCT116.",
            "score": 5,
            "explanation": "The predicted answer accurately covers all key facts from the reference answer. It states the IC50 values for both Hyrtinadine A and compound 156 against HCT116, with no discrepancies. The trends are fully aligned and no important details are missing."
        },
        {
            "query_idx": 1080,
            "query": "In the realm of molecular architecture, which elemental moiety within the alkaloidal derivatives sourced from Dictyodendrlla verongiformis acts as the sovereign regulator, ensuring the dismantling of telomeric perpetuation phenomena?",
            "retrieved_metrics": {
                "reference_idx": [
                    1299
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #sulfate# part of the alkaloids from Dictyodendrlla verongiformis acts as the #sovereign regulator# in dismantling telomeric perpetuation phenomena.",
            "predicted_answer": "The sulfate moiety within the alkaloidal derivatives, specifically Dictyodendrins A and B from Dictyodendrlla verongiformis, acts as the key regulator, ensuring the inhibition of telomerase activity and thus dismantling telomeric perpetuation.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts that the sulfate moiety within the alkaloids from Dictyodendrlla verongiformis acts as the sovereign regulator. It elaborates further by mentioning Dictyodendrins A and B and their role in inhibiting telomerase, which aligns with the dismantling of telomeric perpetuation."
        },
        {
            "query_idx": 1081,
            "query": "Through the intricate web of intracellular metabolic pathways, what ripple effect does the subversion of the CPT1a conduit have on the procurement strategies and existential robustness of malignant cells, particularly when examined within the purview of fatty acid β-oxidation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1302
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The subversion of the #CPT1a# conduit disrupts fatty acid β-oxidation, compromising #energy procurement# and existential robustness of malignant cells by limiting their energy supply.",
            "predicted_answer": "Subverting the CPT1a conduit disrupts fatty acid β-oxidation, depriving malignant cells of a critical energy source. This can weaken their survival and proliferation, making CPT1a an attractive target for cancer therapeutics.",
            "score": 3,
            "explanation": "The predicted answer captures the disruption of fatty acid β-oxidation caused by subverting the CPT1a conduit and its impact on malignant cells' energy procurement. It aligns with the reference but omits direct mention of \"existential robustness.\" The main points are present, but one key detail is missed."
        },
        {
            "query_idx": 1082,
            "query": "What are the intricate molecular tapestries woven by fascaplysin that invoke the symphony of autophagic rejuvenation, contributing to the heightened susceptibility of cancer cells to embrace the orchestrated cessation prompted by TRAIL pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1278
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Fascaplysin induces autophagy by activating the #ROS pathway#, inhibiting survivin, and increasing #TRAIL-induced# cancer cell death, enhancing susceptibility to programmed cell death.",
            "predicted_answer": "Fascaplysin activates autophagy by inhibiting the PI3K/Akt/mTOR pathway and triggering ROS, enhancing TRAIL-induced cancer cell death. This mechanism increases cancer cells' susceptibility to TRAIL, making fascaplysin a potential drug to overcome TRAIL resistance.",
            "score": 3,
            "explanation": "The predicted answer includes key elements like the activation of the ROS pathway and TRAIL-induced cancer cell death, aligning with the reference. However, it misses the inhibition of survivin, a key detail impacting completeness."
        },
        {
            "query_idx": 1083,
            "query": "What distinctive molecular adornment is embraced by Indimicin B, and upon which cellular congregation does it exert a moderate influential potency?",
            "retrieved_metrics": {
                "reference_idx": [
                    1300
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Indimicin B features a #1$^{'}$, 3$^{'}$-dimethyl-2$^{'}$-hydroindole# moiety and exerts moderate potency on the #MCF-7# cell line.",
            "predicted_answer": "Indimicin B features a unique 1',3'-dimethyl-2'-hydroindole moiety and exerts moderate cytotoxicity against the MCF-7 cell line.",
            "score": 5,
            "explanation": "The predicted answer fully covers both key facts from the reference answer: the 1',3'-dimethyl-2'-hydroindole moiety and moderate potency against the MCF-7 cell line. The meanings are consistent, and no critical information is omitted or contradicted."
        },
        {
            "query_idx": 1084,
            "query": "What underlying discrepancies render the crystallographic configuration of ratCPT2 an unreliable blueprint for deciphering the complex architectural enigma of CPT1A, in the realm of status quo impediments related to membrane-bound activity preservation and protein solubility?",
            "retrieved_metrics": {
                "reference_idx": [
                    1308
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The ratCPT2 structure is unreliable for CPT1A due to #low sequence similarity# and challenges in maintaining membrane-bound enzyme activity and #protein solubility#.",
            "predicted_answer": "The low sequence similarity between ratCPT2 and CPT1A, along with challenges in maintaining CPT1A's enzyme activity and solubility in membrane-like conditions, limits the utility of ratCPT2 as a structural reference for CPT1A.",
            "score": 5,
            "explanation": "The predicted answer covers both key facts emphasized in the reference answer: #low sequence similarity# and #protein solubility#. It also captures the challenges related to enzyme activity in membrane-like conditions. The overall trend and key facts are aligned, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1085,
            "query": "What divergent pathways in the architectural design of the CPT1A amino acid sequence define the transition from its frontier-like N-terminal regulatory realm to the industrious expanse of its C-terminal catalytic domain?",
            "retrieved_metrics": {
                "reference_idx": [
                    1307
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CPT1A's #N-terminal# regulatory region (47 amino acids) transitions into the industrious #C-terminal# catalytic domain through division by two transmembrane helical regions.",
            "predicted_answer": "The CPT1A protein, with 773 amino acids, is divided by two transmembrane helical regions into a small N-terminal regulatory region (about 47 amino acids) and a larger C-terminal catalytic domain.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts from the Reference Answer: identification of the \"N-terminal\" and \"C-terminal\" regions, the length of the N-terminal region, and the use of two transmembrane helical regions for the division. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 1086,
            "query": "In which elusive capacity does Gly710 contribute to the nuanced molecular choreography of succinyl-transferase dynamics within the CPT1A framework, and what abstract repercussions ensue following its mutational alteration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1311
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Gly710 is crucial for #succinyl-transferase# dynamics in CPT1A. Its mutation to G710E abolishes #carnitine palmitoyl-transferase# activity but retains succinylation, affecting molecular choreography.",
            "predicted_answer": "Gly710 is crucial for CPT1A's succinyl-transferase activity. Its mutational alteration, such as G710E, leads to loss of carnitine palmitoyl-transferase activity but retains succinylation, indicating a nuanced role in molecular dynamics.",
            "score": 5,
            "explanation": "The predicted answer includes key elements: Gly710's role in succinyl-transferase and the effects of its G710E mutation. Both answers note the retention of succinylation and loss of carnitine palmitoyl-transferase activity. The predicted answer reflects the meaning and key facts without contradictions or omissions."
        },
        {
            "query_idx": 1087,
            "query": "What emblematic sequences residing within the CPT1A TM2 helix serve as metaphoric linchpins, essential for the assembly into its complex oligomeric structure?",
            "retrieved_metrics": {
                "reference_idx": [
                    1310
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #GXXXG# and #GXXXA# motifs in the CPT1A TM2 helix are essential for its oligomeric structure assembly.",
            "predicted_answer": "The GXXXG and GXXXA motifs in the CPT1A TM2 helix are essential for its oligomerization, acting as key sequences for assembly into the complex structure.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects both key facts from the reference answer: the presence of the #GXXXG# and #GXXXA# motifs critical for oligomeric structure assembly. The phrasing slightly differs, but the meaning is consistent, with no omissions or contradictions."
        },
        {
            "query_idx": 1088,
            "query": "Considering the molecular tapestry that CPT1A weaves, what role does the transformative dance between its tripartite and hexapartite constructs play in altering its receptive threshold to malonyl-CoA, within the broader biochemical ensemble it participates in?",
            "retrieved_metrics": {
                "reference_idx": [
                    1309
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #trimer-hexamer transition# in CPT1A may influence its #sensitivity to malonyl-CoA# within the fatty acid transfer complex in the mitochondrial outer membrane.",
            "predicted_answer": "CPT1A's transition from a trimer to a hexamer can alter its sensitivity to malonyl-CoA, impacting its regulation and function within the fatty acid transfer complex.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts from the reference: the \"trimer-hexamer transition\" and \"sensitivity to malonyl-CoA\" in the context of CPT1A's function. Though it lacks mention of the \"mitochondrial outer membrane,\" this omission does not significantly affect overall alignment."
        },
        {
            "query_idx": 1089,
            "query": "How does CPT1A, as a biochemical maestro, regulate the nuanced succinylation symphony of enolase 1 and S100A10 in threading the narrative of cancer's escalating tale?",
            "retrieved_metrics": {
                "reference_idx": [
                    1312
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CPT1A #modulates succinylation# of enolase 1 to enhance breast cancer growth and S100A10 to facilitate gastric cancer spread, threading the narrative of #cancer progression#.",
            "predicted_answer": "CPT1A modulates the succinylation of enolase 1, promoting breast cancer growth, and S100A10, facilitating gastric cancer spread. This regulation enhances cancer progression.",
            "score": 5,
            "explanation": "The predicted answer covers the key elements: CPT1A's role in modulating succinylation of enolase 1 and S100A10, affecting breast and gastric cancer progression respectively. The trend of cancer progression is also captured. Thus, the answer is aligned with the reference, without significant omissions."
        },
        {
            "query_idx": 1090,
            "query": "In what manner does the synergistic interplay between the molecular maestros PGC-1α and PPARα orchestrate the transcriptional ballet of CPT1A amidst the varied hormonal environs of hepatic tissues?",
            "retrieved_metrics": {
                "reference_idx": [
                    1314
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #synergistic interplay# of PGC-1α and PPARα enhances CPT1A expression, modulating its transcription in the hepatic #hormonal environs#.",
            "predicted_answer": "PGC-1α and PPARα work together to enhance CPT1A expression in the liver, with PGC-1α acting as a coactivator for PPARα. This interaction is crucial for modulating CPT1A transcription in response to hormonal changes.",
            "score": 5,
            "explanation": "The predicted answer includes the #synergistic interplay# between PGC-1α and PPARα and how it influences CPT1A expression. It also mentions the #hormonal changes# in the liver, which aligns with the reference's #hormonal environs#. All key facts are present, and no significant details are missing."
        },
        {
            "query_idx": 1091,
            "query": "What distinct sequence elements are fundamentally woven within the portion residing in the mitochondrial intermembrane expanse of the CPT1A enzymatic structure?",
            "retrieved_metrics": {
                "reference_idx": [
                    1313
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #mitochondrial intermembrane domain# of CPT1A encompasses residues #74-102#.",
            "predicted_answer": "The mitochondrial intermembrane domain of CPT1A includes residues 74-102, which are part of the distinct sequence elements within this region.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the \"mitochondrial intermembrane domain\" and specifies \"residues 74-102,\" aligning fully with the key facts in the reference answer. The meaning is consistent, and there are no significant omissions or errors."
        },
        {
            "query_idx": 1092,
            "query": "In what elaborate choreography does the conductor insulin craft a symphony with malonyl-CoA sensitivity, harmonizing CPT1A's modulation of fatty acid metamorphosis and gluconeogenic music to maintain the orchestral equilibrium of blood glucose levels?",
            "retrieved_metrics": {
                "reference_idx": [
                    1316
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Insulin #lowers# CPT1A expression, enhancing #malonyl-CoA# sensitivity, to modulate fatty acid oxidation and gluconeogenesis, thus maintaining blood glucose equilibrium.",
            "predicted_answer": "Insulin lowers CPT1A expression and increases its sensitivity to malonyl-CoA, limiting fatty acid oxidation and gluconeogenesis to maintain blood glucose levels.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts of insulin lowering CPT1A expression and increasing malonyl-CoA sensitivity, which influences fatty acid oxidation and gluconeogenesis to maintain blood glucose levels. There are no significant omissions or errors, and the overall meaning aligns well with the reference."
        },
        {
            "query_idx": 1093,
            "query": "What role does the hormonic catalyst thyroxine play in the transcriptional crescendo and subsequent protein manifestation of CPT1A within the hepatic biochemical landscape?",
            "retrieved_metrics": {
                "reference_idx": [
                    1317
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The hormone #thyroxine# increases #CPT1A# expression in the liver by interacting with thyroid response elements (TRE) and upregulating PGC-1α mRNA and protein levels in hepatocytes.",
            "predicted_answer": "Thyroxine enhances CPT1A transcription and protein expression in the liver by interacting with thyroid response elements in the CPT1A promoter and increasing PGC-1α levels, thereby boosting fatty acid oxidation.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts from the reference: thyroxine, CPT1A expression, liver interaction with thyroid response elements, and increased PGC-1α, supporting fatty acid oxidation. All essential details are reflected without contradictions, maintaining the intended meaning and completeness."
        },
        {
            "query_idx": 1094,
            "query": "In the intricate realm of genetic deviations within mitochondrial fuel-oxidation pathways, what are the defining temporal manifestations, rhythmic reappearing tendencies, and life-terminating potentialities that characterize the phenomenon of CPT1A deficiency?",
            "retrieved_metrics": {
                "reference_idx": [
                    1320
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CPT1A deficiency is characterized by #rapid onset#, frequent recurrence, and #high mortality#, causing illnesses like hepatic encephalopathy and recurrent hypoglycemia.",
            "predicted_answer": "CPT1A deficiency is characterized by rapid onset, frequent recurrence, and high mortality. It can cause hepatic encephalopathy, recurrent hypoglycemia, hepatomegaly, hyperammonemia, and renal tubular acidosis.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of rapid onset and high mortality, which are emphasized in the reference. It maintains the overall trend, mentioning frequent recurrence and similar illnesses. Extra details do not contradict but enhance the reference content. All crucial information is retained."
        },
        {
            "query_idx": 1095,
            "query": "- What are the dual manifestations of genetic sequence deviations within the molecular dynamic of CPT1A, distinguishing those alterations integral to the catalytic locus's operational disruption from those perturbing the macromolecular equilibrium, thereby indirectly influencing enzymatic efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    1321
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Type one mutations #directly affect# the catalytic center causing activity loss, while type two mutations #affect stability# and indirectly decrease catalytic efficiency.",
            "predicted_answer": "Genetic sequence deviations in CPT1A manifest as type one mutations, directly disrupting the catalytic center and causing loss of activity, and type two mutations, affecting enzyme stability and indirectly reducing catalytic efficiency.",
            "score": 5,
            "explanation": "The predicted answer successfully captures all key facts highlighted by # in the reference answer. It states that type one mutations directly affect the catalytic center and activity, while type two mutations relate to stability and efficiency, aligning with the reference's meaning and details."
        },
        {
            "query_idx": 1096,
            "query": "What envisioned methodologies of metabolic intervention might be invoked to restore equilibrium in renal proton conductance amidst the enigmatic backdrop of CPT1A catalytic disturbance, in the absence of targeted pharmaceutic solutions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1322
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Metabolic intervention might include #diet control# and treatment with #medium chain triglyceride# to restore equilibrium in renal proton conductance for CPT1A deficiency.",
            "predicted_answer": "In the absence of targeted pharmaceuticals, metabolic interventions such as dietary control with medium chain triglycerides can help restore renal proton conductance by improving tubular acidosis in CPT1A deficiency.",
            "score": 5,
            "explanation": "The predicted answer includes both #dietary control# and #medium chain triglycerides#, which are the key methodologies emphasized in the reference for addressing issues related to CPT1A deficiency. Therefore, the predicted answer fully matches the key elements of the reference answer, maintaining the overall trend and completeness."
        },
        {
            "query_idx": 1097,
            "query": "What orchestrative approach within the realm of corrective biological symphonies can be posited to potentially alleviate the complex weave of renal scarring through the meticulous modulation of the CPT1A biochemical sonata?",
            "retrieved_metrics": {
                "reference_idx": [
                    1325
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Modulating the #CPT1A gain of function# could potentially alleviate renal scarring by improving mitochondrial function, thus reducing #renal fibrosis#.",
            "predicted_answer": "A gain-of-function approach in CPT1A, enhancing its activity, may alleviate renal scarring by mitigating mitochondrial dysfunction and reducing fibrosis, as shown in studies on renal fibrosis.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference by mentioning a #CPT1A gain of function# approach and its role in reducing #renal fibrosis#. It captures the key facts and overall trend of improving mitochondrial function, without significant omissions or errors."
        },
        {
            "query_idx": 1098,
            "query": "In the complex arena of prostate cancer cell metabolism, what pivotal function is attributed to CPT1A as it modulates the dynamic interplay between the acceleration of cellular expansion and the conduct of their developmental progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    1324
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CPT1A modulates #prostate cancer# cell proliferation and differentiation by influencing metabolic reprogramming, impacting cellular expansion and developmental progression.",
            "predicted_answer": "CPT1A modulates fatty acid oxidation, which is crucial for providing energy and metabolic intermediates that support prostate cancer cell proliferation and developmental progression.",
            "score": 3,
            "explanation": "The predicted answer captures the key role of CPT1A in prostate cancer cell proliferation, aligning with the emphasis on \"prostate cancer\" in the reference. However, it lacks specific mention of \"differentiation\" and \"metabolic reprogramming,\" which are critical details in the reference answer's context."
        },
        {
            "query_idx": 1099,
            "query": "What enigmatic function does elevated expression of CPT1A undertake in guiding the molecular choreography that modulates immune interactions and enhances treatment resilience in the turbulent arena of GBM tumors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1335
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Elevated #CPT1A# expression #enhances immune escape# in GBM tumors by increasing CD47 expression, thus reducing macrophage phagocytosis and contributing to treatment resistance.",
            "predicted_answer": "Elevated CPT1A expression in GBM enhances radiotherapy resistance and immune escape by increasing CD47, which reduces macrophage phagocytosis of tumor cells. This modulation supports treatment resilience and immune interaction evasion.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference: elevated CPT1A expression, immune escape through increased CD47, and reduced macrophage phagocytosis. It aligns with the trend of treatment resilience and immune interaction, with no omissions or contradictions."
        },
        {
            "query_idx": 1100,
            "query": "What are the implications of etomoxir-induced modulation on the intricate energy transmutation pathways in glioblastoma cells exhibiting resistance climates following radiotherapeutic intervention?",
            "retrieved_metrics": {
                "reference_idx": [
                    1336
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Etomoxir inhibits #OCR# and #ATP production#, indicating energy conversion shifts from glycolysis to FAO in radiotherapy-resistant glioblastoma cells.",
            "predicted_answer": "Etomoxir-induced modulation in radioresistant glioblastoma cells inhibits OCR and ATP production, indicating a shift from glycolysis to fatty acid oxidation (FAO) for energy, which may affect cell survival and resistance.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies that etomoxir inhibits OCR and ATP production, matching the key facts in the reference. It also describes the energy shift from glycolysis to FAO, consistent with the reference, without any significant omissions or contradictions."
        },
        {
            "query_idx": 1101,
            "query": "What are the consequences of perturbing CPT1A's regulatory influence within the biochemical symphony of nucleotide precursor dynamics, and how do these effects meld with the temporal checkpoints characterizing NPC cell proliferation phases?",
            "retrieved_metrics": {
                "reference_idx": [
                    1341
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Perturbing CPT1A's influence depletes #aspartic acid# and dNTP, impairing dNTP synthesis and blocking NPC cell proliferation at the #G1/S transition#, suggesting a lipid metabolism-based treatment strategy.",
            "predicted_answer": "Inhibiting CPT1A depletes aspartic acid and dNTP, impairs de novo dNTP synthesis, and halts NPC cell cycle at the G1/S transition, affecting nucleotide precursor dynamics and DNA replication. This suggests a potential treatment strategy for NPC by regulating lipid metabolism.",
            "score": 5,
            "explanation": "The predicted answer correctly mentions the depletion of aspartic acid and dNTP, impaired dNTP synthesis, and the halting of the NPC cell cycle at the G1/S transition, aligning with the reference. Both mention a strategy involving lipid metabolism, fully covering the key facts."
        },
        {
            "query_idx": 1102,
            "query": "What intrinsic molecular dynamics enable etomoxir and TDGA to intricately interface with the catalytic epicenter of CPT1A, orchestrating their role as inhibitors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1343
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Etomoxir and #TDGA# are ethylene oxide compounds that bind to the #active site# of CPT1A, enabling their inhibitory effects.",
            "predicted_answer": "Etomoxir and TDGA, as ethylene oxide compounds, bind to the active site of CPT1A, inhibiting its catalytic activity. Their molecular structures enable specific interactions with the enzyme's catalytic epicenter.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts highlighted in the reference: TDGA and the active site of CPT1A. It also aligns with the overall trend, describing the inhibitory interaction, and adds a detail about molecular structures. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 1103,
            "query": "How does the nuanced orchestration of biochemical specificity in ST1326 provide a superior level of selective engagement in contrast to etomoxir, particularly with respect to the finely tuned molecular symphony of hepatic enzyme modulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1344
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "ST1326 provides superior #selective engagement# by specifically inhibiting liver #CPT1A#, unlike etomoxir which also affects CPT1B, ensuring precise hepatic enzyme modulation.",
            "predicted_answer": "ST1326 selectively inhibits liver CPT1A, offering superior specificity over etomoxir, which also inhibits CPT1B. This nuanced biochemical engagement enhances hepatic enzyme modulation, making ST1326 more targeted and effective.",
            "score": 5,
            "explanation": "The predicted answer covers all the key facts: selective engagement, specific inhibition of liver CPT1A, and differentiation from etomoxir affecting CPT1B. The terms \"nuanced biochemical engagement\" and \"enhances hepatic enzyme modulation\" align with the reference's emphasis on precise hepatic enzyme modulation. All critical points are present."
        },
        {
            "query_idx": 1104,
            "query": "In what manner does C75's embodiment of a metabolic duality, functioning simultaneously as both an invigorator and suppressor within the intricate interplay of CPT1A activity, cast a shadow over its potential as a viable candidate in the pharmacological arena?",
            "retrieved_metrics": {
                "reference_idx": [
                    1345
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "C75's dual roles as a #stimulant# and #inhibitor# of CPT1A complicate its pharmacological viability, raising concerns about its consistent effectiveness and safety in treatments.",
            "predicted_answer": "C75's dual effect on CPT1A, stimulating at one concentration and inhibiting at another, complicates its pharmacological potential due to the unpredictable impact on metabolic pathways.",
            "score": 3,
            "explanation": "The predicted answer identifies C75's dual function as both a stimulant and inhibitor of CPT1A, capturing the reference's key facts. However, it omits concerns about consistent effectiveness and safety, impacting completeness slightly, yet aligns with the overall trend regarding pharmacological viability."
        },
        {
            "query_idx": 1105,
            "query": "How does the orchestrated modulation of molecular dynamics by CPT1A, through its interaction with the biochemical entity S100A10, influence the various stages of the oncogenic cascade in gastric tissue?",
            "retrieved_metrics": {
                "reference_idx": [
                    1339
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CPT1A-mediated #succinylation# of #S100A10# promotes gastric cancer progression by influencing the oncogenic cascade stages in gastric tissue.",
            "predicted_answer": "CPT1A-mediated succinylation of S100A10 at lysine 47 promotes gastric cancer progression. This interaction enhances the oncogenic cascade in gastric tissue, contributing to cancer development.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions CPT1A-mediated succinylation of S100A10 and its role in promoting gastric cancer, which aligns with the reference answer. The key terms \"succinylation\" and \"S100A10\" are present, and the trend regarding cancer progression through the oncogenic cascade is consistently depicted."
        },
        {
            "query_idx": 1106,
            "query": "In what manner could a strategic arrangement manifest to circumnavigate the complex landscape of perhexiline-induced adverse outcomes resultant from isoform incongruities, while maintaining efficacy in the realm of CPT1A-targeted therapeutic interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1346
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A strategic arrangement could manifest by enhancing #isoform selectivity#, thereby reducing perhexiline-induced adverse outcomes while maintaining efficacy in #CPT1A-targeted# therapeutic interventions.",
            "predicted_answer": "A strategic arrangement could involve enhancing isoform selectivity of CPT1A inhibitors to minimize off-target effects on CPT2, thereby reducing adverse outcomes while maintaining therapeutic efficacy.",
            "score": 5,
            "explanation": "The predicted answer covers both emphasized points: enhancing isoform selectivity and maintaining efficacy in CPT1A-targeted interventions. Though framed slightly differently, the key facts and overall meaning are aligned with the reference answer, indicating no significant omissions or errors."
        },
        {
            "query_idx": 1107,
            "query": "What intricate dynamics characterize the engagement of SRSF3 in the sophisticated orchestration of molecular splicing processes, determining the isoform diversification of B7-H3 within human and murine systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    1353
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "SRSF3 splicing factor engages in isoform diversification of B7-H3 by #binding# directly to exon 4 and/or 6, influencing the #molecular splicing# processes in humans and mice.",
            "predicted_answer": "SRSF3 engages in B7-H3 splicing by binding to exons 4 and/or 6, influencing isoform diversification. In humans, this results in two isoforms (2IgB7-H3 and 4IgB7H3), while mice have only one (2IgB7-H3).",
            "score": 3,
            "explanation": "The Predicted Answer includes the key facts of SRSF3 binding to exon 4 and/or 6 and affecting the isoform diversification of B7-H3, aligning well with the Reference Answer. However, it omits mentioning the broader role in \"molecular splicing processes,\" missing a key detail."
        },
        {
            "query_idx": 1108,
            "query": "In what capacity does the dynamic interplay within the p38 MAPK-eIF4E molecular circuitry orchestrate an upregulation of B7-H3's genetic transcriptional architecture in the varied landscape of malignant cellular constructs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1357
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #p38 MAPK-eIF4E# signaling axis serves as a key regulator of transcription initiation and protein expression of #B7-H3# in tumor cells.",
            "predicted_answer": "The p38 MAPK-eIF4E signaling axis positively regulates B7-H3's transcriptional activity in various cancer cells, enhancing its expression.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts: the involvement of the p38 MAPK-eIF4E signaling axis and the role in regulating B7-H3 in cancer cells, aligning with the reference answer. However, it lacks the specification of transcription initiation and protein expression aspect, affecting completeness."
        },
        {
            "query_idx": 1109,
            "query": "Within the molecular symphony of cellular architecture, what role do the microRNA conductors—namely microRNA-199a, miR-128, and microRNA-187—play in the nuanced regulatory performance affecting the translation of B7-H3's protein expression amidst the dynamic landscape of neoplastic cellular matrices?",
            "retrieved_metrics": {
                "reference_idx": [
                    1356
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "MicroRNA-199a, miR-128, and microRNA-187 regulate #B7-H3# protein expression in #cancer# by directly binding to its mRNA's 3' UTR.",
            "predicted_answer": "MicroRNA-199a, miR-128, and microRNA-187 regulate B7-H3 protein expression in cancer cells by directly binding to the 3' UTR of B7-H3 mRNA, influencing its translation.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts from the reference answer: the role of microRNA-199a, miR-128, and microRNA-187 in regulating B7-H3 protein expression in cancer by binding to the 3' UTR. The predicted answer aligns well with the reference's meaning and details."
        },
        {
            "query_idx": 1110,
            "query": "Within the complex interplay of immune system constituents, what role do the dual Ig and quadruple IgVCVC configurations of the B7-H3 entity perform in conducting the nuanced choreography of T cell behavior, particularly in terms of the restraint on cellular expansion and the modulation of cytokine synthesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    1360
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #2Ig VC# and #4Ig VCVC# forms of B7-H3 inhibit T cell proliferation and downregulate cytokine production.",
            "predicted_answer": "The 2Ig and 4IgVCVC forms of B7-H3 inhibit T cell proliferation and downregulate cytokine production, thereby modulating T cell behavior and restraining cellular expansion.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key points emphasized in the reference answer: both 2Ig VC and 4Ig VCVC forms are mentioned as contributing to the inhibition of T cell proliferation and modulation of cytokine production. The meaning and key details are consistently aligned."
        },
        {
            "query_idx": 1111,
            "query": "What is the nature of the keystone dynamics enacted by B7-H3 within the perpetual renewal systems of progenitorial malignant entities, fostering a robust array of biological fortifications against clinical interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1367
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "B7-H3 contributes to self-renewal in cancer stem cells, fostering #therapeutic resistance# and enhancing #biological fortifications# against clinical interventions.",
            "predicted_answer": "B7-H3 contributes to therapeutic resistance in cancer by supporting the self-renewal and survival of cancer stem cells, thereby fortifying malignancies against clinical treatments.",
            "score": 5,
            "explanation": "The predicted answer captures key facts from the reference: B7-H3's role in self-renewal of cancer stem cells, fostering therapeutic resistance, and enhancing biological fortifications against clinical interventions. The overall trend aligns with the reference answer, and all emphasized points are included."
        },
        {
            "query_idx": 1112,
            "query": "Which inherent tactical feature of CSCs facilitates their ability to evade immunological detection, consequently amplifying the potential for neoplastic spread, resistance to medical interventions, and deteriorating clinical outcomes as elucidated in the context?",
            "retrieved_metrics": {
                "reference_idx": [
                    1368
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#CSCs# use immunomodulatory strategies to evade #immune# detection, leading to metastasis, treatment failure, and unfavorable outcomes.",
            "predicted_answer": "CSCs utilize immunomodulatory strategies, such as the expression of B7-H3, to evade immune detection, facilitating metastasis, treatment resistance, and poor clinical outcomes.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference: use of \"immunomodulatory strategies\" by CSCs to evade \"immune\" detection, leading to metastasis, treatment resistance, and poor clinical outcomes. The mention of B7-H3 adds detail but does not contradict the reference."
        },
        {
            "query_idx": 1113,
            "query": "How did the strategic downregulation of the cryptic regulatory entity B7-H3 reshape the developmental trajectory of precursor lipid-matrix architects, and what intricate cascade of metabolic deviations was orchestrated in the environmental narrative of the investigative study?",
            "retrieved_metrics": {
                "reference_idx": [
                    1374
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #downregulation# of B7-H3 led to reduced glucose and oxidative metabolism, impaired mitochondrial function, increased lipid storage, and spontaneous obesity, affecting #metabolic# and immune homeostasis.",
            "predicted_answer": "The downregulation of B7-H3 led to reduced glucose and oxidative metabolism, impaired mitochondrial function, and increased lipid storage in adipocyte progenitors. This resulted in spontaneous obesity and disrupted metabolic and immune homeostasis in mice.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts emphasized with # symbols in the Reference Answer, such as the downregulation of B7-H3, reduced glucose and oxidative metabolism, impaired mitochondrial function, increased lipid storage, and the impact on metabolic and immune homeostasis. The overall trend and meaning align with the Reference."
        },
        {
            "query_idx": 1114,
            "query": "In the context of post-translational structural metamorphoses, how might the nuanced alterations of B7-H3's molecular architecture modulate its intricate interplay and potential contribution within the pathophysiological tapestries of both type I diabetes, characterized by immune system interactions, and type II diabetes, marked by metabolic challenges?",
            "retrieved_metrics": {
                "reference_idx": [
                    1375
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Post-translational modifications of #B7-H3# potentially influence its #immunoregulatory role# in type I diabetes and contribute to metabolic processes in type II diabetes.",
            "predicted_answer": "Post-translational modifications of B7-H3 can alter its molecular structure, potentially affecting its immunoregulatory role in type I diabetes and its involvement in obesity and insulin resistance in type II diabetes, thus modulating its contribution to both diseases.",
            "score": 5,
            "explanation": "The Predicted Answer accurately captures the key facts about B7-H3's post-translational modifications influencing its \"immunoregulatory role\" in type I diabetes and \"contributing to metabolic processes\" in type II diabetes. All key information with # symbols in the Reference Answer is reflected."
        },
        {
            "query_idx": 1115,
            "query": "How does the microbial integration of H. pylori within the gastric cellular landscapes choreograph the nuanced expression shifts of B7-H3, and what are the underlying pathways mediating this cellular modulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1378
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "H. pylori infection increases #B7-H3# expression in gastric cells via #T4SS# and p38MAPK pathways, alongside increased Th17, Treg, and mixed Th1/Th2 responses.",
            "predicted_answer": "H. pylori infection increases B7-H3 expression in gastric epithelial cells via T4SS components CagA and peptidoglycan, modulating the p38MAPK pathway. This interaction influences immune responses, including Th17, Treg, and mixed Th1/Th2.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the increase of B7-H3 expression and involvement of T4SS and p38MAPK pathways, in line with the reference. It also includes immune responses involving Th17, Treg, and mixed Th1/Th2, fully covering key facts without significant omissions."
        },
        {
            "query_idx": 1116,
            "query": "What conundrum emerges from recent scientific elucidations that contradicts the hypothesized epitopic function of TLT-2 as a mediator in B7-H3 associated co-stimulation of T lymphocytes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1380
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The conundrum is that #TLT-2# does not #bind# human B7-H3, contradicting its hypothesized role in B7-H3 co-stimulation of T lymphocytes.",
            "predicted_answer": "Recent studies revealed that human TLT-2 does not bind to human B7-H3 and does not act as a costimulatory receptor, contradicting earlier hypotheses about its role in B7-H3 associated co-stimulation of T lymphocytes.",
            "score": 5,
            "explanation": "The predicted answer accurately presents the key facts that TLT-2 does not bind to human B7-H3, aligning with the hypothesis contradiction mentioned in the reference. The inclusion of the fact that TLT-2 is not a costimulatory receptor enriches but does not contradict key trends."
        },
        {
            "query_idx": 1117,
            "query": "How does the biochemical conduit of N-glycosylation serve as an essential thread in the tapestry of B7-H3's functional narrative within the dynamic landscape of triple-negative breast cancer, particularly in harmonizing the energetic equilibrium maintenance structures central to immunosuppressive capacities on the cellular battleground?",
            "retrieved_metrics": {
                "reference_idx": [
                    1376
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #N-glycosylation# of B7-H3 is essential for its protein stability, cell surface expression, and #immunosuppressive function#, crucial in triple-negative breast cancer progression.",
            "predicted_answer": "N-glycosylation stabilizes B7-H3, ensuring its expression on cell membranes and enabling its immunosuppressive function in triple-negative breast cancer, thus maintaining an energetic equilibrium that supports tumor progression.",
            "score": 5,
            "explanation": "The predicted answer includes both key elements highlighted in the reference: \"N-glycosylation\" and \"immunosuppressive function\". It also maintains the overall trend and context, referring to protein stability and cell surface expression in relation to triple-negative breast cancer."
        },
        {
            "query_idx": 1118,
            "query": "What are the complex mechanistic insights, as revealed in the contextual narrative, that describe how the molecular beacon termed IL-20RA fortifies the defense of breast cancer cells against the insurgence of chemotherapeutic forces?",
            "retrieved_metrics": {
                "reference_idx": [
                    1383
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "IL-20RA enhances breast cancer cell defense against chemotherapy by promoting #stemness# and upregulating PD-L1 through the JAK1-STAT3-SOX2 pathway, which compromises anticancer immune cell activity.",
            "predicted_answer": "IL-20RA fortifies breast cancer cells against chemotherapy by promoting stemness and tumor-initiating ability via the JAK1-STAT3-SOX2 pathway, enhancing chemoresistance, and upregulating PD-L1 to suppress anticancer immune activity.",
            "score": 5,
            "explanation": "The predicted answer covers key facts: #stemness#, the JAK1-STAT3-SOX2 pathway, and PD-L1 upregulation. It aligns with the reference answer, addressing the mechanism, although it adds details on chemoresistance and tumor-initiating ability, which do not contradict the reference. No key facts are missing."
        },
        {
            "query_idx": 1119,
            "query": "What enigmatic barrier veils the progression towards authoritatively sanctioned treatments targeting the B7-H3 pathway in oncological contexts, hindering therapeutic advancement?",
            "retrieved_metrics": {
                "reference_idx": [
                    1386
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The enigmatic barrier is the #lack# of a known receptor for #B7-H3#, hindering pharmacological targeting and therapeutic advancement in oncology.",
            "predicted_answer": "The primary barrier is the lack of a known receptor for B7-H3, making it difficult to develop targeted therapeutics. Identifying this receptor would significantly advance B7-H3-targeted treatments.",
            "score": 5,
            "explanation": "The Predicted Answer includes all the key facts mentioned in the Reference Answer, specifically the lack of a known receptor for B7-H3, and aligns with the barrier this represents for pharmacological targeting in oncology. There are no omissions or inaccuracies."
        },
        {
            "query_idx": 1120,
            "query": "What multifaceted biochemical nuances, acting within the harmonized cascade of the Wnt/β-catenin axis, serve to thwart the degradation orchestration of β-catenin, thereby weaving into the complex tapestry of colorectal cancer emergence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1391
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Increased secretion of #Wnt ligand proteins# prevents intracellular #degradation of β-catenin# by APC, Axin, GSK-3 complex, contributing to colorectal cancer emergence.",
            "predicted_answer": "Increased Wnt ligand proteins interact with cell surface receptors, inhibiting the degradation of β-catenin by the APC, Axin, and GSK-3β complex. This leads to β-catenin accumulation and nuclear translocation, activating genes involved in colorectal cancer development.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference, mentioning the increase of Wnt ligand proteins and their interaction that inhibits β-catenin degradation, consistent with the APC, Axin, GSK-3β complex role. It encompasses key elements like β-catenin accumulation and cancer development, covering all # elements."
        },
        {
            "query_idx": 1121,
            "query": "What are the fundamental complexities and the intertwining lattice of restrictions that define the process of architecting organoidal constructs as pertained to the ever-evolving extracellular matrix framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1398
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The fundamental complexities include #high cost# and #poor controllability# of the extracellular matrix, along with a complex specific composition and application limitations.",
            "predicted_answer": "The fundamental complexities in architecting organoidal constructs include high cost, complex specific composition, and poor controllability of the extracellular matrix. These factors, along with limitations in application, create a restrictive lattice that hinders the process.",
            "score": 5,
            "explanation": "The predicted answer successfully addresses the key facts: high cost and poor controllability of the extracellular matrix, as well as complex specific composition and application limitations, that were emphasized in the reference answer. The overall meaning and key details are consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 1122,
            "query": "In the intricate dance of genetic symphony, what role do molecular anomalies akin to APC and TP53 mutations play, when entwined with BRAF V600E mutant organoids, in orchestrating the modulation of the ERK/MAPK pathway's activity and shaping the dynamic growth patterns of colorectal neoplastic aggregations within their shared cocultural milieu?",
            "retrieved_metrics": {
                "reference_idx": [
                    1410
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Molecular anomalies like #APC# deletion and #TP53# mutation reduce ERK/MAPK pathway activity, improving growth in BRAF V600E mutant organoids within the colorectal neoplastic coculture environment.",
            "predicted_answer": "APC and TP53 mutations, when combined with BRAF V600E mutant organoids in coculture, reduce ERK/MAPK pathway activity, enhancing the organoid environment and restoring cell growth and proliferation, thus influencing colorectal cancer progression.",
            "score": 5,
            "explanation": "The predicted answer includes key facts about APC and TP53 mutations reducing ERK/MAPK pathway activity and affecting growth in BRAF V600E mutant organoids, aligning with the reference. It highlights the role in colorectal progression, slightly expanding but not contradicting the reference context. All emphasized details are present."
        },
        {
            "query_idx": 1123,
            "query": "Within the multifaceted arena of preclinical investigative platforms, what intricate roles do the contextual dimensions undertake in shaping the disparate pharmacological outcomes observed with 5-fluorouracil and AZD8931 interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1416
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Contextual dimensions influence drug response disparities for #5-fluorouracil# and #AZD8931# by varying preclinical model environments and colorectal carcinogenesis mechanisms.",
            "predicted_answer": "Contextual dimensions in preclinical models, such as the environment and genetic mutations in the RAS/RAF pathway, significantly influence the pharmacological outcomes of 5-fluorouracil and AZD8931, leading to varied drug responses.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions the #5-fluorouracil# and #AZD8931# drugs and acknowledges the impact of contextual dimensions like environmental and genetic factors on pharmacological outcomes, aligning with the reference. However, it omits the specific mention of #colorectal carcinogenesis mechanisms#."
        },
        {
            "query_idx": 1124,
            "query": "In the intricate ballet of colorectal cellular dynamics, what nuanced influence does the synergistic employment of inhibitors disrupting the Wnt pathway in conjunction with 5-fluorouracil exert, particularly when juxtaposed against the solitary orchestration of 5-fluorouracil, in the backdrop of the cellular canvas painted by mutational choreography such as TP53 and RNF43 variations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1415
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #synergistic employment# of Wnt inhibitors with 5-fluorouracil reduces tumor re-aggregation and recurrence compared to #5-fluorouracil alone#, despite the resistance from RNF43 mutations.",
            "predicted_answer": "Combining Wnt inhibitors with 5-fluorouracil reduces tumor cell re-aggregation and recurrence, especially in TP53-mutated colorectal cancers. However, RNF43 tumorigenic mutations show resistance to this combination, differing from RNF43 loss-of-function mutations.",
            "score": 3,
            "explanation": "The predicted answer matches the reference answer by describing the synergistic effect of Wnt inhibitors with 5-fluorouracil, especially in TP53 mutations. It mentions RNF43 resistance but omits a direct comparison to 5-fluorouracil alone, missing one key fact."
        },
        {
            "query_idx": 1125,
            "query": "What role do the nuanced variances within the genetic architecture of KRAS play in shaping the collaborative interaction between cetuximab and trametinib, specifically in tailoring the therapeutic response landscape for individuals navigating the complex molecular terrain of colorectal oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1420
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The nuanced variances within #KRAS# genetic architecture influence the collaborative interaction between cetuximab and #trametinib#, tailoring diverse and individualized therapeutic responses in colorectal oncology.",
            "predicted_answer": "Nuanced variances in KRAS genetic architecture influence the response to cetuximab and trametinib. Patients with different KRAS mutations show varied responses, and trametinib enhances cetuximab's efficacy in responsive cases, highlighting the importance of personalized treatment strategies in colorectal cancer.",
            "score": 3,
            "explanation": "The predicted answer includes key elements like the influence of KRAS variances and the partnership of cetuximab and trametinib in treatment strategies. However, nuances of \"individualized therapeutic responses\" or \"trends in colorectal oncology\" are not explicitly covered. The overall trend aligns but lacks some details."
        },
        {
            "query_idx": 1126,
            "query": "What are the multifaceted influences exerted by nivolumab as an immunological modulator on the infiltrative behavior of CD8+ cytotoxic T-lymphocytes and the transformation of programmed death-ligand 1 presentation within tumor organoids manifesting an overabundance of PD-L1?",
            "retrieved_metrics": {
                "reference_idx": [
                    1421
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Nivolumab increases #CD8+ T-cell infiltration#, decreases #PD-L1 expression#, and reduces tumor cell proliferation in PD-L1-overexpressing tumor organoids, with effects dependent on concentration.",
            "predicted_answer": "Nivolumab increases CD8+ T-cell infiltration, decreases PD-L1 expression, and reduces tumor cell proliferation in PD-L1-overexpressing tumor organoids, with effects dependent on its concentration.",
            "score": 5,
            "explanation": "The predicted answer covers all the key facts from the reference answer: increase in CD8+ T-cell infiltration, decrease in PD-L1 expression, and mention of concentration-dependent effects. The answer is aligned with the overall trend and contains no significant omissions or contradictions."
        },
        {
            "query_idx": 1127,
            "query": "In the convoluted interplay of cellular alliances, how does the role of DKK1, conceptualized as a regulatory arbiter, modulate the tactical impact of PD-1 inhibitors, especially in the context of CRC treatment scenarios where the Wnt/β-catenin pathway is in a state of disarray?",
            "retrieved_metrics": {
                "reference_idx": [
                    1422
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "DKK1 serves as a #regulatory arbiter# by inhibiting #PD-1 inhibitors#, primarily through limiting CD8+ T cell immune function and enhancing tumor cell activation in CRC with aberrant Wnt/β-catenin pathway.",
            "predicted_answer": "DKK1, by inhibiting the Wnt/β-catenin pathway, limits the efficacy of PD-1 inhibitors in CRC treatment, primarily by suppressing CD8+ T cell function and enhancing tumor cell activation. Blocking DKK1 may improve PD-1 inhibitor effectiveness.",
            "score": 3,
            "explanation": "The predicted answer correctly notes DKK1's regulatory role in inhibiting the Wnt/β-catenin pathway, its impact on CD8+ T cells, and tumor activation, aligning with the reference answer. However, it lacks explicit mention of PD-1 inhibition as a key element. So, one critical detail is missing."
        },
        {
            "query_idx": 1128,
            "query": "What were the discernible patterns and demographic transformations observed within diverse racial and ethnic garlands in the pioneering stages of phase 1 metastatic cancer treatment trials conducted across the United States, spanning the years from 2000 to the terminal echoes of 2018, as juxtaposed with established registry benchmarks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1425
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The study found discernible #patterns# of racial and ethnic diversity in phase 1 metastatic cancer trials lacking #alignment# with registry benchmarks from 2000 to 2018.",
            "predicted_answer": "The study found that the enrollment of racial and ethnic minorities in phase 1 metastatic cancer trials from 2000 to 2018 did not align with their representation in the CiNA database, indicating underrepresentation.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of the reference answer, indicating a lack of alignment between racial and ethnic diversity in trial enrollments and registry benchmarks. However, it lacks specific mention of \"patterns\" in diversity. Thus, it's generally aligned but misses one key fact."
        },
        {
            "query_idx": 1129,
            "query": "What prognostic vision was proposed concerning the demographic tapestry featured by racial and ethnic minorities within the initial customary exploration of pharmacological advancements for metastatic cancer treatment across the United States from the year 2000 to the year 2018?",
            "retrieved_metrics": {
                "reference_idx": [
                    1427
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The prognostic vision proposed that there would be continued overrepresentation of #White# participants in early drug trials for metastatic cancer treatment from #2000 to 2018#.",
            "predicted_answer": "The study hypothesized that there would be a continued overrepresentation of White participants in early phase 1 and phase 1 clinical trials for metastatic cancer treatment from 2000 to 2018.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts from the reference answer, including the continued overrepresentation of #White# participants and the timeframe #2000 to 2018#. The meaning is consistent, and no significant details are omitted or contradictory."
        },
        {
            "query_idx": 1130,
            "query": "In what manner do the parameters of confluence delineate the integrative phases, facilitating their passage through the analytical gateway for inclusion, specifically requiring phase 1 data to emerge distinct from phase 2 narratives?",
            "retrieved_metrics": {
                "reference_idx": [
                    1430
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Parameters of #confluence# require phase 1 data to be reported separately from phase 2 narratives to facilitate their integration through the #analytical gateway#.",
            "predicted_answer": "The parameters delineate the integrative phases by requiring phase 1 data to be reported separately from phase 2 data, facilitating distinct analysis and inclusion through the analytical gateway.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"requiring phase 1 data to be reported separately from phase 2\" and \"facilitating integration through the analytical gateway.\" Both terms \"confluence\" and \"analytical gateway\" are adequately referenced, capturing the core meaning and maintaining alignment with the reference."
        },
        {
            "query_idx": 1131,
            "query": "What strategic recalibrations within the intertwined frameworks of participant selection criteria might unveil entrenched biases and promote equitable demographic participation across multifaceted clinical research landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1435
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "By adjusting #inclusion/exclusion criteria# to overcome historic standards, researchers can address systemic biases and promote #equitable demographic# participation in clinical research.",
            "predicted_answer": "Strategic recalibration of participant selection criteria, by avoiding arbitrary or historic standards and addressing systemic biases, can help promote equitable demographic participation and reduce entrenched biases in clinical research.",
            "score": 5,
            "explanation": "The predicted answer captures both key facts: adjusting participant selection criteria (#inclusion/exclusion criteria#) to promote #equitable demographic# participation. It addresses systemic biases akin to the reference. Despite different phrasing, the meaning remains consistently aligned without omissions."
        },
        {
            "query_idx": 1132,
            "query": "What portion of the explorative initiatives elucidated the spectrum of racial and ethnic representations throughout the analytical span stretching from the inception of the 21st century to eighteen years hence, within the cohort of 330 scrutinized inquiries?",
            "retrieved_metrics": {
                "reference_idx": [
                    1433
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Of the #330 inquiries#, #221 reported# on racial and ethnic representations from 2000 to 2018.",
            "predicted_answer": "Of the 330 eligible trials, 221 (67%) reported at least one race and ethnicity, covering a period from 2000 to 2018. No trials in 2000 reported this data.",
            "score": 5,
            "explanation": "The predicted answer contains all the key facts emphasized with # in the reference answer, including \"330 inquiries\" and \"221 reported\" on racial and ethnic representations from 2000 to 2018. The details and trends are aligned with the reference answer, with no significant omissions or errors."
        },
        {
            "query_idx": 1133,
            "query": "In the early chronicles of 2009, what watershed revelation by Sato et al. in the realm of cultivating cellular miniatures signified a breakthrough moment in the grand narrative of organoid model development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1444
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The breakthrough moment in 2009 was Sato et al.'s establishment of long-term organoid cultures from a single #ASC# (adult stem cell).",
            "predicted_answer": "In 2009, Sato et al. achieved a breakthrough by establishing long-term organoid cultures from a single adult stem cell (ASC), marking a significant advancement in organoid model development.",
            "score": 5,
            "explanation": "The predicted answer captures all the key facts emphasized in the reference answer, specifically mentioning the establishment of long-term organoid cultures from a single adult stem cell (ASC) by Sato et al. in 2009. There are no omissions or errors, and the overall trend is consistent."
        },
        {
            "query_idx": 1134,
            "query": "Within the intricate realm of biomimetic landscapes, what concealed potentialities do multi-tissue-oriented organ-in-chip assemblies possess that distinctly enhance their repertoire over basic organoid models in orchestrating the replication of life's complex biological symphonies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1447
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Multi-tissue-oriented #organ-in-chip# assemblies contain #concealed potentialities# for enhanced replication of biological interactions, over basic organoid models, through complex cellular interplay and advanced tissue replication.",
            "predicted_answer": "Organ-in-chip assemblies enhance the replication of complex biological processes by integrating multi-tissue interactions and dynamic microenvironments, offering a more comprehensive model than basic organoids for studying tissue-specific functions and responses.",
            "score": 3,
            "explanation": "The predicted answer aligns with the overall trend of the reference by highlighting the superiority of organ-in-chip assemblies over organoids and mentioning multi-tissue interactions, but fails to directly reference the “concealed potentialities” highlighted as key in the reference. No contradictions are present."
        },
        {
            "query_idx": 1135,
            "query": "In the realm of simulated miniature ecosystems mimicking intestinal and pancreatic domains, how have metaphorical sentinels embedded at cellular barricades emerged as harbingers of preemptive immune vigilance within scholarly investigations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1451
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In #intestinal and pancreatic# tissue studies, #intraepithelial lymphocytes# (IELs) show cytokine signaling and lymphocyte motility, offering a preventative immunosurveillance approach.",
            "predicted_answer": "In scholarly investigations, tissue-native intraepithelial lymphocytes (IELs) in intestinal and pancreatic organoids have emerged as key players, demonstrating cytokine signaling and motility, and showing potential for preemptive immune vigilance.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key facts from the reference, mentioning \"intestinal and pancreatic\" tissue and \"intraepithelial lymphocytes\" (IELs) along with cytokine signaling and motility. No significant omissions or errors are present, aligning with the perceptive trend of preemptive immune vigilance in scholarly investigations."
        },
        {
            "query_idx": 1136,
            "query": "In what manner does the intricate labyrinth of interconnected dynamics challenge the faithful illustration of intestinal maladies, particularly IBS, within PDO constructs, and how might these frameworks be deficient in encapsulating the essential cellular mosaic that governs tissue-specific mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1454
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate dynamics challenge PDO constructs in modeling IBS by missing the #microbiome-gut-brain# axis and failing to mimic #inflammatory cell# cascades and tissue-specific mechanisms.",
            "predicted_answer": "The intricate dynamics of IBS, including immune responses, inflammation, and the microbiome-gut-brain axis, challenge PDO models. These models often fail to capture the full cellular mosaic and tissue-specific mechanisms, making them deficient in fully representing IBS.",
            "score": 3,
            "explanation": "The predicted answer addresses the microbiome-gut-brain axis and mentions inflammation, which aligns with the \"inflammatory cell cascades,\" but does not explicitly state the latter. Tissue-specific mechanisms are also noted. The overall trend is consistent, with one key fact (inflammatory cell cascades) slightly implied but not detailed."
        },
        {
            "query_idx": 1137,
            "query": "What complex potentialities are unlocked when a compendium of RAS-mutation-associated colorectal malignancy samples is utilized within a lattice of combinatorial pharmacologic trials, in exploring the evolution of treatment methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1457
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Utilizing a #biobank# of RAS-mutant colorectal cancers in #combinatorial pharmacologic trials# enables testing thousands of drug combinations efficiently, crucial for overcoming acquired resistance.",
            "predicted_answer": "Utilizing a compendium of RAS-mutation-associated colorectal cancer samples in combinatorial pharmacologic trials allows for the exploration of diverse treatment combinations, aiding in overcoming resistance and accelerating the discovery of effective therapies.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference answer in terms of utilizing RAS-mutant colorectal cancer samples in combinatorial trials for overcoming resistance. However, it omits the specific concept of a \"biobank\" and the idea of \"testing thousands of drug combinations efficiently,\" both of which are key facts."
        },
        {
            "query_idx": 1138,
            "query": "Within the framework of the experimental milieu of the OIC paradigm, how do the tailored, temporal, electro-conductive modulations upon myocardial cellular formations guide their progression towards maturity and alter their chemotherapeutic engagement dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1461
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tailored, temporal, electro-conductive modulations in the #OIC model# guide cardiomyocyte maturation and alter their #chemotherapeutic response# by identifying biokinetic influences of the tumor microenvironment.",
            "predicted_answer": "In the OIC paradigm, tailored electro-conductive modulations influence myocardial cell maturation and their response to chemotherapeutics, such as altering electrical stimulation to guide cell development and enhance drug interaction understanding.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference answer by mentioning the influence of tailored electro-conductive modulations on myocardial cell maturation and chemotherapeutic engagement. However, it misses the specific emphasis on the \"OIC model\" and detailing the \"biokinetic influences\" in the tumor microenvironment mentioned in the reference."
        },
        {
            "query_idx": 1139,
            "query": "Within the tapestry of cellular architecture, what is the fraction of experimental organoid models illustrating disruption in their duplicative threads as contrasted against those displaying unified genomic symphony accompanied by increased susceptibility to the orchestration of poly(ADP-ribose) polymerase inhibition pathway facilitation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1464
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#61%# of experimental organoid models show disruption, compared to #6%# that display a unified genomic symphony with PARPi sensitivity.",
            "predicted_answer": "In the study, 61% of organoids showed stalled replication fork defects, while only 6% had functional homologous recombination and sensitivity to PARP inhibition.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the percentages: 61% of organoids show disruption, and 6% display functional homologous recombination with sensitivity to PARP inhibition. The key facts (#61%# and #6%#) from the reference answer are fully covered. The overall trend is aligned with no significant omissions."
        },
        {
            "query_idx": 1140,
            "query": "What celestial pathway's gravitational influence did the interplay of tumor responses reveal, as demonstrated in Loong et al.'s everolimus treatment investigation within the PDO landscape?",
            "retrieved_metrics": {
                "reference_idx": [
                    1463
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Loong et al.'s investigation highlighted tumors' reliance on the #PTEN pathway# using everolimus in the PDO landscape.",
            "predicted_answer": "The interplay of tumor responses revealed the importance of the PTEN pathway, not a celestial pathway, in Loong et al.'s everolimus treatment investigation within the PDO landscape.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the PTEN pathway as the key focus of Loong et al.'s investigation, aligning with the reference answer's emphasis on the tumor's reliance on this pathway. The accuracy and consistency with the reference answer warrant a high score."
        },
        {
            "query_idx": 1141,
            "query": "In the intricate mosaic of therapeutic outcomes, what proportion of individuals diagnosed with esophageal carcinoma reach an absolute fruition of predefined therapeutic interventions when subjected to early-stage chemoradiotherapeutic protocols?",
            "retrieved_metrics": {
                "reference_idx": [
                    1468
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#25%# of individuals with esophageal carcinoma achieve #complete response# to early-stage chemoradiotherapeutic protocols.",
            "predicted_answer": "Based on the context, 25% of patients with esophageal carcinoma achieve a complete response when subjected to early-stage chemoradiotherapeutic protocols.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: \"#25%#\" and \"achieve #complete response#\" mentioned in the reference answer. The meaning conveyed is consistent with the reference answer, showing no significant omissions or errors."
        },
        {
            "query_idx": 1142,
            "query": "In the intricate dance of cutting-edge medicinal strategies targeting cryptic genetic mutations like EGFR and KRAS within the advanced corridors of lung cancer adversaries, what multifaceted barriers materialize, particularly when resistance festers like a shadow over the aspirational promise of molecular specificity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1471
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The multifaceted barriers include #resistance# to therapies targeting EGFR and KRAS, despite the aspirational promise of #molecular specificity# in advanced lung cancer treatment.",
            "predicted_answer": "Targeting EGFR and KRAS mutations in advanced lung cancer faces significant barriers, particularly the development of resistance. This limits the effectiveness of molecularly specific treatments, despite initial progress.",
            "score": 5,
            "explanation": "The predicted answer covers both key facts: resistance (\"resistance\" to therapies) and molecular specificity (\"molecularly specific treatments\") in advanced lung cancer, mirroring the reference answer. The overall trend is aligned without any significant omissions or errors."
        },
        {
            "query_idx": 1143,
            "query": "In the expansive realm of today's medical endeavors, what is the underlying influence of harnessing the inherent biological mosaic of a patient's own tissue in charting groundbreaking pathways within the domains of pharmaceutical evolution and bespoke medical strategies, according to the outlined context?",
            "retrieved_metrics": {
                "reference_idx": [
                    1470
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Harnessing a patient's #own tissue# data aids #drug development# and personalized medicine by improving preclinical efficiency and therapeutic accuracy, making oncology more affordable and effective.",
            "predicted_answer": "The context highlights that using a patient's own tissue for multi-organ ex vivo modeling can identify both normal tissue toxicity and tumor response, enhancing drug development and personalized medicine. This approach makes oncology more affordable and effective by improving preclinical efficiency and therapeutic accuracy.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts of using a patient's own tissue to enhance drug development and personalized medicine, improving efficiency and accuracy. It captures the trend and aligns with the Reference Answer, omitting no critical information emphasized with # symbols."
        },
        {
            "query_idx": 1144,
            "query": "What interplay of foundational biological structures and experimental methodologies culminates in the augmented realization of oncogenic graft establishment when employing site-specific consonance or circulatory inclusion versus the epidermal embedding approach within PDX model paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1475
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Orthotopic grating or circulatory injection in PDX models has a higher success rate (#30-40%#) for oncogenic graft establishment compared to #subcutaneous grafting#.",
            "predicted_answer": "Orthotopic grafting or injection into the circulation in PDX models yields a higher success rate, up to 30-40%, compared to subcutaneous embedding, enhancing oncogenic graft establishment.",
            "score": 5,
            "explanation": "The Predicted Answer captures the key facts highlighted in the Reference Answer: a higher success rate of 30-40% for orthotopic or circulatory injection compared to subcutaneous grafting in PDX models. The overall trend and essential details align well without omissions or contradictions."
        },
        {
            "query_idx": 1145,
            "query": "What latent proficiencies do genetically stylized mouse models exhibit over the fleeting imitative frameworks of xenograft embodiments in deciphering the dimensional complexities of human oncological phenomena within an immunocompetent continuum?",
            "retrieved_metrics": {
                "reference_idx": [
                    1477
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Genetically engineered mouse models (#GEMMs#) excel at replicating human tumor #genetic characteristics# and allow detailed study in immunocompetent environments, unlike xenograft models.",
            "predicted_answer": "Genetically engineered mouse models (GEMMs) exhibit latent proficiencies in mimicking human tumor genetics and immune interactions, which xenografts cannot. GEMMs allow for inducible gene manipulation, better reflecting the complexities of human oncological phenomena in an immunocompetent setting.",
            "score": 5,
            "explanation": "The predicted answer mentions GEMMs, human tumor genetics, and immunocompetent environments, which align with the key facts in the reference answer. While GEMMs' inducible gene manipulation was noted, this doesn't detract from the alignment. The predicted answer fully covers the key facts."
        },
        {
            "query_idx": 1146,
            "query": "What are the systemic characteristics that differentiate the architectural fidelity and functional mimicry found in the cellular compositions of tumoroids, as opposed to the structural representations inherent in spheroids and the biological reflections articulated within organoids, when considered through the lens of 3D lung cancer emulation models?",
            "retrieved_metrics": {
                "reference_idx": [
                    1480
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tumoroids #mimic native tumors# in both architecture and function, unlike #spheroids#, which focus more on structure and less on functionality compared to organoids.",
            "predicted_answer": "Tumoroids, spheroids, and organoids differ in their cellular composition and functionality. Tumoroids mimic tumor functionality, spheroids focus on structural simplicity, and organoids replicate healthy organ functions and architecture.",
            "score": 3,
            "explanation": "The predicted answer mentions that tumoroids mimic tumor functionality, partially capturing the idea of mimicking native tumors. However, it does not explicitly state that tumoroids mimic architecture. It covers spheroids' structural focus but is incomplete in highlighting the degree of functionality mimicry by organoids."
        },
        {
            "query_idx": 1147,
            "query": "What intrinsic and extrinsic cellular influences, decoded through advanced biomolecular scrutiny, can be perceived as the harbingers of therapeutic resilience observed within the metastatic pulmonary neoplasms when orchestrated in a microengineered multi-system environment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1485
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intrinsic influences of #metastatic# resilience include increased #DNA replication# and glutathione metabolism, identified through proteomics in lung cancer cells within a microengineered system.",
            "predicted_answer": "Intrinsic factors like increased DNA replication and glutathione metabolism, and extrinsic factors such as the microenvironment, contribute to therapeutic resilience in metastatic pulmonary neoplasms, as shown by omic analyses in microengineered systems.",
            "score": 3,
            "explanation": "Both the predicted and reference answers mention intrinsic factors like increased DNA replication and glutathione metabolism in the context of a microengineered system. However, the predicted answer omits the specific mention of \"metastatic\" resilience, which is a key fact emphasized in the reference. Therefore, one key fact is missing."
        },
        {
            "query_idx": 1148,
            "query": "What constitutes the intricate cellular tapestry forming an enigmatic barrier at a neoplastic junction, subtly obstructing the stratagems of immune-related therapeutic efforts?",
            "retrieved_metrics": {
                "reference_idx": [
                    1488
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate cellular tapestry includes an increased proportion of #myeloid-derived suppressor cells# and a decreased proportion of #NK cells# and monocytes at the tumor site.",
            "predicted_answer": "The intricate cellular tapestry at a neoplastic junction includes myeloid-derived suppressor cells (mDSCs), which increase, and NK cells and monocytes, which decrease, forming an immunosuppressive barrier that hinders immune-related therapeutic efforts.",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects the key facts emphasized in the Reference Answer, mentioning the increase of myeloid-derived suppressor cells and the decrease in NK cells and monocytes. This aligns with the reference, covering all crucial details without contradictions or omissions."
        },
        {
            "query_idx": 1149,
            "query": "Within the multifaceted dynamic of the co-culture ecosystem of PDOs and THP-1 participants, what strategic biochemical pathway did trastuzumab leverage to catalyze cellular deconstruction facilitated by immune-dependent mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1490
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Trastuzumab leveraged the antibody-dependent cell-mediated cytotoxicity (#ADCC#) biochemical pathway to catalyze cellular deconstruction via immune-dependent mechanisms in the co-culture ecosystem.",
            "predicted_answer": "Trastuzumab leveraged the antibody-dependent cell-mediated cytotoxicity (ADCC) pathway to catalyze cellular deconstruction in PDOs, facilitated by THP-1 cells.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the ADCC pathway and mentions cellular deconstruction facilitated by THP-1 cells, which is an immune-dependent mechanism. However, it lacks reference to the ‘co-culture ecosystem’, a key aspect of the reference. The overall trend is aligned, but a detail is missing."
        },
        {
            "query_idx": 1150,
            "query": "What symbiotic interaction within the oncological habitat was unveiled by Dijkstra et al., through the utilization of autologous T cells and NSCLC organoid constructs, revealing the rehearsal of antigenic symphonies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1491
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Dijkstra et al. unveiled specific #tumor reactivity# and #antigen presentation# in NSCLC organoids with autologous T cells.",
            "predicted_answer": "Dijkstra et al. demonstrated specific tumor reactivity by co-culturing autologous T cells with NSCLC organoids, revealing antigen presentation within the oncological habitat.",
            "score": 5,
            "explanation": "The predicted answer includes both emphasized key facts: \"specific tumor reactivity\" and \"antigen presentation\" in the context of NSCLC organoids with autologous T cells, aligning fully with the reference answer's core meaning. There are no omissions or inaccuracies."
        },
        {
            "query_idx": 1151,
            "query": "Amidst the multifaceted realm of oncology, particularly within the evolving narrative of advanced NSCLC stages, what proportion of individuals are discerned to exhibit heightened levels of the PD-L1 protein within their cellular framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1493
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "High #PD-L1 expression# is detected in #29.5%# of NSCLC patients at advanced stages.",
            "predicted_answer": "In advanced NSCLC, high PD-L1 expression is detected in approximately 29.5% of patients.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key facts emphasized in the Reference Answer, namely \"high PD-L1 expression\" and \"29.5% of NSCLC patients at advanced stages.\" The meaning is consistent, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1152,
            "query": "What intricately designed architectonic constructs and dynamic components did Hassell et al. integrate into their microenvironment blueprint to echo the harmonious rhythm of mechanical oscillations observed in the tumor milieu?",
            "retrieved_metrics": {
                "reference_idx": [
                    1496
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Hassell et al. integrated #epithelial cells#, #endothelial cells#, and compartments for mechanical breathing motions into their microenvironment blueprint to reflect tumor milieu oscillations.",
            "predicted_answer": "Hassell et al. integrated epithelial and endothelial cells, along with two compartments that mimic mechanical breathing motions, into their microenvironment blueprint to echo the harmonious rhythm of mechanical oscillations observed in the tumor milieu.",
            "score": 5,
            "explanation": "The predicted answer successfully includes all key components from the reference answer: epithelial cells, endothelial cells, and compartments for mechanical breathing motions. These elements reflect the harmonious rhythm of mechanical oscillations in the tumor milieu. The prediction aligns with the reference without omissions or errors."
        },
        {
            "query_idx": 1153,
            "query": "What quartet of molecular narratives, crafted in the artisanal forges of patient-derived tumoroids, serves as architects of prognostic destiny in the tapestry of survival outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1499
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The quartet of molecular narratives comprises four genes: #RHOF#, #SLC16A3#, ANXA10, and CDHR1, identified as predictive biomarkers for survival.",
            "predicted_answer": "The quartet of molecular narratives, identified through patient-derived tumoroids, that serve as architects of prognostic destiny in survival outcomes are RHOF, SLC16A3, ANXA10, and CDHR1.",
            "score": 5,
            "explanation": "The predicted answer includes all four genes: RHOF, SLC16A3, ANXA10, and CDHR1. The emphasis on RHOF and SLC16A3 as key facts is consistent between both answers. The predicted answer aligns well with the reference, covering all critical elements without omissions or contradictions."
        },
        {
            "query_idx": 1154,
            "query": "How does the confluence of disparate imaging realms, symbolizing the functional dynamism and anatomical precision, transmute individual deficiencies into enhanced capabilities within hybrid platforms like PET-CT and PET-MRI?",
            "retrieved_metrics": {
                "reference_idx": [
                    1504
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #confluence# of imaging realms in #hybrid platforms# like PET-CT and PET-MRI enhances capabilities by combining functional and anatomical data, overcoming individual deficiencies.",
            "predicted_answer": "The combination of PET with CT and MRI in hybrid platforms like PET-CT and PET-MRI integrates functional and anatomical data, compensating for individual deficiencies. This synergy enhances diagnostic capabilities by providing detailed anatomical information alongside high-sensitivity functional imaging.",
            "score": 5,
            "explanation": "The Predicted Answer effectively captures the essence of the Reference Answer by emphasizing the integration of functional and anatomical data in hybrid platforms like PET-CT and PET-MRI to enhance capabilities and address deficiencies. It fully reflects the key facts and aligns with the overall trend."
        },
        {
            "query_idx": 1155,
            "query": "What defined expanse within the logarithmic octanol-water partition coefficient domain must be navigated to balance lipophilicity in radiopharmaceutical constructs, thereby ensuring they meet the parameters for optimal physiological performance in vivo?",
            "retrieved_metrics": {
                "reference_idx": [
                    1503
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The lipophilicity in radiopharmaceutical constructs should be balanced within the #log D# range of #1 ≤ log D ≤ 3#.",
            "predicted_answer": "The defined expanse within the logarithmic octanol-water partition coefficient domain for optimal physiological performance in vivo is 1 ≤ log D ≤ 3.",
            "score": 5,
            "explanation": "The predicted answer effectively replicates all key facts from the reference answer, including the emphasis on the #log D# range and the specific range values (#1 ≤ log D ≤ 3#). There are no omissions or inaccuracies; therefore, it aligns wholly with the reference answer."
        },
        {
            "query_idx": 1156,
            "query": "In the realm of NSCLC pharmacological investigations, how do miniaturized fluidic apparatuses, by approximating the organic microcosm, orchestrate an evolution in potency assessment dynamics for panaxatriol, particularly when juxtaposed against their static environment analogues?",
            "retrieved_metrics": {
                "reference_idx": [
                    1495
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Miniaturized fluidic apparatuses, by better mimicking #in vivo conditions#, enhance potency assessment of #panaxatriol# through dynamic screening, real-time monitoring, and controlled drug exposure compared to static conditions.",
            "predicted_answer": "Miniaturized fluidic apparatuses, by mimicking in vivo conditions, enhance the assessment of panaxatriol's potency in NSCLC. They allow for dynamic drug screening, real-time monitoring, and controlled exposure, making them more effective than static environments.",
            "score": 5,
            "explanation": "The predicted answer effectively covers all the key facts emphasized in the reference answer: it mentions \"mimicking in vivo conditions,\" \"enhance assessment,\" \"panaxatriol,\" \"dynamic drug screening,\" \"real-time monitoring,\" and \"controlled exposure.\" The overall trend and meaning align well, with no significant omissions."
        },
        {
            "query_idx": 1157,
            "query": "What are the orchestrated components and nuanced methodologies woven into the fabric of PET imaging's temporal framework, with particular emphasis on the meticulous alignment of visuals and the delineation of regions within static and dynamic anatomical and physiological studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1507
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "PET imaging involves setting parameters for #static# and #dynamic studies#, includes motion correction, MRI-PET coregistration, spatial normalization, ROI generation, and partial volume correction.",
            "predicted_answer": "PET imaging involves data acquisition for static or dynamic studies, with arterial blood sampling for dynamic studies. Data processing includes motion correction, MRI-PET coregistration, spatial normalization, ROI generation, and PVC, ensuring accurate visual alignment and region delineation.",
            "score": 5,
            "explanation": "The Predicted Answer captures the key facts: static and dynamic studies, motion correction, MRI-PET co-registration, spatial normalization, ROI generation, and partial volume correction (PVC). While it includes details like arterial blood sampling, it aligns well with the reference, ensuring completeness of essential elements."
        },
        {
            "query_idx": 1158,
            "query": "In the complex landscape of radioactive transformation processes, what essential procedural convergence encompasses the transmutation of radiological components via mechanized systems or containment apparatus, ensuring adherence to stringent cGMP dogmas for human-oriented implementations within the arenas of positron emission tomography molecular visualization endeavors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1506
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The essential procedural convergence involves the #radiochemical synthesis# in automated modules or hot cell apparatus, ensuring adherence to #cGMP# compliances for human PET molecular imaging applications.",
            "predicted_answer": "The essential procedural convergence involves generating radionuclides, synthesizing radiopharmaceuticals in automated modules or hot cells while adhering to cGMP, and preparing the final formulation with quality control for PET imaging.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts by mentioning the synthesis in automated modules or hot cells, and adherence to cGMP, which aligns with the radiochemical synthesis and cGMP compliance emphasized in the reference answer. Both focus on PET imaging applications, ensuring no significant omissions or errors."
        },
        {
            "query_idx": 1159,
            "query": "Through which intricate methodologies do the probing evaluations of dynamic PET scanner outputs reveal the nuanced interrelations and intricate dance of radiotracers, discerned through the prism of pharmacokinetic and pharmacodynamic mappings?",
            "retrieved_metrics": {
                "reference_idx": [
                    1508
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Dynamic PET data analysis employs #tissue compartmental analysis# and #spectral analysis# to reveal pharmacokinetic and pharmacodynamic mappings of radiotracers, such as binding potential and metabolic processes.",
            "predicted_answer": "Dynamic PET scanner outputs use methodologies like tissue compartmental analysis, spectral analysis, and mathematical graphical analysis to reveal the nuanced interrelations of radiotracers, providing detailed pharmacokinetic and pharmacodynamic mappings.",
            "score": 3,
            "explanation": "The Predicted Answer includes key methodologies: \"tissue compartmental analysis\" and \"spectral analysis,\" as mentioned in the Reference Answer. However, it omits details about \"binding potential and metabolic processes,\" which are essential for completeness. The overall trend aligns, but one key fact is missing."
        },
        {
            "query_idx": 1160,
            "query": "Within the jurisdiction of exploratory nuclear medicine product application, which legislative provision articulates the constructs whereby PET experimental compounds, purposed for investigatory research but not therapeutic trials, traverse a stipulated exemption pathway from IND authorization, predicated on established safety and functional soundness for investigational studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1509
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Section #21 CFR 361.1# by #FDA regulations# details the exemption pathway for PET experimental compounds intended for investigatory research but not for therapeutic trials without IND authorization.",
            "predicted_answer": "Section 21 CFR 361.1 of FDA regulations exempts PET drugs for research use from IND approval, provided they are deemed safe and effective for investigational studies by the Radioactive Drug Research Committee (RDRC).",
            "score": 5,
            "explanation": "The predicted answer correctly includes the key facts: \"Section 21 CFR 361.1,\" \"FDA regulations,\" and the exemption for \"PET drugs for research use\" without IND authorization. It also mentions the Radioactive Drug Research Committee, which aligns with the safety and effectiveness criteria for investigational research."
        },
        {
            "query_idx": 1161,
            "query": "In the exploration of molecular candidate dynamics amidst the cognitive frontier, what analytical frameworks are employed to discern the intricacies of its rapport with biological mediators, particularly in relation to its metabolic choreography and traversal across the molecular conduit?",
            "retrieved_metrics": {
                "reference_idx": [
                    1512
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #proof-of-mechanism# approach analyzes a molecular candidate's interaction with biological mediators through its #metabolism# and blood-brain barrier penetration.",
            "predicted_answer": "Analytical frameworks such as target engagement, proof of mechanism, and proof of concept are used to understand the interactions between molecular candidates and biological mediators, including metabolic processes and traversal across barriers.",
            "score": 5,
            "explanation": "The predicted answer includes the key aspects of \"proof of mechanism,\" \"metabolic processes,\" and \"traversal across barriers,\" which align with the reference's \"proof-of-mechanism\" and \"metabolism\" and \"blood-brain barrier penetration\". The key facts are present and trends are aligned, though exact wording differs slightly."
        },
        {
            "query_idx": 1162,
            "query": "In what manner does the conceptual framework of neuroimaging delineate the quantifiable engagement of neurotransmitter receptors by Rasagiline, translating receptor saturation into a formulaic representation within the analytical paradigms of PET studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1518
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The neuroimaging framework uses #PET studies# to calculate drug-receptor occupancy (#RO%#) by Rasagiline, translating receptor saturation into formulaic representation.",
            "predicted_answer": "Neuroimaging, specifically PET studies, uses the drug-receptor occupancy (RO%) formula to quantify Rasagiline's engagement with MAO-B receptors, translating receptor saturation into a measurable and visual representation.",
            "score": 5,
            "explanation": "The predicted answer contains all key facts: use of PET studies, drug-receptor occupancy (RO%), and Rasagiline's receptor engagement. It aligns with the overall trend and details of the reference answer, despite phrasing differences. No significant omissions or errors are found."
        },
        {
            "query_idx": 1163,
            "query": "What role does the intricate sphere of PET molecular imaging play in deciphering the layered pharmacodynamics of nascent pharmacological compounds, with a focus on orchestrating receptor engagement alterations during the varied stages of drug maturation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1521
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "PET molecular imaging in #receptor occupancy# studies measures drug efficacy, penetration, and binding, aiding in understanding #pharmacodynamics# during drug development stages.",
            "predicted_answer": "PET molecular imaging plays a crucial role in assessing drug-receptor occupancy, providing insights into pharmacodynamics. It measures receptor engagement changes and helps in rational dosage selection, penetration, and specific binding during drug development.",
            "score": 5,
            "explanation": "The Predicted Answer captures the concepts of receptor occupancy and pharmacodynamics, as required by the Reference Answer. Both discuss the measurement of receptor engagement and role in drug development. The essential aspects of receptor occupancy and understanding pharmacodynamics are fully covered."
        },
        {
            "query_idx": 1164,
            "query": "What approaches are undertaken to render the full spectrum of receptor availability with the scarcely perceptible involvement of tracers, analogous to constructing a hidden topography of receptor dynamics via precise ligand engagements?",
            "retrieved_metrics": {
                "reference_idx": [
                    1514
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The approaches involve using #radioligands# that occupy < 5-10% of targets to quantify the full receptor population through #specific binding#.",
            "predicted_answer": "In vivo binding potential uses radioligands that specifically bind to receptors, occupying less than 5-10% of the target. This method quantifies the entire receptor population by excluding free and non-specifically bound radioligands, effectively mapping receptor dynamics.",
            "score": 5,
            "explanation": "The predicted answer includes the use of \"radioligands,\" and specifies they occupy \"less than 5-10% of the target,\" aligning with the reference. It emphasizes \"specific binding\" through excluding free and non-specifically bound radioligands, covering all key facts without contradictions."
        },
        {
            "query_idx": 1165,
            "query": "What is the influence of the molecular congregation's spatial thickness and the subtle grip between molecules on delineating the potential depth of binding, within the context of the dual-compartment tissue framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1526
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #molecular congregation's spatial thickness# and subtle grip influence binding potential depth by affecting the #volume of distribution# in the dual-compartment tissue framework.",
            "predicted_answer": "In the dual-compartment tissue framework, the spatial thickness and subtle grip between molecules influence the binding potential by affecting receptor density and dissociation constant, which are key in calculating the volume of distribution.",
            "score": 5,
            "explanation": "The predicted answer mentions the influence of spatial thickness and subtle grip on binding potential within the dual-compartment tissue framework. It also highlights the volume of distribution, matching the emphasis in the reference answer. Although phrasing differs, key facts remain consistent with no omissions."
        },
        {
            "query_idx": 1166,
            "query": "In the intricate tapestry of transition metal interactions, how do Ruthenium π-complexes act as catalytic weavers, orchestrating the union of $^{18}$F with heteroaromatic phenols in the deoxyfluorination narrative, and what transformative potential does this hold for the domain of automated synthesis innovations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1528
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ruthenium π-complexes lower electron density of heteroaromatic phenols, enabling nucleophilic aromatic substitution with $^{18}$F. This aids #automated synthesis# of tyrosine derivatives with high #radiochemical yields#.",
            "predicted_answer": "Ruthenium π-complexes catalyze the deoxyfluorination of heteroaromatic phenols by lowering their electron density, enabling nucleophilic $^{18}$F incorporation. This method has been automated, achieving high radiochemical yields in synthesizing tyrosine and β-CFT derivatives, advancing automated synthesis innovations.",
            "score": 5,
            "explanation": "The predicted answer includes key facts emphasized in the reference answer: it states that Ruthenium π-complexes enable nucleophilic $^{18}$F substitution and mentions high radiochemical yields. It also notes the automation in synthesis innovations, aligning with the reference's focus on automated synthesis."
        },
        {
            "query_idx": 1167,
            "query": "What are the multifaceted gains associated with the integration of iodonium constructs in the nuanced orchestration of $^{18}$F-radiolabeled biochemical entities for the purpose of engaging with the specialized domains of aromatic tyrosine residues within biomolecular frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1525
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The integration of #iodonium constructs# enables high #radiochemical yield#, regioselectivity, tolerance, and straightforward synthesis in $^{18}$F-radiopharmaceuticals targeting aromatic tyrosine residues.",
            "predicted_answer": "The integration of iodonium constructs in $^{18}$F-radiolabeling offers high radiochemical yield, regioselectivity, and straightforward synthesis, enhancing the targeting of aromatic tyrosine residues in biomolecules for effective PET radiotracer development in oncology and neurology.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts: \"iodonium constructs\", \"high radiochemical yield\", \"regioselectivity\", and \"straightforward synthesis\". However, it omits \"tolerance\" and inaccurately adds details about application in PET radiotracer development, oncology, and neurology. Although generally aligned, the missing key fact affects completeness."
        },
        {
            "query_idx": 1168,
            "query": "What are the intricate considerations involving temporal orchestration and procedural nuances that are required to strategically enhance the predominance of radioactive constituents relative to their non-radioactive counterparts in the realm of Positron Emission Tomography explorations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1529
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Temporal orchestration# involves optimizing radiotracer injection time, radiosynthesis duration, and bombardment time. #Procedural nuances# require managing radionuclide generation to enhance radioactive to non-radioactive atom ratios.",
            "predicted_answer": "To enhance the predominance of radioactive constituents in PET, focus on increasing molar activities through optimal radiotracer injection timing, radiosynthesis duration, and radionuclide generation. This reduces non-radioactive atom saturation, improving signal and image resolution.",
            "score": 3,
            "explanation": "The Predicted Answer captures the key aspects of \"temporal orchestration\" and \"procedural nuances\" by mentioning optimal radiotracer injection timing, radiosynthesis duration, and radionuclide generation. However, it misses the term \"bombardment time,\" affecting completeness but aligning with the overall trend."
        },
        {
            "query_idx": 1169,
            "query": "What intricate function do auxiliary synthetic intermediaries serve as essential components in the orchestration of precision-engineered radioligands tailored for specified clinical applications within research environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1530
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Auxiliary synthetic intermediaries serve as essential #building blocks# in synthesizing #target-specific# radioligands for clinical research, enhancing accessibility and precision.",
            "predicted_answer": "Auxiliary synthetic intermediaries, or secondary precursors, enhance the synthesis of precision-engineered radioligands by providing more accessible and versatile building blocks for clinical and preclinical research applications.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of auxiliary synthetic intermediaries as \"building blocks\" and highlights their role in enhancing precision and accessibility. However, it doesn't explicitly address \"target-specific\" radioligands, which is a key fact in the reference answer, impacting completeness."
        },
        {
            "query_idx": 1170,
            "query": "In what manner does the investigative agent $^{18}$F-Olaparib chart the path through the intricate landscape of tumor evaluation as described by Wilson et al.?",
            "retrieved_metrics": {
                "reference_idx": [
                    1533
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "$^{18}$F-Olaparib targets #PARP-1-expressing# tumors, demonstrating specific uptake in #mice xenografts# for accurate PET imaging as reported by Wilson et al.",
            "predicted_answer": "$^{18}$F-Olaparib charts the path through tumor evaluation by specifically targeting and imaging PARP-1 expression in tumors, as shown in both in-vitro and in-vivo studies by Wilson et al.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies that $^{18}$F-Olaparib targets and images PARP-1 expression in tumors, aligning with the key fact of targeting #PARP-1-expressing# tumors. However, it omits the specific mention of #mice xenografts# for PET imaging, affecting completeness."
        },
        {
            "query_idx": 1171,
            "query": "What interpretive function does the carbon-11 enriched compound known as 3-Piperidinylethoxyanilinoquinazoline fulfill in the context of analyzing the efficacy of oncological interventions, as observed in recent investigative frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1535
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#3-Piperidinylethoxyanilinoquinazoline# is used as a #radiotracer# to assess cancer treatment responses in oncological investigations.",
            "predicted_answer": "The carbon-11 enriched 3-Piperidinylethoxyanilinoquinazoline (PAQ) serves as a radiotracer to assess the effectiveness of oncological treatments, particularly in monitoring the response to tyrosine kinase inhibitors like vandetanib in breast cancer.",
            "score": 5,
            "explanation": "The predicted answer successfully identifies 3-Piperidinylethoxyanilinoquinazoline as a radiotracer, capturing the function as described in the reference answer. However, it provides additional specific information about monitoring response in breast cancer and using tyrosine kinase inhibitors, which is not emphasized in the reference but is not contradictory."
        },
        {
            "query_idx": 1172,
            "query": "How does the catalytic agent of metallic origin participate in steering the chemical metamorphosis detailed in the copper-centered synthesis pathway mentioned within the contextual data?",
            "retrieved_metrics": {
                "reference_idx": [
                    1536
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #copper-mediated# reaction enables the chemical transformation by facilitating the #radiofluorination# process in the synthesis pathway.",
            "predicted_answer": "The copper catalyst facilitates the radiofluorination reaction, enabling the synthesis of the compound. This process is crucial for producing the $^{18}$F-labeled ligand, which targets tumor-associated enzymes like carbonic anhydrase IX and XII in cancer cells.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by mentioning the copper catalyst's role in facilitating the radiofluorination process. However, it adds details about producing the $^{18}$F-labeled ligand, which is supplementary and doesn't contradict the reference. All key facts emphasized with # are present."
        },
        {
            "query_idx": 1173,
            "query": "Within the framework of molecular visualization, how does harnessing the [$^{18}$F]MGS3 entity as a catalytic muse contribute to delineating the heightened presence of histone deacetylases, and what inherent advantages does it reveal in examining disease states through the lattice of positron emission tomography?",
            "retrieved_metrics": {
                "reference_idx": [
                    1534
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Using #[$^{18}$F]MGS3# in PET imaging offers high brain uptake and specific binding, helping to visualize HDAC overexpression linked to cancer and neuropathologies.",
            "predicted_answer": "[$^{18}$F]MGS3, as a radiotracer, enables the visualization of histone deacetylases (HDACs) via PET, revealing their overexpression in diseases. Its high brain uptake and specific binding offer precise localization, aiding in the study of cancer, neurodegenerative, and psychiatric conditions.",
            "score": 5,
            "explanation": "The predicted answer includes critical elements such as the use of [$^{18}$F]MGS3, HDAC visualization through PET, high brain uptake, specific binding, and its involvement in studying cancer and neuro-pathologies. These align well with the key facts highlighted in the reference answer."
        },
        {
            "query_idx": 1174,
            "query": "How do the elusive 5-HT₁B receptors, functioning as molecular sentinels, influence the intricate tapestry of central nervous system ailments, as deciphered through PET imaging utilizing the distinct radioligand [$^{18}$F]AZ10419096?",
            "retrieved_metrics": {
                "reference_idx": [
                    1540
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The 5-HT₁B receptors, imaged using #[$^{18}$F]AZ10419096#, are linked to central nervous system disorders like #anxiety# and #depression#, serving as hallmarks for study with PET imaging.",
            "predicted_answer": "5-HT₁B receptors, when imaged with [$^{18}$F]AZ10419096 via PET, show abnormalities linked to CNS disorders such as anxiety and depression, indicating their role in these conditions.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts that the 5-HT₁B receptors are imaged with [$^{18}$F]AZ10419096 through PET and are related to CNS disorders like anxiety and depression. It accurately reflects the overall meaning and key details from the reference without contradictions."
        },
        {
            "query_idx": 1175,
            "query": "In the realm of chemogenetic orchestration within primate cerebral frameworks, what intrinsic elements account for the nearly doubled perceptive luminosity of [$^{11}$C]DCZ over the enigmatic back-current presented by [$^{11}$C]CLZ in the specialized DREADD civil engineering of neural pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1541
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #signal-to-background ratio# of [$^{11}$C]DCZ is nearly doubled because it has a #much lower background uptake# compared to [$^{11}$C]CLZ.",
            "predicted_answer": "The higher perceptive luminosity of [$^{11}$C]DCZ over [$^{11}$C]CLZ in DREADD-modified neural pathways is due to its greater selectivity for DREADD hM4Di receptors and significantly lower background uptake, resulting in a nearly 2-fold better signal-to-background ratio.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the \"nearly doubled signal-to-background ratio\" and mentions the \"much lower background uptake,\" which are the key facts emphasized in the reference answer. It also accurately captures the overall trend without contradicting any information."
        },
        {
            "query_idx": 1176,
            "query": "In what manner do the intricate interplays and neuronal engagements of [$^{18}$F]FPYBF-2 within the neural tapestry substantiate its credentials as an incisive tool for illuminating the enigmatic amyloid manifestations in Alzheimer's pathology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1543
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate interplays of #[$^{18}$F]FPYBF-2# substantiate its credentials for illuminating #amyloid# manifestations in Alzheimer's by showing high uptake in gray and cerebral white matter.",
            "predicted_answer": "[$^{18}$F]FPYBF-2 demonstrates high uptake in gray and white matter of Alzheimer's patients, making it a powerful PET imaging agent for detecting amyloid plaques, thus illuminating the disease's pathology.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts that [$^{18}$F]FPYBF-2 shows high uptake in both gray and white matter, which are critical for detecting amyloid plaques in Alzheimer's pathology, aligning with the reference answer. It fully covers the key points without omissions."
        },
        {
            "query_idx": 1177,
            "query": "In what ways does the extended temporally bound stability of fluorine-18, juxtaposed with the ephemeral nature of carbon-11, advance the perpetual synthesis cycle and analytical multiplicity in the realm of PET radiopharmacology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1547
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #extended stability# of fluorine-18 enables repeated PET studies in a day, enhancing #analytical multiplicity#; carbon-11 supports diverse synthesis despite a shorter half-life.",
            "predicted_answer": "The extended stability of fluorine-18 (110 min half-life) allows for multiple PET studies in a single day, enhancing synthesis and analysis. In contrast, carbon-11's shorter half-life (20.4 min) limits its use but enables direct insertion into heterocycles, supporting rapid and efficient radiopharmaceutical synthesis.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by highlighting the extended stability of fluorine-18 and its role in enhancing analytical multiplicity through multiple PET studies. It also contrasts with carbon-11's shorter half-life. The key facts and the overall trend are present, with no significant omissions."
        },
        {
            "query_idx": 1178,
            "query": "In what intriguing capacity does the avant-garde radiotracer 10-($+$)[$^{11}$C]DTBZ operate as an illuminative vessel in the expansive tapestry of PET imaging, facilitating the decoding of Parkinson's intricate neurochemical saga?",
            "retrieved_metrics": {
                "reference_idx": [
                    1544
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The avant-garde radiotracer 10-($+$)[$^{11}$C]DTBZ operates by targeting #VMAT$_{2}$# receptors, using PET imaging to study #Parkinson's# disease.",
            "predicted_answer": "10-($+$)[$^{11}$C]DTBZ operates as a radiotracer in PET imaging, targeting VMAT2 receptors to visualize dopamine storage in the brain, aiding in the understanding and diagnosis of Parkinson's disease.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of targeting VMAT2 receptors and its application to Parkinson's disease using PET imaging. The details and trend align closely with the reference, covering both emphasized points with no omissions or contradictory information."
        },
        {
            "query_idx": 1179,
            "query": "Within the multifaceted tapestry of protein modification, how might the orchestrated linkage of K63 ubiquitin chains conceptualize their role in modulating the transformative pathway of Oct4 stability amidst the cellular landscape of the mouse embryonic stem environment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1549
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "K63-linked ubiquitin chains #induce degradation# of Oct4 in #mouse embryonic stem# cells, affecting its stability.",
            "predicted_answer": "K63-linked ubiquitin chains, contrary to their typical role in regulating activity and localization, act as a degradation signal for Oct4 in mouse embryonic stem cells, modulating its stability.",
            "score": 5,
            "explanation": "The predicted answer mentions K63-linked ubiquitin chains induce degradation of Oct4 in mouse embryonic stem cells, successfully covering both key facts emphasized in the reference answer. The overall trend and key details are aligned without significant omissions or errors."
        },
        {
            "query_idx": 1180,
            "query": "What are the molecular nodal points within the ubiquitin architecture that serve as pivotal anchors for interlinking to form polyubiquitin chains?",
            "retrieved_metrics": {
                "reference_idx": [
                    1550
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The molecular nodal points within the ubiquitin architecture are all #lysine (K) residues#, including K6, K11, K27, K29, K33, K48, and K63, that form polyubiquitin chains.",
            "predicted_answer": "The pivotal anchors for interlinking to form polyubiquitin chains are the lysine (K) residues within the ubiquitin molecule, specifically K6, K11, K27, K29, K33, K48, and K63.",
            "score": 5,
            "explanation": "The predicted answer fully contains all key facts emphasized in the reference answer, listing the lysine (K) residues K6, K11, K27, K29, K33, K48, and K63, specified as pivots for forming polyubiquitin chains. The meaning and details align completely, with no omissions or contradictions."
        },
        {
            "query_idx": 1181,
            "query": "What complex architectural symphony defines the divergence in the bathymetry of ubiquitin unit linkages when contrasting the distinct ensemble of mixed polyubiquitin constructs to the intricate webwork inherent in branched polyubiquitin formations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1548
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Mixed polyubiquitin constructs# diverge by employing #distinct residues# for linkage, whereas branched polyubiquitin formations use multiple K residues concurrently.",
            "predicted_answer": "The complex architectural symphony in ubiquitin linkages involves mixed polyubiquitin constructs using different residues for each linkage, while branched formations feature a single ubiquitin unit linking through multiple lysine residues, creating a more intricate network.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects that mixed polyubiquitin constructs use different residues for linkages and correctly identifies branched formations involving multiple lysine (K) residues. It captures the key idea of using different residues in mixed linkages and lysine residues in branched formations."
        },
        {
            "query_idx": 1182,
            "query": "In what manner do E2 enzymes orchestrate the molecular symphony that dictates the architectural nuances of ubiquitin chains within the intricate cellular milieu of human systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    1551
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "E2 enzymes determine the #length# and #topology# of ubiquitin chains by orchestrating the molecular interactions in human cells.",
            "predicted_answer": "E2 enzymes determine the length and topological structure of ubiquitin chains, orchestrating their architectural nuances within human cells. This process is crucial for specific substrate recognition and modification by E3 ligases.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of determining the \"length\" and \"topology\" of ubiquitin chains mentioned in the reference answer. It aligns with the overall trend and context without omissions or contradictions in crucial information."
        },
        {
            "query_idx": 1183,
            "query": "Within the landscape of enzymatic machinations, which architectural augmentations distinctively delineate the fourth hierarchy of E2 entities in terms of their relational dynamics, as compared to their more foundational counterparts?",
            "retrieved_metrics": {
                "reference_idx": [
                    1552
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Class IV E2s feature extensions at #both ends#, enhancing subcellular localization and #interaction# with partners, distinguishing them from other E2 classes.",
            "predicted_answer": "Class IV E2s are distinguished by having extension regions at both the C- and N-termini, which regulate subcellular localization and mediate interactions with other partners.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts from the reference answer, highlighting the extensions at both ends and their roles in subcellular localization and interaction with partners. There are no significant omissions or errors, and the overall meaning is consistent."
        },
        {
            "query_idx": 1184,
            "query": "In the molecular chess game of life, what strategic derivatives arise from the destabilization equilibrium orchestrated by UAE inhibition on the molecular custodians such as p53, and how do these derivatives intricately rechart the pathway of progressive cellular transformation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1556
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "UAE inhibition destabilizes #endoplasmic reticulum#, leading to apoptosis and stabilizes #p53#, delaying cancer progression and activating NFκ B to suppress tumor growth.",
            "predicted_answer": "UAE inhibition destabilizes endoplasmic reticulum homeostasis, leading to apoptosis and stabilization of tumor suppressors like p53. This delays cancer progression and activates the NFκB pathway, further suppressing tumor growth.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the destabilization of the endoplasmic reticulum homeostasis and stabilization of p53 as well as the activation of the NFκB pathway, aligned with the reference. Key facts are present, and the overall trend is consistent, with no significant omissions."
        },
        {
            "query_idx": 1185,
            "query": "What facets of the holistic corporeal scanning paradigm in state-of-the-art PET/CT systems imbue them with enhanced capacity to refine the predictive landscapes of pharmacokinetic and pharmacodynamic assessments, thereby surpassing the conventional imaging modalities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1545
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #total-body# PET/CT enhances #pharmacokinetics# and pharmacodynamics assessments by visualizing radiopharmaceutical distribution and delivering higher sensitivity dynamic scans for comprehensive systemic disease evaluation.",
            "predicted_answer": "The holistic corporeal scanning in state-of-the-art PET/CT systems, with higher sensitivity and total-body dynamic scans, provides more precise pharmacokinetic and pharmacodynamic assessments, surpassing conventional modalities by offering comprehensive kinetic information and better SNR at later time points.",
            "score": 5,
            "explanation": "The predicted answer mentions \"total-body dynamic scans\" and \"higher sensitivity,\" covering the key facts of the #total-body# PET/CT and its higher sensitivity for enhancing pharmacokinetic and pharmacodynamic assessments. The mention of \"comprehensive kinetic information\" aligns generally with \"visualizing radiopharmaceutical distribution.\""
        },
        {
            "query_idx": 1186,
            "query": "How does the ubiquitin proteasome system, likened to an orchestral conductor, play a crucial part in maintaining the symphony of protein homeostasis amidst the complex interplay of cellular dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1558
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #ubiquitin proteasome system# is crucial for #protein homeostasis#, akin to a conductor ensuring harmony in cellular dynamics by regulating protein modification and degradation.",
            "predicted_answer": "The ubiquitin proteasome system (UPS) orchestrates protein homeostasis by selectively tagging and degrading damaged or unnecessary proteins, ensuring the cell functions smoothly. This process is vital for maintaining cellular health and preventing diseases like cancer.",
            "score": 5,
            "explanation": "The predicted answer addresses the role of the ubiquitin proteasome system (UPS) in protein homeostasis, akin to a conductor. It covers key facts like protein tagging, degradation, and cellular health, which align with the reference's emphasis on modification and degradation, missing no critical details."
        },
        {
            "query_idx": 1187,
            "query": "What unique pattern embodied within the phosphorylated constructs does the WW domain of Wwp2 meticulously engage during its molecular recognition process?",
            "retrieved_metrics": {
                "reference_idx": [
                    1566
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The WW domain of Wwp2 engages the #phosphorylated PPxY motif# during its molecular recognition process.",
            "predicted_answer": "The WW domain of Wwp2 specifically recognizes and engages with phosphorylated PPxY motifs during its molecular recognition process.",
            "score": 5,
            "explanation": "The predicted answer accurately covers the key fact emphasized in the reference answer by mentioning the recognition of the \"phosphorylated PPxY motifs\" by the WW domain of Wwp2. There are no significant omissions or errors, and the overall trend is fully aligned."
        },
        {
            "query_idx": 1188,
            "query": "In what capacity does the molecular pivot known as Rbx1 manifest within the structural edifice of the SCF Skp2 ensemble to enable the intricate dance of ubiquitin attachment, and how do its catalytic affinities guide the mechanistic overture of this biochemical sequence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1564
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rbx1, within the #SCF Skp2# complex, recruits E2 via the RING domain, forming the catalytic center with #Cul1# to facilitate ubiquitin transfer to substrates.",
            "predicted_answer": "Rbx1, through its RING domain, recruits E2 enzymes and forms the catalytic center with Cul1, facilitating the direct transfer of ubiquitin to substrates in the SCF Skp2 complex.",
            "score": 5,
            "explanation": "The predicted answer accurately describes the function of Rbx1 in the SCF Skp2 complex, its interaction with E2 through the RING domain, and forming a catalytic center with Cul1, all of which match the key facts emphasized in the reference answer."
        },
        {
            "query_idx": 1189,
            "query": "In the realm of cellular guardians against apoptotic demise, what characteristic molecular blueprint underlies the orchestration of proteic alliances, and through what mechanism does this blueprint contribute to the propensity for neoplastic development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1567
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The characteristic molecular blueprint is the #BIR sequence#, which facilitates protein-protein interactions. This #enhances neoplastic development# by repressing apoptosis and promoting tumor growth.",
            "predicted_answer": "The characteristic molecular blueprint of IAPs includes BIR domains for protein-protein interactions and RING domains. This structure allows IAPs to inhibit apoptosis, contributing to neoplastic development by promoting uncontrolled cell growth, as seen in cancers like melanoma.",
            "score": 5,
            "explanation": "The predicted answer includes #BIR domains# for protein-protein interactions like the reference's #BIR sequence#. It also aligns with the reference answer's emphasis on #enhancing neoplastic development# through repression of apoptosis and promotion of tumor growth. There are no significant omissions or errors."
        },
        {
            "query_idx": 1190,
            "query": "What particular mechanistic blockade does the peptide borate entity, bortezomib, implement to disrupt the proteolytic continuum of the 26S proteasome concerning the therapeutic intervention for multiple myeloma?",
            "retrieved_metrics": {
                "reference_idx": [
                    1568
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The peptide borate entity #bortezomib# disrupts the proteolytic continuum of the 26S proteasome by blocking its #chymotrypsin-like activity# in therapeutic interventions for multiple myeloma.",
            "predicted_answer": "Bortezomib, a peptide borate inhibitor, blocks the chymotrypsin-like activity of the 26S proteasome, disrupting the proteolytic process and serving as a therapeutic intervention for multiple myeloma.",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects the key facts of the Reference Answer, mentioning both “bortezomib” and its blocking of the “chymotrypsin-like activity” of the 26S proteasome. The details align well, with no significant omissions or errors regarding the crucial mechanistic blockade."
        },
        {
            "query_idx": 1191,
            "query": "What role does the molecular interplay between Wwp2 and the catalytic domain of PTEN serve as a catalyst in orchestrating the equilibrium of cellular guardianship and signaling pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1569
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The molecular interplay between #Wwp2# and PTEN's catalytic domain stimulates PTEN's #ubiquitination# and degradation, thus influencing the equilibrium of cellular guardianship and signaling pathways.",
            "predicted_answer": "The molecular interplay between Wwp2 and PTEN's catalytic domain promotes PTEN ubiquitination and degradation, influencing the balance of cellular guardianship and signaling pathways, particularly the PI3K/Akt pathway.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts: the molecular interaction of Wwp2, PTEN's ubiquitination, and degradation's impact on cellular balance. The addition of detail about the PI3K/Akt pathway does not affect its alignment with the reference answer. All emphasized points are covered effectively."
        },
        {
            "query_idx": 1192,
            "query": "In the intricate dance of molecular interactions, which specific catalytic mechanism does the tetrapeptide epoxyketone, carfilzomib, elegantly hinder, and what subsequent ripple effects does this interference cause in the aggregation of molecular substrates within the proteasomal pathway?",
            "retrieved_metrics": {
                "reference_idx": [
                    1570
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Carfilzomib inhibits the #26S proteasome#'s chymotrypsin-like activity, causing #accumulation# of ubiquitinated substrates in the proteasomal pathway.",
            "predicted_answer": "Carfilzomib selectively binds to the 26S proteasome, inhibiting chymotrypsin-like activity, which leads to the accumulation of ubiquitinated substrates, disrupting normal protein degradation and causing molecular aggregation.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized in the reference: it mentions the inhibition of the 26S proteasome, chymotrypsin-like activity, and the accumulation of ubiquitinated substrates, aligning with the reference answer's meaning and completeness without any contradictions."
        },
        {
            "query_idx": 1193,
            "query": "How does the strategic convergence of ixazomib alongside the lenalidomide/dexamethasone constellation act to illuminate a path towards augmented longevity in individuals confronting the challenging journey of myeloma management?",
            "retrieved_metrics": {
                "reference_idx": [
                    1571
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Combining #ixazomib# with lenalidomide/dexamethasone #increases survival rate# in myeloma patients, augmenting longevity by enhancing antitumor effects.",
            "predicted_answer": "The combination of ixazomib with lenalidomide and dexamethasone significantly increases the survival rate of myeloma patients, offering a more effective treatment strategy.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts that ixazomib is combined with lenalidomide and dexamethasone, and such a combination increases the survival rate of myeloma patients. However, it misses the specific mention of \"enhancing antitumor effects,\" impacting the completeness of the answer."
        },
        {
            "query_idx": 1194,
            "query": "What intrinsic attributes could the architectural blueprints of smallness hold in contrast to the expansive molecular formations within the landscape of drug discovery, specifically in terms of their capacity for chemical refinement and the facilitation of novel protein interaction pathways for targeted degradation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1574
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Molecular glue degraders, being #smaller#, are easier to optimize for chemical properties and enable novel #protein interactions# for targeted degradation, unlike larger PROTACs.",
            "predicted_answer": "Architectural blueprints of smallness, like molecular glue degraders, offer advantages in drug discovery due to their smaller size and easier chemical refinement. They facilitate novel protein interactions, enabling targeted degradation more efficiently than larger PROTACs.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference, such as the small size of molecular glue degraders, their ease of chemical refinement, and their ability to enable novel protein interactions for targeted degradation, similar to the reference answer's description."
        },
        {
            "query_idx": 1195,
            "query": "In the intricate landscape of pharmacological breakthroughs targeting enzymatic realms, through what mechanisms does Tak-243 exert its modulatory prowess over UAE in the elaborate context of E1 enzyme regulation, and what prospects does this modulation signal for pioneering therapeutic paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1573
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tak-243 exerts its #modulatory prowess# over UAE by specifically inhibiting the #E1 enzyme#, signaling potential for new therapeutic paradigms targeting enzymatic regulation.",
            "predicted_answer": "Tak-243 inhibits UAE, an E1 enzyme, by binding to its active site and blocking its function. This modulation can disrupt ubiquitin-mediated protein degradation, potentially leading to novel therapeutic approaches for diseases where this pathway is dysregulated.",
            "score": 5,
            "explanation": "The predicted answer includes key facts: Tak-243 inhibits UAE specifically at the E1 enzyme, consistent with the reference answer. It mentions disruption in protein degradation pathways, aligning with the modulation mentioned. It reflects the overall trend and key concepts without contradictions or missing key details."
        },
        {
            "query_idx": 1196,
            "query": "What are the dual manifestations of mechanistic inhibition that serdemetan strategically navigates within its antagonistic endeavors as an HDM2 E3 ligase disruptor?",
            "retrieved_metrics": {
                "reference_idx": [
                    1576
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Serdemetan strategically navigates mechanistic inhibition by preventing p53 #degradation# through HDM2 antagonism and inhibiting #cholesterol transport#.",
            "predicted_answer": "Serdemetan, as an HDM2 E3 ligase antagonist, primarily inhibits the degradation of p53 by disrupting the HDM2-p53 interaction and also inhibits cholesterol transport.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"inhibiting the degradation of p53\" and \"inhibiting cholesterol transport\" as the dual mechanisms of action for serdemetan, both of which align with the key facts emphasized with # in the reference answer. There are no significant omissions or errors."
        },
        {
            "query_idx": 1197,
            "query": "Within the framework of the therapeutic crusade against cellular aberrations, which intricate health predicaments is the molecular endeavor Tak-243 strategically aligned to address amid its clinical probing phase?",
            "retrieved_metrics": {
                "reference_idx": [
                    1572
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tak-243 is strategically aligned to address #refractory acute myeloid leukemia#, #refractory myelodysplastic syndrome#, and chronic myelomonocytic leukemia during its clinical probing phase.",
            "predicted_answer": "Tak-243 is being clinically tested to treat refractory acute myeloid leukemia, refractory myelodysplastic syndrome, and chronic myelomonocytic leukemia by reducing ubiquitination levels and inducing cancer cell death.",
            "score": 5,
            "explanation": "The predicted answer includes all the key conditions (#refractory acute myeloid leukemia#, #refractory myelodysplastic syndrome#, and chronic myelomonocytic leukemia) highlighted in the reference answer. There are no omissions or contradictions, aligning well with the reference content."
        },
        {
            "query_idx": 1198,
            "query": "Within the enigmatic theatre of oncogenesis, how do RING-type E3 IAPs, functioning as subtle conductors of apoptotic inhibition, shape the evolutionary symphony toward the crafting of immune-centric therapeutic avenues?",
            "retrieved_metrics": {
                "reference_idx": [
                    1582
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#RING-type E3 IAPs# regulate oncogenesis by inhibiting apoptosis, influencing #cancer immunotherapy# development as potential therapeutic targets.",
            "predicted_answer": "RING-type E3 IAPs, by inhibiting apoptosis, contribute to cancer development. Targeting these IAPs can enhance immune responses, paving the way for new immunotherapy strategies in cancer treatment.",
            "score": 5,
            "explanation": "The predicted answer correctly mentions that RING-type E3 IAPs inhibit apoptosis and their potential role in cancer immunotherapy, aligning with the key facts of the reference answer. The terminology and trend are consistent, with no significant omissions or contradictory information."
        },
        {
            "query_idx": 1199,
            "query": "How does the molecular conductor known as HOIP orchestrate its symphony within the human body's systemic defense mechanisms, and under what classification does this dynamic biochemical maestro fall?",
            "retrieved_metrics": {
                "reference_idx": [
                    1580
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The molecular conductor #HOIP# orchestrates immune response regulation and falls under #RBR-type E3 inhibitors#.",
            "predicted_answer": "HOIP, an RBR-type E3 ligase, plays a key role in the human immune response. It interacts with and regulates proteins involved in immune signaling. HOIP inhibitors, like bendamustine, are used to treat cancers, indicating its importance in systemic defense.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies HOIP as an RBR-type E3 ligase and its role in immune response regulation, matching key facts. However, it misclassifies HOIP itself as an inhibitor and not under RBR-type E3 inhibitors, which slightly affects the answer's completeness."
        },
        {
            "query_idx": 1200,
            "query": "In what manner do the pharmacological enablers, such as GDC-0152 along with other clinical inhibitors, initiate the proteasome-mediated disassembly of the proteins XIAP and cIAP1, drawing upon mechanisms reminiscent of the Smac/DIABLO paradigm?",
            "retrieved_metrics": {
                "reference_idx": [
                    1579
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The pharmacological enablers like #GDC-0152# initiate #proteasome-mediated disassembly# of XIAP and cIAP1 by mimicking the Smac/DIABLO mechanism.",
            "predicted_answer": "GDC-0152 and other clinical inhibitors mimic the Smac/DIABLO domain to promote the proteasome-dependent degradation of XIAP and cIAP1, facilitating their disassembly.",
            "score": 5,
            "explanation": "The predicted answer fully reflects the key facts: the involvement of GDC-0152, the proteasome-mediated disassembly of XIAP and cIAP1, and the Smac/DIABLO mimicry. The meaning and core details are in line with the reference, satisfying the completeness requirement."
        },
        {
            "query_idx": 1201,
            "query": "In the realm of oncology research's early investigatory stages, what conceptual hurdles arise from the interplay of patient demographic paradigms and trial phase-specific dynamics when calibrating therapeutic dosages, considering the intricate mosaic of immediate and longitudinal tolerability nuances?",
            "retrieved_metrics": {
                "reference_idx": [
                    1587
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Calibrating therapeutic dosages in early oncology trials faces #complexities# due to patient demographic paradigms and differing #tolerances# for toxicities, influenced by immediate and long-term tolerability nuances.",
            "predicted_answer": "In early oncology trials, key hurdles include varying patient tolerances, differing risk profiles, and the need for long-term data. These factors complicate dose calibration, as immediate and longitudinal tolerability must be balanced.",
            "score": 3,
            "explanation": "The predicted answer covers the complexities due to varying patient tolerances and the balance needed for immediate and long-term tolerability, aligning well with the reference. However, it misses discussing the specific role of patient demographic paradigms, a key emphasized fact."
        },
        {
            "query_idx": 1202,
            "query": "What pivotal function do evolutionarily dynamic exploration frameworks serve in orchestrating and refining the strategic allocation of therapeutic dosages within the unfolding narrative of study BLC2001?",
            "retrieved_metrics": {
                "reference_idx": [
                    1590
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Evolutionarily dynamic exploration frameworks in #study BLC2001# identify and refine dosing regimens by analyzing safety and efficacy, optimizing #therapeutic dosages# in real-time.",
            "predicted_answer": "Evolutionarily dynamic exploration frameworks in study BLC2001 enable real-time analysis and adjustment of therapeutic dosages, optimizing efficacy and safety by eliminating suboptimal dosing arms and supplementing those with favorable profiles.",
            "score": 5,
            "explanation": "The Predicted Answer aligns with the overall trend and meaning of the Reference Answer. It talks about the role of evolutionarily dynamic exploration frameworks in study BLC2001 in optimizing therapeutic dosages through real-time analysis of safety and efficacy. However, it slightly diverges by focusing more on dosage arms rather than regimens as the reference indicates, but still reflects the core aspect of optimizing therapeutic dosages."
        },
        {
            "query_idx": 1203,
            "query": "What potential reverberations may arise from misguided alignment in therapeutic calibrations within the initial layers of patient-centric exploratory trials, specifically regarding their complex interplay with comprehensive patient wellness and the successful manifestation of therapeutic intents?",
            "retrieved_metrics": {
                "reference_idx": [
                    1591
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Misguided alignment in therapeutic calibrations can lead to #toxicity#, reduced quality of life, frequent dose adjustments, diminished efficacy, and challenges in developing combination regimens.",
            "predicted_answer": "Misguided alignment in therapeutic calibrations can lead to poor dose optimization, causing adverse effects like toxicity, reduced quality of life, and diminished treatment efficacy, ultimately hindering comprehensive patient wellness and therapeutic success.",
            "score": 3,
            "explanation": "The predicted answer covers most key facts such as toxicity, reduced quality of life, and diminished treatment efficacy. However, it misses \"frequent dose adjustments\" and \"challenges in developing combination regimens,\" which are important aspects of the reference answer."
        },
        {
            "query_idx": 1204,
            "query": "What intricate constellation of pharmacokinetic and dynamic parameters orchestrated the institutional embrace of the recalibrated 8mg daily regimen, with a conditional enhancement to 9mg predicated on phosphorous serum metrics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1593
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Pharmacokinetic# and #pharmacodynamic# analyses indicated that the 8mg daily regimen, with an increase to 9mg if serum PO4 < 5.5mg/dL, maintained optimal PO4 levels and reduced treatment interruptions.",
            "predicted_answer": "The 8mg daily regimen, with a conditional increase to 9mg based on serum phosphorus levels, was adopted after PK/PD analysis showed it optimized phosphorus levels and reduced treatment interruptions.",
            "score": 3,
            "explanation": "The predicted answer reflects the pharmacokinetic and pharmacodynamic considerations and mentions the conditional increase based on serum phosphorus levels, aligning with the reference. However, it does not specify the threshold of \"serum PO4 < 5.5mg/dL,\" making it incomplete on that key detail."
        },
        {
            "query_idx": 1205,
            "query": "What influence did the revelation of advantageous nutritional dynamics exert upon the strategic calibration of ceritinib's pharmacological regimen within the intricate framework of its clinical assessment narrative?",
            "retrieved_metrics": {
                "reference_idx": [
                    1595
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The revelation of a #positive food effect# led to an additional clinical trial to reconsider ceritinib's dosing strategy, aiming to improve its benefit/risk profile.",
            "predicted_answer": "The revelation of a positive food effect led to an additional clinical trial, which evaluated the benefit/risk profile of fed dosing, ultimately influencing the strategic adjustment of ceritinib's pharmacological regimen.",
            "score": 5,
            "explanation": "The predicted answer covers the key fact of a \"positive food effect,\" and aligns with the reference answer regarding the influence on ceritinib's dosing strategy. Both emphasize the strategic adjustment for the benefit/risk profile. No significant details are missing, and there is no contradictory information."
        },
        {
            "query_idx": 1206,
            "query": "Within the intricate weave of early-stage pharmacological investigations, as various dosage regimens are methodically examined, what underlying strategic essence does this investigative endeavor project between the realm of preliminary hypotheses and the horizon of confirmatory inquiries?",
            "retrieved_metrics": {
                "reference_idx": [
                    1592
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The strategic essence of early pharmacological investigations is to evaluate #clinical antitumor activity# and refine #dose selection# for future confirmatory trials.",
            "predicted_answer": "This investigative endeavor aims to refine dose optimization, assess safety and tolerability, and evaluate preliminary antitumor activity, bridging initial hypotheses with data needed for confirmatory trials.",
            "score": 5,
            "explanation": "The predicted answer includes refining dose optimization and mentions the evaluation of preliminary antitumor activity, aligning with the reference's emphasis on dose selection and clinical antitumor activity. It adequately bridges the strategic essence required for future confirmatory trials, covering necessary key facts."
        },
        {
            "query_idx": 1207,
            "query": "What intricate molecular choreography does CC-90009 mobilize to orchestrate the tagging and subsequent deconstruction of GSPT1 within its destined biochemical pathway?",
            "retrieved_metrics": {
                "reference_idx": [
                    1581
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CC-90009 mobilizes the #CRL4 CRBN# E3 complex to #ubiquitinate# GSPT1, leading to its proteasomal degradation.",
            "predicted_answer": "CC-90009 recruits the CRL4 CRBN E3 ubiquitin ligase complex to tag GSPT1 with ubiquitin, marking it for degradation by the proteasome.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts: the recruitment of the CRL4 CRBN E3 ubiquitin ligase complex, ubiquitination of GSPT1, and subsequent proteasomal degradation. The meaning and sequence of events align with the reference answer, maintaining completeness and consistency."
        },
        {
            "query_idx": 1208,
            "query": "How was the dose refinement symphony of the allosteric agent asciminib orchestrated to achieve tailored modulation in dosages for those navigating the chronic myeloid leukemia continuum in its standard phase, and through what differentiated metrics was the therapeutic cadence attuned for patients encapsulating the T315I genetic anomaly?",
            "retrieved_metrics": {
                "reference_idx": [
                    1599
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #dose refinement# of asciminib was achieved using PK/PD modeling, leading to tailored dosages: #40 mg# for chronic phase and 200 mg for T315I mutation patients.",
            "predicted_answer": "The dose refinement for asciminib was orchestrated using PK/PD modeling, selecting 40 mg twice daily for chronic phase patients and 200 mg twice daily for those with the T315I mutation, ensuring target threshold maintenance.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts from the reference answer, including the use of PK/PD modeling for dose refinement and the specific dosages of 40 mg for chronic phase patients and 200 mg for those with the T315I mutation. The meaning is consistent with no significant omissions."
        },
        {
            "query_idx": 1209,
            "query": "In what ways do the diverse architects and artisans of therapeutic innovation harmonize their intellect to ensure that essential queries are articulated and pursued amid the dynamic narrative of the drug development odyssey using the learn-confirm MIDD framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1600
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #learn-confirm MIDD# framework unites diverse experts to ensure essential queries are pursued, focusing on #dose optimization# to maximize benefit versus risk across clinical contexts.",
            "predicted_answer": "Diverse experts in therapeutic innovation use the learn-confirm MIDD framework to collaborate, ensuring essential questions are addressed. This integrated approach focuses on dose optimization and patient benefit, aligning with the evolving goals of drug development.",
            "score": 5,
            "explanation": "The predicted answer reflects the key facts emphasized in the reference answer, such as the use of the learn-confirm MIDD framework and the focus on dose optimization. Both answers align on ensuring essential questions are pursued in drug development, with no significant omissions or errors."
        },
        {
            "query_idx": 1210,
            "query": "Through what nuanced orchestration of dosimetric alignment and therapeutic substantiation was the viability and assured effectiveness of the sanctioned dosage verified for those experiencing RET fusion-integrated pulmonary malignancies and RET-mutant thyroidal growths?",
            "retrieved_metrics": {
                "reference_idx": [
                    1601
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #160 mg# twice daily dosage for selpercatinib was verified through PK/PD models, simulating tumor inhibition while considering #QTc interval prolongation# risks and correlating tumor reduction with survival probability.",
            "predicted_answer": "The viability and assured effectiveness of the sanctioned dosage for RET fusion-positive pulmonary malignancies and RET-mutant thyroidal growths were verified through dose-escalation trials, PK/PD modeling, and simulations that correlated tumor size reduction with improved survival probability.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference in using PK/PD modeling and correlating tumor reduction with survival. However, it omits the specific dosage #160 mg#, the twice daily frequency, and the consideration of #QTc interval prolongation# risks, which are critical details for evaluation."
        },
        {
            "query_idx": 1211,
            "query": "What intricate forces and multifaceted dynamics challenge the steadfast persistence of conceptual decision-making paradigms within the convoluted realms of oncological pharmacology, especially amidst the temporal constraints and the complex biological tapestries characteristic of this pharmacological labyrinth?",
            "retrieved_metrics": {
                "reference_idx": [
                    1604
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The challenges in #oncological pharmacology# include the complexity of disease, patient populations, and #accelerated development# timelines, hindering the consistent application of decision-making frameworks.",
            "predicted_answer": "In oncological pharmacology, the complexity of diseases, diverse patient populations, and accelerated timelines challenge the consistent application of decision-making frameworks like 3 Pillar and 5R, necessitating early evidence generation and regulatory engagement for dose optimization.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts such as \"oncological pharmacology,\" the complexity of diseases, diverse patient populations, and \"accelerated timelines.\" It aligns with the reference by discussing challenges in decision-making frameworks, although it adds additional context about early evidence generation and regulatory engagement."
        },
        {
            "query_idx": 1212,
            "query": "What prospects does an anticipatory Bayesian model harbor for refining the strategic nuances of therapeutic dose modulation in the realm of oncology trials, based on the interpretative synthesis of model-generated priors and the expansive pharmacometric appraisal of tumor dimensional trajectories?",
            "retrieved_metrics": {
                "reference_idx": [
                    1605
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "An #anticipatory Bayesian model# can refine therapeutic dose modulation by using model-generated priors and pharmacometric analysis to forecast dose-efficacy relationships in #oncology trials#.",
            "predicted_answer": "An anticipatory Bayesian model can refine therapeutic dose modulation in oncology trials by integrating model-generated priors and pharmacometric analysis of tumor size, helping to forecast dose-efficacy relationships and optimize dose selection.",
            "score": 5,
            "explanation": "The predicted answer captures the key concepts: \"anticipatory Bayesian model,\" \"therapeutic dose modulation,\" \"model-generated priors,\" \"pharmacometric analysis,\" and \"oncology trials.\" It aligns with the reference answer, including the forecast of dose-efficacy relationships and optimizing dose selection. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 1213,
            "query": "What latent advantages do temporal state transition frameworks exhibit over traditional oncology models in crafting a continuous dialogue between dynamic tumor morphology and survival narrative, amidst the intricate tapestry of longitudinal analysis, resistant to biases of seemingly immortal temporal spaces?",
            "retrieved_metrics": {
                "reference_idx": [
                    1606
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Temporal state transition frameworks offer #multistate modeling#, integrating tumor size, response, and survival data while countering #immortal time bias# in longitudinal analyses, unlike traditional oncology models.",
            "predicted_answer": "Temporal state transition frameworks, such as multistate modeling, better integrate tumor size, response, and survival, reducing immortal time bias and offering a more dynamic, continuous dialogue between tumor changes and patient outcomes.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts from the reference answer: the concept of \"multistate modeling\" and addressing \"immortal time bias\" in the context of tumor and survival data integration. The predicted answer captures these elements and aligns with the reference, ensuring accuracy and completeness."
        },
        {
            "query_idx": 1214,
            "query": "Within the realm of constructing mechanistic paradigms aimed at analogous tumor antigen targeting, what conceptual strategies underpin the exchange and adaptation of essential biological parameters across differentiated immunotherapeutic initiatives, specifically between bispecific T-cell engagers and CAR-T therapy approaches?",
            "retrieved_metrics": {
                "reference_idx": [
                    1609
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The strategies involve #borrowing# biological parameters in models for dose-response and exposure-toxicity relationships between #bispecific T-cell engagers# and CAR-T therapies for similar tumor antigens.",
            "predicted_answer": "Conceptual strategies include borrowing biological system parameters and drug-related platform knowledge, such as exposure-toxicity relationships, to optimize the targeting of shared tumor antigens in both bispecific T-cell engagers and CAR-T therapies.",
            "score": 5,
            "explanation": "The predicted answer captures the key concept of \"borrowing biological parameters\" and includes \"exposure-toxicity relationships.\" It mentions both \"bispecific T-cell engagers\" and \"CAR-T therapies,\" aligning with the reference's key facts and concepts. No significant omissions or errors are present."
        },
        {
            "query_idx": 1215,
            "query": "How did the predictive architecture embodied by the QSP model influence the strategic anticipation of initial experimental outcomes for a innovative ERK inhibitor within the paradigmatic shift towards BRAV600 CRC's therapeutic exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1608
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #QSP model# enabled accurate prediction of phase I clinical responses and helped evaluate potential drug combinations and biomarkers, enhancing strategic anticipation for a new #ERK inhibitor#.",
            "predicted_answer": "The QSP model, by linking EGFR activation and the MAPK pathway, accurately predicted phase I clinical responses for a new ERK inhibitor, aiding in strategic anticipation and evaluation of potential drug combinations for BRAV600 CRC.",
            "score": 3,
            "explanation": "The predicted answer includes key facts like the QSP model and ERK inhibitor, capturing the overall trend about predicting phase I clinical responses and evaluating drug combinations. However, it misses mention of evaluating biomarkers, a key detail from the reference."
        },
        {
            "query_idx": 1216,
            "query": "How might the avant-garde orchestration of mathematical simulations enthrall and refine the calculus of therapeutic administration for neoplastic entities exhibiting a mosaic of clonal diversity and molecular intricacies, while considering resistance development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1610
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Innovative mathematical modeling enables #model-informed# dose optimization by addressing #tumor heterogeneity# and resistance in therapeutic administration for neoplastic entities.",
            "predicted_answer": "Innovative mathematical modeling can refine therapeutic administration by accounting for tumor heterogeneity and resistance, optimizing doses to target diverse clonal populations and molecular intricacies more effectively.",
            "score": 3,
            "explanation": "The predicted answer includes tumor heterogeneity and resistance, aligning with the overall trend. However, it lacks reference to \"#model-informed#\" dose optimization, which is a key aspect of the reference answer. This omission affects the completeness of the prediction."
        },
        {
            "query_idx": 1217,
            "query": "In what manner did the nuanced QSP construct integrate within the elaborate phase Ia/Ib dosing schema to influence the therapeutic navigation for patients confronted with relapsing/refractory non-Hodgkin's lymphoma, thereby facilitating a deliberate mitigation of the cytokine storm challenge via pharmacodynamic foresight?",
            "retrieved_metrics": {
                "reference_idx": [
                    1612
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #QSP model# informed the phase Ia/Ib dosing schema with #step-up dosing# regimens, effectively mitigating cytokine release syndrome (CRS) in relapsing/refractory non-Hodgkin's lymphoma patients.",
            "predicted_answer": "The QSP construct integrated into the phase Ia/Ib dosing schema by proposing step-up dosing regimens, which balanced efficacy and reduced the risk of cytokine release syndrome, thus facilitating therapeutic navigation for relapsing/refractory non-Hodgkin's lymphoma patients.",
            "score": 3,
            "explanation": "The predicted answer covers key facts such as the QSP construct/model and step-up dosing, aligning with the reference's trend. However, it misses mentioning \"mitigating cytokine release syndrome\" (CRS), which affects completeness. Thus, it misses one key fact but contains no contradictory information."
        },
        {
            "query_idx": 1218,
            "query": "Within the analytical framework of regulatory dossier evaluations post-2013, as observed by Bai et al., what has surfaced as the chief role of QSP in navigating elaborate dosing inquiries and supporting medications' dosage architecture?",
            "retrieved_metrics": {
                "reference_idx": [
                    1614
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The chief role of #QSP# identified by Bai et al. is #supporting dosing# questions for phase III dose selection, pediatric study plans, and new drug application submissions.",
            "predicted_answer": "Since 2013, QSP's chief role in regulatory dossiers, as observed by Bai et al., has been to support dosing questions, including phase III dose selection, pediatric study plans, and dosing regimens in new drug applications.",
            "score": 5,
            "explanation": "The predicted answer covers the chief role of QSP in supporting dosing questions related to phase III dose selection, pediatric study plans, and new drug applications, closely matching the reference. All key facts emphasized in the reference with # symbols are present and consistently reflected in the predicted answer."
        },
        {
            "query_idx": 1219,
            "query": "What inferential pharmacokinetic dynamics manifested through saturation phenomena were pivotal in rationalizing the prescribed 200mg/m² cetuximab weekly regimen, guiding its strategic implementation in the exploratory phases of clinical inquiry for metastatic colorectal and head and neck cancer treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1621
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cetuximab's #clearance saturation# plateaued at ~ #200mg/m²#, aiding its weekly regimen recommendation by inferring target engagement and effectiveness for clinical trials in cancer treatment.",
            "predicted_answer": "The saturation of cetuximab clearance, as inferred from pharmacokinetic (PK) modeling, was pivotal. PK data showed that clearance decreased with increasing doses, plateauing at 200mg/m², indicating target saturation and guiding the weekly regimen in clinical trials.",
            "score": 5,
            "explanation": "The predicted answer includes the key concepts from the reference: clearance saturation, a plateau at 200mg/m², and the importance for clinical trials. While the wording differs, it captures the essential details and consistent meaning, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1220,
            "query": "What magnitude of pembrolizumab administration navigates to exceed a 90% interactive continuity with target cellular receptors in tumoral ensembles, as projected by physiologically based modeling simulations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1619
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A dose of #200mg q3w# pembrolizumab is projected to achieve #90%# receptor occupancy in tumoral ensembles.",
            "predicted_answer": "A dose of 200mg q3w of pembrolizumab is projected to achieve at least 90% receptor occupancy in tumoral ensembles, based on PBPK model simulations.",
            "score": 5,
            "explanation": "The predicted answer correctly includes all key facts highlighted in the reference answer, specifically the dose of #200mg q3w# and #90%# receptor occupancy. The meaning and facts are consistent, and there are no omissions or errors."
        },
        {
            "query_idx": 1221,
            "query": "In what manner can the application of a population-scale TGI-OS modeling construct elucidate the complex interplay of durvalumab and atezolizumab within the intricate confines of urothelial carcinoma treatment, particularly regarding the identification of prognostic biomarkers and the appraisal of monotherapy versus combination therapy effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    1626
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A population-scale #TGI-OS modeling# construct aids in identifying #prognostic biomarkers# and evaluating the effectiveness of durvalumab and atezolizumab monotherapy versus combination therapy in urothelial carcinoma treatment.",
            "predicted_answer": "A population-scale TGI-OS model can help identify prognostic biomarkers and evaluate the effectiveness of durvalumab and atezolizumab, both as monotherapies and in combination, for urothelial carcinoma treatment.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts from the reference: \"TGI-OS modeling,\" \"prognostic biomarkers,\" and evaluating durvalumab and atezolizumab both as monotherapy and combination for urothelial carcinoma. It aligns with the reference and has no contradictions, capturing all essential details."
        },
        {
            "query_idx": 1222,
            "query": "In the expansive domain of algorithmic therapeutic exploration, what is the intricate data-driven mechanism employed to delineate the crest of permissible limits and the strategic regimen commencement in dynamic dose-discovery pathways, and which methodological nuance guides its iterative recalibration of subsequent measurements?",
            "retrieved_metrics": {
                "reference_idx": [
                    1631
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #MISED# algorithm employs #Bayesian optimization# to delineate dose limits and iteratively recalibrate doses based on preclinical and clinical trial data responses.",
            "predicted_answer": "MISED, a dose-finding algorithm, uses Bayesian optimization to iteratively adjust doses based on patient responses, identifying the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D).",
            "score": 3,
            "explanation": "The 'Predicted Answer' includes the key facts \"MISED\" and \"Bayesian optimization\" which are emphasized in the 'Reference Answer'. It conveys the iterative dose adjustment based on patient responses, aligning with the overall trend. However, it omits the mention of \"preclinical and clinical trial data responses\", impacting completeness."
        },
        {
            "query_idx": 1223,
            "query": "What enlightening contributions do agent-oriented simulation frameworks offer concerning the complex interplay between bispecific T cell antibodies and the evolving landscape of tumor dynamics, alongside patient-specific responses among various anatomical milieus?",
            "retrieved_metrics": {
                "reference_idx": [
                    1632
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Agent-oriented simulation frameworks reveal the #interaction# between doses, bispecific T cell antibodies, and their impact on #tumor evolution# and patient responses across different anatomical sites.",
            "predicted_answer": "Agent-oriented simulation frameworks, like ABM, help elucidate the complex interactions between bispecific T cell antibodies and tumor dynamics, including dose-response relationships and patient-specific responses across various anatomical sites, aiding in precision medicine.",
            "score": 5,
            "explanation": "The predicted answer captures the interaction between bispecific T cell antibodies and tumor dynamics, including dose-response and patient-specific responses across anatomical sites, aligning well with the reference's key points about interaction and tumor evolution. Though phrased differently, no significant omissions or errors exist."
        },
        {
            "query_idx": 1224,
            "query": "What are the metrics of achieving a beyond 95% rate of target malignancy inhibition within the identified cohort upon administering the translationally derived RP2D of Tepotinib?",
            "retrieved_metrics": {
                "reference_idx": [
                    1636
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #RP2D# of #Tepotinib# achieves over 95% tumor target inhibition in more than 90% of the patient population.",
            "predicted_answer": "The metrics for achieving over 95% target malignancy inhibition with Tepotinib's RP2D include ensuring the dosage provides greater than 95% tumor target inhibition in more than 90% of the patient population, as validated through translational PK/PD modeling and stochastic simulations.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: RP2D of Tepotinib achieves over 95% tumor target inhibition in over 90% of patients, aligning well with the reference. Translational PK/PD modeling and simulations add context but don't contradict or omit key facts. The overall trend and key points are preserved."
        },
        {
            "query_idx": 1225,
            "query": "What fundamental underlying cause dictates the occurrence where observational methodologies involving neoplastic samples inherently yield merely a singular temporal snapshot per participant in clinical investigative settings, contrasting with serially captured data from fluid biomarkers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1635
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tumor biopsies inherently provide a #single temporal snapshot# per patient because they cannot be performed #serially# like fluid biomarkers.",
            "predicted_answer": "The fundamental cause is the invasive nature of tumor biopsies, which limits them to a single time point per patient, unlike fluid biomarkers that can be sampled repeatedly.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts that #tumor biopsies provide a single temporal snapshot# and cannot be #repeatedly performed#, aligning with the reference answer. Both indicate the limitation due to the invasive nature of biopsies in contrast with fluid biomarker collection."
        },
        {
            "query_idx": 1226,
            "query": "What are the prospective implications of harmonizing pharmacometric paradigms with the evolving chronicle of ctDNA trajectories to unveil exposure-response symmetries that may refine early developmental dosing strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1642
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Harmonizing pharmacometric paradigms with ctDNA #trajectories# may refine #dose# optimization by integrating exposure-response relationships in early drug development.",
            "predicted_answer": "Harmonizing pharmacometric paradigms with ctDNA trajectories can refine early dosing strategies by integrating exposure-effect relationships, enabling more accurate dose optimization and potentially improving treatment efficacy.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key concepts from the Reference Answer, such as harmonization of pharmacometric paradigms with ctDNA trajectories and dose optimization through exposure-response relationships. While phrasing differs, the essential meaning and key facts (#trajectories# and #dose#) are present."
        },
        {
            "query_idx": 1227,
            "query": "In what manner might the confluence of advanced imaging modalities and sophisticated textural analytics unveil the intricate choreography of cellular diversity and biological complexity inherent in tumorous compositions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1643
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The confluence of advanced imaging and textural analytics can reveal #cellular diversity# and #biological complexity# within tumors, aiding in drug efficacy prediction and robust E-R relationship establishment.",
            "predicted_answer": "The integration of advanced imaging techniques, such as functional MRI and PET, with textural analytics can reveal detailed insights into tumor biology and heterogeneity, enhancing the understanding of cellular diversity and complexity in tumors.",
            "score": 1,
            "explanation": "The predicted answer includes the key facts of \"cellular diversity\" and \"biological complexity,\" aligning with the reference. However, it omits the role in \"drug efficacy prediction\" and \"E-R relationship establishment,\" missing two emphasized aspects regarding the application of these insights. This impacts completeness."
        },
        {
            "query_idx": 1228,
            "query": "In what way did the sophisticated confluence of symptom-specific patient-reported outcome measures function as a critical dimension in the evaluative framework that precipitated the endorsement of ruxolitinib for myelofibrosis in 2011?",
            "retrieved_metrics": {
                "reference_idx": [
                    1646
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #patient-reported outcome# measure focused on six #symptoms# specific to myelofibrosis, serving as a pivotal secondary endpoint alongside spleen volume reduction, leading to ruxolitinib's approval in 2011.",
            "predicted_answer": "The combined patient-reported outcome (PRO) measure, which included six myelofibrosis-specific symptoms, served as a pivotal secondary endpoint, alongside spleen volume reduction, supporting ruxolitinib's approval in 2011.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts of the reference answer; it mentions the patient-reported outcome measure, the focus on six specific symptoms, and its role as a pivotal secondary endpoint supporting ruxolitinib's approval. There are no significant omissions or discrepancies."
        },
        {
            "query_idx": 1229,
            "query": "What intricacies emerge via the confluence of evaluative schemata within the intricate matrix of dose escalation processes, especially regarding the pluralistic patient settings and nascent patterns in adverse event configurations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1648
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #confluence# of evaluative schemata entails challenges due to #heterogeneous# patient populations and evolving adverse event profiles, complicating PRO assessments and dose escalation strategies.",
            "predicted_answer": "In dose escalation, the confluence of evaluative schemata, such as PROs, faces challenges due to undefined collection methods, small patient numbers, and heterogeneous populations, leading to varied adverse event patterns and quality of life impacts.",
            "score": 3,
            "explanation": "The Predicted Answer captures the key concepts of \"confluence,\" \"heterogeneous populations,\" and \"adverse event patterns.\" However, it misses the specific mention of the challenge in PRO assessments, impacting completeness but does not contradict the Reference Answer."
        },
        {
            "query_idx": 1230,
            "query": "What role does Model-Informed Drug Development (MIDD) assume in synergistically weaving the tapestry of intricate biological diversity and individualized therapeutic refinement, thereby orchestrating the modulation of dosing strategies amidst the complexities of cancer biology and patient heterogeneity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1650
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Model-Informed Drug Development (#MIDD#) integrates data to optimize dosing strategies by considering cancer biology complexity and patient #heterogeneity#, enhancing understanding of drug exposure, efficacy, and toxicity.",
            "predicted_answer": "Model-Informed Drug Development (MIDD) integrates data and quantitative models to better understand drug exposure, efficacy, and toxicity. This approach enhances dose selection and optimization, addressing the complexities of cancer biology and patient heterogeneity.",
            "score": 5,
            "explanation": "The predicted answer captures key facts such as MIDD's role in integrating data to optimize dosing strategies amidst cancer biology complexities and patient heterogeneity. It also mentions understanding drug exposure, efficacy, and toxicity, which aligns with the reference answer."
        },
        {
            "query_idx": 1231,
            "query": "What determinants necessitate the orchestration of intrusive imagery-directed neoplastic sampling during the navigation of clinical conundrums to elucidate the pharmacodynamic footprint of investigational therapeutic entities within the oncological sphere?",
            "retrieved_metrics": {
                "reference_idx": [
                    1649
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Invasive imaging-guided# tumor biopsies are needed to evaluate #PD effects# at the action site, crucial for providing clinical proof of mechanism in pharmacological audits.",
            "predicted_answer": "Invasive imaging-guided tumor biopsies are necessary to evaluate the pharmacodynamic effects of investigational anticancer agents at the site of action, providing crucial data for clinical proof of mechanism and decision-making in early-phase development.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts of \"invasive imaging-guided tumor biopsies\" and \"evaluate the pharmacodynamic effects,\" which align with the reference. It also mentions the importance for clinical proof, matching the overall trend. No significant details are missing or contradicted."
        },
        {
            "query_idx": 1232,
            "query": "What conceptual challenges manifest when TGI models strive to translate the nuanced biological mechanisms of pharmacological interventions, and what supplementary intellectual apparatus could be crucial to enhance their prediction fidelity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1625
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "TGI models face challenges in translating biological mechanisms due to their #semimechanistic# nature. Enhancing prediction fidelity could require #additional experimental data# and complex model formulations.",
            "predicted_answer": "TGI models face challenges in capturing nuanced biological mechanisms, such as distinguishing between growth inhibition and cytotoxicity. Enhancing prediction fidelity requires additional experimental data and more complex model formulations to better elucidate these mechanisms.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by identifying challenges in capturing biological mechanisms and suggesting the need for additional experimental data and complex models to enhance prediction fidelity. However, it lacks mention of the \"semimechanistic\" nature of TGI models, omitting one key fact."
        },
        {
            "query_idx": 1233,
            "query": "Which illustrious guilds of botanical molecular artisans stand as the primary architects of anticancer innovation amongst the pantheon of plant-sourced natural compounds?",
            "retrieved_metrics": {
                "reference_idx": [
                    1656
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #terpenoids#, #flavonoids#, and alkaloids serve as the primary architects of anti-cancer innovation among plant-sourced natural compounds.",
            "predicted_answer": "Terpenoids, flavonoids, and alkaloids are the primary classes of plant-sourced natural compounds that serve as key anticancer agents.",
            "score": 3,
            "explanation": "The predicted answer contains the key classes of compounds, \"terpenoids\" and \"flavonoids,\" as mentioned in the reference, aligning with the overall trend without any contradictory information. However, it fails to mention \"alkaloids,\" impacting completeness."
        },
        {
            "query_idx": 1234,
            "query": "How does the PRO-Common Terminology Criteria for Adverse Events serve as a navigational compass in deciphering the multifaceted E-R dynamics, particularly concerning the nuanced interpretations of patient-reported adversities such as gastrointestinal distress exemplified by diarrhea?",
            "retrieved_metrics": {
                "reference_idx": [
                    1647
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #PRO-CTCAE# helps elucidate E-R dynamics by assessing #patient-reported# adverse effects like diarrhea, balancing dose efficacy and tolerability, impacting quality of life interpretations.",
            "predicted_answer": "The PRO-Common Terminology Criteria for Adverse Events serves as a navigational compass by standardizing patient-reported outcomes, such as gastrointestinal distress, to better understand the efficacy-toxicity balance and optimize dose adjustments.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts: it mentions the role of the PRO-CTCAE in standardizing patient-reported outcomes and its relevance to understanding efficacy-toxicity dynamics and dose adjustments, aligning with the reference's emphasis on patient-reported effects and dose balance. However, it lacks mention of quality of life interpretations."
        },
        {
            "query_idx": 1235,
            "query": "In what manner do the kinetic symphonies orchestrated by Molecular Dynamics enlighten the pathway of pharmaceutical innovation when juxtaposed against the static tableaux that classical mechanisms present?",
            "retrieved_metrics": {
                "reference_idx": [
                    1658
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "MD's #kinetic insights# predict molecular changes, unlike static models, enhancing #drug development# by understanding dynamic receptor structures and reducing late-stage failures.",
            "predicted_answer": "Molecular Dynamics (MD) simulates the motion of biomolecules, providing dynamic insights into their behavior and interactions. This contrasts with classical static models, enhancing drug design by predicting how compounds will behave in the human body, thus improving pharmaceutical innovation.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of MD providing dynamic insights, paralleling the reference's \"kinetic insights.\" However, it omits the key aspect of \"reducing late-stage failures.\" While generally aligned with trends, this omission affects completeness, leading to a score of 3."
        },
        {
            "query_idx": 1236,
            "query": "What singular molecular champion was discerned as the foremost contender amidst the docking procedural dance, and by what elaborate validation process was the enduring stability of its symbiotic association with the target protein ascertained?",
            "retrieved_metrics": {
                "reference_idx": [
                    1663
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The molecular champion identified was #ST055650#, validated for stability with a #50-ns MD simulation# in complex with the target protein.",
            "predicted_answer": "ST055650 was identified as the top-ranked flavonoid. Its stability with the target protein was validated through a 50-ns molecular dynamics (MD) simulation.",
            "score": 5,
            "explanation": "The predicted answer identifies ST055650 as the top contender and mentions its validation through a 50-ns MD simulation, aligning with the key facts in the reference answer. The essential details are present, and the overall trend is consistent without omissions or errors."
        },
        {
            "query_idx": 1237,
            "query": "What strategic framework involving the intricate nexus of molecular interaction assessments did Singh et al. deploy to delineate the engagement spectrum of natural compounds with critical catalytic receptors, particularly in the domain of lung carcinoma therapeutic targets?",
            "retrieved_metrics": {
                "reference_idx": [
                    1669
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Singh et al. used #pharmacophore-guided# activity profiling of natural compounds from the ZINC database to assess interactions with five #tyrosine kinase# receptors in lung cancer therapy.",
            "predicted_answer": "Singh et al. deployed a pharmacophore-guided activity profiling framework to assess the interaction of natural compounds with tyrosine kinase receptors, including EGFR, cMET, ErbB2, FGFR, and ALK, in lung carcinoma.",
            "score": 3,
            "explanation": "The Predicted Answer aligns well with the Reference Answer, mentioning the use of a \"pharmacophore-guided activity profiling\" framework and targeting \"tyrosine kinase receptors.\" However, it omits the source of natural compounds (\"ZINC database\"), which is crucial to completeness."
        },
        {
            "query_idx": 1238,
            "query": "Amidst the molecular theatre of malignancy, how does DEAD box protein 3 (DDX3) maneuver within the intricate pathways of oncogenic transformation, thus impacting its multifaceted progression and cellular transfiguration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1670
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "DEAD box protein 3 (#DDX3#) is overexpressed in various cancers and plays a critical role in cancer #progression#, proliferation, and transformation.",
            "predicted_answer": "DDX3, overexpressed in various cancers, plays a crucial role in cancer progression and transformation. It interacts with multiple proteins, influencing oncogenic pathways and cellular changes.",
            "score": 3,
            "explanation": "The predicted answer covers key facts such as DDX3's overexpression in cancers, and its role in progression and transformation. However, it lacks mention of \"proliferation,\" which impacts completeness. Overall, the trend is aligned and there are no contradictions."
        },
        {
            "query_idx": 1239,
            "query": "What distinct embodiment of molecular affinity emerged from the intricate dialogues between the molecular gateway HER2 and the botanical transmitters sourced from Syzygium alternifolium, within the strategic framework targeting gastric cancer indications?",
            "retrieved_metrics": {
                "reference_idx": [
                    1668
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "HER2 exhibited maximum #affinity# with flavonoids from #Syzygium alternifolium#, showing potential against gastric cancer.",
            "predicted_answer": "The molecular docking studies revealed that HER2 showed the highest affinity with flavonoids from Syzygium alternifolium, particularly 5-hydroxy-7,4'-dimethoxy-6,8-di-C-methylflavone and kaempferol glycosides.",
            "score": 5,
            "explanation": "The predicted answer includes key facts from the reference answer, such as HER2 having the highest affinity with flavonoids from Syzygium alternifolium. Although it adds details about specific compounds, it covers the reference's main points without contradictions. The mention of potential against gastric cancer is implicit."
        },
        {
            "query_idx": 1240,
            "query": "What were the abstract parameters considered to discern curcumin's superior role in the intricate molecular choreography with DDX3, particularly focusing on its affinity symphony and interaction resonance within the binding spectrum?",
            "retrieved_metrics": {
                "reference_idx": [
                    1672
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Curcumin's #superior role# with DDX3 is discerned from binding affinity, key residue interactions, and molecular dynamics (#MD simulation#).",
            "predicted_answer": "The abstract parameters considered included binding affinity, key residue interactions, and molecular dynamics (MD) simulation, which highlighted curcumin's superior role in interacting with DDX3.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts: curcumin's superior role, binding affinity, key residue interactions, and molecular dynamics simulation, all aligned with the Reference Answer. There are no significant omissions or contradictions, and the trends are consistent."
        },
        {
            "query_idx": 1241,
            "query": "In the realm of molecular architecture, what pivotal function does the Hip-Hop algorithm serve in the nuanced symphony of ligand-based pharmacophore discovery, particularly when crafting selective inhibitory motifs for the exuberant CDK7 isoforms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1673
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Hip-Hop algorithm# generates #pharmacophore models# for ligand-based discovery, aiding selective inhibitory motif synthesis for CDK7 isoforms.",
            "predicted_answer": "The Hip-Hop algorithm facilitates the generation of pharmacophore models from a set of selective inhibitors, aiding in the design of specific CDK7 inhibitors for potential cancer treatments.",
            "score": 1,
            "explanation": "The predicted answer captures the core functions of the Hip-Hop algorithm, such as generating pharmacophore models and aiding the design of selective CDK7 inhibitors. However, it does not specifically mention \"ligand-based discovery\" and \"motif synthesis,\" missing two emphasized details from the reference answer."
        },
        {
            "query_idx": 1242,
            "query": "What was the intricate mechanism employed to corroborate the credibility of the ligand-originated prototype, leading to the emergence of the preeminent model for subsequent evaluative consideration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1671
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate mechanism involved using a ligand-based pharmacophore model, validated with #100 actives# and #425 decoys#, followed by screening via docking-based VS and ADMET properties.",
            "predicted_answer": "The credibility of the ligand-originated prototype was corroborated by creating a pharmacophore model using 19 high-affinity ligands, validated with 100 actives and 425 decoys, and further screened through docking-based virtual screening.",
            "score": 3,
            "explanation": "The Predicted Answer includes the key facts of validating with 100 actives and 425 decoys, and the use of docking-based virtual screening, aligning well with the Reference Answer. However, it misses mentioning ADMET properties. Despite this, the main trend and mechanisms are consistent."
        },
        {
            "query_idx": 1243,
            "query": "What intricate parameters and molecular thresholds did compounds T9 and B42 surpass, designating them as leading prospects in the pharmacological challenge against bladder cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1676
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compounds #T9# and #B42# surpassed Lipinski's rule of 5, PK/PD, and toxicity parameters, marking them as promising pharmacological leads against bladder cancer.",
            "predicted_answer": "T9 and B42 surpassed key thresholds including Lipinski's rule of 5, PK/PD, and toxicity parameters, making them promising leads for bladder cancer treatment.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts: the mention of compounds T9 and B42, Lipinski's rule of 5, PK/PD, and toxicity parameters, consistent with the reference. There are no significant omissions or discrepancies, and the overall trend aligns completely with the reference answer."
        },
        {
            "query_idx": 1244,
            "query": "What are the divergent pathways of quality assurance employed in navigating the precision landscapes, ensuring the fidelity of the pharmacophore models crafted in this scientific inquiry?",
            "retrieved_metrics": {
                "reference_idx": [
                    1674
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The divergent pathways are the #ROC curve# and #Güner-Henry approach#, used to validate both ligand and structure-based pharmacophore models.",
            "predicted_answer": "The quality assurance pathways include generating pharmacophore models using the Hip-Hop algorithm and validating them with ROC curves and the Güner-Henry approach. Selected compounds are further screened through molecular docking.",
            "score": 5,
            "explanation": "The predicted answer includes both the #ROC curve# and #Güner-Henry approach#, aligning with the reference answer. However, it additionally mentions generating models with the Hip-Hop algorithm and molecular docking, which isn't in the reference but doesn't contradict it. The core key facts are covered."
        },
        {
            "query_idx": 1245,
            "query": "Within the multi-layered framework of molecular edifices, what notable intrinsic feature in GA-1 underpins its superior efficacy in countering cancerous cell proliferation relative to its progenitor compound?",
            "retrieved_metrics": {
                "reference_idx": [
                    1678
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #C-30 carboxylic group# in #GA-1# is the intrinsic feature enhancing its anti-cancer efficacy compared to its parent compound.",
            "predicted_answer": "The C-30 carboxylic group in GA-1 is the key feature that enhances its anti-cancer activity, making it more effective than its parent compound.",
            "score": 5,
            "explanation": "The predicted answer successfully mentions the key feature, the C-30 carboxylic group in GA-1, relevant to its enhanced anti-cancer activity, aligning fully with the reference answer. There are no omissions or contradictions."
        },
        {
            "query_idx": 1246,
            "query": "Within the sophisticated landscape of biochemical interactions, what elemental force was regarded as the prime catalyst of transformation pertaining to the cancer-combat potential inherent in lonchocarpin?",
            "retrieved_metrics": {
                "reference_idx": [
                    1679
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #hydrophobic interactions# were regarded as the prime catalyst of #transformation# for the cancer-combat potential of lonchocarpin.",
            "predicted_answer": "Hydrophobic interactions were regarded as the prime catalyst of transformation for the cancer-combat potential of lonchocarpin.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key elements of hydrophobic interactions and transformation related to the cancer-combat potential of lonchocarpin, as emphasized in the reference answer. There are no omissions or contradictions between the predicted and reference answers."
        },
        {
            "query_idx": 1247,
            "query": "What intricate analytical mechanism was orchestrated to reveal compound P-902's potency in engaging with the breast cancer mechanistic proxies, specifically AKR1B10, NR3C1, PTGS2, and HER2, by navigating through a conceptual lattice of virtual analog mapping?",
            "retrieved_metrics": {
                "reference_idx": [
                    1675
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compound #P-902#'s potency for breast cancer targets was revealed using 3D-QSAR via #virtual analog mapping# based on pharmacophore templates and field points-based descriptors.",
            "predicted_answer": "A 3D-QSAR model was developed using field points-based descriptors and pharmacophore templates to screen and identify P-902 as the best compound for engaging with AKR1B10, NR3C1, PTGS2, and HER2 in breast cancer.",
            "score": 3,
            "explanation": "The predicted answer covers most key facts in the reference answer including the use of a 3D-QSAR model with field points-based descriptors and pharmacophore templates to engage with specific breast cancer targets. However, it omits \"virtual analog mapping,\" a key aspect in the reference answer."
        },
        {
            "query_idx": 1248,
            "query": "What strategic molecular transfiguration influences the anabolic symphony of cardenolides, facilitating a notable augmentation in their deterrent choreography against pulmonary cell proliferation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1680
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The addition of a #sugar moiety# at the #C3 position# of cardenolides enhances their anti-proliferative impact on lung cancer cells.",
            "predicted_answer": "The addition of a sugar moiety at the C3 position of cardenolides positively influences their anti-proliferative effect on lung cancer cells, enhancing their deterrent properties.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts from the reference: the addition of a \"sugar moiety\" and its location at the \"C3 position\" of cardenolides. The answer aligns with the trend of enhancing anti-proliferative effects against lung cancer cells, without omissions or errors."
        },
        {
            "query_idx": 1249,
            "query": "What strategic matrices are engaged in the comprehensive landscapes for ADMET assessment using QikProp, and how do these matrices intricately unravel the sophisticated narrative of a compound's systemic voyage and its integrative safety dimensions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1684
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Key matrices in the ADMET assessment with QikProp are #Lipinski's Rule of 5# and #polar surface area#, which unravel a compound’s systemic voyage and safety dimensions.",
            "predicted_answer": "QikProp uses 13 parameters, including Lipinski's Rule of 5 and Jorgensen's Rule of 3, to assess ADMET properties. These matrices evaluate a compound's absorption, distribution, metabolism, excretion, and toxicity, providing a comprehensive safety profile.",
            "score": 3,
            "explanation": "The predicted answer includes Lipinski's Rule of 5, aligning with the reference, but does not mention the #polar surface area# crucial for the systemic voyage and safety dimensions. It covers general ADMET aspects but omits one key component, affecting completeness."
        },
        {
            "query_idx": 1250,
            "query": "What advanced methodological journey facilitated by Taha et al., marked by high-grade analytical resolution, was undertaken to navigate through the intricate molecular tapestry of plant extracts, setting the stage for the conceptualization of compound-target and compound-target-pathway interactive frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1686
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Taha et al. used #UPLC-MS/MS# to analyze plant extracts, facilitating compound-target and compound-target-pathway networks utilizing STITCH, DAVID, KEGG, and STRING databases.",
            "predicted_answer": "Taha et al. utilized UPLC-MS/MS for high-grade analysis of plant extracts, followed by deriving compound-target and compound-target-pathway networks using STITCH, DAVID, KEGG, and STRING, and verified the data with in vitro experiments.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes all key facts from the 'Reference Answer': the use of UPLC-MS/MS, analysis of plant extracts, and using STITCH, DAVID, KEGG, and STRING for network creation. It additionally mentions in vitro verification, which does not contradict the reference."
        },
        {
            "query_idx": 1251,
            "query": "What evaluative framework was employed to discern the foremost 20 focal points within the pulmonary carcinoma domain, guided by the principle of connectivity magnitude?",
            "retrieved_metrics": {
                "reference_idx": [
                    1691
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The evaluative framework employed was #degree centrality# (DC), calculated for a PPI network by CentiScaPe, to filter the top #20 targets#.",
            "predicted_answer": "Degree centrality (DC) was used to filter the top 20 targets with the highest connectivity magnitude in the PPI network of lung cancer.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts of using \"#degree centrality#\" and determining the \"#20 targets#\". However, it does not mention that degree centrality was calculated by CentiScaPe. Despite this, there is no contradictory information, and the trend is consistent."
        },
        {
            "query_idx": 1252,
            "query": "What chemical entity, through an intricate exploration involving spatial structural interfacing and dynamic computational trajectory analysis, was recognized as a substantial affiliate with numerous targets linked to breast cellular aberrations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1693
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The chemical entity recognized as a substantial affiliate with numerous targets linked to #breast cellular aberrations# is #β-bourbonene#.",
            "predicted_answer": "Ursolic acid, enterolactone, parthenolide, berberine, and β-bourbonene were identified as having strong binding affinity with multiple breast cancer targets through molecular docking and dynamic computational analysis.",
            "score": 5,
            "explanation": "The predicted answer lists multiple compounds, including β-bourbonene, which matches the key fact in the reference about being a substantial affiliate with breast cellular aberrations. Although additional compounds are mentioned, there is no contradiction, and the key fact about β-bourbonene is present."
        },
        {
            "query_idx": 1253,
            "query": "What assembly of 79 phytochemical orchestrators has been delineated as engaging in nuanced interactions with 35 distinctively responsive genomic expressions within the broader expanse of 384 gene variations, as identified by the interpretative matrix of SwissTargetPrediction?",
            "retrieved_metrics": {
                "reference_idx": [
                    1696
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The assembly of #79 phytochemical orchestrators# engages with #35 genomic expressions# within 384 gene variations, identified by SwissTargetPrediction.",
            "predicted_answer": "The assembly of 79 phytochemicals from Indian plants was found to interact with 35 distinct genomic expressions out of 384 gene variations, as predicted by SwissTargetPrediction.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized in the reference answer: the presence of 79 phytochemicals, interaction with 35 genomic expressions, and the use of SwissTargetPrediction. The overall trend and details are consistent with the reference answer, with no significant omissions or errors."
        },
        {
            "query_idx": 1254,
            "query": "What fraction of the predictive success narrative, in relation to the anticipated cellular specimen responsiveness, did curcumin and resveratrol accomplish regarding their alignment with the forecasted sensitivity profiles?",
            "retrieved_metrics": {
                "reference_idx": [
                    1700
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Curcumin accomplished #6/7#, and resveratrol achieved #5/8# in aligning with the forecasted sensitivity profiles.",
            "predicted_answer": "For curcumin, 6/7 (85.7%) of the cellular specimen responsiveness was accurately predicted, and for resveratrol, 5/8 (62.5%) aligned with the forecasted sensitivity profiles.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts and numbers emphasized in the reference answer: \"6/7\" for curcumin and \"5/8\" for resveratrol, correctly aligning with the forecasted sensitivity profiles. The numbers are accurate, and the information aligns perfectly with the narrative provided by the reference."
        },
        {
            "query_idx": 1255,
            "query": "In the vast landscape navigated by Rayan et al.'s analytical odyssey, what distinct compendiums of molecular assemblages were orchestrated as the articulate and dormant participants within the envisioned pharmacological matrix for unearthing anti-cancer ostensive realities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1701
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rayan et al. orchestrated #617 approved anti-cancer drugs# as actives and #2892 phytochemicals# as inactives within the pharmacological matrix for anti-cancer discovery.",
            "predicted_answer": "Rayan et al. used 617 approved anti-cancer drugs as active compounds and 2892 phytochemicals as inactive compounds to develop a predictive model for identifying natural products with anti-cancer activity.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"#617 approved anti-cancer drugs#\" as active compounds and \"#2892 phytochemicals#\" as inactive compounds, which are consistent with the reference answer. There is no contradictory information, and the overall trend and details align fully."
        },
        {
            "query_idx": 1256,
            "query": "Within the intricate weave of predictive capability assessment, what abstracted performance criteria were utilized to discern the models' efficacy, and which entity emerged as the paragon of classification acumen upon the autonomous cohort?",
            "retrieved_metrics": {
                "reference_idx": [
                    1698
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #MACCS fingerprint# model, evaluated by #Matthew's correlation coefficient# and ROC AUC, demonstrated superior classification ability in identifying NPs, achieving 95% accuracy on the validation set.",
            "predicted_answer": "Matthew's correlation coefficient and area under the receiver operating characteristic curve were used to assess model efficacy. The MACCS fingerprints-based model emerged as the most effective for classification.",
            "score": 3,
            "explanation": "The predicted answer matches the key facts from the reference: the use of the MACCS fingerprint model and the Matthew's correlation coefficient as evaluation criteria. However, it omits the specific mention of achieving 95% accuracy on the validation set, which affects completeness."
        },
        {
            "query_idx": 1257,
            "query": "In the context of probing the intricate networks of cellular receptivity to a suite of 17 novel pharmacological entities, through what comprehensive categorization framework were the cancer cell line populations delineated, before these formed the baseline for constructing anticipatory modeling constructs grounded in machine learning methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1699
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cancer cell lines were classified into #Sensitive, Resistant, Intermediate# groups using #K-Means clustering# in WEKA before constructing machine learning models.",
            "predicted_answer": "The cancer cell line populations were categorized into Sensitive, Resistant, and Intermediate groups using the K-Means clustering algorithm based on IC50 values. This classification served as the baseline for constructing machine learning models.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as the categorization of cancer cell line populations into Sensitive, Resistant, and Intermediate groups using the K-Means clustering algorithm, aligning with the reference answer. However, it omits the use of \"WEKA,\" a specific detail in the reference."
        },
        {
            "query_idx": 1258,
            "query": "What influence does the dynamic spectrum of experimental concentration metrics in xenograft models exert on the calibration process of therapeutic thresholds for inaugural human administrations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1707
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #dynamic spectrum# of experimental concentration metrics in xenograft models influences #calibration# of therapeutic thresholds for First-In-Human studies by guiding target concentration and dose selection.",
            "predicted_answer": "The dynamic spectrum of experimental concentration metrics in xenograft models helps calibrate therapeutic thresholds for first human administrations by identifying target concentration ranges that are likely to be effective, based on antitumor activity observed in animals.",
            "score": 3,
            "explanation": "The Predicted Answer includes the \"dynamic spectrum\", \"calibration\", and the concept of using xenograft models for establishing therapeutic thresholds by identifying effective concentration ranges, aligning with the Reference Answer. However, it omits the specific guidance for dose selection."
        },
        {
            "query_idx": 1259,
            "query": "What evaluative dimension, often metaphorically akin to the chronicle of dimensional fluctuation, serves as a benchmark to quantify oncological inhibition in xenografted creatures, specifically by tracking the narrative of volumetric shifts across chronological phases?",
            "retrieved_metrics": {
                "reference_idx": [
                    1708
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The evaluative dimension is #tumor volume#, serving to quantify oncological inhibition by tracking #tumor growth# over time in xenografted models.",
            "predicted_answer": "Tumor volume over time serves as the benchmark to quantify oncological inhibition in xenografted creatures, tracking volumetric shifts across chronological phases.",
            "score": 3,
            "explanation": "The predicted answer captures the key concept of \"tumor volume\" (#tumor volume#) and the idea of measuring change over time (\"volumetric shifts across chronological phases\"). However, it does not explicitly mention \"tumor growth\" (#tumor growth#). Despite this, the overall trend is consistent."
        },
        {
            "query_idx": 1260,
            "query": "Within the spectrum of three-dimensional cellular orchestration sans external framework, what are the chief methodological stratagems employed to engender a milieu that innately reflects the intricate cell-matrix interplay, particularly in the context of tumorigenic research explorations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1712
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The chief methods include #cellular# self-assembly techniques: agitation-based, hanging drop, liquid overlay, magnetic levitation, and microfluidic, enabling natural #cell-matrix# interaction in tumorigenic research.",
            "predicted_answer": "In tumorigenic research, key scaffold-free techniques include agitation-based, hanging drop, liquid overlay, magnetic levitation, and microfluidic methods. These allow cancer cells to self-assemble their own ECM, naturally modeling cell-matrix interactions.",
            "score": 5,
            "explanation": "The predicted answer effectively captures all key aspects of the reference answer. It mentions the specific scaffold-free techniques (agitation-based, hanging drop, liquid overlay, magnetic levitation, and microfluidic) and the concept of self-assembly that models natural cell-matrix interactions in tumorigenic research, reflecting the important facts and maintaining alignment with the overall trend."
        },
        {
            "query_idx": 1261,
            "query": "In what ways might the interplay between operational nuances of the liquid overlay and hanging drop embodiments, alongside the intrinsic self-assembly tendencies of Panc-1, Mia-PaCa, and CAKI-I cellular frameworks, pose formidable challenges to crafting cellular spheroidal constructs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1719
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #limited self-assembly tendencies# of Panc-1, Mia-PaCa, and CAKI-I make using #liquid overlay and hanging drop# methods challenging for forming cellular spheroidal constructs.",
            "predicted_answer": "The liquid overlay and hanging drop methods, while easy and cost-effective, may be insufficient for Panc-1, Mia-PaCa, and CAKI-I cells due to their low self-aggregation ability, posing challenges in forming stable spheroids.",
            "score": 5,
            "explanation": "The predicted answer acknowledges the limited self-assembly tendencies of Panc-1, Mia-PaCa, and CAKI-I cells and mentions the challenge of forming spheroids using the liquid overlay and hanging drop methods. It covers key facts emphasized with # symbols, aligning with the reference answer's trend."
        },
        {
            "query_idx": 1262,
            "query": "What is the spectrum of triumph variability for the cultivation of personalized neoplastic miniaturized simulations, specifically when analyzing prostatic and colorectal malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1723
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The spectrum of triumph variability for personalized simulations shows a high success rate of 70-100% for #colorectal cancer# and a low rate of #15-20%# for prostate cancer.",
            "predicted_answer": "The success rate for cultivating personalized neoplastic miniaturized simulations varies, with colorectal malignancies having a 70-100% success rate and prostatic malignancies only 15-20%.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts emphasized in the reference answer, providing the success rates for both colorectal (70-100%) and prostatic (15-20%) malignancies. It aligns well with the overall trend, covering all important details without contradictions."
        },
        {
            "query_idx": 1263,
            "query": "Within the realm of cellular cultivation paradigms, what intrinsic element of structural precision does an engineered hydrogel matrix offer over the variable, serendipitous nature of Matrigel, particularly in orchestrating the nuanced symphony of organoid-drug dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1725
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Synthetic hydrogels offer #precision# by being fully defined and growth-factor-free, improving control over #organoid-drug dynamics# compared to Matrigel's batch variability and animal growth factors influence.",
            "predicted_answer": "An engineered hydrogel matrix offers consistent structural precision and reliability, lacking the batch-to-batch variability of Matrigel. This consistency enhances control over organoid-drug interactions, leading to more predictable and reproducible results.",
            "score": 3,
            "explanation": "The predicted answer covers key aspects of structural precision and consistency, addressing the batch variability seen in Matrigel. However, it misses details about the hydrogel being growth-factor-free and fully defined, which affects organoid-drug dynamics control, a key fact in the reference."
        },
        {
            "query_idx": 1264,
            "query": "In the expansive realm of cellular construct cultivation, what emergent biological framework, often chosen in the preponderance of academic investigations, serves as the surrogate microenvironment matrix for nurturing multicellular cancerous formations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1724
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In the realm of cellular construct cultivation, #Matrigel#, an animal-derived hydrogel, serves as the surrogate microenvironment for nurturing #cancer organoids#.",
            "predicted_answer": "Matrigel, an animal-derived protein mixture, is commonly used as the surrogate microenvironment matrix for nurturing multicellular cancerous formations in academic studies.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies \"Matrigel\" and explains its use as a surrogate microenvironment for nurturing multicellular cancerous formations, aligning well with the reference answer. However, it omits the specific term \"cancer organoids\" mentioned in the reference, affecting completeness."
        },
        {
            "query_idx": 1265,
            "query": "To what extent do the inherent murine stromal architectures intricately weave themselves into the sophisticated tapestry of processes involved in the development of organoids originating from patient-derived xenografts, consequently complicating their formation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1730
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The presence of #mouse stromal components# complicates the formation of organoids by necessitating their removal for successful PDxO development.",
            "predicted_answer": "The inherent murine stromal architectures can complicate the formation of organoids from patient-derived xenografts, as these components must be adequately removed to successfully generate PDxOs.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the reference answer, mentioning that murine stromal architectures complicate organoid formation and need removal for successful PDxO development. It reflects the key fact about \"mouse stromal components\" being problematic, without contradicting or missing significant details."
        },
        {
            "query_idx": 1266,
            "query": "Within the realm of crafting organoid formations from PDX specimens, what complexities arise in the meticulous process of extricating non-human stromal interferences, and how proficiently did Guillen and colleagues navigate these to establish enduring organoid cultures with their PDxO iterations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1729
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Guillen# and colleagues successfully navigated stromal complexities, achieving an 85% success rate in deriving 40 PDxO lines from breast cancer PDXs, culturing them over #200 days#.",
            "predicted_answer": "The main complexity in creating PDxOs is the removal of mouse stromal components. Guillen and colleagues successfully navigated this by establishing 40 PDxO lines with an 85% success rate, maintaining genomic concordance with original tumors even after long-term culture.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of achieving an 85% success rate and establishing 40 PDxO lines as presented in the reference. However, the detail of culturing over 200 days is missing in the predicted answer, which affects completeness."
        },
        {
            "query_idx": 1267,
            "query": "What fundamental physiological element within the organizational blueprint of cellular entities enables dye exclusion methodologies to identify living specimens as distinct from deceased, with regard to the permeability selectivity of their membranous barriers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1735
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #intact membrane# of living cells prevents dye entry, enabling dye exclusion assays to differentiate living from dead cells based on #membrane permeability#.",
            "predicted_answer": "The fundamental physiological element is the integrity of the cell membrane. In living cells, intact membranes prevent dyes from entering, whereas in dead cells, compromised membranes allow dye passage, enabling differentiation.",
            "score": 5,
            "explanation": "The predicted answer successfully identifies the \"integrity of the cell membrane\" as crucial for differentiation, as it mentions intact membranes preventing dye entry in living cells, which aligns with \"intact membrane\" and \"membrane permeability\" from the reference answer. No significant information is missing."
        },
        {
            "query_idx": 1268,
            "query": "What impediments arise in achieving a methodological uniformity for the discernment of therapeutic potency amidst the intricate mosaic of 3D in vitro cancer model assessments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1734
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Achieving methodological uniformity in #3D in vitro# cancer model assessments is impeded by the lack of standardized approaches, leading to varied assays and techniques for evaluating therapeutic potency.",
            "predicted_answer": "The lack of well-established and standardized approaches for evaluating therapeutic efficacy in 3D in vitro cancer models leads to variability in methods, making it difficult to achieve methodological uniformity.",
            "score": 3,
            "explanation": "The predicted answer captures the key fact about the lack of standardized approaches and focuses on the difficulty in achieving methodological uniformity within 3D in vitro cancer models, which aligns with the reference answer. However, the reference specifically highlights \"varied assays and techniques,\" a detail not mentioned in the predicted answer."
        },
        {
            "query_idx": 1269,
            "query": "Through what procedural enhancements and theoretical adjustments did Eilenberger et al. elevate the traditional alamarBlue viability protocol, manufacturing a more precise evaluative capacity tailored to the complex architecture of spheroid cultures within their experimentations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1736
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Eilenberger et al. enhanced #assay precision# through #optimizing# the standard alamarBlue protocol, tailoring it for the complex architecture of spheroid cultures.",
            "predicted_answer": "Eilenberger et al. optimized the standard alamarBlue viability protocol, enhancing its precision for spheroid cultures, thus improving the evaluative capacity for complex 3D structures.",
            "score": 5,
            "explanation": "The predicted answer captures the key elements of assay precision and optimization found in the reference answer. It aligns with the reference's focus on enhancing precision for complex spheroid cultures, though it lacks specific mention of \"assay precision\" but maintains the overall trend without contradiction."
        },
        {
            "query_idx": 1270,
            "query": "What transformation occurred in the fidelity of the evaluative signal's clarity due to the temporal extension to a diurnal span, specifically in the context of the spatial organoid conformations subjected to sorafenib treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1738
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #clarity# of the evaluative signal's fidelity in #spatial organoid# conformations improved significantly, with the standard deviation range reduced to 4-10% after 24 hours.",
            "predicted_answer": "The temporal extension to 24 hours improved the clarity and precision of the evaluative signal for spheroids, reducing the standard deviation to 4-10%, while 2D cultures maintained consistent precision.",
            "score": 5,
            "explanation": "The predicted answer effectively conveys the improvement in clarity and precision (fidelity) for spatial organoid conformations due to the temporal extension, aligning with the reference. It includes the critical detail about standard deviation reduction to 4-10%. No significant omissions exist."
        },
        {
            "query_idx": 1271,
            "query": "In the intricate dynamics of comparative pharmacodynamics, what interpretative void arises from IC50's singular concentration snapshot compared to the inclusive spectrum measured by AUC's area under the concentration-response narrative?",
            "retrieved_metrics": {
                "reference_idx": [
                    1746
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The interpretative void from IC50's snapshot is the lack of #comprehensive# information on drug effectiveness across various concentrations, unlike the inclusive spectrum measured by #AUC#.",
            "predicted_answer": "IC50 provides a single concentration threshold for effectiveness, while AUC offers a comprehensive view across multiple concentrations, highlighting the interpretative gap in understanding overall drug efficacy.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts: IC50's limitation due to its singular focus and AUC's comprehensive view across concentrations. It correctly identifies the interpretative gap related to overall drug efficacy. Key facts like \"comprehensive\" and \"AUC\" are present, with no significant omissions."
        },
        {
            "query_idx": 1272,
            "query": "What is the advanced optical modality capable of capturing intricate details within substantial multilayered cellular architecture, thus metaphorically unveiling the concealed stratigraphy of such in vitro constructs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1749
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The advanced optical modality is #confocal microscopy#, capable of capturing intricate details within substantial multilayered cellular architecture.",
            "predicted_answer": "Confocal microscopy is capable of capturing intricate details within substantial multilayered cellular architecture, providing high-resolution images of the internal 3D structure.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"confocal microscopy\" as the optical modality and describes its capability to capture intricate details within substantial multilayered cellular architecture. All key facts emphasized in the reference answer are present and consistent in meaning."
        },
        {
            "query_idx": 1273,
            "query": "In the intricate tapestry of cellular exploration, what are the transcendent functions of mechanized vision systems and non-invasive molecular interpreters in comprehending the enigmatic choreography of cancer pathophysiology and pharmacological influence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1751
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Mechanized vision systems offer #real-time# monitoring and detailed imaging, while non-invasive molecular interpreters like #label-free biosensors# provide insights into cancer biology and drug activity.",
            "predicted_answer": "Mechanized vision systems and non-invasive molecular interpreters, like super-resolution microscopy and automated imaging, provide detailed real-time insights into cancer cell behavior and drug effects, enhancing our understanding of cancer pathophysiology.",
            "score": 3,
            "explanation": "The predicted answer mentions \"real-time insights,\" aligning with the emphasis on \"real-time monitoring\" from the reference. However, it lacks the specific mention of \"label-free biosensors,\" a key component highlighted in the reference. The general trend is maintained, but the omission of this specific fact affects completeness."
        },
        {
            "query_idx": 1274,
            "query": "What philosophical abstractions dictate the strategic alignment of imaging methods with the nuanced volumetric reconstruction needs of spheroids, including considerations for morphological idiosyncrasies that deviate from standard spherical forms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1753
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The strategic alignment of imaging methods relies on #spheroid morphology# and the need for accuracy in #3D reconstruction#, especially for irregular structures needing advanced 3D systems.",
            "predicted_answer": "Philosophical abstractions such as the need for accurate volumetric reconstruction and consideration of morphological idiosyncrasies guide the strategic alignment of imaging methods. For standard spherical spheroids, 2D brightfield imaging may suffice, while irregular structures require advanced 3D imaging systems.",
            "score": 3,
            "explanation": "The predicted answer includes key concepts such as morphological idiosyncrasies, 3D reconstruction, and the need for advanced 3D imaging systems for irregular structures. However, it does not explicitly mention \"spheroid morphology,\" which affects completeness. Though trends are aligned, one key fact is missing."
        },
        {
            "query_idx": 1275,
            "query": "In the intricate context of spheroidal study methodologies, what fundamental shift in the volumetric parameters is perceived as the ultimate gauge of treatment success?",
            "retrieved_metrics": {
                "reference_idx": [
                    1752
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #reduction of spheroid volume# is perceived as the #ultimate gauge# of treatment success in spheroidal studies.",
            "predicted_answer": "In spheroid studies, a reduction in spheroid volume is generally considered the primary indicator of treatment success.",
            "score": 5,
            "explanation": "The Predicted Answer captures both key facts emphasized in the Reference Answer, namely, the reduction in spheroid volume and its role as the primary indicator of treatment success. The meaning is consistent, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1276,
            "query": "What inherent limitations within the functional construct of the Trypan Blue assay restrict its adeptness in discerning and measuring the intricate nuances of dose-responsive pharmacological activity, especially in the context of being juxtaposed with the more specialized 3D-specific evaluative methodologies in multi-dimensional cellular assay environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1741
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Trypan Blue# assay fails to capture dose dependence and exhibits high variability (#CV = 42.7#), unlike 3D-specific assays with low variability.",
            "predicted_answer": "The Trypan Blue assay has limitations in capturing dose-dependence and exhibits high variability (CV = 42.7) in viability results, making it less suitable for measuring nuanced pharmacological activity compared to 3D-specific assays, which show lower variability (CV ≈ 7.5).",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts in the reference answer: the Trypan Blue assay's limitations in capturing dose dependence, its high variability (CV = 42.7), and comparison to the lower variability of 3D-specific assays. No important details are missing, and trends are aligned."
        },
        {
            "query_idx": 1277,
            "query": "In exploring the dynamic realm of onco-therapeutic validation, which specific light-reflective apparatus and analytic digital schema were harnessed by Yao et al. to depict the evolving volumetric narrative of patient-conceived cellular replicas?",
            "retrieved_metrics": {
                "reference_idx": [
                    1756
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Yao et al. used an #inverted microscope# in a brightfield setting and analyzed images with #Image-Pro Plus 6.0# software to monitor organoid size changes.",
            "predicted_answer": "Yao et al. used an inverted microscope in a brightfield setting and Image-Pro Plus 6.0 software to analyze the temporal size changes of patient-derived organoids.",
            "score": 5,
            "explanation": "The predicted answer contains all the key facts emphasized with # symbols in the reference answer, specifically the use of an \"inverted microscope\" and \"Image-Pro Plus 6.0\" software. The overall meaning and critical details are consistent, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1278,
            "query": "In what manner does the optical modulation index orchestrate the utilization of intrinsic cellular luminescent phenomena to elucidate transformation trends in the structural evolution of organoids within patient-derived studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1758
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #optical modulation index# utilizes cellular autofluorescence to assess changes in #organoid size# and optical redox ratio in patient-derived studies.",
            "predicted_answer": "The optical modulation index (OMI) utilizes the natural cellular autofluorescence of NAD(P)H and FAD, measured as the optical redox ratio, to monitor structural changes in organoids, such as size and metabolic state, in patient-derived studies.",
            "score": 5,
            "explanation": "The predicted answer covers key facts from the reference answer: the optical modulation index uses cellular autofluorescence and assesses organoid size. It also includes extra relevant details about NAD(P)H, FAD, and metabolic state, without changing the core meaning. Thus, all important elements are covered."
        },
        {
            "query_idx": 1279,
            "query": "What is the impact of metaphorically aligning growth parameters with primordial dimensional archetypes for each singular organoid construct in refining the acuity of exclusive observational tactics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1757
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Aligning growth parameters with #dimensional archetypes# for each organoid construct improves exclusive #observational tactics# by refining individual organoid monitoring and measurement precision, reducing variability.",
            "predicted_answer": "Metaphorically aligning growth parameters with primordial archetypes for each organoid can refine observational tactics by reducing measurement noise and improving the accuracy of tracking individual organoid responses to treatment.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by discussing the refinement of observational tactics through the alignment with archetypes. However, it misses the key detail of \"dimensional\" archetypes, which is emphasized as a significant factor in the reference answer. This omission affects the completeness."
        },
        {
            "query_idx": 1280,
            "query": "In studies examining the biostructural formations subjected to therapeutic interventions, what abstractly conceptualized quantitative measure serves to encapsulate the differential impacts by contrasting the modified systematics with the unperturbed assemblages, and by which mathematical principle is this disparity meticulously articulated?",
            "retrieved_metrics": {
                "reference_idx": [
                    1762
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The quantitative measure is #Glass's Delta# index, which encapsulates differential impacts using the mathematical principle of mean difference divided by control group's standard deviation.",
            "predicted_answer": "The Glass's Delta index quantitatively measures the differential impact by comparing treated and control groups, defined as the mean difference divided by the standard deviation of the control group.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes the key facts: \"Glass's Delta index\" and \"mean difference divided by control group's standard deviation,\" aligning with the 'Reference Answer'. It accurately captures the essential details without any contradictions or significant omissions in meaning."
        },
        {
            "query_idx": 1281,
            "query": "In the nuanced exploration of pharmacodynamic relationships and investigational models, particularly within the OV4453 and OV4485 cell lines, what emergent alignment exists between the resistive architectures of 3D spheroid constructs and the observed in vivo dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1765
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #3D spheroids# showed higher #carboplatin resistance# than xenograft mice for OV4453 and OV4485, aligning with in vivo dynamics despite differences in specific resistance levels.",
            "predicted_answer": "The 3D spheroid constructs of OV4453 and OV4485 cell lines showed higher carboplatin resistance compared to in vivo xenografts, yet their response patterns aligned with in vivo dynamics.",
            "score": 5,
            "explanation": "The predicted answer contains all the key facts: \"3D spheroids,\" \"higher carboplatin resistance,\" and alignment with \"in vivo dynamics\" as emphasized in the reference. It accurately reflects the meaning and key points without any contradictions or omissions."
        },
        {
            "query_idx": 1282,
            "query": "Within the complex architecture of three-dimensional cellular matrices sourced from HER2-overexpressing oncogenic formations, what intrinsic molecular elements within the conjugated therapeutic paradigm of immunoliposomes conjoined with a monoclonal antibody dictate the orchestration of antiproliferative dynamics observed across variable biological contexts?",
            "retrieved_metrics": {
                "reference_idx": [
                    1768
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The antiproliferative dynamics in #immunoliposomes# with #trastuzumab# depend on cell type, spheroid size, and treatment schedule, surpassing current anti-HER2 strategies.",
            "predicted_answer": "The antiproliferative dynamics are dictated by the specific targeting of HER2 receptors via trastuzumab, enabling immunoliposomes to deliver therapeutic payloads more effectively, which varies with cell type, spheroid size, and treatment scheduling.",
            "score": 5,
            "explanation": "The Predicted Answer accurately addresses the key facts emphasized with # in the Reference Answer, such as \"immunoliposomes\" and \"trastuzumab,\" and reflects the context of variable biological conditions like cell type, spheroid size, and treatment scheduling. No significant omissions or contradictions are detected."
        },
        {
            "query_idx": 1283,
            "query": "Within the diverse and layered architectures of oncological investigations, what are the salient variations in research paradigms that shape and influence the perceptual depth and evaluative clarity of the relational dynamics between PDO representations and the spectrum of patient clinical outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1769
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Diverse research paradigms vary in #tumor type#, cohort size, study design, and statistical methods, affecting the correlation between #PDO representations# and patient outcomes.",
            "predicted_answer": "Research paradigms in oncology vary by tumor type, treatment, cohort size, study design, response definitions, and statistical methods. Most studies offer descriptive comparisons with small cohorts, while few achieve statistically significant correlations or predictive values.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer in terms of varying research paradigms by tumor type, cohort size, study design, and statistical methods. However, it omits specific mention of \"PDO representations,\" which is emphasized in the reference, affecting completeness."
        },
        {
            "query_idx": 1284,
            "query": "What delineation of cellular transformation, assessed through chronological re-calibration of pre-therapeutic and post-therapeutic benchmarks, served as a pivotal prognosticator of the regenerative trajectory in the noteworthy CinClare exploration of rectal malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1772
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #least ratio# of PDO size changes from day 0 to day 24 was a pivotal prognosticator of #tumor regression grade# in the CinClare trial for rectal malignancies.",
            "predicted_answer": "The CinClare trial used the ratio of patient-derived organoid (PDO) size changes at day 24 to day 0 after treatments as a key prognosticator for tumor regression in rectal cancer patients.",
            "score": 5,
            "explanation": "The predicted answer closely aligns with the reference answer. It includes the focus on PDO size changes from day 0 to day 24 as a key prognosticator, and mentions tumor regression, mirroring the key points of the reference answer. The term \"least ratio\" is implied but not explicitly stated."
        },
        {
            "query_idx": 1285,
            "query": "What threshold in the metric of resilience, particularly expressed by the harmony of pharmacological conglomerations, acts as the demarcating factor for defining cellular facsimiles as steadfast against the specified medicinal coalition?",
            "retrieved_metrics": {
                "reference_idx": [
                    1777
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cellular facsimiles are classified as #resistant# if all drug components yield an AUC #≥ 0.56#.",
            "predicted_answer": "The threshold for defining cellular facsimiles as resilient against a medicinal coalition is an AUC ≥ 0.56 for all drug components in the regimen.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference answer, such as the classification of cellular facsimiles as \"resilient\" or \"resistant\" and the AUC threshold of \"≥ 0.56\" for all drug components. The terminology and overall trend are consistent with the reference."
        },
        {
            "query_idx": 1286,
            "query": "What methodological divergence is apparent in Witte et al.'s approach to unraveling mechanistic outcomes of PDO responses to therapeutic symphonies in ovarian cancer treatment cohorts, and how do these orchestral compositions differ from the thematic explorations found in the CinClare and HOPE trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    1781
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Witte et al.'s approach #directly evaluates# combination therapies in vitro, unlike CinClare and HOPE, which assess responses #independently# for each drug.",
            "predicted_answer": "Witte et al. directly evaluated PDO responses to combination treatments in vitro, unlike the CinClare and HOPE trials, which assessed each drug independently.",
            "score": 5,
            "explanation": "The Predicted Answer reflects key facts from the Reference Answer, acknowledging that Witte et al. assess combination therapies in vitro, in contrast to CinClare and HOPE evaluating drugs independently. Both key emphasized points in the Reference are present without contradiction."
        },
        {
            "query_idx": 1287,
            "query": "What abstract connections eluded the quantitative assessments of area under the curve when, notwithstanding their statistically noteworthy linkages with immediate therapeutic indicators and biomarker stabilization, they did not elucidate the profound dynamics of extended clinical prognoses like recurrence events and progression-free survival?",
            "retrieved_metrics": {
                "reference_idx": [
                    1778
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "AUCs, despite #significant correlations# with immediate indicators, failed to elucidate profound dynamics of #recurrence events# and progression-free survival.",
            "predicted_answer": "Quantitative assessments of area under the curve (AUC) correlated with immediate therapeutic indicators and biomarker stabilization but failed to predict long-term outcomes such as recurrence and progression-free survival.",
            "score": 5,
            "explanation": "The Predicted Answer reflects the key facts from the Reference Answer, mentioning the AUC's correlations with immediate indicators and its failure to predict recurrence and progression-free survival. All critical points are covered without any contradictions, maintaining alignment with the Reference Answer."
        },
        {
            "query_idx": 1288,
            "query": "What sophisticated parameters and criteria were used in Schütte et al.'s study to categorize the diverse therapeutic endpoints within the interconnected experimental landscapes of PDO and PDX models, with a focus on the gradations of pharmacological responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    1780
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Schütte et al. used #IC50 values# for PDOs and relative tumor volume for PDXs to categorize drug responses into four categories: #strong-, moderate-, minor-response, or resistance#.",
            "predicted_answer": "Schütte et al. used IC50 values for PDOs and relative tumor volume in PDXs to classify treatment outcomes into four categories: strong, moderate, minor response, or resistance.",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects the key facts from the Reference Answer, including the use of IC50 values for PDOs and relative tumor volume for PDXs. Additionally, it correctly lists the four response categories: strong, moderate, minor, and resistance. The meaning and details are consistent."
        },
        {
            "query_idx": 1289,
            "query": "Within the spectrum of molecular orchestrations seeking to unravel the resilient cellular formations' defenses, what unique interplay of mechanisms empowered complex (4) to exhibit a notably enhanced therapeutic confrontation against DU-145 spheroids over other similar constructs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1787
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Complex #4# exhibited enhanced anticancer activity against DU-145 spheroids due to its ability to induce #disruption# of cell aggregations, surpassing other ruthenium complexes.",
            "predicted_answer": "Complex (4) exhibited enhanced therapeutic activity against DU-145 spheroids by effectively disrupting cell aggregations, outperforming other ruthenium complexes in inducing morphological changes and reducing cell viability.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts from the reference: Complex 4's enhanced activity against DU-145 spheroids and its disruption of cell aggregations. It aligns with the trend of surpassing other ruthenium complexes. All key details are present without contradiction."
        },
        {
            "query_idx": 1290,
            "query": "In what manner did Huang et al. orchestrate their investigative framework to traverse the transformative pathways of drug interactions within the three-dimensional matrix-embedded cellular landscapes, specifically examining the sotorasib response across differing oxygenation levels?",
            "retrieved_metrics": {
                "reference_idx": [
                    1790
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Huang et al. used #Matrigel-based# tumor spheroids to examine #sotorasib# responses under normoxia and hypoxia, utilizing 3D matrix-embedded models.",
            "predicted_answer": "Huang et al. used tumor spheroids embedded in a Matrigel-based ECM to monitor sotorasib responses in non-small cell lung cancer and CRC cells under normoxic and hypoxic conditions.",
            "score": 5,
            "explanation": "The predicted answer successfully covers the key facts emphasized with # in the reference, including the use of Matrigel-based tumor spheroids and sotorasib. It accurately describes the investigation under normoxic and hypoxic conditions. The meaning aligns well, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1291,
            "query": "Within the spectrum of medical effectiveness predictions, what is the degree of inconsistency manifested by patients whose therapeutic outcomes delineated a path deviation from the orchestrated harmony of their organoid resistance alignments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1774
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The degree of inconsistency is manifested by #three patients#, whose clinical outcomes deviated despite their #matched organoids# being resistant to treatments.",
            "predicted_answer": "The context indicates a 15.57% inconsistency rate, where patient outcomes deviated from organoid resistance predictions, showing some therapeutic responses did not align with organoid sensitivities.",
            "score": 1,
            "explanation": "The predicted answer mentions a 15.57% inconsistency rate but does not specify \"three patients\" or comment on \"matched organoids\". The key facts about the number of patients and the nature of organoid resistance are missing, impacting completeness."
        },
        {
            "query_idx": 1292,
            "query": "What multifaceted insights lend weight to the hypothesis that the anticancer capabilities of LXA4 derive from its inhibitory influence on the interactive dynamics of PSCs, instead of directly altering the intrinsic growth behavior of Panc-1 neoplastic constructs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1792
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The anticancer effect of #LXA4# is due to its #PSC inhibition#, as tumor size reduction was noted only in PSC/Panc-1 spheroids, not in Panc-1 alone.",
            "predicted_answer": "Schnittert et al. found that LXA4 significantly reduced the size and growth rate of PSC/Panc-1 spheroids but had no effect on Panc-1 cells alone, indicating its anticancer effects are due to inhibiting PSCs rather than directly altering Panc-1 cell growth.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies that LXA4's anticancer effects are due to PSC inhibition, emphasized as a key fact, and that effects are observed only in PSC/Panc-1 spheroids, not Panc-1 alone. All critical elements of the reference are present without contradiction."
        },
        {
            "query_idx": 1293,
            "query": "How do empirical measurements signal the opening of a preferential therapeutic pathway by employing a reduced concentration Olaparib scheme, intertwined with segmented radiation exposure, when compared to augmented dosage strategies in the domain of triple-negative breast neoplasms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1788
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #low-dose Olaparib# with segmented radiation improved spheroid efficacy more than #high-dose strategies# for triple-negative breast cancer, suggesting a preferential therapeutic pathway.",
            "predicted_answer": "Empirical measurements, such as spheroid size and metabolic activity, indicate that a low-dose Olaparib scheme with fractionated irradiation is more effective than high-dose strategies in treating triple-negative breast cancers.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"low-dose Olaparib\" and \"high-dose strategies,\" aligning with the reference answer. It acknowledges a preferential therapeutic pathway through empirical measurements like \"spheroid size,\" consistent with \"improved spheroid efficacy.\" All key concepts are covered without contradictions."
        },
        {
            "query_idx": 1294,
            "query": "Within the scope of transient pharmacological evaluations, what intrinsic nuance within plocabulin's potency manifestation encapsulates its divergence from conventional sustained administration protocols?",
            "retrieved_metrics": {
                "reference_idx": [
                    1798
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Plocabulin's #potency# manifesting efficiency in #short pulse# treatment diverges from conventional sustained administration protocols, maintaining strong cytotoxic activity in transient pharmacological evaluations.",
            "predicted_answer": "Plocabulin's potency in transient exposure, as seen in wash-out experiments, shows it can be as effective with short pulse treatments as with continuous administration, diverging from conventional sustained protocols.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of plocabulin's potency and its effectiveness in short pulse treatments, aligning with the reference's emphasis on potency and divergence from sustained protocols. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 1295,
            "query": "In the realm of oncological pharmacology, what enigmatic disconnect within the empirical evaluation processes, particularly associated with planar cellular constructs and xenotransplant test beds, acts as a formidable barrier to the fluid translation of investigative outcomes into the clinical arena?",
            "retrieved_metrics": {
                "reference_idx": [
                    1799
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The enigmatic disconnect is the lack of #translatability# of preclinical results from #2D cell cultures# and xenograft models to clinical applications.",
            "predicted_answer": "The disconnect lies in the limited translatability of results from 2D cell cultures and xenograft models to clinical outcomes, hindering effective drug development.",
            "score": 5,
            "explanation": "The key facts in the reference answer, such as \"translatability,\" \"2D cell cultures,\" and \"xenograft models,\" are present in the predicted answer. The predicted answer accurately reflects the meaning and trend of the reference answer with no significant omissions or errors."
        },
        {
            "query_idx": 1296,
            "query": "What latent complexities and procedural intricacies must be navigated for malignant cellular avatars to transcend their current functional scope in catalyzing pharmaceutical innovations and prognosticating pharmacotherapeutic paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1809
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #standardization# of culture protocols and the establishment of quantitative evaluation methods are key complexities in advancing cancer PDOs for pharmaceutical innovations.",
            "predicted_answer": "To transcend their current scope, malignant cellular avatars must overcome challenges in standardizing culture protocols, assay techniques, and quantitative evaluation methods. Additionally, validating drug response predictions and prospectively anticipating therapeutic conditions are crucial.",
            "score": 5,
            "explanation": "The predicted answer includes the key fact of standardizing culture protocols and the establishment of quantitative evaluation methods emphasized in the reference answer. It also adds aspects like assay techniques and validating drug response, which do not contradict the reference. Overall, it covers the same trend."
        },
        {
            "query_idx": 1297,
            "query": "In what manner does the architecture of the predictive model facilitate its journey through the untested avenues of dosing regimens and its mapping out of the critical therapeutic plains crucial for the achievement of tumor eradication within the xenograft experimentative arrangement?",
            "retrieved_metrics": {
                "reference_idx": [
                    1813
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The model predicts outcomes of #untested dosing regimens# and estimates #minimal drug concentration# needed for tumor eradication in xenograft experiments, aiding early clinical study designs.",
            "predicted_answer": "The architecture of the predictive model facilitates exploration of untested dosing regimens by providing tumor/compound-specific efficacy metrics independent of experimental conditions, predicting outcomes for new schedules, and estimating minimal drug concentrations needed for tumor eradication in xenografts.",
            "score": 5,
            "explanation": "The predicted answer matches the reference by mentioning the prediction of untested dosing regimens and estimating minimal drug concentration, aligning with key facts. No contradictory information or significant omissions are present. Both the overall trend and specifics crucial in achieving tumor eradication in xenografts are addressed."
        },
        {
            "query_idx": 1298,
            "query": "What was the envisaged economic magnitude encapsulating the global plight of cancer during the year 2010, and how does the anticipated financial encumbrance foreseen for oncology within the American sphere in the year 2020 juxtapose with this foundational fiscal estimate?",
            "retrieved_metrics": {
                "reference_idx": [
                    1817
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #estimated global cancer cost# was $1.16 trillion in 2010, while the #anticipated U.S. financial encumbrance# for oncology in 2020 was projected at $173 billion.",
            "predicted_answer": "The estimated global cost of cancer was $1.16 trillion in 2010. In the U.S., the projected cost for 2020 was $173 billion, showing a significant increase in financial burden.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the estimated global cancer cost in 2010 as $1.16 trillion and the anticipated U.S. financial cost for 2020 as $173 billion. It captures all key facts and details emphasized in the reference answer without any omissions or contradictions."
        },
        {
            "query_idx": 1299,
            "query": "What avant-garde pharmacological methodologies have orchestrated the decryption of intricate pharmacodynamics, venturing beyond the conventional paradigm of singular target engagement?",
            "retrieved_metrics": {
                "reference_idx": [
                    1823
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "High-throughput #screening# and advancements in #pharmacogenomics# enable exploration of complex drug effects beyond single-target approaches.",
            "predicted_answer": "High-throughput screening and pharmacogenomics have enabled the exploration of more complex drug effects, moving beyond the traditional single-target approach.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes all key components emphasized with # symbols in the 'Reference Answer': both \"screening\" and \"pharmacogenomics\" are present and relevant. The overall trend of exploring complex drug effects beyond a single target is clearly articulated without significant omissions."
        },
        {
            "query_idx": 1300,
            "query": "How have the orchestrated enterprises of the 85 medicinal reimagining initiatives by Cures Within Reach traversed from theoretical innovation into the realm of patient accessibility or advanced stages of experimental validation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1824
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Out of the #85 repurposing projects# funded by Cures Within Reach, #13 drugs# have either been adopted for patient use or advanced to Phase III trials.",
            "predicted_answer": "Cures Within Reach has funded 85 repurposing projects, with 13 drugs now in use by patients or in Phase III clinical trials, transitioning from theoretical innovation to patient accessibility and advanced experimental validation.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the two key facts emphasized in the reference answer: #85 repurposing projects# and #13 drugs# now in patient use or Phase III trials. The meaning and key facts are fully covered, with no significant omissions or errors."
        },
        {
            "query_idx": 1301,
            "query": "In what manner did the dual pharmacological facets of thalidomide, discovered post its initial market removal, contribute to its therapeutic reemergence in ameliorating hematological conditions and catalyze a financial resurgence to annual revenues surpassing the bicentennial million mark?",
            "retrieved_metrics": {
                "reference_idx": [
                    1826
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Thalidomide's #TNFα inhibition# and #antiangiogenic# properties enabled its therapeutic use in multiple myeloma, driving annual sales beyond $200 million.",
            "predicted_answer": "Thalidomide's dual properties of inhibiting TNFα and antiangiogenic effects led to its use in treating multiple myeloma, driving its therapeutic and financial resurgence, with annual revenues exceeding $200 million.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts: \"TNFα inhibition\" and \"antiangiogenic effects,\" consistent with the reference. It also mentions therapeutic use in multiple myeloma and financial resurgence with revenues exceeding $200 million, fully covering all emphasized information with no significant omissions."
        },
        {
            "query_idx": 1302,
            "query": "Within the realm of oncogenic signal transduction, what pivotal intermediary does thalidomide deftly compromise to abrogate the subsequent activation crescendo of the nuclear factor-kappa B process?",
            "retrieved_metrics": {
                "reference_idx": [
                    1827
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Thalidomide compromises #IkB kinase (IKK)# to abrogate nuclear factor-kappa B activation.",
            "predicted_answer": "Thalidomide inhibits IkB kinase (IKK), a pivotal intermediary, thereby preventing the activation of nuclear factor-kappa B (NF-kB).",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"IkB kinase (IKK)\" as the pivotal intermediary compromised by thalidomide, aligning perfectly with the # key facts # in the reference answer. Both answers convey the prevention of nuclear factor-kappa B activation, with no omissions or errors."
        },
        {
            "query_idx": 1303,
            "query": "In what ways do the contrasting methodologies and diagnostic paradigms between oncology and cardiology influence the predominant emphasis on ameliorative strategies for advanced neoplastic diseases vis-a-vis early stage therapeutic interdictions characteristic of cardiovascular pathologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1831
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The focus on early #biomarkers# in #CVD# allows for preventive interventions, whereas cancer treatment emphasizes managing established disease due to insufficient early detection biomarkers.",
            "predicted_answer": "Oncology often emphasizes treating established diseases due to a lack of early biomarkers, while cardiology focuses on early detection and intervention using well-established biomarkers, leading to fewer advanced-stage treatments.",
            "score": 5,
            "explanation": "The predicted answer correctly covers the key facts about oncology's focus on treating established diseases due to a lack of early biomarkers and cardiology's emphasis on early detection through biomarkers. It aligns with the reference and doesn't omit critical information."
        },
        {
            "query_idx": 1304,
            "query": "How does the intricate interplay between the multidimensional pharmacological actions of a solitary medicinal agent and the genetic patchwork of neoplastic tissue present obstacles, especially considering the compounded challenges of pharmaceutical multifunctionality and the genetic diversity of subpopulations within tumors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1836
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #multifunctionality# of drugs and #genetic heterogeneity# in tumors complicate treatment as subclones might have resistance mutations, leading to insufficient outcomes.",
            "predicted_answer": "The interplay between a drug's multifunctionality and tumor genetic diversity creates obstacles, as a single agent may not effectively target all subpopulations within a tumor, leading to resistance and poor treatment outcomes.",
            "score": 3,
            "explanation": "The predicted answer captures the key points of drug multifunctionality and genetic diversity (heterogeneity) in tumors. It sufficiently describes the issue of resistance and poor treatment outcomes without contradicting the reference. It maintains the meaning, even though it lacks mention of resistance mutations in subclones."
        },
        {
            "query_idx": 1305,
            "query": "Within the labyrinth of cellular fortification against therapeutic agents, how does the synergistic interplay between hypermutation and DNA rectification procedures forge a path to the persistent resistance observed in the genomic landscape as explicated?",
            "retrieved_metrics": {
                "reference_idx": [
                    1835
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #synergistic interplay# between #hypermutation# and DNA repair creates a stably resistant genomic configuration, forging persistent resistance against therapeutic agents.",
            "predicted_answer": "The interplay between hypermutation and DNA repair mechanisms generates resistant genotypes, which are then selected for, leading to a stably resistant genomic configuration that contributes to drug resistance.",
            "score": 5,
            "explanation": "The Predicted Answer fully reflects the synergistic interplay between hypermutation and DNA repair, which leads to a stably resistant genomic configuration. All key facts and trends from the Reference Answer are covered without contradictions or significant omissions."
        },
        {
            "query_idx": 1306,
            "query": "What intrinsic architectural paradigm of biological catalysts permits molecular doppelgängers to traverse a spectrum of binding scenarios, leading to collateral interactions and revealing new therapeutic horizons?",
            "retrieved_metrics": {
                "reference_idx": [
                    1837
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intrinsic architectural paradigm is #target promiscuity#, allowing kinase inhibitors to bind to various kinases, creating new therapeutic opportunities through #off-target interactions#.",
            "predicted_answer": "The intrinsic architectural paradigm of biological catalysts, such as kinases, involves a common ATP-binding pocket. This structural similarity allows molecular doppelgängers to bind to multiple targets, leading to collateral interactions and new therapeutic opportunities.",
            "score": 3,
            "explanation": "The predicted answer captures the concept of a shared structural feature in kinases that allows binding to multiple targets, which aligns with the idea of \"target promiscuity.\" However, it does not explicitly mention \"off-target interactions,\" omitting a key fact emphasized in the reference answer."
        },
        {
            "query_idx": 1307,
            "query": "In what ways have established modulators of enzymatic harmony traversed alternative oncological avenues, embarking on new therapeutic journeys without diverging from their initial molecular interaction domains?",
            "retrieved_metrics": {
                "reference_idx": [
                    1839
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Established modulators such as #VEGF inhibitor bevacizumab# and #multi-kinase inhibitor dasatinib# have been repurposed for new cancer indications without changing their initial kinase targets.",
            "predicted_answer": "Established modulators, like VEGF inhibitor bevacizumab and multi-kinase inhibitor dasatinib, have been repurposed for new oncological indications while maintaining their initial molecular interaction domains.",
            "score": 5,
            "explanation": "The predicted answer includes both key examples, VEGF inhibitor bevacizumab and multi-kinase inhibitor dasatinib, as mentioned in the reference answer. It aligns with the trend by indicating that these modulators are repurposed while maintaining their molecular interaction domains. No significant key facts are missing."
        },
        {
            "query_idx": 1308,
            "query": "What are the intricate web of socio-professional dynamics and eligibility conundrums that mold the perceptual frameworks of healthcare providers as they navigate the nuances of engaging their clientele in scientific inquiries, as influenced by systemic and operational vectors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1846
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Physician engagement#, influenced by #trial eligibility criteria#, site accessibility, resource constraints, workload, and financial incentives, shapes healthcare providers' perceptions in engaging patients in scientific inquiries.",
            "predicted_answer": "Socioeconomic factors, patient and physician attitudes, and complex eligibility criteria influence healthcare providers' engagement in clinical trials. Physician involvement is crucial for patient enrollment, affected by trial awareness, resource constraints, and financial incentives.",
            "score": 1,
            "explanation": "The predicted answer includes key elements such as physician engagement, eligibility criteria, and financial incentives, which are emphasized in the reference. However, it misses key details like site accessibility, resource constraints, and workload. Therefore, while aligned, it lacks full coverage of all critical factors."
        },
        {
            "query_idx": 1309,
            "query": "What intrinsic challenges, within the tapestry of cancer research methodologies, might impede the integration of decentralized clinical trials, contrasting with their wider acceptance in healthcare segments addressing disorders like insomnia and neurodegenerative conditions such as Parkinson's disease?",
            "retrieved_metrics": {
                "reference_idx": [
                    1850
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The challenges include complex #inclusion criteria#, infusion-type treatments, and frequent #tumor response assessments#, hindering oncology's acceptance of decentralized clinical trials compared to other disorders.",
            "predicted_answer": "The complexity of inclusion criteria, infusion-based treatments, and frequent tumor response assessments in cancer research pose intrinsic challenges to integrating decentralized clinical trials, unlike in insomnia and Parkinson's disease.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized in the reference answer: \"inclusion criteria\" and \"tumor response assessments,\" along with \"infusion-based treatments.\" The overall meaning and key details are consistent with the reference, with no significant omissions or errors."
        },
        {
            "query_idx": 1310,
            "query": "What are the cascading advantages associated with employing personal monitoring systems in the telehealth management of individuals receiving therapeutic interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1849
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Using #wearable devices# in telehealth allows early detection of treatment-related toxicities and tracks daily activities, enhancing clinical #assessments# and involvement in therapeutic interventions.",
            "predicted_answer": "Cascading advantages include early detection of treatment-related issues, improved patient monitoring, enhanced family involvement, and facilitated access to clinical trials, all contributing to better therapeutic outcomes.",
            "score": 1,
            "explanation": "The predicted answer covers early detection of treatment-related issues, aligning with toxicities. However, it omits the focus on #wearable devices# and specific tracking of #daily activities#. While generally aligned, these omissions impact the completeness concerning the reference answer's emphasis."
        },
        {
            "query_idx": 1311,
            "query": "What intricate delineations within the data mosaic are necessitated by the regulatory gatekeepers' latest directives, prompted by methodological shifts in trial conduct since the global health upheaval, specifically in relation to the provenance of data collection in pharmaceutical dossiers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1848
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Applicants must indicate whether data were collected #remotely# or at the #trial site# due to changes in trial methodology prompted by the latest regulatory directives.",
            "predicted_answer": "The latest directives require specifying whether data were collected remotely or at trial sites, supporting digital health technology and mobile medical professionals to reduce patient burden and increase minority enrollment.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts of the reference answer, indicating whether data were collected remotely or at trial sites, consistent with the regulatory directives. No significant omissions or errors are present, and additional context is provided without contradiction."
        },
        {
            "query_idx": 1312,
            "query": "What proportion of individuals within the examined assemblage, marked by their journey through various cancer typologies, are discerned as having developments within the hematopoietic disorder classification?",
            "retrieved_metrics": {
                "reference_idx": [
                    1853
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A small proportion of the 300 individuals have developments within the #hematological# disorder classification.",
            "predicted_answer": "A small proportion of the examined assemblage was diagnosed with hematological tumors, such as multiple myeloma and acute myeloid leukemia.",
            "score": 5,
            "explanation": "The predicted answer contains the key fact emphasized in the reference answer, which is the \"hematological\" disorder classification. Although it mentions specific conditions (multiple myeloma, acute myeloid leukemia), the overall meaning aligns, and no critical facts are missing or contradictory trends present."
        },
        {
            "query_idx": 1313,
            "query": "What underlying trepidations do clinical practitioners harbor about patient-driven diagnostic initiatives amidst investigational study contexts, and in what manner does this continuum of apprehension align with their adaptability to distant evaluative methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1852
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Clinical practitioners harbor concerns about #decreased oversight# and #sample quality# in patient-driven diagnostics, but are confident in remote assessments like temperature and blood pressure collection.",
            "predicted_answer": "Clinical practitioners are concerned about reduced patient oversight, increased patient responsibility, and the quality of self-collected samples. They are more comfortable with remote assessments for basic metrics like temperature and blood pressure but less so for trial medication compliance.",
            "score": 5,
            "explanation": "The predicted answer successfully mentions concerns about \"reduced patient oversight\" and \"the quality of self-collected samples,\" aligning with the reference answer's \"decreased oversight\" and \"sample quality.\" However, trial medication compliance is not mentioned in the reference, leading to alignment without contradiction."
        },
        {
            "query_idx": 1314,
            "query": "What pivotal levers, analogized as tactical instruments in a strategic game, does the oncologist cite as weaving the intricate fabric of patient immersion in the realm of clinical trials, balancing the dual axes of educational enlightenment and streamlined access coordination?",
            "retrieved_metrics": {
                "reference_idx": [
                    1851
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The oncologist cites #education# on clinical trials and #convenient access# as pivotal levers for enhancing patient participation in clinical trials.",
            "predicted_answer": "The oncologist cites education on clinical trials, convenience of access, and compensation as key levers, balancing patient enlightenment and streamlined participation. Personal circumstances, physician access, and awareness of potential side effects also influence engagement.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of #education# and #convenient access#, aligning well with the reference answer. While it adds additional factors like compensation and personal circumstances, these do not contradict the reference. The meaning and key facts are consistent."
        },
        {
            "query_idx": 1315,
            "query": "What paradigmatic facets of the dispersed investigational methodologies attained superior assessments from the participant cohort, and in what manner was the convergence of digital instrumentation, exemplified by wearable physiological monitors, received by potential contributors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1854
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The paradigms of #DCT solutions# and #wearable devices# received superior assessments from participants, who felt comfortable with health-tracking technologies and telemedicine for clinical trials.",
            "predicted_answer": "The participant cohort highly ranked wearable physiological monitors, home nursing, and telemedicine. These digital tools were well-received for their convenience and ability to replace traditional site visits, enhancing comfort and accessibility in clinical trials.",
            "score": 3,
            "explanation": "The predicted answer effectively covers key facts like \"wearable physiological monitors\" being well-received by participants, the replacement of traditional site visits with digital tools, and telemedicine, aligning with the trends in the reference answer. However, it doesn't explicitly mention \"DCT solutions.\""
        },
        {
            "query_idx": 1316,
            "query": "What underlying tapestry of challenges presents the most significant barrier to enduring patient survival against the backdrop of metastatic bladder afflictions, despite the strategic implementation of surgical removals and age-old cisplatin-infused medicinal symphonies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1856
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #metastasis# of bladder cancer presents the most significant barrier to patient #survival#, with only about 5% surviving for at least 5 years post-diagnosis.",
            "predicted_answer": "The most significant barrier to enduring patient survival in metastatic bladder cancer, despite surgical removals and cisplatin-based treatments, is the high rate of relapse and the limited 5-year survival rate, which is only about 5%.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by emphasizing the critical issue of low survival rates and relapse in metastatic bladder cancer, corresponding with the key facts of metastasis and 5% survival rate over 5 years. Though phrasing varies, there is no contradiction, ensuring trend cohesion and full coverage of key details."
        },
        {
            "query_idx": 1317,
            "query": "What proportion of individuals embarking on a journey freshly diagnosed with bladder cancer find themselves facing the form that delves into muscular territories?",
            "retrieved_metrics": {
                "reference_idx": [
                    1855
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Approximately #25%# of individuals newly diagnosed with bladder cancer face the #muscle-invasive# form.",
            "predicted_answer": "Approximately 25% of individuals newly diagnosed with bladder cancer have the muscle-invasive form.",
            "score": 5,
            "explanation": "The Predicted Answer matches the Reference Answer in both the key percentage (#25%#) and the descriptor (#muscle-invasive#) of the bladder cancer form. The meaning and key facts are fully consistent, with no significant omissions or errors, aligning perfectly with the Reference Answer."
        },
        {
            "query_idx": 1318,
            "query": "What intricacies and transitional hurdles are marked along the labyrinthine journey of introducing DCT solutions into the complexities of cancer care, as revealed through survey observations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1858
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Implementing #DCT solutions# in cancer care faces hurdles like ensuring #data integrity# and protection, despite positive acceptance and potential benefits in patient access and participation.",
            "predicted_answer": "Introducing DCT solutions in cancer care faces hurdles such as ensuring data integrity and protection, despite positive acceptance. These challenges are crucial for maintaining the reliability and security of patient information.",
            "score": 3,
            "explanation": "The predicted answer adequately mentions \"DCT solutions\" and the challenge of \"ensuring data integrity and protection,\" aligning with the reference. However, it omits key information about \"potential benefits in patient access and participation,\" which is emphasized in the reference."
        },
        {
            "query_idx": 1319,
            "query": "What deleterious physiological state could arise from a subtle contact with the imperceptible hazard presented by minute quantities of the elemental form of selenium or its compound derivatives?",
            "retrieved_metrics": {
                "reference_idx": [
                    1863
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Subtle contact with minute quantities of elemental selenium or its compounds can lead to #selenosis#, a deleterious physiological state.",
            "predicted_answer": "Exposure to small amounts of elemental selenium or its compounds can lead to selenosis, a toxic condition characterized by symptoms such as hair loss, nail brittleness, and neurological issues.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key fact emphasized in the reference answer, which is the possibility of developing selenosis from exposure to small amounts of selenium or its compounds. The additional details provided do not contradict or omit any critical information from the reference."
        },
        {
            "query_idx": 1320,
            "query": "What conceivable influence might oncogenic codes have within the intricate milieu of strategic therapeutic selection pathways for high-grade MIUC where immune-resilience is conspicuously minimal?",
            "retrieved_metrics": {
                "reference_idx": [
                    1860
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Oncogenic codes could serve as #predictive biomarker#s for therapeutic decisions in high-grade MIUC, where immune-resilience is low, guiding #biomarker-driven# treatments.",
            "predicted_answer": "Oncogenic codes in high-grade MIUC, such as FGFR3 and HER2, can serve as predictive biomarkers for therapeutic selection, guiding the use of targeted treatments like ADCs, especially where immune-resilience is low.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer, mentioning oncogenic codes as predictive biomarkers guiding targeted treatments and noting low immune-resilience. It specifically includes FGFR3 and HER2, adding precision. However, it misses the term \"biomarker-driven,\" slightly affecting completeness but not the overall trend."
        },
        {
            "query_idx": 1321,
            "query": "What narrative on the interrelationship between variant selenium distribution in geographic sectors and the emergence of oncological conditions is elucidated by evaluating the disparate selenium quantifications alongside symptomatic evaluations in specified patient groups?",
            "retrieved_metrics": {
                "reference_idx": [
                    1864
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "An #inverse relationship# is observed between selenium distribution and cancer, with lower cancer rates in regions of moderate or high #selenium# levels.",
            "predicted_answer": "Evaluating selenium levels alongside symptomatic data in patient groups reveals an inverse relationship between selenium distribution and cancer incidence, with lower cancer rates in areas of higher selenium levels. Selenium deficiency is linked to increased oncological conditions, and supplementation can enhance antioxidant defenses.",
            "score": 5,
            "explanation": "The predicted answer captures the key fact of an \"inverse relationship\" between selenium levels and cancer incidence, and highlights the role of selenium in potentially preventing cancer, consistent with the reference. The mention of selenium deficiency and supplementation enhances completeness without contradiction."
        },
        {
            "query_idx": 1322,
            "query": "Within the intricate tapestry of UC treatment modalities, and in the absence of continuity in preservation therapy following the primary intervention, which subsequent stratagem of enhanced therapeutic engagement is advocated?",
            "retrieved_metrics": {
                "reference_idx": [
                    1861
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Immunotherapy# using #Pembrolizumab# is recommended as the second-line therapy when there is no subsequent maintenance therapy after the primary intervention.",
            "predicted_answer": "For UC patients without continuity in preservation therapy, maintenance immunotherapy (Avelumab) is suggested if the disease does not progress after PCT. If maintenance therapy is not an option, second-line immunotherapy (Pembrolizumab) is recommended.",
            "score": 5,
            "explanation": "The predicted answer mentions immunotherapy as a treatment option, which aligns with the reference answer's mention of \"#Immunotherapy#\". It also specifies \"Pembrolizumab\" as the second-line therapy, consistent with the reference answer. However, it adds \"Avelumab\" as an optional maintenance immunotherapy, which is irrelevant but not contradictory."
        },
        {
            "query_idx": 1323,
            "query": "What inherent attribute of diphenyl diselenide 1 acts like an internal guardian, fortifying macrophages against the disruptive influence of atherogenic pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1866
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The inherent attribute of diphenyl diselenide 1 is its #antioxidant# properties, acting as an internal guardian to fortify macrophages against #atherogenic# pathways.",
            "predicted_answer": "The excellent antioxidant and glutathione-peroxidase-like properties of diphenyl diselenide 1 act as an internal guardian, fortifying macrophages against atherogenic pathways.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"antioxidant\" and \"atherogenic\" from the reference answer, while also mentioning \"glutathione-peroxidase-like properties,\" which does not contradict the reference. The answer is accurate, complete, and aligns well with the reference. No key facts are missing."
        },
        {
            "query_idx": 1324,
            "query": "What influence does Na₂SeO₃, acting as a biochemical agent, impose on the interconnected cellular phenomena and fate-altering pathways of cholangiocarcinoma entities, especially at concentrations spanning from 1 to 10 micromolar, thereby instigating pivotal changes in cellular integrity and operational traits?",
            "retrieved_metrics": {
                "reference_idx": [
                    1869
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Na₂SeO₃ at #1 to 10 µM# concentrations reduces invasion, migration, and epithelial-to-mesenchymal transition in cholangiocarcinoma by inducing #apoptosis# and downregulating N-cadherin.",
            "predicted_answer": "Na₂SeO₃, at 1-10 µM, reduces invasion, migration, and epithelial-to-mesenchymal transition in cholangiocarcinoma cells by inducing apoptosis and downregulating N-cadherin, altering cellular integrity and operational traits.",
            "score": 5,
            "explanation": "The predicted answer fully includes the key facts emphasized with # in the reference answer: the concentration range of 1 to 10 µM, reduction in invasion, migration, epithelial-to-mesenchymal transition, induction of apoptosis, and downregulation of N-cadherin. The overall trends and essential information are consistent."
        },
        {
            "query_idx": 1325,
            "query": "What transformative biochemical topography is charted by the synergistic intervention of ebselen with silver to dismantle the robust defenses of ontologically resistant Gram-negative bacterial entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1873
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ebselen, combined with #silver#, disrupts Gram-negative bacteria defenses by inhibiting TrxR, increasing #reactive oxygen species# in prokaryotic cells.",
            "predicted_answer": "Ebselen, when combined with silver, disrupts the defenses of multi-drug-resistant Gram-negative bacteria by inhibiting thioredoxin reductase and increasing reactive oxygen species, leading to bacterial cell death.",
            "score": 5,
            "explanation": "The Predicted Answer includes both emphasized points from the Reference Answer: the combination with \"silver\" and the \"increase of reactive oxygen species.\" It aligns well with the Reference, detailing the inhibition of thioredoxin reductase. All key facts are present with no significant omissions or errors."
        },
        {
            "query_idx": 1326,
            "query": "What is the numerically defined inflection point, synonymous with the biochemical prowess of diphenyl diselenide 1, that delineates its capacity to traverse intracellular pathways and metaphorically dismantle the cellular integrity of SHSY5Y neuroblastoma cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1882
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The numerically defined inflection point for diphenyl diselenide 1's capacity on SHSY5Y neuroblastoma cells is #IC50 = 30 μM#.",
            "predicted_answer": "The numerically defined inflection point for diphenyl diselenide 1, indicating its cytotoxic effect on SHSY5Y neuroblastoma cells, is an IC50 of 30 μM.",
            "score": 5,
            "explanation": "The predicted answer accurately conveys the key fact emphasized in the reference answer: the IC50 value of 30 μM for diphenyl diselenide 1's effects on SHSY5Y neuroblastoma cells. There are no significant omissions or errors, and the overall trend aligns with the reference answer."
        },
        {
            "query_idx": 1327,
            "query": "How do the inhibitory concentration thresholds, representing the molecular resistance levels, of the selenium-integrated zidovudine entities, numerically coded as 10, 11, and 24, present themselves when interacting with the structural complexities of human bladder cancer cell 5637?",
            "retrieved_metrics": {
                "reference_idx": [
                    1879
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #IC50 values# for the selenium-integrated zidovudine derivatives #10#, 11, and 24 against human bladder cancer cell 5637 are 78.85, 51.63, and 40.4 µM, respectively.",
            "predicted_answer": "The inhibitory concentration (IC50) values for the selenium-integrated zidovudine entities 10, 11, and 24 against human bladder cancer cell 5637 are 78.85, 51.63, and 40.4 µM, respectively.",
            "score": 5,
            "explanation": "The Predicted Answer accurately matches all key facts emphasized in the Reference Answer. It includes the IC50 values for the selenium-integrated zidovudine entities 10, 11, and 24, as noted in the Reference Answer. The numerical results align precisely, with no omissions or inaccuracies."
        },
        {
            "query_idx": 1328,
            "query": "How do the inherent characteristics of selenium, as integrated into diverse pharmacological constructs, manifest as obstacles within the complex landscape of clinical assessment, countering the substantial interest in harnessing their extensive bioactive capabilities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1888
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #high toxicity# of #selenium# limits its clinical exploration, despite its antioxidant, anticancer, and other bioactive properties integrated into pharmacological constructs.",
            "predicted_answer": "The high toxicity of selenium, even when incorporated into bioactive compounds, poses significant obstacles in clinical assessment, despite its extensive bioactive capabilities and potential therapeutic benefits.",
            "score": 3,
            "explanation": "The Predicted Answer covers the key fact of the \"high toxicity\" of \"selenium\" mentioned in the Reference Answer. It aligns with the overall trend by recognizing the obstacles faced due to selenium's properties. However, it omits details on its \"antioxidant, anticancer\" properties, impacting completeness."
        },
        {
            "query_idx": 1329,
            "query": "What intricate navigational paradigms do European entities employ to maneuver through the complex uncertainties of clinical trial validation and economic sustainability, specifically for therapeutic innovations authorized via exclusive regulatory conduits?",
            "retrieved_metrics": {
                "reference_idx": [
                    1890
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "European entities use #managed entry agreements# based on performance and financial metrics to navigate clinical trial evidence uncertainties and economic sustainability for innovative drugs approved via special pathways.",
            "predicted_answer": "European entities use managed entry agreements to address clinical trial uncertainties and economic sustainability, balancing innovation with cost-effectiveness for therapeutics approved through special regulatory pathways.",
            "score": 3,
            "explanation": "The predicted answer captures the concept of European entities using managed entry agreements to navigate clinical trial uncertainties and economic sustainability for innovations approved through special pathways. However, it lacks mention of \"performance and financial metrics,\" a key fact emphasized in the reference answer."
        },
        {
            "query_idx": 1330,
            "query": "What intrinsic frameworks do impetus-oriented incentives utilize to cultivate a fertile environment that nurtures primary technological exploration in the realm of pharmaceutical development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1895
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Impetus-oriented incentives utilize #push policies# such as #public research funding# and tax credits to create a favorable environment for primary technological exploration in pharmaceutical development.",
            "predicted_answer": "Push incentives, such as public research funding, tax credits, and government-sponsored incubators, create a supportive environment that fosters primary technological exploration in pharmaceutical development.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts: \"push incentives,\" \"public research funding,\" and \"tax credits,\" aligning well with the reference answer's emphasis. There are no significant omissions or errors, and the overall meaning is consistent with the reference."
        },
        {
            "query_idx": 1331,
            "query": "What is the extent of the metamorphosis in the numerical proportion of pharmaceuticals bestowed with the rarefied orphan emblem, traversing the temporal spectrum from 2003 to 2022, articulated as a growth ratio?",
            "retrieved_metrics": {
                "reference_idx": [
                    1894
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The growth ratio for pharmaceuticals with the orphan designation increased from #20%# in 2003 to #54%# in 2022.",
            "predicted_answer": "The growth ratio of pharmaceuticals receiving orphan designation increased from 20% in 2003 to 54% in 2022, reflecting a 2.7-fold increase.",
            "score": 5,
            "explanation": "The predicted answer fully captures the key facts emphasized in the reference answer. It correctly states the percentages 20% for 2003 and 54% for 2022. The addition of the 2.7-fold increase is accurate and supports the information provided, with no contradictions."
        },
        {
            "query_idx": 1332,
            "query": "What triadic procedural lenses does the FDA utilize in its quest to unravel the continuum of safety and effectiveness inherent in a potential therapeutic entity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1896
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The FDA utilizes #disease analysis#, #benefit-risk assessment#, and #risk management considerations# to evaluate a drug's safety and efficacy.",
            "predicted_answer": "The FDA uses a three-step process: analyzing the disease and available treatments, assessing benefits and risks based on clinical evidence, and considering risk management.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes all key facts from the 'Reference Answer': disease analysis, benefit-risk assessment, and risk management considerations. The phrasing differs, but the core concepts are present without contradiction or omission, ensuring high consistency with the reference."
        },
        {
            "query_idx": 1333,
            "query": "What strategic oversight methodology is deployed by the governing body of food and drug regulation to traverse the uncertain terrain of adverse health outcomes, especially when confronted with ambiguous patient safety scenarios?",
            "retrieved_metrics": {
                "reference_idx": [
                    1897
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #FDA# employs a #risk evaluation and mitigation strategy (REMS)# to manage adverse health outcomes in uncertain patient safety scenarios.",
            "predicted_answer": "The FDA uses a risk evaluation and mitigation strategy (REMS) to monitor and manage the side effects of drugs, especially in uncertain patient safety scenarios. Additionally, an expert advisory committee provides recommendations, though the FDA is not bound by their judgment.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key elements emphasized in the reference answer: the use of a risk evaluation and mitigation strategy (REMS) by the FDA in managing uncertain patient safety scenarios. No key details are missing, and there is no contradictory information."
        },
        {
            "query_idx": 1334,
            "query": "What transformative ripples did the legislative enactment deemed the Orphan Drug Act impart upon the progressive saga of therapeutic approvals, from its dawn in 1983 through the horizon of 2021, within the intricate sphere of FDA endorsements for medicinal rarities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1899
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Orphan Drug Act# led to #1,033 FDA approvals# for rare disease treatments from 1983 to 2021, addressing large unmet medical needs.",
            "predicted_answer": "The Orphan Drug Act of 1983 significantly increased the development and approval of drugs for rare diseases. By 2021, it led to 6,143 drugs receiving orphan designation, with 1,033 gaining FDA approval, benefiting around 11 million patients.",
            "score": 5,
            "explanation": "The predicted answer captures the key fact of the Orphan Drug Act resulting in \"1,033 FDA approvals\" for rare diseases, which aligns with the reference answer. It also provides additional context about orphan designations and patients benefiting. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 1335,
            "query": "What symbolism of numerical distinction delineates the heightened propensity for therapeutics designated as orphan drugs to successfully navigate clinical trial approval compared to those not bearing such a designation, when examined through the intricate interplay of statistical classifications and evaluative outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1903
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Orphan drugs have a higher chance of FDA approval, with an #AOR# of #2.26#, compared to non-orphan drugs, despite similar clinical development times.",
            "predicted_answer": "Orphan drugs have a 2.26 times higher probability of clinical trial success and FDA approval compared to non-orphan drugs, as indicated by an adjusted odds ratio (AOR) with a 95% confidence interval of 1.37 to 3.71.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference, specifically the \"AOR of 2.26,\" confirming orphan drugs' higher likelihood of approval. It also provides additional details on the 95% confidence interval, enhancing completeness without introducing contradictions. All essential information is present and aligned."
        },
        {
            "query_idx": 1336,
            "query": "What is the relative probability disparity in traversing the transitional journey from the initial research stages to achieving regulatory sanction, comparing neglected pathologies with their typical counterparts within the intricate approval framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1901
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #probability# of orphan indications achieving #FDA approval# is 32.9%, compared to 10.4% for typical counterparts.",
            "predicted_answer": "The relative probability of achieving regulatory approval is higher for neglected pathologies, with a 32.9% success rate from phase 1 to FDA approval, compared to 10.4% for typical counterparts.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key fact that there is a 32.9% success rate from phase 1 to FDA approval for neglected pathologies, compared to 10.4% for typical counterparts, consistent with the reference answer. All key information and context are retained."
        },
        {
            "query_idx": 1337,
            "query": "What is the proportion of uncommon ailments for which therapeutic concoctions have been ingeniously crafted, and what segment of these conditions have garnered official endorsement from authoritative bodies by way of medicinal approval?",
            "retrieved_metrics": {
                "reference_idx": [
                    1900
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#15%# of rare diseases have orphan drugs, and #5%# have received FDA approval.",
            "predicted_answer": "15% of rare diseases have therapeutic concoctions developed, and 5% of these conditions have received FDA approval.",
            "score": 5,
            "explanation": "The predicted answer conveys the same key facts as the reference answer: 15% of rare diseases have treatments developed, and 5% have received FDA approval. Although phrasing differs, such as using \"therapeutic concoctions\" instead of \"orphan drugs,\" the meaning remains consistent."
        },
        {
            "query_idx": 1338,
            "query": "What architectural blueprints have been conceived to modulate the pathways and financial streams of these biopharmaceutical entities classified under partial orphanhood within the fiscal landscapes of pharmacological anomalies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1905
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Scholars proposed #patient thresholds#, #indication-specific pricing#, and indication-specific formularies to modulate pathways and financial streams of partial orphan biopharmaceuticals.",
            "predicted_answer": "Scholars have proposed patient or revenue thresholds, indication-specific pricing, and formularies to control the usage and financial streams of partial orphan drugs, which often become top-selling blockbusters.",
            "score": 3,
            "explanation": "The Predicted Answer correctly includes \"patient thresholds\" and \"indication-specific pricing.\" However, it only mentions \"formularies\" without associating them specifically with indication, as seen in the Reference Answer. Despite this minor omission, the trends and key ideas are largely aligned."
        },
        {
            "query_idx": 1339,
            "query": "What abstract evaluative parameters, anchored in multifaceted considerations of survival implications, the tapestry of life quality, and the intricate progression cadence of ailments, does the FDA utilize to decree a condition's critical standing, thereby conferring upon it the privilege of accelerated advancement under the auspices of their fast track initiative?",
            "retrieved_metrics": {
                "reference_idx": [
                    1906
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The FDA uses #survival implications#, #life quality#, and #progression characteristics# to determine a condition's seriousness for fast track eligibility.",
            "predicted_answer": "The FDA considers a condition's impact on survival, quality of life, and disease progression to determine its critical standing for fast track designation. Conditions like AIDS, cancer, and heart failure qualify due to their severity and unmet medical needs.",
            "score": 5,
            "explanation": "The predicted answer includes all key elements emphasized in the reference answer: survival, quality of life, and disease progression. While phrased slightly differently, it aligns with the overall trend and does not omit any key facts marked with #. There are no contradictions present."
        },
        {
            "query_idx": 1340,
            "query": "What strategic therapeutic enhancement must a novel pharmaceutical entity embody to traverse the landscape of well-established medicinal remedies and ultimately fulfill a niche devoid of clinical solutions, when conventional interventions are prevalent?",
            "retrieved_metrics": {
                "reference_idx": [
                    1907
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A novel pharmaceutical must demonstrate #superior efficacy# or #fewer side effects# than existing treatments to fulfill an unmet medical need amidst conventional interventions.",
            "predicted_answer": "A novel pharmaceutical entity must demonstrate superior efficacy, fewer side effects, or better treatment adherence compared to existing therapies to fulfill an unmet medical need and gain approval.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts from the reference answer: \"superior efficacy\" and \"fewer side effects.\" Additionally, it mentions \"better treatment adherence,\" which aligns with improving therapeutic outcomes. No key facts are missing, and the trend is aligned."
        },
        {
            "query_idx": 1341,
            "query": "What multifaceted hindrances do ultra-orphan therapeutic architects encounter, compared to their peers designing treatments for more prevalent afflictions, in light of the UK's emerging legislative and procedural contemplations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1908
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ultra-orphan therapeutic architects face #challenges# in finding patients, competent investigators, and specialized centers with suitable infrastructure, unlike those working on more prevalent conditions in the UK's current legislative climate.",
            "predicted_answer": "Ultra-orphan therapeutic architects face challenges like finding enough patients, competent investigators, and specialized medical centers. The UK is considering a distinct ultra-orphan designation to address these complexities.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts of challenges related to finding patients, competent investigators, and specialized centers, as mentioned in the reference answer. However, it misses the comparison to those working on prevalent conditions and the specific mention of the UK's legislative climate, affecting completeness."
        },
        {
            "query_idx": 1342,
            "query": "What delineates the intrinsic quantum of incremental Quality-Adjusted Life Year elevation, within the spectrum outlined by Chambers et al., when contrasting entities recognized under the aegis of expeditious approval constructs against those omitted from such pathways, specifically regarding the statistical differentiation in their effectiveness emblem?",
            "retrieved_metrics": {
                "reference_idx": [
                    1909
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intrinsic quantum of incremental #QALY# elevation for fast track entities is #0.254#, compared to 0.014 for non-fast track entities (p < 0.001).",
            "predicted_answer": "Chambers et al. found that fast track designation drugs provided a median incremental Quality-Adjusted Life Year (QALY) benefit of 0.254, significantly higher than 0.014 for those without, indicating a statistically significant difference in effectiveness.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts emphasized in the reference answer, including the #QALY# elevations of #0.254# for fast track entities and 0.014 for non-fast track entities. The overall trend and statistical differentiation are aligned, and no essential information is missing."
        },
        {
            "query_idx": 1343,
            "query": "In what manner do the nuanced hallmarks of medical efficacy elevation operate as pivotal determinants within the dual pathways of drug evaluation triage, as conceptualized under the restructured canons of the Prescription Drug User Fee Act?",
            "retrieved_metrics": {
                "reference_idx": [
                    1914
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Prescription Drug User Fee Act# emphasizes #increased effectiveness# and other improvements as key determinants in prioritizing drug evaluations for expedited review.",
            "predicted_answer": "The hallmarks of medical efficacy, such as increased effectiveness or improved patient outcomes, serve as key determinants for whether a drug receives priority or standard review under the restructured PDUFA, thereby influencing its evaluation and approval timeline.",
            "score": 3,
            "explanation": "The predicted answer includes \"increased effectiveness\" and discusses its role as a determinant under the PDUFA, aligning with the reference answer. However, it omits specific mention of the \"#Prescription Drug User Fee Act#\" itself, missing one key fact. The overall context and trend are consistent."
        },
        {
            "query_idx": 1344,
            "query": "To what extent does the symbolic nomenclature attributed to pharmaceutical advancements cultivate the interpretative frameworks of consumer perception concerning their perceived therapeutic potency and the foundational pillars of scientific substantiation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1918
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #symbolic nomenclature#\"breakthrough\" enhances consumer perception of drugs' #therapeutic potency#, fostering unwarranted optimism about effectiveness and scientific evidence.",
            "predicted_answer": "The term \"breakthrough\" in pharmaceuticals significantly influences consumer perception, leading to higher beliefs in therapeutic potency and scientific substantiation, despite no conclusive evidence of greater effectiveness or innovation.",
            "score": 3,
            "explanation": "The predicted answer accurately captures the idea that the term \"breakthrough\" influences consumer perception of drugs' therapeutic potency and beliefs in scientific substantiation, aligning with the reference answer. However, it lacks the notion of \"unwarranted optimism,\" a key aspect highlighted in the reference."
        },
        {
            "query_idx": 1345,
            "query": "What inferences articulated by Herink et al. illuminate the evidential tapestry concerning breakthrough-designated pharmaceuticals as a kaleidoscope of variance, and in what manner does this relate to the labyrinthine uncertainties surrounding their safety and efficacy as discussed in their 2018 scholarly exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1919
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Herink et al.# concluded that breakthrough drugs have a #heterogeneous# quality of evidence, highlighting uncertainties about their safety and efficacy.",
            "predicted_answer": "Herink et al. concluded that the evidence for breakthrough-designated pharmaceuticals is heterogeneous, highlighting significant uncertainties in their safety and efficacy. This underscores the need for cautious interpretation and further research.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized in the reference: \"Herink et al.\" and \"heterogeneous\" are clearly addressed. It captures the general trend of uncertainties in safety and efficacy related to breakthrough drugs. No key facts are missing or contradictory."
        },
        {
            "query_idx": 1346,
            "query": "In what manner do the metaphorical avenues of eligibility and temporal guidance within the PRIME scheme unfurl in contrast to the FDA's breakthrough therapeutic designation, particularly in the realms of primary versus supplementary explorations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1924
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #PRIME program# excludes supplemental indications, offering #early guidance# based on pre-clinical data, differing from the FDA's breakthrough designation, which includes supplementary applications.",
            "predicted_answer": "The PRIME scheme offers early and intensive guidance, including eligibility for accelerated assessment, but is limited to original indications. In contrast, the FDA's breakthrough therapy designation can apply to both primary and supplementary explorations.",
            "score": 3,
            "explanation": "The predicted answer captures key facts like PRIME's early guidance and focus on original indications, aligning with the reference. However, it omits that the PRIME program excludes supplemental indications based on pre-clinical data, which affects completeness."
        },
        {
            "query_idx": 1347,
            "query": "In the decade-spanning examination of oncological therapies from 2012 to 2022, what quantifiable divergence exists in the pivotal measure of longevity extension between those newly recognized for transformative potential and their standard counterparts?",
            "retrieved_metrics": {
                "reference_idx": [
                    1917
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Breakthrough indications extended #median overall survival# by #1.6 months# more than non-breakthrough indications from 2012 to 2022.",
            "predicted_answer": "From 2012 to 2022, breakthrough oncological therapies were associated with a lower likelihood of death (hazard ratio: 0.69 vs. 0.74) and provided a significant improvement in median overall survival by 1.6 months compared to standard treatments.",
            "score": 5,
            "explanation": "The Predicted Answer aligns well with the Reference Answer by mentioning the extension of \"median overall survival\" by \"1.6 months\" for breakthrough therapies compared to standard treatments. All key facts are retained, and there are no contradictions or significant omissions."
        },
        {
            "query_idx": 1348,
            "query": "What is the nuanced mechanism by which molecular architects engineer the selective deconstruction of proteinaceous targets via proteolytic orchestration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1933
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Molecular architects engineer selective deconstruction of proteins via #PROTACs#, utilizing a dual-ligand system that targets proteins for degradation by recruiting an #E3 ligase#.",
            "predicted_answer": "Molecular architects use PROTACs, which are molecules that bind to a target protein and an E3 ligase, facilitating the selective degradation of the target protein through the cell's ubiquitin-proteasome system.",
            "score": 5,
            "explanation": "The Predicted Answer covers all key points emphasized in the Reference Answer. It mentions \"PROTACs\" and \"E3 ligase,\" aligning well with the mechanism of selective protein degradation. No significant omissions or errors are present, and the overall trend is consistent."
        },
        {
            "query_idx": 1349,
            "query": "Within the realm of genomic architects, what proportion are discerned to possess mirrored ancestral blueprints in accordance with the prescribed paradigm extracted from the Ensembl 93 archive?",
            "retrieved_metrics": {
                "reference_idx": [
                    1934
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Approximately #70%# of human protein-coding genes have an identifiable #paralog# according to the Ensembl 93-derived set of paralog pairs.",
            "predicted_answer": "According to the context, approximately 70% of human protein-coding genes have an identifiable paralog as defined by the criteria from Ensembl 93.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes key facts - approximately 70% of protein-coding genes have a paralog as per Ensembl 93. All emphasized details in the 'Reference Answer' are captured accurately without omissions or errors in the 'Predicted Answer'. This reflects a fully consistent understanding."
        },
        {
            "query_idx": 1350,
            "query": "Within the multifaceted regulatory networks of cellular biomes, what distinctive dynamics does the molecular architect ARID1A execute as part of the SWI/SNF consortium to orchestrate an anti-oncogenic framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1939
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "ARID1A functions as a #tumour suppressor# by encoding a #SWI/SNF# subunit, contributing to an anti-oncogenic framework within cellular biomes.",
            "predicted_answer": "ARID1A, as a SWI/SNF subunit, plays a crucial role in chromatin remodeling and transcriptional regulation, which helps suppress tumor formation by maintaining genomic stability and inhibiting oncogenic pathways.",
            "score": 3,
            "explanation": "The predicted answer aligns generally with the reference by highlighting ARID1A's role in chromatin remodeling and tumor suppression. It mentions the key facts: \"SWI/SNF\" and its tumor-suppressing function. However, it omits directly stating ‘tumor suppressor’ which is a key fact affecting completeness."
        },
        {
            "query_idx": 1351,
            "query": "In the symphony of genomic interventions, what hidden susceptibility of STAG1 emerges during the comparative exploration of STAG2-deficient cellular landscapes, as unveiled by the comprehensive CRISPR orchestration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1944
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "STAG1 is #selectively lethal# in #STAG2-deficient# cells, revealing its susceptibility during the comparative exploration of cellular landscapes.",
            "predicted_answer": "STAG1 becomes selectively lethal in STAG2-deficient cells, as revealed by genome-wide CRISPR screens. This highlights STAG1's hidden susceptibility when STAG2 is absent.",
            "score": 5,
            "explanation": "The Predicted Answer accurately captures the key facts from the Reference Answer: #STAG1 is selectively lethal# and this occurs in #STAG2-deficient# cells. There are no significant omissions or errors, and the overall meaning and specific details are consistent between the two answers."
        },
        {
            "query_idx": 1352,
            "query": "What is the nuanced biochemical allegory encountered in designing therapeutic agents that must achieve discriminative effectiveness against ARID1B, molded by the molecular mimicry between ARID1B and ARID1A in the context of ARID1A mutated cellular ecospheres?",
            "retrieved_metrics": {
                "reference_idx": [
                    1957
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The biochemical allegory involves the challenge of achieving #specificity# against ARID1B due to #molecular mimicry# between ARID1B and ARID1A, risking off-target effects.",
            "predicted_answer": "The nuanced biochemical challenge lies in designing ARID1B inhibitors that selectively target cancer cells with ARID1A mutations, while avoiding off-target effects on ARID1A in normal cells, due to the structural similarity between ARID1A and ARID1B.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts of the biochemical challenge, including the #specificity# in targeting ARID1B and the issue of #molecular mimicry#. It aligns with the Reference Answer, with no contradictions or omissions impacting completeness."
        },
        {
            "query_idx": 1353,
            "query": "In what manner does employing a non-selective suppressive strategy, akin to a cellular dual-action implement, influence the selective termination of tumour cells, specifically when residing within a genetic framework altered by gene B mutation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1961
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Employing a #non-selective# suppressive strategy can result in the #selective# termination of tumor cells with a gene B mutation by targeting the synthetic lethal pair A1 and A2.",
            "predicted_answer": "A non-selective suppressive strategy inhibiting both A1 and A2 can selectively terminate tumour cells with a gene B mutation, while sparing normal cells, due to the synthetic lethal interaction in the mutated genetic framework.",
            "score": 5,
            "explanation": "The predicted answer captures all key aspects of the reference answer. It details the use of a non-selective suppressive strategy and its selective effect on tumor cells with a gene B mutation, involving the synthetic lethal interaction by inhibiting A1 and A2. No key elements are omitted."
        },
        {
            "query_idx": 1354,
            "query": "What inherent characteristics of synthesized gel-like substrates underpin the continuance of uniformity across multifarious pharmacological explorations, enabling the harmonious integration of sophisticated scrutiny methodologies within the landscape of progressive research frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1971
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #synthetic and tunable hydrogels# provide controlled environments, enhancing #reproducibility#, which supports uniformity and integration in pharmacological research.",
            "predicted_answer": "Synthesized gel-like substrates, such as alginate and collagen-based hydrogels, provide a controlled and tunable environment that enhances uniformity and reproducibility across various pharmacological studies.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as \"synthesized gel-like substrates,\" \"tunable environment,\" and \"enhances uniformity and reproducibility,\" covering most of the essential details from the reference. It does not directly mention \"synthetic hydrogels\" but implies it through examples like alginate and collagen-based hydrogels, aligning with the overall trend."
        },
        {
            "query_idx": 1355,
            "query": "In the intricate realm of cancer innovation, how do the cellular replicas fashioned from the enigmatic fabric of mammary Paget's disease unveil pivotal genetic and molecular dialogues that propel the understanding of breast cancer's intricate genomic tapestry?",
            "retrieved_metrics": {
                "reference_idx": [
                    1975
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#MPD organoids# reveal #genomic landscape# by showcasing copy number variations, mutational burden, and cancer-related gene mutations, enhancing breast cancer genomic understanding.",
            "predicted_answer": "Organoids from mammary Paget's disease provide a detailed genomic landscape, including copy number variations and specific mutations, offering insights into breast cancer's genetic and molecular characteristics. This aids in understanding the disease and developing new treatments.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as \"organoids from mammary Paget's Disease,\" \"genomic landscape,\" \"copy number variations,\" and \"specific mutations,\" aligning closely with the reference answer. However, it is missing the reference to \"mutational burden,\" which slightly affects completeness."
        },
        {
            "query_idx": 1356,
            "query": "What interplay exists between the moral conundrums, such as the intricacies of patient acquiescence and the veil of genetic confidentiality, and the evolving narrative of prognostic confidence as cellular constructs shape trust in visionary models for cancer therapeutics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1984
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The interplay lies in balancing #ethical implications# like patient consent and genetic privacy with building #trust# in predictive models for cancer therapeutics using organoid responses.",
            "predicted_answer": "The interplay involves balancing patient consent and genetic privacy with the use of genomic and organoid data to enhance prognostic models. Clear ethical guidelines and informed consent are essential to maintain trust and address moral conundrums in cancer therapeutics.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of balancing patient consent and genetic privacy while emphasizing the need for trust in prognostic models. It covers key ethical implications and maintains the overall alignment with the reference answer, despite minor differences in wording and details."
        },
        {
            "query_idx": 1357,
            "query": "What specific cellular entities and supportive elements are advocated to be woven into the fabric of PDO frameworks to emulate the intricate tapestry of the tumor milieu?",
            "retrieved_metrics": {
                "reference_idx": [
                    1988
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Immune cells, endothelial cells, and stromal components are advocated to be woven into PDO frameworks to emulate the intricate tapestry of the #tumor milieu#.",
            "predicted_answer": "To emulate the tumor milieu, PDO frameworks should incorporate immune cells, endothelial cells, and stromal components, enhancing their physiological relevance and better simulating the tumor microenvironment.",
            "score": 5,
            "explanation": "The predicted answer includes all key elements mentioned in the reference answer, specifically immune cells, endothelial cells, and stromal components, and aligns with the overall trend of emulating the tumor milieu. The information in the predicted answer is consistent with the reference, covering all necessary details."
        },
        {
            "query_idx": 1358,
            "query": "How do collaborative ensembles facilitate the construction of intricate innovation networks, thereby augmenting research productivity and reinforcing discovery mechanisms in the landscape of organoid modeling?",
            "retrieved_metrics": {
                "reference_idx": [
                    1996
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Collaborative ensembles facilitate intricate innovation networks by establishing #interdisciplinary consortia#, standardizing data sharing, validating organoid models, and creating #open-source databases#, enhancing research productivity and discovery mechanisms.",
            "predicted_answer": "Collaborative ensembles in organoid modeling, by integrating interdisciplinary expertise and resources, standardize data sharing, validate models, and create open-source databases. This enhances research productivity and accelerates discovery through refined methodologies and automated systems.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as interdisciplinary expertise (matching interdisciplinary consortia), standardized data sharing, validated models, and open-source databases. It aligns with the reference's trend and does not omit any emphasized information."
        },
        {
            "query_idx": 1359,
            "query": "What complex orchestration of biological interactions are researchers conducting to address the absence of crucial life flows within PDO landscapes, enhancing the capacity of immune response maneuvers in cancer therapeutic strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1987
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Researchers are co-culturing PDOs with #immune cells# to address the absence of #continuous blood flow#, enhancing the capacity of immune response maneuvers in cancer therapeutic strategies.",
            "predicted_answer": "Researchers are developing advanced culture media and microfluidic platforms to support PDO viability and mimic tumor-immune interactions. They are also co-culturing PDOs with immune cells to address the lack of continuous blood flow, enhancing immune response in cancer therapies.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of co-culturing PDOs with immune cells and addressing the absence of continuous blood flow, aligning with the reference. There are no contradictions or significant omissions. The answer effectively mirrors the intended meaning and trends."
        },
        {
            "query_idx": 1360,
            "query": "How does the deliberate spatial choreography of chromosomal domains within the nuclear enclave modulate the myriad orchestrated activities and functional symphonies of genomic expression and cellular regulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1999
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The deliberate #spatial choreography# of chromosomal domains within the nucleus organizes genome expression and regulates #cellular activities# like the cell cycle, stress response, and homeostasis.",
            "predicted_answer": "The deliberate spatial arrangement of chromosomal domains within the nucleus modulates gene expression and cellular regulation by organizing chromosomes into distinct territories, facilitating coordinated physiological programs and genomic activities.",
            "score": 3,
            "explanation": "The predicted answer captures the concept of \"spatial arrangement\" (akin to \"spatial choreography\") and its role in gene expression and cellular regulation, aligning with the reference's focus on cell cycle, stress response, and homeostasis. However, it omits specific cellular activities mentioned."
        },
        {
            "query_idx": 1361,
            "query": "Amidst the cellular orchestra, which particular assembly surrounding the nucleolar periphery does the SH54 molecular probe reveal within the HeLa terrain yet finds absent in the NIH3T3 bioscape?",
            "retrieved_metrics": {
                "reference_idx": [
                    2001
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #SH54 molecular probe# reveals a nuclear body identified as #PTBP1# at the nucleolar periphery in HeLa cells, absent in NIH3T3 cells.",
            "predicted_answer": "The SH54 molecular probe reveals a nuclear body at the nucleolar periphery in HeLa cells, which is absent in NIH3T3 cells. This body is identified as PTBP1.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions that the SH54 molecular probe reveals a nuclear body identified as PTBP1 at the nucleolar periphery in HeLa cells and notes its absence in NIH3T3 cells. All key facts emphasized with # are present and consistent with the reference answer."
        },
        {
            "query_idx": 1362,
            "query": "What underlying postulate guides the intricate approach devised to traverse the myriad of chemical elements, with the goal of recalibrating the intricate symphony of cellular mechanisms that modulate PNC prevalence within cancerous cell conglomerates?",
            "retrieved_metrics": {
                "reference_idx": [
                    2004
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The approach is guided by the postulate that reducing #PNC prevalence# can be achieved by disrupting #cellular activities# that maintain cancer cell metastatic potential or selectively inhibiting PNC-harboring cells.",
            "predicted_answer": "The underlying postulate is that reducing PNC prevalence can interfere with cellular activities essential for cancer cell metastasis or selectively inhibit cells with PNCs, aiming to modulate the complex mechanisms of cancerous cell behavior.",
            "score": 5,
            "explanation": "The predicted answer captures the key postulate of reducing PNC prevalence by interfering with cellular activities essential for cancer metastasis and selectively inhibiting PNC-harboring cells. The information aligns well with the reference answer and contains no significant omissions or contradictions."
        },
        {
            "query_idx": 1363,
            "query": "How do the sophisticated navigational maps presented by PNC structural entities enrich the exploratory pathways in identifying versatile molecular agents adept at traversing the complex terrain of metastasis-associated cellular landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2005
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The sophisticated navigational maps by #PNC# structural entities enhance discovering #selective# molecular agents targeting metastasis in cancer cells, improving therapeutic specificity and reducing toxicity.",
            "predicted_answer": "The sophisticated navigational maps from PNC structural entities help identify versatile molecular agents by increasing the likelihood of finding multitasking compounds that target multiple aspects of metastasis, while also enhancing selectivity for cancer cells and reducing nonspecific toxicity.",
            "score": 3,
            "explanation": "The predicted answer covers the main idea of enhancing the identification of molecular agents targeting metastasis and mentions selectivity and reduced toxicity. However, it misses the key fact of the agents being \"#selective#\" for cancer cells, which is crucial for therapeutic specificity."
        },
        {
            "query_idx": 1364,
            "query": "In what fashion does the temporal alignment of Metarrestin administration influence the continuum of life-prolongation metrics in representations with emergent versus matured macro-metastatic formations within pancreatic oncological mimicries?",
            "retrieved_metrics": {
                "reference_idx": [
                    2006
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Administering #Metarrestin# before macro-metastases formation led to #100% survival# for three months, while post-formation treatment extended survival to four months despite primary tumor growth.",
            "predicted_answer": "Administering Metarrestin before macro-metastases form leads to 100% survival for three months, while post-formation treatment extends survival to four months but does not prevent death from primary tumor growth.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference answer: administering Metarrestin before macro-metastases results in 100% survival for three months, and post-formation treatment extends life by four months. Despite slight wording differences, these facts capture the essential details without contradiction."
        },
        {
            "query_idx": 1365,
            "query": "What element of distinction characterizes the ethereal PNC's communion with Ro-associated Pol III RNA messages, as juxtaposed with its conspicuous absence during the molecular ballet of Ro protein within the cytoplasm of HeLa cellular spheres?",
            "retrieved_metrics": {
                "reference_idx": [
                    2007
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #PNC# associates with #Ro-interacting# Pol III RNAs, located with Y1, Y4, and Y5, but is absent with Ro protein in the cytoplasm of HeLa cells.",
            "predicted_answer": "The ethereal PNC's communion with Ro-associated Pol III RNA messages (Y1, Y4, Y5) distinguishes it, while the Ro protein is absent in the PNC, remaining cytoplasmic in HeLa cells.",
            "score": 5,
            "explanation": "The predicted answer covers the key points: PNC's association with Ro-associated Pol III RNAs, including Y1, Y4, and Y5, and the absence of Ro protein in the PNC, remaining cytoplasmic in HeLa cells. The information is accurate and consistent with the reference answer."
        },
        {
            "query_idx": 1366,
            "query": "What elements serve as the underlying testament to the coalescence of protein and RNA manifestations featuring RMRP within the overarching molecular assemblies associated with PNCs?",
            "retrieved_metrics": {
                "reference_idx": [
                    2009
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "RMRP co-fractionation with #PTBP1# and #CUGBP1# in larger complexes supports the coalescence of protein and RNA manifestations in PNCs.",
            "predicted_answer": "RMRP, a component of RNAse MRP, localizes to PNCs and interacts with proteins like PTBP1 and CUGBP1, forming larger complexes. This interaction serves as the underlying testament to the coalescence of protein and RNA in PNCs.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies RMRP's localization to PNCs and interaction with PTBP1 and CUGBP1 in larger complexes, which aligns with the emphasis in the reference answer. The key facts are present, and the overall trend is consistent without significant omissions or contradictions."
        },
        {
            "query_idx": 1367,
            "query": "How does the deliberate attenuation of PTBP1, in contrast to CUGBP1, manifest in the integrity of polynucleotide conclaves, and what insights does this afford into PTBP1's quintessential function in the orchestration of cellular synthesis frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    2011
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Deliberate #attenuation# of PTBP1, unlike CUGBP1, disrupts PNC integrity, highlighting PTBP1's essential role in maintaining structural and functional coherence in cellular synthesis frameworks.",
            "predicted_answer": "The deliberate attenuation of PTBP1, unlike CUGBP1, disrupts the integrity of polynucleotide conclaves, indicating PTBP1's essential role in maintaining their structure and function, crucial for RNA metabolism and cellular synthesis.",
            "score": 5,
            "explanation": "The predicted answer captures the deliberate attenuation of PTBP1 and its impact on the integrity of polynucleotide conclaves, aligning with the reference answer's portrayal of PTBP1's essential role. While terminology differs slightly, all key facts and trends are accurately reflected without omissions or contradictions."
        },
        {
            "query_idx": 1368,
            "query": "How does the modulation of Pol I activity initiate a sequence of transformative events influencing the structural fidelity of PNC entities and the architectural evolution of nucleolar frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    2016
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Modulating #Pol I# activity disrupts #PNCTR# levels, affecting PNC structure and inducing nucleolar segregation, impacting both PNC integrity and nucleolar architecture.",
            "predicted_answer": "Modulating Pol I activity can disrupt PNC structure by lowering PNCTR levels and inducing nucleolar segregation, thereby affecting the architectural integrity of both PNCs and nucleoli.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts from the reference answer—it mentions Pol I, PNCTR levels, disruption of PNC structure, and nucleolar segregation. The meaning and trend align well with the reference answer, meeting all critical elements without contradictions."
        },
        {
            "query_idx": 1369,
            "query": "What manifestations suggest that Pol III RNA embarks on its journey towards molecular convergence zones in a post-creation phase, as opposed to commencing its origination within these regions?",
            "retrieved_metrics": {
                "reference_idx": [
                    2015
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The presence of #BrU labeling# in PNCs and #non-colocalization# of Pol III-dependent genes indicate RNA is transported to PNCs post-transcription.",
            "predicted_answer": "The context indicates that Pol III RNA does not originate within PNCs, as these regions do not colocalize with Pol III-dependent genes. Instead, the RNA is transported to PNCs post-transcriptionally, suggesting it embarks on its journey towards these convergence zones after creation.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by noting that Pol III RNA is transported post-transcriptionally and does not colocalize with Pol III-dependent genes. However, it omits the key fact of \"#BrU labeling# in PNCs\". Thus, one emphasized point is missing."
        },
        {
            "query_idx": 1370,
            "query": "What segment of the population experiencing advanced stages of breast malignancy becomes enmeshed with skeletal interferences at the point of diagnostic revelation?",
            "retrieved_metrics": {
                "reference_idx": [
                    2017
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Approximately #70%# of patients with #advanced breast cancer# develop bone metastases at the time of diagnosis.",
            "predicted_answer": "Approximately 70% of patients with advanced breast cancer develop bone metastases at the time of diagnosis, indicating a significant segment enmeshed with skeletal interferences.",
            "score": 5,
            "explanation": "The predicted answer correctly includes the key facts: approximately 70% and advanced breast cancer, as emphasized in the reference answer. There are no significant omissions or errors, demonstrating full alignment with the reference."
        },
        {
            "query_idx": 1371,
            "query": "In what ways do the emergent complexities and inherent confines of tri-dimensional constructs manifest as obstacles in navigating the latent intricacies and multi-dimensional interplay characteristic of osteotropic metastatic inquiries?",
            "retrieved_metrics": {
                "reference_idx": [
                    2018
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The obstacles include #irregular cellular proliferation#, #autofluorescence#, and changes in genetic/epigenetic expression, complicating the study of multi-dimensional interplay in osteotropic metastatic inquiries.",
            "predicted_answer": "Emergent complexities in 3D models, such as irregular cellular proliferation and changes in genetic expression, pose challenges. These limitations hinder the accurate replication of the tumor microenvironment and the latency period, complicating osteotropic metastatic studies.",
            "score": 3,
            "explanation": "The predicted answer includes \"irregular cellular proliferation\" and \"changes in genetic expression,\" aligning with the reference answer. However, it omits \"autofluorescence,\" an emphasized key fact, limiting completeness. The predicted answer matches the trend but lacks this critical detail."
        },
        {
            "query_idx": 1372,
            "query": "What is the temporal midpoint of the survival continuum for individuals grappling with metastatic breast malignancy, and through what interactions of cellular architects is the osseous spread delineated?",
            "retrieved_metrics": {
                "reference_idx": [
                    2020
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The temporal midpoint for metastatic breast cancer survival is #2-3 years#. The osseous spread is delineated through interactions between malignant cells, #osteoblasts#, and osteoclasts.",
            "predicted_answer": "The temporal midpoint of the survival continuum for individuals with metastatic breast cancer is approximately 1-1.5 years. Osseous spread is delineated through interactions between malignant cells, osteoblasts, and osteoclasts, leading to either osteolytic or osteoblastic bone metastases.",
            "score": 1,
            "explanation": "The predicted answer mentions a survival midpoint of 1-1.5 years, differing from the reference's 2-3 years. It includes interactions with osteoblasts and osteoclasts, aligning with the reference. However, the incorrect survival time and missing osteoclasts/osteoblast distinction reduces completeness."
        },
        {
            "query_idx": 1373,
            "query": "What orchestrated strategies and transformative powers do the wandering neoplastic mammary agents deploy to mold and recalibrate the symbiotic ecosystem within their skeletal sanctuary amidst the broader narrative of mammary cancer's expansive odyssey of metastasis?",
            "retrieved_metrics": {
                "reference_idx": [
                    2021
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #wandering neoplastic mammary agents# induce growth factors and cytokines, activate osteoclasts, inhibit osteoblasts, causing bone resorption, disrupting the #symbiotic ecosystem# in the skeletal sanctuary.",
            "predicted_answer": "Malignant mammary cells induce upregulation of growth factors and cytokines in the bone, activating osteoclasts and inhibiting osteoblasts. This leads to imbalanced bone resorption and formation, shaping the metastatic microenvironment.",
            "score": 5,
            "explanation": "The 'Predicted Answer' accurately reflects the key facts emphasized in the 'Reference Answer', such as the role of neoplastic agents in inducing growth factors and cytokines, activating osteoclasts, and inhibiting osteoblasts. It captures the overall trend without contradictions or omissions related to the #symbiotic ecosystem#."
        },
        {
            "query_idx": 1374,
            "query": "In the symbiotic interplay of the bone's structural matrix, what orchestrative role do the collagenous harmonics undertake in the emergence and growth of hydroxyapatite structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    2023
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Collagenous# harmonics play a key role in #hydroxyapatite# nucleation and growth within the bone's structural matrix.",
            "predicted_answer": "Collagenous harmonics in the bone's structural matrix guide the nucleation and growth of hydroxyapatite, contributing to the bone's strength and stability.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference: it mentions \"collagenous harmonics\" and their role in \"hydroxyapatite\" nucleation and growth. The answer aligns with the trend of emphasizing the contribution to the bone's structure, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1375,
            "query": "What are the intricate interdependencies within the spatial and biochemical conversations between circulating malignant entities and their microenvironmental landscapes that may fuel the ongoing debate about the therapeutic effectiveness and adverse outcomes associated with bone-modifying compounds in the context of metastatic bone disease management?",
            "retrieved_metrics": {
                "reference_idx": [
                    2022
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #complex interplay# between malignant cells and their microenvironment affects the debate on the #efficacy# and side effects of bone-modifying compounds in metastatic bone disease management.",
            "predicted_answer": "The debate on the effectiveness and side effects of bone-modifying compounds in metastatic bone disease is fueled by the complex interplay between circulating malignant cells, the tumor, and the bone microenvironment, including chemoattractants from osteocytes.",
            "score": 3,
            "explanation": "The predicted answer covers the #complex interplay# between malignant cells and their microenvironment affecting the debate on the effectiveness and side effects of bone-modifying compounds. Both mention the tumor microenvironment, but #efficacy# is distinctly highlighted in the reference but not in the predicted answer."
        },
        {
            "query_idx": 1376,
            "query": "Which biochemical envoys and medicinal influences command the cessation of osteoclast activity, and through what mechanisms do the architects and custodians of bone establish communication with their extracellular environment through integrin pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    2025
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#TGF-β#, #bisphosphonates#, and estrogen drive osteoclast apoptosis. Osteoblasts use integrins like α$_{v}$β$_{3}$ and α$_{2}$β$_{1}$ to communicate with the ECM.",
            "predicted_answer": "TGF-β and bisphosphonates command the cessation of osteoclast activity, often through inducing apoptosis. Osteoblasts and osteocytes communicate with their extracellular environment via integrins, such as α₂β₁ and β₃, which bind to collagen and RGD sequences.",
            "score": 1,
            "explanation": "The Predicted Answer includes TGF-β and bisphosphonates as drivers of osteoclast activity cessation but omits estrogen. It addresses osteoblast integrin communication but does not specifically mention α$_{v}$β$_{3}$. Thus, critical details about estrogen and specific integrin types are missing."
        },
        {
            "query_idx": 1377,
            "query": "In the elaborate ecosystem of extracellular matrix modulation, what pivotal role do the regulatory elements identified as matrix metalloproteinases play in directing the metamorphic pathway of cellular structures, and what distinct interactive paradigm characterizes the engagement of sialoprotein with these cellular components within the matrix realm?",
            "retrieved_metrics": {
                "reference_idx": [
                    2024
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Matrix metalloproteinases (#MMP#) drive matrix #remodeling#, orchestrating MSCs to osteoblasts and osteoblasts to osteocytes. Sialoprotein interacts with cells and hydroxyapatite via RGD.",
            "predicted_answer": "Matrix metalloproteinases (MMPs) direct matrix remodeling and guide cellular differentiation, such as MSCs to osteoblasts. Sialoprotein, a glycosylated protein, interacts with cells and hydroxyapatite via RGD sequences, playing a role in the ECM's structural and functional dynamics.",
            "score": 3,
            "explanation": "The predicted answer aligns with the overall trend of the reference by highlighting MMPs' role in matrix remodeling and differentiation. However, it is missing the detail about MMPs orchestrating the transition from osteoblasts to osteocytes, and lacks clarity on MSC specification, impacting completeness."
        },
        {
            "query_idx": 1378,
            "query": "In what ways do the intertwining influences of ionic characters, specifically fluoride and carbonate, artistically modulate the mineral scaffold's structural precision in their roles as architects of the bone's crystalline blueprint?",
            "retrieved_metrics": {
                "reference_idx": [
                    2027
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intertwining influences of #fluoride# enhance crystallinity, while #carbonate# decreases crystallinity, artistically modulating the bone's mineral scaffold.",
            "predicted_answer": "Fluoride enhances the crystallinity of the bone, making it more structurally precise, while carbonate decreases crystallinity, leading to a less ordered structure. These ionic characters modulate the mineral scaffold's precision in the bone's crystalline blueprint.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts that fluoride enhances and carbonate decreases crystallinity, consistent with the reference answer. The overall trend and emphasis on ionic characters' role in modulating the bone's mineral scaffold are maintained without any omissions or errors."
        },
        {
            "query_idx": 1379,
            "query": "In what manner does TGF-β engage in the complex choreography involving cellular interplays, where cancerous cell integration triggers the symbiotic degradation of osseous matter, thereby modulating cellular specialization and intensification of osteoclastic processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2028
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "TGF-β #release# inhibits osteoblast differentiation and #aggravates# osteoclasts' osteolytic activity upon cancer cell-induced bone resorption.",
            "predicted_answer": "TGF-β, released during bone resorption by cancer cells, inhibits osteoblast differentiation and enhances osteoclastic activity, thus promoting the degradation of osseous matter and intensifying osteolytic processes.",
            "score": 5,
            "explanation": "The predicted answer includes key elements: TGF-β release, inhibition of osteoblast differentiation, and increased osteoclastic activity. While phrased differently, it aligns with the reference's trend of bone degradation via cancerous processes. Both express TGF-β's role in osteolytic activity, though \"aggravates\" is interpreted as \"enhances.\""
        },
        {
            "query_idx": 1380,
            "query": "What intricate interplay within the tumor-oriented microcosm presents formidable barriers to the evolution of pharmacological interventions aimed at rectifying neoplastic growth, considering the ecological interactions at play?",
            "retrieved_metrics": {
                "reference_idx": [
                    2031
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #intricate interplay# involves endothelial cells, fibroblasts, and immune cells, leading to complex #barriers# that hinder pharmacological interventions in neoplastic growth within the tumor microenvironment.",
            "predicted_answer": "The tumor microenvironment (TME) presents barriers to pharmacological interventions due to complex interactions among endothelial cells, fibroblasts, and immune cells, which can both inhibit and promote tumor growth and metastasis, complicating drug efficacy.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of the intricate interplay and barriers involving endothelial cells, fibroblasts, and immune cells within the tumor microenvironment. It aligns well with the reference by noting both inhibitory and promotional roles affecting pharmacological interventions."
        },
        {
            "query_idx": 1381,
            "query": "In what complex dimensions do the variable expression levels of the cytokine IL-6 intertwine with the progressive colonization of osseous tissues and the amplified invasion into numerous visceral territories?",
            "retrieved_metrics": {
                "reference_idx": [
                    2035
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The variable expression levels of #IL-6# are linked to #bone metastasis# and the number of additional metastasized organs.",
            "predicted_answer": "IL-6 expression levels are linked to bone metastasis and the spread to multiple organs, playing a role in the colonization of osseous tissues and invasion into visceral territories.",
            "score": 3,
            "explanation": "The Predicted Answer captures the key facts of IL-6 being linked to bone metastasis and its role in spreading to multiple organs (visceral territories). However, it lacks the detail on the \"number of additional metastasized organs,\" which is emphasized in the Reference Answer as critical."
        },
        {
            "query_idx": 1382,
            "query": "In the orchestration of cellular universes within engineered tridimensional matrices, what intrinsic benefits do microcarrier-supported frameworks confer, particularly in fostering cellular expansion and augmenting pharmacological resilience during the meticulous reimagining of dense tumor landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2044
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Microcarrier-supported frameworks provide #enhanced proliferation# and #improved drug resistance#, facilitating cellular expansion and pharmacological resilience in complex tumor landscapes.",
            "predicted_answer": "Microcarrier-supported frameworks enhance cellular expansion by providing more surface area for growth and improving cell adhesion and proliferation. They also augment pharmacological resilience by stimulating cell interactions and drug resistance, which is beneficial for reconstructing dense tumor landscapes.",
            "score": 5,
            "explanation": "The predicted answer effectively conveys the key facts of #enhanced proliferation# and #improved drug resistance# from the reference answer. It aligns with the trend and meaning of the reference, capturing the essential benefits of microcarrier-supported frameworks in cellular expansion and pharmacological resilience."
        },
        {
            "query_idx": 1383,
            "query": "What intrinsic mechanisms within the microcosm of tumor-on-chip systems afford them an unparalleled edge in swiftly determining the therapeutic value of chemotherapy agents compared to traditional methodologies within the hierarchical structures of cancer treatment paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    2050
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cancer-on-chip systems use #3D multichannel# microfluidics to replicate patient tumor characteristics, determining chemotherapy #success rate# in under 12 hours, unlike traditional methodologies.",
            "predicted_answer": "Cancer-on-a-chip systems provide a 3D, multichannel microfluidic environment that closely mimics tumor characteristics, allowing for rapid and accurate assessment of chemotherapy effectiveness within 12 hours, outpacing traditional methods.",
            "score": 3,
            "explanation": "The predicted answer covers key aspects such as \"3D, multichannel microfluidic environment\" and the assessment occurring \"within 12 hours,\" aligning with the reference. However, it misses the detail on \"success rate,\" crucial to completeness, hence slightly incomplete but overall consistent."
        },
        {
            "query_idx": 1384,
            "query": "What implications arise from diminishing PTH-rP on the strategic inclinations demonstrated by breast cancer cells within their osseous colonization tactics?",
            "retrieved_metrics": {
                "reference_idx": [
                    2029
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Neutralizing #PTH-rP# eliminates the #bone metastatic# behavior of breast cancer cells, disrupting their osseous colonization tactics through decreased osteoclast activation.",
            "predicted_answer": "Diminishing PTH-rP reduces osteoclast activation and bone resorption, thereby decreasing the ability of breast cancer cells to colonize bone. This limits their strategic inclinations for osseous metastasis.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as the reduction in osteoclast activation and bone resorption linked to diminishing PTH-rP, aligning with the reference answer's emphasis on neutralizing PTH-rP and its impact on bone metastasis. Both answers highlight similar effects on breast cancer cells."
        },
        {
            "query_idx": 1385,
            "query": "To what extent do the minute platforms designed for cellular assessment, particularly those manifesting from biocompatible polymeric substances, excel in providing enhanced translucent interfaces for biological monitoring and superior gaseous permeable pathways compared to other conventional material constructs used in in-vitro investigative frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    2052
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Miniature platforms made of #PDMS# excel in providing #enhanced translucent# interfaces and superior gaseous permeability for biological monitoring compared to conventional materials in in-vitro frameworks.",
            "predicted_answer": "Minute platforms, especially those made from biocompatible polymers like PDMS, excel by offering superior transparency for monitoring and high permeability to gases, outperforming many conventional materials in in-vitro settings.",
            "score": 5,
            "explanation": "The predicted answer mentions PDMS as a biocompatible polymer, which aligns with the reference answer's use of PDMS. It also highlights superior transparency and gas permeability, covering the enhanced translucent interfaces and gaseous permeability mentioned in the reference answer. There are no omissions or contradictions."
        },
        {
            "query_idx": 1386,
            "query": "In what ways does the bone-on-chip framework pioneered by Hao et al. offer fresh insights into the intricate traversal of breast cancer cellular entities, and how does this perspective diverge from the time-honored in vivo landscapes typically harnessed in the quest for understanding metastasis?",
            "retrieved_metrics": {
                "reference_idx": [
                    2055
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #bone-on-chip# framework reveals unique breast cancer colonization traits, enabling #in vitro# studies, diverging from traditional in vivo models with comprehensive tumor microenvironment simulations.",
            "predicted_answer": "The bone-on-chip model by Hao et al. offers fresh insights by simulating the 3D interaction of breast cancer cells with the bone matrix, replicating in vivo colonization characteristics. This diverges from traditional in vivo studies by enabling controlled, faster, and more detailed observations of metastasis.",
            "score": 3,
            "explanation": "The predicted answer covers the bone-on-chip model and its novel insights into breast cancer cell interaction with the bone matrix. It also notes a divergence from traditional in vivo models. However, it misses the emphasis on enabling \"in vitro\" studies and \"comprehensive tumor microenvironment simulations.\""
        },
        {
            "query_idx": 1387,
            "query": "In the labyrinthine process through which these malignant envoys initiate their voyage and subsequent lodgment within the skeletal realm, what series of transformations and interactions do these cells undergo, intricately intertwining with their new microenvironment to secure their presence and thrive therein?",
            "retrieved_metrics": {
                "reference_idx": [
                    2063
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tumor cells undergo #epithelial-to-mesenchymal transition#, spread in blood circulation, lodge in bone, induce osteolytic lesions, and suppress immune response to thrive in the skeletal realm.",
            "predicted_answer": "Tumor cells undergo genetic and phenotypic changes, including an epithelial-to-mesenchymal transition. They enter the bloodstream, reach the bone, and interact with the microenvironment to reduce immune response and create osteolytic lesions, securing their presence.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts from the reference answer, such as \"epithelial-to-mesenchymal transition,\" \"blood circulation,\" \"bone,\" \"osteolytic lesions,\" and \"immune response.\" There are no significant omissions or contradictions, aligning well with the reference answer."
        },
        {
            "query_idx": 1388,
            "query": "What are the cascading repercussions when a multitude of 4T1 cellular entities is introduced into the osseous landscape, particularly concerning immediate structural impacts and secondary systemic influences at proximate and divergent corporeal locales?",
            "retrieved_metrics": {
                "reference_idx": [
                    2066
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Introducing #10,000 4T1 cells# into the tibia causes #osteolytic lesions# and can metastasize to the femur, lungs, and forelimbs, affecting local and distant anatomical sites.",
            "predicted_answer": "Introducing a multitude of 4T1 cells into the osseous landscape causes osteolytic lesions, and higher concentrations lead to metastasis in the femur, lungs, and forelimbs, affecting both local and distant body areas.",
            "score": 3,
            "explanation": "The 'Predicted Answer' captures the essential impacts like osteolytic lesions and metastasis to anatomical sites such as the femur, lungs, and forelimbs, aligning with the 'Reference Answer'. However, it misses the key detail of introducing specifically #10,000 4T1 cells#. This omission impacts completeness."
        },
        {
            "query_idx": 1389,
            "query": "In the elaborate tapestry woven by impermeable substrates and gas conduits within microfluidic domains, what nuanced roles do these elements play in orchestrating the adaptive voyage of pulmonary carcinoma cells through the influential corridors of the Wnt signaling apparatus amid chemically infused gradients?",
            "retrieved_metrics": {
                "reference_idx": [
                    2060
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Impermeable substrates and gas conduits regulate oxygen gradients, influencing #pulmonary carcinoma cells#' migration via the #Wnt signaling# pathway in chemically infused microfluidic gradients.",
            "predicted_answer": "In microfluidic domains, impermeable substrates and gas conduits help control oxygen levels, while chemical gradients guide the migration of pulmonary carcinoma cells via the Wnt signaling pathway, influencing their adaptive journey.",
            "score": 5,
            "explanation": "The Predicted Answer closely aligns with the Reference Answer. It mentions the regulation of oxygen levels and the guidance of pulmonary carcinoma cell migration through the Wnt signaling pathway, aligning with the chemically infused microfluidic gradient context. All key facts (#) are present without omissions."
        },
        {
            "query_idx": 1390,
            "query": "What are the fundamental biochemical divergences and morphological intricacies that define the limited inclination towards osseous metastasis in murine models, in contrast to the prevalent cellular migration to bone observed in human neoplastic processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2070
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The limited osseous metastasis in mice is due to #metabolic activity# differences and murine #mesenchymal tissue# origins, contrasting with human epithelial-derived cancers.",
            "predicted_answer": "In murine models, breast cancer primarily metastasizes to the lungs, rarely to bone, due to biological differences such as metabolic activity, telomerase length, and tissue origin. Human breast cancer, originating from epithelial cells, frequently metastasizes to bone (80%).",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference by highlighting metabolic activity and tissue origin differences between mice and humans. However, it incorrectly refers to human cancer specifics and omits the distinction regarding murine \"mesenchymal tissue.\" Thus, more than one key fact is missing, impacting completeness."
        },
        {
            "query_idx": 1391,
            "query": "In exploring the conduits of neoplastic proliferation, what are the nuanced restrictions or impediments linked to deploying intracardiac, intravenous, and lipid-based injection methodologies for evoking metastatic incursions into the skeletal matrix?",
            "retrieved_metrics": {
                "reference_idx": [
                    2072
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intracardiac injection lacks #specific bone metastasis#, intravenous leads to #lung tumors#, and fat injection yields low bone metastasis incidence, requiring more subjects.",
            "predicted_answer": "Intracardiac injection is difficult and non-specific for bone metastases. Intravenous injection often leads to lung tumors, rarely reaching bones. Lipid-based injections result in a low rate of bone metastases and require more animals.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference: lack of specificity for bone metastases in intracardiac injections, lung tumors from intravenous injections, and the low incidence of bone metastases with lipid-based injections requiring more subjects. The meaning is consistent with the reference."
        },
        {
            "query_idx": 1392,
            "query": "How does the intricate milieu of the transplantation's ecological niche orchestrate the disparate evolutionary trajectories of neoplastic conduct and their consequential therapeutic reactions, when comparing native anatomical embedding to foreign ecological placements?",
            "retrieved_metrics": {
                "reference_idx": [
                    2078
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #site of transplantation# influences tumor behavior and #treatment response#, differing between orthotopic and alternative sites, impacting evolutionary trajectories and therapeutic reactions.",
            "predicted_answer": "The transplantation site significantly influences tumor behavior and therapeutic responses. Orthotopic implantation, compared to subcutaneous or sub-renal sites, leads to different tumor behaviors and treatment outcomes, affecting the overall efficacy of therapies.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts: the impact of the \"site of transplantation\" on \"tumor behavior\" and \"treatment response\". It aligns with the overall trend of the reference answer, mentioning differences in outcomes between orthotopic and alternative sites. All important details are present."
        },
        {
            "query_idx": 1393,
            "query": "In what ways do existing biological surrogates fail to capture the intricate quiescent phase of malignant cellular entities, and how do ethical and fiscal dimensions further delineate these limitations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2080
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Existing biological surrogates fail to capture #quiescent cancer phases# as immunodeficient models don't mimic stromal interactions. #Ethical and fiscal# issues arise from needing more costly models.",
            "predicted_answer": "Existing biological surrogates, like immunodeficient mice, fail to replicate the quiescent phase of cancer cells and human-specific interactions. Ethical and fiscal constraints limit the use of more accurate but costly models, such as humanized mice and PDX, hindering comprehensive study.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts about the failures of existing biological surrogates in mimicking the quiescent cancer phases and the role of ethical and fiscal constraints. Although it doesn't mention stromal interactions, the overall trend and key facts are aligned without contradiction."
        },
        {
            "query_idx": 1394,
            "query": "What conceptual and practical elevations do in vivo-translated PDX models offer over the encapsulated reality of organoids, regarding dynamic therapeutic assessment and their capacity for scalable, reproducible research frameworks within cancer studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    2085
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In vivo-translated #PDX models# offer systemic evaluations and are #scalable/reproducible# compared to organoids, facilitating dynamic therapeutic assessment and broad research applications in cancer studies.",
            "predicted_answer": "In vivo-translated PDX models offer dynamic therapeutic assessment and scalable, reproducible research by allowing systemic disease study and treatment effect evaluation, closely mimicking clinical responses. They provide a reliable and replicable model for both small and large-scale cancer studies.",
            "score": 5,
            "explanation": "The 'Predicted Answer' captures both key ideas from the 'Reference Answer': PDX models allow for systemic evaluations and are scalable/reproducible, facilitating dynamic therapeutic assessment. All key facts emphasized with # in the reference are present without contradiction."
        },
        {
            "query_idx": 1395,
            "query": "How does the CRISPR-associated RNA molecule guide the cellular molecular ensemble to choreograph the disassembly of intrusive viral nucleic sequences, ensuring the biochemical invalidation of the viral entity?",
            "retrieved_metrics": {
                "reference_idx": [
                    2086
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #CRISPR RNA# directs bacterial machinery to viral sequences, leading to the #destruction# of the invading viral genome.",
            "predicted_answer": "CRISPR RNA guides bacterial molecular machinery to target and break up invading viral DNA, ensuring the destruction of the viral genome.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by stating that CRISPR RNA guides bacterial machinery to target and destroy viral DNA, covering both key facts: \"CRISPR RNA\" and \"destruction of the viral genome.\" There are no significant omissions or contradictions in meaning."
        },
        {
            "query_idx": 1396,
            "query": "How do empirical frameworks, functioning as keystones in the expansive architectural design of therapeutic articulation, vindicate the indispensable reliance placed upon them for demystifying and maneuvering extensive genomic topographies in the orchestration of novel pharmacological designs?",
            "retrieved_metrics": {
                "reference_idx": [
                    2087
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Empirical frameworks justify reliance through #integrated studies# that use genetic data to test hypotheses, crucial for designing and validating #novel pharmacological# strategies.",
            "predicted_answer": "Empirical frameworks, such as CRISPR-CAS, validate their importance by enabling precise genetic modifications and testing in models that closely mimic disease conditions, thus facilitating the development of targeted pharmacological designs.",
            "score": 3,
            "explanation": "The predicted answer mentions empirical frameworks enabling genetic modifications and facilitating targeted designs, aligning with the reference’s idea of empirical testing. However, it misses the key facts of \"integrated studies\" and directly \"using genetic data,\" which affects completeness. No contradictory information is present."
        },
        {
            "query_idx": 1397,
            "query": "How does the CRISPR-Cas9 orchestrate a biological symphony, catalyzing the swift emergence of bespoke animal models while bypassing the intricate web of traditional mutagenic pathways in the pharmacoscientific odyssey?",
            "retrieved_metrics": {
                "reference_idx": [
                    2096
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CRISPR-Cas9 facilitates rapid #animal model# development by enabling one-step #gene editing#, bypassing traditional breeding, thereby accelerating the drug discovery process.",
            "predicted_answer": "CRISPR-Cas9 enables precise, one-step editing of multiple genes in zygotes, bypassing traditional breeding, and swiftly generating bespoke animal models for drug discovery.",
            "score": 5,
            "explanation": "The predicted answer includes the key concepts of \"animal models\" and \"gene editing,\" aligned with the reference. It emphasizes bypassing traditional breeding and accelerating drug discovery. No significant omissions or contradictions are apparent, satisfying the key facts in the reference."
        },
        {
            "query_idx": 1398,
            "query": "What methodological intricacies arise in the context of employing genomic modulation mechanisms, specifically CRISPRa, in the orchestration of mosaic-like data assemblages that map function-loss scenarios pivotal to pharmacological innovation landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2099
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#CRISPRa# may not function if the gene has a loss-of-function in the cell line of interest, and combined screens, while useful, are #experimentally complex#.",
            "predicted_answer": "CRISPRa can activate both primary and secondary TSS transcripts but may yield false negatives if a gene has a loss-of-function. Combined screening strategies, though experimentally complex, enhance data for negative selection, providing functional gain insights.",
            "score": 5,
            "explanation": "The Predicted Answer mentions CRISPRa, loss-of-function, and the complexity of combined screens, aligning with the Reference Answer. It covers both key points: CRISPRa's limitation with loss-of-function genes and the experimental complexity of combined screens. No significant omissions or errors are present."
        },
        {
            "query_idx": 1399,
            "query": "In what manner does the attenuation of KEAP1 influence the intricate dance of pharmacological resistance within the cascade of MEK pathway suppression?",
            "retrieved_metrics": {
                "reference_idx": [
                    2103
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Attenuation of #KEAP1# promotes resistance in the #MEK# inhibition pathway.",
            "predicted_answer": "KEAP1 depletion promotes resistance to MEK inhibition, disrupting the effectiveness of MEK pathway suppression and contributing to pharmacological resistance.",
            "score": 5,
            "explanation": "The predicted answer includes both key components marked in the reference: #KEAP1# and #MEK#. It explains that KEAP1 depletion promotes resistance to MEK inhibition, aligning with the reference’s emphasis on KEAP1's role in MEK pathway resistance, with no significant details missing or contradictions."
        },
        {
            "query_idx": 1400,
            "query": "What intricate conundrum presents itself in the calibration of sgRNA aligned with genomic regions of amplified repetition, and in what nuanced form does this challenge echo through the modulation of the cellular phase continuum?",
            "retrieved_metrics": {
                "reference_idx": [
                    2105
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate conundrum is #misleading positive outcomes# due to aberrant genome copy numbers, causing #replication pressure# and G2/M cell cycle arrest when targeting amplified regions.",
            "predicted_answer": "The challenge in calibrating sgRNA for genomic regions with amplified repetition lies in the potential for replication pressure and G2/M cell cycle arrest, leading to misleading positive outcomes due to induced DNA damage.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the #misleading positive outcomes# as well as the issue of #replication pressure# and G2/M cell cycle arrest, which are the key facts highlighted in the reference. No significant information is omitted, and no contradictions are present."
        },
        {
            "query_idx": 1401,
            "query": "How do the orchestrating entities, CRISPRi and CRISPRa, implement transformative modulations in the initial transcriptional overture to enhance the symphony of biological data acquisition, reflecting an expanded dialogue in cellular narratives?",
            "retrieved_metrics": {
                "reference_idx": [
                    2116
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CRISPRi and CRISPRa target transcription start points to modulate #genetic expression#, enhancing #biological data# acquisition for expanded cellular insights.",
            "predicted_answer": "CRISPRi and CRISPRa target the transcriptional start point to modulate gene expression, either repressing or activating it. This precise control enhances biological data acquisition by altering cellular states, enriching the complexity of cellular narratives.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of targeting transcription start points to modulate gene expression and the enhancement of biological data acquisition, which aligns with the key facts in the reference answer. It suitably expresses \"genetic expression\" and \"biological data\" without contradictions or significant omissions."
        },
        {
            "query_idx": 1402,
            "query": "How do the subtle genetic variations, reminiscent of hidden disturbances within the biological fabric, contribute to the divergence observed in CRISPR experimental paradigms, and what implications could this have for the trajectory of medicinal compound discovery?",
            "retrieved_metrics": {
                "reference_idx": [
                    2115
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Subtle genetic variations lead to #heterogeneity# in CRISPR screening, impacting consistency. This variability influences the #discovery# of medicinal compounds by complicating target identification and validation.",
            "predicted_answer": "Subtle genetic variations, such as in-frame indels, can introduce heterogeneity in CRISPR experiments, affecting screening results. This variability complicates the identification of precise drug targets and may influence the trajectory of medicinal compound discovery.",
            "score": 3,
            "explanation": "The predicted answer accurately acknowledges the role of subtle genetic variations in causing heterogeneity in CRISPR experiments, aligning with the reference. It also mentions effects on medicinal compound discovery but omits the aspect of target validation. The overall trend and key facts are consistent."
        },
        {
            "query_idx": 1403,
            "query": "How do intricate molecular evolutions contribute to the creation of transformative avenues and lasting efficacy of ligand-directed siRNA structures in achieving substantial extra-hepatic reach?",
            "retrieved_metrics": {
                "reference_idx": [
                    2121
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intricate molecular evolutions contribute to #longterm efficacy# and #stability# of ligand-conjugated siRNAs, enabling substantial extra-hepatic delivery.",
            "predicted_answer": "Intricate molecular evolutions, through sophisticated chemical modifications, enhance the stability and long-term efficacy of ligand-conjugated siRNAs, enabling robust extra-hepatic delivery and transformative therapeutic outcomes.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of \"long-term efficacy\" and \"stability\" of ligand-directed siRNA structures, as well as \"extra-hepatic delivery\" referred to in the reference answer. The details align well without contradictions, matching all emphasized components."
        },
        {
            "query_idx": 1404,
            "query": "What therapeutic silencing catalyst, conceptualized to modulate systemic vascular tension, has attained the secondary phase within the spectrum of clinical investigations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2123
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The therapeutic silencing catalyst for modulating systemic vascular tension in Phase 2 clinical trials is #ALN-AGT# for the treatment of #hypertension#.",
            "predicted_answer": "ALN-AGT, an siRNA drug, is in Phase 2 trials for the treatment of hypertension, aiming to modulate systemic vascular tension.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts emphasized with # in the reference: \"ALN-AGT\" and \"hypertension.\" It correctly reflects the meaning of the therapeutic goal and the phase of the trials, aligning with the overall trend without omissions or contradictions."
        },
        {
            "query_idx": 1405,
            "query": "What is the silencing cellular mechanism that has embarked on the penultimate leg of clinical inquiry aimed at combating the ailment of ocular desiccation?",
            "retrieved_metrics": {
                "reference_idx": [
                    2125
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The silencing cellular mechanism is #Tivanisiran# (SYL1001), currently in a #Phase 3# clinical study for treating dry eye disease.",
            "predicted_answer": "The silencing cellular mechanism being explored in clinical trials for ocular desiccation, or dry eye disease, is RNA interference (RNAi) therapy, specifically using siRNAs. Tivanisiran (SYL1001) is in Phase 3 trials for this condition.",
            "score": 5,
            "explanation": "The Predicted Answer accurately identifies the silencing cellular mechanism as Tivanisiran (SYL1001) and notes its status in Phase 3 trials, matching the key details of the Reference Answer. All emphasized facts are present, and the overall trend is consistent without omissions."
        },
        {
            "query_idx": 1406,
            "query": "How do the maestros of genetic architecture, referred to as noncoding RNAs, conduct the intricate movements within the cellular symphony, notably in the arenas of transcriptional overtures and translational orchestrations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2126
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Noncoding RNAs, like #miRNAs# and #tRNAs#, regulate cellular processes by influencing transcription and translation, acting as key players in genetic architecture.",
            "predicted_answer": "Noncoding RNAs, such as miRNAs, rRNAs, tRNAs, snoRNAs, and snRNAs, regulate gene expression by interacting with DNA, RNA, and proteins, thus orchestrating transcriptional and translational processes.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized with # symbols in the reference answer: miRNAs and tRNAs are specified, and their role in regulating transcription and translation is mentioned. The predicted answer provides additional details without contradictions, fully covering the reference answer's key points."
        },
        {
            "query_idx": 1407,
            "query": "In the nuanced fabric of intricate molecular engagement, which specific proteins are designated for focused molecular interception by the siRNA initiatives ALN-APP and ARO-SOD1, amidst the strategic frameworks aimed at mitigating the symptoms of cognitive deterioration, vascular amyloid protein accumulation, and the disruption of neurodegenerative processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2127
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "ALN-APP targets #amyloid precursor proteins#, while ARO-SOD1 targets #superoxide dismutase 1#.",
            "predicted_answer": "ALN-APP targets amyloid precursor proteins (APPs) to address Alzheimer's disease and cerebral amyloid angiopathy. ARO-SOD1 targets superoxide dismutase 1 (SOD1) for treating ALS caused by SOD1 mutations.",
            "score": 5,
            "explanation": "The predicted answer correctly states that ALN-APP targets amyloid precursor proteins and ARO-SOD1 targets superoxide dismutase 1. Both key facts emphasized with # symbols in the reference answer are fully captured in the predicted answer, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1408,
            "query": "In the saga of clinical trials, which distinct trajectories are embarked upon by STP705 and STP707 through their individual mechanisms of therapeutic navigation?",
            "retrieved_metrics": {
                "reference_idx": [
                    2124
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "STP705 targets #isSCC# and #BCC# through local administration, while STP707 addresses solid tumors and fibrotic liver diseases via intravenous injection.",
            "predicted_answer": "STP705 is locally administered for in situ squamous cell carcinoma and basal cell carcinoma, while STP707 is intravenously injected for solid tumors and fibrotic liver diseases.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies the targets of STP705 (#isSCC# and #BCC#) and its local administration, as well as the intravenous application of STP707 for solid tumors and fibrotic liver diseases. All key facts emphasized in the Reference Answer are covered without omissions."
        },
        {
            "query_idx": 1409,
            "query": "What mechanism, resembling the dynamic of selective permeability permitting retention, contributes to the congregating of nanoscale entities in compact neoplastic structures and hepatic environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    2133
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #enhanced permeability and retention (EPR) effect# contributes to the #accumulation of nanoparticles# in tumors and the liver.",
            "predicted_answer": "The enhanced permeability and retention (EPR) effect allows nanoscale entities to accumulate in compact neoplastic structures and hepatic environments by selectively permitting their retention.",
            "score": 5,
            "explanation": "The Predicted Answer accurately mentions the #enhanced permeability and retention (EPR) effect# and #accumulation of nanoparticles#, aligning with the Reference Answer's emphasis. It correctly describes the process without omitting key facts, thus reflecting the essential meaning and trend."
        },
        {
            "query_idx": 1410,
            "query": "What strategic alignments within the intricate synergy of targeted molecular reconnaissance missions and interconnected silencing sequences advance the recalibration of systemic persistence and site-specific aggregation patterns at the cellular frontiers?",
            "retrieved_metrics": {
                "reference_idx": [
                    2139
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Strategic alignment involves using #targeting ligands# to enhance #cellular uptake#, facilitating recalibration of systemic persistence and site-specific aggregation patterns at cellular frontiers.",
            "predicted_answer": "Strategic alignments include optimizing carrier properties and using unique targeting ligands. Covalently linking siRNA to ligands enhances targeted accumulation, reduces clearance, and improves cellular uptake, modulating pharmacokinetic and pharmacodynamic profiles.",
            "score": 5,
            "explanation": "The predicted answer includes the use of #targeting ligands# and enhances #cellular uptake#, matching the emphasized key facts in the reference. It aligns with the overall trend concerning systemic recalibration and site-specific aggregation, showing no contradictions or significant omissions."
        },
        {
            "query_idx": 1411,
            "query": "What instances of emergent architectural blueprints within the sophisticated domain of RNA interference illustrate innovative scaffolding footprints, reflecting recent molecular choreography advancements?",
            "retrieved_metrics": {
                "reference_idx": [
                    2138
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Instances include #asymmetric siRNAs# and #divalent siRNA scaffold#, illustrating innovative scaffolding footprints in RNA interference, reflecting recent molecular choreography advancements.",
            "predicted_answer": "Recent advancements in RNA interference include the development of novel structures like small circular interfering RNAs (sciRNAs), asymmetric siRNAs, and divalent siRNA scaffolds, along with modifications such as ESC+ and GNA, illustrating innovative molecular designs.",
            "score": 5,
            "explanation": "The predicted answer includes both key concepts: #asymmetric siRNAs# and #divalent siRNA scaffold#, as mentioned in the reference answer. It also adds details such as small circular interfering RNAs and specific modifications, which do not contradict the key facts of the reference. Overall, it captures all required information."
        },
        {
            "query_idx": 1412,
            "query": "What potential therapeutic synergies could be unlocked by harmonizing siRNA's molecular reprogramming aptitude with the systemic recalibration provided by chemotherapy agents in a coordinated dual-targeting paradigm?",
            "retrieved_metrics": {
                "reference_idx": [
                    2140
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Harmonizing siRNA with chemotherapy could enhance #efficacy# and overcome drug resistance by modulating epigenetic marks, potentially #reprogramming# gene expression and reversing disease phenotypes.",
            "predicted_answer": "Combining siRNA's ability to reprogram gene expression and modulate epigenetic marks with chemotherapy's systemic effects can enhance treatment efficacy, overcome drug resistance, and reduce off-target effects, creating new therapeutic opportunities.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of enhancing efficacy, overcoming drug resistance, and reprogramming gene expression, which align with the reference answer. The predicted answer also mentions reducing off-target effects, which doesn't contradict the reference. Thus, it comprehensively covers the core points emphasized in the reference."
        },
        {
            "query_idx": 1413,
            "query": "What unexplored dimensions of potential advancement or alteration might manifest within the framework of pathological storytelling through the application of sophisticated RNA-modulating strategies that influence the expression of non-coding RNA, considering their pivotal involvement in complex disease interplays?",
            "retrieved_metrics": {
                "reference_idx": [
                    2142
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The unexplored dimensions include targeting #non-coding RNA# with advanced RNA-modulating strategies, potentially revealing new insights into disease mechanisms and enabling novel #therapeutic interventions#.",
            "predicted_answer": "Sophisticated RNA-modulating strategies, such as siRNAs and adjuvants, can expand the scope of pathological storytelling by targeting non-coding RNAs. This approach may reveal new disease mechanisms and therapeutic opportunities, particularly through the exploration of coding and non-coding RNA interactions.",
            "score": 3,
            "explanation": "The predicted answer covers the targeting of non-coding RNA and mentions the potential for revealing new disease mechanisms, aligning with the reference answer. However, it does not explicitly include novel therapeutic interventions, a key fact from the reference answer."
        },
        {
            "query_idx": 1414,
            "query": "What multifaceted obstacles does the guardianship of molecular architecture within CMC paradigms confront, which in turn subtly modulate the trajectory towards market entry for emerging pharmacological innovations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2144
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The guardianship of molecular architecture in #CMC# paradigms faces obstacles like #monomer supply#, quality control, impurity characterization, and the lack of unified international drug registration standards.",
            "predicted_answer": "CMC paradigms face challenges such as monomer supply, quality control, capacity building, impurity characterization, and separation purification. Additionally, the lack of unified international drug registration standards further complicates market entry for new pharmacological innovations.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts emphasized in the Reference Answer: CMC paradigms, monomer supply, quality control, impurity characterization, and the lack of unified international drug registration standards. The additional mention of capacity building and separation purification does not contradict the reference."
        },
        {
            "query_idx": 1415,
            "query": "In the theatre of thyroid malignancies, what are the commonly perceived murmurs that patients encounter, and what are the primary nodes in the intricate network where cellular itinerants frequently commence their journey of dispersion?",
            "retrieved_metrics": {
                "reference_idx": [
                    2148
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Patients with thyroid cancer often experience #hoarseness# and #dyspnea#. Metastases commonly occur in the lymph nodes of the neck.",
            "predicted_answer": "In thyroid malignancies, patients often encounter hoarseness and a palpable, painless mass. Metastasis typically begins in the neck lymph nodes, followed by the lungs, brain, and bones.",
            "score": 3,
            "explanation": "The Predicted Answer includes the key fact of \"hoarseness\" and mentions metastasis in \"neck lymph nodes,\" aligning with the Reference Answer. However, it omits \"dyspnea\" and inaccurately details further metastasis sites (lungs, brain, bones), not specified in the Reference, affecting completeness."
        },
        {
            "query_idx": 1416,
            "query": "What myriad dimensions of complexity surround the enigmatic endeavor of refining diagnostic precision and stratifying therapeutic interventions in thyroid cancer treatment, especially when aligning the delicate balance between enhancing survival prospects and advancing the holistic quality of life?",
            "retrieved_metrics": {
                "reference_idx": [
                    2150
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Refining diagnostic precision and stratifying treatments for thyroid cancer involve complexity in improving #early diagnosis# and selecting #appropriate treatment# to enhance survival and quality of life.",
            "predicted_answer": "The complexities include improving early diagnosis, selecting appropriate treatments, and balancing survival with quality of life. Reducing unnecessary injury and tailoring therapies are key challenges in thyroid cancer management.",
            "score": 5,
            "explanation": "The predicted answer successfully captures the key facts of improving early diagnosis and selecting appropriate treatments, aligning with the reference answer's emphasis. It also addresses the broader concerns of balancing survival and quality of life. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 1417,
            "query": "What orchestrations within the genetic symphony of thyroid cellular anomalies can be traced to intricacies unveiled amid the complex interplay of SARS-CoV-2 infections?",
            "retrieved_metrics": {
                "reference_idx": [
                    2152
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Gene mutation# and #signaling pathway# abnormalities in thyroid cancer are linked to SARS-CoV-2 infections, emphasizing complex interplay in these cellular anomalies.",
            "predicted_answer": "SARS-CoV-2 infections may influence thyroid cellular anomalies through gene mutations, rearrangements, and signaling pathway disruptions, potentially contributing to the development of thyroid cancer.",
            "score": 5,
            "explanation": "The predicted answer includes key facts like \"gene mutations\" and \"signaling pathway disruptions,\" which correspond to #Gene mutation# and #signaling pathway# in the reference. Both answers align on the connection to SARS-CoV-2 infections and thyroid cancer. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 1418,
            "query": "What strategic protocols should healthcare personnel implement to mitigate the propagation of minute infectious agents in the course of cellular sample acquisition utilizing slender-edge aspiration techniques, considering the dynamics of particle diffusion and ocular shield mandates?",
            "retrieved_metrics": {
                "reference_idx": [
                    2156
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Healthcare personnel should wear #protective masks# with filter respirators, use #eye protection#, and fix cytology specimens with ethanol to mitigate infectious agent spread during aspiration.",
            "predicted_answer": "Healthcare personnel should wear personal protective masks with filter respirators and face shields. They should also fix cytology specimens with ethanol when smearing to mitigate the spread of infectious agents during fine-needle aspiration.",
            "score": 3,
            "explanation": "The predicted answer includes protective masks with filter respirators and ethanol for specimen fixation, matching the reference. However, it omits the #eye protection# mentioned in the reference. Thus, it aligns with the overall trend but lacks one key fact."
        },
        {
            "query_idx": 1419,
            "query": "What are the reverberations within the immune architecture, specifically relating to Treg augmentation and B lymphocyte diminution as instigated by $^{131}$I treatment, and how might these immunological perturbations engage with the continuum of risk factors pertaining to COVID-19 adversity?",
            "retrieved_metrics": {
                "reference_idx": [
                    2160
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "$^{131}$I treatment increases #Treg# and decreases #B lymphocyte#, but does not enhance COVID-19 risk, morbidity, or mortality, indicating limited clinical impact from immune imbalance.",
            "predicted_answer": "$^{131}$I treatment increases Treg cells and decreases B lymphocytes, causing an immune imbalance. However, this does not enhance the risk, morbidity, or mortality of COVID-19, suggesting that these immunological changes do not significantly impact COVID-19 outcomes.",
            "score": 5,
            "explanation": "The predicted answer matches all key facts emphasized in the reference: it mentions the increase in Treg, the decrease in B lymphocyte, and that these changes do not affect COVID-19 risk, morbidity, or mortality. The overall trend is consistent with the reference answer."
        },
        {
            "query_idx": 1420,
            "query": "In the intricate dance of molecular governance, what underlying principles enable the conjugation of siRNA with α TfR1 antibodies to serve as strategic catalysts for inducing transcriptional silencing predominantly within skeletal and cardiac tissues, as opposed to their muted influence in other prominent bodily organs?",
            "retrieved_metrics": {
                "reference_idx": [
                    2141
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #α TfR1# antibody conjugation facilitates #tissue-specific# delivery, achieving transcriptional silencing mainly in skeletal and cardiac tissues, with minimal impact on other organs.",
            "predicted_answer": "The conjugation of siRNA with α TfR1 antibodies enables targeted delivery to skeletal and cardiac tissues, where the silencing effect is maximized due to specific receptor interactions, while minimizing activity in other organs.",
            "score": 5,
            "explanation": "The Predicted Answer aligns with the Reference Answer, covering key concepts like targeted delivery and tissue specificity enabled by α TfR1 conjugation. Although the wording differs slightly, the central idea of inducing transcriptional silencing in skeletal and cardiac tissues while minimizing effects on other organs is intact."
        },
        {
            "query_idx": 1421,
            "query": "What proportionate measure of individuals within the exploratory landscape orchestrated by Abramson et al. arrived at a point of therapeutic equilibrium, and in what manner does this event correlate with the overarching temporal narrative of disease progression suspension?",
            "retrieved_metrics": {
                "reference_idx": [
                    2164
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In the trial by Abramson et al., #53%# of patients achieved #SD#, indicating a period of therapeutic equilibrium correlating with disease progression suspension.",
            "predicted_answer": "In the study by Abramson et al., 23% of patients achieved a partial response (PR) and 53% had stable disease (SD), indicating a therapeutic equilibrium. This correlates with a median progression-free survival (PFS) of 79 weeks, suggesting a suspension in disease progression.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies that 53% of patients achieved stable disease (SD), matching the key fact from the Reference Answer. It also adds context with additional percentages for partial response and discusses the progression-free survival, enhancing overall understanding without contradiction."
        },
        {
            "query_idx": 1422,
            "query": "What are the dueling narratives concerning the therapeutic value dichotomy of sorafenib in addressing anaplastic thyroid carcinoma, in light of its noted therapeutic inclinations observed within controlled simulation environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    2165
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Sorafenib shows #therapeutic# efficacy in #experimental# ATC models, improving survival, yet is ineffective against ATC according to Ito et al., illustrating a therapeutic value dichotomy.",
            "predicted_answer": "The therapeutic value of sorafenib in anaplastic thyroid carcinoma (ATC) is debated. While some studies show it inhibits ATC growth and improves survival in experimental models, others, like Ito et al., report it is not effective for treating ATC.",
            "score": 5,
            "explanation": "The Predicted Answer aligns with the Reference Answer, capturing the key dichotomy: sorafenib's noted therapeutic efficacy in experimental models and its ineffectiveness in Ito et al.'s study. Though phrasing differs slightly, all critical facts marked with # are present."
        },
        {
            "query_idx": 1423,
            "query": "In the landscape of therapeutic pathways for DTC patients, what segment of those who did not thrive on conventional RAI techniques displayed a measure of improvement when subjected to the molecular journey of cabozantinib?",
            "retrieved_metrics": {
                "reference_idx": [
                    2163
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#53%# of DTC patients who did not respond to conventional RAI therapy experienced #improvement# with cabozantinib treatment.",
            "predicted_answer": "In a study of 15 DTC patients who did not respond to standard RAI therapy, 53% showed partial response after treatment with cabozantinib.",
            "score": 5,
            "explanation": "The predicted answer matches the key facts in the reference answer. Both identify that 53% of DTC patients who did not respond to conventional RAI therapy showed improvement with cabozantinib. The use of \"partial response\" in the predicted answer aligns with \"improvement\" in the reference. No significant omissions or errors are present."
        },
        {
            "query_idx": 1424,
            "query": "Within the investigative spectrum focused on the preliminary phase of cabozantinib's deployment for advanced medullary thyroid carcinoma, what fraction of patients manifested a transitional therapeutic response categorized under the partial response domain?",
            "retrieved_metrics": {
                "reference_idx": [
                    2168
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#68%# of patients showed a #partial response# to cabozantinib in the phase I study for advanced medullary thyroid carcinoma.",
            "predicted_answer": "In a phase I study of cabozantinib for advanced medullary thyroid carcinoma, 68% of patients had a confirmed partial response.",
            "score": 5,
            "explanation": "The Predicted Answer accurately mirrors all key details emphasized in the Reference Answer: 68% partial response in patients during a phase I study of cabozantinib for advanced medullary thyroid carcinoma. It maintains the integrity of the data and the critical information without any omissions or contradictions."
        },
        {
            "query_idx": 1425,
            "query": "What divergent timelines of therapeutic persistence and progression deviation characterize the clinical journey of individuals across distinct age spectrums, as they engage with lenvatinib's influence within the context of thyroid anomalies resistant to iodine intervention?",
            "retrieved_metrics": {
                "reference_idx": [
                    2169
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #objective response rate# was higher in younger patients (#72%#) compared to older patients (55%), despite #lenvatinib# improving overall survival in #elderly#.",
            "predicted_answer": "In a phase III trial, lenvatinib showed better overall survival in elderly patients (≤65 vs. >65 years) with RAI-refractory DTC, while younger patients had a higher objective response rate.",
            "score": 3,
            "explanation": "The predicted answer mentions that younger patients had a higher objective response rate, aligning with the reference. However, it omits the specific #72%# response rate in younger patients and #lenvatinib#'s influence on overall survival in #elderly#. Therefore, it misses one key fact affecting completeness."
        },
        {
            "query_idx": 1426,
            "query": "What intricate pharmacokinetic dynamics and therapeutic recalibrations must be orchestrated when embarking upon the administration of chloroquine or hydroxychloroquine in concert with a sorafenib regimen, considering the potential for profound pharmaceutical interactions and the emergence of adverse clinical phenomena?",
            "retrieved_metrics": {
                "reference_idx": [
                    2167
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "When administering #chloroquine/hydroxychloroquine# with #sorafenib#, discontinue sorafenib due to QT prolongation and CYP3A4 inhibition. Stop MKIs if hypokalemia and fever occur; consult cardiology.",
            "predicted_answer": "When administering chloroquine or hydroxychloroquine with sorafenib, discontinue sorafenib due to the risk of QT prolongation and CYP3A4 inhibition. Monitor for symptoms like hypokalemia and fever, and consult cardiology if they occur.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts enclosed with # in the reference: administering chloroquine/hydroxychloroquine with sorafenib, discontinuing sorafenib due to QT prolongation and CYP3A4 inhibition, monitoring for hypokalemia and fever, and consulting cardiology if symptoms appear. No significant omissions or errors are present."
        },
        {
            "query_idx": 1427,
            "query": "What triadic framework of immunological checks and balances could be architected through the modulation of the everolimus-mTOR conduit in the symbiotic management of COVID-19's multifaceted immune challenges?",
            "retrieved_metrics": {
                "reference_idx": [
                    2177
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Everolimus# can shape immune responses in COVID-19 by reducing T lymphocyte proliferation, #attenuating# cytokine storms, and maintaining regulatory T cell activity.",
            "predicted_answer": "The triadic framework involves modulating everolimus-mTOR to reduce conventional T lymphocyte proliferation, attenuate cytokine storms, and maintain regulatory T cell activity, aiding in the balanced immune response to COVID-19.",
            "score": 5,
            "explanation": "The predicted answer accurately captures all the key points from the reference: it mentions the use of \"everolimus-mTOR\" to \"reduce T lymphocyte proliferation,\" \"attenuate cytokine storms,\" and \"maintain regulatory T cell activity,\" aligning fully with the reference while maintaining consistency in meaning without omissions."
        },
        {
            "query_idx": 1428,
            "query": "What intricate mechanistic synergy orchestrates the cooperative pharmacological ballet of lenvatinib and remdesivir in arresting the intricate genetic choreography of SARS-CoV-2's replication processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2171
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #synergistic effects# of lenvatinib and remdesivir inhibit #SARS-CoV-2 replication# by efficiently targeting viral transcription and replication without affecting early replication stages.",
            "predicted_answer": "Lenvatinib and remdesivir synergistically inhibit SARS-CoV-2 replication, likely by more efficiently blocking viral transcription and replication processes, rather than affecting early viral cycle stages.",
            "score": 5,
            "explanation": "The predicted answer closely aligns with the reference answer. It covers the key facts, such as the synergistic inhibition of SARS-CoV-2 replication and targeting viral transcription and replication. However, the emphasis on \"without affecting early replication stages\" is slightly less explicit than in the reference."
        },
        {
            "query_idx": 1429,
            "query": "What transformative revelations does the microcosm-on-a-dynamic-platform afford to the intricate choreography of morphogenetic simulations of cancerous vascular networks?",
            "retrieved_metrics": {
                "reference_idx": [
                    2179
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The microcosm-on-a-dynamic-platform enhances understanding of #cancerous vascular networks# and aids in the #design# of improved morphogenetic simulations using tumor-on-a-chip technology.",
            "predicted_answer": "The microcosm-on-a-dynamic-platform, or tumor-on-a-chip, offers transformative insights into the complex interactions within cancerous vascular networks by enabling detailed studies of the tumor microenvironment and vascularization, enhancing our understanding and aiding in drug development.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of the reference's core idea, focusing on cancerous vascular networks. However, it lacks a focus on the \"design\" of morphogenetic simulations, a key aspect. It aligns with the overall trend by discussing tumor-on-a-chip technology but misses this specific detail."
        },
        {
            "query_idx": 1430,
            "query": "What strategic developmental advantage does the tri-dimensional architectural modeling of oncogenic landscapes offer over traditional paradigms in decoding the intricacies of tumorigenic orchestration and metastatic progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    2184
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tri-dimensional architectural modeling provides a strategic advantage by allowing tumor cells to interact with the #ECM# in all dimensions, maintaining #morphology# and gene expression, enhancing understanding of tumorigenesis and metastasis.",
            "predicted_answer": "Tri-dimensional architectural modeling allows for a more accurate representation of tumor cell interactions with the extracellular matrix, maintaining morphology and heterogeneity, which enhances understanding of tumorigenesis and metastasis.",
            "score": 3,
            "explanation": "The Predicted Answer mentions the interactions of tumor cells with the extracellular matrix (ECM) and maintains morphology, aligning with the Reference Answer. However, it lacks mention of gene expression, a key fact in the Reference Answer, affecting completeness."
        },
        {
            "query_idx": 1431,
            "query": "In the stratified examination of therapeutic efficacy documented by Hanna et al., what fractional response frequencies emerged amidst the heterogeneous landscape of thyroid carcinomas, encompassing DTC, MTC, and ATC?",
            "retrieved_metrics": {
                "reference_idx": [
                    2176
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The fractional response frequencies were #3%# for DTC, #10%# for MTC, and 14% for ATC.",
            "predicted_answer": "Hanna et al. reported partial response rates of 3% in DTC, 10% in MTC, and 14% in ATC patients.",
            "score": 5,
            "explanation": "The predicted answer contains the key fractional response frequencies of 3% for DTC and 10% for MTC as emphasized in the reference answer. However, it also aligns with the 14% response rate for ATC, preserving the overall meaning and trend."
        },
        {
            "query_idx": 1432,
            "query": "What intrinsic synergistic properties, notably within elastomeric compounds like transparency and adaptability, substantiate their seamless integration into illumination crafting methodologies for the development of diminutive fluidic pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    2190
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Transparency# and #flexibility# of PDMS make it ideal for integration into illumination crafting methodologies for creating diminutive fluidic pathways.",
            "predicted_answer": "PDMS's transparency and flexibility enable its seamless integration into illumination crafting for microfluidic pathways, allowing precise light manipulation and adaptability during fabrication.",
            "score": 5,
            "explanation": "The predicted answer successfully mentions the key properties of PDMS, which are \"transparency\" and \"flexibility,\" aligning with the reference answer's focus. Additionally, it reflects the application in illumination crafting for microfluidic pathways, maintaining the core theme without contradictions."
        },
        {
            "query_idx": 1433,
            "query": "Within the sophisticated convergence of organic and engineered realms as orchestrated by Hachey et al. (2021), what enhancements functioned as catalytic entities, weaving together the tapestry of endothelial passages with the structured pathways of microfluidic channels?",
            "retrieved_metrics": {
                "reference_idx": [
                    2191
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Laminin# served as a catalytic entity, enabling the anastomosis of #endothelial cells# and microfluidic channels in Hachey et al. (2021) study.",
            "predicted_answer": "In Hachey et al. (2021), laminin and the mixture of normal human lung fibroblasts, endothelial cells, and tumor microtissues functioned as catalytic entities, facilitating the anastomosis of endothelial passages with microfluidic channels.",
            "score": 5,
            "explanation": "The Predicted Answer captures key elements, such as \"#laminin#\" and the connection between \"#endothelial cells#\" and microfluidic channels. However, it introduces additional elements (normal human lung fibroblasts, tumor microtissues) not mentioned in the Reference Answer. Despite these additions, the core details required are present."
        },
        {
            "query_idx": 1434,
            "query": "What transformative process did Miller et al. (2018) utilize to configure hollow constructs within a collagen-gelated environment, through the strategic withdrawal of mandrel rods, thereby enabling the establishment of endothelial inhabitations that simulate vascular networks?",
            "retrieved_metrics": {
                "reference_idx": [
                    2192
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Miller et al. (2018) utilized #mandrel rods# to create #hollow channels# in collagen gel, allowing endothelial cells to form simulated vascular networks.",
            "predicted_answer": "Miller et al. (2018) utilized the strategic withdrawal of mandrel rods from a collagen-gelated environment to create hollow channels, which were then seeded with endothelial cells to simulate vascular networks.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: use of #mandrel rods#, creation of #hollow channels# in a collagen-gelated environment, and the establishment of endothelial inhabitation for simulating vascular networks. The main points are consistent with the reference answer, with no significant omissions."
        },
        {
            "query_idx": 1435,
            "query": "Within the complex interplay of 3D bioprinting's sacrificial templating technique, how does the strategic liberation of Pluronic F-127 ink facilitate the emergence of ethereal passageways mimicking vascular arrangements?",
            "retrieved_metrics": {
                "reference_idx": [
                    2197
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The strategic liberation of #Pluronic F-127# ink creates #hollow channels#, allowing endothelial and pericytes to form blood vessels, mimicking vascular arrangements.",
            "predicted_answer": "In sacrificial templating, Pluronic F-127 ink is strategically printed to form vascular-like structures. Upon liberation, it dissolves, creating hollow channels that mimic blood vessels, which are then lined with endothelial and pericyte cells.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference answer: the use of Pluronic F-127, the creation of hollow channels, and the role of endothelial and pericytes in forming blood vessels. The predicted answer is aligned with the reference answer and contains no contradictory information."
        },
        {
            "query_idx": 1436,
            "query": "What orchestrated approach did Kim et al. implement to influence and direct the minute fluid currents within the composite matrix of their functionally sculpted cellular habitat, specifically designed to emulate vascularity in a tumor analogue?",
            "retrieved_metrics": {
                "reference_idx": [
                    2193
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Kim et al. orchestrated the control of minute fluid currents by adjusting the #volume difference# between the hollow and tumor channels, directing flow within the #hydrogel#.",
            "predicted_answer": "Kim et al. used needles to create hollow channels in a hydrogel, then seeded endothelial and tumor cells on opposite sides. By adjusting the volume difference between these channels, they controlled the direction of interstitial flow within the hydrogel.",
            "score": 5,
            "explanation": "The predicted answer includes key facts from the reference answer: the adjustment of the \"volume difference\" and the presence of flow within the \"hydrogel,\" aligning with the trend and technical details of controlling fluid currents. No critical details are missing and no contradictory information is present."
        },
        {
            "query_idx": 1437,
            "query": "Within the multifaceted exchanges of cellular cohorts in microvascular systems, what particular methodologies are utilized by MDA-MB-231 and PDAC tumor cells to execute nuanced negotiations with the endothelial guardians, subsequently orchestrating alterations in permeability dynamics of their cohabited domain?",
            "retrieved_metrics": {
                "reference_idx": [
                    2200
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "MDA-MB-231 cells increase vascular permeability by impairing #endothelial cell-cell junctions#, while #PDAC tumor cells# invade and replace endothelium, occupying the lumen.",
            "predicted_answer": "MDA-MB-231 cells increase vascular permeability by impairing endothelial cell junctions, while PDAC cells rapidly invade blood vessels, replacing endothelium and occupying the lumen, both leading to altered permeability.",
            "score": 5,
            "explanation": "The Predicted Answer captures all key facts emphasized in the Reference Answer, including the impact on endothelial cell junctions by MDA-MB-231 cells and the invasion and replacement of endothelium by PDAC cells. There are no omissions or contradictions, maintaining alignment with the Reference Answer."
        },
        {
            "query_idx": 1438,
            "query": "What sophisticated experimental apparatus and methodologies are employed to craft an analogous portrayal of the ever-changing symbiotic habitat observed in the scenario of hepatitis B virus-induced hepatic carcinoma, as showcased in the third schematic illustration?",
            "retrieved_metrics": {
                "reference_idx": [
                    2201
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Human #monocytes# were cultured in #collagen gels# with HepG2 cells, while HBV-specific TCR T cells passed through tumor zones, simulating HBV-related hepatic carcinoma's microenvironment.",
            "predicted_answer": "The experimental setup uses organ-on-a-chip technology, where human monocytes and labeled HepG2 cells are co-cultured in collagen gels. HBV-specific TCR T cells move through the tumor aggregation zone, mimicking the dynamic microenvironment of HBV-related hepatocellular carcinoma.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts with consistency in meaning: human monocytes, collagen gels, co-culture with HepG2 cells, and HBV-specific TCR T cell interactions in a tumor-mimicking environment. The terms and methodology are effectively mirrored, ensuring no significant omissions."
        },
        {
            "query_idx": 1439,
            "query": "What intrinsic merits do the fluidic architecture models possess over the conventional rodent frameworks in enhancing our understanding of the intricate dance between the immune cell sentinels and cancerous formations across varied microenvironmental theatres?",
            "retrieved_metrics": {
                "reference_idx": [
                    2202
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #fluidic architecture# models enable dynamic observation of interactions between #TAMs# and tumor cells, offering reproducible insights into metastasis across different organ microenvironments.",
            "predicted_answer": "Fluidic architecture models offer dynamic and reproducible microenvironments, allowing for real-time observation of interactions between immune cells, like TAMs, and tumor cells. This enhances understanding of metastasis and immune response in a more controlled and human-relevant setting.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts: fluidic architecture models and their dynamic nature, inclusion of TAMs (tumor-associated macrophages), and their role in studying metastasis, aligning with the Reference Answer. No omissions affect understanding. The phrasing differs but reflects the same meaning."
        },
        {
            "query_idx": 1440,
            "query": "What is the outcome of leveraging TGFβ receptor inhibition through sophisticated flow-based manipulation schemes in influencing the disintegration dynamics of endothelial constructs within pancreatic neoplasms?",
            "retrieved_metrics": {
                "reference_idx": [
                    2199
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Leveraging TGFβ receptor inhibition results in significantly reduced #endothelial# cell ablation in pancreatic #neoplasms# over 7 days compared to cases without inhibitors.",
            "predicted_answer": "Leveraging TGFβ receptor inhibition through microfluidic techniques significantly reduces the ablation of vascular endothelial cells in pancreatic neoplasms, indicating a role in stabilizing endothelial constructs.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts of TGFβ receptor inhibition leading to reduced endothelial cell ablation in pancreatic neoplasms. However, it omits the specific timeframe of \"over 7 days\" mentioned in the reference, affecting completeness. The trends and meaning align well but lack this detail."
        },
        {
            "query_idx": 1441,
            "query": "Within the intricate biochemical ensemble of cellular interaction in type I collagen-enhanced matrices, what pivotal function does integrin αvβ3 assume in orchestrating the inflammatory dynamics crucial for initiating and sustaining angiogenic processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2205
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Integrin #αvβ3# plays a critical role in #endothelial cell-macrophage interactions#, influencing inflammation-driven angiogenesis in type I collagen-enhanced matrices.",
            "predicted_answer": "Integrin αvβ3 plays a crucial role in mediating endothelial cell-macrophage interactions, which are essential for inflammation-driven angiogenesis in type I collagen-enhanced matrices.",
            "score": 5,
            "explanation": "The predicted answer covers all the key elements emphasized by the # symbols: integrin αvβ3, endothelial cell-macrophage interactions, and their influence on inflammation-driven angiogenesis in type I collagen-enhanced matrices. It aligns precisely with the reference answer without significant omissions or errors."
        },
        {
            "query_idx": 1442,
            "query": "Within the intricate biological choreography, what influence do the circulatory pathways, akin to arterial conduits, and the lymphatic currents exert in the orchestrated allocation and metamorphic action of anticancer pharmacologic entities within the heterogeneous terrain of tumorous microenvironments?",
            "retrieved_metrics": {
                "reference_idx": [
                    2209
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Blood circulation and #lymphatic drainage# influence anticancer drugs by affecting their #distribution# in tumor tissue, aiding delivery and removal, potentially impacting therapeutic effectiveness.",
            "predicted_answer": "Circulatory pathways and lymphatic currents influence the distribution and action of anticancer drugs by transporting them to the tumor site and facilitating their entry into tumor tissue, while excess drugs are drained through the lymphatic system.",
            "score": 3,
            "explanation": "The predicted answer covers the influence of circulatory pathways and lymphatic currents on anticancer drugs' distribution, aligns with the overall theme, and includes drug transport and lymphatic drainage. However, it misses the impact on therapeutic effectiveness mentioned in the reference answer."
        },
        {
            "query_idx": 1443,
            "query": "In what manner does the enigmatic force of IF catalyze a metamorphosis in macrophage migratory conduct, subsequently sculpting the landscape of cellular invasion exhibited by malignant entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    2208
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The enigmatic force of #IF# enhances macrophage #migration#, resulting in increased cancer cell invasiveness when cocultured, thus promoting cancer aggressiveness.",
            "predicted_answer": "IF enhances macrophage migration, making them faster and more directional. This increased mobility, when macrophages are co-cultured with cancer cells, boosts the invasiveness of the cancer, thus promoting tumor aggressiveness.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts: IF enhances macrophage migration, making them faster and more directional, which aligns with the increased cancer cell invasiveness and promotion of aggressiveness mentioned in the Reference Answer. The overall trend is consistent, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1444,
            "query": "In the interplay of bioenergetic influx and cytostatic influences, what undercurrent of physiological dynamics precipitates the augmentation of spheroidal constructs endowed with vascular conduits at the specified concentration milieu, contrasting with their non-vascular counterparts?",
            "retrieved_metrics": {
                "reference_idx": [
                    2210
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The undercurrent of physiological dynamics is the #proliferation# due to nutrient delivery via vascular conduits surpassing the #cell death# from paclitaxel at 5 ng/ml under perfusion conditions.",
            "predicted_answer": "The augmentation of spheroidal constructs with vascular conduits, compared to non-vascular ones, is driven by enhanced nutrient delivery via perfusable vessels, which supports greater cell proliferation and volume, even under cytostatic conditions.",
            "score": 3,
            "explanation": "The predicted answer touches on proliferation due to nutrient delivery via perfusable vessels, aligning with the reference answer's emphasis on \"proliferation\" and surpassing \"cell death\" at a specified concentration. However, it lacks a direct mention of \"paclitaxel at 5 ng/ml\" and its impact, leading to incomplete coverage."
        },
        {
            "query_idx": 1445,
            "query": "Within the realm of Cao et al.'s 2019 engineered biosphere, what architectural distinction orchestrates the modulation of doxorubicin's therapeutic diminution?",
            "retrieved_metrics": {
                "reference_idx": [
                    2211
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In Cao et al.'s 2019 biosphere, #lymphatic vessel presence# modulates doxorubicin's therapeutic diminution by affecting drug #permeability#.",
            "predicted_answer": "Cao et al. (2019) designed a tumor-on-a-chip with both blood and lymphatic vessels, which showed higher cell viability under doxorubicin treatment, indicating the lymphatic system's role in reducing drug efficacy.",
            "score": 3,
            "explanation": "The predicted answer includes the presence of lymphatic vessels but does not mention their role in drug \"permeability,\" as emphasized in the reference answer. It aligns with the overall trend of lymphatic involvement but misses this specific key fact."
        },
        {
            "query_idx": 1446,
            "query": "What intricate hurdle did Carvalho and colleagues have to navigate regarding the merger process of endothelial cellular elements within the intricately designed microvascular framework of their colorectal tumor simulation model?",
            "retrieved_metrics": {
                "reference_idx": [
                    2213
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Carvalho and colleagues faced the #hurdle# of preventing anastomosis formation between #endothelial cells# in their colorectal tumor simulation model.",
            "predicted_answer": "Carvalho and colleagues faced the challenge of endothelial cells forming vascular buds but not anastomosis, limiting the full integration of the microvascular framework in their colorectal tumor model.",
            "score": 5,
            "explanation": "The predicted answer captures the challenge of endothelial cells forming vascular buds without anastomosis, aligning with the reference answer's emphasis on preventing anastomosis. While phrasing differs, the key concepts of endothelial cells and anastomosis are addressed. No significant information is omitted."
        },
        {
            "query_idx": 1447,
            "query": "What inherent dominance did the vascular-infused multidimensional oncological construct exhibit when juxtaposed with the flat-layered cellular arrangement and diverse cellular configurations in the investigational study led by Hachey et al.?",
            "retrieved_metrics": {
                "reference_idx": [
                    2217
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #vascularized tumor model# exhibited #robustness#, reproducibility, and a gene expression pattern closely matching in vivo tumors, surpassing flat-layered and diverse cellular configurations.",
            "predicted_answer": "The vascularized 3D tumor model exhibited gene expression patterns closely matching in vivo tumors, with better preservation of tumor heterogeneity and robust reproducibility compared to the 2D monolayer and allogeneic cultures.",
            "score": 5,
            "explanation": "The predicted answer successfully includes key elements: the \"vascularized 3D tumor model,\" \"gene expression patterns closely matching in vivo tumors,\" \"robust reproducibility,\" and preservation of tumor heterogeneity. It aligns with the reference and contains no contradictions or significant omissions."
        },
        {
            "query_idx": 1448,
            "query": "In what capacity does the attempt to re-envision the cerebral microcosm present a more intricate architectural complexity in the design of malignant brain tumor simulations, in contrast to crafting the microenvironmental symphony peculiar to metastatic pancreatic formations utilizing tumor-on-a-chip technology pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    2220
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #cerebral microcosm# presents a more intricate architectural complexity in brain tumor simulations due to the brain's #unique nature#, compared to pancreatic metastatic microenvironments.",
            "predicted_answer": "The attempt to re-envision the cerebral microcosm in brain tumor simulations presents greater architectural complexity due to the unique nature of the brain, unlike the more straightforward microenvironmental symphony in metastatic pancreatic formations.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the cerebral microcosm's architectural complexity and the brain's unique nature in brain tumor simulations, as emphasized in the reference. It also correctly contrasts this with metastatic pancreatic microenvironments. The key facts are reflected accurately, with no significant omissions."
        },
        {
            "query_idx": 1449,
            "query": "How does the intricate molecular habitat within the bone marrow's ecosystem orchestrate and modulate the development and advancement of blood-related malignancies through its complex, bidirectional interactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    2223
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #bone marrow# niche can cause malignant mutations and is remodeled by #tumor cells# to promote tumor development and drug resistance.",
            "predicted_answer": "The bone marrow's microenvironment regulates hematopoietic stem cells, and alterations in this niche can lead to malignant mutations. Malignant cells can also remodel the microenvironment, further promoting tumor development and drug resistance.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts of the bone marrow's role in malignant mutations and how tumor cells remodel it to promote malignancy and drug resistance. Both answers describe the interplay within the bone marrow niche and tumor cells, aligning well with the reference."
        },
        {
            "query_idx": 1450,
            "query": "Amidst the elaborate vascular tableau engineered within the neuroblastoma framework, what are the nuanced ramifications wrought by isotretinoin concerning the cessation of cellular vitality, modulation of CD31’s bio-expression, and the apparent resilience of the neoplastic endothelial contingent to its effects?",
            "retrieved_metrics": {
                "reference_idx": [
                    2222
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Isotretinoin induces #apoptosis# and reduces #CD31# expression in neuroblastoma cells, disintegrating the vascular network, but does not affect tumor-derived endothelial cells.",
            "predicted_answer": "Isotretinoin induces apoptosis and reduces CD31 expression in neuroblastoma cells, leading to vascular network disintegration. However, it does not affect tumor-derived endothelial cells or vascular-like structures, showing their resilience.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by stating isotretinoin induces apoptosis and reduces CD31 expression in neuroblastoma cells, leading to vascular disintegration. It also mentions the resilience of tumor-derived endothelial cells, consistent with the reference. All key facts are present without significant omissions."
        },
        {
            "query_idx": 1451,
            "query": "What intricate behavioral patterns did the progenitor-like cellular forms demonstrate within the vascular-proximal microenvironment per Xiao et al. (2019)?",
            "retrieved_metrics": {
                "reference_idx": [
                    2221
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Progenitor-like cellular forms exhibited either #quiescent# or #aggressive# behavior near the microvessels in the vascular-proximal microenvironment.",
            "predicted_answer": "Xiao et al. (2019) observed that brain tumor stem-cell-like cells in the perivascular area exhibited either quiescent or aggressive behavior, demonstrating their dynamic interactions with microvessels.",
            "score": 5,
            "explanation": "The predicted answer effectively covers the key emphasized facts from the reference: the existence of \"quiescent\" and \"aggressive\" behaviors in the vascular-proximal microenvironment. The meaning and trend are consistent with no significant omissions, capturing the observed dynamic interactions."
        },
        {
            "query_idx": 1452,
            "query": "What is the role of cellular metamorphosis in neuroblastoma, specifically as tumor cells simulate endothelium to craft capillary-like conduits, in moderating the outcomes of vascular-targeting therapeutics including bevacizumab?",
            "retrieved_metrics": {
                "reference_idx": [
                    2224
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cellular metamorphosis in neuroblastoma leads to #angiogenic mimicry#, enabling tumor cells to create capillary-like structures, potentially reducing the effectiveness of vascular-targeting therapies like #bevacizumab#.",
            "predicted_answer": "Cellular metamorphosis in neuroblastoma, where tumor cells mimic endothelium to form capillary-like structures, may contribute to the ineffectiveness of vascular-targeting drugs like bevacizumab, as seen in clinical trials.",
            "score": 3,
            "explanation": "The predicted answer includes the essence of \"angiogenic mimicry\" without explicitly naming it, indicating tumor cells imitating the endothelium to form structures that decrease the efficacy of therapies like bevacizumab. It aligns well with the reference, but omits the term \"angiogenic mimicry.\""
        },
        {
            "query_idx": 1453,
            "query": "What influence does the intrinsic water-repellent nature of polydimethylsiloxane exert as a subtle shaper on the precision of tumor-on-a-chip explorations, and how could it unfold into broader challenges, potentially stalling their aspired applications in clinical realms?",
            "retrieved_metrics": {
                "reference_idx": [
                    2226
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #hydrophobic# nature of #PDMS# can lead to drug adsorption, causing erroneous results and limiting the clinical application of tumor-on-a-chip models.",
            "predicted_answer": "The intrinsic hydrophobic nature of PDMS can adsorb anticancer drugs, leading to inaccurate experimental results and limiting clinical applications. This necessitates the development of new materials and standardized guidelines to improve reliability and scalability.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions the hydrophobic nature of PDMS, its role in drug adsorption, and the resulting inaccuracies and clinical limitations. It additionally covers broader challenges like the need for new materials and guidelines, supporting the overall trend and completeness of the reference."
        },
        {
            "query_idx": 1454,
            "query": "Within the realm of engineered constructs mimicking marrow landscapes to unravel blood malignancy dynamics, what indispensable architectural motifs and constituent pillars emerge as quintessential for crafting these micro-wholes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2225
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Microfluidics# and #porous scaffolds# are essential for creating engineered constructs that mimic marrow landscapes for studying blood malignancy dynamics.",
            "predicted_answer": "Indispensable architectural motifs include microfluidics and 3D porous scaffolds, while key constituent pillars are biomimetic materials and cellular components that accurately replicate the bone marrow microenvironment.",
            "score": 5,
            "explanation": "The predicted answer contains the key facts emphasized in the reference answer: both \"microfluidics\" and \"porous scaffolds\" are mentioned as essential components. The predicted answer aligns with the overall trend and includes additional details that do not contradict the reference."
        },
        {
            "query_idx": 1455,
            "query": "How do the intricacies of fiscal efficiency and minimized venture unpredictability serve as catalysts in the inclination toward the reutilization of non-patent pharmaceutical entities within intellectual and altruistic research communities?",
            "retrieved_metrics": {
                "reference_idx": [
                    2236
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricacies of #fiscal efficiency# and #minimized venture unpredictability# favor the reutilization of non-patent pharmaceutical entities, making them attractive for academia and research organizations.",
            "predicted_answer": "Fiscal efficiency and minimized venture unpredictability drive the preference for reusing non-patent pharmaceuticals in research. These entities are cheaper and lower risk, making them ideal for academic and not-for-profit organizations.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of fiscal efficiency and minimized venture unpredictability, aligning with the stated preference for using non-patent pharmaceuticals in academic and not-for-profit research. There are no significant omissions or errors, fully covering the reference's key aspects."
        },
        {
            "query_idx": 1456,
            "query": "What complex impediments inherent in the transmutation of clinically rejected molecular entities into new therapeutic paradigms, especially regarding informational accessibility and antecedent inefficacies, are exposed by the context provided?",
            "retrieved_metrics": {
                "reference_idx": [
                    2237
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Informational accessibility# issues and addressing #antecedent inefficacies# are impediments in repurposing clinically rejected drugs, due to inaccessible data and ensuring previous failure reasons are resolved.",
            "predicted_answer": "The primary impediments include limited accessibility to safety and efficacy data, financial losses from initial failures, and the need to address previous inefficacies to prevent recurrence in new therapeutic applications.",
            "score": 5,
            "explanation": "The Predicted Answer captures the key concepts of \"informational accessibility issues\" and \"addressing antecedent inefficacies\" from the Reference Answer. The phrases \"limited accessibility to safety and efficacy data\" and \"address previous inefficacies\" effectively correspond to these key points."
        },
        {
            "query_idx": 1457,
            "query": "Within the intricate tapestry of therapeutic research and development, what essential superiority does the strategy of engaging with particular molecular focal points offer when juxtaposed with the sweeping examination of phenotypic manifestations within the framework of compound exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    2240
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Engaging specific #molecular targets# enables precise evaluation of drug interactions, minimizing false leads and increasing the likelihood of successful pre-clinical translation, unlike broader phenotypic screenings.",
            "predicted_answer": "Target-based screening offers the advantage of focusing on specific molecular targets, which can lead to a more precise understanding of drug mechanisms and potentially reduce side effects, compared to the broader approach of phenotypic screening.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of focusing on specific molecular targets for precise understanding, similar to the reference answer's emphasis on evaluating drug interactions with molecular targets. However, it omits the advantages of minimizing false leads and improving pre-clinical translation highlighted in the reference."
        },
        {
            "query_idx": 1458,
            "query": "In what manner do Scannell et al. articulate the labyrinthine dynamics of industry alignment with R&D paradigms, as influenced by Eroom's Law, particularly concerning the notion of assumed progressive advancement in these methods?",
            "retrieved_metrics": {
                "reference_idx": [
                    2238
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Scannell et al. suggest Eroom's Law highlights #industry# failure to adopt advanced R&D methods, assuming false progressive advancement, due to market competition and regulatory #hurdles#.",
            "predicted_answer": "Scannell et al. suggest that industry alignment with R&D paradigms, influenced by Eroom's Law, is complicated by overestimating the advancement of R&D methods and focusing on high-risk, high-reward innovations despite increasing regulatory and market challenges.",
            "score": 1,
            "explanation": "The Predicted Answer captures the trend of Eroom's Law complicating industry alignment with R&D paradigms. However, it omits key details about the industry's failure to adopt advanced methods and fails to mention market competition, covering only one of the two emphasized points."
        },
        {
            "query_idx": 1459,
            "query": "What multifaceted methodologies are harnessed within the expansive repositories of pharmaco-explorations to discern the concealed capacities of therapeutic agents when aligned against assorted pathological manifestations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2239
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Multifaceted methodologies include #knowledge-based#, #drug-based#, activity-based, in silico, and in vitro screening to assess therapeutic agents against various pathological manifestations.",
            "predicted_answer": "Pharmaco-explorations use multifaceted methodologies such as knowledge-based, drug-based, activity-based, in silico, and in vitro screening to identify the therapeutic potentials of agents against various diseases.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes all of the multifaceted methodologies mentioned in the 'Reference Answer' (knowledge-based, drug-based, activity-based, in silico, and in vitro screening) without any omissions or contradictions. The key facts are present, and the trend is accurately reflected."
        },
        {
            "query_idx": 1460,
            "query": "Through what investigative framework did Lin et al. ascertain the alignment of the psychiatric remedy imipramine with glioblastoma treatment paradigms, and in what manner does its efficacy delineate itself when juxtaposed with the traditional chemotherapeutic recourse, temozolomide?",
            "retrieved_metrics": {
                "reference_idx": [
                    2242
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Lin et al. employed #genome-wide association studies# to identify imipramine for #glioblastoma# treatment, demonstrating higher sensitivity in GB cells compared to temozolomide.",
            "predicted_answer": "Lin et al. used GWAS to identify imipramine as a potential treatment for glioblastoma. Their study showed that imipramine-targeted GB cells have higher sensitivity compared to temozolomide, the standard chemotherapy.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"GWAS\" as the method to find imipramine. It matches \"glioblastoma\" treatment and indicates that GB cells show higher sensitivity compared to temozolomide. All key facts and meaning from the reference are present without contradictions."
        },
        {
            "query_idx": 1461,
            "query": "What elevated strategic benefit is conferred through the synthesis of multidimensional therapeutic schemas as opposed to the singular trajectory of isolated pharmacological application in managing convoluted conditions such as glioma?",
            "retrieved_metrics": {
                "reference_idx": [
                    2245
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The synthesis of #multidimensional therapeutic# schemas offers #comprehensive and effective# treatment, targeting different aspects of glioma rather than a single approach.",
            "predicted_answer": "Multidimensional therapeutic schemas, or multimodal therapy, offer a more comprehensive approach by targeting various aspects of complex conditions like glioma, potentially increasing effectiveness and patient survival compared to isolated pharmacological treatments.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of multidimensional therapeutic schemas providing a comprehensive approach and mentions the targeting of various aspects of glioma. Both are the key facts emphasized in the reference answer. No significant information is missing, and there's no contradiction."
        },
        {
            "query_idx": 1462,
            "query": "In the delicate dance of pharmacological reengineering, what intrinsic target-centric metamorphosis enabled Tamoxifen to orchestrate its therapeutic prowess against breast cancerous proliferations, following its inefficacy in the realm of ovulation suppression?",
            "retrieved_metrics": {
                "reference_idx": [
                    2241
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tamoxifen's therapeutic prowess against breast cancer emerged from its ability to #block# the #oestrogen receptor#, inhibiting estrogen and slowing growth of ER+ breast cancers.",
            "predicted_answer": "The intrinsic target-centric metamorphosis that enabled Tamoxifen's efficacy against breast cancer was its ability to block the oestrogen receptor (ER), inhibiting oestrogen and slowing the growth of ER+ breast cancers.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts from the reference answer, mentioning Tamoxifen's ability to block the oestrogen receptor and inhibit estrogen, thereby slowing the growth of ER+ breast cancers. Both versions align in meaning without any significant omissions or contradictions."
        },
        {
            "query_idx": 1463,
            "query": "In what way does the conceptual master key strategy, formulated within intricate molecular frameworks, seek to navigate and mitigate the inherent complexities of thorough genetic characterization in personalized cancer therapy, by focusing on a widely applicable protein and pathway paradigm across diverse malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    2248
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #conceptual master key# strategy seeks to mitigate genetic characterization complexities by targeting #prevalent proteins and pathways# in diverse cancers, impacting more patients with less effort.",
            "predicted_answer": "The conceptual master key strategy aims to simplify personalized cancer therapy by targeting common proteins and pathways across different cancers, thus addressing the challenge of extensive genetic profiling and making treatment more broadly applicable and resource-efficient.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the \"conceptual master key\" strategy by addressing the focus on \"common proteins and pathways\" in various cancers, aligning with the reference's emphasis on \"prevalent proteins and pathways.\" Both highlight mitigating genetic complexity and wider applicability, with no significant omissions."
        },
        {
            "query_idx": 1464,
            "query": "What role do linguistic data excavation techniques play in elucidating innovative pharmaceutical redeployment routes for oncogenic genetic markers within the framework of the studies discussed?",
            "retrieved_metrics": {
                "reference_idx": [
                    2246
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Linguistic data excavation techniques, like #text mining#, are pivotal in identifying innovative pharmaceutical redeployment routes, revealing #associations# between drugs and oncogenic genetic markers in cancer studies.",
            "predicted_answer": "Linguistic data excavation techniques, such as text mining, play a crucial role in identifying new associations between drugs and oncogenic genetic markers, facilitating the discovery of potential repurposed drugs for cancer treatment.",
            "score": 3,
            "explanation": "The 'Predicted Answer' includes the use of linguistic data excavation techniques like text mining and highlights their importance in identifying associations between drugs and oncogenic genetic markers. However, it lacks the specific emphasis on \"innovative pharmaceutical redeployment routes\" present in the 'Reference Answer'."
        },
        {
            "query_idx": 1465,
            "query": "What emergent efficacy phenomenon is observed in the transformative alliance of thalidomide with corticosteroids and an alkylating agent, such as melphalan, in the relentless pursuit of subduing myeloma cellular entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    2254
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #emergent efficacy# observed is an increased response rate of #70%# when thalidomide is combined with corticosteroids and an alkylating agent like melphalan against myeloma cells.",
            "predicted_answer": "The emergent efficacy phenomenon observed is a significantly increased response rate, reaching about 70%, when thalidomide is combined with corticosteroids and an alkylating agent like melphalan in treating myeloma.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key facts mentioned in the reference answer: the #emergent efficacy# and the #70%# increased response rate of myeloma treatment with thalidomide, corticosteroids, and melphalan. The meaning and details are consistent between both answers."
        },
        {
            "query_idx": 1466,
            "query": "How does the alliance of academic inquiry with corporate pharmaceutical expertise transform the realm of medicinal repositioning, particularly in relation to resolving the challenges posed by the scarcity of proprietary stewardship and specialized intellectual resources?",
            "retrieved_metrics": {
                "reference_idx": [
                    2263
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The alliance between academia and corporate pharmaceuticals aids #medicinal repositioning# by providing #specialized intellectual resources# for marketing exclusivity and repurposing unused drugs.",
            "predicted_answer": "The alliance integrates academic research with corporate expertise, overcoming challenges like limited proprietary stewardship and specialized IP resources. This collaboration enhances drug repurposing by combining academic innovation with pharmaceutical industry knowledge, facilitating access to off-patent medications and improving development efficiency.",
            "score": 3,
            "explanation": "The predicted answer captures the concept of academic-pharmaceutical collaboration transforming drug repurposing, aligned with the idea of overcoming intellectual resource challenges. However, it misses the specific mention of \"medicinal repositioning\" and \"marketing exclusivity,\" impacting completeness. Essential trends are covered, though with omissions."
        },
        {
            "query_idx": 1467,
            "query": "How does the metaphoric shield of intellectual property manifest a reduced efficacy in the realm of recycled therapeutics as opposed to the genesis of unique molecular constructs, especially when evaluating the intricacies of legal enforcement burdens and the incapacity to deter non-regulated applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    2266
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #reduced efficacy# of IP protection for recycled therapeutics arises from weaker #use patents#, costly enforcement, and inability to deter off-label use and non-regulated applications.",
            "predicted_answer": "The metaphoric shield of intellectual property is weaker for recycled therapeutics because use patents, which protect new applications, are harder to enforce and do not prevent off-label prescriptions, unlike the stronger protection for unique molecular constructs.",
            "score": 3,
            "explanation": "The predicted answer captures the reduced efficacy of IP protection due to weaker use patents and inability to deter off-label uses, aligning with the reference. However, it omits the aspect of costly enforcement, affecting completeness but not contradicting the overall trend."
        },
        {
            "query_idx": 1468,
            "query": "What could be the potential strategic advantages in the domain of pharmaceutical research, derived from employing advanced analytical methodologies for evaluating drug efficacy and mechanisms on intricate pre-clinical simulacra?",
            "retrieved_metrics": {
                "reference_idx": [
                    2268
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Employing advanced analytical methodologies can enhance #drug efficacy# evaluation and optimize drug combinations, reducing potentially unsuccessful clinical trials and resource waste.",
            "predicted_answer": "Employing advanced analytical methodologies in pharmaceutical research can optimize drug combinations, prevent unnecessary clinical trials, and enhance the screening of drug efficacy and mechanisms on pre-clinical models, saving time and resources.",
            "score": 3,
            "explanation": "The 'Predicted Answer' covers key points on optimizing drug combinations and reducing unnecessary trials, aligned with the 'Reference Answer'. However, it lacks a specific mention of \"enhance drug efficacy evaluation,\" which is emphasized in the 'Reference Answer', affecting completeness."
        }
    ]
}